data_2lla_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lla _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.8 p30 . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.432 ' HA ' HD13 ' A' 1559 ' ' LEU . 62.3 m 57.89 28.85 16.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.331 1.02 . . . . 0.0 112.228 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' 1505 ' ' PHE . 9.5 pt20 -142.2 141.5 32.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.12 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 8.9 p -140.81 138.45 34.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 26.0 m -97.67 127.16 43.42 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.423 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.3 p30 -89.25 143.13 30.51 Favored Pre-proline 0 C--N 1.312 -1.022 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.454 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.05 -13.67 19.2 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.885 2.39 . . . . 0.0 113.752 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -74.34 -58.87 3.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.0 p -109.27 -10.9 14.93 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 75.06 33.38 54.81 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.728 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -103.07 143.29 32.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 46.1 t -102.4 127.35 56.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' 1495 ' ' GLN . 93.7 m-85 -93.99 103.61 15.68 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.98 103.15 15.02 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 34.4 tp -85.94 10.06 15.13 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-O 121.847 0.832 . . . . 0.0 110.045 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.69 -19.45 52.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.09 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 20.8 p -71.16 -14.43 62.27 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.328 0.585 . . . . 0.0 111.469 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.66 -69.6 0.76 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.832 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 58.9 mmtt 61.55 146.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' 1512 ' ' ARG . 4.2 tmm_? -71.84 96.9 1.72 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.69 -42.73 11.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 16.8 p -121.62 -31.54 3.98 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.924 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.26 133.17 7.87 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -77.77 125.21 29.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1517 ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' 1526 ' ' ILE . 13.3 t -129.77 100.93 5.67 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 122.86 1.314 . . . . 0.0 110.697 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1518 ' ' ILE . . . . . 0.485 HG23 ' HG2' ' A' 1602 ' ' PRO . 16.4 pt -93.82 155.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.053 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 32.7 t -98.15 130.73 44.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1520 ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 16.7 t70 -99.73 126.53 45.8 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.25 -24.91 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.577 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1522 ' ' ARG . . . . . 0.409 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.7 mtp-105 -85.61 -43.01 13.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1523 ' ' LYS . . . . . 0.47 ' HB2' ' HZ ' ' A' 1545 ' ' PHE . 31.9 mmmt -113.97 -73.93 0.64 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -169.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 179.49 -152.88 11.44 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 3.9 m -84.03 154.49 23.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.2 0.524 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.0 tt -130.6 118.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -103.26 115.52 30.72 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.14 132.27 54.32 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.173 0.511 . . . . 0.0 110.733 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -99.28 87.41 0.76 Allowed Glycine 0 N--CA 1.422 -2.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.895 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 34.7 m -72.56 128.41 35.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.882 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 47.6 t 66.27 15.6 10.15 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 121.513 0.673 . . . . 0.0 111.389 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . 178.44 113.96 0.39 Allowed Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1533 ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' 1535 ' ' LYS . 0.0 OUTLIER -61.71 160.32 11.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 21.3 m -96.99 122.07 48.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.62 0.724 . . . . 0.0 110.281 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' 1533 ' ' GLU . 3.4 mptp? -74.76 -24.67 58.73 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -53.14 -38.54 62.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.852 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 67.1 m -110.01 13.47 23.33 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.105 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 107.92 120.86 4.54 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.51 134.02 59.57 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.144 2.562 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 106.68 -29.36 11.0 Favored Glycine 0 C--N 1.286 -2.214 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.053 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.16 125.88 39.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.601 ' HA3' ' HE2' ' A' 1570 ' ' TYR . . . -99.69 -46.24 1.98 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.78 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -103.11 118.45 36.82 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 48.8 t -124.8 136.88 54.22 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 35.5 t80 -114.45 138.62 50.36 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.85 86.86 2.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.224 1.011 . . . . 0.0 110.868 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1547 ' ' GLY . . . . . 0.417 ' O ' HG13 ' A' 1550 ' ' ILE . . . -165.67 69.34 0.19 Allowed Glycine 0 C--N 1.289 -2.068 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.328 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.0 m 74.95 -34.77 0.27 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 111.595 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 146.09 50.32 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 79.3 mt -78.86 122.21 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' 1551 ' ' LYS . 9.3 mtmp? -96.92 115.16 26.94 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.28 12.73 36.95 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.974 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.801 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.9 133.83 2.12 Favored Glycine 0 N--CA 1.416 -2.64 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.641 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -81.83 141.55 33.34 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.415 ' HB2' ' HA3' ' A' 1542 ' ' GLY . 54.5 t90 -78.32 124.74 28.44 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.21 148.43 33.52 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . 0.255 24.0 mt-30 -77.91 73.54 4.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -99.34 77.43 2.12 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' 1494 ' ' CYS . 95.5 mt -104.93 97.78 7.6 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 7.8 t -117.46 139.1 51.35 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.782 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 86.1 t80 -106.42 109.19 21.04 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.384 0.611 . . . . 0.0 110.045 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 81.4 t -96.23 158.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.63 101.9 0.03 OUTLIER 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.171 0.989 . . . . 0.0 111.514 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 67.73 16.58 9.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.611 1.564 . . . . 0.0 113.549 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 20.2 t -139.94 119.79 13.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 121.987 -0.445 . . . . 0.0 110.317 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.841 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.8 tp -81.91 129.01 34.63 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -112.95 125.35 54.3 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.268 -0.27 . . . . 0.0 111.337 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1568 ' ' LEU . . . . . 0.577 ' HB3' ' HE1' ' A' 1590 ' ' PHE . 66.2 tp -129.68 114.39 15.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 10.4 p -117.99 129.45 74.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.861 0.838 . . . . 0.0 111.334 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.801 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 81.6 m-85 -95.04 115.17 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.64 177.29 4.69 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 5.3 m-20 56.67 64.04 1.78 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.72 -145.12 18.11 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -90.57 146.63 34.68 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.69 141.83 38.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.003 2.468 . . . . 0.0 110.976 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 75.7 m -99.68 142.21 24.2 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.91 -22.26 73.95 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 123.652 2.901 . . . . 0.0 113.911 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -58.21 -65.14 0.7 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.204 0.602 . . . . 0.0 112.399 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.446 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 5.4 m-20 -120.25 -2.53 10.11 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.877 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.9 mm? 69.45 -53.02 0.6 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.208 1.003 . . . . 0.0 113.419 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -62.71 -28.32 69.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.164 0.586 . . . . 0.0 109.836 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.852 HD11 ' HA ' ' A' 1611 ' ' THR . 64.5 mt -82.32 128.72 34.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.859 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 58.7 mttp -118.09 162.49 18.12 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1584 ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 98.3 m-85 -63.62 116.73 5.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -126.98 140.97 51.92 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1586 ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 25.0 m -120.3 116.81 26.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -115.16 114.68 47.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.609 0.718 . . . . 0.0 109.797 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.36 115.48 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 7.7 t -96.67 106.58 18.88 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.841 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 94.3 m-85 -86.56 111.58 20.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.761 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.7 m -108.66 144.96 16.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.615 ' HA ' ' O ' ' A' 1620 ' ' THR . 3.1 p -76.66 143.44 40.11 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 49.4 tptt -157.66 114.01 2.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 24.4 m -71.82 -21.7 61.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.02 7.82 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 110.508 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.7 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -81.94 -67.59 0.77 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 61.47 -129.68 45.42 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.84 -16.78 54.3 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.593 2.196 . . . . 0.0 112.464 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.1 t -120.74 83.53 2.08 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 122.847 1.308 . . . . 0.0 110.59 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.7 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 18.1 m -77.86 143.02 38.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.402 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 13.9 pt20 -104.8 126.11 32.06 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-O 120.984 0.421 . . . . 0.0 111.878 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.485 ' HG2' HG23 ' A' 1518 ' ' ILE . 5.1 Cg_exo -82.83 160.01 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.327 2.685 . . . . 0.0 111.688 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.6 tp -148.78 130.13 14.71 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.601 HD11 HG22 ' A' 1607 ' ' VAL . 43.9 tp -86.36 115.97 24.22 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.2 -52.4 5.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.818 0.342 . . . . 0.0 110.372 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.8 t -167.25 138.85 3.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.601 HG22 HD11 ' A' 1604 ' ' LEU . 69.5 t -110.58 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.9 t70 -94.03 117.89 30.74 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.334 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.56 -6.21 57.9 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -95.93 -51.48 4.44 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.163 0.983 . . . . 0.0 108.935 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.852 ' HA ' HD11 ' A' 1582 ' ' LEU . 0.2 OUTLIER -95.04 -6.99 40.9 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.208 -1.815 . . . . 0.0 110.443 -171.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1612 ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 80.1 m 57.25 26.4 12.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.8 m -93.37 119.58 32.66 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.59 ' HB3' ' HE2' ' A' 1616 ' ' PHE . 85.5 mt -93.82 114.11 26.29 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.957 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.77 108.95 21.76 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.59 ' HE2' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -121.06 138.52 54.14 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.82 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 39.1 t -102.97 138.15 40.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -126.42 114.43 18.17 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.05 100.95 13.32 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.1 t -135.28 153.01 52.03 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.269 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 10.2 m -77.98 -26.48 48.68 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 48.3 mt -72.1 -5.16 33.34 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.146 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1623 ' ' ALA . . . . . 0.423 ' HB3' HG23 ' A' 1620 ' ' THR . . . -75.6 -31.2 59.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 111.793 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 91.0 m -123.28 162.55 22.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1625 ' ' GLU . . . . . 0.425 ' HG3' ' CZ ' ' A' 1505 ' ' PHE . 2.8 mp0 . . . . . 0 N--CA 1.417 -2.103 0 CA-C-O 121.229 0.538 . . . . 0.0 109.921 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1493 ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' 1557 ' ' GLN . 10.1 p30 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 84.2 m 63.59 21.53 12.77 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.471 1.129 . . . . 0.0 110.393 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.3 pt20 -152.35 141.2 21.06 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.4 p -136.52 134.96 49.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 8.8 m -106.93 121.89 45.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.43 125.25 50.49 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.16 -6.46 18.35 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.408 2.072 . . . . 0.0 113.143 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.26 -65.49 0.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.259 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 62.0 p -92.99 -24.88 18.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.859 0.837 . . . . 0.0 110.028 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 88.58 9.31 69.22 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 60.5 t80 -80.81 127.86 33.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.309 0.576 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.7 p -98.96 116.0 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.4 m-85 -79.28 98.92 6.85 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -95.09 104.51 16.38 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.332 0.586 . . . . 0.0 110.739 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.84 -9.37 59.83 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.541 0.686 . . . . 0.0 109.913 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.486 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 45.8 m-80 -70.25 -12.3 61.5 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 57.9 m -84.74 -16.14 42.66 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 32.2 tp -114.1 -20.5 10.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.755 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.572 ' CB ' ' HB ' ' A' 1530 ' ' VAL . 56.4 pttt -54.69 140.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.716 0.635 . . . . 0.0 112.076 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -127.44 102.64 6.97 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1513 ' ' GLU . . . . . 0.456 ' HG3' ' HA3' ' A' 1532 ' ' GLY . 31.9 tt0 -76.21 -20.47 57.43 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 24.6 m -61.32 -25.11 66.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.084 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 96.06 136.39 8.78 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.75 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' 1527 ' ' ARG . 74.3 m-85 -83.5 118.21 23.62 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 172.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 26.6 m -110.6 104.01 12.66 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.68 150.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.21 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.9 m -79.17 115.29 18.74 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.529 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.86 144.64 56.9 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.855 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.3 tt -74.03 -18.46 17.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.642 1.177 . . . . 0.0 110.94 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -90.25 2.82 55.03 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.848 -0.533 . . . . 0.0 109.583 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.5 tptp 79.14 90.19 0.06 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.939 1.696 . . . . 0.0 110.098 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1524 ' ' GLY . . . . . 0.403 ' HA3' ' HZ ' ' A' 1545 ' ' PHE . . . -176.77 -161.02 24.85 Favored Glycine 0 N--CA 1.412 -2.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.2 t -144.6 139.74 28.3 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 15.0 tt -132.62 139.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' 1516 ' ' TYR . 33.4 ttt180 -127.91 120.33 27.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.3 136.08 54.52 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.921 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.7 158.97 14.08 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' 1511 ' ' LYS . 59.9 t -106.48 115.81 48.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 118.237 1.018 . . . . 0.0 108.31 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 77.9 m 57.58 26.83 13.28 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.951 0.782 . . . . 0.0 112.445 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1532 ' ' GLY . . . . . 0.456 ' HA3' ' HG3' ' A' 1513 ' ' GLU . . . -130.04 142.15 13.37 Favored Glycine 0 N--CA 1.414 -2.769 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.38 126.62 35.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' 1537 ' ' CYS . 27.8 m -94.9 98.95 8.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' 1535 ' ' LYS . 10.0 mptt -67.19 -20.88 65.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.639 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.81 -10.17 59.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.892 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1537 ' ' CYS . . . . . 0.586 ' HB2' HG22 ' A' 1534 ' ' VAL . 73.3 m -116.06 7.63 14.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 115.94 137.27 6.1 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.656 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.33 128.07 19.57 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.351 2.034 . . . . 0.0 110.126 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.62 11.73 61.82 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.426 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.8 mm -112.74 128.5 69.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.66 -22.06 7.92 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.929 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -134.1 127.21 31.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 29.0 p -144.36 154.92 43.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.482 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.403 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 44.4 t80 -84.92 134.91 34.25 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -86.2 97.66 10.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 160.41 -91.74 0.11 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.7 p -71.2 -21.15 62.18 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 90.85 18.6 46.89 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.792 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 22.8 pt -74.14 131.4 35.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.248 0.547 . . . . 0.0 110.004 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 19.8 pttm -84.17 142.52 30.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.38 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -113.21 11.56 18.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.921 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.28 135.94 2.18 Favored Glycine 0 N--CA 1.433 -1.509 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.755 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1554 ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' 1572 ' ' ASP . 29.3 mtpp -75.37 150.89 38.28 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.157 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.77 125.98 26.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.322 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.11 158.39 43.87 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1557 ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' A' 1493 ' ' ASN . 3.4 pt20 -124.16 33.53 5.26 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.927 0.87 . . . . 0.0 109.622 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.88 95.73 7.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.482 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.31 110.9 23.37 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 15.9 p -89.48 119.19 29.71 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.264 0.554 . . . . 0.0 111.359 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1561 ' ' TYR . . . . . 0.646 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 16.0 t80 -92.93 101.17 13.52 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 94.3 t -106.89 104.89 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.739 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.32 63.32 1.91 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.214 1.406 . . . . 0.0 111.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1564 ' ' GLN . . . . . 0.646 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 64.5 mt-30 66.12 11.62 7.95 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 113.908 -1.496 . . . . 0.0 114.197 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 93.4 t -116.87 139.2 44.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.829 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.6 113.64 22.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -109.02 114.68 28.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.898 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.79 110.81 17.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.53 121.61 66.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.859 0.837 . . . . 0.0 111.703 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.921 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.3 m-85 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.167 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.433 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 36.9 mt-10 -101.02 174.31 6.07 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' 1554 ' ' LYS . 9.8 t70 53.97 73.26 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.738 1.615 . . . . 0.0 111.5 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -96.25 -140.09 10.89 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 0.2 OUTLIER -87.37 138.94 31.9 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 1575 ' ' PRO . . . . . 0.66 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 14.9 Cg_exo -68.38 135.39 33.79 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.854 2.369 . . . . 0.0 112.975 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 62.7 m -98.76 131.02 26.49 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.823 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.1 2.54 2.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.414 2.742 . . . . 0.0 115.542 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -72.88 -50.45 23.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.965 0.412 . . . . 0.0 110.172 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.877 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 17.3 m120 -132.43 -0.1 3.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.45 -47.12 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.39 -5.81 48.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.146 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.877 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 61.5 mt -89.05 126.54 35.48 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.66 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 98.1 mttt -133.24 159.04 41.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -61.51 113.24 2.57 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.986 0.804 . . . . 0.0 108.86 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.433 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.6 mtpt -124.51 136.16 53.77 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.8 m -120.0 116.12 25.11 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 6.1 p -110.34 109.76 29.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.927 0.87 . . . . 0.0 109.67 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.85 111.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.036 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 67.1 m -92.3 112.01 23.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 94.9 m-85 -86.53 103.1 14.73 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' 1619 ' ' HIS . 29.7 m -105.84 161.49 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.194 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.7 t -76.88 136.89 38.88 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.601 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 23.3 tptm -149.99 105.23 3.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 77.0 p -62.36 -37.78 87.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.256 0.55 . . . . 0.0 110.281 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.64 76.3 3.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.531 0.682 . . . . 0.0 110.213 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -128.09 -64.38 0.96 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.837 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 66.91 -133.6 31.74 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 -20.1 35.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.405 2.07 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.9 p -102.49 73.22 1.3 Allowed 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.66 0.743 . . . . 0.0 111.034 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.514 ' HB3' ' HB ' ' A' 1620 ' ' THR . 42.1 m -86.03 105.56 16.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 24.4 mt-30 -77.01 126.14 85.91 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -171.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.1 Cg_endo -83.99 111.37 1.65 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 123.398 2.732 . . . . 0.0 110.702 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' 1617 ' ' SER . 62.0 tp -88.68 123.53 33.22 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.04 91.72 5.52 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.25 -59.13 3.44 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.865 -175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 46.4 m -158.91 132.4 7.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 65.2 t -106.75 111.04 33.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.15 102.47 14.51 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.97 -20.2 60.43 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.438 -170.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.57 -45.52 12.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.962 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.794 ' HA ' HD12 ' A' 1582 ' ' LEU . 68.4 p -85.72 -16.35 39.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.504 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.6 m 71.1 26.64 3.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 110.413 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 9.7 m -93.11 116.7 29.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.825 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 80.2 mt -99.09 116.91 32.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -100.82 117.33 34.69 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -120.68 133.42 55.35 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.866 0.466 . . . . 0.0 110.216 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 19.5 m -107.21 103.77 13.23 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -95.46 107.05 19.18 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.601 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 26.2 m80 -83.37 104.18 13.32 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' 1600 ' ' SER . 10.2 t -131.99 150.42 52.16 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.449 0.642 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.7 p -77.13 -22.15 53.07 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.28 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 44.6 tp -71.42 -7.09 45.05 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.434 0.635 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.72 -4.19 26.89 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.226 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.9 m -87.07 176.61 7.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 . . . . . 0 N--CA 1.437 -1.091 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 72.3 m 64.55 40.32 6.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.853 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.4 pt20 -136.63 152.03 49.98 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 13.8 p -157.87 139.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.6 m -97.59 132.94 42.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.435 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 8.2 p30 -99.23 126.77 36.75 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.06 -10.69 29.67 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.786 2.324 . . . . 0.0 113.828 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -61.58 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 27.2 p -96.46 -26.55 15.26 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.135 0.493 . . . . 0.0 111.653 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 89.81 11.57 63.47 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1503 ' ' TYR . . . . . 0.403 ' HB3' HD22 ' A' 1498 ' ' ASN . 87.7 t80 -83.92 136.91 33.91 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 114.954 -0.623 . . . . 0.0 109.914 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' 1497 ' ' THR . 49.0 t -99.54 114.18 36.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' 1495 ' ' GLN . 98.5 m-85 -77.12 98.66 5.12 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.11 108.05 19.63 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1507 ' ' LEU . . . . . 0.55 HD11 HD21 ' A' 1510 ' ' LEU . 15.7 tp -86.22 4.24 39.55 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.673 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.591 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 51.2 m-80 -70.92 -18.66 62.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 47.4 t -80.18 -10.83 59.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.55 HD21 HD11 ' A' 1507 ' ' LEU . 69.0 tp -116.6 -25.61 7.33 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.95 -0.469 . . . . 0.0 111.469 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' 1530 ' ' VAL . 19.2 pttp -56.49 142.33 39.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.647 0.737 . . . . 0.0 112.571 -174.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -128.76 106.07 8.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1513 ' ' GLU . . . . . 0.41 ' HA ' ' HA3' ' A' 1532 ' ' GLY . 32.4 tt0 -65.01 -34.11 77.66 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.634 0.773 . . . . 0.0 110.799 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 20.4 m -72.95 -11.69 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.429 0.633 . . . . 0.0 110.341 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.656 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 78.33 161.66 18.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 114.587 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -97.98 128.74 44.73 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 25.2 m -100.53 98.2 8.82 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1518 ' ' ILE . . . . . 0.406 HG13 HG22 ' A' 1526 ' ' ILE . 18.1 pt -109.04 111.14 34.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.822 0.82 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1519 ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.7 t -95.67 112.38 24.11 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.686 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -100.62 120.68 40.41 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.4 -10.16 11.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.521 0.677 . . . . 0.0 112.384 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -92.99 -39.01 11.35 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 121.956 -0.465 . . . . 0.0 110.713 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1523 ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' 1523 ' ' LYS . 71.8 mmtt -109.23 -34.9 6.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 136.99 177.74 15.27 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1525 ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' 1519 ' ' SER . 32.5 t -79.85 127.99 32.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.406 HG22 HG13 ' A' 1518 ' ' ILE . 10.7 tt -123.08 122.3 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -108.35 116.05 31.25 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.13 120.29 37.31 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.297 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.656 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -93.52 118.96 5.82 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' 1511 ' ' LYS . 46.0 t -75.45 116.17 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.676 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 68.1 m 59.1 20.43 8.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.216 0.948 . . . . 0.0 112.047 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1532 ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' 1513 ' ' GLU . . . -135.86 132.8 6.3 Favored Glycine 0 N--CA 1.401 -3.685 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1533 ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' 1535 ' ' LYS . 21.6 mt-10 -76.39 130.02 37.44 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 15.4 m -80.1 93.1 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.52 0.676 . . . . 0.0 110.901 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' 1533 ' ' GLU . 0.0 OUTLIER -59.3 -26.45 64.99 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.49 -178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.17 -37.3 66.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.176 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 43.3 t -107.19 -25.37 11.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.948 0.404 . . . . 0.0 110.133 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 143.17 144.92 4.34 Favored Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.3 152.2 81.09 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.547 2.165 . . . . 0.0 110.795 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.5 -27.35 6.43 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.807 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.0 mm -89.59 136.09 24.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.04 -37.12 2.58 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.294 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -125.84 128.07 47.06 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 44.2 t -139.59 139.86 36.9 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.686 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.411 ' HZ ' HD13 ' A' 1614 ' ' LEU . 98.2 m-85 -87.02 124.29 33.04 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1546 ' ' GLU . . . . . 0.556 ' HB2' ' HB3' ' A' 1525 ' ' SER . 47.4 mt-10 -82.05 107.99 15.19 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.738 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 172.39 -71.65 0.1 Allowed Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.3 m -106.9 -24.82 11.91 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.572 0.701 . . . . 0.0 109.397 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 103.7 34.33 3.85 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.02 131.03 35.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.433 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 25.8 pttm -93.22 138.65 31.41 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.95 8.06 43.26 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 140.74 149.48 5.28 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.876 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.31 155.72 17.36 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.385 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.676 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 39.0 t90 -71.49 143.61 49.95 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.2 152.74 38.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -106.07 9.88 32.29 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.59 107.12 19.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.063 0.458 . . . . 0.0 110.651 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 74.6 mt -88.59 125.8 34.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.863 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.8 m -90.24 121.84 32.62 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.2 t80 -98.89 116.12 30.4 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 122.23 -0.294 . . . . 0.0 110.416 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.4 t -121.24 80.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 38.7 t70 40.45 83.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.154 1.781 . . . . 0.0 114.518 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 64.05 19.24 11.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.498 1.119 . . . . 0.0 112.849 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 58.6 t -133.9 119.89 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.42 133.87 37.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.943 0.401 . . . . 0.0 110.302 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.863 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -110.83 114.7 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.573 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 34.1 tp -116.45 107.35 14.66 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.559 HG23 HG22 ' A' 1587 ' ' VAL . 17.1 t -105.99 108.55 25.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.095 -174.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.602 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 61.3 m-85 -82.08 107.16 14.56 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' A' 1585 ' ' LYS . 37.5 mt-10 -106.5 178.33 4.59 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.585 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.586 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 24.4 t70 56.73 67.06 1.04 Allowed 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.87 1.356 . . . . 0.0 111.241 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1573 ' ' GLY . . . . . 0.433 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -93.25 -155.25 31.81 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 173.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -82.57 158.17 66.22 Favored Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 117.605 0.703 . . . . 0.0 109.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.63 140.08 35.28 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.272 1.981 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 83.5 m -101.33 133.92 20.61 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.196 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.09 7.8 1.0 Allowed 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.31 2.673 . . . . 0.0 113.633 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.33 -52.96 6.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.13 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.524 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 2.4 m-20 -131.83 -2.36 3.71 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.802 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 31.9 tp 71.47 -47.82 0.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.908 1.283 . . . . 0.0 113.032 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -73.33 -12.81 60.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.451 0.643 . . . . 0.0 110.277 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.876 HD13 ' HA ' ' A' 1611 ' ' THR . 89.4 mt -85.58 127.62 34.51 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.042 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 44.5 mttm -112.54 152.92 28.27 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.494 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -60.07 123.62 17.7 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.725 0.64 . . . . 0.0 109.87 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' 1571 ' ' GLU . 62.8 mttt -131.69 131.4 43.06 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.6 t -120.86 116.66 25.6 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.559 HG22 HG23 ' A' 1569 ' ' VAL . 3.3 p -108.12 101.32 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.966 0.889 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.72 114.11 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.3 m -95.93 109.63 21.97 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.731 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.658 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.4 m-85 -86.18 108.1 18.18 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 m -103.87 166.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 13.0 t -75.96 120.39 21.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 123.988 0.915 . . . . 0.0 112.91 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.72 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 48.1 tptt -152.55 99.47 2.47 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.3 m -65.82 -30.81 71.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1595 ' ' ASP . . . . . 0.72 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 10.3 t70 -85.57 67.76 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -143.54 -56.44 0.39 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.718 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 79.09 -160.92 46.84 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.63 -20.14 35.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 110.869 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -92.31 53.97 2.23 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.923 0.868 . . . . 0.0 109.102 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.1 m -62.3 140.66 58.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.015 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -106.32 124.61 35.24 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 52.8 Cg_endo -87.92 133.88 3.07 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.167 2.578 . . . . 0.0 112.515 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.1 tp -118.92 134.93 54.85 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.412 HD13 HG23 ' A' 1607 ' ' VAL . 45.1 tp -72.76 118.86 16.21 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.34 -43.37 12.93 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1606 ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' 1615 ' ' PHE . 21.6 t -179.9 146.98 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.412 HG23 HD13 ' A' 1604 ' ' LEU . 95.9 t -123.09 121.14 62.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1608 ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' 1610 ' ' HIS . 32.5 t70 -115.2 103.09 10.5 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.742 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.4 8.28 7.93 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.049 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1610 ' ' HIS . . . . . 0.432 ' HB2' ' OD2' ' A' 1608 ' ' ASP . 51.7 m80 -88.81 -51.48 5.62 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.876 ' HA ' HD13 ' A' 1582 ' ' LEU . 1.6 m -98.84 -6.17 29.63 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.526 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 76.6 m 62.1 30.74 17.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.257 1.023 . . . . 0.0 111.198 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 14.5 m -97.3 116.7 30.0 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.41 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.589 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 84.7 mt -96.93 120.2 36.83 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.31 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1615 ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' 1606 ' ' SER . 72.7 m-85 -105.21 112.22 25.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.589 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.1 m-85 -122.41 135.39 54.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 42.1 p -113.05 110.89 21.22 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' 1602 ' ' PRO . 1.5 t-105 -97.24 115.91 28.49 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 48.6 m80 -83.59 99.43 10.17 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -128.74 151.12 49.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.881 0.848 . . . . 0.0 111.485 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.9 m -76.88 -27.69 55.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.434 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.44 -5.95 40.22 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.277 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.59 -1.44 35.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.594 0.711 . . . . 0.0 110.345 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 12.3 t -113.77 170.32 8.34 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.442 -0.841 0 O-C-N 123.869 0.731 . . . . 0.0 110.022 178.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1493 ' ' ASN . . . . . 0.531 ' HB2' ' OE1' ' A' 1557 ' ' GLN . 3.6 p-10 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.439 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 64.9 m 73.27 0.09 3.55 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.053 0.93 . . . . 0.0 112.113 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.407 ' HB3' ' OD1' ' A' 1506 ' ' ASP . 21.1 pt20 -128.91 147.39 50.83 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.9 p -132.48 118.25 34.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 122.112 0.958 . . . . 0.0 110.868 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.762 HG21 HG21 ' A' 1504 ' ' VAL . 6.0 m -96.37 101.51 13.16 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.19 122.17 49.38 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.36 -8.02 19.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.215 2.61 . . . . 0.0 112.53 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.95 -56.61 17.4 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.758 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1501 ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' 1503 ' ' TYR . 57.7 p -101.01 -28.39 12.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 85.46 10.77 76.44 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.45 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1503 ' ' TYR . . . . . 0.416 ' CD2' ' HB ' ' A' 1501 ' ' THR . 56.6 m-85 -99.54 131.6 45.43 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.762 HG21 HG21 ' A' 1497 ' ' THR . 28.3 t -90.48 99.23 9.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -83.32 105.71 14.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1506 ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' 1495 ' ' GLN . 24.3 t70 -105.26 112.03 25.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.228 0.537 . . . . 0.0 111.862 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.9 tp -85.27 -4.49 59.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.035 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.689 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 62.6 m-80 -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 69.6 m -77.3 -10.03 59.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.111 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.442 ' HB2' HD11 ' A' 1622 ' ' LEU . 26.2 tp -109.92 8.05 24.11 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.434 0.635 . . . . 0.0 109.493 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 53.5 mtmt -58.54 143.7 45.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.646 ' H ' ' HB ' ' A' 1530 ' ' VAL . 32.2 tpt180 -127.25 97.9 5.09 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -25.38 60.27 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.522 0.514 . . . . 0.0 110.711 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 45.5 t -67.6 -26.31 66.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 88.14 153.82 26.66 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -89.8 114.78 26.56 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 6.5 p -103.56 92.34 4.42 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.03 0.919 . . . . 0.0 109.8 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.5 pt -120.55 153.44 23.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.742 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1519 ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' 1524 ' ' GLY . 15.5 p -103.95 118.27 36.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.79 174.69 1.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.515 0.509 . . . . 0.0 111.009 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.2 tp -61.85 -24.26 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.74 -5.82 58.48 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 73.73 74.44 0.13 Allowed 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.918 1.687 . . . . 0.0 112.454 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1524 ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' 1519 ' ' SER . . . -151.37 139.16 6.98 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 174.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 47.6 m -87.78 129.2 35.26 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.898 0.849 . . . . 0.0 111.673 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.4 tt -122.0 142.1 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -118.24 116.74 27.4 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.546 0.738 . . . . 0.0 109.076 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.61 125.92 43.92 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.86 129.74 10.0 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.449 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.646 ' HB ' ' H ' ' A' 1512 ' ' ARG . 47.5 t -79.52 115.22 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.514 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.669 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 69.9 m 46.25 66.91 0.85 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 125.141 1.526 . . . . 0.0 113.461 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -171.25 175.17 44.92 Favored Glycine 0 N--CA 1.404 -3.459 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.78 134.89 48.54 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.7 m -88.9 97.13 6.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.739 0.78 . . . . 0.0 110.689 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -22.54 54.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.941 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.22 -26.44 66.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.653 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 61.5 m -102.91 0.2 32.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.32 150.63 18.26 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.58 145.79 87.89 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.404 2.069 . . . . 0.0 112.48 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1540 ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' 1555 ' ' TRP . . . 82.41 14.73 75.67 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 114.81 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.33 131.62 63.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 118.082 0.941 . . . . 0.0 109.221 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.49 -28.31 7.18 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.901 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.796 0.332 . . . . 0.0 111.147 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 69.0 m -142.59 149.24 38.74 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.477 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 56.1 t80 -94.88 118.81 32.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.75 110.02 4.7 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.17 0.918 . . . . 0.0 112.488 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 144.82 -80.04 0.23 Allowed Glycine 0 C--N 1.296 -1.677 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.032 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 20.1 m -72.38 -19.77 61.56 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.321 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 79.29 41.78 13.06 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.621 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' 1545 ' ' PHE . 20.9 pt -93.46 131.01 41.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 56.4 mttm -85.44 129.2 34.87 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.552 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -98.86 7.73 45.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.055 0.455 . . . . 0.0 111.172 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.62 146.02 4.31 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.985 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 50.6 tttm -69.32 145.46 52.99 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.028 0.931 . . . . 0.0 109.588 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.66 ' CZ3' ' HA ' ' A' 1531 ' ' CYS . 7.0 t-105 -66.24 109.67 2.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.75 161.23 41.06 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1557 ' ' GLN . . . . . 0.531 ' OE1' ' HB2' ' A' 1493 ' ' ASN . 51.2 mt-30 -120.6 67.83 0.85 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.033 0.92 . . . . 0.0 108.849 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.4 tptt -96.86 95.38 7.82 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.776 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 4.2 mm? -104.7 104.85 14.73 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.111 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.3 m -100.07 139.46 35.71 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 89.3 t80 -113.98 117.8 32.33 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.479 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1562 ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 67.6 t -103.43 153.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.28 100.79 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 123.901 0.881 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 68.47 19.06 8.89 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.959 1.704 . . . . 0.0 112.33 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1565 ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 49.0 t -134.07 119.57 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.7 tp -87.37 140.18 29.79 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.804 ' HB2' ' HB2' ' A' 1560 ' ' SER . 23.9 mm-40 -124.65 115.25 20.48 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.722 -0.611 . . . . 0.0 111.097 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 63.0 tp -109.9 120.31 42.08 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.477 HG22 HG21 ' A' 1587 ' ' VAL . 32.5 t -117.35 131.45 70.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.132 0.491 . . . . 0.0 110.461 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.717 ' HB2' ' HB2' ' A' 1586 ' ' SER . 63.5 m-85 -103.1 105.8 16.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.65 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.442 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.91 92.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.934 1.396 . . . . 0.0 112.179 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.33 -158.07 12.9 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.507 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.83 151.57 52.54 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.99 147.59 3.38 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.529 2.819 . . . . 0.0 114.766 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1576 ' ' CYS . . . . . 0.664 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 17.2 t -98.22 130.25 28.85 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.139 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.76 -27.48 84.88 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.142 2.562 . . . . 0.0 113.911 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.31 33.9 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.477 HD21 HD11 ' A' 1582 ' ' LEU . 92.8 m-20 -126.5 8.31 7.05 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.86 -62.54 0.34 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.785 1.234 . . . . 0.0 114.078 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.27 4.51 8.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' 1576 ' ' CYS . 92.5 mt -90.36 154.54 19.61 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' 1585 ' ' LYS . 94.1 mttt -123.86 154.09 40.15 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1584 ' ' TYR . . . . . 0.422 ' HE2' ' HB ' ' A' 1550 ' ' ILE . 27.1 m-85 -62.73 116.82 5.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' 1583 ' ' LYS . 28.9 mtpp -115.05 133.82 55.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1586 ' ' SER . . . . . 0.717 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 37.5 m -120.01 122.36 40.96 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.212 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.477 HG21 HG22 ' A' 1569 ' ' VAL . 6.6 p -126.75 111.27 25.42 Favored 'Isoleucine or valine' 0 C--O 1.25 1.096 0 CA-C-O 121.975 0.893 . . . . 0.0 110.725 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.0 110.88 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.746 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1589 ' ' SER . . . . . 0.49 ' HA ' ' NE2' ' A' 1567 ' ' GLN . 29.5 m -88.53 111.18 21.55 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.727 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.5 m-85 -86.97 106.64 17.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.0 m -98.53 153.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1620 ' ' THR . 48.7 t -86.96 133.85 33.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.16 0.981 . . . . 0.0 113.166 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 55.0 tptt -147.33 105.38 3.74 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.1 t -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.601 0.715 . . . . 0.0 110.645 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.29 -3.17 57.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.717 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.877 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -83.98 -42.81 15.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.5 -156.41 51.0 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.976 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.06 -4.1 14.69 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.441 2.761 . . . . 0.0 113.098 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 17.8 p -90.54 -49.69 6.36 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 49.5 m 69.34 145.77 0.05 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.379 1.072 . . . . 0.0 113.144 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.844 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 97.8 mt-30 -87.84 121.88 70.54 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.338 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.0 Cg_endo -88.43 118.67 1.07 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.466 2.777 . . . . 0.0 111.661 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 63.5 tp -130.8 124.69 31.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.224 0.535 . . . . 0.0 109.974 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.67 HD23 HG23 ' A' 1607 ' ' VAL . 62.6 tp -87.16 126.73 34.98 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 58.4 tp -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 60.4 p -178.35 142.67 0.26 Allowed 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.015 0.822 . . . . 0.0 109.943 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.67 HG23 HD23 ' A' 1604 ' ' LEU . 61.9 t -94.37 117.47 38.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.69 113.15 26.31 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.324 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.95 -2.0 45.96 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 45.9 m80 -82.33 -41.2 20.37 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.382 0.61 . . . . 0.0 110.677 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.555 ' HA ' HD12 ' A' 1582 ' ' LEU . 33.8 p -121.58 -9.81 8.89 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 75.5 m 65.68 35.07 7.18 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.149 0.976 . . . . 0.0 111.397 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -96.48 122.92 39.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.096 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.535 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 88.7 mt -91.27 112.81 24.88 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -98.41 115.6 28.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.086 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.535 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 86.9 m-85 -123.41 140.21 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 40.0 m -120.67 103.69 9.33 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -95.51 122.01 37.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.844 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 46.9 m-70 -90.73 102.98 15.74 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.4 t -127.48 153.89 45.76 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.046 0.45 . . . . 0.0 110.447 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.2 m -79.59 -25.28 41.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' 1510 ' ' LEU . 33.4 mt -70.7 -4.75 25.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.708 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.45 -23.44 40.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.625 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 60.3 m -79.31 159.68 27.1 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.6 p-10 . . . . . 0 N--CA 1.434 -1.229 0 CA-C-O 121.086 0.469 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.424 ' HB2' ' OD1' ' A' 1508 ' ' ASN . 82.9 m 55.1 25.06 6.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' 1505 ' ' PHE . 25.0 pt20 -132.91 119.15 19.8 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 124.89 71.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.376 0.608 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 9.1 m -88.71 109.7 20.36 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.32 138.4 45.16 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.246 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.2 -2.75 12.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.686 2.257 . . . . 0.0 113.572 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -82.33 -63.89 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.813 0.34 . . . . 0.0 110.618 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1501 ' ' THR . . . . . 0.467 HG23 ' HG2' ' A' 1625 ' ' GLU . 24.6 p -98.13 -20.17 17.48 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.4 3.35 81.72 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.87 133.62 43.17 Favored 'General case' 0 C--O 1.254 1.325 0 C-N-CA 123.074 0.55 . . . . 0.0 109.842 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 65.4 t -95.33 111.75 26.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' 1495 ' ' GLN . 82.8 m-85 -85.04 103.03 13.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.2 108.06 19.4 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.48 -8.75 59.61 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.494 ' HA ' ' HD3' ' A' 1511 ' ' LYS . 90.2 m-20 -59.79 -24.02 63.77 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.62 1.968 . . . . 0.0 112.789 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 6.9 p -86.36 -11.0 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.04 0.448 . . . . 0.0 111.531 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 49.1 tp -116.0 -22.33 9.05 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 122.207 -0.308 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' 1531 ' ' CYS . 22.2 pttp -46.79 131.38 11.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.035 0.921 . . . . 0.0 113.472 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -126.93 101.11 6.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.293 -172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1513 ' ' GLU . . . . . 0.428 ' CD ' ' HZ1' ' A' 1535 ' ' LYS . 28.6 tt0 -65.54 -37.75 87.62 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.91 0.756 . . . . 0.0 110.967 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 41.3 m -63.49 -18.42 63.78 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.395 0.617 . . . . 0.0 110.447 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 86.11 149.14 12.65 Favored Glycine 0 N--CA 1.415 -2.74 0 CA-C-N 115.278 -0.874 . . . . 0.0 114.635 173.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -80.83 114.35 19.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 20.0 m -99.45 98.84 9.7 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 27.4 pt -115.84 145.7 21.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.511 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 35.8 t -111.03 130.5 55.58 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.287 0.565 . . . . 0.0 109.912 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.44 153.86 42.94 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.97 -22.76 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.373 0.606 . . . . 0.0 111.62 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -79.51 3.75 17.78 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.43 0.692 . . . . 0.0 111.042 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 56.9 tptt 73.52 87.18 0.1 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.75 1.62 . . . . 0.0 110.442 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -169.11 117.2 0.7 Allowed Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 50.4 m -81.62 120.79 25.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 120.785 0.326 . . . . 0.0 110.815 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.792 ' HB ' ' HD1' ' A' 1545 ' ' PHE . 14.6 tt -114.41 128.24 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.5 ttm180 -116.95 115.5 25.59 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.2 mp -114.78 114.93 26.23 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.303 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -83.55 111.16 3.38 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' 1511 ' ' LYS . 7.2 p -85.97 116.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.981 -0.717 . . . . 0.0 109.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.54 ' HB2' ' HB2' ' A' 1511 ' ' LYS . 85.7 m 64.94 15.63 10.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.421 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.91 140.21 8.99 Favored Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -76.81 146.88 37.53 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.6 p -89.19 99.32 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 122.291 1.043 . . . . 0.0 110.959 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.428 ' HZ1' ' CD ' ' A' 1513 ' ' GLU . 0.3 OUTLIER -65.48 -19.36 65.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.187 -174.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.57 -36.5 78.66 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.899 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 78.0 m -106.96 -24.29 12.06 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 129.63 152.61 7.61 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.482 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.25 146.86 95.79 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.981 2.454 . . . . 0.0 110.815 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 97.41 -14.61 63.23 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.866 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.98 136.15 51.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.39 -47.12 0.82 Allowed Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.99 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -108.28 125.9 52.21 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 43.9 t -141.98 139.12 32.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.792 ' HD1' ' HB ' ' A' 1526 ' ' ILE . 57.4 t80 -108.72 121.58 45.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.24 -30.96 71.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -66.2 112.91 5.29 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.4 m 72.93 1.31 3.98 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.029 0.932 . . . . 0.0 110.629 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 58.59 41.9 95.83 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.441 HG13 ' HB3' ' A' 1545 ' ' PHE . 27.5 pt -90.82 142.05 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.769 0.795 . . . . 0.0 112.238 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 84.7 mttt -82.08 137.74 34.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.756 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -120.41 15.39 12.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.189 0.519 . . . . 0.0 110.202 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.882 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 157.79 128.51 1.03 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.96 -1.114 . . . . 0.0 114.221 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.9 tttp -72.75 139.53 47.19 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 125.248 1.419 . . . . 0.0 107.319 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 55.5 t90 -72.78 134.43 44.94 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.88 159.57 35.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.39 88.69 2.83 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1558 ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 40.2 mmtm -131.21 90.81 2.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.35 111.05 23.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 17.6 m -116.16 127.82 55.13 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.4 101.1 13.31 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -138.38 150.15 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.7 t70 65.68 15.2 9.94 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.803 0.811 . . . . 0.0 108.979 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 70.08 12.71 7.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.058 1.743 . . . . 0.0 110.682 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 63.0 t -117.53 151.91 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.851 0.86 . . . . 0.0 109.865 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.784 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.1 mp -86.28 124.34 32.55 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.134 -0.354 . . . . 0.0 110.588 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.981 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.4 tp -128.55 118.01 22.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' 1571 ' ' GLU . 10.5 p -126.39 117.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 112.983 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.882 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 54.4 m-85 -92.13 102.34 14.87 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.893 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.571 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 44.6 mt-10 -107.67 166.58 10.57 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 20.6 t70 68.94 71.0 0.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.274 1.035 . . . . 0.0 111.734 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.0 -137.16 9.68 Favored Glycine 0 N--CA 1.421 -2.333 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.45 153.96 65.62 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.21 151.03 84.52 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.081 1.854 . . . . 0.0 110.587 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 72.7 m -97.3 137.87 21.18 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.8 -25.94 78.31 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.547 2.832 . . . . 0.0 113.449 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.11 -67.25 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.57 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.9 m120 -109.53 -3.68 16.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.1 mm? 67.98 -53.11 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.702 1.201 . . . . 0.0 113.336 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -61.8 -18.21 59.07 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.372 1.469 . . . . 0.0 111.82 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 81.0 mt -82.93 141.66 32.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -116.17 146.94 41.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.88 118.97 9.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 86.9 mttt -130.16 137.62 50.21 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1586 ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 14.5 m -119.84 116.28 25.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -108.36 114.92 47.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.972 0.892 . . . . 0.0 110.408 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.61 122.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.443 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 19.6 m -109.16 114.77 28.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 91.7 m-85 -86.79 109.61 19.38 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -102.4 159.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 35.6 t -76.28 130.24 37.86 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.19 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.581 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 47.3 tptt -159.82 106.59 1.65 Allowed 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 19.8 m -72.04 -25.96 62.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1595 ' ' ASP . . . . . 0.581 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 34.4 t70 -81.54 19.81 0.98 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.564 1.146 . . . . 0.0 110.68 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -95.03 -39.39 10.19 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.691 -0.631 . . . . 0.0 110.508 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 71.57 -162.53 54.3 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.871 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.7 -14.69 33.31 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.228 2.619 . . . . 0.0 112.12 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.1 p -81.94 -50.9 8.62 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.734 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 49.3 m 65.54 108.87 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.025 0.828 . . . . 0.0 111.198 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.483 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 48.4 mt-30 -74.27 124.85 90.24 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.716 -172.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 11.7 Cg_endo -92.97 108.02 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 123.329 2.686 . . . . 0.0 111.251 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.21 116.23 28.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.758 HD23 HG22 ' A' 1607 ' ' VAL . 5.4 tt -77.8 108.3 10.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 63.5 tp -74.92 -54.58 6.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.987 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 23.1 t -169.4 151.19 4.42 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.758 HG22 HD23 ' A' 1604 ' ' LEU . 83.9 t -117.92 110.75 31.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.18 104.57 16.61 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.399 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.44 5.38 17.82 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.445 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 56.1 m80 -88.63 -44.23 10.76 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.529 ' HA ' HD12 ' A' 1582 ' ' LEU . 0.7 OUTLIER -112.05 -0.08 15.79 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.6 -176.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 60.3 m 63.01 30.64 16.32 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.185 0.994 . . . . 0.0 111.235 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -99.05 118.56 36.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.726 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.606 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 78.6 mt -97.26 119.29 35.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -102.75 115.44 30.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.606 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 69.4 m-85 -125.74 126.72 45.05 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.01 0.433 . . . . 0.0 110.263 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 20.2 m -106.07 112.66 25.8 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -97.17 119.03 34.92 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.453 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 64.6 m-70 -89.8 112.87 24.32 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 14.9 t -139.46 152.18 46.8 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.18 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 6.9 m -74.89 -23.7 58.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' A' 1505 ' ' PHE . 41.7 mt -72.6 -5.55 38.05 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.347 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.09 16.87 25.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.327 0.584 . . . . 0.0 110.404 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 59.0 m -113.15 151.26 31.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.062 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1625 ' ' GLU . . . . . 0.467 ' HG2' HG23 ' A' 1501 ' ' THR . 5.4 mp0 . . . . . 0 C--N 1.316 -0.862 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.245 0.867 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 15.0 t 69.03 26.34 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.626 1.203 . . . . 0.0 109.503 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -156.13 151.17 26.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -114.02 132.33 63.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.807 HG23 HG22 ' A' 1504 ' ' VAL . 63.3 m -141.72 105.75 4.77 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.1 p30 -98.34 129.34 30.76 Favored Pre-proline 0 N--CA 1.435 -1.218 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.754 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.05 -11.78 31.1 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.425 2.083 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -55.72 10.7 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.586 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 38.9 p -118.98 -6.28 10.5 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 77.11 34.38 41.91 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1503 ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' 1497 ' ' THR . 41.0 t80 -83.57 109.61 17.55 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.807 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -128.01 107.6 16.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 O-C-N 123.748 0.655 . . . . 0.0 109.477 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.661 ' HZ ' ' HA ' ' A' 1625 ' ' GLU . 8.3 m-85 -120.87 106.49 11.7 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -91.89 108.8 20.18 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.366 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1507 ' ' LEU . . . . . 0.515 HD13 HD23 ' A' 1510 ' ' LEU . 18.5 tp -89.27 -5.87 57.25 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.964 0.888 . . . . 0.0 109.321 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.447 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 53.1 m-80 -62.21 -26.8 68.56 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.8 t -74.29 -10.67 59.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.515 HD23 HD13 ' A' 1507 ' ' LEU . 35.8 tp -111.87 6.85 19.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.301 0.572 . . . . 0.0 110.451 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.744 ' HA ' ' HB ' ' A' 1530 ' ' VAL . 35.1 mtmm -57.29 153.8 11.58 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.627 ' HD2' ' H ' ' A' 1530 ' ' VAL . 0.0 OUTLIER -84.0 176.76 8.62 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.116 -174.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -51.75 5.32 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 35.1 t -128.16 -38.39 1.8 Allowed 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.595 ' HA2' ' HG3' ' A' 1512 ' ' ARG . . . 158.2 161.68 11.18 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.07 129.04 48.29 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 19.9 m -99.09 99.64 10.68 Favored 'General case' 0 N--CA 1.425 -1.711 0 O-C-N 123.788 0.68 . . . . 0.0 109.196 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.1 pt -119.58 155.84 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 8.1 t -107.59 141.17 39.48 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.22 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.36 170.05 16.86 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.842 1.257 . . . . 0.0 107.874 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.48 -23.91 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.899 0.857 . . . . 0.0 110.032 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -84.45 1.16 46.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.876 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 74.41 10.66 4.2 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 126.013 1.725 . . . . 0.0 114.459 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -71.83 123.57 9.88 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 41.5 m -81.79 124.14 29.4 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.76 132.99 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 CA-C-O 121.315 0.578 . . . . 0.0 109.566 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -107.24 116.35 31.78 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.39 140.77 52.64 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.273 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -106.62 151.17 16.92 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.744 ' HB ' ' HA ' ' A' 1511 ' ' LYS . 24.5 t -92.22 115.02 30.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 31.4 m 55.98 24.55 7.81 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.677 1.236 . . . . 0.0 111.88 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -139.06 169.82 24.31 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -99.15 131.25 45.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' 1537 ' ' CYS . 14.3 m -88.06 93.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.508 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -50.6 -38.27 44.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.653 -173.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.78 -19.67 65.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1537 ' ' CYS . . . . . 0.599 ' HB2' HG23 ' A' 1534 ' ' VAL . 64.6 m -109.73 9.43 24.88 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.476 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.74 155.11 10.98 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.093 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 131.43 13.34 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.612 2.208 . . . . 0.0 111.347 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1540 ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' 1554 ' ' LYS . . . 79.93 19.55 69.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.553 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1541 ' ' ILE . . . . . 0.467 ' CD1' ' HD3' ' A' 1551 ' ' LYS . 45.1 mm -114.19 137.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -114.83 -18.04 6.62 Favored Glycine 0 C--N 1.32 -0.306 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.563 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.26 133.95 30.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 19.2 p -149.11 152.43 36.14 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.509 0.188 . . . . 0.0 111.509 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -94.46 118.53 31.78 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.17 110.48 13.19 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.454 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.6 -71.26 0.27 Allowed Glycine 0 C--N 1.282 -2.449 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 3.0 m -87.85 -20.4 26.09 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.91 44.53 11.96 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.75 150.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.467 ' HD3' ' CD1' ' A' 1541 ' ' ILE . 49.9 mttm -90.92 134.46 34.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.09 17.12 11.64 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.425 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 160.32 126.6 0.84 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.886 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1554 ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' 1540 ' ' GLY . 32.6 ttmt -84.08 147.19 27.51 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.784 0.834 . . . . 0.0 109.997 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 64.3 t90 -64.86 129.25 39.04 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 123.775 0.672 . . . . 0.0 109.673 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.99 156.99 6.36 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -124.21 65.58 1.06 Allowed 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.913 0.863 . . . . 0.0 109.553 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -94.59 92.98 7.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.424 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.88 115.12 27.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 11.7 m -112.9 124.92 53.71 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.422 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.9 t80 -88.62 101.79 14.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 59.5 t -117.4 102.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.945 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.3 68.68 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.673 1.589 . . . . 0.0 112.739 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.57 9.77 6.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.051 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.5 t -125.78 135.44 63.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 O-C-N 121.948 -0.47 . . . . 0.0 110.018 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.11 118.27 25.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.86 118.21 36.31 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.08 119.63 37.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.453 HG22 HG23 ' A' 1587 ' ' VAL . 26.3 t -114.12 115.11 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.993 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.475 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 66.4 m-85 -96.82 92.33 6.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' 1585 ' ' LYS . 14.8 pt-20 -110.84 176.17 5.14 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.587 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.2 t70 66.8 80.15 0.22 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.921 1.288 . . . . 0.0 111.683 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -122.21 -131.44 3.9 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.81 159.17 63.93 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.62 157.93 16.43 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.226 1.95 . . . . 0.0 113.012 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 84.8 m -98.45 136.86 20.7 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.627 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.82 6.26 3.85 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.518 2.145 . . . . 0.0 113.64 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.52 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.732 0.301 . . . . 0.0 110.556 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.42 -1.13 18.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.913 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.95 -50.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 33.1 m80 -79.86 26.24 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.452 0.701 . . . . 0.0 112.419 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.88 125.54 44.13 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.49 ' O ' ' HD2' ' A' 1585 ' ' LYS . 67.0 mttm -112.28 160.01 18.07 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -64.14 126.54 28.07 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' 1571 ' ' GLU . 1.3 mptp? -111.01 133.2 53.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.0 t -120.25 115.68 24.08 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.453 HG23 HG22 ' A' 1569 ' ' VAL . 7.8 p -112.7 124.73 69.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.607 0.718 . . . . 0.0 110.8 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.05 116.42 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 24.0 m -94.22 110.69 22.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.701 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 90.3 m-85 -88.25 111.07 21.25 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 22.3 m -110.14 155.2 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.778 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 25.4 t -75.08 123.24 24.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.338 0.589 . . . . 0.0 110.603 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 52.9 tptt -146.97 116.72 7.15 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1594 ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' 1596 ' ' ALA . 20.3 m -82.89 -20.41 35.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.294 0.568 . . . . 0.0 109.535 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1595 ' ' ASP . . . . . 0.586 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -79.29 14.19 1.62 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.592 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -94.22 -56.53 2.81 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.234 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.79 -166.39 41.14 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 -16.32 37.47 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.048 2.499 . . . . 0.0 112.561 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 11.5 p -91.74 -35.51 14.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.295 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.887 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 35.0 m 66.12 177.14 0.22 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.911 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.676 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 91.0 mt-30 -114.9 119.35 39.3 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.776 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1602 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -94.18 111.85 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 123.224 2.616 . . . . 0.0 109.597 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 59.3 tp -126.46 126.55 43.96 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.0 tp -74.93 120.31 20.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.85 -53.31 5.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.909 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 48.7 m -164.6 149.39 9.67 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 109.88 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 86.8 t -115.51 119.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.11 106.03 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.218 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.29 2.59 27.43 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.3 -24.21 16.3 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.759 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1611 ' ' THR . . . . . . . . . . . . . 24.5 p -115.39 -3.45 12.43 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.861 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 86.2 m 61.22 28.16 17.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.384 1.074 . . . . 0.0 111.532 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 25.3 m -105.56 124.61 49.84 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.378 0.609 . . . . 0.0 110.154 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.99 125.48 39.68 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.82 118.68 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 135.33 54.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 39.8 t -110.34 119.23 38.56 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -107.39 104.62 14.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.676 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.2 m-70 -83.74 105.83 14.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.6 t -132.26 152.36 51.39 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.532 0.682 . . . . 0.0 111.296 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 15.9 m -80.19 -22.6 41.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.339 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 37.2 tp -71.33 -6.52 40.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.347 0.594 . . . . 0.0 110.621 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.28 5.79 42.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.673 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 71.3 m -88.61 140.89 29.0 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.122 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1625 ' ' GLU . . . . . 0.661 ' HA ' ' HZ ' ' A' 1505 ' ' PHE . 2.3 mp0 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.066 1.746 . . . . 0.0 114.241 -174.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 22.5 t-20 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 43.9 t 71.17 3.95 4.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.794 1.283 . . . . 0.0 109.993 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.7 pt20 -150.56 143.55 24.74 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.4 p -136.05 128.51 45.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 121.216 0.531 . . . . 0.0 109.568 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.41 HG22 HG21 ' A' 1504 ' ' VAL . 23.4 m -92.65 108.21 19.8 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 3.4 p30 -81.52 138.8 47.7 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.799 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.25 4.49 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.612 2.208 . . . . 0.0 113.546 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -88.85 -59.25 2.28 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.924 0.392 . . . . 0.0 110.333 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1501 ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 6.8 p -104.41 -12.51 16.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.74 13.33 83.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.546 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 84.0 t80 -86.17 130.94 34.36 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.41 HG21 HG22 ' A' 1497 ' ' THR . 45.3 t -89.82 108.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.3 m-85 -79.11 105.93 10.79 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1506 ' ' ASP . . . . . 0.439 ' O ' HD11 ' A' 1622 ' ' LEU . 9.3 t70 -94.84 102.63 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 30.9 tp -86.58 2.7 47.29 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.626 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' 1511 ' ' LYS . 28.8 m-80 -71.84 -18.61 62.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.379 0.609 . . . . 0.0 109.84 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 59.0 m -82.18 -19.33 40.09 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.137 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' 1598 ' ' PRO . 0.2 OUTLIER -115.84 10.29 15.27 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' 1530 ' ' VAL . 19.3 pttp -76.17 134.03 40.03 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.574 0.702 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.567 ' H ' HG21 ' A' 1530 ' ' VAL . 1.9 tpm_? -127.81 94.03 3.84 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1513 ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' 1513 ' ' GLU . 0.2 OUTLIER -75.19 -14.93 60.58 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -174.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 13.8 p -78.84 -13.15 59.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 91.17 137.78 7.49 Favored Glycine 0 N--CA 1.424 -2.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.173 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' 1527 ' ' ARG . 83.0 m-85 -82.28 126.68 32.4 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 11.8 p -102.54 90.13 3.75 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 123.73 0.644 . . . . 0.0 109.452 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 19.3 pt -109.29 159.47 8.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.154 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.4 m -83.79 127.16 33.61 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.821 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.48 157.94 19.07 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1521 ' ' ILE . . . . . 0.708 ' HB ' HD21 ' A' 1604 ' ' LEU . 14.7 tt -70.84 -23.54 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.627 0.727 . . . . 0.0 109.432 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -71.65 -0.92 11.97 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.234 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 71.22 83.56 0.14 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.055 1.342 . . . . 0.0 110.6 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 173.85 179.95 44.82 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 14.4 m -110.31 139.67 45.26 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.22 133.7 67.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' 1516 ' ' TYR . 24.5 ttm180 -111.31 112.87 24.95 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.71 120.63 37.15 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.49 125.3 8.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' 1511 ' ' LYS . 17.0 m -96.19 117.73 41.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.515 ' HA ' ' CH2' ' A' 1555 ' ' TRP . 74.6 m 72.57 10.49 5.66 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.172 0.989 . . . . 0.0 112.776 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -145.8 142.65 10.82 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.77 140.53 30.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.7 m -76.67 97.23 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 122.829 1.3 . . . . 0.0 109.543 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.71 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -61.19 -21.2 63.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.867 -174.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.43 -19.01 36.73 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.787 0.327 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1537 ' ' CYS . . . . . 0.632 ' HB2' HG23 ' A' 1534 ' ' VAL . 76.2 m -105.76 4.95 30.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 110.03 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.47 145.96 13.18 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.188 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.46 129.18 23.14 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.9 2.4 . . . . 0.0 111.843 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 103.7 -5.79 47.87 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.552 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.8 mm -93.48 128.24 45.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.609 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -91.63 -40.64 5.28 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.85 134.92 33.96 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1544 ' ' CYS . . . . . 0.511 ' SG ' HG22 ' A' 1534 ' ' VAL . 26.7 p -141.53 150.48 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 81.8 t80 -96.16 130.19 43.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.5 107.54 8.84 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 123.835 0.709 . . . . 0.0 109.765 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.79 -89.19 0.12 Allowed Glycine 0 C--N 1.283 -2.399 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.3 m -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.945 0.403 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 86.35 27.23 30.95 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 26.1 pt -82.96 141.53 14.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 22.9 pttm -94.51 138.58 32.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.96 12.0 37.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.73 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.874 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.49 147.52 4.68 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.443 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -82.69 150.79 26.56 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.699 0.399 . . . . 0.0 110.134 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.515 ' CH2' ' HA ' ' A' 1531 ' ' CYS . 30.0 t-105 -69.05 123.87 22.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.38 174.44 15.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.97 44.09 1.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1558 ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' 1568 ' ' LEU . 32.2 mmtp -81.81 77.25 8.66 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.357 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.58 98.42 7.05 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 16.8 m -111.97 139.99 47.02 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 93.2 t80 -97.35 103.26 15.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 17.6 m -130.75 113.09 23.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.879 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.9 t70 59.5 44.08 15.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 110.439 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 62.7 17.22 9.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.348 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.9 t -110.49 126.14 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.93 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.3 tp -90.0 115.77 27.54 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -102.2 120.17 40.01 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.29 -0.256 . . . . 0.0 111.034 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1568 ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' 1558 ' ' LYS . 26.6 tp -106.31 109.08 20.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.428 HG22 HG23 ' A' 1587 ' ' VAL . 21.9 t -109.67 119.3 58.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.099 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.874 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 53.7 m-85 -94.61 115.9 28.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.44 161.2 16.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.053 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 12.0 t70 56.94 71.96 0.54 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.341 1.856 . . . . 0.0 113.499 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -90.84 -136.21 6.63 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -96.26 144.92 28.67 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1575 ' ' PRO . . . . . 0.819 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 36.9 Cg_endo -67.89 141.84 55.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.225 1.95 . . . . 0.0 112.427 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 74.9 m -98.37 141.41 22.9 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.31 -12.52 35.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.658 2.905 . . . . 0.0 114.846 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -70.33 -61.95 1.58 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.1 m120 -119.97 -4.93 10.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.3 mm? 70.42 -48.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.202 1.001 . . . . 0.0 113.374 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 26.3 m80 -76.17 -4.54 42.25 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.959 0.409 . . . . 0.0 111.97 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.727 HD11 ' HA ' ' A' 1611 ' ' THR . 61.9 mt -101.06 120.13 39.75 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.819 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.6 mttt -118.41 163.23 17.05 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -52.63 110.64 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 36.2 tptt -116.93 130.96 57.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 9.3 t -127.0 118.97 25.55 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.581 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.428 HG23 HG22 ' A' 1569 ' ' VAL . 6.7 p -118.26 111.33 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.836 0.827 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.32 108.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 49.0 m -88.54 109.56 20.17 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.547 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.93 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.9 m-85 -85.92 104.57 15.69 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.3 m -101.52 163.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' 1620 ' ' THR . 46.2 t -97.23 144.65 26.83 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.399 -172.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.513 ' HG2' ' OE1' ' A' 1601 ' ' GLN . 17.6 tppt? -150.47 115.38 5.3 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 5.3 p -61.52 -41.51 97.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.19 25.64 1.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -97.1 -63.3 1.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.052 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 75.84 -156.01 47.16 Favored Glycine 0 C--O 1.25 1.104 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1598 ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' 1510 ' ' LEU . 41.4 Cg_endo -66.45 -20.95 54.11 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.888 2.392 . . . . 0.0 111.422 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 p -94.44 62.42 2.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.607 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 17.3 m -63.67 149.04 47.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.325 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.618 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 39.7 mt-30 -87.14 128.55 55.15 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.9 Cg_endo -91.36 134.35 1.63 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.977 2.451 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.704 ' HB3' ' HB3' ' A' 1617 ' ' SER . 64.7 tp -131.66 108.03 9.22 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.033 0.445 . . . . 0.0 110.388 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.708 HD21 ' HB ' ' A' 1521 ' ' ILE . 64.3 tp -68.15 116.4 8.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 39.1 tp -98.15 -63.36 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.016 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 34.8 m -150.33 137.49 19.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 81.0 t -131.61 119.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.03 126.75 52.91 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.514 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -80.91 -10.21 59.74 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.95 -52.17 6.92 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.343 0.592 . . . . 0.0 109.513 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.727 ' HA ' HD11 ' A' 1582 ' ' LEU . 46.0 p -92.41 -19.64 21.85 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 63.6 m 66.89 23.34 9.97 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.415 1.086 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -81.18 120.99 25.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.159 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.663 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 90.1 mt -102.39 115.94 31.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.299 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.32 114.77 29.22 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.663 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.0 m-85 -122.02 135.91 54.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.441 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.704 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 37.4 t -107.86 114.92 29.21 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -109.2 118.29 36.33 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.618 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 38.9 m-70 -98.58 101.33 12.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.2 t -129.27 152.95 48.28 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.395 0.617 . . . . 0.0 110.982 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.7 m -75.77 -25.68 56.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.317 0.58 . . . . 0.0 109.706 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' 1622 ' ' LEU . 6.8 tt -64.04 -16.8 62.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.673 0.789 . . . . 0.0 110.284 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.36 59.71 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 35.0 m -94.53 140.99 29.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.012 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1625 ' ' GLU . . . . . 0.503 ' HG2' ' OG1' ' A' 1501 ' ' THR . 3.5 mp0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 75.94 22.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.672 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.7 pt20 -153.27 118.66 5.22 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.644 -1.162 . . . . 0.0 107.999 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -121.83 130.36 74.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.262 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 3.8 m -103.84 106.05 16.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 6.7 p30 -91.67 134.09 29.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.62 -175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1499 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 6.6 Cg_exo -67.02 -25.36 44.33 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.893 2.395 . . . . 0.0 113.057 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -56.06 -61.81 2.13 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.014 0.435 . . . . 0.0 111.894 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 21.6 p -96.43 -15.18 21.91 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 69.33 41.23 79.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -128.85 136.42 50.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 120.827 0.346 . . . . 0.0 110.252 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 118.17 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.897 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.9 m-85 -87.18 106.72 18.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -86.39 99.02 11.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.2 tp -84.94 4.49 33.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 122.739 1.257 . . . . 0.0 108.791 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.509 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 62.9 m-20 -58.87 -28.6 66.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.478 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.1 t -79.33 -11.56 59.93 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.049 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.588 ' HB2' HD13 ' A' 1622 ' ' LEU . 20.0 tp -111.73 1.56 16.74 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.687 -0.633 . . . . 0.0 110.602 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.513 ' HE2' ' SG ' ' A' 1531 ' ' CYS . 100.0 mttt -50.21 160.48 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.549 ' HG3' ' CA ' ' A' 1515 ' ' GLY . 9.2 ttp180 -68.49 105.21 2.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.147 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -91.03 -44.68 9.16 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 167.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.3 t -121.96 -35.22 3.21 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.314 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.549 ' CA ' ' HG3' ' A' 1512 ' ' ARG . . . 103.19 162.68 25.55 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.31 121.03 44.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.0 m -117.57 99.18 6.8 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 20.1 pt -101.43 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.506 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1519 ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' 1525 ' ' SER . 24.1 t -93.64 114.68 27.05 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.663 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1520 ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 13.7 t70 -89.3 113.96 25.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.83 -18.83 20.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.727 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1522 ' ' ARG . . . . . 0.472 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.1 mtp180 -76.3 -47.32 24.08 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.73 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.83 -59.3 1.36 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.862 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -175.43 -165.44 31.54 Favored Glycine 0 C--O 1.215 -1.056 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.279 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1525 ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' 1519 ' ' SER . 20.3 m -91.18 154.14 19.53 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 117.385 0.593 . . . . 0.0 111.167 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.459 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.0 tt -134.55 132.59 54.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -111.78 116.59 30.95 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.71 137.07 50.1 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.71 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -107.39 100.0 1.48 Allowed Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 7.1 p -76.64 116.69 20.2 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.513 ' SG ' ' HE2' ' A' 1511 ' ' LYS . 46.8 t 70.3 3.69 4.55 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.601 0.715 . . . . 0.0 111.418 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -132.16 149.1 19.34 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1533 ' ' GLU . . . . . 0.607 ' HB2' ' HD2' ' A' 1535 ' ' LYS . 38.5 mt-10 -88.16 131.84 34.56 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 11.3 m -87.95 81.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.311 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.607 ' HD2' ' HB2' ' A' 1533 ' ' GLU . 0.0 OUTLIER -67.6 -13.56 62.18 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.958 0.885 . . . . 0.0 110.7 -175.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.96 -32.96 70.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.45 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 51.8 t -108.01 3.67 24.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.398 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 124.22 150.52 7.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.699 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.66 149.31 38.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.402 2.068 . . . . 0.0 111.171 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.13 14.25 80.61 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.927 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1541 ' ' ILE . . . . . 0.416 HD11 ' HD3' ' A' 1551 ' ' LYS . 44.7 mm -112.86 135.17 53.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -102.28 -35.03 4.01 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.184 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.58 141.23 39.22 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.993 -0.71 . . . . 0.0 110.676 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1544 ' ' CYS . . . . . 0.408 ' SG ' HG23 ' A' 1541 ' ' ILE . 57.2 m -141.75 146.79 36.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.674 ' HB3' HG13 ' A' 1550 ' ' ILE . 35.2 t80 -97.6 134.78 40.35 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.37 100.86 9.47 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.351 0.596 . . . . 0.0 109.841 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -162.98 -108.35 0.22 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.5 m -84.9 -5.94 59.34 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 101.03 46.49 1.73 Allowed Glycine 0 CA--C 1.491 -1.41 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.674 HG13 ' HB3' ' A' 1545 ' ' PHE . 14.0 pt -83.7 132.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.048 0.451 . . . . 0.0 109.991 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' 1541 ' ' ILE . 58.6 mttp -87.42 138.06 31.81 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.542 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -104.88 11.68 33.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.434 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.17 146.86 4.58 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.338 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1554 ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' 1572 ' ' ASP . 1.9 mptm? -77.86 147.31 35.2 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 66.0 t90 -69.77 128.84 37.82 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -158.18 158.52 34.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -104.58 88.4 2.93 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.721 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.8 tptt -130.36 83.69 2.14 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.166 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.39 125.29 40.78 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 7.9 m -121.58 139.82 53.03 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.046 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.3 t80 -106.66 110.06 22.14 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 65.9 t -116.04 92.66 2.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 34.05 88.23 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.359 1.864 . . . . 0.0 115.018 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 67.12 9.34 6.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.506 1.123 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 48.0 t -132.29 136.17 56.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.912 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.5 tp -96.58 136.86 36.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.683 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -120.33 127.05 51.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.844 -0.535 . . . . 0.0 110.771 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.7 tp -124.71 124.48 42.24 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.628 HG21 HG22 ' A' 1587 ' ' VAL . 19.6 t -120.47 122.82 69.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.26 0.552 . . . . 0.0 112.051 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.699 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 59.8 m-85 -101.51 113.43 26.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.3 161.14 17.59 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.762 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' 1554 ' ' LYS . 35.7 t70 60.2 83.19 0.14 Allowed 'General case' 0 C--O 1.209 -1.033 0 O-C-N 124.657 1.223 . . . . 0.0 113.173 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.83 2.31 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -124.23 150.25 63.15 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.21 136.7 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.623 2.216 . . . . 0.0 111.662 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1576 ' ' CYS . . . . . 0.419 ' C ' ' H ' ' A' 1578 ' ' ALA . 64.5 m -99.65 132.6 22.8 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.43 16.13 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.67 2.913 . . . . 0.0 113.949 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1578 ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -79.41 -49.36 12.48 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.568 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 16.7 m120 -146.85 8.65 0.98 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 29.5 tp 68.93 -47.1 0.57 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.51 1.524 . . . . 0.0 113.98 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 36.3 m80 -75.34 -11.07 59.98 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.552 0.692 . . . . 0.0 110.045 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.688 HD23 HG21 ' A' 1611 ' ' THR . 57.8 mt -85.39 128.15 34.62 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.04 162.55 30.5 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.74 112.2 3.59 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -126.14 134.8 51.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.1 t -126.92 125.46 41.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.628 HG22 HG21 ' A' 1569 ' ' VAL . 6.5 p -119.85 117.86 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.693 0.758 . . . . 0.0 109.307 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.77 116.37 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 8.4 t -96.17 104.96 16.95 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.912 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.3 m-85 -87.05 111.5 20.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 34.5 m -105.08 159.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 42.6 t -77.54 128.82 34.81 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 112.501 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.445 ' HB3' ' HB1' ' A' 1596 ' ' ALA . 58.4 tptt -145.69 109.18 4.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.8 m -71.57 -28.14 63.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.143 0.496 . . . . 0.0 112.199 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.16 30.22 6.1 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.567 0.698 . . . . 0.0 111.15 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' 1593 ' ' LYS . . . -84.74 -52.38 6.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.787 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 78.13 -159.49 47.22 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.71 -20.77 26.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.848 2.365 . . . . 0.0 111.708 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.2 t -96.81 58.55 1.65 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 123.031 1.396 . . . . 0.0 108.847 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 12.7 m -63.42 130.42 44.35 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.726 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.7 mt-30 -81.6 125.89 77.28 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -89.61 105.87 0.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.456 2.77 . . . . 0.0 110.873 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 62.9 tp -91.98 130.25 37.77 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.93 127.01 31.7 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1605 ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' 1617 ' ' SER . 99.3 mt -88.36 -58.32 2.6 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 44.6 m -164.62 147.26 8.66 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 108.989 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 64.6 t -107.91 111.71 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -98.59 91.66 5.25 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -70.04 -33.06 71.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.382 -1.735 . . . . 0.0 115.226 -165.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 51.4 t60 -70.68 -36.9 73.55 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.539 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.688 HG21 HD23 ' A' 1582 ' ' LEU . 0.0 OUTLIER -98.21 0.55 46.04 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.769 -176.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.9 m 55.27 31.1 15.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.565 0.746 . . . . 0.0 111.735 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 29.5 m -99.45 126.86 45.44 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.336 0.589 . . . . 0.0 110.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.567 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 87.0 mt -108.65 118.98 38.2 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.345 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.87 117.97 35.41 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.567 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 79.1 m-85 -128.14 135.95 50.47 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.616 0.366 . . . . 0.0 110.663 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.573 ' HB2' HD23 ' A' 1605 ' ' LEU . 22.7 t -106.68 110.94 23.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -98.25 111.89 24.07 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 17.0 m170 -81.4 98.36 8.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 12.1 t -129.4 153.09 48.24 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.611 0.72 . . . . 0.0 112.012 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 23.5 m -77.88 -21.45 51.26 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.71 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.588 HD13 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.8 -5.63 35.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.901 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.91 1.68 40.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.479 0.657 . . . . 0.0 109.48 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -103.18 162.31 13.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.837 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 173.471 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' 1508 ' ' ASN . 6.5 t 61.69 23.03 13.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.687 1.195 . . . . 0.0 110.967 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -149.37 155.01 39.8 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -155.39 136.1 4.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 10.7 m -99.55 131.86 45.27 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -83.22 118.83 72.8 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.121 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.82 -16.46 44.45 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.991 2.46 . . . . 0.0 114.516 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -76.7 -62.89 1.48 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.542 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.5 p -97.16 -16.86 20.24 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 84.03 24.32 48.99 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.793 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -92.26 132.11 36.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.203 0.501 . . . . 0.0 109.88 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 25.6 t -101.13 106.8 20.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -81.38 104.15 11.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.76 93.08 7.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.646 0.736 . . . . 0.0 110.203 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 36.1 tp -84.69 -8.38 58.88 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' 1494 ' ' CYS . 59.6 t30 -65.99 -27.96 68.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.502 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 8.5 t -84.76 -11.86 54.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 -36.66 9.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' 1530 ' ' VAL . 2.2 pptp? -44.3 127.84 5.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -98.08 107.98 20.58 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.423 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -69.36 -34.63 74.87 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.74 0.65 . . . . 0.0 111.649 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 64.2 m -65.14 -17.4 64.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.247 0.546 . . . . 0.0 110.646 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.401 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 83.18 143.83 5.3 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.279 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -77.09 114.28 15.73 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1517 ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' 1526 ' ' ILE . 7.8 m -107.93 96.88 6.69 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1518 ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' 1525 ' ' SER . 27.6 pt -102.79 134.23 44.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.73 -175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.2 m -89.15 92.61 9.26 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.73 123.2 40.35 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.579 0.704 . . . . 0.0 111.509 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.25 -16.07 20.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.595 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1522 ' ' ARG . . . . . 0.499 ' HD2' HD23 ' A' 1604 ' ' LEU . 69.1 mtt180 -94.17 -26.38 16.71 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.227 -0.921 . . . . 0.0 112.283 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 52.4 tptt -129.36 -59.27 1.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.854 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 166.21 -166.74 38.96 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.526 -0.845 . . . . 0.0 110.999 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1525 ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' 1518 ' ' ILE . 20.2 m -94.4 112.27 24.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.323 0.582 . . . . 0.0 109.458 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' 1545 ' ' PHE . 10.8 tt -120.94 140.48 44.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.436 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -110.84 115.28 29.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.64 119.84 36.2 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.401 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -91.72 127.96 9.14 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.552 ' O ' ' HB2' ' A' 1511 ' ' LYS . 21.7 t -81.04 116.39 25.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' 1530 ' ' VAL . 60.7 m 70.67 -24.46 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 172.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -105.07 140.83 15.17 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.69 142.61 44.43 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 120.7 0.286 . . . . 0.0 110.353 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 17.5 m -78.16 81.79 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.428 1.109 . . . . 0.0 109.075 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.556 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.38 -12.01 3.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.716 1.607 . . . . 0.0 112.941 -173.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 -29.17 35.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.664 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.0 t -93.66 -3.95 51.51 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 122.129 0.966 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 132.5 158.36 8.88 Favored Glycine 0 N--CA 1.422 -2.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.2 135.68 32.43 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 123.18 2.587 . . . . 0.0 111.351 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 76.48 9.74 85.91 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.871 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1541 ' ' ILE . . . . . 0.575 HD13 ' HG2' ' A' 1551 ' ' LYS . 46.5 mm -93.04 133.32 34.61 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -103.58 -48.5 1.19 Allowed Glycine 0 C--N 1.323 -0.155 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.525 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.05 129.39 54.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 53.5 t -148.06 138.65 22.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.627 0.251 . . . . 0.0 110.467 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' 1526 ' ' ILE . 96.6 m-85 -78.57 127.45 32.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.48 103.43 6.48 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 123.728 0.643 . . . . 0.0 109.862 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.68 -76.26 0.22 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1548 ' ' THR . . . . . 0.502 ' HB ' HG13 ' A' 1550 ' ' ILE . 16.7 m -81.25 -23.59 37.92 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.072 0.463 . . . . 0.0 110.637 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.57 37.38 10.7 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.385 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' 1548 ' ' THR . 62.9 mt -84.77 129.33 37.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.575 ' HG2' HD13 ' A' 1541 ' ' ILE . 11.2 mptt -92.32 133.41 35.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1552 ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' 1584 ' ' TYR . . . -111.42 16.16 20.94 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.349 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.797 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.73 138.19 2.81 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.835 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.63 142.81 27.98 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 124.954 1.302 . . . . 0.0 109.188 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 68.5 t90 -64.16 140.2 58.84 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.887 0.875 . . . . 0.0 110.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -162.26 -179.96 7.43 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -130.95 31.64 4.44 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 118.195 0.452 . . . . 0.0 112.074 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1558 ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' 1560 ' ' SER . 48.8 tptt -84.15 81.79 8.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.834 0.826 . . . . 0.0 109.921 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' 1568 ' ' LEU . 0.5 OUTLIER -93.2 98.18 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.3 t -89.62 158.7 17.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.15 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -130.29 104.77 7.47 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 96.3 t -115.07 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 36.5 t70 49.95 74.55 0.2 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.843 1.257 . . . . 0.0 112.365 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 67.91 -9.73 0.45 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.829 1.252 . . . . 0.0 113.654 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 85.6 t -107.17 132.19 55.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.775 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 9.4 mp -81.86 141.3 33.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' 1560 ' ' SER . 26.8 mm-40 -131.56 114.86 15.37 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1568 ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' 1559 ' ' LEU . 64.0 tp -123.04 136.08 54.69 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 8.9 p -135.45 135.42 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-O 121.373 0.606 . . . . 0.0 110.413 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.797 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 70.8 m-85 -105.53 104.6 14.36 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -102.71 163.44 12.22 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 30.4 t70 64.95 79.29 0.26 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 124.282 1.033 . . . . 0.0 112.027 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.83 -106.35 2.95 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.86 160.05 35.05 Favored Pre-proline 0 C--N 1.281 -2.399 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.42 151.52 48.05 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.054 1.836 . . . . 0.0 110.969 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 78.2 m -103.13 126.96 30.86 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.369 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.18 -23.82 63.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.86 3.04 . . . . 0.0 113.681 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -63.6 -65.35 0.69 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.593 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 22.7 t-20 -111.72 -14.72 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.377 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.43 -45.08 0.61 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.116 0.966 . . . . 0.0 113.132 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1581 ' ' HIS . . . . . 0.408 ' HB2' ' OD1' ' A' 1579 ' ' ASN . 56.3 m80 -68.05 -19.32 64.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.721 0.772 . . . . 0.0 110.036 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.954 HD11 ' HA ' ' A' 1611 ' ' THR . 41.6 mt -95.08 140.96 29.29 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.642 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 62.0 mttm -132.42 161.41 33.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1584 ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' 1552 ' ' ALA . 97.3 m-85 -65.34 116.53 6.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' 1613 ' ' THR . 21.5 mtpp -129.74 130.38 45.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1586 ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' 1570 ' ' TYR . 12.3 p -120.82 120.43 35.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 120.724 0.297 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -116.1 119.54 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.97 108.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 11.8 p -86.01 114.85 23.22 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.617 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.827 ' HD1' ' HE3' ' A' 1618 ' ' TRP . 53.9 m-85 -93.98 109.17 20.92 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.3 m -108.91 168.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' 1624 ' ' CYS . 38.0 t -75.96 117.51 17.76 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.771 0.828 . . . . 0.0 111.084 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.759 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 56.7 tptt -146.13 88.06 1.78 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1594 ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' 1621 ' ' SER . 17.9 m -73.84 -13.35 60.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.621 0.724 . . . . 0.0 110.263 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1595 ' ' ASP . . . . . 0.759 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 29.9 t70 -80.96 -7.36 59.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -93.03 -64.39 1.1 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 72.63 -123.99 9.29 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.37 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.04 -16.57 49.7 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.741 2.961 . . . . 0.0 113.741 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.9 p -83.01 -66.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.463 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' 1620 ' ' THR . 51.3 m 61.05 97.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.322 1.014 . . . . 0.0 110.463 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 14.5 mm100 -101.61 131.61 22.74 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.072 -171.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.9 Cg_endo -86.03 112.76 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.431 2.754 . . . . 0.0 111.345 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.01 125.5 47.63 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.499 HD23 ' HD2' ' A' 1522 ' ' ARG . 47.6 tp -78.79 116.22 18.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.116 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.74 -51.37 8.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.074 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.5 t -164.08 135.68 4.65 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.475 HG21 HD22 ' A' 1604 ' ' LEU . 93.4 t -102.51 111.26 31.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.9 t70 -104.24 99.52 9.24 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.798 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.59 8.62 9.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -82.24 -51.58 7.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.954 ' HA ' HD11 ' A' 1582 ' ' LEU . 0.7 OUTLIER -103.23 -4.04 24.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.816 -173.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.7 m 62.53 31.19 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 110.376 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1613 ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' 1585 ' ' LYS . 23.6 m -103.72 125.56 50.28 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.921 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.59 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 85.7 mt -98.72 119.93 38.29 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.064 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.53 109.93 22.01 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.59 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.2 m-85 -121.29 134.72 55.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.1 t -108.73 107.28 17.66 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.827 ' HE3' ' HD1' ' A' 1590 ' ' PHE . 18.4 t90 -93.99 106.69 18.65 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.454 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 72.4 m-70 -83.32 103.6 12.84 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.733 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' 1600 ' ' SER . 9.8 t -139.21 153.83 47.93 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.359 0.599 . . . . 0.0 109.996 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1621 ' ' SER . . . . . 0.569 ' HB3' ' HA ' ' A' 1594 ' ' SER . 0.8 OUTLIER -76.86 -24.88 52.63 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.357 177.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.94 -8.64 54.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 122.203 1.002 . . . . 0.0 109.145 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -109.8 12.42 24.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.73 0.776 . . . . 0.0 110.173 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1624 ' ' CYS . . . . . 0.468 ' HB2' ' HA ' ' A' 1592 ' ' CYS . 33.8 t -110.7 164.9 12.29 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.734 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1493 ' ' ASN . . . . . 0.618 ' HB2' ' HG2' ' A' 1495 ' ' GLN . 31.5 m-80 . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.838 ' HB3' ' HB3' ' A' 1507 ' ' LEU . 72.4 m 71.16 22.95 4.25 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.111 0.964 . . . . 0.0 110.026 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.618 ' HG2' ' HB2' ' A' 1493 ' ' ASN . 10.4 pt20 -128.17 128.18 44.33 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 9.5 p -131.08 132.45 63.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.776 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 19.9 m -93.64 129.52 39.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 11.5 p30 -89.1 136.16 30.72 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.852 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1499 ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 1.8 Cg_endo -82.14 -12.5 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.998 1.798 . . . . 0.0 110.8 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.49 76.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.679 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.7 p -126.23 -30.18 2.93 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 111.12 11.7 17.66 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.254 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 66.1 t80 -84.84 136.63 33.58 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.358 -0.495 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 64.7 t -99.91 119.3 47.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' 1495 ' ' GLN . 88.2 m-85 -87.61 104.45 16.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.76 101.02 12.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.791 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1507 ' ' LEU . . . . . 0.838 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 18.3 tp -83.31 -10.04 58.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.791 1.281 . . . . 0.0 107.975 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.481 ' O ' ' HG3' ' A' 1511 ' ' LYS . 6.9 p30 -67.05 -14.87 63.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.213 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.7 m -89.42 -6.44 56.55 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.578 ' HB2' HD11 ' A' 1622 ' ' LEU . 34.2 tp -114.65 9.35 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' 1508 ' ' ASN . 48.7 mttp -43.34 148.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.506 ' HB2' ' HA2' ' A' 1515 ' ' GLY . 0.1 OUTLIER -68.22 147.85 51.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.66 -173.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.21 -66.14 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 42.9 t -116.89 -19.98 9.62 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 167.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' 1512 ' ' ARG . . . 137.16 143.42 4.58 Favored Glycine 0 N--CA 1.414 -2.829 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' 1527 ' ' ARG . 41.7 m-85 -69.02 113.72 6.65 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.2 m -113.01 90.94 3.48 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.76 152.88 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.475 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 41.4 m -92.62 137.13 32.63 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.88 175.48 7.27 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1521 ' ' ILE . . . . . 0.411 HG21 ' HG3' ' A' 1522 ' ' ARG . 15.2 tt -58.0 -25.49 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 CA-C-O 121.189 0.519 . . . . 0.0 111.95 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1522 ' ' ARG . . . . . 0.411 ' HG3' HG21 ' A' 1521 ' ' ILE . 68.0 mtp180 -92.45 3.15 56.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.113 0.482 . . . . 0.0 111.135 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 77.83 25.49 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.687 1.595 . . . . 0.0 114.492 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -91.7 125.47 8.06 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 69.7 m -79.02 122.25 25.96 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 120.949 0.404 . . . . 0.0 110.282 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.57 136.03 52.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.585 ' HB3' ' SG ' ' A' 1544 ' ' CYS . 50.2 ttm-85 -114.92 123.42 49.09 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.02 134.68 53.39 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.253 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.79 119.08 5.14 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' 1511 ' ' LYS . 27.5 m -96.12 143.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-N 117.036 0.418 . . . . 0.0 109.969 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.588 ' HA ' HE22 ' A' 1557 ' ' GLN . 72.5 m 74.61 -37.75 0.36 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.873 1.269 . . . . 0.0 113.203 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -131.8 150.44 19.55 Favored Glycine 0 N--CA 1.416 -2.642 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.79 155.04 37.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 124.24 0.612 . . . . 0.0 111.531 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -96.92 89.64 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 122.265 1.031 . . . . 0.0 110.219 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -64.85 -20.86 66.63 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.491 -175.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.38 -45.64 80.46 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.021 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 54.0 m -92.78 -15.08 27.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.161 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 148.88 136.88 2.73 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.34 137.4 74.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.853 2.369 . . . . 0.0 112.572 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 85.44 -5.92 81.74 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.705 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.0 mm -91.68 141.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.04 -29.59 3.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.179 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -135.86 120.05 17.77 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1544 ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' 1527 ' ' ARG . 8.1 p -127.95 144.61 51.1 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 111.17 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 78.7 t80 -105.35 125.53 51.08 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.26 57.26 3.53 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.054 0.931 . . . . 0.0 111.246 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1547 ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' 1549 ' ' GLY . . . -164.28 114.13 0.58 Allowed Glycine 0 C--N 1.289 -2.043 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1548 ' ' THR . . . . . 0.434 ' HB ' HG13 ' A' 1550 ' ' ILE . 28.2 m 72.46 -22.23 0.22 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.122 0.969 . . . . 0.0 110.938 -174.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1549 ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' 1547 ' ' GLY . . . 85.49 35.29 12.1 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 72.8 mt -64.33 138.22 23.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 123.934 0.432 . . . . 0.0 109.926 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 10.1 mptt -101.55 120.56 40.5 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -102.44 14.82 30.94 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.165 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 147.6 144.13 3.95 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.348 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 54.0 pttt -96.0 155.14 16.88 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.674 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 42.1 t90 -63.82 134.95 56.17 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.824 0.703 . . . . 0.0 110.164 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -169.86 164.06 9.71 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1557 ' ' GLN . . . . . 0.588 HE22 ' HA ' ' A' 1531 ' ' CYS . 19.2 mm-40 -122.32 83.25 2.08 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 120.933 0.397 . . . . 0.0 110.475 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1558 ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' 1560 ' ' SER . 1.7 tmtp? -107.06 98.94 8.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 111.6 23.41 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.469 ' HB2' ' HE2' ' A' 1558 ' ' LYS . 9.7 t -120.14 119.59 33.73 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.53 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 58.3 t80 -86.31 113.53 22.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.66 84.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 15.4 t70 45.52 81.77 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.016 1.726 . . . . 0.0 113.334 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 68.26 -0.23 2.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.341 1.056 . . . . 0.0 113.434 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.3 t -116.89 128.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 13.4 tp -96.52 122.66 39.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -103.95 119.82 39.74 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.079 -0.388 . . . . 0.0 110.666 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 66.9 tp -116.16 130.18 56.67 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 82.4 t -118.83 129.9 74.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.674 ' HE1' ' HA ' ' A' 1555 ' ' TRP . 38.7 m-85 -121.54 97.26 5.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.04 -178.68 3.56 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.444 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 23.4 t70 61.71 63.7 1.12 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.829 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.82 -121.62 4.67 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.367 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 17.0 m-20 -88.8 145.21 34.39 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1575 ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 16.0 Cg_exo -72.23 142.98 38.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.605 2.203 . . . . 0.0 109.676 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 69.1 m -98.13 134.05 22.46 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.56 8.34 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.136 2.557 . . . . 0.0 113.625 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -80.36 -51.71 8.54 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.569 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.1 m120 -134.2 0.93 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.99 -54.47 0.56 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 44.0 m80 -75.1 -16.33 60.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.882 0.373 . . . . 0.0 110.959 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.817 HD13 ' HA ' ' A' 1611 ' ' THR . 62.0 mt -82.52 123.62 29.35 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.565 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 94.5 mttt -122.78 162.62 21.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -64.1 115.08 4.61 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.54 ' HB3' ' HZ2' ' A' 1585 ' ' LYS . 8.7 mtpm? -128.54 131.87 48.25 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.543 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 20.4 t -120.12 131.27 54.98 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -121.88 120.82 62.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.53 105.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 23.6 m -90.35 110.55 21.63 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.727 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.6 m-85 -86.21 112.47 21.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.7 m -101.13 161.56 3.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' 1624 ' ' CYS . 45.0 t -81.24 137.08 35.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.713 0.768 . . . . 0.0 112.117 -173.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' 1596 ' ' ALA . 25.1 tptp -154.65 98.76 2.1 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 46.8 t -61.41 -28.8 69.52 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.12 0.486 . . . . 0.0 110.358 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.93 81.82 1.55 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.573 1.177 . . . . 0.0 109.054 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' 1593 ' ' LYS . . . -125.96 -29.64 3.06 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.593 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.01 168.46 40.59 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.43 -10.96 30.56 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 123.21 2.607 . . . . 0.0 111.86 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.1 p -90.7 -40.76 11.67 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.847 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 38.2 m 68.27 169.54 0.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.735 1.214 . . . . 0.0 110.955 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 13.2 mm-40 -114.5 120.85 37.13 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.347 -174.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.2 Cg_endo -91.19 101.95 0.24 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 123.117 2.545 . . . . 0.0 111.288 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' 1617 ' ' SER . 63.3 tp -89.75 119.66 30.34 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.17 109.86 16.11 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.18 -63.5 1.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.171 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.9 m -144.51 143.33 30.79 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.903 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 60.7 t -118.93 110.88 31.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.29 108.71 20.3 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.139 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -80.4 -0.1 35.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -100.8 -48.24 4.54 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.423 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.817 ' HA ' HD13 ' A' 1582 ' ' LEU . 58.0 p -95.42 -7.0 39.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.43 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.4 m 64.63 25.88 13.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.765 0.826 . . . . 0.0 111.476 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 57.8 m -93.59 127.03 39.07 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 121.352 0.596 . . . . 0.0 109.918 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 69.8 mt -102.51 127.77 49.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.786 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -110.63 114.75 28.38 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.37 135.35 54.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.299 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 15.2 m -108.71 103.52 12.62 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -94.03 107.84 19.72 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.47 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 76.4 m-70 -78.79 99.92 6.91 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 13.2 t -134.08 153.05 52.06 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 110.264 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.7 m -73.17 -29.07 62.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.448 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' 1510 ' ' LEU . 62.5 mt -74.42 -4.58 37.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -82.81 -25.7 32.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.336 0.589 . . . . 0.0 111.722 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1624 ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' 1592 ' ' CYS . 14.4 p -117.52 177.98 4.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.432 -1.347 0 CA-C-O 122.23 1.014 . . . . 0.0 110.157 177.706 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 64.4 m-80 . . . . . 0 CA--C 1.481 -1.676 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 6.6 t 62.11 30.92 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.274 1.035 . . . . 0.0 110.965 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' 1505 ' ' PHE . 24.8 pt20 -152.61 145.7 24.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.061 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.3 p -145.5 134.99 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.693 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 22.7 m -92.03 125.66 36.8 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' 1503 ' ' TYR . 9.5 p30 -86.39 147.25 43.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.091 -0.643 . . . . 0.0 109.859 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.45 2.71 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.574 2.183 . . . . 0.0 113.894 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -92.88 -57.77 2.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.203 0.525 . . . . 0.0 111.297 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 35.0 p -105.99 -17.7 14.26 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.945 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 80.66 19.23 68.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.842 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1503 ' ' TYR . . . . . 0.514 ' HB3' ' ND2' ' A' 1498 ' ' ASN . 53.3 t80 -79.45 133.62 36.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 48.6 t -99.83 110.11 26.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' 1495 ' ' GLN . 96.2 m-85 -80.86 106.77 13.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -97.97 102.77 14.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.299 0.571 . . . . 0.0 112.048 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.04 -4.88 56.0 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.341 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.72 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 52.3 m-80 -62.6 -29.9 70.94 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 25.3 t -71.93 -14.97 62.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.793 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.12 3.05 15.89 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 122.397 -0.189 . . . . 0.0 111.129 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.72 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 55.6 mtmt -58.8 118.79 6.12 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.851 0.834 . . . . 0.0 112.985 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -106.6 97.33 7.14 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.001 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -34.59 64.7 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 125.44 1.496 . . . . 0.0 113.53 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.5 m -81.26 -19.82 42.27 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 85.32 155.99 25.64 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.904 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' 1527 ' ' ARG . 71.5 m-85 -92.43 133.09 36.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 9.4 p -112.07 91.5 3.68 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 16.9 pt -96.39 152.07 3.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.301 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 19.6 t -97.82 118.89 35.4 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.704 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1520 ' ' ASP . . . . . 0.548 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 1.9 t70 -74.46 151.65 39.55 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.569 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.7 tt -79.55 -16.25 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.645 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1522 ' ' ARG . . . . . 0.548 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 10.4 mtp-105 -87.62 1.96 52.24 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1523 ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.9 mmtt 72.45 77.75 0.15 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.002 1.721 . . . . 0.0 113.603 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -165.09 163.26 36.36 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 107.431 -2.267 . . . . 0.0 107.431 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.3 m -109.71 140.54 43.45 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 118.184 0.992 . . . . 0.0 109.488 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.471 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.8 tt -124.65 130.39 73.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' 1516 ' ' TYR . 17.7 ttm180 -112.68 119.14 37.06 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.383 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.39 127.01 47.85 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.947 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.37 129.47 9.89 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' 1511 ' ' LYS . 18.4 m -85.86 115.49 27.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.112 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 21.7 m 62.92 12.61 5.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.469 1.107 . . . . 0.0 111.714 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -135.56 147.56 19.24 Favored Glycine 0 N--CA 1.415 -2.76 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1533 ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' 1533 ' ' GLU . 0.1 OUTLIER -77.9 141.18 39.22 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 123.802 0.354 . . . . 0.0 110.219 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.3 m -85.23 87.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 122.01 0.909 . . . . 0.0 109.28 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.551 ' HD2' ' H ' ' A' 1535 ' ' LYS . 2.1 mptp? -59.39 -28.96 67.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.683 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.19 -36.75 71.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.579 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.5 m -96.86 -29.14 13.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.053 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 152.32 159.25 8.88 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.932 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.5 143.88 31.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.288 1.992 . . . . 0.0 111.323 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.46 6.21 89.38 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.537 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.0 131.62 59.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -95.57 -32.88 6.7 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.302 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.21 138.96 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.6 p -145.37 158.3 43.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' 1526 ' ' ILE . 38.8 t80 -113.91 106.17 14.13 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.31 106.76 7.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 122.011 0.91 . . . . 0.0 109.976 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.8 -67.39 0.3 Allowed Glycine 0 C--N 1.276 -2.754 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 -21.77 29.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 81.91 21.31 61.57 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 43.1 pt -91.7 151.1 3.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.215 0.531 . . . . 0.0 111.124 -176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.734 ' HD2' ' HB2' ' A' 1574 ' ' ASP . 74.7 mttt -87.43 156.43 19.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -124.41 7.51 8.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.415 0.626 . . . . 0.0 110.593 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.815 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 146.75 144.46 4.04 Favored Glycine 0 C--O 1.256 1.473 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.948 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -85.28 160.73 19.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.688 0.744 . . . . 0.0 110.377 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 70.3 t90 -62.86 132.63 52.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.368 0.667 . . . . 0.0 110.795 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.1 p30 -167.35 173.08 9.15 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -128.92 41.06 3.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 118.127 0.422 . . . . 0.0 110.04 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -72.11 103.31 3.25 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.077 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 98.8 mt -116.91 96.86 5.66 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.817 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 20.0 m -87.51 115.22 24.79 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 72.4 t80 -94.97 102.37 14.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -118.99 92.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-O 121.165 0.507 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.9 t70 54.04 69.97 0.66 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.371 1.068 . . . . 0.0 112.012 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 67.98 2.83 3.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.543 -1.208 . . . . 0.0 114.028 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.37 126.76 66.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.88 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.9 mp -94.05 118.03 30.95 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.402 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.817 ' HB2' ' HB2' ' A' 1560 ' ' SER . 17.4 mm-40 -102.64 114.01 27.87 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.57 107.7 18.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.589 HG21 HG23 ' A' 1587 ' ' VAL . 17.5 t -111.85 117.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.867 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.815 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 50.6 m-85 -93.64 101.73 13.89 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.9 177.72 4.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.865 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.738 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 34.2 t0 47.16 63.23 2.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 112.289 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -73.73 -77.08 0.64 Allowed Glycine 0 N--CA 1.42 -2.396 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.816 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.734 ' HB2' ' HD2' ' A' 1551 ' ' LYS . 13.7 t70 -165.55 156.08 11.89 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.63 145.85 46.43 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.34 2.026 . . . . 0.0 112.38 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1576 ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 52.0 t -97.43 139.07 21.2 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.75 -28.07 76.0 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.203 2.602 . . . . 0.0 114.376 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.48 -44.9 49.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.881 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.869 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 40.5 t-20 -144.8 110.98 5.52 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.54 -15.07 9.7 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 46.1 m80 -94.0 -1.93 53.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 122.085 -0.384 . . . . 0.0 111.843 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.869 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 42.5 mt -90.66 154.8 19.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.738 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 66.4 mttm -127.35 151.35 48.89 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.282 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -61.43 120.09 9.81 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' 1583 ' ' LYS . 92.8 mttt -137.92 140.59 40.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.1 p -130.92 123.68 29.44 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 120.799 0.333 . . . . 0.0 110.417 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.589 HG23 HG21 ' A' 1569 ' ' VAL . 7.5 p -108.97 113.85 45.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.688 0.756 . . . . 0.0 110.178 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.89 109.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 25.9 m -92.37 111.96 23.73 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.0 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.88 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.5 m-85 -86.22 108.22 18.27 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 30.7 m -111.73 167.0 5.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.577 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 46.2 t -76.56 150.89 36.47 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.287 0.565 . . . . 0.0 112.258 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.74 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 22.6 tptp -170.86 115.06 0.44 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 174.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 8.3 t -75.44 -28.93 59.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.296 0.498 . . . . 0.0 111.921 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.03 12.34 24.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.287 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' 1593 ' ' LYS . . . -66.73 -51.84 51.33 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -172.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.63 179.04 40.81 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.71 -28.99 19.97 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.773 2.315 . . . . 0.0 113.033 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 -26.4 20.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 109.855 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' 1619 ' ' HIS . 21.3 m 63.38 -175.94 0.15 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.586 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.784 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 6.9 pt20 -116.24 121.44 33.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.821 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 9.6 Cg_endo -92.34 117.45 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.47 2.78 . . . . 0.0 112.111 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.2 tp -97.15 124.86 41.31 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.573 HD11 HG22 ' A' 1607 ' ' VAL . 60.4 tp -80.35 112.78 18.01 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.73 -50.49 8.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.144 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.9 t -175.22 140.28 0.5 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.445 0.466 . . . . 0.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.573 HG22 HD11 ' A' 1604 ' ' LEU . 83.9 t -107.9 110.17 30.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.57 102.41 12.29 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.24 -1.44 44.92 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.958 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -91.92 -39.74 11.54 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.617 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.61 ' HA ' HD13 ' A' 1582 ' ' LEU . 25.3 p -99.96 -2.15 35.34 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 90.8 m 58.57 33.93 23.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.901 0.858 . . . . 0.0 111.033 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 24.5 m -112.75 128.75 56.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.555 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.592 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 67.2 mt -105.13 134.64 47.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.033 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.68 115.94 26.07 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.592 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.5 m-85 -130.14 137.27 50.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.76 0.314 . . . . 0.0 110.892 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 21.0 t -108.45 108.27 19.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.406 ' NE1' ' HB2' ' A' 1600 ' ' SER . 11.7 t-105 -97.59 106.9 19.29 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.784 ' HB2' ' HG3' ' A' 1601 ' ' GLN . 66.0 m-70 -86.77 109.58 19.35 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 7.7 t -130.59 149.9 52.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.298 0.57 . . . . 0.0 110.916 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.1 p -78.87 -26.41 43.96 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' 1622 ' ' LEU . 3.1 tm? -72.81 -6.93 48.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.113 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.15 2.41 40.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 0.0 109.819 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 63.4 m -87.59 133.05 33.86 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.08 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.338 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1493 ' ' ASN . . . . . 0.456 ' C ' ' H ' ' A' 1495 ' ' GLN . 39.6 t-20 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 38.5 t 76.48 -21.23 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.385 1.474 . . . . 0.0 110.834 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.456 ' H ' ' C ' ' A' 1493 ' ' ASN . 29.3 pt20 -118.04 154.28 32.29 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -142.36 136.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 40.2 m -88.5 126.69 35.37 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.815 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.444 HD21 ' HE2' ' A' 1505 ' ' PHE . 27.9 t-20 -91.57 106.65 17.55 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.29 -19.62 55.97 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.263 2.642 . . . . 0.0 114.61 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -72.65 -53.75 10.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.061 0.458 . . . . 0.0 110.852 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 17.5 p -96.53 -12.34 24.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 79.31 3.93 88.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.67 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 68.8 t80 -85.02 135.24 34.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.401 0.619 . . . . 0.0 110.485 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 38.9 t -97.68 115.85 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.444 ' HE2' HD21 ' A' 1498 ' ' ASN . 97.3 m-85 -89.35 107.63 19.17 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -107.14 120.16 41.35 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.57 0.7 . . . . 0.0 110.7 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1507 ' ' LEU . . . . . 0.507 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 38.3 tp -79.42 -6.38 56.73 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -53.81 -31.07 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.47 1.508 . . . . 0.0 112.641 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 33.3 t -77.74 -20.9 52.68 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.028 0.442 . . . . 0.0 110.663 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 23.0 tp -116.63 -5.59 11.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.97 0.414 . . . . 0.0 111.568 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.6 154.07 42.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.493 0.663 . . . . 0.0 111.901 -175.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -121.63 122.01 38.67 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.187 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -68.79 -26.35 65.16 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.539 0.736 . . . . 0.0 110.476 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 14.0 t -89.2 -7.23 56.0 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 75.73 -164.43 53.94 Favored Glycine 0 N--CA 1.427 -1.921 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.473 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.76 145.81 43.24 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1517 ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' 1526 ' ' ILE . 32.6 m -142.61 100.63 3.72 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 28.2 pt -121.51 132.4 70.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.87 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1519 ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.0 t -80.0 112.65 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.72 136.95 32.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.089 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.65 -32.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.606 1.163 . . . . 0.0 112.839 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -74.73 -34.13 62.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 28.8 tptp -141.21 -58.69 0.49 Allowed 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.054 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 175.21 -163.41 33.45 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.379 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1525 ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' 1519 ' ' SER . 45.4 t -81.01 144.01 32.1 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.409 0.623 . . . . 0.0 111.289 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' 1517 ' ' THR . 14.2 tt -127.44 134.26 66.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.402 ' HG3' ' OG1' ' A' 1517 ' ' THR . 41.3 ttm180 -124.23 103.78 8.44 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.432 0.634 . . . . 0.0 109.593 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.83 144.84 51.74 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.016 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -111.66 139.53 15.64 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.519 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 16.2 m -98.01 117.8 43.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 16.4 m 69.73 19.08 7.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.975 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -153.42 168.71 32.13 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.26 149.56 26.76 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 20.7 m -94.87 90.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.318 1.056 . . . . 0.0 108.306 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.555 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -63.94 -13.72 48.06 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.402 -172.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.56 -12.96 60.33 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 123.149 0.58 . . . . 0.0 110.569 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1537 ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' 1551 ' ' LYS . 24.9 t -117.12 11.81 14.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.43 163.5 14.58 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.238 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 136.29 12.65 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.472 2.114 . . . . 0.0 111.48 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.83 21.6 79.09 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.588 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 118.19 50.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -94.04 -24.82 18.72 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.678 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.13 132.34 31.83 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 14.1 t -139.94 147.81 41.06 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.479 ' HB3' HG13 ' A' 1550 ' ' ILE . 63.8 t80 -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.13 81.57 8.4 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.306 1.051 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -158.27 85.02 0.13 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 7.6 m 69.63 16.76 7.97 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.214 1.007 . . . . 0.0 109.351 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 62.69 67.31 2.14 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.182 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' 1545 ' ' PHE . 23.7 pt -108.6 138.46 35.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 117.061 0.431 . . . . 0.0 110.015 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.425 ' HG2' ' SG ' ' A' 1537 ' ' CYS . 54.6 mttm -88.69 138.86 31.04 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -114.94 18.28 16.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.065 0.46 . . . . 0.0 111.231 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 148.2 136.71 2.77 Favored Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.948 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 61.0 tttm -85.07 143.54 28.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.429 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 37.3 t90 -69.29 134.27 48.92 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.632 0.73 . . . . 0.0 111.099 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 p30 -158.88 164.42 35.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -124.27 78.45 1.65 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 118.808 0.731 . . . . 0.0 112.4 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -108.23 92.19 3.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.551 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.14 96.36 7.44 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.8 m -96.93 138.14 34.94 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.542 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1561 ' ' TYR . . . . . 0.584 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 7.4 t80 -110.8 101.02 9.67 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 52.9 t -103.64 88.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.175 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.18 72.72 0.28 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.606 1.163 . . . . 0.0 111.49 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1564 ' ' GLN . . . . . 0.584 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 26.6 mp0 57.67 24.56 10.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.269 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 51.6 t -126.81 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.835 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 11.0 tp -82.31 135.96 35.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' 1560 ' ' SER . 26.6 mm-40 -124.45 135.54 53.33 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.804 0.442 . . . . 0.0 110.115 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.95 120.79 18.56 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.573 HG22 HG22 ' A' 1587 ' ' VAL . 39.2 t -119.14 129.48 75.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.322 0.582 . . . . 0.0 111.25 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.9 m-85 -107.34 111.86 24.41 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.462 174.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.541 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 48.1 mt-10 -117.56 177.26 4.82 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.198 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 17.5 t70 64.51 43.88 4.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.2 1.0 . . . . 0.0 111.446 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -89.32 -139.59 7.31 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.2 155.33 84.28 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 117.062 0.431 . . . . 0.0 110.351 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.69 148.97 72.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.339 2.026 . . . . 0.0 110.459 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 52.4 t -98.21 126.22 40.72 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -63.99 -7.18 12.73 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.091 2.527 . . . . 0.0 114.335 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -76.71 -61.16 2.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.036 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -117.67 -5.37 11.14 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 69.5 -45.28 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -70.56 -21.99 62.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.8 0.809 . . . . 0.0 109.173 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' 1611 ' ' THR . 93.5 mt -82.91 142.42 31.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 60.8 mttm -127.88 162.59 26.34 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -68.38 114.23 6.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.541 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.5 mtpt -128.03 138.99 52.79 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.569 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 27.0 t -120.91 120.0 34.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.573 HG22 HG22 ' A' 1569 ' ' VAL . 7.7 p -112.31 110.27 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 121.98 0.895 . . . . 0.0 109.941 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 107.74 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 15.4 p -90.73 112.91 24.87 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.069 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.835 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 85.4 m-85 -89.06 106.35 18.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -105.64 156.66 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' 1620 ' ' THR . 26.2 t -95.1 139.16 31.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.409 -1.317 . . . . 0.0 113.612 -171.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 27.9 tptp -137.67 98.25 3.63 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.6 m -57.59 -29.26 64.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -100.76 6.21 43.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.285 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -64.67 -58.11 7.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 51.91 -114.53 3.24 Favored Glycine 0 N--CA 1.446 -0.694 0 O-C-N 123.767 0.667 . . . . 0.0 112.625 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.63 -19.96 53.65 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.269 2.646 . . . . 0.0 112.957 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.6 t -117.24 74.46 0.92 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.705 1.241 . . . . 0.0 110.399 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 50.7 m -86.42 116.88 24.86 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.09 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.2 mt-30 -93.52 123.92 58.76 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -173.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 1.4 Cg_endo -84.79 113.15 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.244 2.63 . . . . 0.0 110.449 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.46 HD12 HD21 ' A' 1605 ' ' LEU . 2.2 tm? -96.45 117.55 31.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 34.7 tp -82.96 111.59 18.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1605 ' ' LEU . . . . . 0.46 HD21 HD12 ' A' 1603 ' ' LEU . 90.6 mt -70.78 -55.68 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.483 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 11.9 t -170.88 153.04 3.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 99.4 t -105.19 111.66 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.56 108.35 19.38 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.626 -1.229 . . . . 0.0 110.163 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -81.46 1.84 31.47 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.1 t60 -89.85 -51.36 5.53 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.913 ' HA ' HD12 ' A' 1582 ' ' LEU . 0.2 OUTLIER -98.03 -7.37 29.98 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.361 -170.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 77.8 m 55.19 34.09 21.93 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.276 1.036 . . . . 0.0 112.361 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 22.3 m -104.55 127.05 52.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.023 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.468 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 83.1 mt -92.62 120.9 33.51 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.125 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -103.12 104.19 14.32 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.468 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 67.2 m-85 -118.66 128.99 55.04 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 67.2 m -109.25 105.63 15.14 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.491 ' HE3' ' CD2' ' A' 1590 ' ' PHE . 11.5 t90 -92.49 109.54 20.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 59.9 m-70 -80.53 96.81 6.9 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.616 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' 1592 ' ' CYS . 7.9 t -127.88 153.43 46.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.886 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 11.6 m -72.67 -25.86 61.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.145 0.497 . . . . 0.0 111.333 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' 1622 ' ' LEU . 7.2 tt -68.26 -13.26 62.12 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -89.28 -3.35 58.55 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 46.5 m -78.4 169.46 18.21 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.937 -0.477 . . . . 0.0 109.965 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 168.545 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 6.3 t 68.84 9.66 7.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.919 0.888 . . . . 0.0 111.102 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.1 pt20 -140.46 138.22 34.51 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.5 p -139.33 132.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.7 m -93.64 114.38 26.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.489 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 4.7 p30 -79.99 133.08 58.56 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1499 ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 12.2 Cg_exo -67.87 -32.15 29.83 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.535 2.157 . . . . 0.0 112.903 -176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -55.75 -64.38 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 32.1 p -96.78 -20.51 18.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.94 0.4 . . . . 0.0 111.958 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.34 1.54 74.99 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.183 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -77.18 128.78 34.99 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.672 0.749 . . . . 0.0 111.931 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' 1497 ' ' THR . 22.1 t -85.9 108.2 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' 1495 ' ' GLN . 87.9 m-85 -84.67 100.58 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.41 120.51 39.72 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1507 ' ' LEU . . . . . 0.587 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 25.7 tp -83.96 3.83 32.41 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 121.993 0.902 . . . . 0.0 109.146 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.627 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 1.8 m-20 -57.68 -29.34 64.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.535 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1509 ' ' SER . . . . . 0.414 ' HB2' HD11 ' A' 1622 ' ' LEU . 10.0 m -71.41 -20.25 62.15 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.642 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.435 ' HB2' HD13 ' A' 1622 ' ' LEU . 0.2 OUTLIER -101.63 -11.02 19.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.627 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 46.3 mtmt -70.54 152.65 43.74 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.764 0.792 . . . . 0.0 112.317 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' 1515 ' ' GLY . 38.7 ttt180 -127.23 119.81 27.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 104.173 -2.529 . . . . 0.0 104.173 172.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.11 -45.74 71.95 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.828 0.705 . . . . 0.0 112.004 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.6 m -81.68 -2.49 50.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.154 0.502 . . . . 0.0 111.136 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.418 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 77.98 177.77 48.0 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.411 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.98 114.25 27.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 28.9 m -103.63 102.27 12.14 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.7 pt -122.41 138.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1519 ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' 1525 ' ' SER . 34.3 t -94.39 109.72 21.55 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.59 129.32 37.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.62 -20.09 22.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.85 0.719 . . . . 0.0 112.716 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -99.9 -32.25 11.09 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.595 -0.69 . . . . 0.0 110.583 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1523 ' ' LYS . . . . . 0.622 ' HE2' HG13 ' A' 1607 ' ' VAL . 26.7 mmtm -102.62 -62.94 1.21 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 151.87 -168.54 31.2 Favored Glycine 0 C--N 1.296 -1.655 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1525 ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' 1519 ' ' SER . 44.7 m -85.39 126.6 33.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 -177.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.93 140.31 48.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -118.72 117.2 28.27 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.48 120.67 38.83 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.358 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -97.09 102.44 2.74 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 57.5 t -62.24 115.67 2.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.554 ' HB2' ' CD ' ' A' 1511 ' ' LYS . 21.8 m 60.0 24.83 14.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.553 1.141 . . . . 0.0 111.824 176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.12 173.08 25.02 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -108.84 139.08 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.38 0.609 . . . . 0.0 110.846 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' 1537 ' ' CYS . 15.1 m -94.61 93.49 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.038 0.923 . . . . 0.0 109.149 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.474 ' HD2' ' H ' ' A' 1535 ' ' LYS . 9.1 mptt -54.73 -30.06 55.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.521 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.56 -18.11 63.62 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.681 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1537 ' ' CYS . . . . . 0.471 ' HB2' HG22 ' A' 1534 ' ' VAL . 80.9 m -113.44 14.0 19.02 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.978 0.418 . . . . 0.0 110.323 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1538 ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 110.68 128.91 5.48 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1539 ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 52.7 Cg_exo -59.54 127.98 25.61 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.932 2.421 . . . . 0.0 111.547 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 91.96 0.16 71.94 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.496 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1541 ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' 1554 ' ' LYS . 47.7 mm -93.79 134.82 30.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -105.07 -37.68 2.65 Favored Glycine 0 CA--C 1.503 -0.684 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.484 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.6 42.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1544 ' ' CYS . . . . . 0.419 ' SG ' HG21 ' A' 1534 ' ' VAL . 31.0 p -137.76 153.83 49.67 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.602 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.429 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 51.6 t80 -94.88 138.33 32.78 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.95 89.64 8.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.666 0.746 . . . . 0.0 110.311 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -178.96 85.43 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 71.3 m 76.85 -37.17 0.27 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.155 0.982 . . . . 0.0 112.394 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 132.32 46.23 0.12 Allowed Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.744 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 73.4 mt -78.52 134.73 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 9.4 mptt -96.32 140.86 30.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.53 12.19 10.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.528 0.68 . . . . 0.0 109.552 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.849 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 142.04 134.82 3.02 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.476 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1554 ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' 1541 ' ' ILE . 25.2 pttm -82.76 153.73 25.11 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.66 135.62 50.11 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 173.62 16.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1557 ' ' GLN . . . . . 0.475 ' H ' ' NE2' ' A' 1557 ' ' GLN . 0.0 OUTLIER -100.02 11.58 38.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.402 0.439 . . . . 0.0 111.077 -172.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -84.94 100.28 11.52 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -168.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' 1494 ' ' CYS . 68.2 mt -115.63 119.92 37.69 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.308 172.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 51.0 m -107.85 122.52 46.95 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 78.9 t80 -94.93 101.32 13.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.988 0.899 . . . . 0.0 108.826 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 85.1 t -93.71 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -34.57 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.862 1.665 . . . . 0.0 113.137 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 20.2 mp0 56.95 18.25 3.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.868 2.067 . . . . 0.0 114.571 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 135.12 62.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.137 0.494 . . . . 0.0 111.088 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.51 113.95 26.04 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -102.94 114.1 28.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.35 124.11 49.86 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 13.1 p -120.48 133.93 65.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 111.355 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.849 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 64.6 m-85 -107.6 106.3 16.59 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.06 167.56 10.16 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.252 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.98 78.38 0.29 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.304 1.041 . . . . 0.0 111.796 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1573 ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -106.26 -149.6 17.28 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -94.92 143.88 26.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1575 ' ' PRO . . . . . 0.495 ' HG3' ' HE2' ' A' 1583 ' ' LYS . 13.7 Cg_exo -69.01 146.75 65.88 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.845 2.364 . . . . 0.0 113.218 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 67.7 m -107.59 141.76 23.73 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.66 13.58 0.45 Allowed 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.574 2.849 . . . . 0.0 113.599 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.95 -38.5 22.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.691 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 28.1 t-20 -150.95 -6.7 0.27 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.041 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.14 -43.12 0.55 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.99 0.916 . . . . 0.0 113.424 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 59.9 m80 -77.37 -6.53 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.716 0.77 . . . . 0.0 110.78 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' 1611 ' ' THR . 63.3 mt -98.94 130.72 45.33 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.495 ' HE2' ' HG3' ' A' 1575 ' ' PRO . 96.1 mttt -128.73 161.95 28.54 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.456 0.473 . . . . 0.0 109.794 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1584 ' ' TYR . . . . . 0.429 ' O ' ' HA3' ' A' 1573 ' ' GLY . 98.9 m-85 -65.01 113.84 4.16 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.985 0.803 . . . . 0.0 109.1 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -129.33 137.62 51.1 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 17.3 t -121.49 130.81 53.79 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.3 p -125.43 116.83 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-O 121.96 0.886 . . . . 0.0 109.141 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.3 113.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.7 p -89.81 109.52 20.51 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.698 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.6 m-85 -86.81 103.06 14.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -99.39 166.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.552 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 18.6 t -84.6 130.31 34.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.469 0.652 . . . . 0.0 112.094 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 17.4 tptp -152.32 100.07 2.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.1 t -70.84 -14.4 62.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 0.0 111.591 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.19 1.89 55.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.375 0.607 . . . . 0.0 109.68 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -75.12 -65.9 0.83 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 108.18 -166.27 12.97 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.944 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.0 -20.23 44.82 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 124.275 3.317 . . . . 0.0 115.028 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 5.7 t -111.98 -22.09 11.23 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.891 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.699 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 48.0 m 65.41 -174.25 0.18 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.713 174.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 45.9 mt-30 -110.47 120.59 43.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1602 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 125.7 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.906 2.404 . . . . 0.0 110.256 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 55.0 tp -129.0 126.05 38.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.676 -0.64 . . . . 0.0 111.027 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.13 118.68 20.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.24 -56.17 4.08 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.291 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 13.7 p -168.69 150.43 4.85 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.622 HG13 ' HE2' ' A' 1523 ' ' LYS . 98.2 t -115.0 114.26 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.71 109.05 20.05 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.01 -3.77 52.87 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.056 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -87.35 -51.79 5.75 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' 1582 ' ' LEU . 27.2 p -96.55 -8.25 32.41 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.614 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 72.9 m 65.7 25.92 11.45 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.929 0.892 . . . . 0.0 112.024 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 30.5 m -90.67 123.79 34.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.121 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.542 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 73.0 mt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.488 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -107.33 116.44 31.94 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.542 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 76.7 m-85 -126.96 140.04 52.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.981 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 78.3 p -111.21 116.3 30.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.423 ' HB3' ' CD1' ' A' 1590 ' ' PHE . 4.7 t-105 -99.74 111.79 24.09 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.615 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 71.0 m-70 -86.85 99.08 11.57 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 9.4 t -124.99 152.37 44.31 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.911 0.862 . . . . 0.0 112.131 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.3 m -76.46 -22.75 54.18 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.453 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' 1510 ' ' LEU . 39.9 mt -73.38 -5.21 38.3 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.175 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.77 12.77 30.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.525 0.679 . . . . 0.0 110.391 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 61.3 m -100.23 137.84 38.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.911 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.425 -1.707 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 63.52 26.84 14.92 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.615 0.721 . . . . 0.0 111.392 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.2 pt20 -156.52 134.93 11.45 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.9 p -142.32 131.57 22.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.786 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.496 HG21 HG21 ' A' 1504 ' ' VAL . 10.6 m -98.63 129.09 45.13 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 38.5 p30 -85.91 127.63 61.47 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -70.2 -15.21 35.39 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.72 1.613 . . . . 0.0 110.855 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -65.63 -63.32 1.12 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.832 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 72.4 p -110.13 -14.06 14.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.579 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.12 14.78 58.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.303 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 71.0 t80 -92.16 137.42 32.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.496 HG21 HG21 ' A' 1497 ' ' THR . 43.3 t -102.91 128.49 55.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' 1495 ' ' GLN . 79.3 m-85 -104.14 98.6 8.39 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.22 102.07 14.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 120.805 0.336 . . . . 0.0 110.339 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 25.1 tp -79.03 -15.96 57.52 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -66.8 -16.81 64.53 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.516 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 17.9 m -87.61 -13.2 43.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.307 0.575 . . . . 0.0 109.61 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' 1598 ' ' PRO . 36.6 tp -116.44 16.53 15.64 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.975 0.893 . . . . 0.0 109.034 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.71 173.1 1.85 Allowed 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.865 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -53.57 104.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.639 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -100.26 -45.05 5.74 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 50.9 m -119.12 -23.65 6.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.543 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 87.4 129.44 2.88 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -74.83 114.88 13.8 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 5.8 m -119.21 100.18 7.17 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1518 ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' 1602 ' ' PRO . 21.1 pt -103.3 140.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.774 -173.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 36.7 t -99.64 115.59 29.78 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.19 160.29 27.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 14.2 tt -62.93 -23.16 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.036 0.535 . . . . 0.0 112.311 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -81.73 3.58 25.1 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.2 tptm 76.34 30.7 0.66 Allowed 'General case' 0 C--N 1.351 0.661 0 C-N-CA 125.895 1.678 . . . . 0.0 108.085 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -82.43 108.72 2.98 Favored Glycine 0 N--CA 1.418 -2.517 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.063 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.1 m -86.63 102.87 14.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.8 tt -113.87 134.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.472 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -115.41 126.98 55.04 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.516 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 125.26 41.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -104.45 90.39 0.72 Allowed Glycine 0 N--CA 1.418 -2.518 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 21.3 m -62.61 116.04 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.55 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 98.9 m 61.03 20.44 10.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.971 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -146.27 91.13 0.15 Allowed Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.55 132.66 49.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 124.548 0.793 . . . . 0.0 110.384 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 18.1 m -93.91 104.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.246 0.546 . . . . 0.0 111.362 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -16.41 60.87 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.176 0.512 . . . . 0.0 111.896 -175.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.34 -27.96 68.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.879 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.1 t -113.55 24.1 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 91.55 137.33 7.46 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.949 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.41 156.41 60.46 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.267 1.978 . . . . 0.0 111.457 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.7 8.55 87.65 Favored Glycine 0 C--N 1.304 -1.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.483 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1541 ' ' ILE . . . . . 0.501 HG21 ' SG ' ' A' 1544 ' ' CYS . 45.3 mm -110.44 134.77 51.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.598 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -89.37 -42.55 5.49 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.217 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.29 147.35 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 122.661 -0.317 . . . . 0.0 110.598 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1544 ' ' CYS . . . . . 0.501 ' SG ' HG21 ' A' 1541 ' ' ILE . 59.2 m -152.43 156.22 39.06 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.278 0.631 . . . . 0.0 111.046 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.492 ' HB3' HG12 ' A' 1550 ' ' ILE . 64.9 t80 -94.22 119.05 32.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.09 102.09 3.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.985 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 151.49 -64.86 0.37 Allowed Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.367 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 21.9 p -91.25 -24.4 19.88 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.742 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.61 19.7 59.57 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.789 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' 1545 ' ' PHE . 44.6 pt -71.37 126.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 58.3 mttm -83.45 134.77 34.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.19 10.09 41.78 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.068 0.461 . . . . 0.0 111.402 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 139.0 146.04 4.87 Favored Glycine 0 C--O 1.254 1.357 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.817 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.54 146.5 36.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.635 0.255 . . . . 0.0 110.773 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.55 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 28.1 t90 -75.57 133.33 40.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.124 0.487 . . . . 0.0 110.332 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 10.2 p30 -146.76 -178.81 6.38 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.55 27.41 7.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.306 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1558 ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 44.0 mmtm -85.24 82.4 8.39 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.035 0.921 . . . . 0.0 111.849 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.44 103.93 16.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.338 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 6.9 t -90.05 109.68 20.71 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -83.6 101.8 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.8 t -114.75 95.13 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.067 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 23.5 t70 52.49 67.62 0.95 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.699 1.199 . . . . 0.0 112.137 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 63.92 9.88 4.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.851 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 37.5 t -119.75 136.7 56.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.38 131.6 39.87 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.299 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' 1560 ' ' SER . 86.9 mm-40 -116.28 114.63 24.63 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.57 119.47 38.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.553 HG21 ' HG3' ' A' 1571 ' ' GLU . 14.1 p -121.12 122.59 67.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.133 0.968 . . . . 0.0 112.526 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.669 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 57.6 m-85 -100.1 108.4 20.54 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.659 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.553 ' HG3' HG21 ' A' 1569 ' ' VAL . 46.0 mt-10 -117.68 168.54 10.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.296 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.652 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 35.8 t70 61.28 70.18 0.62 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.075 1.35 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.94 -133.17 5.62 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.875 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' 1584 ' ' TYR . 31.0 t70 -74.93 136.81 73.2 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.55 138.29 17.18 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.46 2.106 . . . . 0.0 112.589 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 56.2 m -98.78 126.3 39.26 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.87 8.15 2.12 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.944 2.429 . . . . 0.0 114.645 -173.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -77.2 -35.67 55.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 109.965 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.593 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 18.9 t-20 -136.05 -20.92 1.45 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.684 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 18.8 tp 75.83 -33.13 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.075 1.35 . . . . 0.0 112.504 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1581 ' ' HIS . . . . . 0.496 ' HB3' ' OD1' ' A' 1579 ' ' ASN . 40.8 t-80 -81.47 -14.88 56.51 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.861 HD11 ' HA ' ' A' 1611 ' ' THR . 83.3 mt -82.47 133.45 35.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.367 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 49.2 mttm -130.04 163.8 25.71 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1584 ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' 1574 ' ' ASP . 97.4 m-85 -72.05 117.61 13.88 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.85 171.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 134.18 55.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1586 ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 16.0 m -119.41 116.56 26.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -109.3 111.0 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.893 0.854 . . . . 0.0 110.051 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.3 mp -102.15 107.41 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.244 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 113.44 25.72 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.667 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.3 m-85 -86.22 112.32 21.25 Favored 'General case' 0 C--O 1.256 1.395 0 CA-C-O 120.708 0.289 . . . . 0.0 110.244 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.5 m -106.93 166.74 3.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 124.26 1.024 . . . . 0.0 109.124 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 43.0 t -77.05 143.24 39.44 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.412 0.625 . . . . 0.0 112.648 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.648 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 25.5 tptp -167.07 101.71 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.8 m -68.66 -28.52 66.96 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.649 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.2 71.04 3.86 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.581 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -142.63 -64.02 0.42 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.936 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 68.78 -144.76 42.41 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.402 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1598 ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' 1510 ' ' LEU . 40.7 Cg_endo -66.23 -11.96 33.54 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.013 3.142 . . . . 0.0 113.396 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.4 t -123.24 77.08 1.44 Allowed 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.581 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 51.0 m -70.74 147.8 48.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.795 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.604 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 9.3 pt20 -108.55 120.85 45.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-O 121.56 0.695 . . . . 0.0 112.492 -170.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.464 ' HG3' HG21 ' A' 1518 ' ' ILE . 88.2 Cg_endo -80.78 139.42 12.36 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.4 tm? -106.66 111.02 23.38 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.759 HD22 HG21 ' A' 1607 ' ' VAL . 4.8 tt -81.53 112.5 18.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.14 -66.38 0.8 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 55.0 m -158.09 136.25 10.84 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.742 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.759 HG21 HD22 ' A' 1604 ' ' LEU . 90.9 t -95.36 111.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.99 118.65 29.71 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.599 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -80.72 -6.84 58.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.37 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -94.22 -51.81 4.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.563 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.861 ' HA ' HD11 ' A' 1582 ' ' LEU . 41.7 p -97.16 -14.77 21.27 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.012 0.195 . . . . 0.0 111.447 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1612 ' ' CYS . . . . . 0.43 ' HB3' ' CD1' ' A' 1584 ' ' TYR . 69.5 m 67.33 26.54 8.47 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.364 1.04 . . . . 0.0 110.742 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 19.3 m -86.87 116.81 25.19 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.703 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 74.6 mt -94.07 116.21 28.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -100.58 111.75 24.04 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.703 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 91.5 m-85 -128.44 136.73 51.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.334 0.587 . . . . 0.0 111.577 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.9 m -112.22 106.41 14.98 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.459 ' HB2' HG23 ' A' 1588 ' ' ILE . 1.4 t-105 -89.99 114.95 26.89 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.648 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 42.6 m80 -78.0 101.26 6.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 11.7 t -129.35 153.31 47.99 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.576 0.703 . . . . 0.0 111.074 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.2 m -73.28 -28.82 62.32 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.3 -6.49 43.51 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 121.45 0.643 . . . . 0.0 111.558 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -92.84 -4.45 52.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.435 0.636 . . . . 0.0 110.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 7.4 m -99.12 129.23 45.37 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.424 -1.725 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.753 178.719 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.223 -0.293 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 37.6 m -87.71 11.53 15.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.596 0.713 . . . . 0.0 109.484 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.5 pt20 -152.01 136.33 16.73 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.6 p -132.61 126.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.35 0.595 . . . . 0.0 110.209 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 14.3 m -90.32 116.68 28.47 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.455 HD21 ' HE1' ' A' 1505 ' ' PHE . 28.1 p30 -73.8 143.94 82.15 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.777 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1499 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 7.7 Cg_exo -73.52 -31.73 8.58 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.876 1.717 . . . . 0.0 112.01 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -62.08 -65.42 0.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 8.7 p -97.69 -11.65 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 74.28 40.17 41.77 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 83.9 t80 -111.72 130.5 55.76 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.033 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' 1497 ' ' THR . 47.6 t -90.28 118.95 36.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.455 ' HE1' HD21 ' A' 1498 ' ' ASN . 90.8 m-85 -91.29 108.21 19.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.55 106.43 17.53 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.335 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1507 ' ' LEU . . . . . 0.593 HD12 HD21 ' A' 1510 ' ' LEU . 28.1 tp -83.97 -3.12 57.75 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -51.17 -38.42 52.08 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 125.855 1.662 . . . . 0.0 111.571 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 4.9 m -68.13 -19.21 64.8 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.593 HD21 HD12 ' A' 1507 ' ' LEU . 50.6 tp -117.24 5.69 12.69 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.928 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.489 ' HD2' ' HB2' ' A' 1531 ' ' CYS . 22.8 pttm -88.09 129.53 35.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.319 -175.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -128.44 118.29 22.85 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.99 -37.28 78.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 2.7 m -56.17 -25.1 45.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.744 1.218 . . . . 0.0 110.273 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.689 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 87.07 177.12 49.05 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.316 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.65 124.9 43.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1517 ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' 1527 ' ' ARG . 2.6 m -103.04 98.41 8.36 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 15.4 pt -106.39 151.11 8.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.268 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1519 ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' 1525 ' ' SER . 12.8 p -109.44 130.98 55.47 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.94 154.91 40.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.3 tp -62.94 -26.16 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.287 0.635 . . . . 0.0 111.824 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -85.86 3.42 41.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 86.92 20.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.613 1.565 . . . . 0.0 112.519 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -83.58 80.23 1.84 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1525 ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' 1519 ' ' SER . 15.0 m -69.65 127.7 33.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' 1543 ' ' ALA . 7.6 tt -129.49 134.07 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.45 0.643 . . . . 0.0 110.153 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' 1517 ' ' THR . 58.2 ttt180 -105.82 119.77 40.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1528 ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' 1528 ' ' LEU . 0.7 OUTLIER -122.61 125.14 45.06 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -178.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.689 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -97.79 143.93 16.99 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 23.8 t -100.01 116.49 43.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.571 ' HA ' ' OE1' ' A' 1557 ' ' GLN . 62.0 m 63.95 20.99 12.46 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.078 0.862 . . . . 0.0 110.801 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -142.84 111.91 0.69 Allowed Glycine 0 N--CA 1.407 -3.271 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.76 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.18 133.4 47.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.9 m -90.85 95.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 122.258 1.028 . . . . 0.0 108.313 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.65 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.05 -28.17 64.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.913 -173.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.21 -16.56 61.95 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1537 ' ' CYS . . . . . 0.659 ' HB2' HG23 ' A' 1534 ' ' VAL . 96.7 m -102.76 -5.33 23.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.243 0.544 . . . . 0.0 109.538 173.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 131.44 145.03 5.52 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 132.49 29.67 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.166 1.91 . . . . 0.0 111.119 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.14 23.08 76.87 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.042 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.44 127.28 66.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' 1570 ' ' TYR . . . -100.8 -35.21 4.38 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.69 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1543 ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' 1526 ' ' ILE . . . -129.22 121.88 28.55 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.2 p -132.42 142.74 49.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.013 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' 1552 ' ' ALA . 73.8 m-85 -90.05 141.49 28.62 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.66 -26.27 64.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -89.88 126.79 8.45 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 6.7 m 75.48 -21.34 0.31 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 124.762 1.225 . . . . 0.0 112.009 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.22 30.36 54.88 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.63 150.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.165 0.507 . . . . 0.0 110.252 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.676 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 18.3 pttm -97.06 145.58 25.83 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1552 ' ' ALA . . . . . 0.48 ' HB3' ' CE2' ' A' 1545 ' ' PHE . . . -106.02 8.9 32.58 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.218 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.35 141.13 3.18 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.553 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.55 150.52 36.54 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.478 ' HA ' ' HE2' ' A' 1570 ' ' TYR . 35.2 t90 -63.78 124.49 21.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.694 0.759 . . . . 0.0 110.506 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.14 153.06 37.16 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1557 ' ' GLN . . . . . 0.571 ' OE1' ' HA ' ' A' 1531 ' ' CYS . 13.4 mm100 -108.72 22.63 15.67 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 123.753 0.658 . . . . 0.0 109.653 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 27.9 tptp -77.17 82.44 3.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.144 0.973 . . . . 0.0 111.57 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.48 HD13 ' HB3' ' A' 1566 ' ' LEU . 50.5 tp -91.33 116.2 28.64 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.262 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.4 m -103.31 147.14 27.44 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 60.7 t80 -117.51 135.0 54.23 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.027 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1562 ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' 1565 ' ' VAL . 18.0 m -134.05 160.51 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.33 106.1 0.09 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.073 0.949 . . . . 0.0 112.887 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 71.9 17.59 5.25 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.15 1.78 . . . . 0.0 112.413 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1565 ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' 1562 ' ' VAL . 59.5 t -139.8 124.68 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 93.3 mt -96.04 129.39 43.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.613 ' HB2' ' HB2' ' A' 1560 ' ' SER . 18.1 mm-40 -113.6 114.27 26.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 19.6 mt -104.81 119.47 39.08 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 36.1 t -116.72 108.58 25.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.294 0.569 . . . . 0.0 110.517 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 45.8 m-85 -93.22 113.35 25.54 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.812 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.54 -177.17 3.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.448 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.663 ' HA ' ' HD2' ' A' 1583 ' ' LYS . 5.1 m-20 68.33 27.98 6.38 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.713 0.633 . . . . 0.0 112.242 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1573 ' ' GLY . . . . . 0.676 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -74.07 -167.63 16.37 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.581 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 1.5 m-20 -72.19 162.63 72.65 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 122.338 -0.507 . . . . 0.0 112.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -65.23 144.35 80.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.572 2.181 . . . . 0.0 112.479 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1576 ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 43.9 t -98.23 140.18 21.7 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 124.677 1.191 . . . . 0.0 109.991 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.61 -22.12 73.63 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.068 2.512 . . . . 0.0 114.069 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.21 -26.56 60.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.849 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 36.9 t-20 -171.11 120.21 0.51 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1580 ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' 1580 ' ' LEU . 2.4 mm? -56.16 -27.22 53.47 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.593 1.157 . . . . 0.0 114.112 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.6 m80 -91.09 3.23 55.29 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.849 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 57.6 mt -89.94 121.55 32.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.663 ' HD2' ' HA ' ' A' 1572 ' ' ASP . 50.7 mtmt -103.27 156.88 17.4 Favored 'General case' 0 C--N 1.272 -2.795 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -61.88 119.83 9.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.73 0.644 . . . . 0.0 110.881 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' 1583 ' ' LYS . 0.6 OUTLIER -104.38 131.11 52.09 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 1586 ' ' SER . . . . . 0.592 ' HB3' ' HB2' ' A' 1570 ' ' TYR . 23.1 t -123.15 116.07 22.83 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -116.82 112.87 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-O 122.097 0.951 . . . . 0.0 110.321 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.41 101.51 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 47.5 m -90.96 110.25 21.49 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.21 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.5 m-85 -86.05 104.84 16.02 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.3 m -98.13 159.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.638 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 41.6 t -76.02 122.28 23.98 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.624 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' 1595 ' ' ASP . 20.4 tptm -149.7 90.12 1.68 Allowed 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.6 t -68.37 -15.26 63.49 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.466 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1595 ' ' ASP . . . . . 0.408 ' HB2' ' HE2' ' A' 1593 ' ' LYS . 29.3 m-20 -85.63 4.3 36.93 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 122.175 -0.328 . . . . 0.0 111.505 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.749 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -83.28 -61.12 1.93 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-O 120.734 0.302 . . . . 0.0 111.165 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 87.87 -141.75 17.28 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.838 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.52 -16.9 38.81 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.337 2.691 . . . . 0.0 112.97 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.8 t -125.97 89.78 3.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 122.45 1.119 . . . . 0.0 109.553 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.749 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 23.2 m -76.25 148.17 37.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.2 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 56.3 mt-30 -96.19 122.06 58.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.4 Cg_endo -87.14 113.67 1.0 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.402 2.734 . . . . 0.0 110.708 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.59 119.33 36.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.871 0.367 . . . . 0.0 110.291 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.438 HD12 ' CZ ' ' A' 1616 ' ' PHE . 39.0 tp -76.5 126.07 30.33 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.39 -65.47 1.01 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 73.7 m -159.51 156.29 27.94 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.499 HG13 HD21 ' A' 1614 ' ' LEU . 96.0 t -110.37 112.39 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 171.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.68 109.03 13.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.86 -6.42 58.59 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.208 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -95.16 -29.0 14.77 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.043 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.726 ' HA ' HD12 ' A' 1582 ' ' LEU . 35.9 p -114.86 -15.22 11.87 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.961 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 97.8 m 66.14 58.8 0.7 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.556 1.169 . . . . 0.0 111.097 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 23.5 m -120.94 130.37 53.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.281 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.499 HD21 HG13 ' A' 1607 ' ' VAL . 73.6 mt -96.81 117.4 31.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.33 103.33 13.33 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.498 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -114.82 131.53 56.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.829 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 74.7 p -109.53 108.46 18.93 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -92.68 108.01 19.65 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' 1600 ' ' SER . 64.4 m-70 -83.66 97.72 9.25 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -126.45 152.14 46.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.759 0.79 . . . . 0.0 111.808 -173.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.6 m -78.25 -25.99 47.06 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.405 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' 1510 ' ' LEU . 43.2 mt -70.61 -6.07 34.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.957 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -95.18 -9.55 33.07 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.538 0.685 . . . . 0.0 110.432 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -82.85 135.77 34.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.151 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 45.1 t 61.86 33.41 17.63 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 123.042 1.401 . . . . 0.0 110.16 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' 1505 ' ' PHE . 8.6 pt20 -156.46 146.55 21.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 11.7 p -148.14 135.55 13.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.459 ' HG1' HG22 ' A' 1504 ' ' VAL . 14.0 m -94.94 116.98 29.38 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.447 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.4 p30 -78.66 138.03 58.54 Favored Pre-proline 0 C--N 1.31 -1.134 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.604 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.08 -1.9 11.98 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 113.647 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -83.52 -68.57 0.7 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.68 0.276 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 12.1 p -89.22 -24.99 21.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.65 13.95 64.19 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.55 139.97 30.34 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.459 HG22 ' HG1' ' A' 1497 ' ' THR . 44.5 t -92.55 116.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.466 ' HZ ' ' HG2' ' A' 1625 ' ' GLU . 82.3 m-85 -81.24 95.33 6.91 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.04 95.35 10.28 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.001 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 31.8 tp -86.01 -11.1 53.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.51 0.672 . . . . 0.0 110.996 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' 1511 ' ' LYS . 9.1 p30 -71.68 -13.22 61.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.947 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 74.3 m -84.23 -10.85 57.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.128 173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.76 4.06 19.63 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.004 -0.435 . . . . 0.0 111.033 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.612 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 58.0 pttt -90.79 157.74 17.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.079 0.466 . . . . 0.0 111.262 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -128.88 137.03 51.22 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -30.08 70.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 22.3 t -78.27 -11.54 59.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.805 0.812 . . . . 0.0 109.101 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 76.57 -174.67 53.75 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.512 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.87 121.36 44.44 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.5 m -105.88 103.87 13.46 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1518 ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' 1602 ' ' PRO . 25.9 pt -108.66 139.91 29.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.201 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 10.0 p -87.11 139.29 30.72 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 121.616 0.722 . . . . 0.0 111.571 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -95.23 151.84 18.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.16 -25.87 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 124.567 1.147 . . . . 0.0 112.952 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.58 2.67 18.48 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.08 -0.387 . . . . 0.0 111.841 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.9 tptm 70.04 68.97 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.731 1.253 . . . . 0.0 109.481 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -150.47 174.61 29.79 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 16.5 t -146.39 146.79 30.75 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 118.559 1.18 . . . . 0.0 108.421 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.34 134.47 60.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.1 ttm105 -110.15 113.85 26.87 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.17 129.36 56.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.18 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.75 91.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' 1511 ' ' LYS . 92.8 t -64.1 116.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.612 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 60.8 m 58.45 18.46 5.65 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.79 0.681 . . . . 0.0 112.695 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -154.07 101.85 0.21 Allowed Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.0 132.64 54.5 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 121.26 0.552 . . . . 0.0 111.723 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.5 m -78.87 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.958 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -18.01 17.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.095 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.33 -31.82 73.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.27 -0.38 26.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.501 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 123.97 158.11 10.01 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.378 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.9 130.77 11.63 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.395 2.063 . . . . 0.0 111.935 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.86 5.24 81.4 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.572 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1541 ' ' ILE . . . . . 0.436 ' CD1' ' HD2' ' A' 1551 ' ' LYS . 41.1 mm -98.77 117.49 43.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.15 -19.73 18.11 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.49 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -137.27 120.28 16.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.4 p -131.03 136.77 48.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.395 0.617 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 76.8 t80 -96.26 116.12 28.51 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.6 104.81 4.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.623 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -176.12 -105.67 0.19 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 5.2 m -73.88 -25.23 59.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 109.46 57.53 0.53 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 61.3 mt -94.14 125.12 46.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.436 ' HD2' ' CD1' ' A' 1541 ' ' ILE . 43.2 mtmt -83.91 126.26 32.82 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -105.48 9.0 33.69 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.246 0.546 . . . . 0.0 110.767 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.759 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 147.86 146.58 4.37 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.329 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.5 144.93 27.66 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.733 0.777 . . . . 0.0 111.541 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1555 ' ' TRP . . . . . 0.505 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 65.6 t90 -65.54 151.21 46.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.158 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -164.99 167.31 18.58 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -119.26 20.52 12.56 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -91.01 96.71 10.76 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.463 0.649 . . . . 0.0 110.336 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.462 HD22 HD12 ' A' 1568 ' ' LEU . 69.2 mt -94.19 109.38 21.18 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 20.1 m -92.94 120.84 33.67 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 75.6 t80 -93.23 102.39 14.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1562 ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' 1565 ' ' VAL . 49.2 t -115.65 88.88 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.681 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.0 t70 48.03 81.41 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.927 1.291 . . . . 0.0 113.799 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 70.35 -9.19 0.79 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1565 ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' 1562 ' ' VAL . 7.4 p -116.98 132.13 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.539 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 14.7 tp -88.15 119.08 28.2 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -107.06 129.11 54.86 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.435 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1568 ' ' LEU . . . . . 0.462 HD12 HD22 ' A' 1559 ' ' LEU . 54.9 tp -126.8 109.88 12.49 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 172.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.554 HG23 HG22 ' A' 1587 ' ' VAL . 38.7 t -110.9 128.5 67.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.759 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 75.2 m-85 -104.43 119.33 38.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.13 177.28 4.78 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.781 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.546 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 8.7 t70 52.65 70.33 0.59 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.227 1.411 . . . . 0.0 111.85 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.94 -135.82 8.87 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.321 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.5 145.54 48.23 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.18 142.72 31.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.607 2.205 . . . . 0.0 111.526 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1576 ' ' CYS . . . . . 0.478 ' C ' ' H ' ' A' 1578 ' ' ALA . 78.2 m -98.39 132.17 24.76 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.746 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.44 20.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.578 2.852 . . . . 0.0 112.714 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1578 ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -86.81 -55.47 3.83 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.55 7.67 2.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.282 0.563 . . . . 0.0 109.766 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 2.2 tm? 68.93 -50.88 0.59 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.508 1.523 . . . . 0.0 112.358 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.7 t60 -68.49 -13.46 62.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.358 0.663 . . . . 0.0 110.408 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.67 134.98 35.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 85.6 mttt -125.84 152.45 45.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -67.08 117.48 9.18 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.864 0.728 . . . . 0.0 109.393 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.14 135.45 48.88 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 13.1 p -121.03 121.25 37.54 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.683 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.554 HG22 HG23 ' A' 1569 ' ' VAL . 4.2 p -106.15 113.63 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.552 0.691 . . . . 0.0 109.735 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.42 110.12 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1589 ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' 1565 ' ' VAL . 42.3 m -93.34 118.62 31.5 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.854 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 90.9 m-85 -86.58 110.2 19.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.2 m -107.42 152.38 9.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' 1620 ' ' THR . 40.3 t -81.98 142.53 32.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.273 0.558 . . . . 0.0 112.404 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' 1619 ' ' HIS . 42.4 tptt -163.29 97.35 0.9 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.457 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 9.5 p -56.65 -32.28 65.21 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.871 0.868 . . . . 0.0 112.09 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1595 ' ' ASP . . . . . 0.436 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.674 0.79 . . . . 0.0 112.037 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -80.27 -41.6 24.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.767 0.318 . . . . 0.0 111.519 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.2 -163.68 39.66 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.7 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.63 -15.64 21.63 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.272 2.648 . . . . 0.0 113.168 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.3 p -86.13 -42.02 14.24 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.76 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 23.4 m 72.21 161.75 0.25 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.18 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -115.52 121.65 34.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' 1518 ' ' ILE . 55.3 Cg_endo -84.2 121.46 2.72 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.73 118.38 33.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.471 HD23 HG21 ' A' 1607 ' ' VAL . 49.7 tp -78.42 116.84 19.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 46.8 tp -79.94 -56.12 4.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.608 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 50.9 m -164.21 136.24 4.75 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 122.614 0.365 . . . . 0.0 110.171 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.471 HG21 HD23 ' A' 1604 ' ' LEU . 82.3 t -103.35 110.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.22 100.17 10.35 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.487 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -80.58 7.07 10.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.081 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -89.8 -51.34 5.55 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.942 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1611 ' ' THR . . . . . . . . . . . . . 49.9 p -99.74 -9.53 22.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.581 0.229 . . . . 0.0 111.218 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 66.6 m 69.54 23.27 6.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.656 1.182 . . . . 0.0 111.075 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 13.4 m -91.22 114.23 26.7 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' 1616 ' ' PHE . 79.6 mt -93.83 121.91 35.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.92 113.56 27.18 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' 1614 ' ' LEU . 76.0 m-85 -121.9 139.19 53.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.1 m -119.92 108.81 14.79 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -93.14 110.24 21.74 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.511 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 39.4 m-70 -83.04 107.77 15.87 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.8 t -132.79 152.98 51.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.622 0.576 . . . . 0.0 110.068 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.7 m -70.62 -27.62 64.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.41 0.624 . . . . 0.0 110.065 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.82 -5.87 37.43 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.347 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -84.73 -9.01 58.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.605 0.717 . . . . 0.0 110.501 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.7 m -94.58 144.26 25.74 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1625 ' ' GLU . . . . . 0.466 ' HG2' ' HZ ' ' A' 1505 ' ' PHE . 47.3 mt-10 . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 121.51 0.671 . . . . 0.0 109.698 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 CA--C 1.499 -1.008 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 95.3 m 70.91 -1.4 2.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.602 0.715 . . . . 0.0 112.325 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -149.2 161.53 41.81 Favored 'General case' 0 N--CA 1.405 -2.692 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.5 p -146.74 121.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-O 121.88 0.847 . . . . 0.0 110.514 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.604 HG23 HG23 ' A' 1504 ' ' VAL . 17.7 m -91.67 104.18 16.68 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.05 135.9 47.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.087 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 -12.37 20.18 Favored 'Trans proline' 0 C--N 1.332 -0.324 0 C-N-CA 122.591 2.194 . . . . 0.0 112.212 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -66.51 -67.34 0.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.544 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 25.4 p -99.54 -23.0 15.23 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.45 73.28 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.376 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -74.63 137.4 42.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.177 0.513 . . . . 0.0 110.023 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.604 HG23 HG23 ' A' 1497 ' ' THR . 41.7 t -100.02 121.56 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -115.08 108.56 16.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.33 127.44 51.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.722 0.772 . . . . 0.0 109.479 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.4 tp -90.78 4.65 51.06 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' 1511 ' ' LYS . 79.7 m-20 -67.42 -27.21 66.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.415 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 35.9 p -79.61 -18.29 51.93 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.801 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' 1598 ' ' PRO . 25.6 mt -109.63 4.26 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.08 -0.388 . . . . 0.0 111.657 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' 1508 ' ' ASN . 21.1 pttp -85.17 153.02 22.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' 1515 ' ' GLY . 55.1 ttt180 -120.88 129.49 53.53 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.32 -42.76 92.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 111.111 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.0 m -82.25 1.45 36.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.54 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.56 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 76.37 166.21 22.37 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.405 0.447 . . . . 0.0 113.981 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' 1527 ' ' ARG . 89.0 m-85 -98.68 123.78 43.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.1 m -103.93 97.75 7.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.87 125.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.134 0.492 . . . . 0.0 111.664 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1519 ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' 1525 ' ' SER . 38.7 m -94.3 116.65 29.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1520 ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' 1604 ' ' LEU . 2.0 m-20 -119.43 99.72 6.85 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1521 ' ' ILE . . . . . 0.468 HG22 HD12 ' A' 1521 ' ' ILE . 47.8 mt 63.26 -104.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.932 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.97 -12.52 12.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.59 -35.6 79.29 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.728 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 122.26 -161.94 16.24 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1525 ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' 1519 ' ' SER . 9.0 m -96.21 123.1 39.71 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 7.7 tt -112.13 127.45 69.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.498 ' HG2' HG12 ' A' 1534 ' ' VAL . 40.1 ttm180 -104.83 118.57 36.89 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1528 ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' 1528 ' ' LEU . 1.2 mp -118.3 122.46 42.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.513 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' 1532 ' ' GLY . . . -100.88 97.2 1.66 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.31 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 60.3 t -66.27 115.2 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1531 ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' 1511 ' ' LYS . 68.0 m 59.65 15.15 4.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.858 0.863 . . . . 0.0 113.207 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1532 ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' 1529 ' ' GLY . . . -141.16 112.73 0.79 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1533 ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' 1535 ' ' LYS . 33.6 mt-10 -63.41 140.96 58.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.498 HG12 ' HG2' ' A' 1527 ' ' ARG . 16.0 m -85.41 89.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.265 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' 1533 ' ' GLU . 0.2 OUTLIER -62.33 -19.04 62.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.219 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.66 -23.08 64.51 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.708 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 32.0 t -121.74 4.7 10.02 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.599 0.714 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 102.41 152.08 24.1 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.979 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.09 153.19 75.51 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.492 2.128 . . . . 0.0 111.264 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.45 -10.07 70.83 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.331 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1541 ' ' ILE . . . . . 0.409 HD11 ' HD3' ' A' 1551 ' ' LYS . 42.4 mm -98.37 129.8 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.5 -50.64 1.28 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.108 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.03 132.49 55.49 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 49.1 t -136.52 149.98 48.42 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.414 0.15 . . . . 0.0 110.889 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.456 ' HZ ' HD11 ' A' 1614 ' ' LEU . 67.1 m-85 -93.63 160.75 14.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.817 0.818 . . . . 0.0 112.867 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.77 -22.18 66.78 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.701 2.0 . . . . 0.0 113.073 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -119.65 130.18 8.35 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.035 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1548 ' ' THR . . . . . 0.434 ' HB ' HG21 ' A' 1550 ' ' ILE . 23.9 m 73.77 -13.65 0.73 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 112.562 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.28 36.02 35.98 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.434 HG21 ' HB ' ' A' 1548 ' ' THR . 36.2 pt -81.51 143.03 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.606 ' HG2' ' OD1' ' A' 1574 ' ' ASP . 17.2 pttm -92.99 145.05 24.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.593 0.711 . . . . 0.0 111.434 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.15 15.67 26.0 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.627 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.779 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 141.2 141.48 3.98 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.934 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1554 ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' 1572 ' ' ASP . 48.0 mtpt -78.78 159.9 27.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 72.7 t90 -67.22 141.26 57.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.774 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.39 172.37 18.46 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.2 24.25 5.95 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.448 1.099 . . . . 0.0 109.757 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.37 103.36 15.41 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.258 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.33 130.56 54.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.0 t -121.38 109.67 15.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.12 103.54 15.59 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 95.8 t -127.7 105.01 13.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.318 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.4 t70 58.19 60.93 2.47 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 111.223 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.99 24.51 9.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.207 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1565 ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' 1590 ' ' PHE . 96.2 t -126.6 122.44 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.79 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.88 123.75 34.64 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.711 ' HB2' ' HB3' ' A' 1560 ' ' SER . 17.4 mm-40 -102.0 114.5 28.66 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.418 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.0 tp -116.64 102.71 9.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.522 HG23 HG21 ' A' 1587 ' ' VAL . 35.0 t -107.12 120.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.095 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.779 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 79.5 m-85 -86.21 108.94 18.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.7 154.44 21.64 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.219 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' A' 1554 ' ' LYS . 13.0 t70 56.21 86.11 0.07 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.753 1.621 . . . . 0.0 113.852 173.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1573 ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -107.32 -152.23 18.0 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.606 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 0.7 OUTLIER -83.23 146.57 51.46 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 116.962 0.381 . . . . 0.0 110.276 176.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 1575 ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 7.2 Cg_exo -73.52 143.92 35.22 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.234 2.623 . . . . 0.0 112.665 -175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.4 142.78 25.44 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.825 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.56 11.66 0.78 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.172 2.582 . . . . 0.0 114.091 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.45 -56.15 4.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.869 0.366 . . . . 0.0 110.543 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.78 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.4 m120 -133.91 7.91 3.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.806 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.0 mm? 70.48 -55.53 0.62 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.403 1.081 . . . . 0.0 113.096 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -74.88 -12.99 60.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.489 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.78 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 65.1 mt -82.45 131.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 95.3 mttt -131.39 162.09 30.93 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.733 0.645 . . . . 0.0 110.142 -174.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1584 ' ' TYR . . . . . 0.422 ' O ' ' HA3' ' A' 1573 ' ' GLY . 97.0 m-85 -66.87 112.64 4.39 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 123.937 0.773 . . . . 0.0 109.531 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -129.32 147.04 51.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.0 p -129.85 121.67 27.17 Favored 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.364 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.522 HG21 HG23 ' A' 1569 ' ' VAL . 3.0 p -111.36 111.22 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.853 0.835 . . . . 0.0 109.364 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.95 106.06 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 43.8 m -87.48 110.0 20.0 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.763 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.79 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.7 m-85 -86.04 101.66 13.13 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.4 m -100.02 160.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.224 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 28.3 t -76.46 120.53 21.81 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -143.16 97.08 3.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -107.7 19.2 20.46 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.073 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -70.52 -38.82 74.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.157 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 91.51 -174.07 37.75 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.146 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1598 ' ' PRO . . . . . 0.412 ' O ' HD21 ' A' 1510 ' ' LEU . 70.8 Cg_endo -71.78 -15.23 30.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.36 2.707 . . . . 0.0 112.028 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.7 p -79.91 -48.83 12.81 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 40.0 m 68.47 161.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.815 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.493 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 19.5 mt-30 -107.0 119.77 50.17 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.448 -0.783 . . . . 0.0 110.571 -174.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 3.8 Cg_endo -89.96 116.25 0.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.429 2.752 . . . . 0.0 112.006 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 56.6 tp -115.47 120.01 38.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' 1520 ' ' ASP . 60.8 tp -70.9 113.24 7.76 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.9 tp -87.93 -63.49 1.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.571 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 67.2 m -147.34 138.38 23.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.922 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 62.5 t -122.78 112.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -97.87 124.66 42.37 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.552 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.21 -8.27 59.36 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -102.78 -51.5 3.28 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.214 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.716 ' HA ' HD11 ' A' 1582 ' ' LEU . 36.4 p -86.83 -14.69 41.4 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 73.4 m 61.85 23.19 13.59 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.082 0.953 . . . . 0.0 111.637 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -86.14 115.65 23.84 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.456 HD11 ' HZ ' ' A' 1545 ' ' PHE . 87.1 mt -91.52 126.71 36.69 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.958 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.05 116.37 31.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.23 137.58 53.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.6 m -110.25 103.68 12.39 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.413 ' O ' ' HA ' ' A' 1590 ' ' PHE . 11.3 t-105 -99.47 105.81 17.78 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 85.2 m-70 -81.02 100.65 9.08 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.4 t -122.71 153.66 39.14 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.647 0.736 . . . . 0.0 111.474 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.7 m -76.11 -26.37 56.33 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.365 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.43 -5.23 31.22 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -90.59 -23.95 20.69 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.553 0.692 . . . . 0.0 110.242 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 66.8 m -72.91 142.26 47.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.483 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.0 p30 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.407 0.146 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.417 ' HA ' ' HG ' ' A' 1559 ' ' LEU . 85.3 m -121.99 15.29 10.78 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.49 1.138 . . . . 0.0 108.818 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.6 pt20 -139.05 116.88 11.54 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.2 p -137.57 141.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.669 ' HB ' HG23 ' A' 1504 ' ' VAL . 6.7 t -121.12 167.76 12.3 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 24.5 p30 -131.96 150.99 77.68 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.92 16.12 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.311 2.007 . . . . 0.0 112.413 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -93.69 -56.79 2.77 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.39 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.7 p -103.08 -27.97 12.25 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.61 0.719 . . . . 0.0 110.198 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.68 27.38 57.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.857 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 61.4 t80 -98.4 132.68 43.66 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.669 HG23 ' HB ' ' A' 1497 ' ' THR . 43.1 t -96.54 110.1 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' 1495 ' ' GLN . 65.7 m-85 -76.56 102.84 6.25 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.88 107.38 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.836 0.35 . . . . 0.0 110.777 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 -4.48 59.17 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.199 1.0 . . . . 0.0 109.153 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.528 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 48.6 m-80 -71.07 -21.28 62.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.896 -177.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 58.8 p -80.98 -7.65 59.59 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.667 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.66 11.35 15.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 33.1 mtmm -59.55 176.24 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.153 0.501 . . . . 0.0 111.677 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.792 ' HD3' HG12 ' A' 1534 ' ' VAL . 18.3 ttp180 -66.97 93.46 0.28 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.201 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.93 -38.99 10.43 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 168.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 28.3 t -118.37 -40.23 2.95 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.194 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.62 175.56 32.48 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' 1527 ' ' ARG . 12.4 m-85 -113.79 141.95 46.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1517 ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' 1526 ' ' ILE . 88.2 m -142.72 103.41 4.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.379 0.609 . . . . 0.0 110.845 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 22.7 pt -119.82 148.73 22.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 45.4 m -114.48 123.65 49.95 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.138 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.79 155.45 39.29 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.841 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.64 -24.7 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 124.087 0.955 . . . . 0.0 112.079 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1522 ' ' ARG . . . . . 0.822 HH22 HG13 ' A' 1607 ' ' VAL . 80.0 mtm180 -81.01 3.1 24.22 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.311 0.644 . . . . 0.0 111.262 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.78 62.15 0.33 Allowed 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.554 1.142 . . . . 0.0 111.038 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -121.42 91.48 0.47 Allowed Glycine 0 N--CA 1.409 -3.134 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.5 m -78.85 104.18 9.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1526 ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.2 tt -98.18 125.98 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.515 0.674 . . . . 0.0 109.317 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' 1516 ' ' TYR . 44.1 ttt180 -108.35 125.27 51.52 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.34 140.39 50.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.121 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -122.66 126.41 6.35 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 106.568 -2.613 . . . . 0.0 106.568 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.1 m -89.51 118.74 35.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.126 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 55.8 m 69.86 10.9 7.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.823 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -136.43 130.47 5.27 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1533 ' ' GLU . . . . . 0.596 ' HG3' ' HE3' ' A' 1535 ' ' LYS . 12.7 pt-20 -74.91 129.3 37.43 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.265 0.555 . . . . 0.0 111.62 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.792 HG12 ' HD3' ' A' 1512 ' ' ARG . 17.7 m -92.58 99.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 122.005 0.907 . . . . 0.0 109.842 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.596 ' HE3' ' HG3' ' A' 1533 ' ' GLU . 9.8 mptt -67.15 -12.12 59.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.071 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.18 -43.64 74.53 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 125.683 1.593 . . . . 0.0 109.151 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 58.1 m -104.23 -7.19 20.26 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.95 163.5 9.54 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.533 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.86 139.16 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.112 1.875 . . . . 0.0 111.365 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 71.88 30.43 65.84 Favored Glycine 0 C--N 1.305 -1.193 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.388 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.21 129.04 75.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -104.6 -35.84 3.19 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.116 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -122.78 124.67 43.86 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 27.4 p -140.07 154.64 47.12 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.755 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.556 ' HB2' ' HB ' ' A' 1550 ' ' ILE . 91.1 m-85 -93.96 116.48 28.93 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.13 100.65 3.7 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.484 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -174.8 -94.92 0.1 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 94.0 m -95.78 -37.42 10.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 117.153 0.477 . . . . 0.0 110.706 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 143.44 31.21 0.1 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.581 -1.295 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' 1545 ' ' PHE . 64.9 mt -71.39 125.17 29.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' 1574 ' ' ASP . 36.3 mttp -99.29 132.45 44.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.03 4.89 29.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.924 0.392 . . . . 0.0 111.285 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.932 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 156.94 140.19 2.89 Favored Glycine 0 C--O 1.254 1.403 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.027 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 60.4 mttp -79.21 155.51 28.57 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 67.5 t90 -64.57 124.91 23.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.17 140.53 7.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1557 ' ' GLN . . . . . 0.411 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 90.1 mt-30 -106.63 79.53 1.36 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -127.68 98.25 5.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.272 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' 1494 ' ' CYS . 34.6 mt -101.43 107.57 18.92 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.343 0.592 . . . . 0.0 109.89 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.07 113.72 26.06 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -90.71 101.35 14.1 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 78.3 t -135.47 141.4 42.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 60.54 24.02 13.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.791 0.836 . . . . 0.0 110.397 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 65.92 16.62 10.54 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 124.166 0.986 . . . . 0.0 110.855 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 7.3 p -121.49 155.29 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.802 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.6 mp -91.28 129.81 37.23 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -119.99 115.66 24.21 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.13 102.02 8.95 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' 1587 ' ' VAL . 7.6 p -106.95 112.51 40.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.563 0.697 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.932 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 30.6 m-85 -81.75 102.38 10.72 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -102.3 161.64 13.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.111 0.482 . . . . 0.0 111.896 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 8.5 t70 63.15 66.02 0.75 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.102 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -91.16 -93.0 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.391 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.556 ' HB2' ' H ' ' A' 1551 ' ' LYS . 3.3 t70 -123.25 149.82 58.58 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.02 137.58 82.58 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.776 2.317 . . . . 0.0 112.855 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 24.8 t -101.79 128.93 27.65 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.251 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.67 16.92 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.559 2.84 . . . . 0.0 114.283 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.54 -41.12 16.8 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.39 10.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.167 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 1.7 tm? 69.84 -53.7 0.61 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.274 1.43 . . . . 0.0 111.761 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -65.92 -24.01 66.74 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.032 0.533 . . . . 0.0 110.752 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' 1611 ' ' THR . 85.4 mt -81.11 141.08 34.64 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' 1585 ' ' LYS . 62.1 mttp -132.08 158.0 42.72 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -59.66 121.36 11.44 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 124.122 0.889 . . . . 0.0 109.474 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' 1583 ' ' LYS . 43.9 mtmt -130.76 134.42 46.86 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1586 ' ' SER . . . . . 0.628 ' HB3' HD11 ' A' 1614 ' ' LEU . 13.6 p -123.53 116.77 23.72 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.426 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' 1569 ' ' VAL . 7.5 p -102.83 109.31 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.066 0.936 . . . . 0.0 110.649 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1588 ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' 1618 ' ' TRP . 3.4 mp -97.62 108.85 22.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 14.7 t -95.9 119.51 34.52 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.802 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 88.8 m-85 -89.83 106.35 18.41 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 169.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' 1620 ' ' THR . 38.7 t -104.77 141.23 36.86 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 117.484 -1.686 . . . . 0.0 115.325 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 53.8 tptt -151.45 100.57 2.74 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.952 170.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1594 ' ' SER . . . . . 0.442 ' HA ' ' HB3' ' A' 1621 ' ' SER . 41.0 p -66.09 -9.63 32.9 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1595 ' ' ASP . . . . . 0.509 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 8.0 m-20 -92.97 6.21 48.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.893 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.728 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -76.55 -74.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 109.45 -120.13 5.69 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.614 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.05 17.77 1.69 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.477 2.785 . . . . 0.0 110.708 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1599 ' ' THR . . . . . 0.409 ' C ' ' HG ' ' A' 1600 ' ' SER . 13.6 t -153.76 -176.05 5.65 Favored 'General case' 1 N--CA 1.377 -4.121 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.728 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 41.4 m -155.48 155.7 33.95 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.566 0.746 . . . . 0.0 109.004 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.76 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 44.5 mt-30 -87.79 121.44 70.84 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 1.0 OUTLIER -88.95 128.78 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.391 2.727 . . . . 0.0 111.51 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' 1617 ' ' SER . 2.2 tm? -130.54 114.91 16.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.97 106.91 4.45 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 61.0 tp -75.02 -53.98 7.98 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.242 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.2 t -169.81 151.58 4.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.822 HG13 HH22 ' A' 1522 ' ' ARG . 65.0 t -125.91 131.78 71.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 19.2 t70 -110.74 117.17 32.72 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.8 -8.58 59.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -72.09 -40.46 68.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.761 0.315 . . . . 0.0 110.479 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.591 ' HA ' HD11 ' A' 1582 ' ' LEU . 23.4 p -121.66 -5.45 9.19 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 62.1 m 67.56 32.6 5.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.048 0.928 . . . . 0.0 111.152 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 44.1 m -92.04 126.61 37.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.959 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' 1586 ' ' SER . 59.0 mt -101.39 132.12 47.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.68 119.15 37.09 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.38 137.05 54.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.86 0.362 . . . . 0.0 111.621 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 27.3 m -104.11 105.42 15.57 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.452 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 12.6 t-105 -101.44 118.85 37.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 14.8 m-70 -94.79 97.57 10.14 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' 1592 ' ' CYS . 11.7 t -123.26 151.05 42.73 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.348 0.594 . . . . 0.0 111.608 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1621 ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' 1594 ' ' SER . 1.0 OUTLIER -74.23 -23.81 59.22 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.778 0.799 . . . . 0.0 110.49 178.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.74 -4.91 34.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.519 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -93.29 -5.86 48.78 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.793 0.33 . . . . 0.0 111.445 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 20.5 m -91.64 137.61 32.22 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 169.824 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 23.1 p-10 . . . . . 0 C--O 1.244 0.796 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.45 ' HA ' HD12 ' A' 1559 ' ' LEU . 6.1 t 59.03 33.3 22.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.003 1.321 . . . . 0.0 110.255 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -150.27 154.45 37.92 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.7 p -141.62 138.24 32.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.446 HG21 HG23 ' A' 1504 ' ' VAL . 23.7 m -104.08 113.59 27.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1498 ' ' ASN . . . . . 0.495 HD22 ' HB2' ' A' 1503 ' ' TYR . 6.0 p30 -81.89 130.86 59.01 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.34 -3.37 13.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.568 2.179 . . . . 0.0 112.649 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -75.44 -53.95 7.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.727 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1501 ' ' THR . . . . . 0.429 ' HB ' ' CD1' ' A' 1503 ' ' TYR . 17.2 p -109.21 -14.11 14.54 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.5 26.54 59.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.599 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1503 ' ' TYR . . . . . 0.495 ' HB2' HD22 ' A' 1498 ' ' ASN . 13.8 m-85 -99.22 120.4 39.46 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.22 -0.49 . . . . 0.0 109.977 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.446 HG23 HG21 ' A' 1497 ' ' THR . 25.4 t -89.39 113.35 25.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -100.23 111.18 23.44 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1506 ' ' ASP . . . . . 0.696 ' HB2' HD21 ' A' 1508 ' ' ASN . 3.0 p30 -104.01 130.87 51.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.059 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.79 0.18 56.12 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.082 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1508 ' ' ASN . . . . . 0.696 HD21 ' HB2' ' A' 1506 ' ' ASP . 41.4 m-80 -63.0 -38.5 91.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.49 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.9 t -71.08 -3.97 22.64 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.315 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.596 ' HB2' HD13 ' A' 1622 ' ' LEU . 0.9 OUTLIER -114.16 -41.78 3.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.266 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' 1508 ' ' ASN . 22.0 pttp -65.57 144.21 57.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' 1515 ' ' GLY . 40.5 ttm180 -88.58 161.92 16.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -50.11 -54.98 16.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.346 1.058 . . . . 0.0 111.342 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 3.0 p -87.6 -2.62 58.74 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 123.675 0.79 . . . . 0.0 111.872 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1515 ' ' GLY . . . . . 0.49 ' HA3' ' HA2' ' A' 1529 ' ' GLY . . . 86.74 -139.74 16.65 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -176.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' 1527 ' ' ARG . 95.7 m-85 -124.63 121.65 35.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 117.467 0.633 . . . . 0.0 111.124 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 32.9 m -110.5 94.83 5.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.25 155.3 11.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.355 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 22.4 m -79.9 131.21 35.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.447 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.31 147.8 27.74 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.852 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.77 -25.97 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.901 0.88 . . . . 0.0 112.727 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -83.87 3.26 34.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.987 0.422 . . . . 0.0 110.165 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1523 ' ' LYS . . . . . 0.601 ' HZ1' ' HB2' ' A' 1523 ' ' LYS . 0.1 OUTLIER 74.28 84.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.772 1.629 . . . . 0.0 111.358 -177.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1524 ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' 1545 ' ' PHE . . . -175.22 156.36 22.19 Favored Glycine 0 N--CA 1.404 -3.465 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 4.2 m -114.13 101.68 9.44 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.6 tt -83.41 119.71 33.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.196 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' 1516 ' ' TYR . 43.3 ttm180 -109.78 112.74 24.97 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.974 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.36 118.78 30.33 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.583 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1529 ' ' GLY . . . . . 0.49 ' HA2' ' HA3' ' A' 1515 ' ' GLY . . . -90.03 106.79 3.37 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 89.2 t -59.73 116.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 36.1 m 63.21 12.6 6.24 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.071 0.857 . . . . 0.0 111.609 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -129.27 172.4 19.79 Favored Glycine 0 N--CA 1.42 -2.395 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.063 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.97 141.74 40.64 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1534 ' ' VAL . . . . . 0.404 HG13 ' HG2' ' A' 1527 ' ' ARG . 26.6 m -103.9 90.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.252 1.025 . . . . 0.0 109.605 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -65.1 -16.61 63.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.82 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -64.83 -22.21 66.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.92 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 21.6 t -111.87 -13.67 13.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.429 0.633 . . . . 0.0 110.043 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.67 155.27 6.46 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.217 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.08 141.12 35.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.467 2.111 . . . . 0.0 111.071 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.85 8.87 87.23 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.331 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.56 135.05 46.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.23 -37.29 2.51 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.007 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -124.03 123.99 41.57 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 122.707 -0.29 . . . . 0.0 110.325 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 45.0 t -136.69 153.43 50.89 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.296 0.569 . . . . 0.0 110.821 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.455 ' CZ ' ' HA3' ' A' 1524 ' ' GLY . 58.9 t80 -90.15 100.29 13.15 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.494 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1546 ' ' GLU . . . . . 0.702 ' HG3' HG22 ' A' 1548 ' ' THR . 11.8 pt-20 47.71 21.24 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.784 2.034 . . . . 0.0 115.221 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 63.55 27.47 70.97 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.516 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1548 ' ' THR . . . . . 0.702 HG22 ' HG3' ' A' 1546 ' ' GLU . 32.9 p -83.24 -15.95 48.33 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 118.689 1.244 . . . . 0.0 109.985 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 122.6 -14.91 8.6 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.718 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 50.7 mt -79.48 118.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.423 ' HZ1' ' HB2' ' A' 1551 ' ' LYS . 8.6 mtmp? -97.79 137.48 36.6 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.499 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -111.48 11.63 21.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.369 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.833 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 155.53 130.55 1.33 Allowed Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.432 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.4 tttp -81.71 155.26 25.62 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 61.6 t90 -73.21 128.53 35.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.315 0.578 . . . . 0.0 110.08 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.47 139.5 14.31 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -86.89 78.16 9.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.287 0.565 . . . . 0.0 110.46 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 54.0 tptt -114.82 96.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.805 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' 1494 ' ' CYS . 86.2 mt -109.84 103.34 12.12 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.568 -1.196 . . . . 0.0 107.997 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.863 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 29.2 t -101.77 141.47 34.58 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 20.3 t80 -121.59 101.16 7.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1562 ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' 1565 ' ' VAL . 98.5 t -134.88 127.29 48.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.281 -176.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.37 33.83 22.57 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.441 1.115 . . . . 0.0 110.0 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 70.94 -0.03 3.2 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.351 1.06 . . . . 0.0 113.236 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1565 ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' 1562 ' ' VAL . 9.5 p -98.98 134.18 38.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.2 tp -84.97 132.26 34.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.863 ' HB2' ' HB3' ' A' 1560 ' ' SER . 94.0 mt-30 -122.07 114.99 21.68 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.739 -0.601 . . . . 0.0 112.121 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 48.4 tp -102.86 112.65 25.55 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' 1571 ' ' GLU . 44.4 t -105.83 112.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.592 -172.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.833 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 77.4 m-85 -95.19 115.2 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.457 ' HG2' HG11 ' A' 1569 ' ' VAL . 8.9 mm-40 -111.56 165.54 11.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 33.5 t70 60.72 80.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.474 1.109 . . . . 0.0 111.871 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.46 -127.56 6.14 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 1.0 OUTLIER -113.5 147.25 37.11 Favored Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 122.604 -0.35 . . . . 0.0 111.033 175.379 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1575 ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 23.5 Cg_exo -66.52 134.31 35.19 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.404 2.736 . . . . 0.0 112.832 -176.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 85.6 m -98.8 149.06 35.38 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.276 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.42 3.99 4.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.849 2.366 . . . . 0.0 115.869 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.29 -67.18 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.915 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 6.8 m-20 -110.26 2.19 19.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.246 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? 71.69 -57.62 0.61 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.337 1.055 . . . . 0.0 113.707 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -76.23 -10.44 59.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 111.168 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' 1611 ' ' THR . 70.8 mt -83.17 124.58 30.66 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 88.0 mttt -119.31 162.75 18.22 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.835 0.709 . . . . 0.0 110.043 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -58.97 109.34 0.81 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 124.01 0.819 . . . . 0.0 109.705 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -112.2 131.77 55.29 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.5 t -121.77 118.72 29.74 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.701 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -115.33 107.49 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.969 0.89 . . . . 0.0 109.844 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.96 107.32 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1589 ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' 1617 ' ' SER . 25.0 m -91.52 116.3 28.75 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.733 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 92.4 m-85 -86.12 105.53 16.6 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1591 ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' 1617 ' ' SER . 65.3 t -93.95 152.05 3.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.009 -175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.5 t -75.26 134.52 41.09 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.107 0.955 . . . . 0.0 112.822 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 54.3 tptt -149.68 101.34 3.06 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 171.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 71.1 m -63.21 -37.76 88.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.494 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -97.77 71.69 2.24 Favored 'General case' 0 N--CA 1.423 -1.813 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.937 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -133.3 -57.76 0.9 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.756 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.69 -147.67 38.91 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.94 -21.9 36.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.217 1.944 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.7 p -91.06 67.21 5.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 122.312 1.053 . . . . 0.0 109.356 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 15.1 m -76.85 161.77 28.16 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.685 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 16.9 mm-40 -105.43 121.11 47.29 Favored Pre-proline 0 C--N 1.301 -1.5 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.096 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1602 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.31 152.76 30.87 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.678 2.252 . . . . 0.0 110.104 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1603 ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' 1617 ' ' SER . 66.3 tp -154.88 120.3 5.03 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.102 -0.374 . . . . 0.0 110.979 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.61 113.47 16.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 42.8 tp -88.93 -43.51 11.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 40.1 t -167.62 150.65 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 84.9 t -130.6 111.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1608 ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' 1612 ' ' CYS . 31.7 t70 -93.65 122.74 36.42 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.521 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -80.14 -11.78 59.72 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.38 -52.5 5.16 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.166 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.654 ' HA ' HD11 ' A' 1582 ' ' LEU . 47.2 p -98.03 -17.03 19.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.974 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1612 ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' 1608 ' ' ASP . 75.6 m 69.95 25.18 4.94 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 124.108 0.88 . . . . 0.0 111.586 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 21.6 m -80.38 118.1 21.71 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.98 126.88 41.52 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.16 118.03 35.67 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.37 139.23 53.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1617 ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' 1589 ' ' SER . 21.7 m -121.65 103.72 9.1 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.666 0.746 . . . . 0.0 109.382 175.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -92.89 107.53 19.29 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -175.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.588 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 43.5 m80 -78.0 97.42 5.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.8 t -131.09 154.02 48.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.528 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.5 m -76.15 -25.09 54.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1622 ' ' LEU . . . . . 0.596 HD13 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.89 -5.03 31.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.471 0.653 . . . . 0.0 111.835 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.7 -3.05 30.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.066 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.1 m -96.04 144.71 26.07 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 168.142 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 38.6 t-20 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1494 ' ' CYS . . . . . 0.401 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 79.4 m -77.44 1.24 19.75 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.009 0.923 . . . . 0.0 111.816 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1495 ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.6 pt20 -117.15 118.25 31.82 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -118.96 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.831 0.824 . . . . 0.0 110.784 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1497 ' ' THR . . . . . 0.462 HG22 HG21 ' A' 1504 ' ' VAL . 24.8 m -96.49 125.9 41.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.243 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.93 133.52 30.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.73 4.53 6.84 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.21 1.94 . . . . 0.0 112.468 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -78.67 -68.38 0.65 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 19.7 p -101.26 -19.75 15.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.043 0.449 . . . . 0.0 111.826 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 100.29 2.24 55.72 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.539 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1503 ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' 1625 ' ' GLU . 56.3 m-85 -72.45 141.25 48.61 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.068 0.461 . . . . 0.0 111.605 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1504 ' ' VAL . . . . . 0.462 HG21 HG22 ' A' 1497 ' ' THR . 48.2 t -108.84 118.94 57.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1505 ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' 1495 ' ' GLN . 58.7 m-85 -95.39 101.56 13.29 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.25 112.32 24.51 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.066 0.46 . . . . 0.0 110.084 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 27.7 tp -84.86 -2.02 57.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.485 0.66 . . . . 0.0 111.143 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -79.6 -21.96 44.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.6 0.714 . . . . 0.0 109.781 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 28.4 t -78.24 -10.13 59.52 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1510 ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' 1598 ' ' PRO . 0.5 OUTLIER -106.34 -45.66 4.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1511 ' ' LYS . . . . . 0.544 ' HB2' ' HB ' ' A' 1530 ' ' VAL . 21.3 pttp -49.5 146.53 3.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 114.326 -173.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1512 ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 0.0 OUTLIER -103.72 127.31 51.2 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -64.04 -43.19 96.31 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.668 0.605 . . . . 0.0 112.391 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 47.6 m -86.25 6.27 30.44 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.037 0.446 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 80.33 161.14 23.9 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 113.152 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1516 ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' 1527 ' ' ARG . 81.0 m-85 -100.22 118.17 35.98 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 94.0 m -93.97 100.64 12.75 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.88 142.02 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 42.5 t -102.74 136.43 42.58 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1520 ' ' ASP . . . . . 0.532 ' HB2' HD21 ' A' 1604 ' ' LEU . 0.1 OUTLIER -84.49 175.14 9.5 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.82 -21.02 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 121.212 0.529 . . . . 0.0 111.293 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -91.9 3.05 56.05 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.15 0.58 . . . . 0.0 111.489 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1523 ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 17.2 mmtm 80.96 19.09 0.47 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -80.38 105.02 2.32 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 19.2 m -84.2 98.08 9.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.0 tt -103.78 133.86 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.125 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1527 ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' 1516 ' ' TYR . 29.4 ttt180 -108.9 112.74 25.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.99 122.99 47.94 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -98.15 127.0 9.09 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1530 ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' 1511 ' ' LYS . 58.9 t -87.85 116.94 30.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 83.7 m 69.68 0.63 3.06 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -134.34 140.76 12.04 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.0 137.75 41.74 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.008 0.432 . . . . 0.0 110.508 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 9.5 m -79.26 87.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.034 0.921 . . . . 0.0 109.973 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1535 ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.14 -18.56 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.379 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.91 -20.65 62.47 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 110.969 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.1 m -117.52 -20.49 9.01 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.304 -0.248 . . . . 0.0 111.561 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1538 ' ' GLY . . . . . 0.425 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 146.94 154.11 6.1 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.31 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1539 ' ' PRO . . . . . 0.425 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 24.2 Cg_exo -69.6 142.24 48.1 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 123.288 2.659 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.51 10.26 79.14 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.331 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.04 134.17 49.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1542 ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -101.25 -41.3 2.61 Favored Glycine 0 C--O 1.221 -0.661 0 C-N-CA 119.97 -1.11 . . . . 0.0 112.096 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -126.26 134.97 51.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.4 p -145.11 151.99 39.36 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 121.221 -0.192 . . . . 0.0 110.682 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1545 ' ' PHE . . . . . 0.428 ' HB2' HG13 ' A' 1550 ' ' ILE . 85.4 m-85 -92.26 120.1 32.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.77 109.73 10.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.612 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 165.09 -73.21 0.17 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 16.8 p -97.3 -18.09 19.38 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.526 0.679 . . . . 0.0 110.194 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 89.63 19.06 50.06 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1550 ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' 1545 ' ' PHE . 23.5 pt -66.43 135.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.712 0.768 . . . . 0.0 111.192 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1551 ' ' LYS . . . . . 0.419 ' HG3' ' OD1' ' A' 1574 ' ' ASP . 29.2 mttp -79.42 137.54 37.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.735 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1552 ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' 1584 ' ' TYR . . . -120.3 19.52 12.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.925 0.869 . . . . 0.0 108.763 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1553 ' ' GLY . . . . . 0.852 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 151.81 124.38 1.11 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.894 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1554 ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' 1554 ' ' LYS . 33.2 ttmt -83.83 144.59 29.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 90.0 t90 -59.92 131.74 51.81 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 123.73 0.644 . . . . 0.0 110.353 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -164.29 145.35 8.33 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -112.2 85.8 2.22 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -126.75 104.84 8.29 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.736 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1559 ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 3.5 mm? -100.57 118.06 35.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.188 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1560 ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 32.1 t -110.84 147.86 33.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 28.6 t80 -130.0 128.66 42.48 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.661 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1562 ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 73.2 t -113.33 156.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1563 ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' 1564 ' ' GLN . 19.5 t70 -48.11 113.21 0.69 Allowed 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 118.056 0.389 . . . . 0.0 110.653 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1564 ' ' GLN . . . . . 0.589 ' HB2' ' SG ' ' A' 1624 ' ' CYS . 7.4 pt20 56.2 21.28 5.12 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.857 2.063 . . . . 0.0 113.466 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1565 ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 58.9 t -137.11 118.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1566 ' ' LEU . . . . . 0.781 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.0 tp -89.26 131.84 35.17 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1567 ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' 1560 ' ' SER . 79.9 mm-40 -115.64 114.87 25.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -123.78 111.39 16.07 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1569 ' ' VAL . . . . . 0.696 HG23 HG22 ' A' 1587 ' ' VAL . 32.3 t -112.15 123.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.621 0.724 . . . . 0.0 111.285 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1570 ' ' TYR . . . . . 0.852 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 33.9 m-85 -98.96 100.82 12.04 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.245 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1571 ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 34.6 mt-10 -99.91 179.34 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.048 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.61 68.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.759 1.624 . . . . 0.0 112.766 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.97 -131.5 7.32 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.291 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1574 ' ' ASP . . . . . 0.419 ' OD1' ' HG3' ' A' 1551 ' ' LYS . 0.2 OUTLIER -89.83 140.38 27.82 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1575 ' ' PRO . . . . . 0.651 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 25.2 Cg_exo -66.27 142.26 65.91 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.663 2.242 . . . . 0.0 112.051 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1576 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 81.5 m -98.15 138.42 20.91 Favored Pre-proline 0 C--N 1.285 -2.224 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1577 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.2 Cg_exo -58.47 -22.74 60.63 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.619 2.879 . . . . 0.0 114.529 -172.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.29 46.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1579 ' ' ASN . . . . . 0.62 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.7 m120 -124.17 -8.24 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1580 ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' 1575 ' ' PRO . 3.7 mm? 68.17 -51.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.635 1.174 . . . . 0.0 113.376 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.1 m80 -73.42 -13.5 61.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.635 0.255 . . . . 0.0 111.578 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1582 ' ' LEU . . . . . 0.62 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 33.1 mt -90.28 132.56 35.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1583 ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.1 mttt -132.96 162.16 32.39 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1584 ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' 1552 ' ' ALA . 82.8 m-85 -62.86 117.46 6.39 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1585 ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 96.1 mttt -130.34 143.28 50.67 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 19.7 m -119.77 116.96 26.97 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1587 ' ' VAL . . . . . 0.696 HG22 HG23 ' A' 1569 ' ' VAL . 3.6 p -106.87 110.02 30.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.49 111.06 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.9 t -95.93 109.26 21.65 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1590 ' ' PHE . . . . . 0.781 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 88.0 m-85 -87.29 115.02 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.9 m -107.58 152.79 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1592 ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' 1620 ' ' THR . 6.3 m -76.39 124.64 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.206 0.527 . . . . 0.0 111.53 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1593 ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 21.8 tptp -139.32 112.37 8.03 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.0 t -70.64 -22.3 62.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.505 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 110.95 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1596 ' ' ALA . . . . . 0.855 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -90.35 -77.28 0.41 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 74.13 -143.68 32.33 Favored Glycine 0 C--O 1.248 1.011 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1598 ' ' PRO . . . . . 0.542 ' HA ' HD21 ' A' 1510 ' ' LEU . 40.2 Cg_endo -67.28 -21.72 47.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.344 2.03 . . . . 0.0 110.802 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 4.1 p -94.37 70.68 3.73 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.343 1.068 . . . . 0.0 109.352 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1600 ' ' SER . . . . . 0.855 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 30.5 m -75.73 167.83 21.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.931 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1601 ' ' GLN . . . . . 0.842 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 23.1 mt-30 -107.5 121.39 44.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.419 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1602 ' ' PRO . . . . . 0.445 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.3 Cg_endo -88.97 128.77 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.063 2.509 . . . . 0.0 110.658 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 44.8 tp -141.75 136.82 31.13 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.905 -0.497 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1604 ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' 1520 ' ' ASP . 67.7 tp -79.63 124.84 28.91 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.49 -39.7 9.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.3 t -177.0 161.41 1.92 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1607 ' ' VAL . . . . . 0.523 HG22 HD22 ' A' 1614 ' ' LEU . 7.5 p -141.78 138.92 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.0 119.87 36.09 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.04 -5.81 58.06 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 57.2 m80 -83.62 -51.2 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.599 0.714 . . . . 0.0 109.08 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1611 ' ' THR . . . . . 0.619 ' HA ' HD11 ' A' 1582 ' ' LEU . 0.2 OUTLIER -100.64 -9.3 22.05 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.917 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 74.6 m 63.99 37.53 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.294 1.038 . . . . 0.0 110.534 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1613 ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' 1611 ' ' THR . 6.1 m -87.53 113.97 23.71 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.414 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1614 ' ' LEU . . . . . 0.589 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 60.0 mt -93.38 115.72 28.27 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -100.74 112.47 24.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1616 ' ' PHE . . . . . 0.589 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 54.7 m-85 -120.79 131.28 54.38 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.764 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 12.8 p -102.82 104.41 14.68 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.886 0.85 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1618 ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 17.2 t-105 -92.63 114.93 27.62 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1619 ' ' HIS . . . . . 0.842 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.7 m-70 -88.45 102.06 14.53 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1620 ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.5 t -135.92 153.66 51.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.056 0.455 . . . . 0.0 110.739 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.5 m -74.15 -26.09 60.11 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.13 -5.65 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.045 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -77.1 -34.39 56.84 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.606 0.717 . . . . 0.0 109.527 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1624 ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' 1564 ' ' GLN . 1.8 m -98.58 171.81 7.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.54 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1625 ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' 1503 ' ' TYR . 40.9 mt-10 . . . . . 0 N--CA 1.426 -1.674 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 CA--C 1.495 -1.135 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 35.8 m -92.29 124.62 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.17 120.59 14.01 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -126.69 79.74 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.528 1.156 . . . . 0.0 108.648 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.8 p30 -93.6 -34.73 13.2 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.132 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.432 ' HA ' HD13 ' A' 1559 ' ' LEU . 62.3 m 57.89 28.85 16.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.331 1.02 . . . . 0.0 112.228 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' 1505 ' ' PHE . 9.5 pt20 -142.2 141.5 32.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.12 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 8.9 p -140.81 138.45 34.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 26.0 m -97.67 127.16 43.42 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.423 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.3 p30 -89.25 143.13 30.51 Favored Pre-proline 0 C--N 1.312 -1.022 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.454 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.05 -13.67 19.2 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.885 2.39 . . . . 0.0 113.752 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -74.34 -58.87 3.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.0 p -109.27 -10.9 14.93 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 75.06 33.38 54.81 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.728 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -103.07 143.29 32.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 46.1 t -102.4 127.35 56.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' 1495 ' ' GLN . 93.7 m-85 -93.99 103.61 15.68 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.98 103.15 15.02 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 34.4 tp -85.94 10.06 15.13 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-O 121.847 0.832 . . . . 0.0 110.045 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.69 -19.45 52.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.09 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 20.8 p -71.16 -14.43 62.27 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.328 0.585 . . . . 0.0 111.469 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.66 -69.6 0.76 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.832 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 58.9 mmtt 61.55 146.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' 1512 ' ' ARG . 4.2 tmm_? -71.84 96.9 1.72 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.69 -42.73 11.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 16.8 p -121.62 -31.54 3.98 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.924 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.26 133.17 7.87 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -77.77 125.21 29.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1517 ' ' THR . . . . . 0.578 ' HA ' ' O ' ' A' 1526 ' ' ILE . 13.3 t -129.77 100.93 5.67 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 122.86 1.314 . . . . 0.0 110.697 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1518 ' ' ILE . . . . . 0.485 HG23 ' HG2' ' A' 1602 ' ' PRO . 16.4 pt -93.82 155.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.053 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 32.7 t -98.15 130.73 44.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1520 ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 16.7 t70 -99.73 126.53 45.8 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.25 -24.91 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.577 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1522 ' ' ARG . . . . . 0.409 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.7 mtp-105 -85.61 -43.01 13.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1523 ' ' LYS . . . . . 0.47 ' HB2' ' HZ ' ' A' 1545 ' ' PHE . 31.9 mmmt -113.97 -73.93 0.64 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -169.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 179.49 -152.88 11.44 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 3.9 m -84.03 154.49 23.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.2 0.524 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.0 tt -130.6 118.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -103.26 115.52 30.72 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.14 132.27 54.32 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.173 0.511 . . . . 0.0 110.733 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -99.28 87.41 0.76 Allowed Glycine 0 N--CA 1.422 -2.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.895 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 34.7 m -72.56 128.41 35.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.882 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 47.6 t 66.27 15.6 10.15 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 121.513 0.673 . . . . 0.0 111.389 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . 178.44 113.96 0.39 Allowed Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1533 ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' 1535 ' ' LYS . 0.0 OUTLIER -61.71 160.32 11.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 21.3 m -96.99 122.07 48.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.62 0.724 . . . . 0.0 110.281 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' 1533 ' ' GLU . 3.4 mptp? -74.76 -24.67 58.73 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -53.14 -38.54 62.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.852 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 67.1 m -110.01 13.47 23.33 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.105 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 107.92 120.86 4.54 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.51 134.02 59.57 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.144 2.562 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 106.68 -29.36 11.0 Favored Glycine 0 C--N 1.286 -2.214 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.053 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.16 125.88 39.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.601 ' HA3' ' HE2' ' A' 1570 ' ' TYR . . . -99.69 -46.24 1.98 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.78 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -103.11 118.45 36.82 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 48.8 t -124.8 136.88 54.22 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 35.5 t80 -114.45 138.62 50.36 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.85 86.86 2.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.224 1.011 . . . . 0.0 110.868 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1547 ' ' GLY . . . . . 0.417 ' O ' HG13 ' A' 1550 ' ' ILE . . . -165.67 69.34 0.19 Allowed Glycine 0 C--N 1.289 -2.068 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.328 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.0 m 74.95 -34.77 0.27 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 111.595 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 146.09 50.32 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 79.3 mt -78.86 122.21 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' 1551 ' ' LYS . 9.3 mtmp? -96.92 115.16 26.94 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.28 12.73 36.95 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.974 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.801 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.9 133.83 2.12 Favored Glycine 0 N--CA 1.416 -2.64 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.641 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -81.83 141.55 33.34 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.415 ' HB2' ' HA3' ' A' 1542 ' ' GLY . 54.5 t90 -78.32 124.74 28.44 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.21 148.43 33.52 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . 0.255 24.0 mt-30 -77.91 73.54 4.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -99.34 77.43 2.12 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' 1494 ' ' CYS . 95.5 mt -104.93 97.78 7.6 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 7.8 t -117.46 139.1 51.35 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.782 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 86.1 t80 -106.42 109.19 21.04 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.384 0.611 . . . . 0.0 110.045 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 81.4 t -96.23 158.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.63 101.9 0.03 OUTLIER 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.171 0.989 . . . . 0.0 111.514 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 67.73 16.58 9.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.611 1.564 . . . . 0.0 113.549 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 20.2 t -139.94 119.79 13.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 121.987 -0.445 . . . . 0.0 110.317 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.841 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.8 tp -81.91 129.01 34.63 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -112.95 125.35 54.3 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.268 -0.27 . . . . 0.0 111.337 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1568 ' ' LEU . . . . . 0.577 ' HB3' ' HE1' ' A' 1590 ' ' PHE . 66.2 tp -129.68 114.39 15.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 10.4 p -117.99 129.45 74.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.861 0.838 . . . . 0.0 111.334 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.801 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 81.6 m-85 -95.04 115.17 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.64 177.29 4.69 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 5.3 m-20 56.67 64.04 1.78 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.72 -145.12 18.11 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -90.57 146.63 34.68 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.69 141.83 38.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.003 2.468 . . . . 0.0 110.976 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 75.7 m -99.68 142.21 24.2 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -61.91 -22.26 73.95 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 123.652 2.901 . . . . 0.0 113.911 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -58.21 -65.14 0.7 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.204 0.602 . . . . 0.0 112.399 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.446 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 5.4 m-20 -120.25 -2.53 10.11 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.877 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.9 mm? 69.45 -53.02 0.6 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.208 1.003 . . . . 0.0 113.419 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -62.71 -28.32 69.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.164 0.586 . . . . 0.0 109.836 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.852 HD11 ' HA ' ' A' 1611 ' ' THR . 64.5 mt -82.32 128.72 34.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.859 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 58.7 mttp -118.09 162.49 18.12 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1584 ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 98.3 m-85 -63.62 116.73 5.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -126.98 140.97 51.92 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1586 ' ' SER . . . . . 0.5 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 25.0 m -120.3 116.81 26.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -115.16 114.68 47.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.609 0.718 . . . . 0.0 109.797 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.36 115.48 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 7.7 t -96.67 106.58 18.88 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.841 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 94.3 m-85 -86.56 111.58 20.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.761 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.7 m -108.66 144.96 16.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.615 ' HA ' ' O ' ' A' 1620 ' ' THR . 3.1 p -76.66 143.44 40.11 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 49.4 tptt -157.66 114.01 2.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 24.4 m -71.82 -21.7 61.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.02 7.82 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 110.508 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.7 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -81.94 -67.59 0.77 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 61.47 -129.68 45.42 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.84 -16.78 54.3 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.593 2.196 . . . . 0.0 112.464 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.1 t -120.74 83.53 2.08 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 122.847 1.308 . . . . 0.0 110.59 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.7 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 18.1 m -77.86 143.02 38.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.402 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 13.9 pt20 -104.8 126.11 32.06 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-O 120.984 0.421 . . . . 0.0 111.878 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.485 ' HG2' HG23 ' A' 1518 ' ' ILE . 5.1 Cg_exo -82.83 160.01 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.327 2.685 . . . . 0.0 111.688 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.6 tp -148.78 130.13 14.71 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.601 HD11 HG22 ' A' 1607 ' ' VAL . 43.9 tp -86.36 115.97 24.22 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.2 -52.4 5.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.818 0.342 . . . . 0.0 110.372 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.8 t -167.25 138.85 3.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.601 HG22 HD11 ' A' 1604 ' ' LEU . 69.5 t -110.58 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.9 t70 -94.03 117.89 30.74 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.334 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.56 -6.21 57.9 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -95.93 -51.48 4.44 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.163 0.983 . . . . 0.0 108.935 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.852 ' HA ' HD11 ' A' 1582 ' ' LEU . 0.2 OUTLIER -95.04 -6.99 40.9 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.208 -1.815 . . . . 0.0 110.443 -171.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1612 ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 80.1 m 57.25 26.4 12.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.8 m -93.37 119.58 32.66 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.59 ' HB3' ' HE2' ' A' 1616 ' ' PHE . 85.5 mt -93.82 114.11 26.29 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.957 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.77 108.95 21.76 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.59 ' HE2' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -121.06 138.52 54.14 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.82 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 39.1 t -102.97 138.15 40.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -126.42 114.43 18.17 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.05 100.95 13.32 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.1 t -135.28 153.01 52.03 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.269 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 10.2 m -77.98 -26.48 48.68 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 48.3 mt -72.1 -5.16 33.34 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.146 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1623 ' ' ALA . . . . . 0.423 ' HB3' HG23 ' A' 1620 ' ' THR . . . -75.6 -31.2 59.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 111.793 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 91.0 m -123.28 162.55 22.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1625 ' ' GLU . . . . . 0.425 ' HG3' ' CZ ' ' A' 1505 ' ' PHE . 2.8 mp0 -70.02 102.82 2.11 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.229 0.538 . . . . 0.0 109.921 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -81.86 145.12 30.55 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.07 -11.17 58.93 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.43 0.633 . . . . 0.0 110.784 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.64 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 92.3 t -89.56 97.38 6.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 120.991 0.424 . . . . 0.0 110.586 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 52.6 tt0 55.22 81.13 0.12 Allowed 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.043 1.337 . . . . 0.0 110.934 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -118.72 92.67 3.87 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 122.579 1.181 . . . . 0.0 111.821 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1493 ' ' ASN . . . . . 0.617 ' HB2' ' HB2' ' A' 1557 ' ' GLN . 10.1 p30 -125.57 127.99 47.24 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.915 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 84.2 m 63.59 21.53 12.77 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.471 1.129 . . . . 0.0 110.393 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.3 pt20 -152.35 141.2 21.06 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.4 p -136.52 134.96 49.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 8.8 m -106.93 121.89 45.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.43 125.25 50.49 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.16 -6.46 18.35 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.408 2.072 . . . . 0.0 113.143 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.26 -65.49 0.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.259 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 62.0 p -92.99 -24.88 18.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.859 0.837 . . . . 0.0 110.028 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 88.58 9.31 69.22 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 60.5 t80 -80.81 127.86 33.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.309 0.576 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.7 p -98.96 116.0 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.4 m-85 -79.28 98.92 6.85 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -95.09 104.51 16.38 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.332 0.586 . . . . 0.0 110.739 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.84 -9.37 59.83 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.541 0.686 . . . . 0.0 109.913 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.486 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 45.8 m-80 -70.25 -12.3 61.5 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 57.9 m -84.74 -16.14 42.66 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 32.2 tp -114.1 -20.5 10.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.755 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.572 ' CB ' ' HB ' ' A' 1530 ' ' VAL . 56.4 pttt -54.69 140.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.716 0.635 . . . . 0.0 112.076 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -127.44 102.64 6.97 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1513 ' ' GLU . . . . . 0.456 ' HG3' ' HA3' ' A' 1532 ' ' GLY . 31.9 tt0 -76.21 -20.47 57.43 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 24.6 m -61.32 -25.11 66.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.084 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 96.06 136.39 8.78 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.75 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' 1527 ' ' ARG . 74.3 m-85 -83.5 118.21 23.62 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 172.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 26.6 m -110.6 104.01 12.66 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.68 150.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.21 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.9 m -79.17 115.29 18.74 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.529 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.86 144.64 56.9 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.855 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.3 tt -74.03 -18.46 17.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.642 1.177 . . . . 0.0 110.94 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -90.25 2.82 55.03 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.848 -0.533 . . . . 0.0 109.583 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.5 tptp 79.14 90.19 0.06 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.939 1.696 . . . . 0.0 110.098 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1524 ' ' GLY . . . . . 0.403 ' HA3' ' HZ ' ' A' 1545 ' ' PHE . . . -176.77 -161.02 24.85 Favored Glycine 0 N--CA 1.412 -2.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.2 t -144.6 139.74 28.3 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 15.0 tt -132.62 139.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' 1516 ' ' TYR . 33.4 ttt180 -127.91 120.33 27.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.3 136.08 54.52 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.921 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.7 158.97 14.08 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' 1511 ' ' LYS . 59.9 t -106.48 115.81 48.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 118.237 1.018 . . . . 0.0 108.31 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 77.9 m 57.58 26.83 13.28 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.951 0.782 . . . . 0.0 112.445 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1532 ' ' GLY . . . . . 0.456 ' HA3' ' HG3' ' A' 1513 ' ' GLU . . . -130.04 142.15 13.37 Favored Glycine 0 N--CA 1.414 -2.769 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.38 126.62 35.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.586 HG22 ' HB2' ' A' 1537 ' ' CYS . 27.8 m -94.9 98.95 8.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' 1535 ' ' LYS . 10.0 mptt -67.19 -20.88 65.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.639 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.81 -10.17 59.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.892 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1537 ' ' CYS . . . . . 0.586 ' HB2' HG22 ' A' 1534 ' ' VAL . 73.3 m -116.06 7.63 14.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 115.94 137.27 6.1 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.656 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.33 128.07 19.57 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.351 2.034 . . . . 0.0 110.126 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.62 11.73 61.82 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.426 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.8 mm -112.74 128.5 69.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.66 -22.06 7.92 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.929 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -134.1 127.21 31.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 29.0 p -144.36 154.92 43.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.482 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.403 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 44.4 t80 -84.92 134.91 34.25 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -86.2 97.66 10.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 160.41 -91.74 0.11 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.7 p -71.2 -21.15 62.18 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 90.85 18.6 46.89 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.792 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 22.8 pt -74.14 131.4 35.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.248 0.547 . . . . 0.0 110.004 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 19.8 pttm -84.17 142.52 30.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.38 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -113.21 11.56 18.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.921 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.28 135.94 2.18 Favored Glycine 0 N--CA 1.433 -1.509 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.755 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1554 ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' 1572 ' ' ASP . 29.3 mtpp -75.37 150.89 38.28 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.157 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.77 125.98 26.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.322 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.11 158.39 43.87 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1557 ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' A' 1493 ' ' ASN . 3.4 pt20 -124.16 33.53 5.26 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.927 0.87 . . . . 0.0 109.622 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.88 95.73 7.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.482 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.31 110.9 23.37 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 15.9 p -89.48 119.19 29.71 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.264 0.554 . . . . 0.0 111.359 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1561 ' ' TYR . . . . . 0.646 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 16.0 t80 -92.93 101.17 13.52 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 94.3 t -106.89 104.89 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.739 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.32 63.32 1.91 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.214 1.406 . . . . 0.0 111.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1564 ' ' GLN . . . . . 0.646 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 64.5 mt-30 66.12 11.62 7.95 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 113.908 -1.496 . . . . 0.0 114.197 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 93.4 t -116.87 139.2 44.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.829 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.6 113.64 22.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -109.02 114.68 28.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.898 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.79 110.81 17.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.53 121.61 66.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.859 0.837 . . . . 0.0 111.703 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.921 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.3 m-85 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.167 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.433 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 36.9 mt-10 -101.02 174.31 6.07 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' 1554 ' ' LYS . 9.8 t70 53.97 73.26 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.738 1.615 . . . . 0.0 111.5 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -96.25 -140.09 10.89 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 0.2 OUTLIER -87.37 138.94 31.9 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 1575 ' ' PRO . . . . . 0.66 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 14.9 Cg_exo -68.38 135.39 33.79 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.854 2.369 . . . . 0.0 112.975 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 62.7 m -98.76 131.02 26.49 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.823 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.1 2.54 2.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.414 2.742 . . . . 0.0 115.542 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -72.88 -50.45 23.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.965 0.412 . . . . 0.0 110.172 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.877 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 17.3 m120 -132.43 -0.1 3.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.45 -47.12 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.39 -5.81 48.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.146 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.877 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 61.5 mt -89.05 126.54 35.48 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.66 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 98.1 mttt -133.24 159.04 41.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -61.51 113.24 2.57 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.986 0.804 . . . . 0.0 108.86 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.433 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.6 mtpt -124.51 136.16 53.77 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.8 m -120.0 116.12 25.11 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 6.1 p -110.34 109.76 29.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.927 0.87 . . . . 0.0 109.67 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.85 111.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.036 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 67.1 m -92.3 112.01 23.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.829 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 94.9 m-85 -86.53 103.1 14.73 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' 1619 ' ' HIS . 29.7 m -105.84 161.49 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.194 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.7 t -76.88 136.89 38.88 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.601 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 23.3 tptm -149.99 105.23 3.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 77.0 p -62.36 -37.78 87.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.256 0.55 . . . . 0.0 110.281 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.64 76.3 3.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.531 0.682 . . . . 0.0 110.213 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -128.09 -64.38 0.96 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.837 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 66.91 -133.6 31.74 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 -20.1 35.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.405 2.07 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.9 p -102.49 73.22 1.3 Allowed 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.66 0.743 . . . . 0.0 111.034 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.514 ' HB3' ' HB ' ' A' 1620 ' ' THR . 42.1 m -86.03 105.56 16.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.447 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 24.4 mt-30 -77.01 126.14 85.91 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -171.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.1 Cg_endo -83.99 111.37 1.65 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 123.398 2.732 . . . . 0.0 110.702 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' 1617 ' ' SER . 62.0 tp -88.68 123.53 33.22 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.04 91.72 5.52 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.25 -59.13 3.44 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.865 -175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 46.4 m -158.91 132.4 7.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 65.2 t -106.75 111.04 33.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.15 102.47 14.51 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.97 -20.2 60.43 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.438 -170.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.57 -45.52 12.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.962 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.794 ' HA ' HD12 ' A' 1582 ' ' LEU . 68.4 p -85.72 -16.35 39.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.504 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.6 m 71.1 26.64 3.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 110.413 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 9.7 m -93.11 116.7 29.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.825 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 80.2 mt -99.09 116.91 32.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -100.82 117.33 34.69 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -120.68 133.42 55.35 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.866 0.466 . . . . 0.0 110.216 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 19.5 m -107.21 103.77 13.23 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -95.46 107.05 19.18 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.601 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 26.2 m80 -83.37 104.18 13.32 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' 1600 ' ' SER . 10.2 t -131.99 150.42 52.16 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.449 0.642 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.7 p -77.13 -22.15 53.07 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.28 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 44.6 tp -71.42 -7.09 45.05 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.434 0.635 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.72 -4.19 26.89 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.226 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.9 m -87.07 176.61 7.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.99 122.26 31.38 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -111.09 117.17 32.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.44 -23.32 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--O 1.251 1.138 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.901 -178.806 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1489 ' ' MET . . . . . 0.681 ' HG3' HG21 ' A' 1490 ' ' VAL . 22.5 ptp . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 121.029 0.443 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1490 ' ' VAL . . . . . 0.681 HG21 ' HG3' ' A' 1489 ' ' MET . 57.2 t -116.31 88.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -87.37 91.53 8.76 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' 1495 ' ' GLN . 10.4 p-10 -73.46 82.16 1.45 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.724 -1.58 . . . . 0.0 114.042 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -92.88 80.58 4.64 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 72.3 m 64.55 40.32 6.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.853 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.4 pt20 -136.63 152.03 49.98 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 13.8 p -157.87 139.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.6 m -97.59 132.94 42.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.435 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 8.2 p30 -99.23 126.77 36.75 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.06 -10.69 29.67 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.786 2.324 . . . . 0.0 113.828 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -61.58 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 27.2 p -96.46 -26.55 15.26 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.135 0.493 . . . . 0.0 111.653 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 89.81 11.57 63.47 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1503 ' ' TYR . . . . . 0.403 ' HB3' HD22 ' A' 1498 ' ' ASN . 87.7 t80 -83.92 136.91 33.91 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 114.954 -0.623 . . . . 0.0 109.914 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' 1497 ' ' THR . 49.0 t -99.54 114.18 36.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' 1495 ' ' GLN . 98.5 m-85 -77.12 98.66 5.12 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.11 108.05 19.63 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1507 ' ' LEU . . . . . 0.55 HD11 HD21 ' A' 1510 ' ' LEU . 15.7 tp -86.22 4.24 39.55 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.673 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.591 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 51.2 m-80 -70.92 -18.66 62.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 47.4 t -80.18 -10.83 59.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.55 HD21 HD11 ' A' 1507 ' ' LEU . 69.0 tp -116.6 -25.61 7.33 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.95 -0.469 . . . . 0.0 111.469 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.666 ' HB2' ' O ' ' A' 1530 ' ' VAL . 19.2 pttp -56.49 142.33 39.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.647 0.737 . . . . 0.0 112.571 -174.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -128.76 106.07 8.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1513 ' ' GLU . . . . . 0.41 ' HA ' ' HA3' ' A' 1532 ' ' GLY . 32.4 tt0 -65.01 -34.11 77.66 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.634 0.773 . . . . 0.0 110.799 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 20.4 m -72.95 -11.69 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.429 0.633 . . . . 0.0 110.341 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.656 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 78.33 161.66 18.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 114.587 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -97.98 128.74 44.73 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 25.2 m -100.53 98.2 8.82 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1518 ' ' ILE . . . . . 0.406 HG13 HG22 ' A' 1526 ' ' ILE . 18.1 pt -109.04 111.14 34.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.822 0.82 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1519 ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.7 t -95.67 112.38 24.11 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.686 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 15.2 t70 -100.62 120.68 40.41 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.4 -10.16 11.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.521 0.677 . . . . 0.0 112.384 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -92.99 -39.01 11.35 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 121.956 -0.465 . . . . 0.0 110.713 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1523 ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' 1523 ' ' LYS . 71.8 mmtt -109.23 -34.9 6.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 136.99 177.74 15.27 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1525 ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' 1519 ' ' SER . 32.5 t -79.85 127.99 32.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.406 HG22 HG13 ' A' 1518 ' ' ILE . 10.7 tt -123.08 122.3 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -108.35 116.05 31.25 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.13 120.29 37.31 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.297 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.656 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -93.52 118.96 5.82 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.666 ' O ' ' HB2' ' A' 1511 ' ' LYS . 46.0 t -75.45 116.17 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.676 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 68.1 m 59.1 20.43 8.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.216 0.948 . . . . 0.0 112.047 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1532 ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' 1513 ' ' GLU . . . -135.86 132.8 6.3 Favored Glycine 0 N--CA 1.401 -3.685 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1533 ' ' GLU . . . . . 0.507 ' O ' ' HD3' ' A' 1535 ' ' LYS . 21.6 mt-10 -76.39 130.02 37.44 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 15.4 m -80.1 93.1 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.52 0.676 . . . . 0.0 110.901 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' 1533 ' ' GLU . 0.0 OUTLIER -59.3 -26.45 64.99 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.49 -178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.17 -37.3 66.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.176 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 43.3 t -107.19 -25.37 11.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.948 0.404 . . . . 0.0 110.133 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 143.17 144.92 4.34 Favored Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.3 152.2 81.09 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.547 2.165 . . . . 0.0 110.795 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.5 -27.35 6.43 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.807 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.0 mm -89.59 136.09 24.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.04 -37.12 2.58 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.294 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -125.84 128.07 47.06 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 44.2 t -139.59 139.86 36.9 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.686 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.411 ' HZ ' HD13 ' A' 1614 ' ' LEU . 98.2 m-85 -87.02 124.29 33.04 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1546 ' ' GLU . . . . . 0.556 ' HB2' ' HB3' ' A' 1525 ' ' SER . 47.4 mt-10 -82.05 107.99 15.19 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.738 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 172.39 -71.65 0.1 Allowed Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.3 m -106.9 -24.82 11.91 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.572 0.701 . . . . 0.0 109.397 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 103.7 34.33 3.85 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.02 131.03 35.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.433 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 25.8 pttm -93.22 138.65 31.41 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.95 8.06 43.26 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 140.74 149.48 5.28 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.876 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.31 155.72 17.36 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.385 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.676 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 39.0 t90 -71.49 143.61 49.95 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.2 152.74 38.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -106.07 9.88 32.29 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.59 107.12 19.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.063 0.458 . . . . 0.0 110.651 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 74.6 mt -88.59 125.8 34.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.863 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.8 m -90.24 121.84 32.62 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.2 t80 -98.89 116.12 30.4 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 122.23 -0.294 . . . . 0.0 110.416 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.4 t -121.24 80.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 38.7 t70 40.45 83.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.154 1.781 . . . . 0.0 114.518 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 64.05 19.24 11.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.498 1.119 . . . . 0.0 112.849 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 58.6 t -133.9 119.89 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.42 133.87 37.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.943 0.401 . . . . 0.0 110.302 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.863 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -110.83 114.7 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.573 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 34.1 tp -116.45 107.35 14.66 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.559 HG23 HG22 ' A' 1587 ' ' VAL . 17.1 t -105.99 108.55 25.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.095 -174.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.602 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 61.3 m-85 -82.08 107.16 14.56 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.405 ' HG2' ' HG2' ' A' 1585 ' ' LYS . 37.5 mt-10 -106.5 178.33 4.59 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.585 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.586 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 24.4 t70 56.73 67.06 1.04 Allowed 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.87 1.356 . . . . 0.0 111.241 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1573 ' ' GLY . . . . . 0.433 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -93.25 -155.25 31.81 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 173.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -82.57 158.17 66.22 Favored Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 117.605 0.703 . . . . 0.0 109.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.63 140.08 35.28 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.272 1.981 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 83.5 m -101.33 133.92 20.61 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.196 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.09 7.8 1.0 Allowed 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.31 2.673 . . . . 0.0 113.633 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.33 -52.96 6.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.13 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.524 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 2.4 m-20 -131.83 -2.36 3.71 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.802 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 31.9 tp 71.47 -47.82 0.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.908 1.283 . . . . 0.0 113.032 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -73.33 -12.81 60.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.451 0.643 . . . . 0.0 110.277 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.876 HD13 ' HA ' ' A' 1611 ' ' THR . 89.4 mt -85.58 127.62 34.51 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.042 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.586 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 44.5 mttm -112.54 152.92 28.27 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.494 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -60.07 123.62 17.7 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.725 0.64 . . . . 0.0 109.87 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.405 ' HG2' ' HG2' ' A' 1571 ' ' GLU . 62.8 mttt -131.69 131.4 43.06 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.6 t -120.86 116.66 25.6 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.559 HG22 HG23 ' A' 1569 ' ' VAL . 3.3 p -108.12 101.32 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.966 0.889 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.72 114.11 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.3 m -95.93 109.63 21.97 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.731 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.658 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.4 m-85 -86.18 108.1 18.18 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 m -103.87 166.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 13.0 t -75.96 120.39 21.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 123.988 0.915 . . . . 0.0 112.91 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.72 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 48.1 tptt -152.55 99.47 2.47 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.3 m -65.82 -30.81 71.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1595 ' ' ASP . . . . . 0.72 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 10.3 t70 -85.57 67.76 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -143.54 -56.44 0.39 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.718 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 79.09 -160.92 46.84 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.63 -20.14 35.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 110.869 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -92.31 53.97 2.23 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.923 0.868 . . . . 0.0 109.102 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.1 m -62.3 140.66 58.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.015 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -106.32 124.61 35.24 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 52.8 Cg_endo -87.92 133.88 3.07 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.167 2.578 . . . . 0.0 112.515 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.1 tp -118.92 134.93 54.85 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.412 HD13 HG23 ' A' 1607 ' ' VAL . 45.1 tp -72.76 118.86 16.21 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.34 -43.37 12.93 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1606 ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' 1615 ' ' PHE . 21.6 t -179.9 146.98 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.412 HG23 HD13 ' A' 1604 ' ' LEU . 95.9 t -123.09 121.14 62.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1608 ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' 1610 ' ' HIS . 32.5 t70 -115.2 103.09 10.5 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.742 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.4 8.28 7.93 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.049 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1610 ' ' HIS . . . . . 0.432 ' HB2' ' OD2' ' A' 1608 ' ' ASP . 51.7 m80 -88.81 -51.48 5.62 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.876 ' HA ' HD13 ' A' 1582 ' ' LEU . 1.6 m -98.84 -6.17 29.63 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.526 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 76.6 m 62.1 30.74 17.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.257 1.023 . . . . 0.0 111.198 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 14.5 m -97.3 116.7 30.0 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.41 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.589 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 84.7 mt -96.93 120.2 36.83 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.31 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1615 ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' 1606 ' ' SER . 72.7 m-85 -105.21 112.22 25.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.589 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.1 m-85 -122.41 135.39 54.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 42.1 p -113.05 110.89 21.22 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' 1602 ' ' PRO . 1.5 t-105 -97.24 115.91 28.49 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 48.6 m80 -83.59 99.43 10.17 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -128.74 151.12 49.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.881 0.848 . . . . 0.0 111.485 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.9 m -76.88 -27.69 55.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.434 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.44 -5.95 40.22 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.277 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.59 -1.44 35.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.594 0.711 . . . . 0.0 110.345 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 12.3 t -113.77 170.32 8.34 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.59 99.08 0.2 Allowed 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 123.869 0.731 . . . . 0.0 110.022 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -122.78 141.63 51.61 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 -26.08 15.01 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.583 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.309 -1.169 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 -175.747 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1489 ' ' MET . . . . . 0.693 ' HG2' HG12 ' A' 1490 ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1490 ' ' VAL . . . . . 0.693 HG12 ' HG2' ' A' 1489 ' ' MET . 26.8 m -127.18 149.26 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.91 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -153.58 88.69 1.29 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.854 ' HB2' ' HG3' ' A' 1495 ' ' GLN . 38.2 p-10 -150.8 107.58 3.53 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.826 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1493 ' ' ASN . . . . . 0.531 ' HB2' ' OE1' ' A' 1557 ' ' GLN . 3.6 p-10 -117.32 123.43 46.5 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.439 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 64.9 m 73.27 0.09 3.55 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.053 0.93 . . . . 0.0 112.113 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.854 ' HG3' ' HB2' ' A' 1492 ' ' ASP . 21.1 pt20 -128.91 147.39 50.83 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.9 p -132.48 118.25 34.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 122.112 0.958 . . . . 0.0 110.868 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.762 HG21 HG21 ' A' 1504 ' ' VAL . 6.0 m -96.37 101.51 13.16 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.19 122.17 49.38 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.36 -8.02 19.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.215 2.61 . . . . 0.0 112.53 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.95 -56.61 17.4 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.758 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1501 ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' 1503 ' ' TYR . 57.7 p -101.01 -28.39 12.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 85.46 10.77 76.44 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.45 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1503 ' ' TYR . . . . . 0.416 ' CD2' ' HB ' ' A' 1501 ' ' THR . 56.6 m-85 -99.54 131.6 45.43 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.762 HG21 HG21 ' A' 1497 ' ' THR . 28.3 t -90.48 99.23 9.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -83.32 105.71 14.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1506 ' ' ASP . . . . . 0.407 ' OD1' ' HB3' ' A' 1495 ' ' GLN . 24.3 t70 -105.26 112.03 25.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.228 0.537 . . . . 0.0 111.862 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.9 tp -85.27 -4.49 59.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.035 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.689 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 62.6 m-80 -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 69.6 m -77.3 -10.03 59.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.111 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.442 ' HB2' HD11 ' A' 1622 ' ' LEU . 26.2 tp -109.92 8.05 24.11 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.434 0.635 . . . . 0.0 109.493 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 53.5 mtmt -58.54 143.7 45.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.646 ' H ' ' HB ' ' A' 1530 ' ' VAL . 32.2 tpt180 -127.25 97.9 5.09 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -25.38 60.27 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.522 0.514 . . . . 0.0 110.711 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 45.5 t -67.6 -26.31 66.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 88.14 153.82 26.66 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -89.8 114.78 26.56 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 6.5 p -103.56 92.34 4.42 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.03 0.919 . . . . 0.0 109.8 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.5 pt -120.55 153.44 23.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.742 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1519 ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' 1524 ' ' GLY . 15.5 p -103.95 118.27 36.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.79 174.69 1.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.515 0.509 . . . . 0.0 111.009 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.2 tp -61.85 -24.26 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.74 -5.82 58.48 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 73.73 74.44 0.13 Allowed 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.918 1.687 . . . . 0.0 112.454 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1524 ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' 1519 ' ' SER . . . -151.37 139.16 6.98 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 174.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 47.6 m -87.78 129.2 35.26 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.898 0.849 . . . . 0.0 111.673 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.4 tt -122.0 142.1 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -118.24 116.74 27.4 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.546 0.738 . . . . 0.0 109.076 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.61 125.92 43.92 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.86 129.74 10.0 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.449 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.646 ' HB ' ' H ' ' A' 1512 ' ' ARG . 47.5 t -79.52 115.22 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.514 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.669 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 69.9 m 46.25 66.91 0.85 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 125.141 1.526 . . . . 0.0 113.461 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -171.25 175.17 44.92 Favored Glycine 0 N--CA 1.404 -3.459 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.78 134.89 48.54 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.7 m -88.9 97.13 6.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.739 0.78 . . . . 0.0 110.689 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -22.54 54.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.941 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.22 -26.44 66.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.653 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 61.5 m -102.91 0.2 32.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.32 150.63 18.26 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.58 145.79 87.89 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.404 2.069 . . . . 0.0 112.48 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1540 ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' 1555 ' ' TRP . . . 82.41 14.73 75.67 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 114.81 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.33 131.62 63.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 118.082 0.941 . . . . 0.0 109.221 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.49 -28.31 7.18 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.901 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.796 0.332 . . . . 0.0 111.147 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 69.0 m -142.59 149.24 38.74 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.477 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 56.1 t80 -94.88 118.81 32.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.75 110.02 4.7 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.17 0.918 . . . . 0.0 112.488 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 144.82 -80.04 0.23 Allowed Glycine 0 C--N 1.296 -1.677 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.032 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 20.1 m -72.38 -19.77 61.56 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.321 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 79.29 41.78 13.06 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.621 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.425 ' CG1' ' HB3' ' A' 1545 ' ' PHE . 20.9 pt -93.46 131.01 41.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 56.4 mttm -85.44 129.2 34.87 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.552 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -98.86 7.73 45.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.055 0.455 . . . . 0.0 111.172 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.62 146.02 4.31 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.985 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 50.6 tttm -69.32 145.46 52.99 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.028 0.931 . . . . 0.0 109.588 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.66 ' CZ3' ' HA ' ' A' 1531 ' ' CYS . 7.0 t-105 -66.24 109.67 2.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.75 161.23 41.06 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -178.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1557 ' ' GLN . . . . . 0.531 ' OE1' ' HB2' ' A' 1493 ' ' ASN . 51.2 mt-30 -120.6 67.83 0.85 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.033 0.92 . . . . 0.0 108.849 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.4 tptt -96.86 95.38 7.82 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.776 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 4.2 mm? -104.7 104.85 14.73 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.111 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.804 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.3 m -100.07 139.46 35.71 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 89.3 t80 -113.98 117.8 32.33 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.479 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1562 ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 67.6 t -103.43 153.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.28 100.79 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 123.901 0.881 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 68.47 19.06 8.89 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.959 1.704 . . . . 0.0 112.33 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1565 ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 49.0 t -134.07 119.57 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.7 tp -87.37 140.18 29.79 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.804 ' HB2' ' HB2' ' A' 1560 ' ' SER . 23.9 mm-40 -124.65 115.25 20.48 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.722 -0.611 . . . . 0.0 111.097 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 63.0 tp -109.9 120.31 42.08 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.477 HG22 HG21 ' A' 1587 ' ' VAL . 32.5 t -117.35 131.45 70.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.132 0.491 . . . . 0.0 110.461 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.717 ' HB2' ' HB2' ' A' 1586 ' ' SER . 63.5 m-85 -103.1 105.8 16.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.65 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.442 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.91 92.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.934 1.396 . . . . 0.0 112.179 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.33 -158.07 12.9 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.507 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.83 151.57 52.54 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.99 147.59 3.38 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.529 2.819 . . . . 0.0 114.766 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1576 ' ' CYS . . . . . 0.664 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 17.2 t -98.22 130.25 28.85 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.139 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.76 -27.48 84.88 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.142 2.562 . . . . 0.0 113.911 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.31 33.9 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.477 HD21 HD11 ' A' 1582 ' ' LEU . 92.8 m-20 -126.5 8.31 7.05 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.86 -62.54 0.34 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.785 1.234 . . . . 0.0 114.078 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.27 4.51 8.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.664 ' HB2' ' HB3' ' A' 1576 ' ' CYS . 92.5 mt -90.36 154.54 19.61 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' 1585 ' ' LYS . 94.1 mttt -123.86 154.09 40.15 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1584 ' ' TYR . . . . . 0.422 ' HE2' ' HB ' ' A' 1550 ' ' ILE . 27.1 m-85 -62.73 116.82 5.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' 1583 ' ' LYS . 28.9 mtpp -115.05 133.82 55.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1586 ' ' SER . . . . . 0.717 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 37.5 m -120.01 122.36 40.96 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.212 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.477 HG21 HG22 ' A' 1569 ' ' VAL . 6.6 p -126.75 111.27 25.42 Favored 'Isoleucine or valine' 0 C--O 1.25 1.096 0 CA-C-O 121.975 0.893 . . . . 0.0 110.725 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.0 110.88 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.746 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1589 ' ' SER . . . . . 0.49 ' HA ' ' NE2' ' A' 1567 ' ' GLN . 29.5 m -88.53 111.18 21.55 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.727 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.5 m-85 -86.97 106.64 17.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.0 m -98.53 153.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1620 ' ' THR . 48.7 t -86.96 133.85 33.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.16 0.981 . . . . 0.0 113.166 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 55.0 tptt -147.33 105.38 3.74 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.1 t -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.601 0.715 . . . . 0.0 110.645 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.29 -3.17 57.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.717 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.877 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -83.98 -42.81 15.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.5 -156.41 51.0 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.976 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.06 -4.1 14.69 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.441 2.761 . . . . 0.0 113.098 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 17.8 p -90.54 -49.69 6.36 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 49.5 m 69.34 145.77 0.05 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.379 1.072 . . . . 0.0 113.144 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.844 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 97.8 mt-30 -87.84 121.88 70.54 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.338 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.0 Cg_endo -88.43 118.67 1.07 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.466 2.777 . . . . 0.0 111.661 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 63.5 tp -130.8 124.69 31.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.224 0.535 . . . . 0.0 109.974 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.67 HD23 HG23 ' A' 1607 ' ' VAL . 62.6 tp -87.16 126.73 34.98 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 58.4 tp -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 60.4 p -178.35 142.67 0.26 Allowed 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.015 0.822 . . . . 0.0 109.943 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.67 HG23 HD23 ' A' 1604 ' ' LEU . 61.9 t -94.37 117.47 38.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.69 113.15 26.31 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.324 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.95 -2.0 45.96 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 45.9 m80 -82.33 -41.2 20.37 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.382 0.61 . . . . 0.0 110.677 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.555 ' HA ' HD12 ' A' 1582 ' ' LEU . 33.8 p -121.58 -9.81 8.89 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 75.5 m 65.68 35.07 7.18 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.149 0.976 . . . . 0.0 111.397 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -96.48 122.92 39.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.096 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.535 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 88.7 mt -91.27 112.81 24.88 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -98.41 115.6 28.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.086 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.535 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 86.9 m-85 -123.41 140.21 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 40.0 m -120.67 103.69 9.33 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -95.51 122.01 37.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.844 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 46.9 m-70 -90.73 102.98 15.74 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.4 t -127.48 153.89 45.76 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.046 0.45 . . . . 0.0 110.447 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.2 m -79.59 -25.28 41.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' 1510 ' ' LEU . 33.4 mt -70.7 -4.75 25.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.708 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.45 -23.44 40.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.625 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 60.3 m -79.31 159.68 27.1 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -50.55 132.61 25.5 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -80.24 116.36 20.29 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -86.34 -31.04 21.76 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.69 -171.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.848 -179.727 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1490 ' ' VAL . . . . . 0.589 HG12 ' H ' ' A' 1492 ' ' ASP . 38.9 t -95.05 141.64 14.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -75.54 -1.1 22.76 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.589 ' H ' HG12 ' A' 1490 ' ' VAL . 13.9 t70 51.7 79.48 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.633 1.573 . . . . 0.0 109.393 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -136.65 85.81 2.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.17 -174.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.424 ' HB2' ' OD1' ' A' 1508 ' ' ASN . 82.9 m 55.1 25.06 6.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' 1505 ' ' PHE . 25.0 pt20 -132.91 119.15 19.8 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 124.89 71.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.376 0.608 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 9.1 m -88.71 109.7 20.36 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.32 138.4 45.16 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.246 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.2 -2.75 12.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.686 2.257 . . . . 0.0 113.572 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -82.33 -63.89 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.813 0.34 . . . . 0.0 110.618 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1501 ' ' THR . . . . . 0.467 HG23 ' HG2' ' A' 1625 ' ' GLU . 24.6 p -98.13 -20.17 17.48 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.4 3.35 81.72 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.87 133.62 43.17 Favored 'General case' 0 C--O 1.254 1.325 0 C-N-CA 123.074 0.55 . . . . 0.0 109.842 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 65.4 t -95.33 111.75 26.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' 1495 ' ' GLN . 82.8 m-85 -85.04 103.03 13.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.2 108.06 19.4 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.48 -8.75 59.61 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.494 ' HA ' ' HD3' ' A' 1511 ' ' LYS . 90.2 m-20 -59.79 -24.02 63.77 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.62 1.968 . . . . 0.0 112.789 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 6.9 p -86.36 -11.0 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.04 0.448 . . . . 0.0 111.531 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 49.1 tp -116.0 -22.33 9.05 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 122.207 -0.308 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' 1531 ' ' CYS . 22.2 pttp -46.79 131.38 11.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.035 0.921 . . . . 0.0 113.472 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -126.93 101.11 6.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.293 -172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1513 ' ' GLU . . . . . 0.428 ' CD ' ' HZ1' ' A' 1535 ' ' LYS . 28.6 tt0 -65.54 -37.75 87.62 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.91 0.756 . . . . 0.0 110.967 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 41.3 m -63.49 -18.42 63.78 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.395 0.617 . . . . 0.0 110.447 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 86.11 149.14 12.65 Favored Glycine 0 N--CA 1.415 -2.74 0 CA-C-N 115.278 -0.874 . . . . 0.0 114.635 173.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -80.83 114.35 19.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 20.0 m -99.45 98.84 9.7 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 27.4 pt -115.84 145.7 21.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.511 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 35.8 t -111.03 130.5 55.58 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.287 0.565 . . . . 0.0 109.912 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.44 153.86 42.94 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.97 -22.76 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.373 0.606 . . . . 0.0 111.62 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -79.51 3.75 17.78 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.43 0.692 . . . . 0.0 111.042 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 56.9 tptt 73.52 87.18 0.1 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.75 1.62 . . . . 0.0 110.442 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -169.11 117.2 0.7 Allowed Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 50.4 m -81.62 120.79 25.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 120.785 0.326 . . . . 0.0 110.815 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.792 ' HB ' ' HD1' ' A' 1545 ' ' PHE . 14.6 tt -114.41 128.24 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.5 ttm180 -116.95 115.5 25.59 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.2 mp -114.78 114.93 26.23 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.303 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -83.55 111.16 3.38 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' 1511 ' ' LYS . 7.2 p -85.97 116.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.981 -0.717 . . . . 0.0 109.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.54 ' HB2' ' HB2' ' A' 1511 ' ' LYS . 85.7 m 64.94 15.63 10.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.421 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.91 140.21 8.99 Favored Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -76.81 146.88 37.53 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.6 p -89.19 99.32 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 122.291 1.043 . . . . 0.0 110.959 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.428 ' HZ1' ' CD ' ' A' 1513 ' ' GLU . 0.3 OUTLIER -65.48 -19.36 65.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.187 -174.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.57 -36.5 78.66 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.899 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 78.0 m -106.96 -24.29 12.06 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 129.63 152.61 7.61 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.482 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.25 146.86 95.79 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.981 2.454 . . . . 0.0 110.815 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 97.41 -14.61 63.23 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.866 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.98 136.15 51.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.39 -47.12 0.82 Allowed Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.99 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -108.28 125.9 52.21 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 43.9 t -141.98 139.12 32.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.792 ' HD1' ' HB ' ' A' 1526 ' ' ILE . 57.4 t80 -108.72 121.58 45.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.24 -30.96 71.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -66.2 112.91 5.29 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.4 m 72.93 1.31 3.98 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.029 0.932 . . . . 0.0 110.629 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 58.59 41.9 95.83 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.441 HG13 ' HB3' ' A' 1545 ' ' PHE . 27.5 pt -90.82 142.05 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.769 0.795 . . . . 0.0 112.238 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 84.7 mttt -82.08 137.74 34.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.756 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -120.41 15.39 12.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.189 0.519 . . . . 0.0 110.202 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.882 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 157.79 128.51 1.03 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.96 -1.114 . . . . 0.0 114.221 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.9 tttp -72.75 139.53 47.19 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 125.248 1.419 . . . . 0.0 107.319 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 55.5 t90 -72.78 134.43 44.94 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.88 159.57 35.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.39 88.69 2.83 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1558 ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 40.2 mmtm -131.21 90.81 2.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.35 111.05 23.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 17.6 m -116.16 127.82 55.13 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.4 101.1 13.31 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -138.38 150.15 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.7 t70 65.68 15.2 9.94 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.803 0.811 . . . . 0.0 108.979 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 70.08 12.71 7.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.058 1.743 . . . . 0.0 110.682 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 63.0 t -117.53 151.91 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.851 0.86 . . . . 0.0 109.865 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.784 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.1 mp -86.28 124.34 32.55 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.134 -0.354 . . . . 0.0 110.588 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.981 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.4 tp -128.55 118.01 22.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' 1571 ' ' GLU . 10.5 p -126.39 117.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 112.983 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.882 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 54.4 m-85 -92.13 102.34 14.87 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.893 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.571 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 44.6 mt-10 -107.67 166.58 10.57 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 20.6 t70 68.94 71.0 0.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.274 1.035 . . . . 0.0 111.734 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.0 -137.16 9.68 Favored Glycine 0 N--CA 1.421 -2.333 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.45 153.96 65.62 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.21 151.03 84.52 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.081 1.854 . . . . 0.0 110.587 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 72.7 m -97.3 137.87 21.18 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.8 -25.94 78.31 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.547 2.832 . . . . 0.0 113.449 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.11 -67.25 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.57 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.9 m120 -109.53 -3.68 16.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.1 mm? 67.98 -53.11 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.702 1.201 . . . . 0.0 113.336 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -61.8 -18.21 59.07 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.372 1.469 . . . . 0.0 111.82 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 81.0 mt -82.93 141.66 32.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -116.17 146.94 41.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.88 118.97 9.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 86.9 mttt -130.16 137.62 50.21 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1586 ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 14.5 m -119.84 116.28 25.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -108.36 114.92 47.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.972 0.892 . . . . 0.0 110.408 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.61 122.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.443 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 19.6 m -109.16 114.77 28.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 91.7 m-85 -86.79 109.61 19.38 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -102.4 159.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 35.6 t -76.28 130.24 37.86 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.19 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.581 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 47.3 tptt -159.82 106.59 1.65 Allowed 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 19.8 m -72.04 -25.96 62.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1595 ' ' ASP . . . . . 0.581 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 34.4 t70 -81.54 19.81 0.98 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.564 1.146 . . . . 0.0 110.68 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -95.03 -39.39 10.19 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.691 -0.631 . . . . 0.0 110.508 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 71.57 -162.53 54.3 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.871 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.7 -14.69 33.31 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.228 2.619 . . . . 0.0 112.12 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.1 p -81.94 -50.9 8.62 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.734 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 49.3 m 65.54 108.87 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.025 0.828 . . . . 0.0 111.198 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.483 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 48.4 mt-30 -74.27 124.85 90.24 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.716 -172.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 11.7 Cg_endo -92.97 108.02 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 123.329 2.686 . . . . 0.0 111.251 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.21 116.23 28.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.758 HD23 HG22 ' A' 1607 ' ' VAL . 5.4 tt -77.8 108.3 10.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 63.5 tp -74.92 -54.58 6.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.987 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 23.1 t -169.4 151.19 4.42 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.758 HG22 HD23 ' A' 1604 ' ' LEU . 83.9 t -117.92 110.75 31.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.18 104.57 16.61 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.399 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.44 5.38 17.82 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.445 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 56.1 m80 -88.63 -44.23 10.76 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.529 ' HA ' HD12 ' A' 1582 ' ' LEU . 0.7 OUTLIER -112.05 -0.08 15.79 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.6 -176.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 60.3 m 63.01 30.64 16.32 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.185 0.994 . . . . 0.0 111.235 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -99.05 118.56 36.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.726 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.606 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 78.6 mt -97.26 119.29 35.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -102.75 115.44 30.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.606 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 69.4 m-85 -125.74 126.72 45.05 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.01 0.433 . . . . 0.0 110.263 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 20.2 m -106.07 112.66 25.8 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -97.17 119.03 34.92 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.453 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 64.6 m-70 -89.8 112.87 24.32 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 14.9 t -139.46 152.18 46.8 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.18 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 6.9 m -74.89 -23.7 58.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' A' 1505 ' ' PHE . 41.7 mt -72.6 -5.55 38.05 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.347 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.09 16.87 25.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.327 0.584 . . . . 0.0 110.404 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 59.0 m -113.15 151.26 31.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.062 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1625 ' ' GLU . . . . . 0.467 ' HG2' HG23 ' A' 1501 ' ' THR . 5.4 mp0 -83.89 132.94 34.75 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -81.8 118.08 22.6 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.13 -58.93 2.44 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.308 -1.23 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 34.4 m -84.54 131.04 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.35 112.89 24.1 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.941 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.19 53.31 2.22 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.157 0.98 . . . . 0.0 110.548 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -85.0 112.63 20.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 15.0 t 69.03 26.34 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.626 1.203 . . . . 0.0 109.503 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -156.13 151.17 26.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -114.02 132.33 63.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.807 HG23 HG22 ' A' 1504 ' ' VAL . 63.3 m -141.72 105.75 4.77 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.1 p30 -98.34 129.34 30.76 Favored Pre-proline 0 N--CA 1.435 -1.218 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.754 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.05 -11.78 31.1 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.425 2.083 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -55.72 10.7 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.586 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 38.9 p -118.98 -6.28 10.5 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 77.11 34.38 41.91 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1503 ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' 1497 ' ' THR . 41.0 t80 -83.57 109.61 17.55 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.807 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -128.01 107.6 16.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 O-C-N 123.748 0.655 . . . . 0.0 109.477 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.661 ' HZ ' ' HA ' ' A' 1625 ' ' GLU . 8.3 m-85 -120.87 106.49 11.7 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -91.89 108.8 20.18 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.366 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1507 ' ' LEU . . . . . 0.515 HD13 HD23 ' A' 1510 ' ' LEU . 18.5 tp -89.27 -5.87 57.25 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.964 0.888 . . . . 0.0 109.321 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.447 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 53.1 m-80 -62.21 -26.8 68.56 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.8 t -74.29 -10.67 59.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.515 HD23 HD13 ' A' 1507 ' ' LEU . 35.8 tp -111.87 6.85 19.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.301 0.572 . . . . 0.0 110.451 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.744 ' HA ' ' HB ' ' A' 1530 ' ' VAL . 35.1 mtmm -57.29 153.8 11.58 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.627 ' HD2' ' H ' ' A' 1530 ' ' VAL . 0.0 OUTLIER -84.0 176.76 8.62 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.116 -174.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -51.75 5.32 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 35.1 t -128.16 -38.39 1.8 Allowed 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.595 ' HA2' ' HG3' ' A' 1512 ' ' ARG . . . 158.2 161.68 11.18 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.07 129.04 48.29 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 19.9 m -99.09 99.64 10.68 Favored 'General case' 0 N--CA 1.425 -1.711 0 O-C-N 123.788 0.68 . . . . 0.0 109.196 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.1 pt -119.58 155.84 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 8.1 t -107.59 141.17 39.48 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.22 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.36 170.05 16.86 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.842 1.257 . . . . 0.0 107.874 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.48 -23.91 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.899 0.857 . . . . 0.0 110.032 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -84.45 1.16 46.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.876 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 74.41 10.66 4.2 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 126.013 1.725 . . . . 0.0 114.459 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -71.83 123.57 9.88 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 41.5 m -81.79 124.14 29.4 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.76 132.99 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 CA-C-O 121.315 0.578 . . . . 0.0 109.566 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -107.24 116.35 31.78 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.39 140.77 52.64 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.273 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -106.62 151.17 16.92 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.744 ' HB ' ' HA ' ' A' 1511 ' ' LYS . 24.5 t -92.22 115.02 30.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 31.4 m 55.98 24.55 7.81 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.677 1.236 . . . . 0.0 111.88 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -139.06 169.82 24.31 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -99.15 131.25 45.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.599 HG23 ' HB2' ' A' 1537 ' ' CYS . 14.3 m -88.06 93.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.508 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -50.6 -38.27 44.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.653 -173.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.78 -19.67 65.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1537 ' ' CYS . . . . . 0.599 ' HB2' HG23 ' A' 1534 ' ' VAL . 64.6 m -109.73 9.43 24.88 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.476 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.74 155.11 10.98 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.093 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 131.43 13.34 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.612 2.208 . . . . 0.0 111.347 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1540 ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' 1554 ' ' LYS . . . 79.93 19.55 69.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.553 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1541 ' ' ILE . . . . . 0.467 ' CD1' ' HD3' ' A' 1551 ' ' LYS . 45.1 mm -114.19 137.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -114.83 -18.04 6.62 Favored Glycine 0 C--N 1.32 -0.306 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.563 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.26 133.95 30.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 19.2 p -149.11 152.43 36.14 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.509 0.188 . . . . 0.0 111.509 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -94.46 118.53 31.78 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.17 110.48 13.19 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.454 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.6 -71.26 0.27 Allowed Glycine 0 C--N 1.282 -2.449 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 3.0 m -87.85 -20.4 26.09 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.91 44.53 11.96 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.75 150.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.467 ' HD3' ' CD1' ' A' 1541 ' ' ILE . 49.9 mttm -90.92 134.46 34.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.09 17.12 11.64 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.425 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 160.32 126.6 0.84 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.886 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1554 ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' 1540 ' ' GLY . 32.6 ttmt -84.08 147.19 27.51 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.784 0.834 . . . . 0.0 109.997 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 64.3 t90 -64.86 129.25 39.04 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 123.775 0.672 . . . . 0.0 109.673 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.99 156.99 6.36 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -124.21 65.58 1.06 Allowed 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.913 0.863 . . . . 0.0 109.553 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -94.59 92.98 7.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.424 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.88 115.12 27.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 11.7 m -112.9 124.92 53.71 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.422 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.9 t80 -88.62 101.79 14.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 59.5 t -117.4 102.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.945 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.3 68.68 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.673 1.589 . . . . 0.0 112.739 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.57 9.77 6.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.051 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.5 t -125.78 135.44 63.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 O-C-N 121.948 -0.47 . . . . 0.0 110.018 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.701 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.11 118.27 25.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.86 118.21 36.31 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.08 119.63 37.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.453 HG22 HG23 ' A' 1587 ' ' VAL . 26.3 t -114.12 115.11 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.993 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.475 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 66.4 m-85 -96.82 92.33 6.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' 1585 ' ' LYS . 14.8 pt-20 -110.84 176.17 5.14 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.587 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.2 t70 66.8 80.15 0.22 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.921 1.288 . . . . 0.0 111.683 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -122.21 -131.44 3.9 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.81 159.17 63.93 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.62 157.93 16.43 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.226 1.95 . . . . 0.0 113.012 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 84.8 m -98.45 136.86 20.7 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.627 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.82 6.26 3.85 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.518 2.145 . . . . 0.0 113.64 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.52 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.732 0.301 . . . . 0.0 110.556 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.42 -1.13 18.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.913 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.95 -50.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 33.1 m80 -79.86 26.24 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.452 0.701 . . . . 0.0 112.419 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.88 125.54 44.13 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.49 ' O ' ' HD2' ' A' 1585 ' ' LYS . 67.0 mttm -112.28 160.01 18.07 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -64.14 126.54 28.07 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' 1571 ' ' GLU . 1.3 mptp? -111.01 133.2 53.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.0 t -120.25 115.68 24.08 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.453 HG23 HG22 ' A' 1569 ' ' VAL . 7.8 p -112.7 124.73 69.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.607 0.718 . . . . 0.0 110.8 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.05 116.42 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 24.0 m -94.22 110.69 22.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.701 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 90.3 m-85 -88.25 111.07 21.25 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 22.3 m -110.14 155.2 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.778 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 25.4 t -75.08 123.24 24.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.338 0.589 . . . . 0.0 110.603 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 52.9 tptt -146.97 116.72 7.15 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1594 ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' 1596 ' ' ALA . 20.3 m -82.89 -20.41 35.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.294 0.568 . . . . 0.0 109.535 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1595 ' ' ASP . . . . . 0.586 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -79.29 14.19 1.62 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.592 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' 1600 ' ' SER . . . -94.22 -56.53 2.81 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.234 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.79 -166.39 41.14 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 -16.32 37.47 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.048 2.499 . . . . 0.0 112.561 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 11.5 p -91.74 -35.51 14.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.295 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.887 ' HA ' ' HB2' ' A' 1596 ' ' ALA . 35.0 m 66.12 177.14 0.22 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.911 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.676 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 91.0 mt-30 -114.9 119.35 39.3 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.776 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1602 ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -94.18 111.85 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 123.224 2.616 . . . . 0.0 109.597 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 59.3 tp -126.46 126.55 43.96 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.0 tp -74.93 120.31 20.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.85 -53.31 5.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.909 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 48.7 m -164.6 149.39 9.67 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 109.88 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 86.8 t -115.51 119.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.11 106.03 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.218 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.29 2.59 27.43 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.3 -24.21 16.3 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.759 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1611 ' ' THR . . . . . . . . . . . . . 24.5 p -115.39 -3.45 12.43 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.861 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 86.2 m 61.22 28.16 17.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.384 1.074 . . . . 0.0 111.532 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 25.3 m -105.56 124.61 49.84 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.378 0.609 . . . . 0.0 110.154 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.99 125.48 39.68 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.82 118.68 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 135.33 54.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 39.8 t -110.34 119.23 38.56 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -107.39 104.62 14.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.676 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.2 m-70 -83.74 105.83 14.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.6 t -132.26 152.36 51.39 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.532 0.682 . . . . 0.0 111.296 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 15.9 m -80.19 -22.6 41.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.339 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 37.2 tp -71.33 -6.52 40.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.347 0.594 . . . . 0.0 110.621 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.28 5.79 42.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.673 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 71.3 m -88.61 140.89 29.0 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.122 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1625 ' ' GLU . . . . . 0.661 ' HA ' ' HZ ' ' A' 1505 ' ' PHE . 2.3 mp0 -44.12 151.69 0.22 Allowed 'General case' 0 C--O 1.253 1.252 0 C-N-CA 126.066 1.746 . . . . 0.0 114.241 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.85 152.56 19.6 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -95.13 -26.26 16.09 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -178.18 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 CA--C 1.516 -0.341 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 21.8 t -74.14 -19.74 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 72.36 5.64 5.32 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.555 0.742 . . . . 0.0 111.426 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.403 ' OD1' ' HA ' ' A' 1496 ' ' VAL . 16.7 t70 -97.65 61.58 1.62 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -126.1 124.41 40.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.582 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 43.9 t 71.17 3.95 4.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.794 1.283 . . . . 0.0 109.993 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.7 pt20 -150.56 143.55 24.74 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1496 ' ' VAL . . . . . 0.403 ' HA ' ' OD1' ' A' 1492 ' ' ASP . 7.4 p -136.05 128.51 45.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 121.216 0.531 . . . . 0.0 109.568 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.41 HG22 HG21 ' A' 1504 ' ' VAL . 23.4 m -92.65 108.21 19.8 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 3.4 p30 -81.52 138.8 47.7 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.799 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.25 4.49 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.612 2.208 . . . . 0.0 113.546 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -88.85 -59.25 2.28 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.924 0.392 . . . . 0.0 110.333 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1501 ' ' THR . . . . . 0.503 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 6.8 p -104.41 -12.51 16.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.74 13.33 83.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.546 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 84.0 t80 -86.17 130.94 34.36 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.41 HG21 HG22 ' A' 1497 ' ' THR . 45.3 t -89.82 108.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.3 m-85 -79.11 105.93 10.79 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1506 ' ' ASP . . . . . 0.439 ' O ' HD11 ' A' 1622 ' ' LEU . 9.3 t70 -94.84 102.63 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 30.9 tp -86.58 2.7 47.29 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.626 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' 1511 ' ' LYS . 28.8 m-80 -71.84 -18.61 62.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.379 0.609 . . . . 0.0 109.84 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 59.0 m -82.18 -19.33 40.09 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.137 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.577 HD23 ' HA ' ' A' 1598 ' ' PRO . 0.2 OUTLIER -115.84 10.29 15.27 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' 1530 ' ' VAL . 19.3 pttp -76.17 134.03 40.03 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.574 0.702 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.567 ' H ' HG21 ' A' 1530 ' ' VAL . 1.9 tpm_? -127.81 94.03 3.84 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1513 ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' 1513 ' ' GLU . 0.2 OUTLIER -75.19 -14.93 60.58 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -174.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 13.8 p -78.84 -13.15 59.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 91.17 137.78 7.49 Favored Glycine 0 N--CA 1.424 -2.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.173 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' 1527 ' ' ARG . 83.0 m-85 -82.28 126.68 32.4 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 11.8 p -102.54 90.13 3.75 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 123.73 0.644 . . . . 0.0 109.452 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 19.3 pt -109.29 159.47 8.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.154 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.4 m -83.79 127.16 33.61 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.821 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.48 157.94 19.07 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1521 ' ' ILE . . . . . 0.708 ' HB ' HD21 ' A' 1604 ' ' LEU . 14.7 tt -70.84 -23.54 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.627 0.727 . . . . 0.0 109.432 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -71.65 -0.92 11.97 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.234 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 71.22 83.56 0.14 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.055 1.342 . . . . 0.0 110.6 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 173.85 179.95 44.82 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 14.4 m -110.31 139.67 45.26 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.22 133.7 67.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' 1516 ' ' TYR . 24.5 ttm180 -111.31 112.87 24.95 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.71 120.63 37.15 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.462 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.49 125.3 8.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' 1511 ' ' LYS . 17.0 m -96.19 117.73 41.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.515 ' HA ' ' CH2' ' A' 1555 ' ' TRP . 74.6 m 72.57 10.49 5.66 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.172 0.989 . . . . 0.0 112.776 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -145.8 142.65 10.82 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.77 140.53 30.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.7 m -76.67 97.23 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 122.829 1.3 . . . . 0.0 109.543 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.71 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -61.19 -21.2 63.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.867 -174.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.43 -19.01 36.73 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.787 0.327 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1537 ' ' CYS . . . . . 0.632 ' HB2' HG23 ' A' 1534 ' ' VAL . 76.2 m -105.76 4.95 30.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 110.03 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.47 145.96 13.18 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.188 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.46 129.18 23.14 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.9 2.4 . . . . 0.0 111.843 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 103.7 -5.79 47.87 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.552 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.8 mm -93.48 128.24 45.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.609 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -91.63 -40.64 5.28 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.85 134.92 33.96 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1544 ' ' CYS . . . . . 0.511 ' SG ' HG22 ' A' 1534 ' ' VAL . 26.7 p -141.53 150.48 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 81.8 t80 -96.16 130.19 43.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.5 107.54 8.84 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 123.835 0.709 . . . . 0.0 109.765 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.79 -89.19 0.12 Allowed Glycine 0 C--N 1.283 -2.399 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.3 m -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.945 0.403 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 86.35 27.23 30.95 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 26.1 pt -82.96 141.53 14.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 22.9 pttm -94.51 138.58 32.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.96 12.0 37.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.73 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.874 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.49 147.52 4.68 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.443 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -82.69 150.79 26.56 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.699 0.399 . . . . 0.0 110.134 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.515 ' CH2' ' HA ' ' A' 1531 ' ' CYS . 30.0 t-105 -69.05 123.87 22.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.38 174.44 15.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.97 44.09 1.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1558 ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' 1568 ' ' LEU . 32.2 mmtp -81.81 77.25 8.66 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.357 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.58 98.42 7.05 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 16.8 m -111.97 139.99 47.02 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 93.2 t80 -97.35 103.26 15.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 17.6 m -130.75 113.09 23.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.879 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.9 t70 59.5 44.08 15.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 110.439 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 62.7 17.22 9.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.348 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.9 t -110.49 126.14 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.93 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.3 tp -90.0 115.77 27.54 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -102.2 120.17 40.01 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.29 -0.256 . . . . 0.0 111.034 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1568 ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' 1558 ' ' LYS . 26.6 tp -106.31 109.08 20.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.428 HG22 HG23 ' A' 1587 ' ' VAL . 21.9 t -109.67 119.3 58.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.099 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.874 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 53.7 m-85 -94.61 115.9 28.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.44 161.2 16.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.053 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 12.0 t70 56.94 71.96 0.54 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.341 1.856 . . . . 0.0 113.499 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -90.84 -136.21 6.63 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -96.26 144.92 28.67 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1575 ' ' PRO . . . . . 0.819 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 36.9 Cg_endo -67.89 141.84 55.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.225 1.95 . . . . 0.0 112.427 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 74.9 m -98.37 141.41 22.9 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.31 -12.52 35.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.658 2.905 . . . . 0.0 114.846 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -70.33 -61.95 1.58 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.1 m120 -119.97 -4.93 10.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.3 mm? 70.42 -48.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.202 1.001 . . . . 0.0 113.374 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 26.3 m80 -76.17 -4.54 42.25 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.959 0.409 . . . . 0.0 111.97 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.727 HD11 ' HA ' ' A' 1611 ' ' THR . 61.9 mt -101.06 120.13 39.75 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.819 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.6 mttt -118.41 163.23 17.05 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -52.63 110.64 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 36.2 tptt -116.93 130.96 57.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 9.3 t -127.0 118.97 25.55 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.581 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.428 HG23 HG22 ' A' 1569 ' ' VAL . 6.7 p -118.26 111.33 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.836 0.827 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.32 108.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 49.0 m -88.54 109.56 20.17 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.547 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.93 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.9 m-85 -85.92 104.57 15.69 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.3 m -101.52 163.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' 1620 ' ' THR . 46.2 t -97.23 144.65 26.83 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.399 -172.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.513 ' HG2' ' OE1' ' A' 1601 ' ' GLN . 17.6 tppt? -150.47 115.38 5.3 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 5.3 p -61.52 -41.51 97.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.19 25.64 1.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -97.1 -63.3 1.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.052 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 75.84 -156.01 47.16 Favored Glycine 0 C--O 1.25 1.104 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1598 ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' 1510 ' ' LEU . 41.4 Cg_endo -66.45 -20.95 54.11 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.888 2.392 . . . . 0.0 111.422 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 p -94.44 62.42 2.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.607 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 17.3 m -63.67 149.04 47.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.325 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.618 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 39.7 mt-30 -87.14 128.55 55.15 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.9 Cg_endo -91.36 134.35 1.63 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.977 2.451 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.704 ' HB3' ' HB3' ' A' 1617 ' ' SER . 64.7 tp -131.66 108.03 9.22 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.033 0.445 . . . . 0.0 110.388 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.708 HD21 ' HB ' ' A' 1521 ' ' ILE . 64.3 tp -68.15 116.4 8.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 39.1 tp -98.15 -63.36 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.016 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 34.8 m -150.33 137.49 19.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 81.0 t -131.61 119.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.03 126.75 52.91 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.514 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -80.91 -10.21 59.74 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.95 -52.17 6.92 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.343 0.592 . . . . 0.0 109.513 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.727 ' HA ' HD11 ' A' 1582 ' ' LEU . 46.0 p -92.41 -19.64 21.85 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 63.6 m 66.89 23.34 9.97 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.415 1.086 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -81.18 120.99 25.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.159 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.663 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 90.1 mt -102.39 115.94 31.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.299 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.32 114.77 29.22 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.663 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.0 m-85 -122.02 135.91 54.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.441 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.704 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 37.4 t -107.86 114.92 29.21 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -109.2 118.29 36.33 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.618 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 38.9 m-70 -98.58 101.33 12.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.2 t -129.27 152.95 48.28 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.395 0.617 . . . . 0.0 110.982 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.7 m -75.77 -25.68 56.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.317 0.58 . . . . 0.0 109.706 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' 1622 ' ' LEU . 6.8 tt -64.04 -16.8 62.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.673 0.789 . . . . 0.0 110.284 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.36 59.71 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 35.0 m -94.53 140.99 29.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.012 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1625 ' ' GLU . . . . . 0.503 ' HG2' ' OG1' ' A' 1501 ' ' THR . 3.5 mp0 -71.91 90.22 1.12 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.05 157.98 25.25 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.165 -1.834 . . . . 0.0 113.314 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -63.5 -33.95 76.7 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.079 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.432 -1.335 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.825 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 7.2 p -88.68 128.37 40.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 72.12 129.08 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.596 1.559 . . . . 0.0 110.606 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.4 ' OD1' HD12 ' A' 1559 ' ' LEU . 1.0 OUTLIER -81.92 151.25 27.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.588 0.709 . . . . 0.0 110.824 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -131.95 61.84 1.65 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.385 169.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 75.94 22.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.672 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.7 pt20 -153.27 118.66 5.22 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.644 -1.162 . . . . 0.0 107.999 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -121.83 130.36 74.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.262 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 3.8 m -103.84 106.05 16.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 6.7 p30 -91.67 134.09 29.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.62 -175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1499 ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 6.6 Cg_exo -67.02 -25.36 44.33 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.893 2.395 . . . . 0.0 113.057 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -56.06 -61.81 2.13 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.014 0.435 . . . . 0.0 111.894 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 21.6 p -96.43 -15.18 21.91 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 69.33 41.23 79.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -128.85 136.42 50.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 120.827 0.346 . . . . 0.0 110.252 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 2.8 p -94.89 118.17 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.897 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.9 m-85 -87.18 106.72 18.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -86.39 99.02 11.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.2 tp -84.94 4.49 33.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 122.739 1.257 . . . . 0.0 108.791 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.509 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 62.9 m-20 -58.87 -28.6 66.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.478 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.1 t -79.33 -11.56 59.93 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.049 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.588 ' HB2' HD13 ' A' 1622 ' ' LEU . 20.0 tp -111.73 1.56 16.74 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.687 -0.633 . . . . 0.0 110.602 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.513 ' HE2' ' SG ' ' A' 1531 ' ' CYS . 100.0 mttt -50.21 160.48 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.549 ' HG3' ' CA ' ' A' 1515 ' ' GLY . 9.2 ttp180 -68.49 105.21 2.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.147 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -91.03 -44.68 9.16 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 167.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.3 t -121.96 -35.22 3.21 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.314 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.549 ' CA ' ' HG3' ' A' 1512 ' ' ARG . . . 103.19 162.68 25.55 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.31 121.03 44.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.0 m -117.57 99.18 6.8 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 20.1 pt -101.43 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.506 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1519 ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' 1525 ' ' SER . 24.1 t -93.64 114.68 27.05 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.663 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1520 ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 13.7 t70 -89.3 113.96 25.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.83 -18.83 20.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.727 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1522 ' ' ARG . . . . . 0.472 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.1 mtp180 -76.3 -47.32 24.08 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.73 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.83 -59.3 1.36 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.862 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -175.43 -165.44 31.54 Favored Glycine 0 C--O 1.215 -1.056 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.279 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1525 ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' 1519 ' ' SER . 20.3 m -91.18 154.14 19.53 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 117.385 0.593 . . . . 0.0 111.167 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.459 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.0 tt -134.55 132.59 54.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -111.78 116.59 30.95 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.71 137.07 50.1 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.71 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -107.39 100.0 1.48 Allowed Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 7.1 p -76.64 116.69 20.2 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.513 ' SG ' ' HE2' ' A' 1511 ' ' LYS . 46.8 t 70.3 3.69 4.55 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.601 0.715 . . . . 0.0 111.418 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -132.16 149.1 19.34 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1533 ' ' GLU . . . . . 0.607 ' HB2' ' HD2' ' A' 1535 ' ' LYS . 38.5 mt-10 -88.16 131.84 34.56 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 11.3 m -87.95 81.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.311 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.607 ' HD2' ' HB2' ' A' 1533 ' ' GLU . 0.0 OUTLIER -67.6 -13.56 62.18 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.958 0.885 . . . . 0.0 110.7 -175.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.96 -32.96 70.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.45 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 51.8 t -108.01 3.67 24.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.398 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 124.22 150.52 7.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.699 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.66 149.31 38.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.402 2.068 . . . . 0.0 111.171 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.13 14.25 80.61 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.927 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1541 ' ' ILE . . . . . 0.416 HD11 ' HD3' ' A' 1551 ' ' LYS . 44.7 mm -112.86 135.17 53.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -102.28 -35.03 4.01 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.184 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.58 141.23 39.22 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.993 -0.71 . . . . 0.0 110.676 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1544 ' ' CYS . . . . . 0.408 ' SG ' HG23 ' A' 1541 ' ' ILE . 57.2 m -141.75 146.79 36.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.674 ' HB3' HG13 ' A' 1550 ' ' ILE . 35.2 t80 -97.6 134.78 40.35 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.37 100.86 9.47 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.351 0.596 . . . . 0.0 109.841 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -162.98 -108.35 0.22 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.5 m -84.9 -5.94 59.34 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 101.03 46.49 1.73 Allowed Glycine 0 CA--C 1.491 -1.41 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.674 HG13 ' HB3' ' A' 1545 ' ' PHE . 14.0 pt -83.7 132.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.048 0.451 . . . . 0.0 109.991 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.416 ' HD3' HD11 ' A' 1541 ' ' ILE . 58.6 mttp -87.42 138.06 31.81 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.542 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -104.88 11.68 33.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.434 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.17 146.86 4.58 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.338 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1554 ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' 1572 ' ' ASP . 1.9 mptm? -77.86 147.31 35.2 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 66.0 t90 -69.77 128.84 37.82 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -158.18 158.52 34.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -104.58 88.4 2.93 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.721 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.8 tptt -130.36 83.69 2.14 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.166 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.4 HD12 ' OD1' ' A' 1492 ' ' ASP . 11.0 mp -96.39 125.29 40.78 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.683 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 7.9 m -121.58 139.82 53.03 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.046 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.3 t80 -106.66 110.06 22.14 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 65.9 t -116.04 92.66 2.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 34.05 88.23 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.359 1.864 . . . . 0.0 115.018 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 67.12 9.34 6.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.506 1.123 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 48.0 t -132.29 136.17 56.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.912 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.5 tp -96.58 136.86 36.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.683 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -120.33 127.05 51.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.844 -0.535 . . . . 0.0 110.771 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.7 tp -124.71 124.48 42.24 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.628 HG21 HG22 ' A' 1587 ' ' VAL . 19.6 t -120.47 122.82 69.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.26 0.552 . . . . 0.0 112.051 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.699 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 59.8 m-85 -101.51 113.43 26.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.3 161.14 17.59 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.762 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' 1554 ' ' LYS . 35.7 t70 60.2 83.19 0.14 Allowed 'General case' 0 C--O 1.209 -1.033 0 O-C-N 124.657 1.223 . . . . 0.0 113.173 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.83 2.31 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -124.23 150.25 63.15 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.21 136.7 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.623 2.216 . . . . 0.0 111.662 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1576 ' ' CYS . . . . . 0.419 ' C ' ' H ' ' A' 1578 ' ' ALA . 64.5 m -99.65 132.6 22.8 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.43 16.13 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.67 2.913 . . . . 0.0 113.949 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1578 ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -79.41 -49.36 12.48 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.568 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 16.7 m120 -146.85 8.65 0.98 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 29.5 tp 68.93 -47.1 0.57 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.51 1.524 . . . . 0.0 113.98 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 36.3 m80 -75.34 -11.07 59.98 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.552 0.692 . . . . 0.0 110.045 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.688 HD23 HG21 ' A' 1611 ' ' THR . 57.8 mt -85.39 128.15 34.62 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.04 162.55 30.5 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -65.74 112.2 3.59 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -126.14 134.8 51.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.1 t -126.92 125.46 41.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.628 HG22 HG21 ' A' 1569 ' ' VAL . 6.5 p -119.85 117.86 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.693 0.758 . . . . 0.0 109.307 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.77 116.37 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 8.4 t -96.17 104.96 16.95 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.912 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.3 m-85 -87.05 111.5 20.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 34.5 m -105.08 159.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 42.6 t -77.54 128.82 34.81 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 112.501 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.445 ' HB3' ' HB1' ' A' 1596 ' ' ALA . 58.4 tptt -145.69 109.18 4.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.8 m -71.57 -28.14 63.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.143 0.496 . . . . 0.0 112.199 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.16 30.22 6.1 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.567 0.698 . . . . 0.0 111.15 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' 1593 ' ' LYS . . . -84.74 -52.38 6.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.787 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 78.13 -159.49 47.22 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.71 -20.77 26.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.848 2.365 . . . . 0.0 111.708 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.2 t -96.81 58.55 1.65 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 123.031 1.396 . . . . 0.0 108.847 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 12.7 m -63.42 130.42 44.35 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.726 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.465 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.7 mt-30 -81.6 125.89 77.28 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -89.61 105.87 0.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.456 2.77 . . . . 0.0 110.873 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 62.9 tp -91.98 130.25 37.77 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.93 127.01 31.7 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1605 ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' 1617 ' ' SER . 99.3 mt -88.36 -58.32 2.6 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 44.6 m -164.62 147.26 8.66 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 108.989 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 64.6 t -107.91 111.71 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -98.59 91.66 5.25 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -70.04 -33.06 71.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.382 -1.735 . . . . 0.0 115.226 -165.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 51.4 t60 -70.68 -36.9 73.55 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.539 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.688 HG21 HD23 ' A' 1582 ' ' LEU . 0.0 OUTLIER -98.21 0.55 46.04 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.769 -176.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.9 m 55.27 31.1 15.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.565 0.746 . . . . 0.0 111.735 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 29.5 m -99.45 126.86 45.44 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.336 0.589 . . . . 0.0 110.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.567 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 87.0 mt -108.65 118.98 38.2 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.345 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.87 117.97 35.41 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.567 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 79.1 m-85 -128.14 135.95 50.47 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.616 0.366 . . . . 0.0 110.663 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.573 ' HB2' HD23 ' A' 1605 ' ' LEU . 22.7 t -106.68 110.94 23.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -98.25 111.89 24.07 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 17.0 m170 -81.4 98.36 8.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 12.1 t -129.4 153.09 48.24 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.611 0.72 . . . . 0.0 112.012 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 23.5 m -77.88 -21.45 51.26 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.71 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.588 HD13 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.8 -5.63 35.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.901 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.91 1.68 40.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.479 0.657 . . . . 0.0 109.48 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -103.18 162.31 13.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.837 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.11 133.7 45.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -81.54 114.51 20.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.9 -23.17 13.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.428 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.334 178.709 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 CA--C 1.511 -0.541 0 CA-C-O 121.146 0.498 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 35.1 m -126.1 161.44 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.493 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -98.96 89.22 4.21 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.85 117.97 6.79 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.34 -74.18 0.56 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' 1508 ' ' ASN . 6.5 t 61.69 23.03 13.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.687 1.195 . . . . 0.0 110.967 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -149.37 155.01 39.8 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -155.39 136.1 4.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 10.7 m -99.55 131.86 45.27 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -83.22 118.83 72.8 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.121 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.82 -16.46 44.45 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.991 2.46 . . . . 0.0 114.516 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -76.7 -62.89 1.48 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.542 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.5 p -97.16 -16.86 20.24 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 84.03 24.32 48.99 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.793 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -92.26 132.11 36.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.203 0.501 . . . . 0.0 109.88 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 25.6 t -101.13 106.8 20.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -81.38 104.15 11.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.76 93.08 7.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.646 0.736 . . . . 0.0 110.203 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 36.1 tp -84.69 -8.38 58.88 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.534 ' HB2' ' HB3' ' A' 1494 ' ' CYS . 59.6 t30 -65.99 -27.96 68.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.502 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 8.5 t -84.76 -11.86 54.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 -36.66 9.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' 1530 ' ' VAL . 2.2 pptp? -44.3 127.84 5.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -98.08 107.98 20.58 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.423 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -69.36 -34.63 74.87 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.74 0.65 . . . . 0.0 111.649 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 64.2 m -65.14 -17.4 64.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.247 0.546 . . . . 0.0 110.646 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.401 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 83.18 143.83 5.3 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.279 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -77.09 114.28 15.73 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1517 ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' 1526 ' ' ILE . 7.8 m -107.93 96.88 6.69 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1518 ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' 1525 ' ' SER . 27.6 pt -102.79 134.23 44.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.73 -175.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.2 m -89.15 92.61 9.26 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.73 123.2 40.35 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.579 0.704 . . . . 0.0 111.509 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.25 -16.07 20.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.595 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1522 ' ' ARG . . . . . 0.499 ' HD2' HD23 ' A' 1604 ' ' LEU . 69.1 mtt180 -94.17 -26.38 16.71 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.227 -0.921 . . . . 0.0 112.283 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 52.4 tptt -129.36 -59.27 1.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.854 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 166.21 -166.74 38.96 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.526 -0.845 . . . . 0.0 110.999 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1525 ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' 1518 ' ' ILE . 20.2 m -94.4 112.27 24.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.323 0.582 . . . . 0.0 109.458 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' 1545 ' ' PHE . 10.8 tt -120.94 140.48 44.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.436 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -110.84 115.28 29.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.64 119.84 36.2 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.401 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -91.72 127.96 9.14 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.552 ' O ' ' HB2' ' A' 1511 ' ' LYS . 21.7 t -81.04 116.39 25.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' 1530 ' ' VAL . 60.7 m 70.67 -24.46 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 172.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -105.07 140.83 15.17 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.69 142.61 44.43 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 120.7 0.286 . . . . 0.0 110.353 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 17.5 m -78.16 81.79 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.428 1.109 . . . . 0.0 109.075 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.556 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.38 -12.01 3.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.716 1.607 . . . . 0.0 112.941 -173.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 -29.17 35.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.664 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.0 t -93.66 -3.95 51.51 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 122.129 0.966 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 132.5 158.36 8.88 Favored Glycine 0 N--CA 1.422 -2.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.2 135.68 32.43 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 123.18 2.587 . . . . 0.0 111.351 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 76.48 9.74 85.91 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.871 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1541 ' ' ILE . . . . . 0.575 HD13 ' HG2' ' A' 1551 ' ' LYS . 46.5 mm -93.04 133.32 34.61 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -103.58 -48.5 1.19 Allowed Glycine 0 C--N 1.323 -0.155 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.525 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.05 129.39 54.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 53.5 t -148.06 138.65 22.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.627 0.251 . . . . 0.0 110.467 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' 1526 ' ' ILE . 96.6 m-85 -78.57 127.45 32.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.48 103.43 6.48 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 123.728 0.643 . . . . 0.0 109.862 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.68 -76.26 0.22 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1548 ' ' THR . . . . . 0.502 ' HB ' HG13 ' A' 1550 ' ' ILE . 16.7 m -81.25 -23.59 37.92 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.072 0.463 . . . . 0.0 110.637 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.57 37.38 10.7 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.385 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' 1548 ' ' THR . 62.9 mt -84.77 129.33 37.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.575 ' HG2' HD13 ' A' 1541 ' ' ILE . 11.2 mptt -92.32 133.41 35.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1552 ' ' ALA . . . . . 0.5 ' HA ' ' HB3' ' A' 1584 ' ' TYR . . . -111.42 16.16 20.94 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.349 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.797 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.73 138.19 2.81 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.835 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.63 142.81 27.98 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 124.954 1.302 . . . . 0.0 109.188 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 68.5 t90 -64.16 140.2 58.84 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.887 0.875 . . . . 0.0 110.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -162.26 -179.96 7.43 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -130.95 31.64 4.44 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 118.195 0.452 . . . . 0.0 112.074 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1558 ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' 1560 ' ' SER . 48.8 tptt -84.15 81.79 8.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.834 0.826 . . . . 0.0 109.921 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' 1568 ' ' LEU . 0.5 OUTLIER -93.2 98.18 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.3 t -89.62 158.7 17.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.15 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -130.29 104.77 7.47 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 96.3 t -115.07 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 36.5 t70 49.95 74.55 0.2 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.843 1.257 . . . . 0.0 112.365 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 67.91 -9.73 0.45 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.829 1.252 . . . . 0.0 113.654 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 85.6 t -107.17 132.19 55.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.775 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 9.4 mp -81.86 141.3 33.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' 1560 ' ' SER . 26.8 mm-40 -131.56 114.86 15.37 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1568 ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' 1559 ' ' LEU . 64.0 tp -123.04 136.08 54.69 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 8.9 p -135.45 135.42 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-O 121.373 0.606 . . . . 0.0 110.413 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.797 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 70.8 m-85 -105.53 104.6 14.36 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -102.71 163.44 12.22 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 30.4 t70 64.95 79.29 0.26 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 124.282 1.033 . . . . 0.0 112.027 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.83 -106.35 2.95 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.86 160.05 35.05 Favored Pre-proline 0 C--N 1.281 -2.399 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.42 151.52 48.05 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.054 1.836 . . . . 0.0 110.969 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 78.2 m -103.13 126.96 30.86 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.369 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.18 -23.82 63.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.86 3.04 . . . . 0.0 113.681 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -63.6 -65.35 0.69 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.593 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 22.7 t-20 -111.72 -14.72 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.377 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.43 -45.08 0.61 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.116 0.966 . . . . 0.0 113.132 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1581 ' ' HIS . . . . . 0.408 ' HB2' ' OD1' ' A' 1579 ' ' ASN . 56.3 m80 -68.05 -19.32 64.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.721 0.772 . . . . 0.0 110.036 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.954 HD11 ' HA ' ' A' 1611 ' ' THR . 41.6 mt -95.08 140.96 29.29 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.642 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 62.0 mttm -132.42 161.41 33.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1584 ' ' TYR . . . . . 0.5 ' HB3' ' HA ' ' A' 1552 ' ' ALA . 97.3 m-85 -65.34 116.53 6.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' 1613 ' ' THR . 21.5 mtpp -129.74 130.38 45.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1586 ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' 1570 ' ' TYR . 12.3 p -120.82 120.43 35.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 120.724 0.297 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -116.1 119.54 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.97 108.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 11.8 p -86.01 114.85 23.22 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.617 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.827 ' HD1' ' HE3' ' A' 1618 ' ' TRP . 53.9 m-85 -93.98 109.17 20.92 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.3 m -108.91 168.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.468 ' HA ' ' HB2' ' A' 1624 ' ' CYS . 38.0 t -75.96 117.51 17.76 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.771 0.828 . . . . 0.0 111.084 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.759 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 56.7 tptt -146.13 88.06 1.78 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1594 ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' 1621 ' ' SER . 17.9 m -73.84 -13.35 60.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.621 0.724 . . . . 0.0 110.263 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1595 ' ' ASP . . . . . 0.759 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 29.9 t70 -80.96 -7.36 59.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -93.03 -64.39 1.1 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 72.63 -123.99 9.29 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.37 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.04 -16.57 49.7 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.741 2.961 . . . . 0.0 113.741 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.9 p -83.01 -66.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.463 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' 1620 ' ' THR . 51.3 m 61.05 97.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.322 1.014 . . . . 0.0 110.463 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 14.5 mm100 -101.61 131.61 22.74 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.072 -171.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.9 Cg_endo -86.03 112.76 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.431 2.754 . . . . 0.0 111.345 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.01 125.5 47.63 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.499 HD23 ' HD2' ' A' 1522 ' ' ARG . 47.6 tp -78.79 116.22 18.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.116 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.74 -51.37 8.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.074 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.5 t -164.08 135.68 4.65 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.475 HG21 HD22 ' A' 1604 ' ' LEU . 93.4 t -102.51 111.26 31.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.9 t70 -104.24 99.52 9.24 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.798 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.59 8.62 9.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -82.24 -51.58 7.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.954 ' HA ' HD11 ' A' 1582 ' ' LEU . 0.7 OUTLIER -103.23 -4.04 24.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.816 -173.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.7 m 62.53 31.19 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 110.376 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1613 ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' 1585 ' ' LYS . 23.6 m -103.72 125.56 50.28 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.921 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.59 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 85.7 mt -98.72 119.93 38.29 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.064 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.53 109.93 22.01 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.59 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.2 m-85 -121.29 134.72 55.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.1 t -108.73 107.28 17.66 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.827 ' HE3' ' HD1' ' A' 1590 ' ' PHE . 18.4 t90 -93.99 106.69 18.65 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.454 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 72.4 m-70 -83.32 103.6 12.84 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.733 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' 1600 ' ' SER . 9.8 t -139.21 153.83 47.93 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.359 0.599 . . . . 0.0 109.996 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1621 ' ' SER . . . . . 0.569 ' HB3' ' HA ' ' A' 1594 ' ' SER . 0.8 OUTLIER -76.86 -24.88 52.63 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.357 177.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.94 -8.64 54.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 122.203 1.002 . . . . 0.0 109.145 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -109.8 12.42 24.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.73 0.776 . . . . 0.0 110.173 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1624 ' ' CYS . . . . . 0.468 ' HB2' ' HA ' ' A' 1592 ' ' CYS . 33.8 t -110.7 164.9 12.29 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -56.3 139.52 47.96 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.2 115.66 19.88 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.077 0.941 . . . . 0.0 111.99 -164.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.41 7.17 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.149 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 CA--C 1.491 -1.289 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 42.1 t 60.88 74.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 70.01 82.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.918 -170.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.11 164.1 3.27 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1493 ' ' ASN . . . . . 0.618 ' HB2' ' HG2' ' A' 1495 ' ' GLN . 31.5 m-80 -94.04 12.43 26.34 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 123.004 0.522 . . . . 0.0 110.237 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.838 ' HB3' ' HB3' ' A' 1507 ' ' LEU . 72.4 m 71.16 22.95 4.25 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.111 0.964 . . . . 0.0 110.026 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.618 ' HG2' ' HB2' ' A' 1493 ' ' ASN . 10.4 pt20 -128.17 128.18 44.33 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 9.5 p -131.08 132.45 63.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.776 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 19.9 m -93.64 129.52 39.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.438 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 11.5 p30 -89.1 136.16 30.72 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.852 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1499 ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 1.8 Cg_endo -82.14 -12.5 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.998 1.798 . . . . 0.0 110.8 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.49 76.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.679 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.7 p -126.23 -30.18 2.93 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 111.12 11.7 17.66 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.254 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 66.1 t80 -84.84 136.63 33.58 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.358 -0.495 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 64.7 t -99.91 119.3 47.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' 1495 ' ' GLN . 88.2 m-85 -87.61 104.45 16.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.76 101.02 12.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.791 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1507 ' ' LEU . . . . . 0.838 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 18.3 tp -83.31 -10.04 58.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.791 1.281 . . . . 0.0 107.975 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.481 ' O ' ' HG3' ' A' 1511 ' ' LYS . 6.9 p30 -67.05 -14.87 63.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.213 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.7 m -89.42 -6.44 56.55 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.578 ' HB2' HD11 ' A' 1622 ' ' LEU . 34.2 tp -114.65 9.35 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' 1508 ' ' ASN . 48.7 mttp -43.34 148.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.506 ' HB2' ' HA2' ' A' 1515 ' ' GLY . 0.1 OUTLIER -68.22 147.85 51.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.66 -173.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.21 -66.14 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 42.9 t -116.89 -19.98 9.62 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 167.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' 1512 ' ' ARG . . . 137.16 143.42 4.58 Favored Glycine 0 N--CA 1.414 -2.829 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' 1527 ' ' ARG . 41.7 m-85 -69.02 113.72 6.65 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.2 m -113.01 90.94 3.48 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.76 152.88 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.475 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 41.4 m -92.62 137.13 32.63 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.88 175.48 7.27 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1521 ' ' ILE . . . . . 0.411 HG21 ' HG3' ' A' 1522 ' ' ARG . 15.2 tt -58.0 -25.49 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 CA-C-O 121.189 0.519 . . . . 0.0 111.95 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1522 ' ' ARG . . . . . 0.411 ' HG3' HG21 ' A' 1521 ' ' ILE . 68.0 mtp180 -92.45 3.15 56.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.113 0.482 . . . . 0.0 111.135 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 77.83 25.49 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.687 1.595 . . . . 0.0 114.492 175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -91.7 125.47 8.06 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 69.7 m -79.02 122.25 25.96 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 120.949 0.404 . . . . 0.0 110.282 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.57 136.03 52.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.585 ' HB3' ' SG ' ' A' 1544 ' ' CYS . 50.2 ttm-85 -114.92 123.42 49.09 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.02 134.68 53.39 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.253 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.79 119.08 5.14 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' 1511 ' ' LYS . 27.5 m -96.12 143.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-N 117.036 0.418 . . . . 0.0 109.969 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.588 ' HA ' HE22 ' A' 1557 ' ' GLN . 72.5 m 74.61 -37.75 0.36 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.873 1.269 . . . . 0.0 113.203 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -131.8 150.44 19.55 Favored Glycine 0 N--CA 1.416 -2.642 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.79 155.04 37.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 124.24 0.612 . . . . 0.0 111.531 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -96.92 89.64 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 122.265 1.031 . . . . 0.0 110.219 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -64.85 -20.86 66.63 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.491 -175.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.38 -45.64 80.46 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.021 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 54.0 m -92.78 -15.08 27.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.161 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 148.88 136.88 2.73 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.34 137.4 74.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.853 2.369 . . . . 0.0 112.572 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 85.44 -5.92 81.74 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.705 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.0 mm -91.68 141.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.462 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.04 -29.59 3.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.179 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -135.86 120.05 17.77 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1544 ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' 1527 ' ' ARG . 8.1 p -127.95 144.61 51.1 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 111.17 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 78.7 t80 -105.35 125.53 51.08 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.26 57.26 3.53 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.054 0.931 . . . . 0.0 111.246 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1547 ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' 1549 ' ' GLY . . . -164.28 114.13 0.58 Allowed Glycine 0 C--N 1.289 -2.043 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1548 ' ' THR . . . . . 0.434 ' HB ' HG13 ' A' 1550 ' ' ILE . 28.2 m 72.46 -22.23 0.22 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.122 0.969 . . . . 0.0 110.938 -174.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1549 ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' 1547 ' ' GLY . . . 85.49 35.29 12.1 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 72.8 mt -64.33 138.22 23.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 123.934 0.432 . . . . 0.0 109.926 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 10.1 mptt -101.55 120.56 40.5 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -102.44 14.82 30.94 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.165 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 147.6 144.13 3.95 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.348 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 54.0 pttt -96.0 155.14 16.88 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.674 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 42.1 t90 -63.82 134.95 56.17 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.824 0.703 . . . . 0.0 110.164 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -169.86 164.06 9.71 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1557 ' ' GLN . . . . . 0.588 HE22 ' HA ' ' A' 1531 ' ' CYS . 19.2 mm-40 -122.32 83.25 2.08 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 120.933 0.397 . . . . 0.0 110.475 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1558 ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' 1560 ' ' SER . 1.7 tmtp? -107.06 98.94 8.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 111.6 23.41 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.469 ' HB2' ' HE2' ' A' 1558 ' ' LYS . 9.7 t -120.14 119.59 33.73 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.53 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 58.3 t80 -86.31 113.53 22.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.66 84.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 15.4 t70 45.52 81.77 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.016 1.726 . . . . 0.0 113.334 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 68.26 -0.23 2.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.341 1.056 . . . . 0.0 113.434 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.3 t -116.89 128.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.727 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 13.4 tp -96.52 122.66 39.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -103.95 119.82 39.74 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.079 -0.388 . . . . 0.0 110.666 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 66.9 tp -116.16 130.18 56.67 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 82.4 t -118.83 129.9 74.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.674 ' HE1' ' HA ' ' A' 1555 ' ' TRP . 38.7 m-85 -121.54 97.26 5.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.04 -178.68 3.56 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.444 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 23.4 t70 61.71 63.7 1.12 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.829 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.82 -121.62 4.67 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.367 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 17.0 m-20 -88.8 145.21 34.39 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1575 ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 16.0 Cg_exo -72.23 142.98 38.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.605 2.203 . . . . 0.0 109.676 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 69.1 m -98.13 134.05 22.46 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.56 8.34 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.136 2.557 . . . . 0.0 113.625 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -80.36 -51.71 8.54 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.569 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.1 m120 -134.2 0.93 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.99 -54.47 0.56 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 44.0 m80 -75.1 -16.33 60.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.882 0.373 . . . . 0.0 110.959 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.817 HD13 ' HA ' ' A' 1611 ' ' THR . 62.0 mt -82.52 123.62 29.35 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.565 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 94.5 mttt -122.78 162.62 21.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -64.1 115.08 4.61 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.54 ' HB3' ' HZ2' ' A' 1585 ' ' LYS . 8.7 mtpm? -128.54 131.87 48.25 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.543 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 20.4 t -120.12 131.27 54.98 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -121.88 120.82 62.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.53 105.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 23.6 m -90.35 110.55 21.63 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.727 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.6 m-85 -86.21 112.47 21.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.7 m -101.13 161.56 3.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' 1624 ' ' CYS . 45.0 t -81.24 137.08 35.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.713 0.768 . . . . 0.0 112.117 -173.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' 1596 ' ' ALA . 25.1 tptp -154.65 98.76 2.1 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 46.8 t -61.41 -28.8 69.52 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.12 0.486 . . . . 0.0 110.358 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.93 81.82 1.55 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.573 1.177 . . . . 0.0 109.054 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' 1593 ' ' LYS . . . -125.96 -29.64 3.06 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.593 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.01 168.46 40.59 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.43 -10.96 30.56 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 123.21 2.607 . . . . 0.0 111.86 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.1 p -90.7 -40.76 11.67 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.847 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 38.2 m 68.27 169.54 0.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.735 1.214 . . . . 0.0 110.955 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 13.2 mm-40 -114.5 120.85 37.13 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.347 -174.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.2 Cg_endo -91.19 101.95 0.24 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 123.117 2.545 . . . . 0.0 111.288 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' 1617 ' ' SER . 63.3 tp -89.75 119.66 30.34 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.17 109.86 16.11 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.18 -63.5 1.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.171 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.9 m -144.51 143.33 30.79 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.903 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 60.7 t -118.93 110.88 31.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.29 108.71 20.3 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.139 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -80.4 -0.1 35.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -100.8 -48.24 4.54 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.423 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.817 ' HA ' HD13 ' A' 1582 ' ' LEU . 58.0 p -95.42 -7.0 39.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.43 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.4 m 64.63 25.88 13.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.765 0.826 . . . . 0.0 111.476 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 57.8 m -93.59 127.03 39.07 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 121.352 0.596 . . . . 0.0 109.918 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 69.8 mt -102.51 127.77 49.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.786 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -110.63 114.75 28.38 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.37 135.35 54.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.299 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 15.2 m -108.71 103.52 12.62 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -94.03 107.84 19.72 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.47 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 76.4 m-70 -78.79 99.92 6.91 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 13.2 t -134.08 153.05 52.06 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 110.264 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.7 m -73.17 -29.07 62.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.448 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' 1510 ' ' LEU . 62.5 mt -74.42 -4.58 37.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -82.81 -25.7 32.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.336 0.589 . . . . 0.0 111.722 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1624 ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' 1592 ' ' CYS . 14.4 p -117.52 177.98 4.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.4 84.75 0.81 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.23 1.014 . . . . 0.0 110.157 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -81.77 137.06 35.39 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.209 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -124.8 -22.59 4.5 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.337 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--O 1.243 0.744 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.311 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 46.8 t -108.17 -24.11 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 71.34 16.35 6.11 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.793 1.237 . . . . 0.0 111.181 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.68 77.6 1.37 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -147.65 92.87 2.13 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.119 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 6.6 t 62.11 30.92 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.274 1.035 . . . . 0.0 110.965 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' 1505 ' ' PHE . 24.8 pt20 -152.61 145.7 24.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.061 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.3 p -145.5 134.99 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.693 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 22.7 m -92.03 125.66 36.8 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' 1503 ' ' TYR . 9.5 p30 -86.39 147.25 43.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.091 -0.643 . . . . 0.0 109.859 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.45 2.71 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.574 2.183 . . . . 0.0 113.894 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -92.88 -57.77 2.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.203 0.525 . . . . 0.0 111.297 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 35.0 p -105.99 -17.7 14.26 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.945 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 80.66 19.23 68.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.842 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1503 ' ' TYR . . . . . 0.514 ' HB3' ' ND2' ' A' 1498 ' ' ASN . 53.3 t80 -79.45 133.62 36.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 48.6 t -99.83 110.11 26.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' 1495 ' ' GLN . 96.2 m-85 -80.86 106.77 13.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -97.97 102.77 14.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.299 0.571 . . . . 0.0 112.048 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.04 -4.88 56.0 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.341 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.72 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 52.3 m-80 -62.6 -29.9 70.94 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 25.3 t -71.93 -14.97 62.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.793 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.12 3.05 15.89 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 122.397 -0.189 . . . . 0.0 111.129 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.72 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 55.6 mtmt -58.8 118.79 6.12 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.851 0.834 . . . . 0.0 112.985 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -106.6 97.33 7.14 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.001 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -34.59 64.7 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 125.44 1.496 . . . . 0.0 113.53 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.5 m -81.26 -19.82 42.27 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 85.32 155.99 25.64 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.904 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' 1527 ' ' ARG . 71.5 m-85 -92.43 133.09 36.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 9.4 p -112.07 91.5 3.68 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 16.9 pt -96.39 152.07 3.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.301 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 19.6 t -97.82 118.89 35.4 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.704 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1520 ' ' ASP . . . . . 0.548 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 1.9 t70 -74.46 151.65 39.55 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.569 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.7 tt -79.55 -16.25 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.645 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1522 ' ' ARG . . . . . 0.548 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 10.4 mtp-105 -87.62 1.96 52.24 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1523 ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.9 mmtt 72.45 77.75 0.15 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.002 1.721 . . . . 0.0 113.603 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -165.09 163.26 36.36 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 107.431 -2.267 . . . . 0.0 107.431 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.3 m -109.71 140.54 43.45 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 118.184 0.992 . . . . 0.0 109.488 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.471 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.8 tt -124.65 130.39 73.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' 1516 ' ' TYR . 17.7 ttm180 -112.68 119.14 37.06 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.383 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.39 127.01 47.85 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.947 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.37 129.47 9.89 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' 1511 ' ' LYS . 18.4 m -85.86 115.49 27.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.112 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 21.7 m 62.92 12.61 5.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.469 1.107 . . . . 0.0 111.714 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -135.56 147.56 19.24 Favored Glycine 0 N--CA 1.415 -2.76 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1533 ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' 1533 ' ' GLU . 0.1 OUTLIER -77.9 141.18 39.22 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 123.802 0.354 . . . . 0.0 110.219 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.3 m -85.23 87.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 122.01 0.909 . . . . 0.0 109.28 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.551 ' HD2' ' H ' ' A' 1535 ' ' LYS . 2.1 mptp? -59.39 -28.96 67.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.683 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.19 -36.75 71.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.579 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.5 m -96.86 -29.14 13.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.053 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 152.32 159.25 8.88 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.932 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.5 143.88 31.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.288 1.992 . . . . 0.0 111.323 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.46 6.21 89.38 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.537 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.0 131.62 59.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -95.57 -32.88 6.7 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.302 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.21 138.96 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.6 p -145.37 158.3 43.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.471 ' CD2' ' HB ' ' A' 1526 ' ' ILE . 38.8 t80 -113.91 106.17 14.13 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.31 106.76 7.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 122.011 0.91 . . . . 0.0 109.976 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.8 -67.39 0.3 Allowed Glycine 0 C--N 1.276 -2.754 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 -21.77 29.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 81.91 21.31 61.57 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 43.1 pt -91.7 151.1 3.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.215 0.531 . . . . 0.0 111.124 -176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.734 ' HD2' ' HB2' ' A' 1574 ' ' ASP . 74.7 mttt -87.43 156.43 19.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -124.41 7.51 8.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.415 0.626 . . . . 0.0 110.593 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.815 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 146.75 144.46 4.04 Favored Glycine 0 C--O 1.256 1.473 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.948 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -85.28 160.73 19.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.688 0.744 . . . . 0.0 110.377 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 70.3 t90 -62.86 132.63 52.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.368 0.667 . . . . 0.0 110.795 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.1 p30 -167.35 173.08 9.15 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -128.92 41.06 3.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 118.127 0.422 . . . . 0.0 110.04 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -72.11 103.31 3.25 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.077 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 98.8 mt -116.91 96.86 5.66 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.817 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 20.0 m -87.51 115.22 24.79 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 72.4 t80 -94.97 102.37 14.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -118.99 92.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-O 121.165 0.507 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.9 t70 54.04 69.97 0.66 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.371 1.068 . . . . 0.0 112.012 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 67.98 2.83 3.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.543 -1.208 . . . . 0.0 114.028 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.37 126.76 66.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.88 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.9 mp -94.05 118.03 30.95 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.402 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.817 ' HB2' ' HB2' ' A' 1560 ' ' SER . 17.4 mm-40 -102.64 114.01 27.87 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.57 107.7 18.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.589 HG21 HG23 ' A' 1587 ' ' VAL . 17.5 t -111.85 117.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.867 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.815 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 50.6 m-85 -93.64 101.73 13.89 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.9 177.72 4.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.865 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.738 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 34.2 t0 47.16 63.23 2.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 112.289 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -73.73 -77.08 0.64 Allowed Glycine 0 N--CA 1.42 -2.396 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.816 175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.734 ' HB2' ' HD2' ' A' 1551 ' ' LYS . 13.7 t70 -165.55 156.08 11.89 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.63 145.85 46.43 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.34 2.026 . . . . 0.0 112.38 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1576 ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 52.0 t -97.43 139.07 21.2 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -62.75 -28.07 76.0 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.203 2.602 . . . . 0.0 114.376 -177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.48 -44.9 49.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.881 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.869 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 40.5 t-20 -144.8 110.98 5.52 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.54 -15.07 9.7 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 46.1 m80 -94.0 -1.93 53.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 122.085 -0.384 . . . . 0.0 111.843 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.869 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 42.5 mt -90.66 154.8 19.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.738 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 66.4 mttm -127.35 151.35 48.89 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.282 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -61.43 120.09 9.81 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' 1583 ' ' LYS . 92.8 mttt -137.92 140.59 40.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.1 p -130.92 123.68 29.44 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 120.799 0.333 . . . . 0.0 110.417 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.589 HG23 HG21 ' A' 1569 ' ' VAL . 7.5 p -108.97 113.85 45.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.688 0.756 . . . . 0.0 110.178 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.89 109.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 25.9 m -92.37 111.96 23.73 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.0 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.88 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.5 m-85 -86.22 108.22 18.27 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 30.7 m -111.73 167.0 5.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.577 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 46.2 t -76.56 150.89 36.47 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.287 0.565 . . . . 0.0 112.258 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.74 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 22.6 tptp -170.86 115.06 0.44 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 174.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 8.3 t -75.44 -28.93 59.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.296 0.498 . . . . 0.0 111.921 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.03 12.34 24.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.287 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.656 ' HB3' ' HB3' ' A' 1593 ' ' LYS . . . -66.73 -51.84 51.33 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -172.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.63 179.04 40.81 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.71 -28.99 19.97 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.773 2.315 . . . . 0.0 113.033 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 -26.4 20.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 109.855 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' 1619 ' ' HIS . 21.3 m 63.38 -175.94 0.15 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.586 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.784 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 6.9 pt20 -116.24 121.44 33.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.821 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 9.6 Cg_endo -92.34 117.45 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.47 2.78 . . . . 0.0 112.111 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.607 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.2 tp -97.15 124.86 41.31 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.573 HD11 HG22 ' A' 1607 ' ' VAL . 60.4 tp -80.35 112.78 18.01 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.73 -50.49 8.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.144 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.9 t -175.22 140.28 0.5 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.445 0.466 . . . . 0.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.573 HG22 HD11 ' A' 1604 ' ' LEU . 83.9 t -107.9 110.17 30.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.57 102.41 12.29 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.24 -1.44 44.92 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.958 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -91.92 -39.74 11.54 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.617 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.61 ' HA ' HD13 ' A' 1582 ' ' LEU . 25.3 p -99.96 -2.15 35.34 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 90.8 m 58.57 33.93 23.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.901 0.858 . . . . 0.0 111.033 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 24.5 m -112.75 128.75 56.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.555 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.592 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 67.2 mt -105.13 134.64 47.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.033 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.68 115.94 26.07 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.592 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.5 m-85 -130.14 137.27 50.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.76 0.314 . . . . 0.0 110.892 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 21.0 t -108.45 108.27 19.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.406 ' NE1' ' HB2' ' A' 1600 ' ' SER . 11.7 t-105 -97.59 106.9 19.29 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.784 ' HB2' ' HG3' ' A' 1601 ' ' GLN . 66.0 m-70 -86.77 109.58 19.35 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 7.7 t -130.59 149.9 52.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.298 0.57 . . . . 0.0 110.916 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.1 p -78.87 -26.41 43.96 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.504 ' O ' HD13 ' A' 1622 ' ' LEU . 3.1 tm? -72.81 -6.93 48.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.113 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.15 2.41 40.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 0.0 109.819 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 63.4 m -87.59 133.05 33.86 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.08 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -61.79 150.28 37.54 Favored 'General case' 0 C--O 1.252 1.211 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -83.41 127.18 33.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.88 -56.77 11.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.11 0.481 . . . . 0.0 110.742 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.415 -2.177 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.636 177.664 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 43.1 t -110.09 94.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.46 133.47 35.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.89 62.93 6.72 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.044 0.926 . . . . 0.0 109.434 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1493 ' ' ASN . . . . . 0.456 ' C ' ' H ' ' A' 1495 ' ' GLN . 39.6 t-20 -112.45 102.58 10.69 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 38.5 t 76.48 -21.23 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.385 1.474 . . . . 0.0 110.834 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.456 ' H ' ' C ' ' A' 1493 ' ' ASN . 29.3 pt20 -118.04 154.28 32.29 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -142.36 136.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 40.2 m -88.5 126.69 35.37 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.815 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.444 HD21 ' HE2' ' A' 1505 ' ' PHE . 27.9 t-20 -91.57 106.65 17.55 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.29 -19.62 55.97 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.263 2.642 . . . . 0.0 114.61 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -72.65 -53.75 10.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.061 0.458 . . . . 0.0 110.852 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 17.5 p -96.53 -12.34 24.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 79.31 3.93 88.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.67 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1503 ' ' TYR . . . . . 0.419 ' CE1' ' HA ' ' A' 1628 ' ' VAL . 68.8 t80 -85.02 135.24 34.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.401 0.619 . . . . 0.0 110.485 -176.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 38.9 t -97.68 115.85 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.444 ' HE2' HD21 ' A' 1498 ' ' ASN . 97.3 m-85 -89.35 107.63 19.17 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -107.14 120.16 41.35 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.57 0.7 . . . . 0.0 110.7 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1507 ' ' LEU . . . . . 0.507 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 38.3 tp -79.42 -6.38 56.73 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -53.81 -31.07 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.47 1.508 . . . . 0.0 112.641 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 33.3 t -77.74 -20.9 52.68 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.028 0.442 . . . . 0.0 110.663 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 23.0 tp -116.63 -5.59 11.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.97 0.414 . . . . 0.0 111.568 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.6 154.07 42.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.493 0.663 . . . . 0.0 111.901 -175.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -121.63 122.01 38.67 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.187 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -68.79 -26.35 65.16 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.539 0.736 . . . . 0.0 110.476 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 14.0 t -89.2 -7.23 56.0 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 75.73 -164.43 53.94 Favored Glycine 0 N--CA 1.427 -1.921 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.473 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.76 145.81 43.24 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1517 ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' 1526 ' ' ILE . 32.6 m -142.61 100.63 3.72 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 28.2 pt -121.51 132.4 70.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.87 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1519 ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.0 t -80.0 112.65 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.72 136.95 32.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.089 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.65 -32.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.606 1.163 . . . . 0.0 112.839 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -74.73 -34.13 62.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 28.8 tptp -141.21 -58.69 0.49 Allowed 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.054 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 175.21 -163.41 33.45 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.379 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1525 ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' 1519 ' ' SER . 45.4 t -81.01 144.01 32.1 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.409 0.623 . . . . 0.0 111.289 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' 1517 ' ' THR . 14.2 tt -127.44 134.26 66.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.402 ' HG3' ' OG1' ' A' 1517 ' ' THR . 41.3 ttm180 -124.23 103.78 8.44 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.432 0.634 . . . . 0.0 109.593 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.83 144.84 51.74 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.016 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -111.66 139.53 15.64 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.519 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 16.2 m -98.01 117.8 43.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 16.4 m 69.73 19.08 7.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.975 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -153.42 168.71 32.13 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.26 149.56 26.76 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 20.7 m -94.87 90.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.318 1.056 . . . . 0.0 108.306 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.555 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -63.94 -13.72 48.06 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.402 -172.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.56 -12.96 60.33 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 123.149 0.58 . . . . 0.0 110.569 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1537 ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' 1551 ' ' LYS . 24.9 t -117.12 11.81 14.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.43 163.5 14.58 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.238 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 136.29 12.65 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.472 2.114 . . . . 0.0 111.48 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.83 21.6 79.09 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.588 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 118.19 50.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.494 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -94.04 -24.82 18.72 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.678 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.13 132.34 31.83 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 14.1 t -139.94 147.81 41.06 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.479 ' HB3' HG13 ' A' 1550 ' ' ILE . 63.8 t80 -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.13 81.57 8.4 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.306 1.051 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -158.27 85.02 0.13 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 7.6 m 69.63 16.76 7.97 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.214 1.007 . . . . 0.0 109.351 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 62.69 67.31 2.14 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.182 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' 1545 ' ' PHE . 23.7 pt -108.6 138.46 35.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 117.061 0.431 . . . . 0.0 110.015 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.425 ' HG2' ' SG ' ' A' 1537 ' ' CYS . 54.6 mttm -88.69 138.86 31.04 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -114.94 18.28 16.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.065 0.46 . . . . 0.0 111.231 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 148.2 136.71 2.77 Favored Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.948 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 61.0 tttm -85.07 143.54 28.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.429 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 37.3 t90 -69.29 134.27 48.92 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.632 0.73 . . . . 0.0 111.099 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 p30 -158.88 164.42 35.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -124.27 78.45 1.65 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 118.808 0.731 . . . . 0.0 112.4 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -108.23 92.19 3.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.551 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.14 96.36 7.44 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.8 m -96.93 138.14 34.94 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.542 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1561 ' ' TYR . . . . . 0.584 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 7.4 t80 -110.8 101.02 9.67 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 52.9 t -103.64 88.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.175 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.18 72.72 0.28 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.606 1.163 . . . . 0.0 111.49 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1564 ' ' GLN . . . . . 0.584 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 26.6 mp0 57.67 24.56 10.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.269 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 51.6 t -126.81 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.835 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 11.0 tp -82.31 135.96 35.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.558 ' HB2' ' HB2' ' A' 1560 ' ' SER . 26.6 mm-40 -124.45 135.54 53.33 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.804 0.442 . . . . 0.0 110.115 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.95 120.79 18.56 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.573 HG22 HG22 ' A' 1587 ' ' VAL . 39.2 t -119.14 129.48 75.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.322 0.582 . . . . 0.0 111.25 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.9 m-85 -107.34 111.86 24.41 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.462 174.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.541 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 48.1 mt-10 -117.56 177.26 4.82 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.198 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 17.5 t70 64.51 43.88 4.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.2 1.0 . . . . 0.0 111.446 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -89.32 -139.59 7.31 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.2 155.33 84.28 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 117.062 0.431 . . . . 0.0 110.351 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.69 148.97 72.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.339 2.026 . . . . 0.0 110.459 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 52.4 t -98.21 126.22 40.72 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -63.99 -7.18 12.73 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.091 2.527 . . . . 0.0 114.335 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -76.71 -61.16 2.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.036 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -117.67 -5.37 11.14 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 69.5 -45.28 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -70.56 -21.99 62.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.8 0.809 . . . . 0.0 109.173 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' 1611 ' ' THR . 93.5 mt -82.91 142.42 31.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 60.8 mttm -127.88 162.59 26.34 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -68.38 114.23 6.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.541 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.5 mtpt -128.03 138.99 52.79 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.569 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 27.0 t -120.91 120.0 34.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.573 HG22 HG22 ' A' 1569 ' ' VAL . 7.7 p -112.31 110.27 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 121.98 0.895 . . . . 0.0 109.941 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 107.74 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 15.4 p -90.73 112.91 24.87 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.069 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.835 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 85.4 m-85 -89.06 106.35 18.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -105.64 156.66 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.545 ' HA ' ' O ' ' A' 1620 ' ' THR . 26.2 t -95.1 139.16 31.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.409 -1.317 . . . . 0.0 113.612 -171.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 27.9 tptp -137.67 98.25 3.63 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.6 m -57.59 -29.26 64.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -100.76 6.21 43.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.285 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -64.67 -58.11 7.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 51.91 -114.53 3.24 Favored Glycine 0 N--CA 1.446 -0.694 0 O-C-N 123.767 0.667 . . . . 0.0 112.625 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.63 -19.96 53.65 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.269 2.646 . . . . 0.0 112.957 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.6 t -117.24 74.46 0.92 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.705 1.241 . . . . 0.0 110.399 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 50.7 m -86.42 116.88 24.86 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.09 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.2 mt-30 -93.52 123.92 58.76 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -173.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 1.4 Cg_endo -84.79 113.15 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.244 2.63 . . . . 0.0 110.449 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.46 HD12 HD21 ' A' 1605 ' ' LEU . 2.2 tm? -96.45 117.55 31.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 34.7 tp -82.96 111.59 18.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1605 ' ' LEU . . . . . 0.46 HD21 HD12 ' A' 1603 ' ' LEU . 90.6 mt -70.78 -55.68 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.483 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 11.9 t -170.88 153.04 3.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 99.4 t -105.19 111.66 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.56 108.35 19.38 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.626 -1.229 . . . . 0.0 110.163 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -81.46 1.84 31.47 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.1 t60 -89.85 -51.36 5.53 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.913 ' HA ' HD12 ' A' 1582 ' ' LEU . 0.2 OUTLIER -98.03 -7.37 29.98 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.361 -170.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 77.8 m 55.19 34.09 21.93 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.276 1.036 . . . . 0.0 112.361 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 22.3 m -104.55 127.05 52.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.023 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.468 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 83.1 mt -92.62 120.9 33.51 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.125 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -103.12 104.19 14.32 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.468 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 67.2 m-85 -118.66 128.99 55.04 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 67.2 m -109.25 105.63 15.14 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.491 ' HE3' ' CD2' ' A' 1590 ' ' PHE . 11.5 t90 -92.49 109.54 20.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 59.9 m-70 -80.53 96.81 6.9 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.616 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' 1592 ' ' CYS . 7.9 t -127.88 153.43 46.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.886 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 11.6 m -72.67 -25.86 61.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.145 0.497 . . . . 0.0 111.333 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' 1622 ' ' LEU . 7.2 tt -68.26 -13.26 62.12 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -89.28 -3.35 58.55 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 46.5 m -78.4 169.46 18.21 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.937 -0.477 . . . . 0.0 109.965 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.77 82.46 3.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -83.48 121.81 27.69 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.678 -170.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.33 -64.57 0.77 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 124.567 1.167 . . . . 0.0 109.059 176.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1628 ' ' VAL . . . . . 0.419 ' HA ' ' CE1' ' A' 1503 ' ' TYR . 84.7 t . . . . . 0 C--N 1.317 -0.843 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 C--O 1.224 -0.289 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 63.5 t -68.12 -59.17 4.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 117.969 0.349 . . . . 0.0 110.365 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -126.7 83.64 2.19 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.38 -171.47 3.37 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.076 -168.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.9 169.36 10.98 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 6.3 t 68.84 9.66 7.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.919 0.888 . . . . 0.0 111.102 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.1 pt20 -140.46 138.22 34.51 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.5 p -139.33 132.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.7 m -93.64 114.38 26.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.489 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 4.7 p30 -79.99 133.08 58.56 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1499 ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 12.2 Cg_exo -67.87 -32.15 29.83 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.535 2.157 . . . . 0.0 112.903 -176.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -55.75 -64.38 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 32.1 p -96.78 -20.51 18.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.94 0.4 . . . . 0.0 111.958 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.34 1.54 74.99 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.183 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -77.18 128.78 34.99 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.672 0.749 . . . . 0.0 111.931 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' 1497 ' ' THR . 22.1 t -85.9 108.2 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' 1495 ' ' GLN . 87.9 m-85 -84.67 100.58 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.41 120.51 39.72 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1507 ' ' LEU . . . . . 0.587 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 25.7 tp -83.96 3.83 32.41 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 121.993 0.902 . . . . 0.0 109.146 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.627 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 1.8 m-20 -57.68 -29.34 64.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.535 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1509 ' ' SER . . . . . 0.414 ' HB2' HD11 ' A' 1622 ' ' LEU . 10.0 m -71.41 -20.25 62.15 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.642 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.435 ' HB2' HD13 ' A' 1622 ' ' LEU . 0.2 OUTLIER -101.63 -11.02 19.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.627 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 46.3 mtmt -70.54 152.65 43.74 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.764 0.792 . . . . 0.0 112.317 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' 1515 ' ' GLY . 38.7 ttt180 -127.23 119.81 27.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 104.173 -2.529 . . . . 0.0 104.173 172.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.11 -45.74 71.95 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.828 0.705 . . . . 0.0 112.004 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.6 m -81.68 -2.49 50.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.154 0.502 . . . . 0.0 111.136 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.418 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 77.98 177.77 48.0 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.411 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.98 114.25 27.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 28.9 m -103.63 102.27 12.14 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.7 pt -122.41 138.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1519 ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' 1525 ' ' SER . 34.3 t -94.39 109.72 21.55 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.59 129.32 37.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.62 -20.09 22.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.85 0.719 . . . . 0.0 112.716 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -99.9 -32.25 11.09 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.595 -0.69 . . . . 0.0 110.583 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1523 ' ' LYS . . . . . 0.622 ' HE2' HG13 ' A' 1607 ' ' VAL . 26.7 mmtm -102.62 -62.94 1.21 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 151.87 -168.54 31.2 Favored Glycine 0 C--N 1.296 -1.655 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1525 ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' 1519 ' ' SER . 44.7 m -85.39 126.6 33.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 -177.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.93 140.31 48.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -118.72 117.2 28.27 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.48 120.67 38.83 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.358 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -97.09 102.44 2.74 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 57.5 t -62.24 115.67 2.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.554 ' HB2' ' CD ' ' A' 1511 ' ' LYS . 21.8 m 60.0 24.83 14.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.553 1.141 . . . . 0.0 111.824 176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.12 173.08 25.02 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -108.84 139.08 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.38 0.609 . . . . 0.0 110.846 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' 1537 ' ' CYS . 15.1 m -94.61 93.49 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.038 0.923 . . . . 0.0 109.149 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.474 ' HD2' ' H ' ' A' 1535 ' ' LYS . 9.1 mptt -54.73 -30.06 55.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.521 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.56 -18.11 63.62 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.681 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1537 ' ' CYS . . . . . 0.471 ' HB2' HG22 ' A' 1534 ' ' VAL . 80.9 m -113.44 14.0 19.02 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.978 0.418 . . . . 0.0 110.323 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1538 ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 110.68 128.91 5.48 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1539 ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 52.7 Cg_exo -59.54 127.98 25.61 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.932 2.421 . . . . 0.0 111.547 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 91.96 0.16 71.94 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.496 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1541 ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' 1554 ' ' LYS . 47.7 mm -93.79 134.82 30.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -105.07 -37.68 2.65 Favored Glycine 0 CA--C 1.503 -0.684 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.484 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.6 42.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1544 ' ' CYS . . . . . 0.419 ' SG ' HG21 ' A' 1534 ' ' VAL . 31.0 p -137.76 153.83 49.67 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.602 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.429 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 51.6 t80 -94.88 138.33 32.78 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.95 89.64 8.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.666 0.746 . . . . 0.0 110.311 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -178.96 85.43 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 71.3 m 76.85 -37.17 0.27 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.155 0.982 . . . . 0.0 112.394 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 132.32 46.23 0.12 Allowed Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.744 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 73.4 mt -78.52 134.73 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 9.4 mptt -96.32 140.86 30.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.53 12.19 10.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.528 0.68 . . . . 0.0 109.552 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.849 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 142.04 134.82 3.02 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.476 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1554 ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' 1541 ' ' ILE . 25.2 pttm -82.76 153.73 25.11 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.66 135.62 50.11 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 173.62 16.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1557 ' ' GLN . . . . . 0.475 ' H ' ' NE2' ' A' 1557 ' ' GLN . 0.0 OUTLIER -100.02 11.58 38.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.402 0.439 . . . . 0.0 111.077 -172.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -84.94 100.28 11.52 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -168.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' 1494 ' ' CYS . 68.2 mt -115.63 119.92 37.69 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.308 172.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 51.0 m -107.85 122.52 46.95 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 78.9 t80 -94.93 101.32 13.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.988 0.899 . . . . 0.0 108.826 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 85.1 t -93.71 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -34.57 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.862 1.665 . . . . 0.0 113.137 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 20.2 mp0 56.95 18.25 3.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.868 2.067 . . . . 0.0 114.571 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 135.12 62.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.137 0.494 . . . . 0.0 111.088 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.679 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.51 113.95 26.04 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -102.94 114.1 28.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.35 124.11 49.86 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 13.1 p -120.48 133.93 65.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 111.355 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.849 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 64.6 m-85 -107.6 106.3 16.59 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.06 167.56 10.16 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.252 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.98 78.38 0.29 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.304 1.041 . . . . 0.0 111.796 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1573 ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -106.26 -149.6 17.28 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -94.92 143.88 26.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1575 ' ' PRO . . . . . 0.495 ' HG3' ' HE2' ' A' 1583 ' ' LYS . 13.7 Cg_exo -69.01 146.75 65.88 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.845 2.364 . . . . 0.0 113.218 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 67.7 m -107.59 141.76 23.73 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.66 13.58 0.45 Allowed 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.574 2.849 . . . . 0.0 113.599 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.95 -38.5 22.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.691 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 28.1 t-20 -150.95 -6.7 0.27 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.041 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.14 -43.12 0.55 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.99 0.916 . . . . 0.0 113.424 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 59.9 m80 -77.37 -6.53 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.716 0.77 . . . . 0.0 110.78 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' 1611 ' ' THR . 63.3 mt -98.94 130.72 45.33 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.495 ' HE2' ' HG3' ' A' 1575 ' ' PRO . 96.1 mttt -128.73 161.95 28.54 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.456 0.473 . . . . 0.0 109.794 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1584 ' ' TYR . . . . . 0.429 ' O ' ' HA3' ' A' 1573 ' ' GLY . 98.9 m-85 -65.01 113.84 4.16 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.985 0.803 . . . . 0.0 109.1 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -129.33 137.62 51.1 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 17.3 t -121.49 130.81 53.79 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.3 p -125.43 116.83 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-O 121.96 0.886 . . . . 0.0 109.141 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.3 113.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.7 p -89.81 109.52 20.51 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.698 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.6 m-85 -86.81 103.06 14.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -99.39 166.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.552 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 18.6 t -84.6 130.31 34.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.469 0.652 . . . . 0.0 112.094 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 17.4 tptp -152.32 100.07 2.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.1 t -70.84 -14.4 62.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 0.0 111.591 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.19 1.89 55.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.375 0.607 . . . . 0.0 109.68 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.699 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -75.12 -65.9 0.83 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 108.18 -166.27 12.97 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.944 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.0 -20.23 44.82 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 124.275 3.317 . . . . 0.0 115.028 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 5.7 t -111.98 -22.09 11.23 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.891 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.699 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 48.0 m 65.41 -174.25 0.18 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.713 174.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.615 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 45.9 mt-30 -110.47 120.59 43.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1602 ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -90.69 125.7 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.906 2.404 . . . . 0.0 110.256 174.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 55.0 tp -129.0 126.05 38.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.676 -0.64 . . . . 0.0 111.027 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.13 118.68 20.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.24 -56.17 4.08 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.291 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 13.7 p -168.69 150.43 4.85 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.622 HG13 ' HE2' ' A' 1523 ' ' LYS . 98.2 t -115.0 114.26 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.71 109.05 20.05 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.01 -3.77 52.87 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.056 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -87.35 -51.79 5.75 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.739 ' HA ' HD11 ' A' 1582 ' ' LEU . 27.2 p -96.55 -8.25 32.41 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.614 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 72.9 m 65.7 25.92 11.45 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.929 0.892 . . . . 0.0 112.024 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 30.5 m -90.67 123.79 34.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.121 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.542 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 73.0 mt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.488 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -107.33 116.44 31.94 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.542 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 76.7 m-85 -126.96 140.04 52.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.981 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 78.3 p -111.21 116.3 30.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.423 ' HB3' ' CD1' ' A' 1590 ' ' PHE . 4.7 t-105 -99.74 111.79 24.09 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.615 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 71.0 m-70 -86.85 99.08 11.57 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 9.4 t -124.99 152.37 44.31 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.911 0.862 . . . . 0.0 112.131 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.3 m -76.46 -22.75 54.18 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.453 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' 1510 ' ' LEU . 39.9 mt -73.38 -5.21 38.3 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.175 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.77 12.77 30.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.525 0.679 . . . . 0.0 110.391 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 61.3 m -100.23 137.84 38.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.911 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.55 123.12 31.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -81.99 121.95 27.17 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.88 -45.81 73.44 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.803 0.811 . . . . 0.0 108.826 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 N--CA 1.423 -1.81 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.552 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1489 ' ' MET . . . . . 0.421 ' H2 ' ' HB3' ' A' 1492 ' ' ASP . 68.6 mtm . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 24.0 m -62.8 98.29 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.592 0.71 . . . . 0.0 112.892 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 57.65 31.93 21.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.693 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.421 ' HB3' ' H2 ' ' A' 1489 ' ' MET . 11.4 t70 -138.75 86.38 2.14 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.099 -1.409 . . . . 0.0 107.573 -175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -139.7 136.17 33.94 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 63.52 26.84 14.92 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.615 0.721 . . . . 0.0 111.392 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.2 pt20 -156.52 134.93 11.45 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.9 p -142.32 131.57 22.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.786 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.496 HG21 HG21 ' A' 1504 ' ' VAL . 10.6 m -98.63 129.09 45.13 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 38.5 p30 -85.91 127.63 61.47 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -70.2 -15.21 35.39 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.72 1.613 . . . . 0.0 110.855 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -65.63 -63.32 1.12 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.832 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 72.4 p -110.13 -14.06 14.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.579 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.12 14.78 58.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.303 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 71.0 t80 -92.16 137.42 32.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.496 HG21 HG21 ' A' 1497 ' ' THR . 43.3 t -102.91 128.49 55.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.504 ' O ' ' HA ' ' A' 1495 ' ' GLN . 79.3 m-85 -104.14 98.6 8.39 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.22 102.07 14.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 120.805 0.336 . . . . 0.0 110.339 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 25.1 tp -79.03 -15.96 57.52 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -66.8 -16.81 64.53 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.516 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 17.9 m -87.61 -13.2 43.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.307 0.575 . . . . 0.0 109.61 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' 1598 ' ' PRO . 36.6 tp -116.44 16.53 15.64 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.975 0.893 . . . . 0.0 109.034 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.71 173.1 1.85 Allowed 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.865 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -53.57 104.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.639 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -100.26 -45.05 5.74 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 50.9 m -119.12 -23.65 6.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.543 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 87.4 129.44 2.88 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -74.83 114.88 13.8 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 5.8 m -119.21 100.18 7.17 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1518 ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' 1602 ' ' PRO . 21.1 pt -103.3 140.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.774 -173.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 36.7 t -99.64 115.59 29.78 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.19 160.29 27.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 14.2 tt -62.93 -23.16 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.036 0.535 . . . . 0.0 112.311 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -81.73 3.58 25.1 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.2 tptm 76.34 30.7 0.66 Allowed 'General case' 0 C--N 1.351 0.661 0 C-N-CA 125.895 1.678 . . . . 0.0 108.085 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -82.43 108.72 2.98 Favored Glycine 0 N--CA 1.418 -2.517 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.063 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.1 m -86.63 102.87 14.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.8 tt -113.87 134.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.472 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -115.41 126.98 55.04 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.516 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 125.26 41.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -104.45 90.39 0.72 Allowed Glycine 0 N--CA 1.418 -2.518 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 21.3 m -62.61 116.04 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.55 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 98.9 m 61.03 20.44 10.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.971 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -146.27 91.13 0.15 Allowed Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.55 132.66 49.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 124.548 0.793 . . . . 0.0 110.384 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 18.1 m -93.91 104.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.246 0.546 . . . . 0.0 111.362 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -16.41 60.87 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.176 0.512 . . . . 0.0 111.896 -175.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.34 -27.96 68.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.879 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.1 t -113.55 24.1 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 91.55 137.33 7.46 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.949 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.41 156.41 60.46 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.267 1.978 . . . . 0.0 111.457 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.7 8.55 87.65 Favored Glycine 0 C--N 1.304 -1.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.483 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1541 ' ' ILE . . . . . 0.501 HG21 ' SG ' ' A' 1544 ' ' CYS . 45.3 mm -110.44 134.77 51.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.598 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -89.37 -42.55 5.49 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.217 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.29 147.35 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 122.661 -0.317 . . . . 0.0 110.598 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1544 ' ' CYS . . . . . 0.501 ' SG ' HG21 ' A' 1541 ' ' ILE . 59.2 m -152.43 156.22 39.06 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.278 0.631 . . . . 0.0 111.046 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.492 ' HB3' HG12 ' A' 1550 ' ' ILE . 64.9 t80 -94.22 119.05 32.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.09 102.09 3.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.985 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 151.49 -64.86 0.37 Allowed Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.367 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 21.9 p -91.25 -24.4 19.88 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.742 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.61 19.7 59.57 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.789 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' 1545 ' ' PHE . 44.6 pt -71.37 126.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 58.3 mttm -83.45 134.77 34.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.19 10.09 41.78 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.068 0.461 . . . . 0.0 111.402 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.669 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 139.0 146.04 4.87 Favored Glycine 0 C--O 1.254 1.357 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.817 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.54 146.5 36.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.635 0.255 . . . . 0.0 110.773 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.55 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 28.1 t90 -75.57 133.33 40.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.124 0.487 . . . . 0.0 110.332 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 10.2 p30 -146.76 -178.81 6.38 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.55 27.41 7.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.306 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1558 ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 44.0 mmtm -85.24 82.4 8.39 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.035 0.921 . . . . 0.0 111.849 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.44 103.93 16.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.338 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 6.9 t -90.05 109.68 20.71 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -83.6 101.8 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.8 t -114.75 95.13 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.067 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 23.5 t70 52.49 67.62 0.95 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.699 1.199 . . . . 0.0 112.137 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 63.92 9.88 4.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.851 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 37.5 t -119.75 136.7 56.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.38 131.6 39.87 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.299 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' 1560 ' ' SER . 86.9 mm-40 -116.28 114.63 24.63 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.57 119.47 38.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.553 HG21 ' HG3' ' A' 1571 ' ' GLU . 14.1 p -121.12 122.59 67.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.133 0.968 . . . . 0.0 112.526 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.669 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 57.6 m-85 -100.1 108.4 20.54 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.659 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.553 ' HG3' HG21 ' A' 1569 ' ' VAL . 46.0 mt-10 -117.68 168.54 10.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.296 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.652 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 35.8 t70 61.28 70.18 0.62 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.075 1.35 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.94 -133.17 5.62 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.875 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' 1584 ' ' TYR . 31.0 t70 -74.93 136.81 73.2 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.55 138.29 17.18 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.46 2.106 . . . . 0.0 112.589 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 56.2 m -98.78 126.3 39.26 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.87 8.15 2.12 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.944 2.429 . . . . 0.0 114.645 -173.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -77.2 -35.67 55.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 109.965 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.593 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 18.9 t-20 -136.05 -20.92 1.45 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.684 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 18.8 tp 75.83 -33.13 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.075 1.35 . . . . 0.0 112.504 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1581 ' ' HIS . . . . . 0.496 ' HB3' ' OD1' ' A' 1579 ' ' ASN . 40.8 t-80 -81.47 -14.88 56.51 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.861 HD11 ' HA ' ' A' 1611 ' ' THR . 83.3 mt -82.47 133.45 35.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.367 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 49.2 mttm -130.04 163.8 25.71 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1584 ' ' TYR . . . . . 0.471 ' CD2' ' HB3' ' A' 1574 ' ' ASP . 97.4 m-85 -72.05 117.61 13.88 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.85 171.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 134.18 55.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1586 ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 16.0 m -119.41 116.56 26.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -109.3 111.0 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.893 0.854 . . . . 0.0 110.051 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.3 mp -102.15 107.41 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.244 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 113.44 25.72 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.667 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.3 m-85 -86.22 112.32 21.25 Favored 'General case' 0 C--O 1.256 1.395 0 CA-C-O 120.708 0.289 . . . . 0.0 110.244 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.5 m -106.93 166.74 3.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 124.26 1.024 . . . . 0.0 109.124 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 43.0 t -77.05 143.24 39.44 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.412 0.625 . . . . 0.0 112.648 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.648 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 25.5 tptp -167.07 101.71 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.8 m -68.66 -28.52 66.96 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.649 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.2 71.04 3.86 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.581 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -142.63 -64.02 0.42 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.936 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 68.78 -144.76 42.41 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.402 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1598 ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' 1510 ' ' LEU . 40.7 Cg_endo -66.23 -11.96 33.54 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.013 3.142 . . . . 0.0 113.396 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.4 t -123.24 77.08 1.44 Allowed 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.581 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 51.0 m -70.74 147.8 48.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.795 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.604 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 9.3 pt20 -108.55 120.85 45.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-O 121.56 0.695 . . . . 0.0 112.492 -170.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.464 ' HG3' HG21 ' A' 1518 ' ' ILE . 88.2 Cg_endo -80.78 139.42 12.36 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.4 tm? -106.66 111.02 23.38 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.759 HD22 HG21 ' A' 1607 ' ' VAL . 4.8 tt -81.53 112.5 18.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.14 -66.38 0.8 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 55.0 m -158.09 136.25 10.84 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.742 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.759 HG21 HD22 ' A' 1604 ' ' LEU . 90.9 t -95.36 111.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.99 118.65 29.71 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.599 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -80.72 -6.84 58.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.37 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -94.22 -51.81 4.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.563 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.861 ' HA ' HD11 ' A' 1582 ' ' LEU . 41.7 p -97.16 -14.77 21.27 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.012 0.195 . . . . 0.0 111.447 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1612 ' ' CYS . . . . . 0.43 ' HB3' ' CD1' ' A' 1584 ' ' TYR . 69.5 m 67.33 26.54 8.47 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.364 1.04 . . . . 0.0 110.742 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 19.3 m -86.87 116.81 25.19 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.703 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 74.6 mt -94.07 116.21 28.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -100.58 111.75 24.04 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.703 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 91.5 m-85 -128.44 136.73 51.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.334 0.587 . . . . 0.0 111.577 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.9 m -112.22 106.41 14.98 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.459 ' HB2' HG23 ' A' 1588 ' ' ILE . 1.4 t-105 -89.99 114.95 26.89 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.648 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 42.6 m80 -78.0 101.26 6.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 11.7 t -129.35 153.31 47.99 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.576 0.703 . . . . 0.0 111.074 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.2 m -73.28 -28.82 62.32 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.3 -6.49 43.51 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 121.45 0.643 . . . . 0.0 111.558 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -92.84 -4.45 52.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.435 0.636 . . . . 0.0 110.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 7.4 m -99.12 129.23 45.37 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.38 124.06 24.36 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.753 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -81.12 116.62 21.13 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -88.66 -51.96 5.4 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.232 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.238 0.484 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 11.1 p -92.95 142.75 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.89 99.69 12.02 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.293 0.568 . . . . 0.0 111.881 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -118.66 141.53 48.51 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -178.7 -179.75 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 37.6 m -87.71 11.53 15.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.596 0.713 . . . . 0.0 109.484 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.5 pt20 -152.01 136.33 16.73 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.6 p -132.61 126.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.35 0.595 . . . . 0.0 110.209 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 14.3 m -90.32 116.68 28.47 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.455 HD21 ' HE1' ' A' 1505 ' ' PHE . 28.1 p30 -73.8 143.94 82.15 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.777 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1499 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 7.7 Cg_exo -73.52 -31.73 8.58 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.876 1.717 . . . . 0.0 112.01 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -62.08 -65.42 0.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 8.7 p -97.69 -11.65 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 74.28 40.17 41.77 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 83.9 t80 -111.72 130.5 55.76 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.033 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' 1497 ' ' THR . 47.6 t -90.28 118.95 36.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.455 ' HE1' HD21 ' A' 1498 ' ' ASN . 90.8 m-85 -91.29 108.21 19.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.55 106.43 17.53 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.335 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1507 ' ' LEU . . . . . 0.593 HD12 HD21 ' A' 1510 ' ' LEU . 28.1 tp -83.97 -3.12 57.75 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -51.17 -38.42 52.08 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 125.855 1.662 . . . . 0.0 111.571 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 4.9 m -68.13 -19.21 64.8 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.593 HD21 HD12 ' A' 1507 ' ' LEU . 50.6 tp -117.24 5.69 12.69 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.928 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.489 ' HD2' ' HB2' ' A' 1531 ' ' CYS . 22.8 pttm -88.09 129.53 35.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.319 -175.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -128.44 118.29 22.85 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.99 -37.28 78.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 2.7 m -56.17 -25.1 45.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.744 1.218 . . . . 0.0 110.273 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.689 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 87.07 177.12 49.05 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.316 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.65 124.9 43.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1517 ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' 1527 ' ' ARG . 2.6 m -103.04 98.41 8.36 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 15.4 pt -106.39 151.11 8.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.268 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1519 ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' 1525 ' ' SER . 12.8 p -109.44 130.98 55.47 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.94 154.91 40.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.3 tp -62.94 -26.16 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.287 0.635 . . . . 0.0 111.824 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 50.1 mtp180 -85.86 3.42 41.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 86.92 20.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.613 1.565 . . . . 0.0 112.519 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -83.58 80.23 1.84 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1525 ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' 1519 ' ' SER . 15.0 m -69.65 127.7 33.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.409 HD12 ' HB3' ' A' 1543 ' ' ALA . 7.6 tt -129.49 134.07 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.45 0.643 . . . . 0.0 110.153 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' 1517 ' ' THR . 58.2 ttt180 -105.82 119.77 40.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1528 ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' 1528 ' ' LEU . 0.7 OUTLIER -122.61 125.14 45.06 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -178.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.689 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -97.79 143.93 16.99 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 23.8 t -100.01 116.49 43.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.571 ' HA ' ' OE1' ' A' 1557 ' ' GLN . 62.0 m 63.95 20.99 12.46 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.078 0.862 . . . . 0.0 110.801 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -142.84 111.91 0.69 Allowed Glycine 0 N--CA 1.407 -3.271 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.76 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.18 133.4 47.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.9 m -90.85 95.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 122.258 1.028 . . . . 0.0 108.313 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.65 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.05 -28.17 64.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.913 -173.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.21 -16.56 61.95 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1537 ' ' CYS . . . . . 0.659 ' HB2' HG23 ' A' 1534 ' ' VAL . 96.7 m -102.76 -5.33 23.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.243 0.544 . . . . 0.0 109.538 173.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 131.44 145.03 5.52 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 132.49 29.67 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.166 1.91 . . . . 0.0 111.119 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.14 23.08 76.87 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.042 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.44 127.28 66.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.453 ' HA3' ' CE2' ' A' 1570 ' ' TYR . . . -100.8 -35.21 4.38 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.69 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1543 ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' 1526 ' ' ILE . . . -129.22 121.88 28.55 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.2 p -132.42 142.74 49.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.013 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' 1552 ' ' ALA . 73.8 m-85 -90.05 141.49 28.62 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.66 -26.27 64.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -89.88 126.79 8.45 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 6.7 m 75.48 -21.34 0.31 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 124.762 1.225 . . . . 0.0 112.009 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.22 30.36 54.88 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.63 150.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.165 0.507 . . . . 0.0 110.252 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.676 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 18.3 pttm -97.06 145.58 25.83 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1552 ' ' ALA . . . . . 0.48 ' HB3' ' CE2' ' A' 1545 ' ' PHE . . . -106.02 8.9 32.58 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.218 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.35 141.13 3.18 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.553 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.55 150.52 36.54 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.478 ' HA ' ' HE2' ' A' 1570 ' ' TYR . 35.2 t90 -63.78 124.49 21.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.694 0.759 . . . . 0.0 110.506 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.14 153.06 37.16 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1557 ' ' GLN . . . . . 0.571 ' OE1' ' HA ' ' A' 1531 ' ' CYS . 13.4 mm100 -108.72 22.63 15.67 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 123.753 0.658 . . . . 0.0 109.653 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 27.9 tptp -77.17 82.44 3.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.144 0.973 . . . . 0.0 111.57 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.48 HD13 ' HB3' ' A' 1566 ' ' LEU . 50.5 tp -91.33 116.2 28.64 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.262 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.4 m -103.31 147.14 27.44 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 60.7 t80 -117.51 135.0 54.23 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.027 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1562 ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' 1565 ' ' VAL . 18.0 m -134.05 160.51 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.33 106.1 0.09 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.073 0.949 . . . . 0.0 112.887 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 71.9 17.59 5.25 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.15 1.78 . . . . 0.0 112.413 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1565 ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' 1562 ' ' VAL . 59.5 t -139.8 124.68 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 93.3 mt -96.04 129.39 43.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.613 ' HB2' ' HB2' ' A' 1560 ' ' SER . 18.1 mm-40 -113.6 114.27 26.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 19.6 mt -104.81 119.47 39.08 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 36.1 t -116.72 108.58 25.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.294 0.569 . . . . 0.0 110.517 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 45.8 m-85 -93.22 113.35 25.54 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.812 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.54 -177.17 3.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.448 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.663 ' HA ' ' HD2' ' A' 1583 ' ' LYS . 5.1 m-20 68.33 27.98 6.38 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.713 0.633 . . . . 0.0 112.242 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1573 ' ' GLY . . . . . 0.676 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -74.07 -167.63 16.37 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.581 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 1.5 m-20 -72.19 162.63 72.65 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 122.338 -0.507 . . . . 0.0 112.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -65.23 144.35 80.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.572 2.181 . . . . 0.0 112.479 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1576 ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 43.9 t -98.23 140.18 21.7 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 124.677 1.191 . . . . 0.0 109.991 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.61 -22.12 73.63 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.068 2.512 . . . . 0.0 114.069 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.21 -26.56 60.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.849 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 36.9 t-20 -171.11 120.21 0.51 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1580 ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' 1580 ' ' LEU . 2.4 mm? -56.16 -27.22 53.47 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.593 1.157 . . . . 0.0 114.112 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.6 m80 -91.09 3.23 55.29 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.849 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 57.6 mt -89.94 121.55 32.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.663 ' HD2' ' HA ' ' A' 1572 ' ' ASP . 50.7 mtmt -103.27 156.88 17.4 Favored 'General case' 0 C--N 1.272 -2.795 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -61.88 119.83 9.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.73 0.644 . . . . 0.0 110.881 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' 1583 ' ' LYS . 0.6 OUTLIER -104.38 131.11 52.09 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 1586 ' ' SER . . . . . 0.592 ' HB3' ' HB2' ' A' 1570 ' ' TYR . 23.1 t -123.15 116.07 22.83 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -116.82 112.87 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-O 122.097 0.951 . . . . 0.0 110.321 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.41 101.51 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 47.5 m -90.96 110.25 21.49 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.21 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.5 m-85 -86.05 104.84 16.02 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.3 m -98.13 159.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.638 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 41.6 t -76.02 122.28 23.98 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.624 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' 1595 ' ' ASP . 20.4 tptm -149.7 90.12 1.68 Allowed 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.6 t -68.37 -15.26 63.49 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.466 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1595 ' ' ASP . . . . . 0.408 ' HB2' ' HE2' ' A' 1593 ' ' LYS . 29.3 m-20 -85.63 4.3 36.93 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 122.175 -0.328 . . . . 0.0 111.505 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.749 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -83.28 -61.12 1.93 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-O 120.734 0.302 . . . . 0.0 111.165 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 87.87 -141.75 17.28 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.838 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.52 -16.9 38.81 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.337 2.691 . . . . 0.0 112.97 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.8 t -125.97 89.78 3.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 122.45 1.119 . . . . 0.0 109.553 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.749 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 23.2 m -76.25 148.17 37.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.2 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 56.3 mt-30 -96.19 122.06 58.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.4 Cg_endo -87.14 113.67 1.0 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.402 2.734 . . . . 0.0 110.708 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.59 119.33 36.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.871 0.367 . . . . 0.0 110.291 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.438 HD12 ' CZ ' ' A' 1616 ' ' PHE . 39.0 tp -76.5 126.07 30.33 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.39 -65.47 1.01 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 73.7 m -159.51 156.29 27.94 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.499 HG13 HD21 ' A' 1614 ' ' LEU . 96.0 t -110.37 112.39 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 171.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.68 109.03 13.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.86 -6.42 58.59 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.208 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -95.16 -29.0 14.77 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.043 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.726 ' HA ' HD12 ' A' 1582 ' ' LEU . 35.9 p -114.86 -15.22 11.87 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.961 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 97.8 m 66.14 58.8 0.7 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.556 1.169 . . . . 0.0 111.097 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 23.5 m -120.94 130.37 53.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.281 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.499 HD21 HG13 ' A' 1607 ' ' VAL . 73.6 mt -96.81 117.4 31.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.33 103.33 13.33 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.498 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -114.82 131.53 56.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.829 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 74.7 p -109.53 108.46 18.93 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -92.68 108.01 19.65 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' 1600 ' ' SER . 64.4 m-70 -83.66 97.72 9.25 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -126.45 152.14 46.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.759 0.79 . . . . 0.0 111.808 -173.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.6 m -78.25 -25.99 47.06 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.405 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' 1510 ' ' LEU . 43.2 mt -70.61 -6.07 34.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.957 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -95.18 -9.55 33.07 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.538 0.685 . . . . 0.0 110.432 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -82.85 135.77 34.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.85 89.08 0.57 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -91.6 121.03 32.9 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.492 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.09 -44.21 18.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 -179.731 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 89.7 mmm . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 -41.93 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.208 1.004 . . . . 0.0 108.44 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -123.51 106.67 10.8 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.052 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' 1495 ' ' GLN . 63.4 m-20 -87.73 72.14 9.52 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.849 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -89.34 94.09 9.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 45.1 t 61.86 33.41 17.63 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 123.042 1.401 . . . . 0.0 110.16 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' 1492 ' ' ASP . 8.6 pt20 -156.46 146.55 21.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 11.7 p -148.14 135.55 13.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.459 ' HG1' HG22 ' A' 1504 ' ' VAL . 14.0 m -94.94 116.98 29.38 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.447 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.4 p30 -78.66 138.03 58.54 Favored Pre-proline 0 C--N 1.31 -1.134 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.604 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.08 -1.9 11.98 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 113.647 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -83.52 -68.57 0.7 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.68 0.276 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 12.1 p -89.22 -24.99 21.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.65 13.95 64.19 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.55 139.97 30.34 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.459 HG22 ' HG1' ' A' 1497 ' ' THR . 44.5 t -92.55 116.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.466 ' HZ ' ' HG2' ' A' 1625 ' ' GLU . 82.3 m-85 -81.24 95.33 6.91 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.04 95.35 10.28 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.001 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 31.8 tp -86.01 -11.1 53.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.51 0.672 . . . . 0.0 110.996 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.439 ' O ' ' HG2' ' A' 1511 ' ' LYS . 9.1 p30 -71.68 -13.22 61.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.947 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 74.3 m -84.23 -10.85 57.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.128 173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.76 4.06 19.63 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.004 -0.435 . . . . 0.0 111.033 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.612 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 58.0 pttt -90.79 157.74 17.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.079 0.466 . . . . 0.0 111.262 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -128.88 137.03 51.22 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -30.08 70.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 22.3 t -78.27 -11.54 59.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.805 0.812 . . . . 0.0 109.101 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 76.57 -174.67 53.75 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.512 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.87 121.36 44.44 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.5 m -105.88 103.87 13.46 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1518 ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' 1602 ' ' PRO . 25.9 pt -108.66 139.91 29.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.201 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 10.0 p -87.11 139.29 30.72 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 121.616 0.722 . . . . 0.0 111.571 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -95.23 151.84 18.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.16 -25.87 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 124.567 1.147 . . . . 0.0 112.952 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.58 2.67 18.48 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.08 -0.387 . . . . 0.0 111.841 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.9 tptm 70.04 68.97 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.731 1.253 . . . . 0.0 109.481 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -150.47 174.61 29.79 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 16.5 t -146.39 146.79 30.75 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 118.559 1.18 . . . . 0.0 108.421 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.34 134.47 60.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.1 ttm105 -110.15 113.85 26.87 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.17 129.36 56.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.18 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.75 91.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' 1511 ' ' LYS . 92.8 t -64.1 116.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.612 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 60.8 m 58.45 18.46 5.65 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.79 0.681 . . . . 0.0 112.695 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -154.07 101.85 0.21 Allowed Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.0 132.64 54.5 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 121.26 0.552 . . . . 0.0 111.723 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.5 m -78.87 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.958 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -18.01 17.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.095 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.33 -31.82 73.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.27 -0.38 26.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.501 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 123.97 158.11 10.01 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.378 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.9 130.77 11.63 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.395 2.063 . . . . 0.0 111.935 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.86 5.24 81.4 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.572 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1541 ' ' ILE . . . . . 0.436 ' CD1' ' HD2' ' A' 1551 ' ' LYS . 41.1 mm -98.77 117.49 43.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.15 -19.73 18.11 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.49 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -137.27 120.28 16.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.4 p -131.03 136.77 48.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.395 0.617 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 76.8 t80 -96.26 116.12 28.51 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.6 104.81 4.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.623 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -176.12 -105.67 0.19 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 5.2 m -73.88 -25.23 59.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 109.46 57.53 0.53 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 61.3 mt -94.14 125.12 46.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.436 ' HD2' ' CD1' ' A' 1541 ' ' ILE . 43.2 mtmt -83.91 126.26 32.82 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -105.48 9.0 33.69 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.246 0.546 . . . . 0.0 110.767 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.759 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 147.86 146.58 4.37 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.329 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.5 144.93 27.66 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.733 0.777 . . . . 0.0 111.541 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.505 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 65.6 t90 -65.54 151.21 46.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.158 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -164.99 167.31 18.58 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -119.26 20.52 12.56 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -91.01 96.71 10.76 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.463 0.649 . . . . 0.0 110.336 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.462 HD22 HD12 ' A' 1568 ' ' LEU . 69.2 mt -94.19 109.38 21.18 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 20.1 m -92.94 120.84 33.67 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 75.6 t80 -93.23 102.39 14.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1562 ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' 1565 ' ' VAL . 49.2 t -115.65 88.88 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.681 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.0 t70 48.03 81.41 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.927 1.291 . . . . 0.0 113.799 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 70.35 -9.19 0.79 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1565 ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' 1562 ' ' VAL . 7.4 p -116.98 132.13 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.539 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.854 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 14.7 tp -88.15 119.08 28.2 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -107.06 129.11 54.86 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.435 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1568 ' ' LEU . . . . . 0.462 HD12 HD22 ' A' 1559 ' ' LEU . 54.9 tp -126.8 109.88 12.49 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 172.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.554 HG23 HG22 ' A' 1587 ' ' VAL . 38.7 t -110.9 128.5 67.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.759 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 75.2 m-85 -104.43 119.33 38.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.13 177.28 4.78 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.781 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.546 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 8.7 t70 52.65 70.33 0.59 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.227 1.411 . . . . 0.0 111.85 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.94 -135.82 8.87 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.321 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.5 145.54 48.23 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.18 142.72 31.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.607 2.205 . . . . 0.0 111.526 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1576 ' ' CYS . . . . . 0.478 ' C ' ' H ' ' A' 1578 ' ' ALA . 78.2 m -98.39 132.17 24.76 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.746 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.44 20.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.578 2.852 . . . . 0.0 112.714 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1578 ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -86.81 -55.47 3.83 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.55 7.67 2.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.282 0.563 . . . . 0.0 109.766 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 2.2 tm? 68.93 -50.88 0.59 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.508 1.523 . . . . 0.0 112.358 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.7 t60 -68.49 -13.46 62.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.358 0.663 . . . . 0.0 110.408 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.67 134.98 35.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.546 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 85.6 mttt -125.84 152.45 45.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -67.08 117.48 9.18 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.864 0.728 . . . . 0.0 109.393 174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.14 135.45 48.88 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 13.1 p -121.03 121.25 37.54 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.683 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.554 HG22 HG23 ' A' 1569 ' ' VAL . 4.2 p -106.15 113.63 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.552 0.691 . . . . 0.0 109.735 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.42 110.12 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1589 ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' 1565 ' ' VAL . 42.3 m -93.34 118.62 31.5 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.854 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 90.9 m-85 -86.58 110.2 19.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.2 m -107.42 152.38 9.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' 1620 ' ' THR . 40.3 t -81.98 142.53 32.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.273 0.558 . . . . 0.0 112.404 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.511 ' CB ' ' HB3' ' A' 1619 ' ' HIS . 42.4 tptt -163.29 97.35 0.9 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.457 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 9.5 p -56.65 -32.28 65.21 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.871 0.868 . . . . 0.0 112.09 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1595 ' ' ASP . . . . . 0.436 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.674 0.79 . . . . 0.0 112.037 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -80.27 -41.6 24.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.767 0.318 . . . . 0.0 111.519 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.2 -163.68 39.66 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.7 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.63 -15.64 21.63 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.272 2.648 . . . . 0.0 113.168 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.3 p -86.13 -42.02 14.24 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.76 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 23.4 m 72.21 161.75 0.25 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.18 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -115.52 121.65 34.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.429 ' HG3' HG21 ' A' 1518 ' ' ILE . 55.3 Cg_endo -84.2 121.46 2.72 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.73 118.38 33.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.471 HD23 HG21 ' A' 1607 ' ' VAL . 49.7 tp -78.42 116.84 19.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 46.8 tp -79.94 -56.12 4.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.608 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 50.9 m -164.21 136.24 4.75 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 122.614 0.365 . . . . 0.0 110.171 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.471 HG21 HD23 ' A' 1604 ' ' LEU . 82.3 t -103.35 110.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.22 100.17 10.35 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.487 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -80.58 7.07 10.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.081 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -89.8 -51.34 5.55 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.942 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1611 ' ' THR . . . . . . . . . . . . . 49.9 p -99.74 -9.53 22.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.581 0.229 . . . . 0.0 111.218 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 66.6 m 69.54 23.27 6.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.656 1.182 . . . . 0.0 111.075 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 13.4 m -91.22 114.23 26.7 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' 1616 ' ' PHE . 79.6 mt -93.83 121.91 35.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.92 113.56 27.18 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' 1614 ' ' LEU . 76.0 m-85 -121.9 139.19 53.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.1 m -119.92 108.81 14.79 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 24.3 t-105 -93.14 110.24 21.74 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.511 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 39.4 m-70 -83.04 107.77 15.87 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.8 t -132.79 152.98 51.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.622 0.576 . . . . 0.0 110.068 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.7 m -70.62 -27.62 64.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.41 0.624 . . . . 0.0 110.065 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.82 -5.87 37.43 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.347 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -84.73 -9.01 58.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.605 0.717 . . . . 0.0 110.501 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.7 m -94.58 144.26 25.74 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1625 ' ' GLU . . . . . 0.466 ' HG2' ' HZ ' ' A' 1505 ' ' PHE . 47.3 mt-10 -69.83 105.54 2.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.51 0.671 . . . . 0.0 109.698 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -81.17 136.93 35.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.58 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -62.48 1.85 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.792 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.878 0.371 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 50.4 t -94.06 -48.53 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -74.45 155.73 37.71 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.77 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.485 ' HB3' ' HA ' ' A' 1496 ' ' VAL . 9.2 m-20 -54.66 104.52 0.12 Allowed 'General case' 0 C--O 1.239 0.515 0 O-C-N 124.654 1.221 . . . . 0.0 110.123 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.42 126.78 51.31 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 95.3 m 70.91 -1.4 2.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.602 0.715 . . . . 0.0 112.325 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.455 ' O ' ' HB3' ' A' 1492 ' ' ASP . 29.4 pt20 -149.2 161.53 41.81 Favored 'General case' 0 N--CA 1.405 -2.692 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1496 ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' A' 1492 ' ' ASP . 14.5 p -146.74 121.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-O 121.88 0.847 . . . . 0.0 110.514 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.604 HG23 HG23 ' A' 1504 ' ' VAL . 17.7 m -91.67 104.18 16.68 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.05 135.9 47.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.087 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 -12.37 20.18 Favored 'Trans proline' 0 C--N 1.332 -0.324 0 C-N-CA 122.591 2.194 . . . . 0.0 112.212 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -66.51 -67.34 0.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.544 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 25.4 p -99.54 -23.0 15.23 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.45 73.28 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.376 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -74.63 137.4 42.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.177 0.513 . . . . 0.0 110.023 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.604 HG23 HG23 ' A' 1497 ' ' THR . 41.7 t -100.02 121.56 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -115.08 108.56 16.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.33 127.44 51.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.722 0.772 . . . . 0.0 109.479 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.4 tp -90.78 4.65 51.06 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' 1511 ' ' LYS . 79.7 m-20 -67.42 -27.21 66.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.415 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 35.9 p -79.61 -18.29 51.93 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.801 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' 1598 ' ' PRO . 25.6 mt -109.63 4.26 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.08 -0.388 . . . . 0.0 111.657 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' 1508 ' ' ASN . 21.1 pttp -85.17 153.02 22.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' 1515 ' ' GLY . 55.1 ttt180 -120.88 129.49 53.53 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.32 -42.76 92.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 111.111 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.0 m -82.25 1.45 36.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.54 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.56 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 76.37 166.21 22.37 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.405 0.447 . . . . 0.0 113.981 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' 1527 ' ' ARG . 89.0 m-85 -98.68 123.78 43.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.1 m -103.93 97.75 7.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.87 125.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.134 0.492 . . . . 0.0 111.664 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1519 ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' 1525 ' ' SER . 38.7 m -94.3 116.65 29.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1520 ' ' ASP . . . . . 0.527 ' HB3' HD21 ' A' 1604 ' ' LEU . 2.0 m-20 -119.43 99.72 6.85 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1521 ' ' ILE . . . . . 0.468 HG22 HD12 ' A' 1521 ' ' ILE . 47.8 mt 63.26 -104.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.932 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.97 -12.52 12.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.59 -35.6 79.29 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.728 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 122.26 -161.94 16.24 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1525 ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' 1519 ' ' SER . 9.0 m -96.21 123.1 39.71 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 7.7 tt -112.13 127.45 69.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.498 ' HG2' HG12 ' A' 1534 ' ' VAL . 40.1 ttm180 -104.83 118.57 36.89 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1528 ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' 1528 ' ' LEU . 1.2 mp -118.3 122.46 42.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.513 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' 1532 ' ' GLY . . . -100.88 97.2 1.66 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.31 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 60.3 t -66.27 115.2 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1531 ' ' CYS . . . . . 0.413 ' HB2' ' HD2' ' A' 1511 ' ' LYS . 68.0 m 59.65 15.15 4.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.858 0.863 . . . . 0.0 113.207 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1532 ' ' GLY . . . . . 0.425 ' O ' ' HA3' ' A' 1529 ' ' GLY . . . -141.16 112.73 0.79 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1533 ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' 1535 ' ' LYS . 33.6 mt-10 -63.41 140.96 58.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.498 HG12 ' HG2' ' A' 1527 ' ' ARG . 16.0 m -85.41 89.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.265 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.417 ' HD2' ' O ' ' A' 1533 ' ' GLU . 0.2 OUTLIER -62.33 -19.04 62.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.219 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.66 -23.08 64.51 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.708 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 32.0 t -121.74 4.7 10.02 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.599 0.714 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 102.41 152.08 24.1 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.979 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.09 153.19 75.51 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.492 2.128 . . . . 0.0 111.264 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.45 -10.07 70.83 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.331 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1541 ' ' ILE . . . . . 0.409 HD11 ' HD3' ' A' 1551 ' ' LYS . 42.4 mm -98.37 129.8 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.5 -50.64 1.28 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.108 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.03 132.49 55.49 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 49.1 t -136.52 149.98 48.42 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.414 0.15 . . . . 0.0 110.889 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.456 ' HZ ' HD11 ' A' 1614 ' ' LEU . 67.1 m-85 -93.63 160.75 14.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.817 0.818 . . . . 0.0 112.867 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.77 -22.18 66.78 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.701 2.0 . . . . 0.0 113.073 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -119.65 130.18 8.35 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.035 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1548 ' ' THR . . . . . 0.434 ' HB ' HG21 ' A' 1550 ' ' ILE . 23.9 m 73.77 -13.65 0.73 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 112.562 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.28 36.02 35.98 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.434 HG21 ' HB ' ' A' 1548 ' ' THR . 36.2 pt -81.51 143.03 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.606 ' HG2' ' OD1' ' A' 1574 ' ' ASP . 17.2 pttm -92.99 145.05 24.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.593 0.711 . . . . 0.0 111.434 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.15 15.67 26.0 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.627 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.779 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 141.2 141.48 3.98 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.934 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1554 ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' 1572 ' ' ASP . 48.0 mtpt -78.78 159.9 27.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 72.7 t90 -67.22 141.26 57.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.774 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.39 172.37 18.46 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.2 24.25 5.95 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.448 1.099 . . . . 0.0 109.757 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.37 103.36 15.41 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.258 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.33 130.56 54.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.0 t -121.38 109.67 15.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.12 103.54 15.59 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 95.8 t -127.7 105.01 13.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.318 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.4 t70 58.19 60.93 2.47 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 111.223 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.99 24.51 9.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.207 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1565 ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' 1590 ' ' PHE . 96.2 t -126.6 122.44 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.79 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.88 123.75 34.64 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.711 ' HB2' ' HB3' ' A' 1560 ' ' SER . 17.4 mm-40 -102.0 114.5 28.66 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.418 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.0 tp -116.64 102.71 9.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.522 HG23 HG21 ' A' 1587 ' ' VAL . 35.0 t -107.12 120.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.095 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.779 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 79.5 m-85 -86.21 108.94 18.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.7 154.44 21.64 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.219 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' A' 1554 ' ' LYS . 13.0 t70 56.21 86.11 0.07 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.753 1.621 . . . . 0.0 113.852 173.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1573 ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -107.32 -152.23 18.0 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.606 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 0.7 OUTLIER -83.23 146.57 51.46 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 116.962 0.381 . . . . 0.0 110.276 176.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 1575 ' ' PRO . . . . . 0.436 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 7.2 Cg_exo -73.52 143.92 35.22 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.234 2.623 . . . . 0.0 112.665 -175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.4 142.78 25.44 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.825 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.56 11.66 0.78 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.172 2.582 . . . . 0.0 114.091 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.45 -56.15 4.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.869 0.366 . . . . 0.0 110.543 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.78 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.4 m120 -133.91 7.91 3.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.806 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.0 mm? 70.48 -55.53 0.62 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.403 1.081 . . . . 0.0 113.096 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -74.88 -12.99 60.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.489 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.78 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 65.1 mt -82.45 131.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 95.3 mttt -131.39 162.09 30.93 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.733 0.645 . . . . 0.0 110.142 -174.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1584 ' ' TYR . . . . . 0.422 ' O ' ' HA3' ' A' 1573 ' ' GLY . 97.0 m-85 -66.87 112.64 4.39 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 123.937 0.773 . . . . 0.0 109.531 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -129.32 147.04 51.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.0 p -129.85 121.67 27.17 Favored 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.364 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.522 HG21 HG23 ' A' 1569 ' ' VAL . 3.0 p -111.36 111.22 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.853 0.835 . . . . 0.0 109.364 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.95 106.06 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 43.8 m -87.48 110.0 20.0 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.763 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.79 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.7 m-85 -86.04 101.66 13.13 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.4 m -100.02 160.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.224 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 28.3 t -76.46 120.53 21.81 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1593 ' ' LYS . . . . . . . . . . . . . 55.6 tptt -143.16 97.08 3.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -107.7 19.2 20.46 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.073 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -70.52 -38.82 74.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.157 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 91.51 -174.07 37.75 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.146 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1598 ' ' PRO . . . . . 0.412 ' O ' HD21 ' A' 1510 ' ' LEU . 70.8 Cg_endo -71.78 -15.23 30.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.36 2.707 . . . . 0.0 112.028 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.7 p -79.91 -48.83 12.81 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 40.0 m 68.47 161.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.815 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.493 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 19.5 mt-30 -107.0 119.77 50.17 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.448 -0.783 . . . . 0.0 110.571 -174.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 3.8 Cg_endo -89.96 116.25 0.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.429 2.752 . . . . 0.0 112.006 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 56.6 tp -115.47 120.01 38.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' 1520 ' ' ASP . 60.8 tp -70.9 113.24 7.76 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.9 tp -87.93 -63.49 1.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.571 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 67.2 m -147.34 138.38 23.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.922 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 62.5 t -122.78 112.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -97.87 124.66 42.37 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.552 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.21 -8.27 59.36 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -102.78 -51.5 3.28 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.214 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.716 ' HA ' HD11 ' A' 1582 ' ' LEU . 36.4 p -86.83 -14.69 41.4 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 73.4 m 61.85 23.19 13.59 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.082 0.953 . . . . 0.0 111.637 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -86.14 115.65 23.84 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.456 HD11 ' HZ ' ' A' 1545 ' ' PHE . 87.1 mt -91.52 126.71 36.69 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.958 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.05 116.37 31.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.23 137.58 53.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.6 m -110.25 103.68 12.39 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.413 ' O ' ' HA ' ' A' 1590 ' ' PHE . 11.3 t-105 -99.47 105.81 17.78 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 85.2 m-70 -81.02 100.65 9.08 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.4 t -122.71 153.66 39.14 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.647 0.736 . . . . 0.0 111.474 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.7 m -76.11 -26.37 56.33 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.365 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.43 -5.23 31.22 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -90.59 -23.95 20.69 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.553 0.692 . . . . 0.0 110.242 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 66.8 m -72.91 142.26 47.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.483 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.73 94.23 1.74 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.8 129.68 34.66 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.42 -170.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.05 -44.71 19.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.891 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.31 -1.129 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.717 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 23.8 ptm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1490 ' ' VAL . . . . . 0.455 HG13 ' HG3' ' A' 1491 ' ' GLN . 12.3 p 176.16 -33.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -176.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1491 ' ' GLN . . . . . 0.455 ' HG3' HG13 ' A' 1490 ' ' VAL . 98.1 mt-30 -94.91 22.09 6.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.356 1.074 . . . . 0.0 108.985 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1492 ' ' ASP . . . . . 0.593 ' HA ' ' O ' ' A' 1495 ' ' GLN . 4.4 m-20 -86.97 72.54 10.08 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.788 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.0 p30 -88.58 -72.85 0.52 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.36 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.417 ' HA ' ' HG ' ' A' 1559 ' ' LEU . 85.3 m -121.99 15.29 10.78 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.49 1.138 . . . . 0.0 108.818 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.6 pt20 -139.05 116.88 11.54 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.2 p -137.57 141.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.669 ' HB ' HG23 ' A' 1504 ' ' VAL . 6.7 t -121.12 167.76 12.3 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 24.5 p30 -131.96 150.99 77.68 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.92 16.12 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.311 2.007 . . . . 0.0 112.413 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -93.69 -56.79 2.77 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.39 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.7 p -103.08 -27.97 12.25 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.61 0.719 . . . . 0.0 110.198 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.68 27.38 57.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.857 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 61.4 t80 -98.4 132.68 43.66 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.669 HG23 ' HB ' ' A' 1497 ' ' THR . 43.1 t -96.54 110.1 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.64 ' O ' ' HA ' ' A' 1495 ' ' GLN . 65.7 m-85 -76.56 102.84 6.25 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.88 107.38 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.836 0.35 . . . . 0.0 110.777 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 -4.48 59.17 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.199 1.0 . . . . 0.0 109.153 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.528 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 48.6 m-80 -71.07 -21.28 62.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.896 -177.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 58.8 p -80.98 -7.65 59.59 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.667 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.66 11.35 15.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.528 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 33.1 mtmm -59.55 176.24 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.153 0.501 . . . . 0.0 111.677 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.792 ' HD3' HG12 ' A' 1534 ' ' VAL . 18.3 ttp180 -66.97 93.46 0.28 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.201 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.93 -38.99 10.43 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 168.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 28.3 t -118.37 -40.23 2.95 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.194 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.62 175.56 32.48 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' 1527 ' ' ARG . 12.4 m-85 -113.79 141.95 46.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1517 ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' 1526 ' ' ILE . 88.2 m -142.72 103.41 4.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.379 0.609 . . . . 0.0 110.845 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 22.7 pt -119.82 148.73 22.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 45.4 m -114.48 123.65 49.95 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.138 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.79 155.45 39.29 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.841 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.64 -24.7 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 124.087 0.955 . . . . 0.0 112.079 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1522 ' ' ARG . . . . . 0.822 HH22 HG13 ' A' 1607 ' ' VAL . 80.0 mtm180 -81.01 3.1 24.22 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.311 0.644 . . . . 0.0 111.262 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.78 62.15 0.33 Allowed 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.554 1.142 . . . . 0.0 111.038 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -121.42 91.48 0.47 Allowed Glycine 0 N--CA 1.409 -3.134 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.5 m -78.85 104.18 9.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1526 ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.2 tt -98.18 125.98 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.515 0.674 . . . . 0.0 109.317 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' 1516 ' ' TYR . 44.1 ttt180 -108.35 125.27 51.52 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.34 140.39 50.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.121 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -122.66 126.41 6.35 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 106.568 -2.613 . . . . 0.0 106.568 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.1 m -89.51 118.74 35.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.126 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 55.8 m 69.86 10.9 7.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.823 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -136.43 130.47 5.27 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1533 ' ' GLU . . . . . 0.596 ' HG3' ' HE3' ' A' 1535 ' ' LYS . 12.7 pt-20 -74.91 129.3 37.43 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.265 0.555 . . . . 0.0 111.62 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.792 HG12 ' HD3' ' A' 1512 ' ' ARG . 17.7 m -92.58 99.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 122.005 0.907 . . . . 0.0 109.842 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.596 ' HE3' ' HG3' ' A' 1533 ' ' GLU . 9.8 mptt -67.15 -12.12 59.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.071 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.18 -43.64 74.53 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 125.683 1.593 . . . . 0.0 109.151 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 58.1 m -104.23 -7.19 20.26 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.95 163.5 9.54 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.533 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.86 139.16 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.112 1.875 . . . . 0.0 111.365 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 71.88 30.43 65.84 Favored Glycine 0 C--N 1.305 -1.193 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.388 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.21 129.04 75.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -104.6 -35.84 3.19 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.116 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -122.78 124.67 43.86 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 27.4 p -140.07 154.64 47.12 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.755 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.556 ' HB2' ' HB ' ' A' 1550 ' ' ILE . 91.1 m-85 -93.96 116.48 28.93 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.13 100.65 3.7 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.484 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -174.8 -94.92 0.1 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 94.0 m -95.78 -37.42 10.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 117.153 0.477 . . . . 0.0 110.706 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 143.44 31.21 0.1 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.581 -1.295 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' 1545 ' ' PHE . 64.9 mt -71.39 125.17 29.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' 1574 ' ' ASP . 36.3 mttp -99.29 132.45 44.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.03 4.89 29.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.924 0.392 . . . . 0.0 111.285 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.932 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 156.94 140.19 2.89 Favored Glycine 0 C--O 1.254 1.403 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.027 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 60.4 mttp -79.21 155.51 28.57 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 67.5 t90 -64.57 124.91 23.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.17 140.53 7.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1557 ' ' GLN . . . . . 0.411 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 90.1 mt-30 -106.63 79.53 1.36 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -127.68 98.25 5.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.272 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' 1494 ' ' CYS . 34.6 mt -101.43 107.57 18.92 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.343 0.592 . . . . 0.0 109.89 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.07 113.72 26.06 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -90.71 101.35 14.1 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 78.3 t -135.47 141.4 42.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 60.54 24.02 13.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.791 0.836 . . . . 0.0 110.397 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 65.92 16.62 10.54 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 124.166 0.986 . . . . 0.0 110.855 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 7.3 p -121.49 155.29 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.802 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.6 mp -91.28 129.81 37.23 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -119.99 115.66 24.21 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.13 102.02 8.95 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' 1587 ' ' VAL . 7.6 p -106.95 112.51 40.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.563 0.697 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.932 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 30.6 m-85 -81.75 102.38 10.72 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -102.3 161.64 13.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.111 0.482 . . . . 0.0 111.896 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 8.5 t70 63.15 66.02 0.75 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.102 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -91.16 -93.0 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.391 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.556 ' HB2' ' H ' ' A' 1551 ' ' LYS . 3.3 t70 -123.25 149.82 58.58 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.02 137.58 82.58 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.776 2.317 . . . . 0.0 112.855 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 24.8 t -101.79 128.93 27.65 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.251 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.67 16.92 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.559 2.84 . . . . 0.0 114.283 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.54 -41.12 16.8 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.39 10.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.167 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 1.7 tm? 69.84 -53.7 0.61 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.274 1.43 . . . . 0.0 111.761 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -65.92 -24.01 66.74 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.032 0.533 . . . . 0.0 110.752 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' 1611 ' ' THR . 85.4 mt -81.11 141.08 34.64 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.447 ' O ' ' HG3' ' A' 1585 ' ' LYS . 62.1 mttp -132.08 158.0 42.72 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -59.66 121.36 11.44 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 124.122 0.889 . . . . 0.0 109.474 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' 1583 ' ' LYS . 43.9 mtmt -130.76 134.42 46.86 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1586 ' ' SER . . . . . 0.628 ' HB3' HD11 ' A' 1614 ' ' LEU . 13.6 p -123.53 116.77 23.72 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.426 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' 1569 ' ' VAL . 7.5 p -102.83 109.31 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.066 0.936 . . . . 0.0 110.649 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1588 ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' 1618 ' ' TRP . 3.4 mp -97.62 108.85 22.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 14.7 t -95.9 119.51 34.52 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.802 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 88.8 m-85 -89.83 106.35 18.41 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 169.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' 1620 ' ' THR . 38.7 t -104.77 141.23 36.86 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 117.484 -1.686 . . . . 0.0 115.325 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.509 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 53.8 tptt -151.45 100.57 2.74 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.952 170.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1594 ' ' SER . . . . . 0.442 ' HA ' ' HB3' ' A' 1621 ' ' SER . 41.0 p -66.09 -9.63 32.9 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1595 ' ' ASP . . . . . 0.509 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 8.0 m-20 -92.97 6.21 48.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.893 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.728 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -76.55 -74.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 109.45 -120.13 5.69 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.614 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.05 17.77 1.69 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.477 2.785 . . . . 0.0 110.708 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1599 ' ' THR . . . . . 0.409 ' C ' ' HG ' ' A' 1600 ' ' SER . 13.6 t -153.76 -176.05 5.65 Favored 'General case' 1 N--CA 1.377 -4.121 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.728 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 41.4 m -155.48 155.7 33.95 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.566 0.746 . . . . 0.0 109.004 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.76 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 44.5 mt-30 -87.79 121.44 70.84 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 1.0 OUTLIER -88.95 128.78 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.391 2.727 . . . . 0.0 111.51 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' 1617 ' ' SER . 2.2 tm? -130.54 114.91 16.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.97 106.91 4.45 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 61.0 tp -75.02 -53.98 7.98 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.242 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.2 t -169.81 151.58 4.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.822 HG13 HH22 ' A' 1522 ' ' ARG . 65.0 t -125.91 131.78 71.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 19.2 t70 -110.74 117.17 32.72 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.8 -8.58 59.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -72.09 -40.46 68.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.761 0.315 . . . . 0.0 110.479 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.591 ' HA ' HD11 ' A' 1582 ' ' LEU . 23.4 p -121.66 -5.45 9.19 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 62.1 m 67.56 32.6 5.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.048 0.928 . . . . 0.0 111.152 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 44.1 m -92.04 126.61 37.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.959 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' 1586 ' ' SER . 59.0 mt -101.39 132.12 47.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.68 119.15 37.09 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.38 137.05 54.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.86 0.362 . . . . 0.0 111.621 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 27.3 m -104.11 105.42 15.57 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.452 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 12.6 t-105 -101.44 118.85 37.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 14.8 m-70 -94.79 97.57 10.14 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' 1592 ' ' CYS . 11.7 t -123.26 151.05 42.73 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.348 0.594 . . . . 0.0 111.608 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1621 ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' 1594 ' ' SER . 1.0 OUTLIER -74.23 -23.81 59.22 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.778 0.799 . . . . 0.0 110.49 178.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.74 -4.91 34.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.519 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -93.29 -5.86 48.78 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.793 0.33 . . . . 0.0 111.445 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 20.5 m -91.64 137.61 32.22 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 111.98 10.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -80.69 117.93 21.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.67 -22.23 43.76 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.932 -174.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.306 -1.303 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.179 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1489 ' ' MET . . . . . 0.549 ' HG3' HG21 ' A' 1490 ' ' VAL . 13.7 tpt . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1490 ' ' VAL . . . . . 0.549 HG21 ' HG3' ' A' 1489 ' ' MET . 25.5 t 62.64 56.46 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 122.713 1.244 . . . . 0.0 108.631 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -131.74 117.57 18.78 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.01 75.46 10.14 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.963 1.363 . . . . 0.0 110.696 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -71.28 -54.77 9.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.942 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.45 ' HA ' HD12 ' A' 1559 ' ' LEU . 6.1 t 59.03 33.3 22.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.003 1.321 . . . . 0.0 110.255 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -150.27 154.45 37.92 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.7 p -141.62 138.24 32.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.446 HG21 HG23 ' A' 1504 ' ' VAL . 23.7 m -104.08 113.59 27.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1498 ' ' ASN . . . . . 0.495 HD22 ' HB2' ' A' 1503 ' ' TYR . 6.0 p30 -81.89 130.86 59.01 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.34 -3.37 13.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.568 2.179 . . . . 0.0 112.649 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -75.44 -53.95 7.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.727 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1501 ' ' THR . . . . . 0.429 ' HB ' ' CD1' ' A' 1503 ' ' TYR . 17.2 p -109.21 -14.11 14.54 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.5 26.54 59.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.599 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1503 ' ' TYR . . . . . 0.495 ' HB2' HD22 ' A' 1498 ' ' ASN . 13.8 m-85 -99.22 120.4 39.46 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.22 -0.49 . . . . 0.0 109.977 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.446 HG23 HG21 ' A' 1497 ' ' THR . 25.4 t -89.39 113.35 25.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -100.23 111.18 23.44 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1506 ' ' ASP . . . . . 0.696 ' HB2' HD21 ' A' 1508 ' ' ASN . 3.0 p30 -104.01 130.87 51.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.059 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.79 0.18 56.12 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.082 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1508 ' ' ASN . . . . . 0.696 HD21 ' HB2' ' A' 1506 ' ' ASP . 41.4 m-80 -63.0 -38.5 91.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.49 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.9 t -71.08 -3.97 22.64 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.315 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.596 ' HB2' HD13 ' A' 1622 ' ' LEU . 0.9 OUTLIER -114.16 -41.78 3.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.266 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' 1508 ' ' ASN . 22.0 pttp -65.57 144.21 57.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' 1515 ' ' GLY . 40.5 ttm180 -88.58 161.92 16.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -50.11 -54.98 16.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.346 1.058 . . . . 0.0 111.342 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 3.0 p -87.6 -2.62 58.74 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 123.675 0.79 . . . . 0.0 111.872 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1515 ' ' GLY . . . . . 0.49 ' HA3' ' HA2' ' A' 1529 ' ' GLY . . . 86.74 -139.74 16.65 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -176.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' 1527 ' ' ARG . 95.7 m-85 -124.63 121.65 35.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 117.467 0.633 . . . . 0.0 111.124 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 32.9 m -110.5 94.83 5.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.25 155.3 11.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.355 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 22.4 m -79.9 131.21 35.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.447 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.31 147.8 27.74 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.852 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.77 -25.97 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.901 0.88 . . . . 0.0 112.727 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -83.87 3.26 34.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.987 0.422 . . . . 0.0 110.165 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1523 ' ' LYS . . . . . 0.601 ' HZ1' ' HB2' ' A' 1523 ' ' LYS . 0.1 OUTLIER 74.28 84.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.772 1.629 . . . . 0.0 111.358 -177.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1524 ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' 1545 ' ' PHE . . . -175.22 156.36 22.19 Favored Glycine 0 N--CA 1.404 -3.465 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 4.2 m -114.13 101.68 9.44 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.6 tt -83.41 119.71 33.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.196 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' 1516 ' ' TYR . 43.3 ttm180 -109.78 112.74 24.97 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.974 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.36 118.78 30.33 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.583 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1529 ' ' GLY . . . . . 0.49 ' HA2' ' HA3' ' A' 1515 ' ' GLY . . . -90.03 106.79 3.37 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 89.2 t -59.73 116.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 36.1 m 63.21 12.6 6.24 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.071 0.857 . . . . 0.0 111.609 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -129.27 172.4 19.79 Favored Glycine 0 N--CA 1.42 -2.395 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.063 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.97 141.74 40.64 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1534 ' ' VAL . . . . . 0.404 HG13 ' HG2' ' A' 1527 ' ' ARG . 26.6 m -103.9 90.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.252 1.025 . . . . 0.0 109.605 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -65.1 -16.61 63.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.82 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -64.83 -22.21 66.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.92 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 21.6 t -111.87 -13.67 13.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.429 0.633 . . . . 0.0 110.043 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.67 155.27 6.46 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.217 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.08 141.12 35.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.467 2.111 . . . . 0.0 111.071 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.85 8.87 87.23 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.331 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.5 mm -106.56 135.05 46.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.23 -37.29 2.51 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.007 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -124.03 123.99 41.57 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 122.707 -0.29 . . . . 0.0 110.325 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 45.0 t -136.69 153.43 50.89 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.296 0.569 . . . . 0.0 110.821 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.455 ' CZ ' ' HA3' ' A' 1524 ' ' GLY . 58.9 t80 -90.15 100.29 13.15 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.494 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1546 ' ' GLU . . . . . 0.702 ' HG3' HG22 ' A' 1548 ' ' THR . 11.8 pt-20 47.71 21.24 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.784 2.034 . . . . 0.0 115.221 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 63.55 27.47 70.97 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.516 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1548 ' ' THR . . . . . 0.702 HG22 ' HG3' ' A' 1546 ' ' GLU . 32.9 p -83.24 -15.95 48.33 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 118.689 1.244 . . . . 0.0 109.985 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 122.6 -14.91 8.6 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.718 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 50.7 mt -79.48 118.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.423 ' HZ1' ' HB2' ' A' 1551 ' ' LYS . 8.6 mtmp? -97.79 137.48 36.6 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.499 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -111.48 11.63 21.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.369 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.833 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 155.53 130.55 1.33 Allowed Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.432 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.4 tttp -81.71 155.26 25.62 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1555 ' ' TRP . . . . . 0.536 ' HH2' ' HA ' ' A' 1490 ' ' VAL . 61.6 t90 -73.21 128.53 35.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.315 0.578 . . . . 0.0 110.08 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.47 139.5 14.31 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -86.89 78.16 9.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.287 0.565 . . . . 0.0 110.46 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 54.0 tptt -114.82 96.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.805 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' 1494 ' ' CYS . 86.2 mt -109.84 103.34 12.12 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.568 -1.196 . . . . 0.0 107.997 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.863 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 29.2 t -101.77 141.47 34.58 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 20.3 t80 -121.59 101.16 7.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1562 ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' 1565 ' ' VAL . 98.5 t -134.88 127.29 48.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.281 -176.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.37 33.83 22.57 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.441 1.115 . . . . 0.0 110.0 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 70.94 -0.03 3.2 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.351 1.06 . . . . 0.0 113.236 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1565 ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' 1562 ' ' VAL . 9.5 p -98.98 134.18 38.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.2 tp -84.97 132.26 34.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.863 ' HB2' ' HB3' ' A' 1560 ' ' SER . 94.0 mt-30 -122.07 114.99 21.68 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.739 -0.601 . . . . 0.0 112.121 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 48.4 tp -102.86 112.65 25.55 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' 1571 ' ' GLU . 44.4 t -105.83 112.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.592 -172.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.833 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 77.4 m-85 -95.19 115.2 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.457 ' HG2' HG11 ' A' 1569 ' ' VAL . 8.9 mm-40 -111.56 165.54 11.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 33.5 t70 60.72 80.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.474 1.109 . . . . 0.0 111.871 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.46 -127.56 6.14 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 1.0 OUTLIER -113.5 147.25 37.11 Favored Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 122.604 -0.35 . . . . 0.0 111.033 175.379 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1575 ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 23.5 Cg_exo -66.52 134.31 35.19 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.404 2.736 . . . . 0.0 112.832 -176.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 85.6 m -98.8 149.06 35.38 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.276 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.42 3.99 4.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.849 2.366 . . . . 0.0 115.869 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.29 -67.18 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.915 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.51 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 6.8 m-20 -110.26 2.19 19.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.246 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? 71.69 -57.62 0.61 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.337 1.055 . . . . 0.0 113.707 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -76.23 -10.44 59.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 111.168 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' 1611 ' ' THR . 70.8 mt -83.17 124.58 30.66 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 88.0 mttt -119.31 162.75 18.22 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.835 0.709 . . . . 0.0 110.043 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -58.97 109.34 0.81 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 124.01 0.819 . . . . 0.0 109.705 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -112.2 131.77 55.29 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.5 t -121.77 118.72 29.74 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.701 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -115.33 107.49 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.969 0.89 . . . . 0.0 109.844 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.96 107.32 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1589 ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' 1617 ' ' SER . 25.0 m -91.52 116.3 28.75 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.733 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 92.4 m-85 -86.12 105.53 16.6 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1591 ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' 1617 ' ' SER . 65.3 t -93.95 152.05 3.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.009 -175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.5 t -75.26 134.52 41.09 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.107 0.955 . . . . 0.0 112.822 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 54.3 tptt -149.68 101.34 3.06 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 171.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 71.1 m -63.21 -37.76 88.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.494 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -97.77 71.69 2.24 Favored 'General case' 0 N--CA 1.423 -1.813 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.937 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' 1600 ' ' SER . . . -133.3 -57.76 0.9 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.756 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.69 -147.67 38.91 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.94 -21.9 36.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.217 1.944 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.7 p -91.06 67.21 5.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 122.312 1.053 . . . . 0.0 109.356 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' 1596 ' ' ALA . 15.1 m -76.85 161.77 28.16 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.685 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 16.9 mm-40 -105.43 121.11 47.29 Favored Pre-proline 0 C--N 1.301 -1.5 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.096 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1602 ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.31 152.76 30.87 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.678 2.252 . . . . 0.0 110.104 175.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1603 ' ' LEU . . . . . 0.471 ' HB3' ' O ' ' A' 1617 ' ' SER . 66.3 tp -154.88 120.3 5.03 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.102 -0.374 . . . . 0.0 110.979 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.61 113.47 16.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 42.8 tp -88.93 -43.51 11.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 40.1 t -167.62 150.65 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 84.9 t -130.6 111.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1608 ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' A' 1612 ' ' CYS . 31.7 t70 -93.65 122.74 36.42 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.521 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -80.14 -11.78 59.72 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.38 -52.5 5.16 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.166 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.654 ' HA ' HD11 ' A' 1582 ' ' LEU . 47.2 p -98.03 -17.03 19.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.974 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1612 ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' 1608 ' ' ASP . 75.6 m 69.95 25.18 4.94 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 124.108 0.88 . . . . 0.0 111.586 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 21.6 m -80.38 118.1 21.71 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.98 126.88 41.52 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.16 118.03 35.67 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.37 139.23 53.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1617 ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' 1589 ' ' SER . 21.7 m -121.65 103.72 9.1 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.666 0.746 . . . . 0.0 109.382 175.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -92.89 107.53 19.29 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -175.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.588 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 43.5 m80 -78.0 97.42 5.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.8 t -131.09 154.02 48.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.528 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.5 m -76.15 -25.09 54.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1622 ' ' LEU . . . . . 0.596 HD13 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.89 -5.03 31.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.471 0.653 . . . . 0.0 111.835 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.7 -3.05 30.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.066 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.1 m -96.04 144.71 26.07 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.64 112.27 3.57 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 168.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1626 ' ' GLN . . . . . 0.53 ' HG3' ' H ' ' A' 1628 ' ' VAL . 5.4 tp60 -80.58 142.29 34.23 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -164.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -71.71 -32.83 68.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.035 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1628 ' ' VAL . . . . . 0.53 ' H ' ' HG3' ' A' 1626 ' ' GLN . 2.6 p . . . . . 0 C--N 1.308 -1.207 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.54 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 68.0 t -89.34 119.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.26 124.28 27.9 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.33 127.66 39.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -132.19 166.53 21.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1494 ' ' CYS . . . . . 0.401 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 79.4 m -77.44 1.24 19.75 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.009 0.923 . . . . 0.0 111.816 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1495 ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.6 pt20 -117.15 118.25 31.82 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -118.96 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.831 0.824 . . . . 0.0 110.784 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1497 ' ' THR . . . . . 0.462 HG22 HG21 ' A' 1504 ' ' VAL . 24.8 m -96.49 125.9 41.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.243 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.93 133.52 30.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.73 4.53 6.84 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.21 1.94 . . . . 0.0 112.468 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -78.67 -68.38 0.65 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 19.7 p -101.26 -19.75 15.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.043 0.449 . . . . 0.0 111.826 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 100.29 2.24 55.72 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.539 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1503 ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' 1625 ' ' GLU . 56.3 m-85 -72.45 141.25 48.61 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.068 0.461 . . . . 0.0 111.605 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1504 ' ' VAL . . . . . 0.462 HG21 HG22 ' A' 1497 ' ' THR . 48.2 t -108.84 118.94 57.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1505 ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' 1495 ' ' GLN . 58.7 m-85 -95.39 101.56 13.29 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.25 112.32 24.51 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.066 0.46 . . . . 0.0 110.084 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 27.7 tp -84.86 -2.02 57.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.485 0.66 . . . . 0.0 111.143 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -79.6 -21.96 44.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.6 0.714 . . . . 0.0 109.781 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 28.4 t -78.24 -10.13 59.52 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1510 ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' 1598 ' ' PRO . 0.5 OUTLIER -106.34 -45.66 4.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1511 ' ' LYS . . . . . 0.544 ' HB2' ' HB ' ' A' 1530 ' ' VAL . 21.3 pttp -49.5 146.53 3.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 114.326 -173.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1512 ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 0.0 OUTLIER -103.72 127.31 51.2 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -64.04 -43.19 96.31 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.668 0.605 . . . . 0.0 112.391 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 47.6 m -86.25 6.27 30.44 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.037 0.446 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 80.33 161.14 23.9 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 113.152 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1516 ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' 1527 ' ' ARG . 81.0 m-85 -100.22 118.17 35.98 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 94.0 m -93.97 100.64 12.75 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.88 142.02 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 42.5 t -102.74 136.43 42.58 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1520 ' ' ASP . . . . . 0.532 ' HB2' HD21 ' A' 1604 ' ' LEU . 0.1 OUTLIER -84.49 175.14 9.5 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.82 -21.02 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 121.212 0.529 . . . . 0.0 111.293 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -91.9 3.05 56.05 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.15 0.58 . . . . 0.0 111.489 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1523 ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 17.2 mmtm 80.96 19.09 0.47 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -80.38 105.02 2.32 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 19.2 m -84.2 98.08 9.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.0 tt -103.78 133.86 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.125 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1527 ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' 1516 ' ' TYR . 29.4 ttt180 -108.9 112.74 25.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.99 122.99 47.94 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -98.15 127.0 9.09 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1530 ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' 1511 ' ' LYS . 58.9 t -87.85 116.94 30.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 83.7 m 69.68 0.63 3.06 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -134.34 140.76 12.04 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.0 137.75 41.74 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.008 0.432 . . . . 0.0 110.508 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 9.5 m -79.26 87.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.034 0.921 . . . . 0.0 109.973 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1535 ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.14 -18.56 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.379 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.91 -20.65 62.47 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 110.969 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.1 m -117.52 -20.49 9.01 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.304 -0.248 . . . . 0.0 111.561 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1538 ' ' GLY . . . . . 0.425 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 146.94 154.11 6.1 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.31 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1539 ' ' PRO . . . . . 0.425 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 24.2 Cg_exo -69.6 142.24 48.1 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 123.288 2.659 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.51 10.26 79.14 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.331 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.04 134.17 49.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1542 ' ' GLY . . . . . 0.401 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -101.25 -41.3 2.61 Favored Glycine 0 C--O 1.221 -0.661 0 C-N-CA 119.97 -1.11 . . . . 0.0 112.096 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -126.26 134.97 51.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.4 p -145.11 151.99 39.36 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 121.221 -0.192 . . . . 0.0 110.682 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1545 ' ' PHE . . . . . 0.428 ' HB2' HG13 ' A' 1550 ' ' ILE . 85.4 m-85 -92.26 120.1 32.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.77 109.73 10.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.612 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 165.09 -73.21 0.17 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 16.8 p -97.3 -18.09 19.38 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.526 0.679 . . . . 0.0 110.194 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 89.63 19.06 50.06 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1550 ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' 1545 ' ' PHE . 23.5 pt -66.43 135.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.712 0.768 . . . . 0.0 111.192 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1551 ' ' LYS . . . . . 0.419 ' HG3' ' OD1' ' A' 1574 ' ' ASP . 29.2 mttp -79.42 137.54 37.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.735 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1552 ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' 1584 ' ' TYR . . . -120.3 19.52 12.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.925 0.869 . . . . 0.0 108.763 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1553 ' ' GLY . . . . . 0.852 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 151.81 124.38 1.11 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.894 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1554 ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' 1554 ' ' LYS . 33.2 ttmt -83.83 144.59 29.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 90.0 t90 -59.92 131.74 51.81 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 123.73 0.644 . . . . 0.0 110.353 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -164.29 145.35 8.33 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -112.2 85.8 2.22 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -126.75 104.84 8.29 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.736 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1559 ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 3.5 mm? -100.57 118.06 35.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.188 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1560 ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 32.1 t -110.84 147.86 33.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 28.6 t80 -130.0 128.66 42.48 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.661 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1562 ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 73.2 t -113.33 156.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1563 ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' 1564 ' ' GLN . 19.5 t70 -48.11 113.21 0.69 Allowed 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 118.056 0.389 . . . . 0.0 110.653 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1564 ' ' GLN . . . . . 0.589 ' HB2' ' SG ' ' A' 1624 ' ' CYS . 7.4 pt20 56.2 21.28 5.12 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.857 2.063 . . . . 0.0 113.466 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1565 ' ' VAL . . . . . 0.493 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 58.9 t -137.11 118.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1566 ' ' LEU . . . . . 0.781 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.0 tp -89.26 131.84 35.17 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1567 ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' 1560 ' ' SER . 79.9 mm-40 -115.64 114.87 25.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -123.78 111.39 16.07 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1569 ' ' VAL . . . . . 0.696 HG23 HG22 ' A' 1587 ' ' VAL . 32.3 t -112.15 123.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.621 0.724 . . . . 0.0 111.285 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1570 ' ' TYR . . . . . 0.852 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 33.9 m-85 -98.96 100.82 12.04 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.245 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1571 ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 34.6 mt-10 -99.91 179.34 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.048 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.61 68.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.759 1.624 . . . . 0.0 112.766 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.97 -131.5 7.32 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.291 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1574 ' ' ASP . . . . . 0.419 ' OD1' ' HG3' ' A' 1551 ' ' LYS . 0.2 OUTLIER -89.83 140.38 27.82 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1575 ' ' PRO . . . . . 0.651 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 25.2 Cg_exo -66.27 142.26 65.91 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.663 2.242 . . . . 0.0 112.051 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1576 ' ' CYS . . . . . 0.434 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 81.5 m -98.15 138.42 20.91 Favored Pre-proline 0 C--N 1.285 -2.224 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1577 ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.2 Cg_exo -58.47 -22.74 60.63 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.619 2.879 . . . . 0.0 114.529 -172.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.29 46.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1579 ' ' ASN . . . . . 0.62 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.7 m120 -124.17 -8.24 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1580 ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' 1575 ' ' PRO . 3.7 mm? 68.17 -51.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.635 1.174 . . . . 0.0 113.376 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.1 m80 -73.42 -13.5 61.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.635 0.255 . . . . 0.0 111.578 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1582 ' ' LEU . . . . . 0.62 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 33.1 mt -90.28 132.56 35.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1583 ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.1 mttt -132.96 162.16 32.39 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1584 ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' 1552 ' ' ALA . 82.8 m-85 -62.86 117.46 6.39 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1585 ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 96.1 mttt -130.34 143.28 50.67 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 19.7 m -119.77 116.96 26.97 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1587 ' ' VAL . . . . . 0.696 HG22 HG23 ' A' 1569 ' ' VAL . 3.6 p -106.87 110.02 30.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.49 111.06 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.9 t -95.93 109.26 21.65 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1590 ' ' PHE . . . . . 0.781 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 88.0 m-85 -87.29 115.02 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.9 m -107.58 152.79 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1592 ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' 1620 ' ' THR . 6.3 m -76.39 124.64 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.206 0.527 . . . . 0.0 111.53 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1593 ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 21.8 tptp -139.32 112.37 8.03 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.0 t -70.64 -22.3 62.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.505 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 110.95 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1596 ' ' ALA . . . . . 0.855 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -90.35 -77.28 0.41 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 74.13 -143.68 32.33 Favored Glycine 0 C--O 1.248 1.011 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1598 ' ' PRO . . . . . 0.542 ' HA ' HD21 ' A' 1510 ' ' LEU . 40.2 Cg_endo -67.28 -21.72 47.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.344 2.03 . . . . 0.0 110.802 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 4.1 p -94.37 70.68 3.73 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.343 1.068 . . . . 0.0 109.352 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1600 ' ' SER . . . . . 0.855 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 30.5 m -75.73 167.83 21.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.931 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1601 ' ' GLN . . . . . 0.842 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 23.1 mt-30 -107.5 121.39 44.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.419 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1602 ' ' PRO . . . . . 0.445 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.3 Cg_endo -88.97 128.77 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.063 2.509 . . . . 0.0 110.658 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 44.8 tp -141.75 136.82 31.13 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.905 -0.497 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1604 ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' 1520 ' ' ASP . 67.7 tp -79.63 124.84 28.91 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.49 -39.7 9.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.3 t -177.0 161.41 1.92 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1607 ' ' VAL . . . . . 0.523 HG22 HD22 ' A' 1614 ' ' LEU . 7.5 p -141.78 138.92 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.0 119.87 36.09 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.04 -5.81 58.06 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 57.2 m80 -83.62 -51.2 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.599 0.714 . . . . 0.0 109.08 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1611 ' ' THR . . . . . 0.619 ' HA ' HD11 ' A' 1582 ' ' LEU . 0.2 OUTLIER -100.64 -9.3 22.05 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.917 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 74.6 m 63.99 37.53 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.294 1.038 . . . . 0.0 110.534 -177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1613 ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' 1611 ' ' THR . 6.1 m -87.53 113.97 23.71 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.414 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1614 ' ' LEU . . . . . 0.589 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 60.0 mt -93.38 115.72 28.27 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -100.74 112.47 24.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1616 ' ' PHE . . . . . 0.589 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 54.7 m-85 -120.79 131.28 54.38 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.764 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 12.8 p -102.82 104.41 14.68 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.886 0.85 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1618 ' ' TRP . . . . . 0.445 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 17.2 t-105 -92.63 114.93 27.62 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1619 ' ' HIS . . . . . 0.842 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.7 m-70 -88.45 102.06 14.53 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1620 ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.5 t -135.92 153.66 51.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.056 0.455 . . . . 0.0 110.739 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.5 m -74.15 -26.09 60.11 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.13 -5.65 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.045 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -77.1 -34.39 56.84 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.606 0.717 . . . . 0.0 109.527 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1624 ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' 1564 ' ' GLN . 1.8 m -98.58 171.81 7.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.54 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1625 ' ' GLU . . . . . 0.432 ' HB3' ' CD2' ' A' 1503 ' ' TYR . 40.9 mt-10 -66.76 107.46 2.17 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.28 154.67 27.7 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.541 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.04 -50.43 66.22 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 124.379 1.05 . . . . 0.0 109.651 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 C--N 1.307 -1.245 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.362 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.8 p30 . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 62.3 m 57.89 28.85 16.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.331 1.02 . . . . 0.0 112.228 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' 1505 ' ' PHE . 9.5 pt20 -142.2 141.5 32.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.12 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 8.9 p -140.81 138.45 34.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 26.0 m -97.67 127.16 43.42 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.3 p30 -89.25 143.13 30.51 Favored Pre-proline 0 C--N 1.312 -1.022 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.454 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.05 -13.67 19.2 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.885 2.39 . . . . 0.0 113.752 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -74.34 -58.87 3.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1501 ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 22.0 p -109.27 -10.9 14.93 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 75.06 33.38 54.81 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.728 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -103.07 143.29 32.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 46.1 t -102.4 127.35 56.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' 1495 ' ' GLN . 93.7 m-85 -93.99 103.61 15.68 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.98 103.15 15.02 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 34.4 tp -85.94 10.06 15.13 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-O 121.847 0.832 . . . . 0.0 110.045 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.69 -19.45 52.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.09 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 20.8 p -71.16 -14.43 62.27 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.328 0.585 . . . . 0.0 111.469 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.66 -69.6 0.76 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.832 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 58.9 mmtt 61.55 146.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' 1512 ' ' ARG . 4.2 tmm_? -71.84 96.9 1.72 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.69 -42.73 11.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 16.8 p -121.62 -31.54 3.98 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.924 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.26 133.17 7.87 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -77.77 125.21 29.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1517 ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' 1526 ' ' ILE . 13.3 t -129.77 100.93 5.67 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 122.86 1.314 . . . . 0.0 110.697 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1518 ' ' ILE . . . . . 0.503 HG21 ' HG2' ' A' 1602 ' ' PRO . 16.4 pt -93.82 155.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.053 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 32.7 t -98.15 130.73 44.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1520 ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 16.7 t70 -99.73 126.53 45.8 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.25 -24.91 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.577 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' 1522 ' ' ARG . 28.7 mtp-105 -85.61 -43.01 13.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1523 ' ' LYS . . . . . 0.481 ' HB2' ' HZ ' ' A' 1545 ' ' PHE . 31.9 mmmt -113.97 -73.93 0.64 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -169.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 179.49 -152.88 11.44 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 3.9 m -84.03 154.49 23.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.2 0.524 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.0 tt -130.6 118.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -103.26 115.52 30.72 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.14 132.27 54.32 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.173 0.511 . . . . 0.0 110.733 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -99.28 87.41 0.76 Allowed Glycine 0 N--CA 1.422 -2.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.895 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 34.7 m -72.56 128.41 35.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.882 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 47.6 t 66.27 15.6 10.15 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 121.513 0.673 . . . . 0.0 111.389 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . 178.44 113.96 0.39 Allowed Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.71 160.32 11.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 21.3 m -96.99 122.07 48.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.62 0.724 . . . . 0.0 110.281 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.76 -24.67 58.73 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -53.14 -38.54 62.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.852 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 67.1 m -110.01 13.47 23.33 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.105 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 107.92 120.86 4.54 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.51 134.02 59.57 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.144 2.562 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 106.68 -29.36 11.0 Favored Glycine 0 C--N 1.286 -2.214 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.053 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.16 125.88 39.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.612 ' HA3' ' HE2' ' A' 1570 ' ' TYR . . . -99.69 -46.24 1.98 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.78 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -103.11 118.45 36.82 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 48.8 t -124.8 136.88 54.22 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 35.5 t80 -114.45 138.62 50.36 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.85 86.86 2.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.224 1.011 . . . . 0.0 110.868 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1547 ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' 1550 ' ' ILE . . . -165.67 69.34 0.19 Allowed Glycine 0 C--N 1.289 -2.068 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.328 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.0 m 74.95 -34.77 0.27 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 111.595 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 146.09 50.32 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 79.3 mt -78.86 122.21 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -96.92 115.16 26.94 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.28 12.73 36.95 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.974 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.9 133.83 2.12 Favored Glycine 0 N--CA 1.416 -2.64 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.641 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -81.83 141.55 33.34 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.433 ' HB2' ' HA3' ' A' 1542 ' ' GLY . 54.5 t90 -78.32 124.74 28.44 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.21 148.43 33.52 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . 0.255 24.0 mt-30 -77.91 73.54 4.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -99.34 77.43 2.12 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 95.5 mt -104.93 97.78 7.6 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 7.8 t -117.46 139.1 51.35 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.782 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 86.1 t80 -106.42 109.19 21.04 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.384 0.611 . . . . 0.0 110.045 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 81.4 t -96.23 158.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.63 101.9 0.03 OUTLIER 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.171 0.989 . . . . 0.0 111.514 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 67.73 16.58 9.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.611 1.564 . . . . 0.0 113.549 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 20.2 t -139.94 119.79 13.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 121.987 -0.445 . . . . 0.0 110.317 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.8 tp -81.91 129.01 34.63 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -112.95 125.35 54.3 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.268 -0.27 . . . . 0.0 111.337 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1568 ' ' LEU . . . . . 0.588 ' HB3' ' HE1' ' A' 1590 ' ' PHE . 66.2 tp -129.68 114.39 15.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 10.4 p -117.99 129.45 74.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.861 0.838 . . . . 0.0 111.334 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.827 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 81.6 m-85 -95.04 115.17 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.64 177.29 4.69 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 5.3 m-20 56.67 64.04 1.78 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.72 -145.12 18.11 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -90.57 146.63 34.68 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.69 141.83 38.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.003 2.468 . . . . 0.0 110.976 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1576 ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 75.7 m -99.68 142.21 24.2 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1577 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 16.9 Cg_exo -61.91 -22.26 73.95 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 123.652 2.901 . . . . 0.0 113.911 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -58.21 -65.14 0.7 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.204 0.602 . . . . 0.0 112.399 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.463 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 5.4 m-20 -120.25 -2.53 10.11 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.877 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.9 mm? 69.45 -53.02 0.6 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.208 1.003 . . . . 0.0 113.419 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -62.71 -28.32 69.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.164 0.586 . . . . 0.0 109.836 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' 1611 ' ' THR . 64.5 mt -82.32 128.72 34.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.859 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 58.7 mttp -118.09 162.49 18.12 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 98.3 m-85 -63.62 116.73 5.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -126.98 140.97 51.92 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 25.0 m -120.3 116.81 26.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -115.16 114.68 47.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.609 0.718 . . . . 0.0 109.797 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.36 115.48 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 7.7 t -96.67 106.58 18.88 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 94.3 m-85 -86.56 111.58 20.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.761 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.7 m -108.66 144.96 16.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' 1620 ' ' THR . 3.1 p -76.66 143.44 40.11 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' 1593 ' ' LYS . 49.4 tptt -157.66 114.01 2.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 24.4 m -71.82 -21.7 61.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.02 7.82 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 110.508 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.668 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -81.94 -67.59 0.77 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 61.47 -129.68 45.42 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.84 -16.78 54.3 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.593 2.196 . . . . 0.0 112.464 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.1 t -120.74 83.53 2.08 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 122.847 1.308 . . . . 0.0 110.59 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.668 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 18.1 m -77.86 143.02 38.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.402 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.476 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 13.9 pt20 -104.8 126.11 32.06 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-O 120.984 0.421 . . . . 0.0 111.878 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' 1518 ' ' ILE . 5.1 Cg_exo -82.83 160.01 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.327 2.685 . . . . 0.0 111.688 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.6 tp -148.78 130.13 14.71 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.61 HD11 HG23 ' A' 1607 ' ' VAL . 43.9 tp -86.36 115.97 24.22 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.2 -52.4 5.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.818 0.342 . . . . 0.0 110.372 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.8 t -167.25 138.85 3.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.61 HG23 HD11 ' A' 1604 ' ' LEU . 69.5 t -110.58 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.9 t70 -94.03 117.89 30.74 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.334 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.56 -6.21 57.9 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -95.93 -51.48 4.44 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.163 0.983 . . . . 0.0 108.935 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.844 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -95.04 -6.99 40.9 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.208 -1.815 . . . . 0.0 110.443 -171.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1612 ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 80.1 m 57.25 26.4 12.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.8 m -93.37 119.58 32.66 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.597 ' HB3' ' HE2' ' A' 1616 ' ' PHE . 85.5 mt -93.82 114.11 26.29 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.957 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.77 108.95 21.76 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -121.06 138.52 54.14 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.82 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 39.1 t -102.97 138.15 40.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.423 ' HE1' ' HB2' ' A' 1600 ' ' SER . 8.0 t-105 -126.42 114.43 18.17 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.05 100.95 13.32 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.1 t -135.28 153.01 52.03 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.269 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 10.2 m -77.98 -26.48 48.68 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 48.3 mt -72.1 -5.16 33.34 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.146 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.2 59.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 111.793 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 91.0 m -123.28 162.55 22.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1625 ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' 1505 ' ' PHE . 2.8 mp0 . . . . . 0 N--CA 1.417 -2.103 0 CA-C-O 121.229 0.538 . . . . 0.0 109.921 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1493 ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' 1557 ' ' GLN . 10.1 p30 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 84.2 m 63.59 21.53 12.77 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.471 1.129 . . . . 0.0 110.393 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.3 pt20 -152.35 141.2 21.06 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.4 p -136.52 134.96 49.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 8.8 m -106.93 121.89 45.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.43 125.25 50.49 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.16 -6.46 18.35 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.408 2.072 . . . . 0.0 113.143 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.26 -65.49 0.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.259 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 62.0 p -92.99 -24.88 18.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.859 0.837 . . . . 0.0 110.028 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 88.58 9.31 69.22 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 60.5 t80 -80.81 127.86 33.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.309 0.576 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.7 p -98.96 116.0 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.4 m-85 -79.28 98.92 6.85 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -95.09 104.51 16.38 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.332 0.586 . . . . 0.0 110.739 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.84 -9.37 59.83 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.541 0.686 . . . . 0.0 109.913 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.432 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 45.8 m-80 -70.25 -12.3 61.5 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 57.9 m -84.74 -16.14 42.66 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 32.2 tp -114.1 -20.5 10.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.755 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.574 ' CB ' ' HB ' ' A' 1530 ' ' VAL . 56.4 pttt -54.69 140.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.716 0.635 . . . . 0.0 112.076 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -127.44 102.64 6.97 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1513 ' ' GLU . . . . . 0.443 ' HG3' ' HA3' ' A' 1532 ' ' GLY . 31.9 tt0 -76.21 -20.47 57.43 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 24.6 m -61.32 -25.11 66.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.084 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 96.06 136.39 8.78 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.75 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' 1527 ' ' ARG . 74.3 m-85 -83.5 118.21 23.62 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 172.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 26.6 m -110.6 104.01 12.66 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.68 150.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.21 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.9 m -79.17 115.29 18.74 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.529 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.86 144.64 56.9 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.855 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.3 tt -74.03 -18.46 17.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.642 1.177 . . . . 0.0 110.94 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' 1522 ' ' ARG . 3.7 mmp_? -90.25 2.82 55.03 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.848 -0.533 . . . . 0.0 109.583 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.5 tptp 79.14 90.19 0.06 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.939 1.696 . . . . 0.0 110.098 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1524 ' ' GLY . . . . . 0.41 ' HA3' ' HZ ' ' A' 1545 ' ' PHE . . . -176.77 -161.02 24.85 Favored Glycine 0 N--CA 1.412 -2.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.2 t -144.6 139.74 28.3 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 15.0 tt -132.62 139.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' 1516 ' ' TYR . 33.4 ttt180 -127.91 120.33 27.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.3 136.08 54.52 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.921 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.7 158.97 14.08 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' 1511 ' ' LYS . 59.9 t -106.48 115.81 48.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 118.237 1.018 . . . . 0.0 108.31 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 77.9 m 57.58 26.83 13.28 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.951 0.782 . . . . 0.0 112.445 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1532 ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' 1513 ' ' GLU . . . -130.04 142.15 13.37 Favored Glycine 0 N--CA 1.414 -2.769 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.38 126.62 35.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.8 m -94.9 98.95 8.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' 1535 ' ' LYS . 10.0 mptt -67.19 -20.88 65.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.639 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.81 -10.17 59.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.892 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1537 ' ' CYS . . . . . 0.585 ' HB2' HG23 ' A' 1534 ' ' VAL . 73.3 m -116.06 7.63 14.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 115.94 137.27 6.1 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.656 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.33 128.07 19.57 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.351 2.034 . . . . 0.0 110.126 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.62 11.73 61.82 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.426 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.8 mm -112.74 128.5 69.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.66 -22.06 7.92 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.929 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -134.1 127.21 31.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 29.0 p -144.36 154.92 43.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.482 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.41 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 44.4 t80 -84.92 134.91 34.25 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -86.2 97.66 10.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 160.41 -91.74 0.11 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.7 p -71.2 -21.15 62.18 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 90.85 18.6 46.89 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.792 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 22.8 pt -74.14 131.4 35.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.248 0.547 . . . . 0.0 110.004 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 19.8 pttm -84.17 142.52 30.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.38 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -113.21 11.56 18.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.943 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.28 135.94 2.18 Favored Glycine 0 N--CA 1.433 -1.509 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.755 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' 1572 ' ' ASP . 29.3 mtpp -75.37 150.89 38.28 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.157 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.77 125.98 26.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.322 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.11 158.39 43.87 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1557 ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' 1493 ' ' ASN . 11.1 pt20 -124.16 33.53 5.26 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.927 0.87 . . . . 0.0 109.622 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.88 95.73 7.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.482 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.31 110.9 23.37 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 15.9 p -89.48 119.19 29.71 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.264 0.554 . . . . 0.0 111.359 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1561 ' ' TYR . . . . . 0.675 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 16.0 t80 -92.93 101.17 13.52 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 94.3 t -106.89 104.89 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.739 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.32 63.32 1.91 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.214 1.406 . . . . 0.0 111.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1564 ' ' GLN . . . . . 0.675 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 64.5 mt-30 66.12 11.62 7.95 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 113.908 -1.496 . . . . 0.0 114.197 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 93.4 t -116.87 139.2 44.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.6 113.64 22.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -109.02 114.68 28.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.898 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.79 110.81 17.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.53 121.61 66.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.859 0.837 . . . . 0.0 111.703 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.943 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.3 m-85 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.167 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.438 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 36.9 mt-10 -101.02 174.31 6.07 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' 1554 ' ' LYS . 9.8 t70 53.97 73.26 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.738 1.615 . . . . 0.0 111.5 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -96.25 -140.09 10.89 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.37 138.94 31.9 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 14.9 Cg_exo -68.38 135.39 33.79 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.854 2.369 . . . . 0.0 112.975 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 62.7 m -98.76 131.02 26.49 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.823 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.1 2.54 2.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.414 2.742 . . . . 0.0 115.542 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -72.88 -50.45 23.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.965 0.412 . . . . 0.0 110.172 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.89 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 17.3 m120 -132.43 -0.1 3.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.45 -47.12 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.4 p80 -76.39 -5.81 48.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.146 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 61.5 mt -89.05 126.54 35.48 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 98.1 mttt -133.24 159.04 41.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 91.9 m-85 -61.51 113.24 2.57 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.986 0.804 . . . . 0.0 108.86 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.438 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.6 mtpt -124.51 136.16 53.77 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.8 m -120.0 116.12 25.11 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 6.1 p -110.34 109.76 29.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.927 0.87 . . . . 0.0 109.67 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.85 111.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.036 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 67.1 m -92.3 112.01 23.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 94.9 m-85 -86.53 103.1 14.73 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.7 m -105.84 161.49 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.194 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.7 t -76.88 136.89 38.88 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 23.3 tptm -149.99 105.23 3.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 77.0 p -62.36 -37.78 87.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.256 0.55 . . . . 0.0 110.281 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.64 76.3 3.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.531 0.682 . . . . 0.0 110.213 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -128.09 -64.38 0.96 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.837 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 66.91 -133.6 31.74 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 -20.1 35.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.405 2.07 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.9 p -102.49 73.22 1.3 Allowed 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.66 0.743 . . . . 0.0 111.034 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.51 ' HB3' ' HB ' ' A' 1620 ' ' THR . 42.1 m -86.03 105.56 16.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.473 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 91.2 mt-30 -77.01 126.14 85.91 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -171.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.1 Cg_endo -83.99 111.37 1.65 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 123.398 2.732 . . . . 0.0 110.702 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' 1617 ' ' SER . 62.0 tp -88.68 123.53 33.22 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.04 91.72 5.52 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.25 -59.13 3.44 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.865 -175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1606 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1615 ' ' PHE . 46.4 m -158.91 132.4 7.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 65.2 t -106.75 111.04 33.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.15 102.47 14.51 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.97 -20.2 60.43 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.438 -170.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.57 -45.52 12.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.962 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.806 ' HA ' HD13 ' A' 1582 ' ' LEU . 68.4 p -85.72 -16.35 39.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.504 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1612 ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 79.6 m 71.1 26.64 3.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 110.413 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 9.7 m -93.11 116.7 29.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.825 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 80.2 mt -99.09 116.91 32.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1615 ' ' PHE . . . . . 0.407 ' HD2' ' HB2' ' A' 1606 ' ' SER . 80.5 m-85 -100.82 117.33 34.69 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -120.68 133.42 55.35 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.866 0.466 . . . . 0.0 110.216 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.655 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 19.5 m -107.21 103.77 13.23 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -95.46 107.05 19.18 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 57.6 m-70 -83.37 104.18 13.32 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' 1600 ' ' SER . 10.2 t -131.99 150.42 52.16 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.449 0.642 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.7 p -77.13 -22.15 53.07 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.28 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 44.6 tp -71.42 -7.09 45.05 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.434 0.635 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.72 -4.19 26.89 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.226 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.9 m -87.07 176.61 7.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 . . . . . 0 N--CA 1.437 -1.091 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 72.3 m 64.55 40.32 6.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.853 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.4 pt20 -136.63 152.03 49.98 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 13.8 p -157.87 139.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.6 m -97.59 132.94 42.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' 1503 ' ' TYR . 8.2 p30 -99.23 126.77 36.75 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.06 -10.69 29.67 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.786 2.324 . . . . 0.0 113.828 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -61.58 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 27.2 p -96.46 -26.55 15.26 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.135 0.493 . . . . 0.0 111.653 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 89.81 11.57 63.47 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1503 ' ' TYR . . . . . 0.464 ' HB3' HD21 ' A' 1498 ' ' ASN . 87.7 t80 -83.92 136.91 33.91 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 114.954 -0.623 . . . . 0.0 109.914 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' 1497 ' ' THR . 49.0 t -99.54 114.18 36.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' 1495 ' ' GLN . 98.5 m-85 -77.12 98.66 5.12 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.11 108.05 19.63 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1507 ' ' LEU . . . . . 0.556 HD11 HD23 ' A' 1510 ' ' LEU . 15.7 tp -86.22 4.24 39.55 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.673 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.566 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 51.2 m-80 -70.92 -18.66 62.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 47.4 t -80.18 -10.83 59.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.556 HD23 HD11 ' A' 1507 ' ' LEU . 69.0 tp -116.6 -25.61 7.33 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.95 -0.469 . . . . 0.0 111.469 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' 1530 ' ' VAL . 19.2 pttp -56.49 142.33 39.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.647 0.737 . . . . 0.0 112.571 -174.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -128.76 106.07 8.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1513 ' ' GLU . . . . . 0.423 ' HA ' ' HA3' ' A' 1532 ' ' GLY . 32.4 tt0 -65.01 -34.11 77.66 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.634 0.773 . . . . 0.0 110.799 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 20.4 m -72.95 -11.69 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.429 0.633 . . . . 0.0 110.341 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 78.33 161.66 18.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 114.587 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' 1527 ' ' ARG . 94.5 m-85 -97.98 128.74 44.73 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 25.2 m -100.53 98.2 8.82 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1518 ' ' ILE . . . . . 0.424 HG13 HG23 ' A' 1526 ' ' ILE . 18.1 pt -109.04 111.14 34.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.822 0.82 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1519 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.7 t -95.67 112.38 24.11 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.686 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1520 ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 15.2 t70 -100.62 120.68 40.41 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.4 -10.16 11.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.521 0.677 . . . . 0.0 112.384 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 16.3 mtp180 -92.99 -39.01 11.35 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 121.956 -0.465 . . . . 0.0 110.713 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -109.23 -34.9 6.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 136.99 177.74 15.27 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1525 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1519 ' ' SER . 32.5 t -79.85 127.99 32.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.424 HG23 HG13 ' A' 1518 ' ' ILE . 10.7 tt -123.08 122.3 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' 1516 ' ' TYR . 16.9 ttm180 -108.35 116.05 31.25 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.13 120.29 37.31 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.297 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -93.52 118.96 5.82 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' 1511 ' ' LYS . 46.0 t -75.45 116.17 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.691 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 68.1 m 59.1 20.43 8.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.216 0.948 . . . . 0.0 112.047 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1532 ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' 1513 ' ' GLU . . . -135.86 132.8 6.3 Favored Glycine 0 N--CA 1.401 -3.685 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1533 ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' 1535 ' ' LYS . 21.6 mt-10 -76.39 130.02 37.44 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 15.4 m -80.1 93.1 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.52 0.676 . . . . 0.0 110.901 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' 1533 ' ' GLU . 0.0 OUTLIER -59.3 -26.45 64.99 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.49 -178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.17 -37.3 66.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.176 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 43.3 t -107.19 -25.37 11.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.948 0.404 . . . . 0.0 110.133 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 143.17 144.92 4.34 Favored Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.3 152.2 81.09 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.547 2.165 . . . . 0.0 110.795 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.5 -27.35 6.43 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.807 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.0 mm -89.59 136.09 24.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.04 -37.12 2.58 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.294 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -125.84 128.07 47.06 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 44.2 t -139.59 139.86 36.9 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.686 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.42 ' HZ ' HD11 ' A' 1614 ' ' LEU . 98.2 m-85 -87.02 124.29 33.04 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1546 ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' 1525 ' ' SER . 47.4 mt-10 -82.05 107.99 15.19 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.738 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 172.39 -71.65 0.1 Allowed Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.3 m -106.9 -24.82 11.91 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.572 0.701 . . . . 0.0 109.397 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 103.7 34.33 3.85 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.02 131.03 35.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.444 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 25.8 pttm -93.22 138.65 31.41 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.95 8.06 43.26 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.611 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 140.74 149.48 5.28 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.876 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.31 155.72 17.36 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.385 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.691 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 39.0 t90 -71.49 143.61 49.95 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.2 152.74 38.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -106.07 9.88 32.29 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.59 107.12 19.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.063 0.458 . . . . 0.0 110.651 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.403 HD23 HD13 ' A' 1568 ' ' LEU . 74.6 mt -88.59 125.8 34.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.886 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.8 m -90.24 121.84 32.62 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.2 t80 -98.89 116.12 30.4 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 122.23 -0.294 . . . . 0.0 110.416 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.4 t -121.24 80.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 38.7 t70 40.45 83.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.154 1.781 . . . . 0.0 114.518 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 64.05 19.24 11.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.498 1.119 . . . . 0.0 112.849 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 58.6 t -133.9 119.89 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.42 133.87 37.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.943 0.401 . . . . 0.0 110.302 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.886 ' HB2' ' HB2' ' A' 1560 ' ' SER . 15.3 mm100 -110.83 114.7 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.573 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1568 ' ' LEU . . . . . 0.403 HD13 HD23 ' A' 1559 ' ' LEU . 34.1 tp -116.45 107.35 14.66 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 17.1 t -105.99 108.55 25.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.095 -174.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.611 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 61.3 m-85 -82.08 107.16 14.56 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.5 178.33 4.59 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.585 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 24.4 t70 56.73 67.06 1.04 Allowed 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.87 1.356 . . . . 0.0 111.241 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1573 ' ' GLY . . . . . 0.444 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -93.25 -155.25 31.81 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 173.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -82.57 158.17 66.22 Favored Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 117.605 0.703 . . . . 0.0 109.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.63 140.08 35.28 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.272 1.981 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 83.5 m -101.33 133.92 20.61 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.196 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.09 7.8 1.0 Allowed 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.31 2.673 . . . . 0.0 113.633 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.33 -52.96 6.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.13 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.541 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 2.4 m-20 -131.83 -2.36 3.71 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.802 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 31.9 tp 71.47 -47.82 0.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.908 1.283 . . . . 0.0 113.032 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -73.33 -12.81 60.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.451 0.643 . . . . 0.0 110.277 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.904 HD13 ' HA ' ' A' 1611 ' ' THR . 89.4 mt -85.58 127.62 34.51 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.042 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.616 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 44.5 mttm -112.54 152.92 28.27 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.494 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -60.07 123.62 17.7 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.725 0.64 . . . . 0.0 109.87 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.69 131.4 43.06 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.6 t -120.86 116.66 25.6 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 3.3 p -108.12 101.32 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.966 0.889 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.72 114.11 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.3 m -95.93 109.63 21.97 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.731 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.4 m-85 -86.18 108.1 18.18 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 m -103.87 166.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 13.0 t -75.96 120.39 21.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 123.988 0.915 . . . . 0.0 112.91 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.745 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 48.1 tptt -152.55 99.47 2.47 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.3 m -65.82 -30.81 71.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1595 ' ' ASP . . . . . 0.745 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 10.3 t70 -85.57 67.76 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -143.54 -56.44 0.39 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.718 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 79.09 -160.92 46.84 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.63 -20.14 35.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 110.869 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -92.31 53.97 2.23 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.923 0.868 . . . . 0.0 109.102 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.1 m -62.3 140.66 58.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.015 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -106.32 124.61 35.24 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 52.8 Cg_endo -87.92 133.88 3.07 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.167 2.578 . . . . 0.0 112.515 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.1 tp -118.92 134.93 54.85 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.425 HD11 HG23 ' A' 1607 ' ' VAL . 45.1 tp -72.76 118.86 16.21 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.34 -43.37 12.93 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1606 ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' 1615 ' ' PHE . 21.6 t -179.9 146.98 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.425 HG23 HD11 ' A' 1604 ' ' LEU . 95.9 t -123.09 121.14 62.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1608 ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' 1610 ' ' HIS . 32.5 t70 -115.2 103.09 10.5 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.742 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.4 8.28 7.93 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.049 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1610 ' ' HIS . . . . . 0.428 ' HB2' ' OD2' ' A' 1608 ' ' ASP . 51.7 m80 -88.81 -51.48 5.62 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.904 ' HA ' HD13 ' A' 1582 ' ' LEU . 1.6 m -98.84 -6.17 29.63 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.526 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 76.6 m 62.1 30.74 17.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.257 1.023 . . . . 0.0 111.198 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 14.5 m -97.3 116.7 30.0 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.41 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.599 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 84.7 mt -96.93 120.2 36.83 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.31 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1615 ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' 1606 ' ' SER . 72.7 m-85 -105.21 112.22 25.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.599 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.1 m-85 -122.41 135.39 54.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 42.1 p -113.05 110.89 21.22 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' 1602 ' ' PRO . 1.5 t-105 -97.24 115.91 28.49 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 48.6 m80 -83.59 99.43 10.17 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -128.74 151.12 49.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.881 0.848 . . . . 0.0 111.485 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.9 m -76.88 -27.69 55.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.434 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.44 -5.95 40.22 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.277 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.59 -1.44 35.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.594 0.711 . . . . 0.0 110.345 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 12.3 t -113.77 170.32 8.34 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.442 -0.841 0 O-C-N 123.869 0.731 . . . . 0.0 110.022 178.785 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1493 ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' 1557 ' ' GLN . 3.6 p-10 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.421 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 64.9 m 73.27 0.09 3.55 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.053 0.93 . . . . 0.0 112.113 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.411 ' HB3' ' OD1' ' A' 1506 ' ' ASP . 21.1 pt20 -128.91 147.39 50.83 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.9 p -132.48 118.25 34.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 122.112 0.958 . . . . 0.0 110.868 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.787 HG23 HG22 ' A' 1504 ' ' VAL . 6.0 m -96.37 101.51 13.16 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.19 122.17 49.38 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.36 -8.02 19.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.215 2.61 . . . . 0.0 112.53 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.95 -56.61 17.4 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.758 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1501 ' ' THR . . . . . 0.415 ' HB ' ' CD2' ' A' 1503 ' ' TYR . 57.7 p -101.01 -28.39 12.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 85.46 10.77 76.44 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.45 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1503 ' ' TYR . . . . . 0.415 ' CD2' ' HB ' ' A' 1501 ' ' THR . 56.6 m-85 -99.54 131.6 45.43 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.787 HG22 HG23 ' A' 1497 ' ' THR . 28.3 t -90.48 99.23 9.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -83.32 105.71 14.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1506 ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' 1495 ' ' GLN . 24.3 t70 -105.26 112.03 25.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.228 0.537 . . . . 0.0 111.862 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.9 tp -85.27 -4.49 59.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.035 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.65 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 62.6 m-80 -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 69.6 m -77.3 -10.03 59.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.111 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.452 ' HB2' HD12 ' A' 1622 ' ' LEU . 26.2 tp -109.92 8.05 24.11 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.434 0.635 . . . . 0.0 109.493 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 53.5 mtmt -58.54 143.7 45.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.665 ' H ' ' HB ' ' A' 1530 ' ' VAL . 32.2 tpt180 -127.25 97.9 5.09 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -25.38 60.27 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.522 0.514 . . . . 0.0 110.711 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 45.5 t -67.6 -26.31 66.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 88.14 153.82 26.66 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -89.8 114.78 26.56 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 6.5 p -103.56 92.34 4.42 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.03 0.919 . . . . 0.0 109.8 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.5 pt -120.55 153.44 23.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.742 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1519 ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' 1524 ' ' GLY . 15.5 p -103.95 118.27 36.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.79 174.69 1.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.515 0.509 . . . . 0.0 111.009 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.2 tp -61.85 -24.26 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.74 -5.82 58.48 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 73.73 74.44 0.13 Allowed 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.918 1.687 . . . . 0.0 112.454 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1524 ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1519 ' ' SER . . . -151.37 139.16 6.98 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 174.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 47.6 m -87.78 129.2 35.26 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.898 0.849 . . . . 0.0 111.673 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.4 tt -122.0 142.1 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -118.24 116.74 27.4 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.546 0.738 . . . . 0.0 109.076 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.61 125.92 43.92 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.86 129.74 10.0 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.449 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.665 ' HB ' ' H ' ' A' 1512 ' ' ARG . 47.5 t -79.52 115.22 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.514 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.673 ' HA ' ' CZ3' ' A' 1555 ' ' TRP . 69.9 m 46.25 66.91 0.85 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 125.141 1.526 . . . . 0.0 113.461 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -171.25 175.17 44.92 Favored Glycine 0 N--CA 1.404 -3.459 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.78 134.89 48.54 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.7 m -88.9 97.13 6.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.739 0.78 . . . . 0.0 110.689 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -22.54 54.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.941 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.22 -26.44 66.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.653 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 61.5 m -102.91 0.2 32.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.32 150.63 18.26 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.58 145.79 87.89 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.404 2.069 . . . . 0.0 112.48 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1540 ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' 1555 ' ' TRP . . . 82.41 14.73 75.67 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 114.81 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.33 131.62 63.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 118.082 0.941 . . . . 0.0 109.221 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.49 -28.31 7.18 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.901 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.796 0.332 . . . . 0.0 111.147 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 69.0 m -142.59 149.24 38.74 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.494 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 56.1 t80 -94.88 118.81 32.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.75 110.02 4.7 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.17 0.918 . . . . 0.0 112.488 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 144.82 -80.04 0.23 Allowed Glycine 0 C--N 1.296 -1.677 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.032 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 20.1 m -72.38 -19.77 61.56 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.321 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 79.29 41.78 13.06 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.621 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' 1545 ' ' PHE . 20.9 pt -93.46 131.01 41.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 56.4 mttm -85.44 129.2 34.87 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.552 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -98.86 7.73 45.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.055 0.455 . . . . 0.0 111.172 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.62 146.02 4.31 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.985 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 50.6 tttm -69.32 145.46 52.99 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.028 0.931 . . . . 0.0 109.588 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.673 ' CZ3' ' HA ' ' A' 1531 ' ' CYS . 7.0 t-105 -66.24 109.67 2.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -146.75 161.23 41.06 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1557 ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' 1493 ' ' ASN . 51.2 mt-30 -120.6 67.83 0.85 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.033 0.92 . . . . 0.0 108.849 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.4 tptt -96.86 95.38 7.82 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.776 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 4.2 mm? -104.7 104.85 14.73 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.111 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.809 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.3 m -100.07 139.46 35.71 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 89.3 t80 -113.98 117.8 32.33 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.479 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1562 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 67.6 t -103.43 153.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.28 100.79 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 123.901 0.881 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 68.47 19.06 8.89 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.959 1.704 . . . . 0.0 112.33 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1565 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 49.0 t -134.07 119.57 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.739 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.7 tp -87.37 140.18 29.79 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.809 ' HB2' ' HB2' ' A' 1560 ' ' SER . 14.7 mm100 -124.65 115.25 20.48 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.722 -0.611 . . . . 0.0 111.097 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 63.0 tp -109.9 120.31 42.08 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.494 HG22 HG23 ' A' 1587 ' ' VAL . 32.5 t -117.35 131.45 70.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.132 0.491 . . . . 0.0 110.461 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' 1586 ' ' SER . 63.5 m-85 -103.1 105.8 16.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.65 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.442 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.91 92.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.934 1.396 . . . . 0.0 112.179 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.33 -158.07 12.9 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.507 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.83 151.57 52.54 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.99 147.59 3.38 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.529 2.819 . . . . 0.0 114.766 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1576 ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 17.2 t -98.22 130.25 28.85 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.139 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1577 ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 21.9 Cg_exo -60.76 -27.48 84.88 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.142 2.562 . . . . 0.0 113.911 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.31 33.9 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 13.2 m120 -126.5 8.31 7.05 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.86 -62.54 0.34 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.785 1.234 . . . . 0.0 114.078 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.27 4.51 8.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' 1576 ' ' CYS . 92.5 mt -90.36 154.54 19.61 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' 1585 ' ' LYS . 94.1 mttt -123.86 154.09 40.15 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.431 ' HE2' ' HB ' ' A' 1550 ' ' ILE . 27.1 m-85 -62.73 116.82 5.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' 1583 ' ' LYS . 28.9 mtpp -115.05 133.82 55.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.723 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 37.5 m -120.01 122.36 40.96 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.212 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.494 HG23 HG22 ' A' 1569 ' ' VAL . 6.6 p -126.75 111.27 25.42 Favored 'Isoleucine or valine' 0 C--O 1.25 1.096 0 CA-C-O 121.975 0.893 . . . . 0.0 110.725 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.0 110.88 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.746 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 29.5 m -88.53 111.18 21.55 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.739 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.5 m-85 -86.97 106.64 17.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.0 m -98.53 153.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1620 ' ' THR . 48.7 t -86.96 133.85 33.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.16 0.981 . . . . 0.0 113.166 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.0 tptt -147.33 105.38 3.74 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.1 t -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.601 0.715 . . . . 0.0 110.645 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.29 -3.17 57.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.717 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.904 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.98 -42.81 15.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.5 -156.41 51.0 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.976 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.06 -4.1 14.69 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.441 2.761 . . . . 0.0 113.098 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 17.8 p -90.54 -49.69 6.36 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.904 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.5 m 69.34 145.77 0.05 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.379 1.072 . . . . 0.0 113.144 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 97.8 mt-30 -87.84 121.88 70.54 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.338 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.0 Cg_endo -88.43 118.67 1.07 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.466 2.777 . . . . 0.0 111.661 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' 1617 ' ' SER . 63.5 tp -130.8 124.69 31.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.224 0.535 . . . . 0.0 109.974 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.683 HD21 HG23 ' A' 1607 ' ' VAL . 62.6 tp -87.16 126.73 34.98 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 58.4 tp -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 60.4 p -178.35 142.67 0.26 Allowed 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.015 0.822 . . . . 0.0 109.943 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.683 HG23 HD21 ' A' 1604 ' ' LEU . 61.9 t -94.37 117.47 38.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.69 113.15 26.31 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.324 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.95 -2.0 45.96 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 45.9 m80 -82.33 -41.2 20.37 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.382 0.61 . . . . 0.0 110.677 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.582 ' HA ' HD13 ' A' 1582 ' ' LEU . 33.8 p -121.58 -9.81 8.89 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 75.5 m 65.68 35.07 7.18 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.149 0.976 . . . . 0.0 111.397 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -96.48 122.92 39.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.096 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.555 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 88.7 mt -91.27 112.81 24.88 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -98.41 115.6 28.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.086 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.555 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 86.9 m-85 -123.41 140.21 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' 1603 ' ' LEU . 40.0 m -120.67 103.69 9.33 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -95.51 122.01 37.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.856 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 46.9 m-70 -90.73 102.98 15.74 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.4 t -127.48 153.89 45.76 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.046 0.45 . . . . 0.0 110.447 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.2 m -79.59 -25.28 41.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' 1510 ' ' LEU . 33.4 mt -70.7 -4.75 25.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.708 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.45 -23.44 40.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.625 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 60.3 m -79.31 159.68 27.1 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.6 p-10 . . . . . 0 N--CA 1.434 -1.229 0 CA-C-O 121.086 0.469 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.445 ' HB2' ' OD1' ' A' 1508 ' ' ASN . 82.9 m 55.1 25.06 6.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' 1505 ' ' PHE . 25.0 pt20 -132.91 119.15 19.8 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 124.89 71.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.376 0.608 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 9.1 m -88.71 109.7 20.36 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.32 138.4 45.16 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.246 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.2 -2.75 12.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.686 2.257 . . . . 0.0 113.572 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -82.33 -63.89 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.813 0.34 . . . . 0.0 110.618 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1501 ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' 1625 ' ' GLU . 24.6 p -98.13 -20.17 17.48 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.4 3.35 81.72 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.87 133.62 43.17 Favored 'General case' 0 C--O 1.254 1.325 0 C-N-CA 123.074 0.55 . . . . 0.0 109.842 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 65.4 t -95.33 111.75 26.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' 1495 ' ' GLN . 82.8 m-85 -85.04 103.03 13.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.2 108.06 19.4 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1507 ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 32.5 tp -82.48 -8.75 59.61 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.477 ' HA ' ' HD3' ' A' 1511 ' ' LYS . 90.2 m-20 -59.79 -24.02 63.77 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.62 1.968 . . . . 0.0 112.789 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 6.9 p -86.36 -11.0 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.04 0.448 . . . . 0.0 111.531 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 49.1 tp -116.0 -22.33 9.05 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 122.207 -0.308 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1531 ' ' CYS . 22.2 pttp -46.79 131.38 11.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.035 0.921 . . . . 0.0 113.472 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -126.93 101.11 6.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.293 -172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.54 -37.75 87.62 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.91 0.756 . . . . 0.0 110.967 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 41.3 m -63.49 -18.42 63.78 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.395 0.617 . . . . 0.0 110.447 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 86.11 149.14 12.65 Favored Glycine 0 N--CA 1.415 -2.74 0 CA-C-N 115.278 -0.874 . . . . 0.0 114.635 173.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -80.83 114.35 19.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 20.0 m -99.45 98.84 9.7 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 27.4 pt -115.84 145.7 21.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.511 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 35.8 t -111.03 130.5 55.58 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.287 0.565 . . . . 0.0 109.912 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.44 153.86 42.94 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.97 -22.76 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.373 0.606 . . . . 0.0 111.62 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -79.51 3.75 17.78 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.43 0.692 . . . . 0.0 111.042 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 56.9 tptt 73.52 87.18 0.1 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.75 1.62 . . . . 0.0 110.442 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -169.11 117.2 0.7 Allowed Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 50.4 m -81.62 120.79 25.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 120.785 0.326 . . . . 0.0 110.815 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.802 ' HB ' ' HD1' ' A' 1545 ' ' PHE . 14.6 tt -114.41 128.24 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.5 ttm180 -116.95 115.5 25.59 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.2 mp -114.78 114.93 26.23 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.303 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -83.55 111.16 3.38 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' 1511 ' ' LYS . 7.2 p -85.97 116.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.981 -0.717 . . . . 0.0 109.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1511 ' ' LYS . 85.7 m 64.94 15.63 10.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.421 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.91 140.21 8.99 Favored Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -76.81 146.88 37.53 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.6 p -89.19 99.32 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 122.291 1.043 . . . . 0.0 110.959 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' 1535 ' ' LYS . 0.3 OUTLIER -65.48 -19.36 65.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.187 -174.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.57 -36.5 78.66 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.899 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 78.0 m -106.96 -24.29 12.06 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 129.63 152.61 7.61 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.482 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.25 146.86 95.79 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.981 2.454 . . . . 0.0 110.815 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 97.41 -14.61 63.23 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.866 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.98 136.15 51.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.446 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.39 -47.12 0.82 Allowed Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.99 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -108.28 125.9 52.21 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 43.9 t -141.98 139.12 32.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.802 ' HD1' ' HB ' ' A' 1526 ' ' ILE . 57.4 t80 -108.72 121.58 45.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.24 -30.96 71.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -66.2 112.91 5.29 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.4 m 72.93 1.31 3.98 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.029 0.932 . . . . 0.0 110.629 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 58.59 41.9 95.83 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' 1545 ' ' PHE . 27.5 pt -90.82 142.05 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.769 0.795 . . . . 0.0 112.238 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 84.7 mttt -82.08 137.74 34.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.756 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -120.41 15.39 12.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.189 0.519 . . . . 0.0 110.202 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.91 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 157.79 128.51 1.03 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.96 -1.114 . . . . 0.0 114.221 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.9 tttp -72.75 139.53 47.19 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 125.248 1.419 . . . . 0.0 107.319 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 55.5 t90 -72.78 134.43 44.94 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.88 159.57 35.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.39 88.69 2.83 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1558 ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 40.2 mmtm -131.21 90.81 2.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.35 111.05 23.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 17.6 m -116.16 127.82 55.13 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.4 101.1 13.31 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -138.38 150.15 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.7 t70 65.68 15.2 9.94 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.803 0.811 . . . . 0.0 108.979 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 70.08 12.71 7.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.058 1.743 . . . . 0.0 110.682 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 63.0 t -117.53 151.91 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.851 0.86 . . . . 0.0 109.865 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.1 mp -86.28 124.34 32.55 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.134 -0.354 . . . . 0.0 110.588 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.981 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.4 tp -128.55 118.01 22.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.485 HG22 ' HG3' ' A' 1571 ' ' GLU . 10.5 p -126.39 117.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 112.983 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.91 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 54.4 m-85 -92.13 102.34 14.87 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.893 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.579 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 44.6 mt-10 -107.67 166.58 10.57 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 20.6 t70 68.94 71.0 0.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.274 1.035 . . . . 0.0 111.734 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.0 -137.16 9.68 Favored Glycine 0 N--CA 1.421 -2.333 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.45 153.96 65.62 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.21 151.03 84.52 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.081 1.854 . . . . 0.0 110.587 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 72.7 m -97.3 137.87 21.18 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.8 -25.94 78.31 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.547 2.832 . . . . 0.0 113.449 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.11 -67.25 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.573 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.9 m120 -109.53 -3.68 16.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.1 mm? 67.98 -53.11 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.702 1.201 . . . . 0.0 113.336 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -61.8 -18.21 59.07 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.372 1.469 . . . . 0.0 111.82 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' 1611 ' ' THR . 81.0 mt -82.93 141.66 32.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -116.17 146.94 41.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.88 118.97 9.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 86.9 mttt -130.16 137.62 50.21 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 14.5 m -119.84 116.28 25.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -108.36 114.92 47.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.972 0.892 . . . . 0.0 110.408 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.61 122.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.443 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 19.6 m -109.16 114.77 28.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 91.7 m-85 -86.79 109.61 19.38 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -102.4 159.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 35.6 t -76.28 130.24 37.86 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.19 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.613 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 47.3 tptt -159.82 106.59 1.65 Allowed 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 19.8 m -72.04 -25.96 62.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1595 ' ' ASP . . . . . 0.613 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 34.4 t70 -81.54 19.81 0.98 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.564 1.146 . . . . 0.0 110.68 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.748 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -95.03 -39.39 10.19 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.691 -0.631 . . . . 0.0 110.508 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 71.57 -162.53 54.3 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.871 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.7 -14.69 33.31 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.228 2.619 . . . . 0.0 112.12 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.1 p -81.94 -50.9 8.62 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.748 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.3 m 65.54 108.87 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.025 0.828 . . . . 0.0 111.198 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 48.4 mt-30 -74.27 124.85 90.24 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.716 -172.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 11.7 Cg_endo -92.97 108.02 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 123.329 2.686 . . . . 0.0 111.251 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.21 116.23 28.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.776 HD21 HG23 ' A' 1607 ' ' VAL . 5.4 tt -77.8 108.3 10.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 63.5 tp -74.92 -54.58 6.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.987 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 23.1 t -169.4 151.19 4.42 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.776 HG23 HD21 ' A' 1604 ' ' LEU . 83.9 t -117.92 110.75 31.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.18 104.57 16.61 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.399 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.44 5.38 17.82 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.445 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 56.1 m80 -88.63 -44.23 10.76 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -112.05 -0.08 15.79 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.6 -176.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 60.3 m 63.01 30.64 16.32 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.185 0.994 . . . . 0.0 111.235 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -99.05 118.56 36.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.726 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.62 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 78.6 mt -97.26 119.29 35.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -102.75 115.44 30.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.62 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 69.4 m-85 -125.74 126.72 45.05 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.01 0.433 . . . . 0.0 110.263 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 20.2 m -106.07 112.66 25.8 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -97.17 119.03 34.92 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 64.6 m-70 -89.8 112.87 24.32 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 14.9 t -139.46 152.18 46.8 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.18 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 6.9 m -74.89 -23.7 58.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' 1505 ' ' PHE . 41.7 mt -72.6 -5.55 38.05 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.347 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.09 16.87 25.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.327 0.584 . . . . 0.0 110.404 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 59.0 m -113.15 151.26 31.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.062 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1625 ' ' GLU . . . . . 0.499 ' HG2' HG21 ' A' 1501 ' ' THR . 5.4 mp0 . . . . . 0 C--N 1.316 -0.862 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.245 0.867 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 15.0 t 69.03 26.34 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.626 1.203 . . . . 0.0 109.503 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -156.13 151.17 26.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -114.02 132.33 63.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.827 HG23 HG22 ' A' 1504 ' ' VAL . 63.3 m -141.72 105.75 4.77 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.1 p30 -98.34 129.34 30.76 Favored Pre-proline 0 N--CA 1.435 -1.218 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.754 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.05 -11.78 31.1 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.425 2.083 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -55.72 10.7 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.586 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 38.9 p -118.98 -6.28 10.5 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 77.11 34.38 41.91 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1503 ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' 1497 ' ' THR . 41.0 t80 -83.57 109.61 17.55 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.827 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -128.01 107.6 16.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 O-C-N 123.748 0.655 . . . . 0.0 109.477 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' 1625 ' ' GLU . 8.3 m-85 -120.87 106.49 11.7 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -91.89 108.8 20.18 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.366 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1507 ' ' LEU . . . . . 0.497 HD11 HD23 ' A' 1510 ' ' LEU . 18.5 tp -89.27 -5.87 57.25 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.964 0.888 . . . . 0.0 109.321 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.427 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 53.1 m-80 -62.21 -26.8 68.56 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.8 t -74.29 -10.67 59.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.497 HD23 HD11 ' A' 1507 ' ' LEU . 35.8 tp -111.87 6.85 19.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.301 0.572 . . . . 0.0 110.451 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' 1530 ' ' VAL . 35.1 mtmm -57.29 153.8 11.58 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.64 ' HD2' ' H ' ' A' 1530 ' ' VAL . 0.0 OUTLIER -84.0 176.76 8.62 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.116 -174.301 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1513 ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' 1513 ' ' GLU . 0.0 OUTLIER -89.93 -51.75 5.32 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 35.1 t -128.16 -38.39 1.8 Allowed 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.594 ' HA2' ' HG3' ' A' 1512 ' ' ARG . . . 158.2 161.68 11.18 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.07 129.04 48.29 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 19.9 m -99.09 99.64 10.68 Favored 'General case' 0 N--CA 1.425 -1.711 0 O-C-N 123.788 0.68 . . . . 0.0 109.196 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.1 pt -119.58 155.84 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 8.1 t -107.59 141.17 39.48 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.22 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.36 170.05 16.86 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.842 1.257 . . . . 0.0 107.874 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.48 -23.91 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.899 0.857 . . . . 0.0 110.032 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -84.45 1.16 46.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.876 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 74.41 10.66 4.2 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 126.013 1.725 . . . . 0.0 114.459 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -71.83 123.57 9.88 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 41.5 m -81.79 124.14 29.4 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.76 132.99 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 CA-C-O 121.315 0.578 . . . . 0.0 109.566 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -107.24 116.35 31.78 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.39 140.77 52.64 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.273 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -106.62 151.17 16.92 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' 1511 ' ' LYS . 24.5 t -92.22 115.02 30.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 31.4 m 55.98 24.55 7.81 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.677 1.236 . . . . 0.0 111.88 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -139.06 169.82 24.31 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -99.15 131.25 45.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.615 HG23 ' HB2' ' A' 1537 ' ' CYS . 14.3 m -88.06 93.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.591 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -50.6 -38.27 44.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.653 -173.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.78 -19.67 65.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1537 ' ' CYS . . . . . 0.615 ' HB2' HG23 ' A' 1534 ' ' VAL . 64.6 m -109.73 9.43 24.88 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.476 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.74 155.11 10.98 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.093 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 131.43 13.34 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.612 2.208 . . . . 0.0 111.347 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1540 ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' 1554 ' ' LYS . . . 79.93 19.55 69.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.553 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' A' 1551 ' ' LYS . 45.1 mm -114.19 137.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -114.83 -18.04 6.62 Favored Glycine 0 C--N 1.32 -0.306 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.563 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.26 133.95 30.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 19.2 p -149.11 152.43 36.14 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.509 0.188 . . . . 0.0 111.509 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -94.46 118.53 31.78 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.17 110.48 13.19 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.454 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.6 -71.26 0.27 Allowed Glycine 0 C--N 1.282 -2.449 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 3.0 m -87.85 -20.4 26.09 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.91 44.53 11.96 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.75 150.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.48 ' HD3' ' CD1' ' A' 1541 ' ' ILE . 49.9 mttm -90.92 134.46 34.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.09 17.12 11.64 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.425 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 160.32 126.6 0.84 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.886 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' 1540 ' ' GLY . 32.6 ttmt -84.08 147.19 27.51 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.784 0.834 . . . . 0.0 109.997 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 64.3 t90 -64.86 129.25 39.04 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 123.775 0.672 . . . . 0.0 109.673 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.99 156.99 6.36 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -124.21 65.58 1.06 Allowed 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.913 0.863 . . . . 0.0 109.553 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -94.59 92.98 7.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.424 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.88 115.12 27.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 11.7 m -112.9 124.92 53.71 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.422 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.9 t80 -88.62 101.79 14.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 59.5 t -117.4 102.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.945 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.3 68.68 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.673 1.589 . . . . 0.0 112.739 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.57 9.77 6.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.051 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.5 t -125.78 135.44 63.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 O-C-N 121.948 -0.47 . . . . 0.0 110.018 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.11 118.27 25.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.86 118.21 36.31 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.08 119.63 37.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.463 HG22 HG23 ' A' 1587 ' ' VAL . 26.3 t -114.12 115.11 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.993 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.5 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 66.4 m-85 -96.82 92.33 6.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' 1585 ' ' LYS . 14.8 pt-20 -110.84 176.17 5.14 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.587 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.2 t70 66.8 80.15 0.22 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.921 1.288 . . . . 0.0 111.683 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -122.21 -131.44 3.9 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.81 159.17 63.93 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.62 157.93 16.43 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.226 1.95 . . . . 0.0 113.012 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 84.8 m -98.45 136.86 20.7 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.627 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.82 6.26 3.85 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.518 2.145 . . . . 0.0 113.64 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.52 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.732 0.301 . . . . 0.0 110.556 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -109.42 -1.13 18.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.913 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.95 -50.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 33.1 m80 -79.86 26.24 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.452 0.701 . . . . 0.0 112.419 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.88 125.54 44.13 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' 1585 ' ' LYS . 67.0 mttm -112.28 160.01 18.07 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -64.14 126.54 28.07 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1571 ' ' GLU . 1.3 mptp? -111.01 133.2 53.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.0 t -120.25 115.68 24.08 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.463 HG23 HG22 ' A' 1569 ' ' VAL . 7.8 p -112.7 124.73 69.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.607 0.718 . . . . 0.0 110.8 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.05 116.42 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 24.0 m -94.22 110.69 22.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.724 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 90.3 m-85 -88.25 111.07 21.25 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 22.3 m -110.14 155.2 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.778 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 25.4 t -75.08 123.24 24.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.338 0.589 . . . . 0.0 110.603 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 52.9 tptt -146.97 116.72 7.15 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 20.3 m -82.89 -20.41 35.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.294 0.568 . . . . 0.0 109.535 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1595 ' ' ASP . . . . . 0.597 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -79.29 14.19 1.62 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.592 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -94.22 -56.53 2.81 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.234 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.79 -166.39 41.14 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 -16.32 37.47 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.048 2.499 . . . . 0.0 112.561 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 11.5 p -91.74 -35.51 14.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.295 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.947 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 35.0 m 66.12 177.14 0.22 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.911 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 91.0 mt-30 -114.9 119.35 39.3 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.776 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -94.18 111.85 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 123.224 2.616 . . . . 0.0 109.597 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 59.3 tp -126.46 126.55 43.96 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.0 tp -74.93 120.31 20.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.85 -53.31 5.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.909 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 48.7 m -164.6 149.39 9.67 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 109.88 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 86.8 t -115.51 119.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.11 106.03 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.218 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.29 2.59 27.43 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.3 -24.21 16.3 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.759 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1611 ' ' THR . . . . . . . . . . . . . 24.5 p -115.39 -3.45 12.43 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.861 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 86.2 m 61.22 28.16 17.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.384 1.074 . . . . 0.0 111.532 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 25.3 m -105.56 124.61 49.84 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.378 0.609 . . . . 0.0 110.154 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.99 125.48 39.68 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.82 118.68 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 135.33 54.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 39.8 t -110.34 119.23 38.56 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -107.39 104.62 14.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.2 m-70 -83.74 105.83 14.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.6 t -132.26 152.36 51.39 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.532 0.682 . . . . 0.0 111.296 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 15.9 m -80.19 -22.6 41.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.339 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 37.2 tp -71.33 -6.52 40.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.347 0.594 . . . . 0.0 110.621 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.28 5.79 42.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.673 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 71.3 m -88.61 140.89 29.0 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.122 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1625 ' ' GLU . . . . . 0.707 ' HA ' ' HZ ' ' A' 1505 ' ' PHE . 2.3 mp0 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.066 1.746 . . . . 0.0 114.241 -174.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 t30 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 43.9 t 71.17 3.95 4.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.794 1.283 . . . . 0.0 109.993 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.7 pt20 -150.56 143.55 24.74 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.4 p -136.05 128.51 45.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 121.216 0.531 . . . . 0.0 109.568 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.424 HG23 HG22 ' A' 1504 ' ' VAL . 23.4 m -92.65 108.21 19.8 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 3.4 p30 -81.52 138.8 47.7 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.799 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.25 4.49 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.612 2.208 . . . . 0.0 113.546 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -88.85 -59.25 2.28 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.924 0.392 . . . . 0.0 110.333 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1501 ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 6.8 p -104.41 -12.51 16.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.74 13.33 83.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.546 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 84.0 t80 -86.17 130.94 34.36 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.424 HG22 HG23 ' A' 1497 ' ' THR . 45.3 t -89.82 108.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.3 m-85 -79.11 105.93 10.79 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1506 ' ' ASP . . . . . 0.449 ' O ' HD11 ' A' 1622 ' ' LEU . 9.3 t70 -94.84 102.63 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 30.9 tp -86.58 2.7 47.29 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.626 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' 1511 ' ' LYS . 28.8 m-80 -71.84 -18.61 62.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.379 0.609 . . . . 0.0 109.84 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 59.0 m -82.18 -19.33 40.09 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.137 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' 1598 ' ' PRO . 0.2 OUTLIER -115.84 10.29 15.27 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.64 ' HA ' HG23 ' A' 1530 ' ' VAL . 19.3 pttp -76.17 134.03 40.03 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.574 0.702 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.599 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 1.9 tpm_? -127.81 94.03 3.84 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1513 ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' 1513 ' ' GLU . 0.2 OUTLIER -75.19 -14.93 60.58 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -174.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 13.8 p -78.84 -13.15 59.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 91.17 137.78 7.49 Favored Glycine 0 N--CA 1.424 -2.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.173 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' 1527 ' ' ARG . 83.0 m-85 -82.28 126.68 32.4 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 11.8 p -102.54 90.13 3.75 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 123.73 0.644 . . . . 0.0 109.452 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 19.3 pt -109.29 159.47 8.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.154 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.4 m -83.79 127.16 33.61 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.821 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.48 157.94 19.07 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1521 ' ' ILE . . . . . 0.717 ' HB ' HD21 ' A' 1604 ' ' LEU . 14.7 tt -70.84 -23.54 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.627 0.727 . . . . 0.0 109.432 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.446 HH22 HD21 ' A' 1614 ' ' LEU . 54.4 mtt180 -71.65 -0.92 11.97 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.234 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 71.22 83.56 0.14 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.055 1.342 . . . . 0.0 110.6 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 173.85 179.95 44.82 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 14.4 m -110.31 139.67 45.26 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.22 133.7 67.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' 1516 ' ' TYR . 24.5 ttm180 -111.31 112.87 24.95 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.71 120.63 37.15 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.49 125.3 8.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.0 m -96.19 117.73 41.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.52 ' HA ' ' CH2' ' A' 1555 ' ' TRP . 74.6 m 72.57 10.49 5.66 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.172 0.989 . . . . 0.0 112.776 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -145.8 142.65 10.82 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.77 140.53 30.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.7 m -76.67 97.23 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 122.829 1.3 . . . . 0.0 109.543 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.783 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -61.19 -21.2 63.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.867 -174.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.43 -19.01 36.73 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.787 0.327 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1537 ' ' CYS . . . . . 0.65 ' HB2' HG23 ' A' 1534 ' ' VAL . 76.2 m -105.76 4.95 30.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 110.03 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.47 145.96 13.18 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.188 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.46 129.18 23.14 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.9 2.4 . . . . 0.0 111.843 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 103.7 -5.79 47.87 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.552 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.8 mm -93.48 128.24 45.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.623 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -91.63 -40.64 5.28 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.85 134.92 33.96 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1544 ' ' CYS . . . . . 0.525 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.7 p -141.53 150.48 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 81.8 t80 -96.16 130.19 43.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.5 107.54 8.84 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 123.835 0.709 . . . . 0.0 109.765 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.79 -89.19 0.12 Allowed Glycine 0 C--N 1.283 -2.399 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.3 m -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.945 0.403 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 86.35 27.23 30.95 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 26.1 pt -82.96 141.53 14.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 22.9 pttm -94.51 138.58 32.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.96 12.0 37.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.73 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.887 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.49 147.52 4.68 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.443 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -82.69 150.79 26.56 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.699 0.399 . . . . 0.0 110.134 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.52 ' CH2' ' HA ' ' A' 1531 ' ' CYS . 30.0 t-105 -69.05 123.87 22.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.38 174.44 15.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.97 44.09 1.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1558 ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 32.2 mmtp -81.81 77.25 8.66 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.357 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.58 98.42 7.05 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 16.8 m -111.97 139.99 47.02 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 93.2 t80 -97.35 103.26 15.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 17.6 m -130.75 113.09 23.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.879 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.9 t70 59.5 44.08 15.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 110.439 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 62.7 17.22 9.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.348 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.9 t -110.49 126.14 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.944 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.3 tp -90.0 115.77 27.54 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -102.2 120.17 40.01 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.29 -0.256 . . . . 0.0 111.034 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1568 ' ' LEU . . . . . 0.41 ' HB2' ' HE1' ' A' 1590 ' ' PHE . 26.6 tp -106.31 109.08 20.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.438 HG22 HG23 ' A' 1587 ' ' VAL . 21.9 t -109.67 119.3 58.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.099 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.887 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 53.7 m-85 -94.61 115.9 28.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.44 161.2 16.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.053 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 12.0 t70 56.94 71.96 0.54 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.341 1.856 . . . . 0.0 113.499 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -90.84 -136.21 6.63 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -96.26 144.92 28.67 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.779 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 36.9 Cg_endo -67.89 141.84 55.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.225 1.95 . . . . 0.0 112.427 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 74.9 m -98.37 141.41 22.9 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.31 -12.52 35.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.658 2.905 . . . . 0.0 114.846 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -70.33 -61.95 1.58 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.1 m120 -119.97 -4.93 10.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.3 mm? 70.42 -48.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.202 1.001 . . . . 0.0 113.374 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 26.3 m80 -76.17 -4.54 42.25 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.959 0.409 . . . . 0.0 111.97 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.726 HD13 ' HA ' ' A' 1611 ' ' THR . 61.9 mt -101.06 120.13 39.75 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.779 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.6 mttt -118.41 163.23 17.05 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -52.63 110.64 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 36.2 tptt -116.93 130.96 57.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 9.3 t -127.0 118.97 25.55 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.581 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.438 HG23 HG22 ' A' 1569 ' ' VAL . 6.7 p -118.26 111.33 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.836 0.827 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.32 108.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 49.0 m -88.54 109.56 20.17 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.547 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.944 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.9 m-85 -85.92 104.57 15.69 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.3 m -101.52 163.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' 1620 ' ' THR . 46.2 t -97.23 144.65 26.83 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.399 -172.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.516 ' HG2' ' OE1' ' A' 1601 ' ' GLN . 17.6 tppt? -150.47 115.38 5.3 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 5.3 p -61.52 -41.51 97.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.19 25.64 1.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -97.1 -63.3 1.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.052 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 75.84 -156.01 47.16 Favored Glycine 0 C--O 1.25 1.104 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1598 ' ' PRO . . . . . 0.575 ' HA ' HD21 ' A' 1510 ' ' LEU . 41.4 Cg_endo -66.45 -20.95 54.11 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.888 2.392 . . . . 0.0 111.422 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 p -94.44 62.42 2.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 17.3 m -63.67 149.04 47.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.325 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 39.7 mt-30 -87.14 128.55 55.15 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.9 Cg_endo -91.36 134.35 1.63 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.977 2.451 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' 1617 ' ' SER . 64.7 tp -131.66 108.03 9.22 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.033 0.445 . . . . 0.0 110.388 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' 1521 ' ' ILE . 64.3 tp -68.15 116.4 8.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 39.1 tp -98.15 -63.36 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.016 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 34.8 m -150.33 137.49 19.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 81.0 t -131.61 119.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.03 126.75 52.91 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.514 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -80.91 -10.21 59.74 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.95 -52.17 6.92 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.343 0.592 . . . . 0.0 109.513 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' 1582 ' ' LEU . 46.0 p -92.41 -19.64 21.85 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 63.6 m 66.89 23.34 9.97 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.415 1.086 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -81.18 120.99 25.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.159 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.673 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 90.1 mt -102.39 115.94 31.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.299 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.32 114.77 29.22 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.673 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.0 m-85 -122.02 135.91 54.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.441 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 37.4 t -107.86 114.92 29.21 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -109.2 118.29 36.33 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 38.9 m-70 -98.58 101.33 12.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.2 t -129.27 152.95 48.28 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.395 0.617 . . . . 0.0 110.982 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.7 m -75.77 -25.68 56.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.317 0.58 . . . . 0.0 109.706 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' 1622 ' ' LEU . 6.8 tt -64.04 -16.8 62.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.673 0.789 . . . . 0.0 110.284 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.36 59.71 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 35.0 m -94.53 140.99 29.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.012 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1625 ' ' GLU . . . . . 0.506 ' HG2' ' OG1' ' A' 1501 ' ' THR . 3.5 mp0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 75.94 22.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.672 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.7 pt20 -153.27 118.66 5.22 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.644 -1.162 . . . . 0.0 107.999 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -121.83 130.36 74.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.262 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 3.8 m -103.84 106.05 16.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 6.7 p30 -91.67 134.09 29.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.62 -175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1499 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 6.6 Cg_exo -67.02 -25.36 44.33 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.893 2.395 . . . . 0.0 113.057 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -56.06 -61.81 2.13 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.014 0.435 . . . . 0.0 111.894 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 21.6 p -96.43 -15.18 21.91 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 69.33 41.23 79.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -128.85 136.42 50.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 120.827 0.346 . . . . 0.0 110.252 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.8 p -94.89 118.17 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.897 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.9 m-85 -87.18 106.72 18.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -86.39 99.02 11.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.2 tp -84.94 4.49 33.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 122.739 1.257 . . . . 0.0 108.791 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 62.9 m-20 -58.87 -28.6 66.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.478 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.1 t -79.33 -11.56 59.93 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.049 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' 1622 ' ' LEU . 20.0 tp -111.73 1.56 16.74 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.687 -0.633 . . . . 0.0 110.602 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.52 ' HE2' ' SG ' ' A' 1531 ' ' CYS . 100.0 mttt -50.21 160.48 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.563 ' HG3' ' CA ' ' A' 1515 ' ' GLY . 9.2 ttp180 -68.49 105.21 2.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.147 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -91.03 -44.68 9.16 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 167.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.3 t -121.96 -35.22 3.21 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.314 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' 1512 ' ' ARG . . . 103.19 162.68 25.55 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.31 121.03 44.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.0 m -117.57 99.18 6.8 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1518 ' ' ILE . . . . . 0.419 HG21 ' HG2' ' A' 1602 ' ' PRO . 20.1 pt -101.43 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.506 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1519 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1525 ' ' SER . 24.1 t -93.64 114.68 27.05 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.663 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1520 ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 13.7 t70 -89.3 113.96 25.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.83 -18.83 20.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.727 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.471 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.1 mtp180 -76.3 -47.32 24.08 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.73 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.83 -59.3 1.36 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.862 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -175.43 -165.44 31.54 Favored Glycine 0 C--O 1.215 -1.056 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.279 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1525 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1519 ' ' SER . 20.3 m -91.18 154.14 19.53 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 117.385 0.593 . . . . 0.0 111.167 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.0 tt -134.55 132.59 54.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -111.78 116.59 30.95 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.71 137.07 50.1 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.71 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -107.39 100.0 1.48 Allowed Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 7.1 p -76.64 116.69 20.2 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.52 ' SG ' ' HE2' ' A' 1511 ' ' LYS . 46.8 t 70.3 3.69 4.55 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.601 0.715 . . . . 0.0 111.418 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -132.16 149.1 19.34 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1533 ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' 1535 ' ' LYS . 38.5 mt-10 -88.16 131.84 34.56 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 11.3 m -87.95 81.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.311 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.632 ' HD2' ' HB2' ' A' 1533 ' ' GLU . 0.0 OUTLIER -67.6 -13.56 62.18 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.958 0.885 . . . . 0.0 110.7 -175.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.96 -32.96 70.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.45 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 51.8 t -108.01 3.67 24.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.398 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 124.22 150.52 7.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.699 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.66 149.31 38.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.402 2.068 . . . . 0.0 111.171 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.13 14.25 80.61 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.927 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.429 HD12 ' HD3' ' A' 1551 ' ' LYS . 44.7 mm -112.86 135.17 53.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -102.28 -35.03 4.01 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.184 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.58 141.23 39.22 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.993 -0.71 . . . . 0.0 110.676 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1544 ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' 1541 ' ' ILE . 57.2 m -141.75 146.79 36.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.7 ' HB3' HG13 ' A' 1550 ' ' ILE . 35.2 t80 -97.6 134.78 40.35 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.37 100.86 9.47 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.351 0.596 . . . . 0.0 109.841 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -162.98 -108.35 0.22 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.5 m -84.9 -5.94 59.34 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 101.03 46.49 1.73 Allowed Glycine 0 CA--C 1.491 -1.41 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' 1545 ' ' PHE . 14.0 pt -83.7 132.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.048 0.451 . . . . 0.0 109.991 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' 1541 ' ' ILE . 58.6 mttp -87.42 138.06 31.81 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.542 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -104.88 11.68 33.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.434 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.716 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.17 146.86 4.58 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.338 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1572 ' ' ASP . 1.9 mptm? -77.86 147.31 35.2 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 66.0 t90 -69.77 128.84 37.82 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -158.18 158.52 34.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -104.58 88.4 2.93 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.721 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.8 tptt -130.36 83.69 2.14 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.166 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.39 125.29 40.78 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.693 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 7.9 m -121.58 139.82 53.03 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.046 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.3 t80 -106.66 110.06 22.14 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 65.9 t -116.04 92.66 2.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 34.05 88.23 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.359 1.864 . . . . 0.0 115.018 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 67.12 9.34 6.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.506 1.123 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 48.0 t -132.29 136.17 56.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.5 tp -96.58 136.86 36.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' 1560 ' ' SER . 15.3 mm100 -120.33 127.05 51.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.844 -0.535 . . . . 0.0 110.771 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.7 tp -124.71 124.48 42.24 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.634 HG22 HG23 ' A' 1587 ' ' VAL . 19.6 t -120.47 122.82 69.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.26 0.552 . . . . 0.0 112.051 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.716 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 59.8 m-85 -101.51 113.43 26.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.3 161.14 17.59 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.762 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.499 ' O ' ' HD3' ' A' 1554 ' ' LYS . 35.7 t70 60.2 83.19 0.14 Allowed 'General case' 0 C--O 1.209 -1.033 0 O-C-N 124.657 1.223 . . . . 0.0 113.173 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.83 2.31 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.409 ' H ' ' HD2' ' A' 1584 ' ' TYR . 7.5 m-20 -124.23 150.25 63.15 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.21 136.7 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.623 2.216 . . . . 0.0 111.662 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 64.5 m -99.65 132.6 22.8 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.43 16.13 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.67 2.913 . . . . 0.0 113.949 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -79.41 -49.36 12.48 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.582 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 16.7 m120 -146.85 8.65 0.98 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 29.5 tp 68.93 -47.1 0.57 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.51 1.524 . . . . 0.0 113.98 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 36.3 m80 -75.34 -11.07 59.98 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.552 0.692 . . . . 0.0 110.045 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.698 HD22 HG22 ' A' 1611 ' ' THR . 57.8 mt -85.39 128.15 34.62 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.04 162.55 30.5 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.409 ' HD2' ' H ' ' A' 1574 ' ' ASP . 92.5 m-85 -65.74 112.2 3.59 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -126.14 134.8 51.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.1 t -126.92 125.46 41.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.634 HG23 HG22 ' A' 1569 ' ' VAL . 6.5 p -119.85 117.86 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.693 0.758 . . . . 0.0 109.307 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.77 116.37 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 8.4 t -96.17 104.96 16.95 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.925 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.3 m-85 -87.05 111.5 20.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 34.5 m -105.08 159.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 42.6 t -77.54 128.82 34.81 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 112.501 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 58.4 tptt -145.69 109.18 4.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.8 m -71.57 -28.14 63.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.143 0.496 . . . . 0.0 112.199 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.16 30.22 6.1 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.567 0.698 . . . . 0.0 111.15 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -84.74 -52.38 6.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.787 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 78.13 -159.49 47.22 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.71 -20.77 26.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.848 2.365 . . . . 0.0 111.708 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.2 t -96.81 58.55 1.65 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 123.031 1.396 . . . . 0.0 108.847 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 12.7 m -63.42 130.42 44.35 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.726 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.466 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 78.1 mt-30 -81.6 125.89 77.28 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -89.61 105.87 0.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.456 2.77 . . . . 0.0 110.873 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 62.9 tp -91.98 130.25 37.77 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.93 127.01 31.7 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1605 ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' 1617 ' ' SER . 99.3 mt -88.36 -58.32 2.6 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 44.6 m -164.62 147.26 8.66 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 108.989 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 64.6 t -107.91 111.71 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -98.59 91.66 5.25 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -70.04 -33.06 71.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.382 -1.735 . . . . 0.0 115.226 -165.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 51.4 t60 -70.68 -36.9 73.55 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.539 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.698 HG22 HD22 ' A' 1582 ' ' LEU . 0.0 OUTLIER -98.21 0.55 46.04 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.769 -176.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.9 m 55.27 31.1 15.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.565 0.746 . . . . 0.0 111.735 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 29.5 m -99.45 126.86 45.44 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.336 0.589 . . . . 0.0 110.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.581 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 87.0 mt -108.65 118.98 38.2 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.345 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.87 117.97 35.41 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.581 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 79.1 m-85 -128.14 135.95 50.47 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.616 0.366 . . . . 0.0 110.663 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.606 ' HB2' HD21 ' A' 1605 ' ' LEU . 22.7 t -106.68 110.94 23.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -98.25 111.89 24.07 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 17.0 m170 -81.4 98.36 8.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 12.1 t -129.4 153.09 48.24 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.611 0.72 . . . . 0.0 112.012 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 23.5 m -77.88 -21.45 51.26 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.71 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.8 -5.63 35.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.901 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.91 1.68 40.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.479 0.657 . . . . 0.0 109.48 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -103.18 162.31 13.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.837 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 173.471 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1493 ' ' ASN . . . . . 0.726 ' N ' HE21 ' A' 1557 ' ' GLN . 16.8 m120 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1508 ' ' ASN . 6.5 t 61.69 23.03 13.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.687 1.195 . . . . 0.0 110.967 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' 1505 ' ' PHE . 21.5 pt20 -149.37 155.01 39.8 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -155.39 136.1 4.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 10.7 m -99.55 131.86 45.27 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -83.22 118.83 72.8 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.121 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.82 -16.46 44.45 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.991 2.46 . . . . 0.0 114.516 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -76.7 -62.89 1.48 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.542 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.5 p -97.16 -16.86 20.24 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 84.03 24.32 48.99 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.793 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -92.26 132.11 36.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.203 0.501 . . . . 0.0 109.88 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 25.6 t -101.13 106.8 20.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' 1495 ' ' GLN . 76.4 m-85 -81.38 104.15 11.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.76 93.08 7.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.646 0.736 . . . . 0.0 110.203 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 36.1 tp -84.69 -8.38 58.88 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' 1494 ' ' CYS . 59.6 t30 -65.99 -27.96 68.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.502 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 8.5 t -84.76 -11.86 54.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 -36.66 9.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' 1530 ' ' VAL . 2.2 pptp? -44.3 127.84 5.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -98.08 107.98 20.58 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.423 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -69.36 -34.63 74.87 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.74 0.65 . . . . 0.0 111.649 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 64.2 m -65.14 -17.4 64.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.247 0.546 . . . . 0.0 110.646 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 83.18 143.83 5.3 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.279 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -77.09 114.28 15.73 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1517 ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' 1526 ' ' ILE . 7.8 m -107.93 96.88 6.69 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1518 ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' 1525 ' ' SER . 27.6 pt -102.79 134.23 44.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.73 -175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.2 m -89.15 92.61 9.26 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.73 123.2 40.35 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.579 0.704 . . . . 0.0 111.509 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.25 -16.07 20.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.595 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.515 ' HD2' HD23 ' A' 1604 ' ' LEU . 69.1 mtt180 -94.17 -26.38 16.71 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.227 -0.921 . . . . 0.0 112.283 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 52.4 tptt -129.36 -59.27 1.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.854 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 166.21 -166.74 38.96 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.526 -0.845 . . . . 0.0 110.999 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1525 ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' 1518 ' ' ILE . 20.2 m -94.4 112.27 24.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.323 0.582 . . . . 0.0 109.458 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' 1545 ' ' PHE . 10.8 tt -120.94 140.48 44.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.436 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -110.84 115.28 29.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.64 119.84 36.2 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -91.72 127.96 9.14 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' 1511 ' ' LYS . 21.7 t -81.04 116.39 25.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.418 ' SG ' HG12 ' A' 1530 ' ' VAL . 60.7 m 70.67 -24.46 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 172.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -105.07 140.83 15.17 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.69 142.61 44.43 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 120.7 0.286 . . . . 0.0 110.353 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 17.5 m -78.16 81.79 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.428 1.109 . . . . 0.0 109.075 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.628 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.38 -12.01 3.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.716 1.607 . . . . 0.0 112.941 -173.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 -29.17 35.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.664 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.0 t -93.66 -3.95 51.51 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 122.129 0.966 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 132.5 158.36 8.88 Favored Glycine 0 N--CA 1.422 -2.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.2 135.68 32.43 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 123.18 2.587 . . . . 0.0 111.351 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 76.48 9.74 85.91 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.871 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.604 HD12 ' HG2' ' A' 1551 ' ' LYS . 46.5 mm -93.04 133.32 34.61 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -103.58 -48.5 1.19 Allowed Glycine 0 C--N 1.323 -0.155 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.525 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.05 129.39 54.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 53.5 t -148.06 138.65 22.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.627 0.251 . . . . 0.0 110.467 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' 1526 ' ' ILE . 96.6 m-85 -78.57 127.45 32.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.48 103.43 6.48 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 123.728 0.643 . . . . 0.0 109.862 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.68 -76.26 0.22 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1548 ' ' THR . . . . . 0.524 ' HB ' HG13 ' A' 1550 ' ' ILE . 16.7 m -81.25 -23.59 37.92 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.072 0.463 . . . . 0.0 110.637 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.57 37.38 10.7 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.385 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.524 HG13 ' HB ' ' A' 1548 ' ' THR . 62.9 mt -84.77 129.33 37.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.604 ' HG2' HD12 ' A' 1541 ' ' ILE . 11.2 mptt -92.32 133.41 35.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1552 ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' 1584 ' ' TYR . . . -111.42 16.16 20.94 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.349 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.823 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.73 138.19 2.81 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.835 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.63 142.81 27.98 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 124.954 1.302 . . . . 0.0 109.188 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 68.5 t90 -64.16 140.2 58.84 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.887 0.875 . . . . 0.0 110.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -162.26 -179.96 7.43 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1557 ' ' GLN . . . . . 0.726 HE21 ' N ' ' A' 1493 ' ' ASN . 13.9 mm100 -130.95 31.64 4.44 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 118.195 0.452 . . . . 0.0 112.074 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1558 ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' 1560 ' ' SER . 48.8 tptt -84.15 81.79 8.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.834 0.826 . . . . 0.0 109.921 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' 1568 ' ' LEU . 0.5 OUTLIER -93.2 98.18 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.3 t -89.62 158.7 17.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.15 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -130.29 104.77 7.47 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 96.3 t -115.07 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 36.5 t70 49.95 74.55 0.2 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.843 1.257 . . . . 0.0 112.365 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 67.91 -9.73 0.45 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.829 1.252 . . . . 0.0 113.654 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 85.6 t -107.17 132.19 55.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.794 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 9.4 mp -81.86 141.3 33.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' 1560 ' ' SER . 26.8 mm-40 -131.56 114.86 15.37 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1568 ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' 1559 ' ' LEU . 64.0 tp -123.04 136.08 54.69 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 8.9 p -135.45 135.42 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-O 121.373 0.606 . . . . 0.0 110.413 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.823 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 70.8 m-85 -105.53 104.6 14.36 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -102.71 163.44 12.22 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 30.4 t70 64.95 79.29 0.26 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 124.282 1.033 . . . . 0.0 112.027 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.83 -106.35 2.95 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.86 160.05 35.05 Favored Pre-proline 0 C--N 1.281 -2.399 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.42 151.52 48.05 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.054 1.836 . . . . 0.0 110.969 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1576 ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 78.2 m -103.13 126.96 30.86 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1577 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.3 Cg_exo -58.18 -23.82 63.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.86 3.04 . . . . 0.0 113.681 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -63.6 -65.35 0.69 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.604 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 22.7 t-20 -111.72 -14.72 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.377 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.43 -45.08 0.61 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.116 0.966 . . . . 0.0 113.132 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 56.3 m80 -68.05 -19.32 64.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.721 0.772 . . . . 0.0 110.036 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.958 HD13 ' HA ' ' A' 1611 ' ' THR . 41.6 mt -95.08 140.96 29.29 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.642 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 62.0 mttm -132.42 161.41 33.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.529 ' HB3' ' HA ' ' A' 1552 ' ' ALA . 97.3 m-85 -65.34 116.53 6.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' 1613 ' ' THR . 21.5 mtpp -129.74 130.38 45.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' 1570 ' ' TYR . 12.3 p -120.82 120.43 35.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 120.724 0.297 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -116.1 119.54 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.97 108.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 11.8 p -86.01 114.85 23.22 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.617 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.83 ' HD1' ' HE3' ' A' 1618 ' ' TRP . 53.9 m-85 -93.98 109.17 20.92 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.3 m -108.91 168.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' 1624 ' ' CYS . 38.0 t -75.96 117.51 17.76 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.771 0.828 . . . . 0.0 111.084 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.758 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 56.7 tptt -146.13 88.06 1.78 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1594 ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' 1621 ' ' SER . 17.9 m -73.84 -13.35 60.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.621 0.724 . . . . 0.0 110.263 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1595 ' ' ASP . . . . . 0.758 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 29.9 t70 -80.96 -7.36 59.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -93.03 -64.39 1.1 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 72.63 -123.99 9.29 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.37 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.04 -16.57 49.7 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.741 2.961 . . . . 0.0 113.741 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.9 p -83.01 -66.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.463 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' 1620 ' ' THR . 51.3 m 61.05 97.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.322 1.014 . . . . 0.0 110.463 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 14.5 mm100 -101.61 131.61 22.74 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.072 -171.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.9 Cg_endo -86.03 112.76 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.431 2.754 . . . . 0.0 111.345 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.01 125.5 47.63 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.515 HD23 ' HD2' ' A' 1522 ' ' ARG . 47.6 tp -78.79 116.22 18.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.116 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.74 -51.37 8.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.074 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.5 t -164.08 135.68 4.65 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.488 HG23 HD21 ' A' 1604 ' ' LEU . 93.4 t -102.51 111.26 31.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.9 t70 -104.24 99.52 9.24 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.798 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.59 8.62 9.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -82.24 -51.58 7.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.958 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -103.23 -4.04 24.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.816 -173.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.7 m 62.53 31.19 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 110.376 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1613 ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' 1585 ' ' LYS . 23.6 m -103.72 125.56 50.28 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.921 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.602 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 85.7 mt -98.72 119.93 38.29 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.064 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.53 109.93 22.01 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.2 m-85 -121.29 134.72 55.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.1 t -108.73 107.28 17.66 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.83 ' HE3' ' HD1' ' A' 1590 ' ' PHE . 18.4 t90 -93.99 106.69 18.65 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.462 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 72.4 m-70 -83.32 103.6 12.84 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.733 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' 1600 ' ' SER . 9.8 t -139.21 153.83 47.93 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.359 0.599 . . . . 0.0 109.996 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1621 ' ' SER . . . . . 0.596 ' HB3' ' HA ' ' A' 1594 ' ' SER . 0.8 OUTLIER -76.86 -24.88 52.63 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.357 177.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.94 -8.64 54.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 122.203 1.002 . . . . 0.0 109.145 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -109.8 12.42 24.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.73 0.776 . . . . 0.0 110.173 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1624 ' ' CYS . . . . . 0.445 ' HB2' ' HA ' ' A' 1592 ' ' CYS . 33.8 t -110.7 164.9 12.29 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.734 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1493 ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' 1495 ' ' GLN . 31.5 m-80 . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' 1507 ' ' LEU . 72.4 m 71.16 22.95 4.25 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.111 0.964 . . . . 0.0 110.026 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' 1493 ' ' ASN . 10.4 pt20 -128.17 128.18 44.33 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 9.5 p -131.08 132.45 63.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.776 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 19.9 m -93.64 129.52 39.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 11.5 p30 -89.1 136.16 30.72 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.852 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1499 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 1.8 Cg_endo -82.14 -12.5 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.998 1.798 . . . . 0.0 110.8 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.49 76.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.679 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.7 p -126.23 -30.18 2.93 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 111.12 11.7 17.66 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.254 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 66.1 t80 -84.84 136.63 33.58 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.358 -0.495 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1497 ' ' THR . 64.7 t -99.91 119.3 47.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' 1495 ' ' GLN . 88.2 m-85 -87.61 104.45 16.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.76 101.02 12.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.791 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1507 ' ' LEU . . . . . 0.857 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 18.3 tp -83.31 -10.04 58.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.791 1.281 . . . . 0.0 107.975 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' 1511 ' ' LYS . 6.9 p30 -67.05 -14.87 63.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.213 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.7 m -89.42 -6.44 56.55 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.591 ' HB2' HD12 ' A' 1622 ' ' LEU . 34.2 tp -114.65 9.35 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' 1508 ' ' ASN . 48.7 mttp -43.34 148.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.492 ' HB2' ' HA2' ' A' 1515 ' ' GLY . 0.1 OUTLIER -68.22 147.85 51.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.66 -173.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.21 -66.14 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 42.9 t -116.89 -19.98 9.62 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 167.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' 1512 ' ' ARG . . . 137.16 143.42 4.58 Favored Glycine 0 N--CA 1.414 -2.829 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' 1527 ' ' ARG . 41.7 m-85 -69.02 113.72 6.65 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.2 m -113.01 90.94 3.48 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.76 152.88 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.475 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 41.4 m -92.62 137.13 32.63 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.88 175.48 7.27 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1521 ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' 1522 ' ' ARG . 15.2 tt -58.0 -25.49 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 CA-C-O 121.189 0.519 . . . . 0.0 111.95 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.437 ' HG3' HG23 ' A' 1521 ' ' ILE . 68.0 mtp180 -92.45 3.15 56.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.113 0.482 . . . . 0.0 111.135 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1523 ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.6 mmtt 77.83 25.49 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.687 1.595 . . . . 0.0 114.492 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -91.7 125.47 8.06 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 69.7 m -79.02 122.25 25.96 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 120.949 0.404 . . . . 0.0 110.282 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.57 136.03 52.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.593 ' HB3' ' SG ' ' A' 1544 ' ' CYS . 50.2 ttm-85 -114.92 123.42 49.09 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.02 134.68 53.39 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.253 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.79 119.08 5.14 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' 1511 ' ' LYS . 27.5 m -96.12 143.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-N 117.036 0.418 . . . . 0.0 109.969 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.65 ' HA ' HE22 ' A' 1557 ' ' GLN . 72.5 m 74.61 -37.75 0.36 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.873 1.269 . . . . 0.0 113.203 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -131.8 150.44 19.55 Favored Glycine 0 N--CA 1.416 -2.642 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.79 155.04 37.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 124.24 0.612 . . . . 0.0 111.531 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -96.92 89.64 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 122.265 1.031 . . . . 0.0 110.219 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -64.85 -20.86 66.63 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.491 -175.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.38 -45.64 80.46 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.021 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 54.0 m -92.78 -15.08 27.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.161 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 148.88 136.88 2.73 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.34 137.4 74.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.853 2.369 . . . . 0.0 112.572 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 85.44 -5.92 81.74 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.705 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.0 mm -91.68 141.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.04 -29.59 3.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.179 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -135.86 120.05 17.77 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1544 ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' 1527 ' ' ARG . 8.1 p -127.95 144.61 51.1 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 111.17 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 78.7 t80 -105.35 125.53 51.08 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.26 57.26 3.53 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.054 0.931 . . . . 0.0 111.246 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1547 ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' 1549 ' ' GLY . . . -164.28 114.13 0.58 Allowed Glycine 0 C--N 1.289 -2.043 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1548 ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' 1550 ' ' ILE . 28.2 m 72.46 -22.23 0.22 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.122 0.969 . . . . 0.0 110.938 -174.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1549 ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' 1547 ' ' GLY . . . 85.49 35.29 12.1 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 72.8 mt -64.33 138.22 23.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 123.934 0.432 . . . . 0.0 109.926 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' 1551 ' ' LYS . 10.1 mptt -101.55 120.56 40.5 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -102.44 14.82 30.94 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.165 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 147.6 144.13 3.95 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.348 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 54.0 pttt -96.0 155.14 16.88 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.687 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 42.1 t90 -63.82 134.95 56.17 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.824 0.703 . . . . 0.0 110.164 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -169.86 164.06 9.71 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1557 ' ' GLN . . . . . 0.65 HE22 ' HA ' ' A' 1531 ' ' CYS . 19.2 mm-40 -122.32 83.25 2.08 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 120.933 0.397 . . . . 0.0 110.475 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1558 ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' 1560 ' ' SER . 1.7 tmtp? -107.06 98.94 8.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 111.6 23.41 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.494 ' HB2' ' HE2' ' A' 1558 ' ' LYS . 9.7 t -120.14 119.59 33.73 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.53 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 58.3 t80 -86.31 113.53 22.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.66 84.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 15.4 t70 45.52 81.77 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.016 1.726 . . . . 0.0 113.334 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 68.26 -0.23 2.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.341 1.056 . . . . 0.0 113.434 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.3 t -116.89 128.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.725 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 13.4 tp -96.52 122.66 39.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -103.95 119.82 39.74 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.079 -0.388 . . . . 0.0 110.666 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 66.9 tp -116.16 130.18 56.67 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 82.4 t -118.83 129.9 74.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.687 ' HE1' ' HA ' ' A' 1555 ' ' TRP . 38.7 m-85 -121.54 97.26 5.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.04 -178.68 3.56 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.444 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 23.4 t70 61.71 63.7 1.12 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.829 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.82 -121.62 4.67 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.367 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.8 145.21 34.39 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 16.0 Cg_exo -72.23 142.98 38.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.605 2.203 . . . . 0.0 109.676 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 69.1 m -98.13 134.05 22.46 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.56 8.34 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.136 2.557 . . . . 0.0 113.625 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -80.36 -51.71 8.54 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.1 m120 -134.2 0.93 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1580 ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' 1580 ' ' LEU . 4.0 mm? 68.99 -54.47 0.56 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 44.0 m80 -75.1 -16.33 60.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.882 0.373 . . . . 0.0 110.959 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.832 HD13 ' HA ' ' A' 1611 ' ' THR . 62.0 mt -82.52 123.62 29.35 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 94.5 mttt -122.78 162.62 21.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -64.1 115.08 4.61 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' 1613 ' ' THR . 8.7 mtpm? -128.54 131.87 48.25 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.543 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 20.4 t -120.12 131.27 54.98 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -121.88 120.82 62.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.53 105.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 23.6 m -90.35 110.55 21.63 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.725 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.6 m-85 -86.21 112.47 21.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.7 m -101.13 161.56 3.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' 1624 ' ' CYS . 45.0 t -81.24 137.08 35.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.713 0.768 . . . . 0.0 112.117 -173.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 25.1 tptp -154.65 98.76 2.1 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 46.8 t -61.41 -28.8 69.52 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.12 0.486 . . . . 0.0 110.358 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.93 81.82 1.55 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.573 1.177 . . . . 0.0 109.054 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -125.96 -29.64 3.06 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.593 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.01 168.46 40.59 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.43 -10.96 30.56 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 123.21 2.607 . . . . 0.0 111.86 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.1 p -90.7 -40.76 11.67 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.847 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.404 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 38.2 m 68.27 169.54 0.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.735 1.214 . . . . 0.0 110.955 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 13.2 mm-40 -114.5 120.85 37.13 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.347 -174.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.2 Cg_endo -91.19 101.95 0.24 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 123.117 2.545 . . . . 0.0 111.288 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' 1617 ' ' SER . 63.3 tp -89.75 119.66 30.34 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.17 109.86 16.11 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.18 -63.5 1.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.171 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.9 m -144.51 143.33 30.79 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.903 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 60.7 t -118.93 110.88 31.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.29 108.71 20.3 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.139 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -80.4 -0.1 35.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -100.8 -48.24 4.54 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.423 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.832 ' HA ' HD13 ' A' 1582 ' ' LEU . 58.0 p -95.42 -7.0 39.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.43 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.4 m 64.63 25.88 13.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.765 0.826 . . . . 0.0 111.476 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1613 ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' 1585 ' ' LYS . 57.8 m -93.59 127.03 39.07 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 121.352 0.596 . . . . 0.0 109.918 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 69.8 mt -102.51 127.77 49.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.786 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -110.63 114.75 28.38 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.37 135.35 54.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.299 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 15.2 m -108.71 103.52 12.62 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 1.7 t-105 -94.03 107.84 19.72 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.472 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 76.4 m-70 -78.79 99.92 6.91 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 13.2 t -134.08 153.05 52.06 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 110.264 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.7 m -73.17 -29.07 62.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.448 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' 1510 ' ' LEU . 62.5 mt -74.42 -4.58 37.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1623 ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' 1590 ' ' PHE . . . -82.81 -25.7 32.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.336 0.589 . . . . 0.0 111.722 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1624 ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' 1592 ' ' CYS . 14.4 p -117.52 177.98 4.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.432 -1.347 0 CA-C-O 122.23 1.014 . . . . 0.0 110.157 177.706 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 64.4 m-80 . . . . . 0 CA--C 1.481 -1.676 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 6.6 t 62.11 30.92 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.274 1.035 . . . . 0.0 110.965 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' 1505 ' ' PHE . 24.8 pt20 -152.61 145.7 24.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.061 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.3 p -145.5 134.99 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.693 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 22.7 m -92.03 125.66 36.8 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' 1503 ' ' TYR . 9.5 p30 -86.39 147.25 43.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.091 -0.643 . . . . 0.0 109.859 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.45 2.71 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.574 2.183 . . . . 0.0 113.894 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -92.88 -57.77 2.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.203 0.525 . . . . 0.0 111.297 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 35.0 p -105.99 -17.7 14.26 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.945 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 80.66 19.23 68.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.842 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1503 ' ' TYR . . . . . 0.524 ' HB3' ' ND2' ' A' 1498 ' ' ASN . 53.3 t80 -79.45 133.62 36.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 48.6 t -99.83 110.11 26.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' 1495 ' ' GLN . 96.2 m-85 -80.86 106.77 13.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -97.97 102.77 14.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.299 0.571 . . . . 0.0 112.048 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.04 -4.88 56.0 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.341 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.689 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 52.3 m-80 -62.6 -29.9 70.94 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 25.3 t -71.93 -14.97 62.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.793 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.12 3.05 15.89 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 122.397 -0.189 . . . . 0.0 111.129 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 55.6 mtmt -58.8 118.79 6.12 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.851 0.834 . . . . 0.0 112.985 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -106.6 97.33 7.14 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.001 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -34.59 64.7 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 125.44 1.496 . . . . 0.0 113.53 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.5 m -81.26 -19.82 42.27 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 85.32 155.99 25.64 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.904 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' 1527 ' ' ARG . 71.5 m-85 -92.43 133.09 36.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 9.4 p -112.07 91.5 3.68 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 16.9 pt -96.39 152.07 3.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.301 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 19.6 t -97.82 118.89 35.4 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.704 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1520 ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 1.9 t70 -74.46 151.65 39.55 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.569 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.7 tt -79.55 -16.25 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.645 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.549 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 10.4 mtp-105 -87.62 1.96 52.24 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1523 ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.9 mmtt 72.45 77.75 0.15 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.002 1.721 . . . . 0.0 113.603 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -165.09 163.26 36.36 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 107.431 -2.267 . . . . 0.0 107.431 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.3 m -109.71 140.54 43.45 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 118.184 0.992 . . . . 0.0 109.488 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.8 tt -124.65 130.39 73.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' 1516 ' ' TYR . 17.7 ttm180 -112.68 119.14 37.06 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.383 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.39 127.01 47.85 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.947 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.37 129.47 9.89 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' 1511 ' ' LYS . 18.4 m -85.86 115.49 27.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.112 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.473 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 21.7 m 62.92 12.61 5.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.469 1.107 . . . . 0.0 111.714 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -135.56 147.56 19.24 Favored Glycine 0 N--CA 1.415 -2.76 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1533 ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' 1533 ' ' GLU . 0.1 OUTLIER -77.9 141.18 39.22 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 123.802 0.354 . . . . 0.0 110.219 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.3 m -85.23 87.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 122.01 0.909 . . . . 0.0 109.28 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.638 ' HD2' ' H ' ' A' 1535 ' ' LYS . 2.1 mptp? -59.39 -28.96 67.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.683 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.19 -36.75 71.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.579 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.5 m -96.86 -29.14 13.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.053 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 152.32 159.25 8.88 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.932 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.5 143.88 31.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.288 1.992 . . . . 0.0 111.323 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.46 6.21 89.38 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.537 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.0 131.62 59.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -95.57 -32.88 6.7 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.302 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.21 138.96 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.6 p -145.37 158.3 43.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' 1526 ' ' ILE . 38.8 t80 -113.91 106.17 14.13 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.31 106.76 7.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 122.011 0.91 . . . . 0.0 109.976 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.8 -67.39 0.3 Allowed Glycine 0 C--N 1.276 -2.754 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 -21.77 29.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 81.91 21.31 61.57 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 43.1 pt -91.7 151.1 3.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.215 0.531 . . . . 0.0 111.124 -176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.735 ' HD2' ' HB2' ' A' 1574 ' ' ASP . 74.7 mttt -87.43 156.43 19.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -124.41 7.51 8.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.415 0.626 . . . . 0.0 110.593 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 146.75 144.46 4.04 Favored Glycine 0 C--O 1.256 1.473 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.948 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' 1572 ' ' ASP . 14.1 ptmt -85.28 160.73 19.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.688 0.744 . . . . 0.0 110.377 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 70.3 t90 -62.86 132.63 52.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.368 0.667 . . . . 0.0 110.795 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' 1570 ' ' TYR . 9.1 p30 -167.35 173.08 9.15 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -128.92 41.06 3.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 118.127 0.422 . . . . 0.0 110.04 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -72.11 103.31 3.25 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.077 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 98.8 mt -116.91 96.86 5.66 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 20.0 m -87.51 115.22 24.79 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 72.4 t80 -94.97 102.37 14.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -118.99 92.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-O 121.165 0.507 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.9 t70 54.04 69.97 0.66 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.371 1.068 . . . . 0.0 112.012 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 67.98 2.83 3.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.543 -1.208 . . . . 0.0 114.028 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.37 126.76 66.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.9 mp -94.05 118.03 30.95 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.402 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.837 ' HB2' ' HB2' ' A' 1560 ' ' SER . 17.4 mm-40 -102.64 114.01 27.87 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.57 107.7 18.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.606 HG22 HG23 ' A' 1587 ' ' VAL . 17.5 t -111.85 117.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.867 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 50.6 m-85 -93.64 101.73 13.89 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.9 177.72 4.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.865 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.774 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 34.2 t0 47.16 63.23 2.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 112.289 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1573 ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' 1584 ' ' TYR . . . -73.73 -77.08 0.64 Allowed Glycine 0 N--CA 1.42 -2.396 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.816 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.735 ' HB2' ' HD2' ' A' 1551 ' ' LYS . 13.7 t70 -165.55 156.08 11.89 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.63 145.85 46.43 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.34 2.026 . . . . 0.0 112.38 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1576 ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 52.0 t -97.43 139.07 21.2 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1577 ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 22.3 Cg_exo -62.75 -28.07 76.0 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.203 2.602 . . . . 0.0 114.376 -177.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.48 -44.9 49.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.881 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.84 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 40.5 t-20 -144.8 110.98 5.52 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.54 -15.07 9.7 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 46.1 m80 -94.0 -1.93 53.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 122.085 -0.384 . . . . 0.0 111.843 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.84 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 42.5 mt -90.66 154.8 19.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 66.4 mttm -127.35 151.35 48.89 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.282 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' 1573 ' ' GLY . 83.5 m-85 -61.43 120.09 9.81 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' 1583 ' ' LYS . 92.8 mttt -137.92 140.59 40.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' 1614 ' ' LEU . 15.1 p -130.92 123.68 29.44 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 120.799 0.333 . . . . 0.0 110.417 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.606 HG23 HG22 ' A' 1569 ' ' VAL . 7.5 p -108.97 113.85 45.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.688 0.756 . . . . 0.0 110.178 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.89 109.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 25.9 m -92.37 111.96 23.73 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.0 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.5 m-85 -86.22 108.22 18.27 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 30.7 m -111.73 167.0 5.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.577 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 46.2 t -76.56 150.89 36.47 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.287 0.565 . . . . 0.0 112.258 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.774 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 22.6 tptp -170.86 115.06 0.44 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 174.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 8.3 t -75.44 -28.93 59.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.296 0.498 . . . . 0.0 111.921 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.03 12.34 24.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.287 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -66.73 -51.84 51.33 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -172.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.63 179.04 40.81 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.71 -28.99 19.97 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.773 2.315 . . . . 0.0 113.033 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 -26.4 20.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 109.855 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' 1619 ' ' HIS . 21.3 m 63.38 -175.94 0.15 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.586 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.813 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 6.9 pt20 -116.24 121.44 33.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.821 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 9.6 Cg_endo -92.34 117.45 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.47 2.78 . . . . 0.0 112.111 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.2 tp -97.15 124.86 41.31 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.585 HD11 HG23 ' A' 1607 ' ' VAL . 60.4 tp -80.35 112.78 18.01 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.73 -50.49 8.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.144 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.9 t -175.22 140.28 0.5 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.445 0.466 . . . . 0.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.585 HG23 HD11 ' A' 1604 ' ' LEU . 83.9 t -107.9 110.17 30.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.57 102.41 12.29 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.24 -1.44 44.92 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.958 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -91.92 -39.74 11.54 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.617 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.629 ' HA ' HD13 ' A' 1582 ' ' LEU . 25.3 p -99.96 -2.15 35.34 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 90.8 m 58.57 33.93 23.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.901 0.858 . . . . 0.0 111.033 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 24.5 m -112.75 128.75 56.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.555 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.6 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 67.2 mt -105.13 134.64 47.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.033 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.68 115.94 26.07 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.6 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.5 m-85 -130.14 137.27 50.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.76 0.314 . . . . 0.0 110.892 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 21.0 t -108.45 108.27 19.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' 1600 ' ' SER . 11.7 t-105 -97.59 106.9 19.29 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.813 ' HB2' ' HG3' ' A' 1601 ' ' GLN . 66.0 m-70 -86.77 109.58 19.35 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 7.7 t -130.59 149.9 52.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.298 0.57 . . . . 0.0 110.916 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.1 p -78.87 -26.41 43.96 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' 1622 ' ' LEU . 3.1 tm? -72.81 -6.93 48.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.113 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.15 2.41 40.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 0.0 109.819 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 63.4 m -87.59 133.05 33.86 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.08 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.338 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1493 ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' 1495 ' ' GLN . 39.6 t-20 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 38.5 t 76.48 -21.23 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.385 1.474 . . . . 0.0 110.834 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.3 pt20 -118.04 154.28 32.29 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -142.36 136.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 40.2 m -88.5 126.69 35.37 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.815 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.449 HD22 ' HE2' ' A' 1505 ' ' PHE . 27.9 t-20 -91.57 106.65 17.55 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.29 -19.62 55.97 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.263 2.642 . . . . 0.0 114.61 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -72.65 -53.75 10.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.061 0.458 . . . . 0.0 110.852 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 17.5 p -96.53 -12.34 24.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 79.31 3.93 88.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.67 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 68.8 t80 -85.02 135.24 34.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.401 0.619 . . . . 0.0 110.485 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 38.9 t -97.68 115.85 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.449 ' HE2' HD22 ' A' 1498 ' ' ASN . 97.3 m-85 -89.35 107.63 19.17 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -107.14 120.16 41.35 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.57 0.7 . . . . 0.0 110.7 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1507 ' ' LEU . . . . . 0.513 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 38.3 tp -79.42 -6.38 56.73 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -53.81 -31.07 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.47 1.508 . . . . 0.0 112.641 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 33.3 t -77.74 -20.9 52.68 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.028 0.442 . . . . 0.0 110.663 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 23.0 tp -116.63 -5.59 11.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.97 0.414 . . . . 0.0 111.568 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.6 154.07 42.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.493 0.663 . . . . 0.0 111.901 -175.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -121.63 122.01 38.67 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.187 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -68.79 -26.35 65.16 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.539 0.736 . . . . 0.0 110.476 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 14.0 t -89.2 -7.23 56.0 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 75.73 -164.43 53.94 Favored Glycine 0 N--CA 1.427 -1.921 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.473 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.76 145.81 43.24 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1517 ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' 1526 ' ' ILE . 32.6 m -142.61 100.63 3.72 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 28.2 pt -121.51 132.4 70.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.87 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1519 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.0 t -80.0 112.65 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.72 136.95 32.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.089 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.65 -32.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.606 1.163 . . . . 0.0 112.839 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -74.73 -34.13 62.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 28.8 tptp -141.21 -58.69 0.49 Allowed 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.054 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 175.21 -163.41 33.45 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.379 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1525 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1519 ' ' SER . 45.4 t -81.01 144.01 32.1 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.409 0.623 . . . . 0.0 111.289 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' THR . 14.2 tt -127.44 134.26 66.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' 1534 ' ' VAL . 41.3 ttm180 -124.23 103.78 8.44 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.432 0.634 . . . . 0.0 109.593 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.83 144.84 51.74 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.016 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -111.66 139.53 15.64 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.519 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 16.2 m -98.01 117.8 43.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 16.4 m 69.73 19.08 7.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.975 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -153.42 168.71 32.13 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.26 149.56 26.76 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' 1527 ' ' ARG . 20.7 m -94.87 90.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.318 1.056 . . . . 0.0 108.306 173.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.622 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -63.94 -13.72 48.06 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.402 -172.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.56 -12.96 60.33 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 123.149 0.58 . . . . 0.0 110.569 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1537 ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' 1551 ' ' LYS . 24.9 t -117.12 11.81 14.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.43 163.5 14.58 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.238 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 136.29 12.65 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.472 2.114 . . . . 0.0 111.48 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.83 21.6 79.09 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.588 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 118.19 50.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -94.04 -24.82 18.72 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.678 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.13 132.34 31.83 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 14.1 t -139.94 147.81 41.06 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.521 ' HB3' HG13 ' A' 1550 ' ' ILE . 63.8 t80 -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.13 81.57 8.4 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.306 1.051 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -158.27 85.02 0.13 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 7.6 m 69.63 16.76 7.97 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.214 1.007 . . . . 0.0 109.351 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 62.69 67.31 2.14 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.182 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' 1545 ' ' PHE . 23.7 pt -108.6 138.46 35.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 117.061 0.431 . . . . 0.0 110.015 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.434 ' HG2' ' SG ' ' A' 1537 ' ' CYS . 54.6 mttm -88.69 138.86 31.04 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -114.94 18.28 16.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.065 0.46 . . . . 0.0 111.231 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 148.2 136.71 2.77 Favored Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.948 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 61.0 tttm -85.07 143.54 28.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.439 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 37.3 t90 -69.29 134.27 48.92 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.632 0.73 . . . . 0.0 111.099 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 p30 -158.88 164.42 35.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -124.27 78.45 1.65 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 118.808 0.731 . . . . 0.0 112.4 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1558 ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 59.5 mmtt -108.23 92.19 3.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.551 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.14 96.36 7.44 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.8 m -96.93 138.14 34.94 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.542 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1561 ' ' TYR . . . . . 0.593 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 7.4 t80 -110.8 101.02 9.67 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 52.9 t -103.64 88.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.175 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.18 72.72 0.28 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.606 1.163 . . . . 0.0 111.49 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1564 ' ' GLN . . . . . 0.593 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 26.6 mp0 57.67 24.56 10.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.269 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 51.6 t -126.81 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 11.0 tp -82.31 135.96 35.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' 1560 ' ' SER . 15.2 mm100 -124.45 135.54 53.33 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.804 0.442 . . . . 0.0 110.115 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.95 120.79 18.56 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.59 HG22 HG23 ' A' 1587 ' ' VAL . 39.2 t -119.14 129.48 75.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.322 0.582 . . . . 0.0 111.25 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.84 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.9 m-85 -107.34 111.86 24.41 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.462 174.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.551 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 48.1 mt-10 -117.56 177.26 4.82 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.198 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 17.5 t70 64.51 43.88 4.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.2 1.0 . . . . 0.0 111.446 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -89.32 -139.59 7.31 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.2 155.33 84.28 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 117.062 0.431 . . . . 0.0 110.351 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.69 148.97 72.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.339 2.026 . . . . 0.0 110.459 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 52.4 t -98.21 126.22 40.72 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -63.99 -7.18 12.73 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.091 2.527 . . . . 0.0 114.335 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -76.71 -61.16 2.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.036 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.429 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 3.2 m-20 -117.67 -5.37 11.14 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 69.5 -45.28 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -70.56 -21.99 62.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.8 0.809 . . . . 0.0 109.173 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.906 HD13 ' HA ' ' A' 1611 ' ' THR . 93.5 mt -82.91 142.42 31.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 60.8 mttm -127.88 162.59 26.34 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -68.38 114.23 6.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.551 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.5 mtpt -128.03 138.99 52.79 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.569 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 27.0 t -120.91 120.0 34.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.59 HG23 HG22 ' A' 1569 ' ' VAL . 7.7 p -112.31 110.27 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 121.98 0.895 . . . . 0.0 109.941 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 107.74 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 15.4 p -90.73 112.91 24.87 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.069 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 85.4 m-85 -89.06 106.35 18.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -105.64 156.66 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' 1620 ' ' THR . 26.2 t -95.1 139.16 31.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.409 -1.317 . . . . 0.0 113.612 -171.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 27.9 tptp -137.67 98.25 3.63 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.6 m -57.59 -29.26 64.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -100.76 6.21 43.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.285 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -64.67 -58.11 7.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 51.91 -114.53 3.24 Favored Glycine 0 N--CA 1.446 -0.694 0 O-C-N 123.767 0.667 . . . . 0.0 112.625 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.63 -19.96 53.65 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.269 2.646 . . . . 0.0 112.957 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.6 t -117.24 74.46 0.92 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.705 1.241 . . . . 0.0 110.399 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.43 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 50.7 m -86.42 116.88 24.86 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.09 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 98.6 mt-30 -93.52 123.92 58.76 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -173.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 1.4 Cg_endo -84.79 113.15 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.244 2.63 . . . . 0.0 110.449 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.473 HD12 HD23 ' A' 1605 ' ' LEU . 2.2 tm? -96.45 117.55 31.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 34.7 tp -82.96 111.59 18.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1605 ' ' LEU . . . . . 0.473 HD23 HD12 ' A' 1603 ' ' LEU . 90.6 mt -70.78 -55.68 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.483 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 11.9 t -170.88 153.04 3.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 99.4 t -105.19 111.66 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.56 108.35 19.38 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.626 -1.229 . . . . 0.0 110.163 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -81.46 1.84 31.47 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.1 t60 -89.85 -51.36 5.53 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.906 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -98.03 -7.37 29.98 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.361 -170.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 77.8 m 55.19 34.09 21.93 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.276 1.036 . . . . 0.0 112.361 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1613 ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' 1585 ' ' LYS . 22.3 m -104.55 127.05 52.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.023 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 83.1 mt -92.62 120.9 33.51 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.125 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -103.12 104.19 14.32 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.476 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 67.2 m-85 -118.66 128.99 55.04 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 67.2 m -109.25 105.63 15.14 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.494 ' HE3' ' CD2' ' A' 1590 ' ' PHE . 11.5 t90 -92.49 109.54 20.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.599 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 59.9 m-70 -80.53 96.81 6.9 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.616 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' 1592 ' ' CYS . 7.9 t -127.88 153.43 46.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.886 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 11.6 m -72.67 -25.86 61.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.145 0.497 . . . . 0.0 111.333 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' 1622 ' ' LEU . 7.2 tt -68.26 -13.26 62.12 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -89.28 -3.35 58.55 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 46.5 m -78.4 169.46 18.21 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.937 -0.477 . . . . 0.0 109.965 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 168.545 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 6.3 t 68.84 9.66 7.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.919 0.888 . . . . 0.0 111.102 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.1 pt20 -140.46 138.22 34.51 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.5 p -139.33 132.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.7 m -93.64 114.38 26.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 4.7 p30 -79.99 133.08 58.56 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1499 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 12.2 Cg_exo -67.87 -32.15 29.83 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.535 2.157 . . . . 0.0 112.903 -176.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -55.75 -64.38 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 32.1 p -96.78 -20.51 18.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.94 0.4 . . . . 0.0 111.958 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.34 1.54 74.99 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.183 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -77.18 128.78 34.99 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.672 0.749 . . . . 0.0 111.931 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1497 ' ' THR . 22.1 t -85.9 108.2 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' 1495 ' ' GLN . 87.9 m-85 -84.67 100.58 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.41 120.51 39.72 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1507 ' ' LEU . . . . . 0.595 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 25.7 tp -83.96 3.83 32.41 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 121.993 0.902 . . . . 0.0 109.146 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.607 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 1.8 m-20 -57.68 -29.34 64.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.535 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1509 ' ' SER . . . . . 0.435 ' HB2' HD11 ' A' 1622 ' ' LEU . 10.0 m -71.41 -20.25 62.15 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.642 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.447 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.2 OUTLIER -101.63 -11.02 19.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.607 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 46.3 mtmt -70.54 152.65 43.74 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.764 0.792 . . . . 0.0 112.317 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' 1515 ' ' GLY . 38.7 ttt180 -127.23 119.81 27.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 104.173 -2.529 . . . . 0.0 104.173 172.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.11 -45.74 71.95 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.828 0.705 . . . . 0.0 112.004 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.6 m -81.68 -2.49 50.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.154 0.502 . . . . 0.0 111.136 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 77.98 177.77 48.0 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.411 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.98 114.25 27.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 28.9 m -103.63 102.27 12.14 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.7 pt -122.41 138.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1519 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1525 ' ' SER . 34.3 t -94.39 109.72 21.55 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.59 129.32 37.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.62 -20.09 22.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.85 0.719 . . . . 0.0 112.716 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -99.9 -32.25 11.09 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.595 -0.69 . . . . 0.0 110.583 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1523 ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' 1607 ' ' VAL . 26.7 mmtm -102.62 -62.94 1.21 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 151.87 -168.54 31.2 Favored Glycine 0 C--N 1.296 -1.655 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1525 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1519 ' ' SER . 44.7 m -85.39 126.6 33.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 -177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.93 140.31 48.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.401 ' HG2' HG11 ' A' 1534 ' ' VAL . 35.8 ttm180 -118.72 117.2 28.27 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.48 120.67 38.83 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.358 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -97.09 102.44 2.74 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 57.5 t -62.24 115.67 2.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.559 ' HB2' ' CD ' ' A' 1511 ' ' LYS . 21.8 m 60.0 24.83 14.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.553 1.141 . . . . 0.0 111.824 176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.12 173.08 25.02 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -108.84 139.08 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.38 0.609 . . . . 0.0 110.846 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' 1537 ' ' CYS . 15.1 m -94.61 93.49 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.038 0.923 . . . . 0.0 109.149 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' 1535 ' ' LYS . 9.1 mptt -54.73 -30.06 55.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.521 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.56 -18.11 63.62 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.681 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1537 ' ' CYS . . . . . 0.472 ' HB2' HG23 ' A' 1534 ' ' VAL . 80.9 m -113.44 14.0 19.02 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.978 0.418 . . . . 0.0 110.323 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1538 ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 110.68 128.91 5.48 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1539 ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 52.7 Cg_exo -59.54 127.98 25.61 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.932 2.421 . . . . 0.0 111.547 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 91.96 0.16 71.94 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.496 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' 1554 ' ' LYS . 47.7 mm -93.79 134.82 30.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -105.07 -37.68 2.65 Favored Glycine 0 CA--C 1.503 -0.684 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.484 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.6 42.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1544 ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' 1534 ' ' VAL . 31.0 p -137.76 153.83 49.67 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.602 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.46 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 51.6 t80 -94.88 138.33 32.78 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.95 89.64 8.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.666 0.746 . . . . 0.0 110.311 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -178.96 85.43 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 71.3 m 76.85 -37.17 0.27 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.155 0.982 . . . . 0.0 112.394 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 132.32 46.23 0.12 Allowed Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.744 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 73.4 mt -78.52 134.73 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' 1574 ' ' ASP . 9.4 mptt -96.32 140.86 30.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.53 12.19 10.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.528 0.68 . . . . 0.0 109.552 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 142.04 134.82 3.02 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.476 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' 1541 ' ' ILE . 25.2 pttm -82.76 153.73 25.11 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.66 135.62 50.11 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 173.62 16.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -100.02 11.58 38.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.402 0.439 . . . . 0.0 111.077 -172.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -84.94 100.28 11.52 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -168.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' 1494 ' ' CYS . 68.2 mt -115.63 119.92 37.69 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.308 172.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 51.0 m -107.85 122.52 46.95 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 78.9 t80 -94.93 101.32 13.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.988 0.899 . . . . 0.0 108.826 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 85.1 t -93.71 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -34.57 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.862 1.665 . . . . 0.0 113.137 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 20.2 mp0 56.95 18.25 3.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.868 2.067 . . . . 0.0 114.571 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 135.12 62.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.137 0.494 . . . . 0.0 111.088 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.51 113.95 26.04 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -102.94 114.1 28.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.35 124.11 49.86 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 13.1 p -120.48 133.93 65.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 111.355 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.865 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 64.6 m-85 -107.6 106.3 16.59 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.06 167.56 10.16 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.252 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.98 78.38 0.29 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.304 1.041 . . . . 0.0 111.796 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1573 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -106.26 -149.6 17.28 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' 1551 ' ' LYS . 24.3 t70 -94.92 143.88 26.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.511 ' HG3' ' HE2' ' A' 1583 ' ' LYS . 13.7 Cg_exo -69.01 146.75 65.88 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.845 2.364 . . . . 0.0 113.218 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 67.7 m -107.59 141.76 23.73 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.66 13.58 0.45 Allowed 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.574 2.849 . . . . 0.0 113.599 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.95 -38.5 22.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.686 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 28.1 t-20 -150.95 -6.7 0.27 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.041 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.14 -43.12 0.55 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.99 0.916 . . . . 0.0 113.424 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 59.9 m80 -77.37 -6.53 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.716 0.77 . . . . 0.0 110.78 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.758 HD13 ' HA ' ' A' 1611 ' ' THR . 63.3 mt -98.94 130.72 45.33 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.511 ' HE2' ' HG3' ' A' 1575 ' ' PRO . 96.1 mttt -128.73 161.95 28.54 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.456 0.473 . . . . 0.0 109.794 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' 1573 ' ' GLY . 98.9 m-85 -65.01 113.84 4.16 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.985 0.803 . . . . 0.0 109.1 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -129.33 137.62 51.1 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 17.3 t -121.49 130.81 53.79 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.3 p -125.43 116.83 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-O 121.96 0.886 . . . . 0.0 109.141 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.3 113.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.7 p -89.81 109.52 20.51 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.698 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.709 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.6 m-85 -86.81 103.06 14.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -99.39 166.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.552 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 18.6 t -84.6 130.31 34.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.469 0.652 . . . . 0.0 112.094 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 17.4 tptp -152.32 100.07 2.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.1 t -70.84 -14.4 62.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 0.0 111.591 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.19 1.89 55.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.375 0.607 . . . . 0.0 109.68 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -75.12 -65.9 0.83 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 108.18 -166.27 12.97 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.944 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.0 -20.23 44.82 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 124.275 3.317 . . . . 0.0 115.028 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 5.7 t -111.98 -22.09 11.23 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.891 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.759 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 48.0 m 65.41 -174.25 0.18 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.713 174.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.618 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 45.9 mt-30 -110.47 120.59 43.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.2 Cg_endo -90.69 125.7 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.906 2.404 . . . . 0.0 110.256 174.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 55.0 tp -129.0 126.05 38.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.676 -0.64 . . . . 0.0 111.027 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.13 118.68 20.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.24 -56.17 4.08 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.291 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 13.7 p -168.69 150.43 4.85 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' 1523 ' ' LYS . 98.2 t -115.0 114.26 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.71 109.05 20.05 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.01 -3.77 52.87 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.056 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -87.35 -51.79 5.75 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.758 ' HA ' HD13 ' A' 1582 ' ' LEU . 27.2 p -96.55 -8.25 32.41 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.614 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 72.9 m 65.7 25.92 11.45 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.929 0.892 . . . . 0.0 112.024 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 30.5 m -90.67 123.79 34.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.121 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.554 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 73.0 mt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.488 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -107.33 116.44 31.94 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 76.7 m-85 -126.96 140.04 52.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.981 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 78.3 p -111.21 116.3 30.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' 1590 ' ' PHE . 4.7 t-105 -99.74 111.79 24.09 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.618 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 71.0 m-70 -86.85 99.08 11.57 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 9.4 t -124.99 152.37 44.31 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.911 0.862 . . . . 0.0 112.131 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.3 m -76.46 -22.75 54.18 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.453 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.9 mt -73.38 -5.21 38.3 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.175 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.77 12.77 30.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.525 0.679 . . . . 0.0 110.391 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 61.3 m -100.23 137.84 38.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.911 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.425 -1.707 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 63.52 26.84 14.92 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.615 0.721 . . . . 0.0 111.392 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.2 pt20 -156.52 134.93 11.45 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.9 p -142.32 131.57 22.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.786 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.512 HG23 HG22 ' A' 1504 ' ' VAL . 10.6 m -98.63 129.09 45.13 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 38.5 p30 -85.91 127.63 61.47 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -70.2 -15.21 35.39 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.72 1.613 . . . . 0.0 110.855 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -65.63 -63.32 1.12 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.832 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 72.4 p -110.13 -14.06 14.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.579 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.12 14.78 58.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.303 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 71.0 t80 -92.16 137.42 32.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.512 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -102.91 128.49 55.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' 1495 ' ' GLN . 79.3 m-85 -104.14 98.6 8.39 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.22 102.07 14.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 120.805 0.336 . . . . 0.0 110.339 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 25.1 tp -79.03 -15.96 57.52 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -66.8 -16.81 64.53 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.516 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 17.9 m -87.61 -13.2 43.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.307 0.575 . . . . 0.0 109.61 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' 1598 ' ' PRO . 36.6 tp -116.44 16.53 15.64 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.975 0.893 . . . . 0.0 109.034 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.71 173.1 1.85 Allowed 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.865 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -53.57 104.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.639 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -100.26 -45.05 5.74 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 50.9 m -119.12 -23.65 6.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.543 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 87.4 129.44 2.88 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -74.83 114.88 13.8 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 5.8 m -119.21 100.18 7.17 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1518 ' ' ILE . . . . . 0.486 HG21 ' HG3' ' A' 1602 ' ' PRO . 21.1 pt -103.3 140.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.774 -173.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 36.7 t -99.64 115.59 29.78 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.19 160.29 27.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 14.2 tt -62.93 -23.16 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.036 0.535 . . . . 0.0 112.311 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -81.73 3.58 25.1 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.2 tptm 76.34 30.7 0.66 Allowed 'General case' 0 C--N 1.351 0.661 0 C-N-CA 125.895 1.678 . . . . 0.0 108.085 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -82.43 108.72 2.98 Favored Glycine 0 N--CA 1.418 -2.517 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.063 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.1 m -86.63 102.87 14.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.8 tt -113.87 134.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.472 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -115.41 126.98 55.04 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.516 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 125.26 41.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -104.45 90.39 0.72 Allowed Glycine 0 N--CA 1.418 -2.518 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 21.3 m -62.61 116.04 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.556 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 98.9 m 61.03 20.44 10.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.971 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -146.27 91.13 0.15 Allowed Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.55 132.66 49.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 124.548 0.793 . . . . 0.0 110.384 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 18.1 m -93.91 104.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.246 0.546 . . . . 0.0 111.362 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -16.41 60.87 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.176 0.512 . . . . 0.0 111.896 -175.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.34 -27.96 68.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.879 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.1 t -113.55 24.1 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 91.55 137.33 7.46 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.949 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.41 156.41 60.46 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.267 1.978 . . . . 0.0 111.457 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.7 8.55 87.65 Favored Glycine 0 C--N 1.304 -1.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.483 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' 1544 ' ' CYS . 45.3 mm -110.44 134.77 51.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -89.37 -42.55 5.49 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.217 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.29 147.35 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 122.661 -0.317 . . . . 0.0 110.598 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1544 ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' 1541 ' ' ILE . 59.2 m -152.43 156.22 39.06 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.278 0.631 . . . . 0.0 111.046 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' 1550 ' ' ILE . 64.9 t80 -94.22 119.05 32.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.09 102.09 3.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.985 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 151.49 -64.86 0.37 Allowed Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.367 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 21.9 p -91.25 -24.4 19.88 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.742 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.61 19.7 59.57 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.789 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' 1545 ' ' PHE . 44.6 pt -71.37 126.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 58.3 mttm -83.45 134.77 34.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.19 10.09 41.78 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.068 0.461 . . . . 0.0 111.402 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 139.0 146.04 4.87 Favored Glycine 0 C--O 1.254 1.357 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.817 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.54 146.5 36.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.635 0.255 . . . . 0.0 110.773 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.556 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 28.1 t90 -75.57 133.33 40.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.124 0.487 . . . . 0.0 110.332 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 10.2 p30 -146.76 -178.81 6.38 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.55 27.41 7.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.306 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1558 ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 44.0 mmtm -85.24 82.4 8.39 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.035 0.921 . . . . 0.0 111.849 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.44 103.93 16.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.338 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 6.9 t -90.05 109.68 20.71 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -83.6 101.8 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.8 t -114.75 95.13 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.067 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 23.5 t70 52.49 67.62 0.95 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.699 1.199 . . . . 0.0 112.137 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 63.92 9.88 4.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.851 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 37.5 t -119.75 136.7 56.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.38 131.6 39.87 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.299 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' 1560 ' ' SER . 86.9 mm-40 -116.28 114.63 24.63 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.57 119.47 38.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' 1571 ' ' GLU . 14.1 p -121.12 122.59 67.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.133 0.968 . . . . 0.0 112.526 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.679 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 57.6 m-85 -100.1 108.4 20.54 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.659 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' 1569 ' ' VAL . 46.0 mt-10 -117.68 168.54 10.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.296 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 35.8 t70 61.28 70.18 0.62 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.075 1.35 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.94 -133.17 5.62 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.875 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' 1584 ' ' TYR . 31.0 t70 -74.93 136.81 73.2 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.55 138.29 17.18 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.46 2.106 . . . . 0.0 112.589 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 56.2 m -98.78 126.3 39.26 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.87 8.15 2.12 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.944 2.429 . . . . 0.0 114.645 -173.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -77.2 -35.67 55.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 109.965 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.606 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 18.9 t-20 -136.05 -20.92 1.45 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.684 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 18.8 tp 75.83 -33.13 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.075 1.35 . . . . 0.0 112.504 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1581 ' ' HIS . . . . . 0.508 ' HB3' ' OD1' ' A' 1579 ' ' ASN . 40.8 t-80 -81.47 -14.88 56.51 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' 1611 ' ' THR . 83.3 mt -82.47 133.45 35.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.367 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 49.2 mttm -130.04 163.8 25.71 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' 1574 ' ' ASP . 97.4 m-85 -72.05 117.61 13.88 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.85 171.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 134.18 55.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.497 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 16.0 m -119.41 116.56 26.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -109.3 111.0 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.893 0.854 . . . . 0.0 110.051 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.3 mp -102.15 107.41 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.244 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 113.44 25.72 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.3 m-85 -86.22 112.32 21.25 Favored 'General case' 0 C--O 1.256 1.395 0 CA-C-O 120.708 0.289 . . . . 0.0 110.244 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.5 m -106.93 166.74 3.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 124.26 1.024 . . . . 0.0 109.124 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 43.0 t -77.05 143.24 39.44 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.412 0.625 . . . . 0.0 112.648 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 25.5 tptp -167.07 101.71 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.8 m -68.66 -28.52 66.96 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.649 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.2 71.04 3.86 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -142.63 -64.02 0.42 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.936 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 68.78 -144.76 42.41 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.402 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1598 ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' 1510 ' ' LEU . 40.7 Cg_endo -66.23 -11.96 33.54 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.013 3.142 . . . . 0.0 113.396 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.4 t -123.24 77.08 1.44 Allowed 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.608 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 51.0 m -70.74 147.8 48.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.795 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.612 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 9.3 pt20 -108.55 120.85 45.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-O 121.56 0.695 . . . . 0.0 112.492 -170.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.486 ' HG3' HG21 ' A' 1518 ' ' ILE . 88.2 Cg_endo -80.78 139.42 12.36 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.4 tm? -106.66 111.02 23.38 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.775 HD21 HG23 ' A' 1607 ' ' VAL . 4.8 tt -81.53 112.5 18.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.14 -66.38 0.8 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 55.0 m -158.09 136.25 10.84 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.742 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.775 HG23 HD21 ' A' 1604 ' ' LEU . 90.9 t -95.36 111.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.99 118.65 29.71 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.599 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -80.72 -6.84 58.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.37 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -94.22 -51.81 4.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.563 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.89 ' HA ' HD13 ' A' 1582 ' ' LEU . 41.7 p -97.16 -14.77 21.27 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.012 0.195 . . . . 0.0 111.447 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1612 ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' 1584 ' ' TYR . 69.5 m 67.33 26.54 8.47 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.364 1.04 . . . . 0.0 110.742 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 19.3 m -86.87 116.81 25.19 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.714 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 74.6 mt -94.07 116.21 28.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -100.58 111.75 24.04 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.714 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 91.5 m-85 -128.44 136.73 51.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.334 0.587 . . . . 0.0 111.577 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.9 m -112.22 106.41 14.98 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.466 ' HB2' HG23 ' A' 1588 ' ' ILE . 1.4 t-105 -89.99 114.95 26.89 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 96.3 m-70 -78.0 101.26 6.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 11.7 t -129.35 153.31 47.99 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.576 0.703 . . . . 0.0 111.074 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.2 m -73.28 -28.82 62.32 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.3 -6.49 43.51 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 121.45 0.643 . . . . 0.0 111.558 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -92.84 -4.45 52.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.435 0.636 . . . . 0.0 110.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 7.4 m -99.12 129.23 45.37 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.424 -1.725 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.753 178.719 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.223 -0.293 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 37.6 m -87.71 11.53 15.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.596 0.713 . . . . 0.0 109.484 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.5 pt20 -152.01 136.33 16.73 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.6 p -132.61 126.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.35 0.595 . . . . 0.0 110.209 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 14.3 m -90.32 116.68 28.47 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.49 HD22 ' HE1' ' A' 1505 ' ' PHE . 28.1 p30 -73.8 143.94 82.15 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.777 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1499 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 7.7 Cg_exo -73.52 -31.73 8.58 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.876 1.717 . . . . 0.0 112.01 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -62.08 -65.42 0.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 8.7 p -97.69 -11.65 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 74.28 40.17 41.77 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 83.9 t80 -111.72 130.5 55.76 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.033 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' 1497 ' ' THR . 47.6 t -90.28 118.95 36.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.49 ' HE1' HD22 ' A' 1498 ' ' ASN . 90.8 m-85 -91.29 108.21 19.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.55 106.43 17.53 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.335 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1507 ' ' LEU . . . . . 0.564 HD11 HD23 ' A' 1510 ' ' LEU . 28.1 tp -83.97 -3.12 57.75 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -51.17 -38.42 52.08 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 125.855 1.662 . . . . 0.0 111.571 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 4.9 m -68.13 -19.21 64.8 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.564 HD23 HD11 ' A' 1507 ' ' LEU . 50.6 tp -117.24 5.69 12.69 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.928 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' 1531 ' ' CYS . 22.8 pttm -88.09 129.53 35.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.319 -175.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -128.44 118.29 22.85 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.99 -37.28 78.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 2.7 m -56.17 -25.1 45.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.744 1.218 . . . . 0.0 110.273 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 87.07 177.12 49.05 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.316 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.65 124.9 43.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1517 ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' 1527 ' ' ARG . 2.6 m -103.04 98.41 8.36 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 15.4 pt -106.39 151.11 8.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.268 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1519 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1525 ' ' SER . 12.8 p -109.44 130.98 55.47 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.94 154.91 40.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.3 tp -62.94 -26.16 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.287 0.635 . . . . 0.0 111.824 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' 1522 ' ' ARG . 50.1 mtp180 -85.86 3.42 41.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1523 ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 44.5 mmtm 86.92 20.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.613 1.565 . . . . 0.0 112.519 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -83.58 80.23 1.84 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1525 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1519 ' ' SER . 15.0 m -69.65 127.7 33.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.425 HD11 ' HB1' ' A' 1543 ' ' ALA . 7.6 tt -129.49 134.07 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.45 0.643 . . . . 0.0 110.153 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' 1517 ' ' THR . 58.2 ttt180 -105.82 119.77 40.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1528 ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' 1528 ' ' LEU . 0.7 OUTLIER -122.61 125.14 45.06 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -178.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -97.79 143.93 16.99 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 23.8 t -100.01 116.49 43.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.584 ' HA ' ' OE1' ' A' 1557 ' ' GLN . 62.0 m 63.95 20.99 12.46 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.078 0.862 . . . . 0.0 110.801 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -142.84 111.91 0.69 Allowed Glycine 0 N--CA 1.407 -3.271 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.76 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.18 133.4 47.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.9 m -90.85 95.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 122.258 1.028 . . . . 0.0 108.313 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.05 -28.17 64.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.913 -173.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.21 -16.56 61.95 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1537 ' ' CYS . . . . . 0.671 ' HB2' HG23 ' A' 1534 ' ' VAL . 96.7 m -102.76 -5.33 23.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.243 0.544 . . . . 0.0 109.538 173.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 131.44 145.03 5.52 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 132.49 29.67 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.166 1.91 . . . . 0.0 111.119 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.14 23.08 76.87 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.042 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.44 127.28 66.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' 1570 ' ' TYR . . . -100.8 -35.21 4.38 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.69 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1543 ' ' ALA . . . . . 0.425 ' HB1' HD11 ' A' 1526 ' ' ILE . . . -129.22 121.88 28.55 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.2 p -132.42 142.74 49.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.013 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' 1552 ' ' ALA . 73.8 m-85 -90.05 141.49 28.62 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.66 -26.27 64.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -89.88 126.79 8.45 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 6.7 m 75.48 -21.34 0.31 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 124.762 1.225 . . . . 0.0 112.009 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.22 30.36 54.88 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.63 150.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.165 0.507 . . . . 0.0 110.252 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.689 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 18.3 pttm -97.06 145.58 25.83 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1552 ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.02 8.9 32.58 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.218 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.831 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.35 141.13 3.18 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.553 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.55 150.52 36.54 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.484 ' HA ' ' HE2' ' A' 1570 ' ' TYR . 35.2 t90 -63.78 124.49 21.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.694 0.759 . . . . 0.0 110.506 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1556 ' ' ASN . . . . . 0.425 HD21 ' HA ' ' A' 1570 ' ' TYR . 8.3 p30 -149.14 153.06 37.16 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1557 ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' 1531 ' ' CYS . 13.4 mm100 -108.72 22.63 15.67 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 123.753 0.658 . . . . 0.0 109.653 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 27.9 tptp -77.17 82.44 3.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.144 0.973 . . . . 0.0 111.57 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' 1566 ' ' LEU . 50.5 tp -91.33 116.2 28.64 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.262 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.4 m -103.31 147.14 27.44 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1561 ' ' TYR . . . . . 0.406 ' HD1' HD23 ' A' 1566 ' ' LEU . 60.7 t80 -117.51 135.0 54.23 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1562 ' ' VAL . . . . . 0.734 HG23 ' HB ' ' A' 1565 ' ' VAL . 18.0 m -134.05 160.51 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.33 106.1 0.09 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.073 0.949 . . . . 0.0 112.887 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 71.9 17.59 5.25 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.15 1.78 . . . . 0.0 112.413 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1565 ' ' VAL . . . . . 0.734 ' HB ' HG23 ' A' 1562 ' ' VAL . 59.5 t -139.8 124.68 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.697 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 93.3 mt -96.04 129.39 43.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' 1560 ' ' SER . 18.1 mm-40 -113.6 114.27 26.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1568 ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' 1568 ' ' LEU . 19.6 mt -104.81 119.47 39.08 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 36.1 t -116.72 108.58 25.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.294 0.569 . . . . 0.0 110.517 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.831 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 45.8 m-85 -93.22 113.35 25.54 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.812 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.54 -177.17 3.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.448 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.668 ' HA ' ' HD2' ' A' 1583 ' ' LYS . 5.1 m-20 68.33 27.98 6.38 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.713 0.633 . . . . 0.0 112.242 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1573 ' ' GLY . . . . . 0.689 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -74.07 -167.63 16.37 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 1.5 m-20 -72.19 162.63 72.65 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 122.338 -0.507 . . . . 0.0 112.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -65.23 144.35 80.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.572 2.181 . . . . 0.0 112.479 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1576 ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 43.9 t -98.23 140.18 21.7 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 124.677 1.191 . . . . 0.0 109.991 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.61 -22.12 73.63 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.068 2.512 . . . . 0.0 114.069 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.21 -26.56 60.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.83 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 36.9 t-20 -171.11 120.21 0.51 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1580 ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' 1580 ' ' LEU . 2.4 mm? -56.16 -27.22 53.47 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.593 1.157 . . . . 0.0 114.112 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.6 m80 -91.09 3.23 55.29 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.83 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 57.6 mt -89.94 121.55 32.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' A' 1572 ' ' ASP . 50.7 mtmt -103.27 156.88 17.4 Favored 'General case' 0 C--N 1.272 -2.795 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -61.88 119.83 9.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.73 0.644 . . . . 0.0 110.881 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' 1583 ' ' LYS . 0.6 OUTLIER -104.38 131.11 52.09 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' 1570 ' ' TYR . 23.1 t -123.15 116.07 22.83 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -116.82 112.87 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-O 122.097 0.951 . . . . 0.0 110.321 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.41 101.51 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 47.5 m -90.96 110.25 21.49 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.21 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.5 m-85 -86.05 104.84 16.02 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.3 m -98.13 159.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.638 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 41.6 t -76.02 122.28 23.98 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.624 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' 1595 ' ' ASP . 20.4 tptm -149.7 90.12 1.68 Allowed 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.6 t -68.37 -15.26 63.49 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.466 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1595 ' ' ASP . . . . . 0.426 ' HB2' ' HE2' ' A' 1593 ' ' LYS . 29.3 m-20 -85.63 4.3 36.93 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 122.175 -0.328 . . . . 0.0 111.505 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.28 -61.12 1.93 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-O 120.734 0.302 . . . . 0.0 111.165 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 87.87 -141.75 17.28 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.838 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.52 -16.9 38.81 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.337 2.691 . . . . 0.0 112.97 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.8 t -125.97 89.78 3.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 122.45 1.119 . . . . 0.0 109.553 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.751 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.2 m -76.25 148.17 37.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.2 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 56.3 mt-30 -96.19 122.06 58.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.4 Cg_endo -87.14 113.67 1.0 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.402 2.734 . . . . 0.0 110.708 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.59 119.33 36.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.871 0.367 . . . . 0.0 110.291 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.448 HD13 ' CZ ' ' A' 1616 ' ' PHE . 39.0 tp -76.5 126.07 30.33 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.39 -65.47 1.01 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 73.7 m -159.51 156.29 27.94 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.513 HG13 HD23 ' A' 1614 ' ' LEU . 96.0 t -110.37 112.39 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 171.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.68 109.03 13.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.86 -6.42 58.59 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.208 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -95.16 -29.0 14.77 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.043 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' 1582 ' ' LEU . 35.9 p -114.86 -15.22 11.87 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.961 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 97.8 m 66.14 58.8 0.7 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.556 1.169 . . . . 0.0 111.097 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 23.5 m -120.94 130.37 53.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.281 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.513 HD23 HG13 ' A' 1607 ' ' VAL . 73.6 mt -96.81 117.4 31.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.33 103.33 13.33 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -114.82 131.53 56.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.829 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 74.7 p -109.53 108.46 18.93 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -92.68 108.01 19.65 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' 1600 ' ' SER . 64.4 m-70 -83.66 97.72 9.25 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -126.45 152.14 46.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.759 0.79 . . . . 0.0 111.808 -173.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.6 m -78.25 -25.99 47.06 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.405 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' 1510 ' ' LEU . 43.2 mt -70.61 -6.07 34.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.957 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -95.18 -9.55 33.07 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.538 0.685 . . . . 0.0 110.432 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -82.85 135.77 34.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.151 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 26.2 m120 . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 45.1 t 61.86 33.41 17.63 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 123.042 1.401 . . . . 0.0 110.16 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' 1505 ' ' PHE . 8.6 pt20 -156.46 146.55 21.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 11.7 p -148.14 135.55 13.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 14.0 m -94.94 116.98 29.38 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.462 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.4 p30 -78.66 138.03 58.54 Favored Pre-proline 0 C--N 1.31 -1.134 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.604 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.08 -1.9 11.98 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 113.647 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -83.52 -68.57 0.7 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.68 0.276 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 12.1 p -89.22 -24.99 21.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.65 13.95 64.19 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.55 139.97 30.34 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 44.5 t -92.55 116.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.484 ' HZ ' ' HG2' ' A' 1625 ' ' GLU . 82.3 m-85 -81.24 95.33 6.91 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.04 95.35 10.28 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.001 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 31.8 tp -86.01 -11.1 53.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.51 0.672 . . . . 0.0 110.996 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' 1511 ' ' LYS . 9.1 p30 -71.68 -13.22 61.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.947 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 74.3 m -84.23 -10.85 57.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.128 173.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.76 4.06 19.63 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.004 -0.435 . . . . 0.0 111.033 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 58.0 pttt -90.79 157.74 17.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.079 0.466 . . . . 0.0 111.262 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -128.88 137.03 51.22 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -30.08 70.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 22.3 t -78.27 -11.54 59.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.805 0.812 . . . . 0.0 109.101 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 76.57 -174.67 53.75 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.512 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.87 121.36 44.44 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.5 m -105.88 103.87 13.46 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1518 ' ' ILE . . . . . 0.442 HG21 ' HG3' ' A' 1602 ' ' PRO . 25.9 pt -108.66 139.91 29.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.201 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 10.0 p -87.11 139.29 30.72 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 121.616 0.722 . . . . 0.0 111.571 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -95.23 151.84 18.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.16 -25.87 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 124.567 1.147 . . . . 0.0 112.952 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.58 2.67 18.48 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.08 -0.387 . . . . 0.0 111.841 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.9 tptm 70.04 68.97 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.731 1.253 . . . . 0.0 109.481 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -150.47 174.61 29.79 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 16.5 t -146.39 146.79 30.75 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 118.559 1.18 . . . . 0.0 108.421 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.34 134.47 60.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.1 ttm105 -110.15 113.85 26.87 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.17 129.36 56.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.18 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.75 91.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' 1511 ' ' LYS . 92.8 t -64.1 116.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.643 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 60.8 m 58.45 18.46 5.65 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.79 0.681 . . . . 0.0 112.695 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1532 ' ' GLY . . . . . 0.41 ' N ' ' HE1' ' A' 1555 ' ' TRP . . . -154.07 101.85 0.21 Allowed Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 178.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.0 132.64 54.5 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 121.26 0.552 . . . . 0.0 111.723 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.5 m -78.87 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.958 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -18.01 17.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.095 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.33 -31.82 73.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.27 -0.38 26.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.501 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 123.97 158.11 10.01 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.378 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.9 130.77 11.63 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.395 2.063 . . . . 0.0 111.935 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.86 5.24 81.4 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.572 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.447 ' CD1' ' HD2' ' A' 1551 ' ' LYS . 41.1 mm -98.77 117.49 43.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.15 -19.73 18.11 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.49 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -137.27 120.28 16.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.4 p -131.03 136.77 48.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.395 0.617 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 76.8 t80 -96.26 116.12 28.51 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.6 104.81 4.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.623 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -176.12 -105.67 0.19 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 5.2 m -73.88 -25.23 59.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 109.46 57.53 0.53 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 61.3 mt -94.14 125.12 46.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.447 ' HD2' ' CD1' ' A' 1541 ' ' ILE . 43.2 mtmt -83.91 126.26 32.82 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -105.48 9.0 33.69 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.246 0.546 . . . . 0.0 110.767 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.784 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 147.86 146.58 4.37 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.329 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.5 144.93 27.66 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.733 0.777 . . . . 0.0 111.541 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1555 ' ' TRP . . . . . 0.504 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 65.6 t90 -65.54 151.21 46.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.158 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -164.99 167.31 18.58 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -119.26 20.52 12.56 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -91.01 96.71 10.76 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.463 0.649 . . . . 0.0 110.336 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.479 HD23 HD13 ' A' 1568 ' ' LEU . 69.2 mt -94.19 109.38 21.18 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 20.1 m -92.94 120.84 33.67 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 75.6 t80 -93.23 102.39 14.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1562 ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' 1565 ' ' VAL . 49.2 t -115.65 88.88 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.681 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.0 t70 48.03 81.41 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.927 1.291 . . . . 0.0 113.799 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 70.35 -9.19 0.79 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1565 ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' 1562 ' ' VAL . 7.4 p -116.98 132.13 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.539 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.874 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 14.7 tp -88.15 119.08 28.2 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -107.06 129.11 54.86 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.435 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1568 ' ' LEU . . . . . 0.479 HD13 HD23 ' A' 1559 ' ' LEU . 54.9 tp -126.8 109.88 12.49 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 172.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 38.7 t -110.9 128.5 67.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.784 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 75.2 m-85 -104.43 119.33 38.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.13 177.28 4.78 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.781 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 8.7 t70 52.65 70.33 0.59 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.227 1.411 . . . . 0.0 111.85 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.94 -135.82 8.87 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.321 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 19.5 t70 -83.5 145.54 48.23 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 6.4 Cg_exo -74.18 142.72 31.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.607 2.205 . . . . 0.0 111.526 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1576 ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' 1578 ' ' ALA . 78.2 m -98.39 132.17 24.76 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.746 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.44 20.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.578 2.852 . . . . 0.0 112.714 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1578 ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -86.81 -55.47 3.83 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.55 7.67 2.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.282 0.563 . . . . 0.0 109.766 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 2.2 tm? 68.93 -50.88 0.59 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.508 1.523 . . . . 0.0 112.358 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.7 t60 -68.49 -13.46 62.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.358 0.663 . . . . 0.0 110.408 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.67 134.98 35.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 85.6 mttt -125.84 152.45 45.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 95.5 m-85 -67.08 117.48 9.18 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.864 0.728 . . . . 0.0 109.393 174.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.14 135.45 48.88 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 13.1 p -121.03 121.25 37.54 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.683 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 4.2 p -106.15 113.63 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.552 0.691 . . . . 0.0 109.735 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.42 110.12 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1589 ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' 1565 ' ' VAL . 42.3 m -93.34 118.62 31.5 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.874 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 90.9 m-85 -86.58 110.2 19.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.2 m -107.42 152.38 9.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' 1620 ' ' THR . 40.3 t -81.98 142.53 32.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.273 0.558 . . . . 0.0 112.404 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.518 ' CB ' ' HB3' ' A' 1619 ' ' HIS . 42.4 tptt -163.29 97.35 0.9 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.457 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 9.5 p -56.65 -32.28 65.21 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.871 0.868 . . . . 0.0 112.09 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1595 ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.674 0.79 . . . . 0.0 112.037 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -80.27 -41.6 24.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.767 0.318 . . . . 0.0 111.519 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.2 -163.68 39.66 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.7 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.63 -15.64 21.63 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.272 2.648 . . . . 0.0 113.168 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.3 p -86.13 -42.02 14.24 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.814 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.4 m 72.21 161.75 0.25 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.18 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -115.52 121.65 34.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.442 ' HG3' HG21 ' A' 1518 ' ' ILE . 55.3 Cg_endo -84.2 121.46 2.72 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.73 118.38 33.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.482 HD21 HG23 ' A' 1607 ' ' VAL . 49.7 tp -78.42 116.84 19.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 46.8 tp -79.94 -56.12 4.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.608 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 50.9 m -164.21 136.24 4.75 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 122.614 0.365 . . . . 0.0 110.171 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.482 HG23 HD21 ' A' 1604 ' ' LEU . 82.3 t -103.35 110.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.22 100.17 10.35 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.487 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -80.58 7.07 10.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.081 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -89.8 -51.34 5.55 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.942 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1611 ' ' THR . . . . . . . . . . . . . 49.9 p -99.74 -9.53 22.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.581 0.229 . . . . 0.0 111.218 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1612 ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 66.6 m 69.54 23.27 6.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.656 1.182 . . . . 0.0 111.075 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 13.4 m -91.22 114.23 26.7 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' 1616 ' ' PHE . 79.6 mt -93.83 121.91 35.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.92 113.56 27.18 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' 1614 ' ' LEU . 76.0 m-85 -121.9 139.19 53.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.1 m -119.92 108.81 14.79 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.403 ' HE1' ' HB2' ' A' 1600 ' ' SER . 24.3 t-105 -93.14 110.24 21.74 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.518 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 39.4 m-70 -83.04 107.77 15.87 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.8 t -132.79 152.98 51.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.622 0.576 . . . . 0.0 110.068 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.7 m -70.62 -27.62 64.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.41 0.624 . . . . 0.0 110.065 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.82 -5.87 37.43 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.347 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1623 ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' 1592 ' ' CYS . . . -84.73 -9.01 58.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.605 0.717 . . . . 0.0 110.501 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.7 m -94.58 144.26 25.74 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1625 ' ' GLU . . . . . 0.484 ' HG2' ' HZ ' ' A' 1505 ' ' PHE . 47.3 mt-10 . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 121.51 0.671 . . . . 0.0 109.698 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 CA--C 1.499 -1.008 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 95.3 m 70.91 -1.4 2.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.602 0.715 . . . . 0.0 112.325 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' 1506 ' ' ASP . 29.4 pt20 -149.2 161.53 41.81 Favored 'General case' 0 N--CA 1.405 -2.692 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.5 p -146.74 121.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-O 121.88 0.847 . . . . 0.0 110.514 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.62 HG23 HG22 ' A' 1504 ' ' VAL . 17.7 m -91.67 104.18 16.68 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.05 135.9 47.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.087 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 -12.37 20.18 Favored 'Trans proline' 0 C--N 1.332 -0.324 0 C-N-CA 122.591 2.194 . . . . 0.0 112.212 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -66.51 -67.34 0.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.544 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1501 ' ' THR . . . . . 0.443 ' H ' ' HG1' ' A' 1501 ' ' THR . 25.4 p -99.54 -23.0 15.23 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.45 73.28 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.376 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -74.63 137.4 42.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.177 0.513 . . . . 0.0 110.023 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.62 HG22 HG23 ' A' 1497 ' ' THR . 41.7 t -100.02 121.56 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -115.08 108.56 16.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1506 ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' 1495 ' ' GLN . 2.5 p-10 -104.33 127.44 51.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.722 0.772 . . . . 0.0 109.479 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.4 tp -90.78 4.65 51.06 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' 1511 ' ' LYS . 79.7 m-20 -67.42 -27.21 66.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.415 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 35.9 p -79.61 -18.29 51.93 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.801 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' 1598 ' ' PRO . 25.6 mt -109.63 4.26 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.08 -0.388 . . . . 0.0 111.657 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' 1508 ' ' ASN . 21.1 pttp -85.17 153.02 22.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' 1515 ' ' GLY . 55.1 ttt180 -120.88 129.49 53.53 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.32 -42.76 92.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 111.111 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.0 m -82.25 1.45 36.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.54 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.567 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 76.37 166.21 22.37 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.405 0.447 . . . . 0.0 113.981 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' 1527 ' ' ARG . 89.0 m-85 -98.68 123.78 43.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.1 m -103.93 97.75 7.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.87 125.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.134 0.492 . . . . 0.0 111.664 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1519 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1525 ' ' SER . 38.7 m -94.3 116.65 29.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1520 ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' 1604 ' ' LEU . 2.0 m-20 -119.43 99.72 6.85 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 47.8 mt 63.26 -104.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.932 170.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.97 -12.52 12.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.59 -35.6 79.29 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.728 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 122.26 -161.94 16.24 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1525 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1519 ' ' SER . 9.0 m -96.21 123.1 39.71 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 7.7 tt -112.13 127.45 69.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.489 ' HG2' HG11 ' A' 1534 ' ' VAL . 40.1 ttm180 -104.83 118.57 36.89 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1528 ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' 1528 ' ' LEU . 1.2 mp -118.3 122.46 42.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.513 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' 1532 ' ' GLY . . . -100.88 97.2 1.66 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.31 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' 1511 ' ' LYS . 60.3 t -66.27 115.2 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1531 ' ' CYS . . . . . 0.466 ' HB2' ' HD2' ' A' 1511 ' ' LYS . 68.0 m 59.65 15.15 4.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.858 0.863 . . . . 0.0 113.207 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1532 ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' 1529 ' ' GLY . . . -141.16 112.73 0.79 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1533 ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' 1535 ' ' LYS . 33.6 mt-10 -63.41 140.96 58.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.489 HG11 ' HG2' ' A' 1527 ' ' ARG . 16.0 m -85.41 89.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.265 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -62.33 -19.04 62.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.219 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.66 -23.08 64.51 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.708 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 32.0 t -121.74 4.7 10.02 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.599 0.714 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 102.41 152.08 24.1 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.979 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.09 153.19 75.51 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.492 2.128 . . . . 0.0 111.264 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.45 -10.07 70.83 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.331 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.433 HD12 ' HD3' ' A' 1551 ' ' LYS . 42.4 mm -98.37 129.8 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.5 -50.64 1.28 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.108 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.03 132.49 55.49 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 49.1 t -136.52 149.98 48.42 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.414 0.15 . . . . 0.0 110.889 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.467 ' HZ ' HD11 ' A' 1614 ' ' LEU . 67.1 m-85 -93.63 160.75 14.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.817 0.818 . . . . 0.0 112.867 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.77 -22.18 66.78 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.701 2.0 . . . . 0.0 113.073 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -119.65 130.18 8.35 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.035 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1548 ' ' THR . . . . . 0.482 ' HB ' HG23 ' A' 1550 ' ' ILE . 23.9 m 73.77 -13.65 0.73 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 112.562 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.28 36.02 35.98 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.482 HG23 ' HB ' ' A' 1548 ' ' THR . 36.2 pt -81.51 143.03 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.623 ' HG2' ' OD1' ' A' 1574 ' ' ASP . 17.2 pttm -92.99 145.05 24.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.593 0.711 . . . . 0.0 111.434 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1552 ' ' ALA . . . . . 0.435 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.15 15.67 26.0 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.627 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.785 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 141.2 141.48 3.98 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.934 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 48.0 mtpt -78.78 159.9 27.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 72.7 t90 -67.22 141.26 57.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.774 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.39 172.37 18.46 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.2 24.25 5.95 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.448 1.099 . . . . 0.0 109.757 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.37 103.36 15.41 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.258 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.33 130.56 54.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.0 t -121.38 109.67 15.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.12 103.54 15.59 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 95.8 t -127.7 105.01 13.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.318 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.4 t70 58.19 60.93 2.47 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 111.223 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.99 24.51 9.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.207 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1565 ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' 1590 ' ' PHE . 96.2 t -126.6 122.44 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.88 123.75 34.64 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' A' 1560 ' ' SER . 17.4 mm-40 -102.0 114.5 28.66 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.418 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.0 tp -116.64 102.71 9.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.53 HG22 HG23 ' A' 1587 ' ' VAL . 35.0 t -107.12 120.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.095 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.785 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 79.5 m-85 -86.21 108.94 18.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.7 154.44 21.64 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.219 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 13.0 t70 56.21 86.11 0.07 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.753 1.621 . . . . 0.0 113.852 173.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1573 ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -107.32 -152.23 18.0 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.623 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 0.7 OUTLIER -83.23 146.57 51.46 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 116.962 0.381 . . . . 0.0 110.276 176.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 7.2 Cg_exo -73.52 143.92 35.22 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.234 2.623 . . . . 0.0 112.665 -175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.4 142.78 25.44 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.825 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.56 11.66 0.78 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.172 2.582 . . . . 0.0 114.091 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.45 -56.15 4.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.869 0.366 . . . . 0.0 110.543 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.778 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.4 m120 -133.91 7.91 3.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.806 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.0 mm? 70.48 -55.53 0.62 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.403 1.081 . . . . 0.0 113.096 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -74.88 -12.99 60.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.489 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 65.1 mt -82.45 131.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 95.3 mttt -131.39 162.09 30.93 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.733 0.645 . . . . 0.0 110.142 -174.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.431 ' O ' ' HA3' ' A' 1573 ' ' GLY . 97.0 m-85 -66.87 112.64 4.39 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 123.937 0.773 . . . . 0.0 109.531 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -129.32 147.04 51.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.0 p -129.85 121.67 27.17 Favored 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.364 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.53 HG23 HG22 ' A' 1569 ' ' VAL . 3.0 p -111.36 111.22 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.853 0.835 . . . . 0.0 109.364 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.95 106.06 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 43.8 m -87.48 110.0 20.0 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.763 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.796 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.7 m-85 -86.04 101.66 13.13 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.4 m -100.02 160.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.224 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 28.3 t -76.46 120.53 21.81 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.6 tptt -143.16 97.08 3.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -107.7 19.2 20.46 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.073 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -70.52 -38.82 74.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.157 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 91.51 -174.07 37.75 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.146 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1598 ' ' PRO . . . . . 0.417 ' O ' HD22 ' A' 1510 ' ' LEU . 70.8 Cg_endo -71.78 -15.23 30.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.36 2.707 . . . . 0.0 112.028 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.7 p -79.91 -48.83 12.81 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.634 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 40.0 m 68.47 161.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.815 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.506 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 19.5 mt-30 -107.0 119.77 50.17 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.448 -0.783 . . . . 0.0 110.571 -174.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 3.8 Cg_endo -89.96 116.25 0.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.429 2.752 . . . . 0.0 112.006 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 56.6 tp -115.47 120.01 38.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' 1520 ' ' ASP . 60.8 tp -70.9 113.24 7.76 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.9 tp -87.93 -63.49 1.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.571 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 67.2 m -147.34 138.38 23.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.922 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 62.5 t -122.78 112.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -97.87 124.66 42.37 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.552 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.21 -8.27 59.36 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -102.78 -51.5 3.28 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.214 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.735 ' HA ' HD13 ' A' 1582 ' ' LEU . 36.4 p -86.83 -14.69 41.4 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 73.4 m 61.85 23.19 13.59 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.082 0.953 . . . . 0.0 111.637 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -86.14 115.65 23.84 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.467 HD11 ' HZ ' ' A' 1545 ' ' PHE . 87.1 mt -91.52 126.71 36.69 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.958 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.05 116.37 31.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.23 137.58 53.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.6 m -110.25 103.68 12.39 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' A' 1600 ' ' SER . 11.3 t-105 -99.47 105.81 17.78 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 85.2 m-70 -81.02 100.65 9.08 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.4 t -122.71 153.66 39.14 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.647 0.736 . . . . 0.0 111.474 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.7 m -76.11 -26.37 56.33 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.365 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' 1622 ' ' LEU . 26.6 mt -71.43 -5.23 31.22 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -90.59 -23.95 20.69 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.553 0.692 . . . . 0.0 110.242 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 66.8 m -72.91 142.26 47.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.483 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.938 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.0 p30 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.407 0.146 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.432 ' HA ' ' HG ' ' A' 1559 ' ' LEU . 85.3 m -121.99 15.29 10.78 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.49 1.138 . . . . 0.0 108.818 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' 1505 ' ' PHE . 17.1 pt20 -139.05 116.88 11.54 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.2 p -137.57 141.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' 1504 ' ' VAL . 6.7 t -121.12 167.76 12.3 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 24.5 p30 -131.96 150.99 77.68 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.92 16.12 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.311 2.007 . . . . 0.0 112.413 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -93.69 -56.79 2.77 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.39 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.7 p -103.08 -27.97 12.25 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.61 0.719 . . . . 0.0 110.198 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.68 27.38 57.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.857 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 61.4 t80 -98.4 132.68 43.66 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' 1497 ' ' THR . 43.1 t -96.54 110.1 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' 1495 ' ' GLN . 65.7 m-85 -76.56 102.84 6.25 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.88 107.38 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.836 0.35 . . . . 0.0 110.777 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 -4.48 59.17 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.199 1.0 . . . . 0.0 109.153 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.539 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 48.6 m-80 -71.07 -21.28 62.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.896 -177.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 58.8 p -80.98 -7.65 59.59 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.667 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.66 11.35 15.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 33.1 mtmm -59.55 176.24 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.153 0.501 . . . . 0.0 111.677 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.811 ' HD3' HG12 ' A' 1534 ' ' VAL . 18.3 ttp180 -66.97 93.46 0.28 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.201 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.93 -38.99 10.43 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 168.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 28.3 t -118.37 -40.23 2.95 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.194 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.62 175.56 32.48 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' 1527 ' ' ARG . 12.4 m-85 -113.79 141.95 46.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1517 ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' 1526 ' ' ILE . 88.2 m -142.72 103.41 4.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.379 0.609 . . . . 0.0 110.845 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 22.7 pt -119.82 148.73 22.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 45.4 m -114.48 123.65 49.95 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.138 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.79 155.45 39.29 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.841 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.64 -24.7 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 124.087 0.955 . . . . 0.0 112.079 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1522 ' ' ARG . . . . . 0.86 HH22 HG11 ' A' 1607 ' ' VAL . 80.0 mtm180 -81.01 3.1 24.22 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.311 0.644 . . . . 0.0 111.262 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.78 62.15 0.33 Allowed 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.554 1.142 . . . . 0.0 111.038 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -121.42 91.48 0.47 Allowed Glycine 0 N--CA 1.409 -3.134 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.5 m -78.85 104.18 9.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1526 ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.2 tt -98.18 125.98 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.515 0.674 . . . . 0.0 109.317 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' 1516 ' ' TYR . 44.1 ttt180 -108.35 125.27 51.52 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.34 140.39 50.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.121 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -122.66 126.41 6.35 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 106.568 -2.613 . . . . 0.0 106.568 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.1 m -89.51 118.74 35.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.126 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 55.8 m 69.86 10.9 7.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.823 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -136.43 130.47 5.27 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1533 ' ' GLU . . . . . 0.572 ' HG3' ' HE3' ' A' 1535 ' ' LYS . 12.7 pt-20 -74.91 129.3 37.43 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.265 0.555 . . . . 0.0 111.62 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.811 HG12 ' HD3' ' A' 1512 ' ' ARG . 17.7 m -92.58 99.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 122.005 0.907 . . . . 0.0 109.842 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.572 ' HE3' ' HG3' ' A' 1533 ' ' GLU . 9.8 mptt -67.15 -12.12 59.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.071 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.18 -43.64 74.53 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 125.683 1.593 . . . . 0.0 109.151 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 58.1 m -104.23 -7.19 20.26 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.95 163.5 9.54 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.533 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.86 139.16 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.112 1.875 . . . . 0.0 111.365 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 71.88 30.43 65.84 Favored Glycine 0 C--N 1.305 -1.193 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.388 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.21 129.04 75.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -104.6 -35.84 3.19 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.116 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -122.78 124.67 43.86 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 27.4 p -140.07 154.64 47.12 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.755 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' 1550 ' ' ILE . 91.1 m-85 -93.96 116.48 28.93 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.13 100.65 3.7 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.484 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -174.8 -94.92 0.1 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 94.0 m -95.78 -37.42 10.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 117.153 0.477 . . . . 0.0 110.706 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 143.44 31.21 0.1 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.581 -1.295 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.588 ' HB ' ' HB2' ' A' 1545 ' ' PHE . 64.9 mt -71.39 125.17 29.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.631 ' H ' ' HB2' ' A' 1574 ' ' ASP . 36.3 mttp -99.29 132.45 44.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.03 4.89 29.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.924 0.392 . . . . 0.0 111.285 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.962 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 156.94 140.19 2.89 Favored Glycine 0 C--O 1.254 1.403 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.027 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 60.4 mttp -79.21 155.51 28.57 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 67.5 t90 -64.57 124.91 23.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -163.17 140.53 7.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1557 ' ' GLN . . . . . 0.403 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 90.1 mt-30 -106.63 79.53 1.36 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -127.68 98.25 5.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.272 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' 1494 ' ' CYS . 34.6 mt -101.43 107.57 18.92 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.343 0.592 . . . . 0.0 109.89 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.07 113.72 26.06 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -90.71 101.35 14.1 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1562 ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' 1565 ' ' VAL . 78.3 t -135.47 141.4 42.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 60.54 24.02 13.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.791 0.836 . . . . 0.0 110.397 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 65.92 16.62 10.54 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 124.166 0.986 . . . . 0.0 110.855 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1565 ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' 1562 ' ' VAL . 7.3 p -121.49 155.29 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.826 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.6 mp -91.28 129.81 37.23 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -119.99 115.66 24.21 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.13 102.02 8.95 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1587 ' ' VAL . 7.6 p -106.95 112.51 40.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.563 0.697 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.962 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 30.6 m-85 -81.75 102.38 10.72 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' 1569 ' ' VAL . 49.5 mt-10 -102.3 161.64 13.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.111 0.482 . . . . 0.0 111.896 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 8.5 t70 63.15 66.02 0.75 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.102 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -91.16 -93.0 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.391 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.631 ' HB2' ' H ' ' A' 1551 ' ' LYS . 3.3 t70 -123.25 149.82 58.58 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.02 137.58 82.58 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.776 2.317 . . . . 0.0 112.855 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 24.8 t -101.79 128.93 27.65 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.251 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.67 16.92 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.559 2.84 . . . . 0.0 114.283 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.54 -41.12 16.8 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.39 10.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.167 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 1.7 tm? 69.84 -53.7 0.61 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.274 1.43 . . . . 0.0 111.761 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -65.92 -24.01 66.74 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.032 0.533 . . . . 0.0 110.752 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' 1611 ' ' THR . 85.4 mt -81.11 141.08 34.64 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' 1585 ' ' LYS . 62.1 mttp -132.08 158.0 42.72 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -59.66 121.36 11.44 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 124.122 0.889 . . . . 0.0 109.474 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' 1583 ' ' LYS . 43.9 mtmt -130.76 134.42 46.86 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.651 ' HB3' HD12 ' A' 1614 ' ' LEU . 13.6 p -123.53 116.77 23.72 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.426 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1569 ' ' VAL . 7.5 p -102.83 109.31 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.066 0.936 . . . . 0.0 110.649 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1588 ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.4 mp -97.62 108.85 22.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 14.7 t -95.9 119.51 34.52 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.826 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 88.8 m-85 -89.83 106.35 18.41 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 169.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' 1620 ' ' THR . 38.7 t -104.77 141.23 36.86 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 117.484 -1.686 . . . . 0.0 115.325 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 53.8 tptt -151.45 100.57 2.74 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.952 170.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1594 ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' 1621 ' ' SER . 41.0 p -66.09 -9.63 32.9 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1595 ' ' ASP . . . . . 0.522 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 8.0 m-20 -92.97 6.21 48.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.893 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -76.55 -74.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 109.45 -120.13 5.69 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.614 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.05 17.77 1.69 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.477 2.785 . . . . 0.0 110.708 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 t -153.76 -176.05 5.65 Favored 'General case' 1 N--CA 1.377 -4.121 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.726 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 41.4 m -155.48 155.7 33.95 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.566 0.746 . . . . 0.0 109.004 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.78 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 44.5 mt-30 -87.79 121.44 70.84 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.454 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.0 OUTLIER -88.95 128.78 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.391 2.727 . . . . 0.0 111.51 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' 1617 ' ' SER . 2.2 tm? -130.54 114.91 16.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.97 106.91 4.45 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 61.0 tp -75.02 -53.98 7.98 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.242 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.2 t -169.81 151.58 4.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.86 HG11 HH22 ' A' 1522 ' ' ARG . 65.0 t -125.91 131.78 71.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 19.2 t70 -110.74 117.17 32.72 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.8 -8.58 59.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -72.09 -40.46 68.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.761 0.315 . . . . 0.0 110.479 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.592 ' HA ' HD13 ' A' 1582 ' ' LEU . 23.4 p -121.66 -5.45 9.19 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 62.1 m 67.56 32.6 5.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.048 0.928 . . . . 0.0 111.152 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 44.1 m -92.04 126.61 37.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.959 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' 1586 ' ' SER . 59.0 mt -101.39 132.12 47.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.68 119.15 37.09 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.38 137.05 54.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.86 0.362 . . . . 0.0 111.621 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 27.3 m -104.11 105.42 15.57 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 12.6 t-105 -101.44 118.85 37.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.78 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 14.8 m-70 -94.79 97.57 10.14 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' 1592 ' ' CYS . 11.7 t -123.26 151.05 42.73 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.348 0.594 . . . . 0.0 111.608 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1621 ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' 1594 ' ' SER . 1.0 OUTLIER -74.23 -23.81 59.22 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.778 0.799 . . . . 0.0 110.49 178.153 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.74 -4.91 34.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.519 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -93.29 -5.86 48.78 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.793 0.33 . . . . 0.0 111.445 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 20.5 m -91.64 137.61 32.22 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 169.824 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 23.1 p-10 . . . . . 0 C--O 1.244 0.796 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 6.1 t 59.03 33.3 22.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.003 1.321 . . . . 0.0 110.255 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -150.27 154.45 37.92 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.7 p -141.62 138.24 32.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.452 HG23 HG22 ' A' 1504 ' ' VAL . 23.7 m -104.08 113.59 27.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1498 ' ' ASN . . . . . 0.574 HD21 ' HB2' ' A' 1503 ' ' TYR . 6.0 p30 -81.89 130.86 59.01 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.34 -3.37 13.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.568 2.179 . . . . 0.0 112.649 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -75.44 -53.95 7.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.727 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1501 ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' 1503 ' ' TYR . 17.2 p -109.21 -14.11 14.54 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.5 26.54 59.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.599 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1503 ' ' TYR . . . . . 0.574 ' HB2' HD21 ' A' 1498 ' ' ASN . 13.8 m-85 -99.22 120.4 39.46 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.22 -0.49 . . . . 0.0 109.977 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.452 HG22 HG23 ' A' 1497 ' ' THR . 25.4 t -89.39 113.35 25.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -100.23 111.18 23.44 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 3.0 p30 -104.01 130.87 51.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.059 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.79 0.18 56.12 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.082 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1508 ' ' ASN . . . . . 0.623 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 23.6 m120 -63.0 -38.5 91.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.49 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.9 t -71.08 -3.97 22.64 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.315 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.635 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.9 OUTLIER -114.16 -41.78 3.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.266 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' 1508 ' ' ASN . 22.0 pttp -65.57 144.21 57.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' 1515 ' ' GLY . 40.5 ttm180 -88.58 161.92 16.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -50.11 -54.98 16.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.346 1.058 . . . . 0.0 111.342 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 3.0 p -87.6 -2.62 58.74 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 123.675 0.79 . . . . 0.0 111.872 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' 1529 ' ' GLY . . . 86.74 -139.74 16.65 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -176.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 95.7 m-85 -124.63 121.65 35.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 117.467 0.633 . . . . 0.0 111.124 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 32.9 m -110.5 94.83 5.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.25 155.3 11.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.355 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 22.4 m -79.9 131.21 35.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.447 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.31 147.8 27.74 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.852 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.77 -25.97 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.901 0.88 . . . . 0.0 112.727 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -83.87 3.26 34.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.987 0.422 . . . . 0.0 110.165 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.28 84.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.772 1.629 . . . . 0.0 111.358 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1524 ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' 1545 ' ' PHE . . . -175.22 156.36 22.19 Favored Glycine 0 N--CA 1.404 -3.465 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 4.2 m -114.13 101.68 9.44 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.6 tt -83.41 119.71 33.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.196 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 43.3 ttm180 -109.78 112.74 24.97 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.974 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.36 118.78 30.33 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.583 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' 1515 ' ' GLY . . . -90.03 106.79 3.37 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 89.2 t -59.73 116.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 36.1 m 63.21 12.6 6.24 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.071 0.857 . . . . 0.0 111.609 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -129.27 172.4 19.79 Favored Glycine 0 N--CA 1.42 -2.395 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.063 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.97 141.74 40.64 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.413 HG11 ' HG2' ' A' 1527 ' ' ARG . 26.6 m -103.9 90.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.252 1.025 . . . . 0.0 109.605 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -65.1 -16.61 63.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.82 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -64.83 -22.21 66.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.92 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 21.6 t -111.87 -13.67 13.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.429 0.633 . . . . 0.0 110.043 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.67 155.27 6.46 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.217 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.08 141.12 35.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.467 2.111 . . . . 0.0 111.071 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.85 8.87 87.23 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.331 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1541 ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' 1551 ' ' LYS . 46.5 mm -106.56 135.05 46.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.23 -37.29 2.51 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.007 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -124.03 123.99 41.57 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 122.707 -0.29 . . . . 0.0 110.325 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 45.0 t -136.69 153.43 50.89 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.296 0.569 . . . . 0.0 110.821 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' 1524 ' ' GLY . 58.9 t80 -90.15 100.29 13.15 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.494 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1546 ' ' GLU . . . . . 0.725 ' HG3' HG23 ' A' 1548 ' ' THR . 11.8 pt-20 47.71 21.24 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.784 2.034 . . . . 0.0 115.221 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 63.55 27.47 70.97 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.516 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1548 ' ' THR . . . . . 0.725 HG23 ' HG3' ' A' 1546 ' ' GLU . 32.9 p -83.24 -15.95 48.33 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 118.689 1.244 . . . . 0.0 109.985 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 122.6 -14.91 8.6 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.718 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 50.7 mt -79.48 118.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' 1541 ' ' ILE . 8.6 mtmp? -97.79 137.48 36.6 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.499 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -111.48 11.63 21.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.369 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.859 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 155.53 130.55 1.33 Allowed Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.432 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.4 tttp -81.71 155.26 25.62 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 61.6 t90 -73.21 128.53 35.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.315 0.578 . . . . 0.0 110.08 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.47 139.5 14.31 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -86.89 78.16 9.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.287 0.565 . . . . 0.0 110.46 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 54.0 tptt -114.82 96.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.805 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 86.2 mt -109.84 103.34 12.12 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.568 -1.196 . . . . 0.0 107.997 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.877 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 29.2 t -101.77 141.47 34.58 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 20.3 t80 -121.59 101.16 7.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1562 ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' 1565 ' ' VAL . 98.5 t -134.88 127.29 48.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.281 -176.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.37 33.83 22.57 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.441 1.115 . . . . 0.0 110.0 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 70.94 -0.03 3.2 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.351 1.06 . . . . 0.0 113.236 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1565 ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' 1562 ' ' VAL . 9.5 p -98.98 134.18 38.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.752 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.2 tp -84.97 132.26 34.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.877 ' HB2' ' HB3' ' A' 1560 ' ' SER . 94.0 mt-30 -122.07 114.99 21.68 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.739 -0.601 . . . . 0.0 112.121 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 48.4 tp -102.86 112.65 25.55 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.471 HG12 ' HG2' ' A' 1571 ' ' GLU . 44.4 t -105.83 112.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.592 -172.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.859 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 77.4 m-85 -95.19 115.2 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.471 ' HG2' HG12 ' A' 1569 ' ' VAL . 8.9 mm-40 -111.56 165.54 11.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 33.5 t70 60.72 80.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.474 1.109 . . . . 0.0 111.871 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.46 -127.56 6.14 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 1.0 OUTLIER -113.5 147.25 37.11 Favored Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 122.604 -0.35 . . . . 0.0 111.033 175.379 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 23.5 Cg_exo -66.52 134.31 35.19 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.404 2.736 . . . . 0.0 112.832 -176.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 85.6 m -98.8 149.06 35.38 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.276 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.42 3.99 4.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.849 2.366 . . . . 0.0 115.869 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.29 -67.18 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.915 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.523 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 6.8 m-20 -110.26 2.19 19.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.246 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? 71.69 -57.62 0.61 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.337 1.055 . . . . 0.0 113.707 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -76.23 -10.44 59.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 111.168 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.669 HD13 ' HA ' ' A' 1611 ' ' THR . 70.8 mt -83.17 124.58 30.66 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 88.0 mttt -119.31 162.75 18.22 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.835 0.709 . . . . 0.0 110.043 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -58.97 109.34 0.81 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 124.01 0.819 . . . . 0.0 109.705 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -112.2 131.77 55.29 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.5 t -121.77 118.72 29.74 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.701 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -115.33 107.49 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.969 0.89 . . . . 0.0 109.844 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.96 107.32 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1589 ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' 1617 ' ' SER . 25.0 m -91.52 116.3 28.75 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 92.4 m-85 -86.12 105.53 16.6 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1591 ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' 1617 ' ' SER . 65.3 t -93.95 152.05 3.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.009 -175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.5 t -75.26 134.52 41.09 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.107 0.955 . . . . 0.0 112.822 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 54.3 tptt -149.68 101.34 3.06 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 171.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 71.1 m -63.21 -37.76 88.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.494 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -97.77 71.69 2.24 Favored 'General case' 0 N--CA 1.423 -1.813 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.937 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -133.3 -57.76 0.9 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.756 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.69 -147.67 38.91 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.94 -21.9 36.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.217 1.944 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.7 p -91.06 67.21 5.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 122.312 1.053 . . . . 0.0 109.356 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.535 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 15.1 m -76.85 161.77 28.16 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.685 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 16.9 mm-40 -105.43 121.11 47.29 Favored Pre-proline 0 C--N 1.301 -1.5 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.096 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.7 Cg_exo -77.31 152.76 30.87 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.678 2.252 . . . . 0.0 110.104 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1603 ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' 1617 ' ' SER . 66.3 tp -154.88 120.3 5.03 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.102 -0.374 . . . . 0.0 110.979 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.61 113.47 16.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 42.8 tp -88.93 -43.51 11.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 40.1 t -167.62 150.65 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 84.9 t -130.6 111.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1608 ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' 1612 ' ' CYS . 31.7 t70 -93.65 122.74 36.42 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.521 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -80.14 -11.78 59.72 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.38 -52.5 5.16 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.166 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.669 ' HA ' HD13 ' A' 1582 ' ' LEU . 47.2 p -98.03 -17.03 19.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.974 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1612 ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' 1608 ' ' ASP . 75.6 m 69.95 25.18 4.94 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 124.108 0.88 . . . . 0.0 111.586 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 21.6 m -80.38 118.1 21.71 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.98 126.88 41.52 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.16 118.03 35.67 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.37 139.23 53.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1617 ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' 1589 ' ' SER . 21.7 m -121.65 103.72 9.1 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.666 0.746 . . . . 0.0 109.382 175.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -92.89 107.53 19.29 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -175.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.6 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 96.9 m-70 -78.0 97.42 5.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.8 t -131.09 154.02 48.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.528 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.5 m -76.15 -25.09 54.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1622 ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.89 -5.03 31.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.471 0.653 . . . . 0.0 111.835 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.7 -3.05 30.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.066 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.1 m -96.04 144.71 26.07 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 168.142 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 38.6 t-20 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1494 ' ' CYS . . . . . 0.406 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 79.4 m -77.44 1.24 19.75 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.009 0.923 . . . . 0.0 111.816 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1495 ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.6 pt20 -117.15 118.25 31.82 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -118.96 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.831 0.824 . . . . 0.0 110.784 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1497 ' ' THR . . . . . 0.477 HG23 HG22 ' A' 1504 ' ' VAL . 24.8 m -96.49 125.9 41.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.243 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.93 133.52 30.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.73 4.53 6.84 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.21 1.94 . . . . 0.0 112.468 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -78.67 -68.38 0.65 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 19.7 p -101.26 -19.75 15.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.043 0.449 . . . . 0.0 111.826 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 100.29 2.24 55.72 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.539 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1503 ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' 1625 ' ' GLU . 56.3 m-85 -72.45 141.25 48.61 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.068 0.461 . . . . 0.0 111.605 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1504 ' ' VAL . . . . . 0.477 HG22 HG23 ' A' 1497 ' ' THR . 48.2 t -108.84 118.94 57.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1505 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1495 ' ' GLN . 58.7 m-85 -95.39 101.56 13.29 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.25 112.32 24.51 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.066 0.46 . . . . 0.0 110.084 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 27.7 tp -84.86 -2.02 57.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.485 0.66 . . . . 0.0 111.143 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -79.6 -21.96 44.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.6 0.714 . . . . 0.0 109.781 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 28.4 t -78.24 -10.13 59.52 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1510 ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' 1598 ' ' PRO . 0.5 OUTLIER -106.34 -45.66 4.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1511 ' ' LYS . . . . . 0.577 ' HB2' ' HB ' ' A' 1530 ' ' VAL . 21.3 pttp -49.5 146.53 3.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 114.326 -173.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1512 ' ' ARG . . . . . 0.511 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 0.0 OUTLIER -103.72 127.31 51.2 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.177 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -64.04 -43.19 96.31 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.668 0.605 . . . . 0.0 112.391 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 47.6 m -86.25 6.27 30.44 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.037 0.446 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1515 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 80.33 161.14 23.9 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 113.152 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 81.0 m-85 -100.22 118.17 35.98 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 94.0 m -93.97 100.64 12.75 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.88 142.02 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 42.5 t -102.74 136.43 42.58 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1520 ' ' ASP . . . . . 0.54 ' HB2' HD22 ' A' 1604 ' ' LEU . 0.1 OUTLIER -84.49 175.14 9.5 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.82 -21.02 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 121.212 0.529 . . . . 0.0 111.293 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -91.9 3.05 56.05 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.15 0.58 . . . . 0.0 111.489 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1523 ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 17.2 mmtm 80.96 19.09 0.47 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -80.38 105.02 2.32 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 19.2 m -84.2 98.08 9.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.0 tt -103.78 133.86 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.125 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 29.4 ttt180 -108.9 112.74 25.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.99 122.99 47.94 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1529 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -98.15 127.0 9.09 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 174.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1530 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1511 ' ' LYS . 58.9 t -87.85 116.94 30.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 83.7 m 69.68 0.63 3.06 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -134.34 140.76 12.04 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.0 137.75 41.74 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.008 0.432 . . . . 0.0 110.508 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1534 ' ' VAL . . . . . 0.406 HG21 ' SG ' ' A' 1544 ' ' CYS . 9.5 m -79.26 87.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.034 0.921 . . . . 0.0 109.973 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1535 ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.14 -18.56 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.379 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.91 -20.65 62.47 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 110.969 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.1 m -117.52 -20.49 9.01 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.304 -0.248 . . . . 0.0 111.561 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1538 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 146.94 154.11 6.1 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.31 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1539 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 24.2 Cg_exo -69.6 142.24 48.1 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 123.288 2.659 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.51 10.26 79.14 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.331 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.04 134.17 49.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1542 ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -101.25 -41.3 2.61 Favored Glycine 0 C--O 1.221 -0.661 0 C-N-CA 119.97 -1.11 . . . . 0.0 112.096 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -126.26 134.97 51.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1544 ' ' CYS . . . . . 0.406 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.4 p -145.11 151.99 39.36 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 121.221 -0.192 . . . . 0.0 110.682 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1545 ' ' PHE . . . . . 0.435 ' HB2' HG13 ' A' 1550 ' ' ILE . 85.4 m-85 -92.26 120.1 32.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.77 109.73 10.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.612 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 165.09 -73.21 0.17 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 16.8 p -97.3 -18.09 19.38 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.526 0.679 . . . . 0.0 110.194 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 89.63 19.06 50.06 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1550 ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' 1545 ' ' PHE . 23.5 pt -66.43 135.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.712 0.768 . . . . 0.0 111.192 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1551 ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' 1574 ' ' ASP . 29.2 mttp -79.42 137.54 37.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.735 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1552 ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' 1584 ' ' TYR . . . -120.3 19.52 12.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.925 0.869 . . . . 0.0 108.763 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1553 ' ' GLY . . . . . 0.882 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 151.81 124.38 1.11 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.894 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1554 ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' 1554 ' ' LYS . 33.2 ttmt -83.83 144.59 29.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 90.0 t90 -59.92 131.74 51.81 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 123.73 0.644 . . . . 0.0 110.353 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -164.29 145.35 8.33 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -112.2 85.8 2.22 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -126.75 104.84 8.29 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.736 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1559 ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 3.5 mm? -100.57 118.06 35.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.188 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1560 ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 32.1 t -110.84 147.86 33.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 28.6 t80 -130.0 128.66 42.48 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.661 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1562 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 73.2 t -113.33 156.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1563 ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' 1564 ' ' GLN . 19.5 t70 -48.11 113.21 0.69 Allowed 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 118.056 0.389 . . . . 0.0 110.653 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1564 ' ' GLN . . . . . 0.608 ' HB2' ' SG ' ' A' 1624 ' ' CYS . 7.4 pt20 56.2 21.28 5.12 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.857 2.063 . . . . 0.0 113.466 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1565 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 58.9 t -137.11 118.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1566 ' ' LEU . . . . . 0.778 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.0 tp -89.26 131.84 35.17 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1567 ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' 1560 ' ' SER . 13.3 mm100 -115.64 114.87 25.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -123.78 111.39 16.07 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1569 ' ' VAL . . . . . 0.712 HG22 HG23 ' A' 1587 ' ' VAL . 32.3 t -112.15 123.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.621 0.724 . . . . 0.0 111.285 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1570 ' ' TYR . . . . . 0.882 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 33.9 m-85 -98.96 100.82 12.04 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.245 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1571 ' ' GLU . . . . . 0.557 ' HG2' ' HD3' ' A' 1585 ' ' LYS . 34.6 mt-10 -99.91 179.34 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.048 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.61 68.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.759 1.624 . . . . 0.0 112.766 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.97 -131.5 7.32 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.291 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1574 ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' 1551 ' ' LYS . 0.2 OUTLIER -89.83 140.38 27.82 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.488 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1575 ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 25.2 Cg_exo -66.27 142.26 65.91 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.663 2.242 . . . . 0.0 112.051 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1576 ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 81.5 m -98.15 138.42 20.91 Favored Pre-proline 0 C--N 1.285 -2.224 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1577 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.2 Cg_exo -58.47 -22.74 60.63 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.619 2.879 . . . . 0.0 114.529 -172.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.29 46.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1579 ' ' ASN . . . . . 0.624 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.7 m120 -124.17 -8.24 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1580 ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' 1575 ' ' PRO . 3.7 mm? 68.17 -51.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.635 1.174 . . . . 0.0 113.376 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.1 m80 -73.42 -13.5 61.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.635 0.255 . . . . 0.0 111.578 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1582 ' ' LEU . . . . . 0.624 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 33.1 mt -90.28 132.56 35.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1583 ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.1 mttt -132.96 162.16 32.39 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1584 ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 82.8 m-85 -62.86 117.46 6.39 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1585 ' ' LYS . . . . . 0.557 ' HD3' ' HG2' ' A' 1571 ' ' GLU . 96.1 mttt -130.34 143.28 50.67 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1586 ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 19.7 m -119.77 116.96 26.97 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1587 ' ' VAL . . . . . 0.712 HG23 HG22 ' A' 1569 ' ' VAL . 3.6 p -106.87 110.02 30.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.49 111.06 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.9 t -95.93 109.26 21.65 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1590 ' ' PHE . . . . . 0.778 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 88.0 m-85 -87.29 115.02 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.9 m -107.58 152.79 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1592 ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' 1620 ' ' THR . 6.3 m -76.39 124.64 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.206 0.527 . . . . 0.0 111.53 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1593 ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 21.8 tptp -139.32 112.37 8.03 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.0 t -70.64 -22.3 62.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.505 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 110.95 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1596 ' ' ALA . . . . . 0.749 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -90.35 -77.28 0.41 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 74.13 -143.68 32.33 Favored Glycine 0 C--O 1.248 1.011 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1598 ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' 1510 ' ' LEU . 40.2 Cg_endo -67.28 -21.72 47.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.344 2.03 . . . . 0.0 110.802 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 4.1 p -94.37 70.68 3.73 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.343 1.068 . . . . 0.0 109.352 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1600 ' ' SER . . . . . 0.749 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 30.5 m -75.73 167.83 21.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.931 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1601 ' ' GLN . . . . . 0.854 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 23.1 mt-30 -107.5 121.39 44.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.419 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1602 ' ' PRO . . . . . 0.446 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.3 Cg_endo -88.97 128.77 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.063 2.509 . . . . 0.0 110.658 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 44.8 tp -141.75 136.82 31.13 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.905 -0.497 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1604 ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' 1520 ' ' ASP . 67.7 tp -79.63 124.84 28.91 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.49 -39.7 9.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.3 t -177.0 161.41 1.92 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1607 ' ' VAL . . . . . 0.518 HG23 HD23 ' A' 1614 ' ' LEU . 7.5 p -141.78 138.92 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.0 119.87 36.09 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.04 -5.81 58.06 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 57.2 m80 -83.62 -51.2 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.599 0.714 . . . . 0.0 109.08 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1611 ' ' THR . . . . . 0.607 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -100.64 -9.3 22.05 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.917 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 1612 ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 74.6 m 63.99 37.53 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.294 1.038 . . . . 0.0 110.534 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1613 ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' 1611 ' ' THR . 6.1 m -87.53 113.97 23.71 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.414 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1614 ' ' LEU . . . . . 0.594 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 60.0 mt -93.38 115.72 28.27 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -100.74 112.47 24.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1616 ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 54.7 m-85 -120.79 131.28 54.38 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.764 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 12.8 p -102.82 104.41 14.68 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.886 0.85 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1618 ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 17.2 t-105 -92.63 114.93 27.62 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1619 ' ' HIS . . . . . 0.854 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.7 m-70 -88.45 102.06 14.53 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1620 ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.5 t -135.92 153.66 51.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.056 0.455 . . . . 0.0 110.739 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.5 m -74.15 -26.09 60.11 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.13 -5.65 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.045 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -77.1 -34.39 56.84 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.606 0.717 . . . . 0.0 109.527 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1624 ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' 1564 ' ' GLN . 1.8 m -98.58 171.81 7.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.54 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1625 ' ' GLU . . . . . 0.43 ' HB3' ' CD2' ' A' 1503 ' ' TYR . 40.9 mt-10 . . . . . 0 N--CA 1.426 -1.674 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 CA--C 1.495 -1.135 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 35.8 m -92.29 124.62 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.17 120.59 14.01 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.419 ' HA ' ' HH2' ' A' 1555 ' ' TRP . 5.0 p-10 -126.69 79.74 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.528 1.156 . . . . 0.0 108.648 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.8 p30 -93.6 -34.73 13.2 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.132 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 62.3 m 57.89 28.85 16.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.331 1.02 . . . . 0.0 112.228 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' 1505 ' ' PHE . 9.5 pt20 -142.2 141.5 32.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.12 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 8.9 p -140.81 138.45 34.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 26.0 m -97.67 127.16 43.42 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.3 p30 -89.25 143.13 30.51 Favored Pre-proline 0 C--N 1.312 -1.022 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.454 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.05 -13.67 19.2 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.885 2.39 . . . . 0.0 113.752 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -74.34 -58.87 3.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1501 ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 22.0 p -109.27 -10.9 14.93 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 75.06 33.38 54.81 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.728 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -103.07 143.29 32.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 46.1 t -102.4 127.35 56.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' 1495 ' ' GLN . 93.7 m-85 -93.99 103.61 15.68 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.98 103.15 15.02 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 34.4 tp -85.94 10.06 15.13 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-O 121.847 0.832 . . . . 0.0 110.045 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.69 -19.45 52.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.09 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 20.8 p -71.16 -14.43 62.27 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.328 0.585 . . . . 0.0 111.469 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.66 -69.6 0.76 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.832 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 58.9 mmtt 61.55 146.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' 1512 ' ' ARG . 4.2 tmm_? -71.84 96.9 1.72 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.69 -42.73 11.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 16.8 p -121.62 -31.54 3.98 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.924 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.26 133.17 7.87 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -77.77 125.21 29.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1517 ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' 1526 ' ' ILE . 13.3 t -129.77 100.93 5.67 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 122.86 1.314 . . . . 0.0 110.697 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1518 ' ' ILE . . . . . 0.503 HG21 ' HG2' ' A' 1602 ' ' PRO . 16.4 pt -93.82 155.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.053 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 32.7 t -98.15 130.73 44.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1520 ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 16.7 t70 -99.73 126.53 45.8 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.25 -24.91 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.577 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' 1522 ' ' ARG . 28.7 mtp-105 -85.61 -43.01 13.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1523 ' ' LYS . . . . . 0.481 ' HB2' ' HZ ' ' A' 1545 ' ' PHE . 31.9 mmmt -113.97 -73.93 0.64 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -169.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 179.49 -152.88 11.44 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 3.9 m -84.03 154.49 23.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.2 0.524 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.0 tt -130.6 118.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -103.26 115.52 30.72 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.14 132.27 54.32 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.173 0.511 . . . . 0.0 110.733 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -99.28 87.41 0.76 Allowed Glycine 0 N--CA 1.422 -2.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.895 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 34.7 m -72.56 128.41 35.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.882 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 47.6 t 66.27 15.6 10.15 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 121.513 0.673 . . . . 0.0 111.389 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . 178.44 113.96 0.39 Allowed Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.71 160.32 11.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 21.3 m -96.99 122.07 48.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.62 0.724 . . . . 0.0 110.281 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.76 -24.67 58.73 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -53.14 -38.54 62.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.852 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 67.1 m -110.01 13.47 23.33 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.105 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 107.92 120.86 4.54 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.51 134.02 59.57 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.144 2.562 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 106.68 -29.36 11.0 Favored Glycine 0 C--N 1.286 -2.214 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.053 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.16 125.88 39.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.612 ' HA3' ' HE2' ' A' 1570 ' ' TYR . . . -99.69 -46.24 1.98 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.78 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -103.11 118.45 36.82 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 48.8 t -124.8 136.88 54.22 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 35.5 t80 -114.45 138.62 50.36 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.85 86.86 2.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.224 1.011 . . . . 0.0 110.868 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1547 ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' 1550 ' ' ILE . . . -165.67 69.34 0.19 Allowed Glycine 0 C--N 1.289 -2.068 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.328 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.0 m 74.95 -34.77 0.27 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 111.595 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 146.09 50.32 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 79.3 mt -78.86 122.21 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -96.92 115.16 26.94 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.28 12.73 36.95 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.974 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.9 133.83 2.12 Favored Glycine 0 N--CA 1.416 -2.64 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.641 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -81.83 141.55 33.34 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.433 ' HB2' ' HA3' ' A' 1542 ' ' GLY . 54.5 t90 -78.32 124.74 28.44 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.21 148.43 33.52 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . 0.255 24.0 mt-30 -77.91 73.54 4.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -99.34 77.43 2.12 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 95.5 mt -104.93 97.78 7.6 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 7.8 t -117.46 139.1 51.35 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.782 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 86.1 t80 -106.42 109.19 21.04 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.384 0.611 . . . . 0.0 110.045 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 81.4 t -96.23 158.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.63 101.9 0.03 OUTLIER 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.171 0.989 . . . . 0.0 111.514 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 67.73 16.58 9.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.611 1.564 . . . . 0.0 113.549 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 20.2 t -139.94 119.79 13.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 121.987 -0.445 . . . . 0.0 110.317 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.8 tp -81.91 129.01 34.63 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -112.95 125.35 54.3 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.268 -0.27 . . . . 0.0 111.337 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1568 ' ' LEU . . . . . 0.588 ' HB3' ' HE1' ' A' 1590 ' ' PHE . 66.2 tp -129.68 114.39 15.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 10.4 p -117.99 129.45 74.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.861 0.838 . . . . 0.0 111.334 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.827 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 81.6 m-85 -95.04 115.17 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.64 177.29 4.69 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 5.3 m-20 56.67 64.04 1.78 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.72 -145.12 18.11 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -90.57 146.63 34.68 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.69 141.83 38.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.003 2.468 . . . . 0.0 110.976 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1576 ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 75.7 m -99.68 142.21 24.2 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1577 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 16.9 Cg_exo -61.91 -22.26 73.95 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 123.652 2.901 . . . . 0.0 113.911 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -58.21 -65.14 0.7 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.204 0.602 . . . . 0.0 112.399 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.463 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 5.4 m-20 -120.25 -2.53 10.11 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.877 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.9 mm? 69.45 -53.02 0.6 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.208 1.003 . . . . 0.0 113.419 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -62.71 -28.32 69.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.164 0.586 . . . . 0.0 109.836 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' 1611 ' ' THR . 64.5 mt -82.32 128.72 34.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.859 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 58.7 mttp -118.09 162.49 18.12 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 98.3 m-85 -63.62 116.73 5.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -126.98 140.97 51.92 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 25.0 m -120.3 116.81 26.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -115.16 114.68 47.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.609 0.718 . . . . 0.0 109.797 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.36 115.48 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 7.7 t -96.67 106.58 18.88 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 94.3 m-85 -86.56 111.58 20.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.761 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.7 m -108.66 144.96 16.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' 1620 ' ' THR . 3.1 p -76.66 143.44 40.11 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' 1593 ' ' LYS . 49.4 tptt -157.66 114.01 2.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 24.4 m -71.82 -21.7 61.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.02 7.82 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 110.508 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.668 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -81.94 -67.59 0.77 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 61.47 -129.68 45.42 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.84 -16.78 54.3 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.593 2.196 . . . . 0.0 112.464 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.1 t -120.74 83.53 2.08 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 122.847 1.308 . . . . 0.0 110.59 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.668 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 18.1 m -77.86 143.02 38.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.402 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.476 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 13.9 pt20 -104.8 126.11 32.06 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-O 120.984 0.421 . . . . 0.0 111.878 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' 1518 ' ' ILE . 5.1 Cg_exo -82.83 160.01 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.327 2.685 . . . . 0.0 111.688 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.6 tp -148.78 130.13 14.71 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.61 HD11 HG23 ' A' 1607 ' ' VAL . 43.9 tp -86.36 115.97 24.22 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.2 -52.4 5.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.818 0.342 . . . . 0.0 110.372 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.8 t -167.25 138.85 3.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.61 HG23 HD11 ' A' 1604 ' ' LEU . 69.5 t -110.58 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.9 t70 -94.03 117.89 30.74 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.334 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.56 -6.21 57.9 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -95.93 -51.48 4.44 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.163 0.983 . . . . 0.0 108.935 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.844 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -95.04 -6.99 40.9 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.208 -1.815 . . . . 0.0 110.443 -171.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1612 ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 80.1 m 57.25 26.4 12.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.8 m -93.37 119.58 32.66 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.597 ' HB3' ' HE2' ' A' 1616 ' ' PHE . 85.5 mt -93.82 114.11 26.29 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.957 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.77 108.95 21.76 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -121.06 138.52 54.14 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.82 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 39.1 t -102.97 138.15 40.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.423 ' HE1' ' HB2' ' A' 1600 ' ' SER . 8.0 t-105 -126.42 114.43 18.17 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.05 100.95 13.32 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.1 t -135.28 153.01 52.03 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.269 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 10.2 m -77.98 -26.48 48.68 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 48.3 mt -72.1 -5.16 33.34 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.146 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.2 59.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 111.793 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 91.0 m -123.28 162.55 22.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1625 ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' 1505 ' ' PHE . 2.8 mp0 -70.02 102.82 2.11 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.229 0.538 . . . . 0.0 109.921 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -81.86 145.12 30.55 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.07 -11.17 58.93 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.43 0.633 . . . . 0.0 110.784 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.64 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 92.3 t -89.56 97.38 6.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 120.991 0.424 . . . . 0.0 110.586 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 52.6 tt0 55.22 81.13 0.12 Allowed 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.043 1.337 . . . . 0.0 110.934 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -118.72 92.67 3.87 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 122.579 1.181 . . . . 0.0 111.821 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1493 ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' 1557 ' ' GLN . 10.1 p30 -125.57 127.99 47.24 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.915 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 84.2 m 63.59 21.53 12.77 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.471 1.129 . . . . 0.0 110.393 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.3 pt20 -152.35 141.2 21.06 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.4 p -136.52 134.96 49.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 8.8 m -106.93 121.89 45.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.43 125.25 50.49 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.16 -6.46 18.35 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.408 2.072 . . . . 0.0 113.143 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.26 -65.49 0.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.259 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 62.0 p -92.99 -24.88 18.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.859 0.837 . . . . 0.0 110.028 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 88.58 9.31 69.22 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 60.5 t80 -80.81 127.86 33.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.309 0.576 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.7 p -98.96 116.0 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.4 m-85 -79.28 98.92 6.85 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -95.09 104.51 16.38 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.332 0.586 . . . . 0.0 110.739 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.84 -9.37 59.83 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.541 0.686 . . . . 0.0 109.913 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.432 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 45.8 m-80 -70.25 -12.3 61.5 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 57.9 m -84.74 -16.14 42.66 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 32.2 tp -114.1 -20.5 10.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.755 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.574 ' CB ' ' HB ' ' A' 1530 ' ' VAL . 56.4 pttt -54.69 140.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.716 0.635 . . . . 0.0 112.076 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -127.44 102.64 6.97 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1513 ' ' GLU . . . . . 0.443 ' HG3' ' HA3' ' A' 1532 ' ' GLY . 31.9 tt0 -76.21 -20.47 57.43 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 24.6 m -61.32 -25.11 66.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.084 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 96.06 136.39 8.78 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.75 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' 1527 ' ' ARG . 74.3 m-85 -83.5 118.21 23.62 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 172.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 26.6 m -110.6 104.01 12.66 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.68 150.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.21 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.9 m -79.17 115.29 18.74 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.529 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.86 144.64 56.9 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.855 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.3 tt -74.03 -18.46 17.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.642 1.177 . . . . 0.0 110.94 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' 1522 ' ' ARG . 3.7 mmp_? -90.25 2.82 55.03 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.848 -0.533 . . . . 0.0 109.583 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.5 tptp 79.14 90.19 0.06 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.939 1.696 . . . . 0.0 110.098 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1524 ' ' GLY . . . . . 0.41 ' HA3' ' HZ ' ' A' 1545 ' ' PHE . . . -176.77 -161.02 24.85 Favored Glycine 0 N--CA 1.412 -2.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.2 t -144.6 139.74 28.3 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 15.0 tt -132.62 139.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' 1516 ' ' TYR . 33.4 ttt180 -127.91 120.33 27.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.3 136.08 54.52 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.921 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.7 158.97 14.08 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' 1511 ' ' LYS . 59.9 t -106.48 115.81 48.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 118.237 1.018 . . . . 0.0 108.31 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 77.9 m 57.58 26.83 13.28 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.951 0.782 . . . . 0.0 112.445 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1532 ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' 1513 ' ' GLU . . . -130.04 142.15 13.37 Favored Glycine 0 N--CA 1.414 -2.769 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.38 126.62 35.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.8 m -94.9 98.95 8.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' 1535 ' ' LYS . 10.0 mptt -67.19 -20.88 65.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.639 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.81 -10.17 59.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.892 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1537 ' ' CYS . . . . . 0.585 ' HB2' HG23 ' A' 1534 ' ' VAL . 73.3 m -116.06 7.63 14.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 115.94 137.27 6.1 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.656 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.33 128.07 19.57 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.351 2.034 . . . . 0.0 110.126 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.62 11.73 61.82 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.426 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.8 mm -112.74 128.5 69.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.66 -22.06 7.92 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.929 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -134.1 127.21 31.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 29.0 p -144.36 154.92 43.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.482 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.41 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 44.4 t80 -84.92 134.91 34.25 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -86.2 97.66 10.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 160.41 -91.74 0.11 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.7 p -71.2 -21.15 62.18 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 90.85 18.6 46.89 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.792 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 22.8 pt -74.14 131.4 35.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.248 0.547 . . . . 0.0 110.004 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 19.8 pttm -84.17 142.52 30.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.38 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -113.21 11.56 18.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.943 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.28 135.94 2.18 Favored Glycine 0 N--CA 1.433 -1.509 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.755 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' 1572 ' ' ASP . 29.3 mtpp -75.37 150.89 38.28 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.157 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.77 125.98 26.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.322 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.11 158.39 43.87 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1557 ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' 1493 ' ' ASN . 11.1 pt20 -124.16 33.53 5.26 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.927 0.87 . . . . 0.0 109.622 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.88 95.73 7.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.482 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.31 110.9 23.37 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 15.9 p -89.48 119.19 29.71 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.264 0.554 . . . . 0.0 111.359 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1561 ' ' TYR . . . . . 0.675 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 16.0 t80 -92.93 101.17 13.52 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 94.3 t -106.89 104.89 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.739 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.32 63.32 1.91 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.214 1.406 . . . . 0.0 111.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1564 ' ' GLN . . . . . 0.675 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 64.5 mt-30 66.12 11.62 7.95 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 113.908 -1.496 . . . . 0.0 114.197 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 93.4 t -116.87 139.2 44.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.6 113.64 22.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -109.02 114.68 28.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.898 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.79 110.81 17.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.53 121.61 66.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.859 0.837 . . . . 0.0 111.703 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.943 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.3 m-85 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.167 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.438 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 36.9 mt-10 -101.02 174.31 6.07 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' 1554 ' ' LYS . 9.8 t70 53.97 73.26 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.738 1.615 . . . . 0.0 111.5 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -96.25 -140.09 10.89 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.37 138.94 31.9 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 14.9 Cg_exo -68.38 135.39 33.79 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.854 2.369 . . . . 0.0 112.975 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 62.7 m -98.76 131.02 26.49 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.823 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.1 2.54 2.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.414 2.742 . . . . 0.0 115.542 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -72.88 -50.45 23.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.965 0.412 . . . . 0.0 110.172 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.89 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 17.3 m120 -132.43 -0.1 3.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.45 -47.12 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.4 p80 -76.39 -5.81 48.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.146 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 61.5 mt -89.05 126.54 35.48 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 98.1 mttt -133.24 159.04 41.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 91.9 m-85 -61.51 113.24 2.57 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.986 0.804 . . . . 0.0 108.86 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.438 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.6 mtpt -124.51 136.16 53.77 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.8 m -120.0 116.12 25.11 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 6.1 p -110.34 109.76 29.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.927 0.87 . . . . 0.0 109.67 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.85 111.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.036 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 67.1 m -92.3 112.01 23.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 94.9 m-85 -86.53 103.1 14.73 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 29.7 m -105.84 161.49 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.194 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.7 t -76.88 136.89 38.88 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 23.3 tptm -149.99 105.23 3.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 77.0 p -62.36 -37.78 87.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.256 0.55 . . . . 0.0 110.281 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.64 76.3 3.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.531 0.682 . . . . 0.0 110.213 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -128.09 -64.38 0.96 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.837 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 66.91 -133.6 31.74 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 -20.1 35.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.405 2.07 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.9 p -102.49 73.22 1.3 Allowed 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.66 0.743 . . . . 0.0 111.034 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.51 ' HB3' ' HB ' ' A' 1620 ' ' THR . 42.1 m -86.03 105.56 16.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.473 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 91.2 mt-30 -77.01 126.14 85.91 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -171.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.1 Cg_endo -83.99 111.37 1.65 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 123.398 2.732 . . . . 0.0 110.702 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' 1617 ' ' SER . 62.0 tp -88.68 123.53 33.22 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.04 91.72 5.52 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.25 -59.13 3.44 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.865 -175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1606 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1615 ' ' PHE . 46.4 m -158.91 132.4 7.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 65.2 t -106.75 111.04 33.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.15 102.47 14.51 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.97 -20.2 60.43 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.438 -170.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.57 -45.52 12.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.962 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.806 ' HA ' HD13 ' A' 1582 ' ' LEU . 68.4 p -85.72 -16.35 39.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.504 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1612 ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 79.6 m 71.1 26.64 3.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 110.413 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 9.7 m -93.11 116.7 29.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.825 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 80.2 mt -99.09 116.91 32.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1615 ' ' PHE . . . . . 0.407 ' HD2' ' HB2' ' A' 1606 ' ' SER . 80.5 m-85 -100.82 117.33 34.69 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -120.68 133.42 55.35 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.866 0.466 . . . . 0.0 110.216 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.655 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 19.5 m -107.21 103.77 13.23 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -95.46 107.05 19.18 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 57.6 m-70 -83.37 104.18 13.32 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' 1600 ' ' SER . 10.2 t -131.99 150.42 52.16 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.449 0.642 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.7 p -77.13 -22.15 53.07 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.28 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 44.6 tp -71.42 -7.09 45.05 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.434 0.635 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.72 -4.19 26.89 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.226 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.9 m -87.07 176.61 7.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.99 122.26 31.38 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -111.09 117.17 32.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.44 -23.32 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--O 1.251 1.138 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.901 -178.806 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1489 ' ' MET . . . . . 0.696 ' HG3' HG23 ' A' 1490 ' ' VAL . 22.5 ptp . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 121.029 0.443 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1490 ' ' VAL . . . . . 0.696 HG23 ' HG3' ' A' 1489 ' ' MET . 57.2 t -116.31 88.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -87.37 91.53 8.76 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' 1495 ' ' GLN . 10.4 p-10 -73.46 82.16 1.45 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.724 -1.58 . . . . 0.0 114.042 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -92.88 80.58 4.64 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 72.3 m 64.55 40.32 6.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.853 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.548 ' HG2' ' HA ' ' A' 1492 ' ' ASP . 10.4 pt20 -136.63 152.03 49.98 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 13.8 p -157.87 139.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.6 m -97.59 132.94 42.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' 1503 ' ' TYR . 8.2 p30 -99.23 126.77 36.75 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.06 -10.69 29.67 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.786 2.324 . . . . 0.0 113.828 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -61.58 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 27.2 p -96.46 -26.55 15.26 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.135 0.493 . . . . 0.0 111.653 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 89.81 11.57 63.47 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1503 ' ' TYR . . . . . 0.464 ' HB3' HD21 ' A' 1498 ' ' ASN . 87.7 t80 -83.92 136.91 33.91 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 114.954 -0.623 . . . . 0.0 109.914 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' 1497 ' ' THR . 49.0 t -99.54 114.18 36.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' 1495 ' ' GLN . 98.5 m-85 -77.12 98.66 5.12 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.11 108.05 19.63 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1507 ' ' LEU . . . . . 0.556 HD11 HD23 ' A' 1510 ' ' LEU . 15.7 tp -86.22 4.24 39.55 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.673 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.566 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 51.2 m-80 -70.92 -18.66 62.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 47.4 t -80.18 -10.83 59.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.556 HD23 HD11 ' A' 1507 ' ' LEU . 69.0 tp -116.6 -25.61 7.33 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.95 -0.469 . . . . 0.0 111.469 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' 1530 ' ' VAL . 19.2 pttp -56.49 142.33 39.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.647 0.737 . . . . 0.0 112.571 -174.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -128.76 106.07 8.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1513 ' ' GLU . . . . . 0.423 ' HA ' ' HA3' ' A' 1532 ' ' GLY . 32.4 tt0 -65.01 -34.11 77.66 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.634 0.773 . . . . 0.0 110.799 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 20.4 m -72.95 -11.69 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.429 0.633 . . . . 0.0 110.341 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 78.33 161.66 18.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 114.587 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' 1527 ' ' ARG . 94.5 m-85 -97.98 128.74 44.73 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 25.2 m -100.53 98.2 8.82 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1518 ' ' ILE . . . . . 0.424 HG13 HG23 ' A' 1526 ' ' ILE . 18.1 pt -109.04 111.14 34.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.822 0.82 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1519 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.7 t -95.67 112.38 24.11 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.686 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1520 ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 15.2 t70 -100.62 120.68 40.41 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.4 -10.16 11.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.521 0.677 . . . . 0.0 112.384 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 16.3 mtp180 -92.99 -39.01 11.35 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 121.956 -0.465 . . . . 0.0 110.713 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -109.23 -34.9 6.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 136.99 177.74 15.27 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1525 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1519 ' ' SER . 32.5 t -79.85 127.99 32.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.424 HG23 HG13 ' A' 1518 ' ' ILE . 10.7 tt -123.08 122.3 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' 1516 ' ' TYR . 16.9 ttm180 -108.35 116.05 31.25 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.13 120.29 37.31 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.297 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -93.52 118.96 5.82 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' 1511 ' ' LYS . 46.0 t -75.45 116.17 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.691 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 68.1 m 59.1 20.43 8.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.216 0.948 . . . . 0.0 112.047 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1532 ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' 1513 ' ' GLU . . . -135.86 132.8 6.3 Favored Glycine 0 N--CA 1.401 -3.685 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1533 ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' 1535 ' ' LYS . 21.6 mt-10 -76.39 130.02 37.44 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 15.4 m -80.1 93.1 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.52 0.676 . . . . 0.0 110.901 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' 1533 ' ' GLU . 0.0 OUTLIER -59.3 -26.45 64.99 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.49 -178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.17 -37.3 66.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.176 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 43.3 t -107.19 -25.37 11.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.948 0.404 . . . . 0.0 110.133 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 143.17 144.92 4.34 Favored Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.3 152.2 81.09 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.547 2.165 . . . . 0.0 110.795 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.5 -27.35 6.43 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.807 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.0 mm -89.59 136.09 24.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.04 -37.12 2.58 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.294 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -125.84 128.07 47.06 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 44.2 t -139.59 139.86 36.9 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.686 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.42 ' HZ ' HD11 ' A' 1614 ' ' LEU . 98.2 m-85 -87.02 124.29 33.04 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1546 ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' 1525 ' ' SER . 47.4 mt-10 -82.05 107.99 15.19 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.738 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 172.39 -71.65 0.1 Allowed Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.3 m -106.9 -24.82 11.91 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.572 0.701 . . . . 0.0 109.397 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 103.7 34.33 3.85 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.02 131.03 35.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.444 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 25.8 pttm -93.22 138.65 31.41 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.95 8.06 43.26 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.611 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 140.74 149.48 5.28 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.876 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.31 155.72 17.36 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.385 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.691 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 39.0 t90 -71.49 143.61 49.95 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.2 152.74 38.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -106.07 9.88 32.29 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.59 107.12 19.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.063 0.458 . . . . 0.0 110.651 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.403 HD23 HD13 ' A' 1568 ' ' LEU . 74.6 mt -88.59 125.8 34.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.886 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.8 m -90.24 121.84 32.62 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.2 t80 -98.89 116.12 30.4 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 122.23 -0.294 . . . . 0.0 110.416 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.4 t -121.24 80.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 38.7 t70 40.45 83.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.154 1.781 . . . . 0.0 114.518 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 64.05 19.24 11.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.498 1.119 . . . . 0.0 112.849 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 58.6 t -133.9 119.89 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.42 133.87 37.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.943 0.401 . . . . 0.0 110.302 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.886 ' HB2' ' HB2' ' A' 1560 ' ' SER . 15.3 mm100 -110.83 114.7 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.573 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1568 ' ' LEU . . . . . 0.403 HD13 HD23 ' A' 1559 ' ' LEU . 34.1 tp -116.45 107.35 14.66 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 17.1 t -105.99 108.55 25.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.095 -174.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.611 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 61.3 m-85 -82.08 107.16 14.56 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.5 178.33 4.59 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.585 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 24.4 t70 56.73 67.06 1.04 Allowed 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.87 1.356 . . . . 0.0 111.241 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1573 ' ' GLY . . . . . 0.444 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -93.25 -155.25 31.81 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 173.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -82.57 158.17 66.22 Favored Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 117.605 0.703 . . . . 0.0 109.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.63 140.08 35.28 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.272 1.981 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 83.5 m -101.33 133.92 20.61 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.196 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.09 7.8 1.0 Allowed 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.31 2.673 . . . . 0.0 113.633 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.33 -52.96 6.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.13 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.541 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 2.4 m-20 -131.83 -2.36 3.71 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.802 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 31.9 tp 71.47 -47.82 0.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.908 1.283 . . . . 0.0 113.032 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -73.33 -12.81 60.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.451 0.643 . . . . 0.0 110.277 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.904 HD13 ' HA ' ' A' 1611 ' ' THR . 89.4 mt -85.58 127.62 34.51 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.042 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.616 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 44.5 mttm -112.54 152.92 28.27 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.494 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -60.07 123.62 17.7 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.725 0.64 . . . . 0.0 109.87 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.69 131.4 43.06 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.6 t -120.86 116.66 25.6 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 3.3 p -108.12 101.32 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.966 0.889 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.72 114.11 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.3 m -95.93 109.63 21.97 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.731 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.4 m-85 -86.18 108.1 18.18 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 m -103.87 166.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 13.0 t -75.96 120.39 21.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 123.988 0.915 . . . . 0.0 112.91 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.745 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 48.1 tptt -152.55 99.47 2.47 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.3 m -65.82 -30.81 71.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1595 ' ' ASP . . . . . 0.745 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 10.3 t70 -85.57 67.76 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -143.54 -56.44 0.39 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.718 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 79.09 -160.92 46.84 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.63 -20.14 35.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 110.869 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -92.31 53.97 2.23 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.923 0.868 . . . . 0.0 109.102 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.1 m -62.3 140.66 58.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.015 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -106.32 124.61 35.24 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 52.8 Cg_endo -87.92 133.88 3.07 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.167 2.578 . . . . 0.0 112.515 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.1 tp -118.92 134.93 54.85 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.425 HD11 HG23 ' A' 1607 ' ' VAL . 45.1 tp -72.76 118.86 16.21 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.34 -43.37 12.93 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1606 ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' 1615 ' ' PHE . 21.6 t -179.9 146.98 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.425 HG23 HD11 ' A' 1604 ' ' LEU . 95.9 t -123.09 121.14 62.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1608 ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' 1610 ' ' HIS . 32.5 t70 -115.2 103.09 10.5 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.742 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.4 8.28 7.93 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.049 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1610 ' ' HIS . . . . . 0.428 ' HB2' ' OD2' ' A' 1608 ' ' ASP . 51.7 m80 -88.81 -51.48 5.62 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.904 ' HA ' HD13 ' A' 1582 ' ' LEU . 1.6 m -98.84 -6.17 29.63 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.526 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 76.6 m 62.1 30.74 17.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.257 1.023 . . . . 0.0 111.198 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 14.5 m -97.3 116.7 30.0 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.41 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.599 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 84.7 mt -96.93 120.2 36.83 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.31 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1615 ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' 1606 ' ' SER . 72.7 m-85 -105.21 112.22 25.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.599 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.1 m-85 -122.41 135.39 54.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 42.1 p -113.05 110.89 21.22 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' 1602 ' ' PRO . 1.5 t-105 -97.24 115.91 28.49 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 48.6 m80 -83.59 99.43 10.17 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -128.74 151.12 49.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.881 0.848 . . . . 0.0 111.485 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.9 m -76.88 -27.69 55.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.434 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.44 -5.95 40.22 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.277 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.59 -1.44 35.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.594 0.711 . . . . 0.0 110.345 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 12.3 t -113.77 170.32 8.34 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.59 99.08 0.2 Allowed 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 123.869 0.731 . . . . 0.0 110.022 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -122.78 141.63 51.61 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 -26.08 15.01 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.583 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.309 -1.169 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 -175.747 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1489 ' ' MET . . . . . 0.715 ' HG2' HG13 ' A' 1490 ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1490 ' ' VAL . . . . . 0.715 HG13 ' HG2' ' A' 1489 ' ' MET . 26.8 m -127.18 149.26 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.91 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -153.58 88.69 1.29 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.887 ' HB2' ' HG3' ' A' 1495 ' ' GLN . 38.2 p-10 -150.8 107.58 3.53 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.826 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1493 ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' 1557 ' ' GLN . 3.6 p-10 -117.32 123.43 46.5 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.421 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 64.9 m 73.27 0.09 3.55 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.053 0.93 . . . . 0.0 112.113 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.887 ' HG3' ' HB2' ' A' 1492 ' ' ASP . 21.1 pt20 -128.91 147.39 50.83 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.9 p -132.48 118.25 34.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 122.112 0.958 . . . . 0.0 110.868 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.787 HG23 HG22 ' A' 1504 ' ' VAL . 6.0 m -96.37 101.51 13.16 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.19 122.17 49.38 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.36 -8.02 19.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.215 2.61 . . . . 0.0 112.53 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.95 -56.61 17.4 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.758 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1501 ' ' THR . . . . . 0.415 ' HB ' ' CD2' ' A' 1503 ' ' TYR . 57.7 p -101.01 -28.39 12.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 85.46 10.77 76.44 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.45 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1503 ' ' TYR . . . . . 0.415 ' CD2' ' HB ' ' A' 1501 ' ' THR . 56.6 m-85 -99.54 131.6 45.43 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.787 HG22 HG23 ' A' 1497 ' ' THR . 28.3 t -90.48 99.23 9.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -83.32 105.71 14.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1506 ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' 1495 ' ' GLN . 24.3 t70 -105.26 112.03 25.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.228 0.537 . . . . 0.0 111.862 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.9 tp -85.27 -4.49 59.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.035 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.65 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 62.6 m-80 -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 69.6 m -77.3 -10.03 59.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.111 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.452 ' HB2' HD12 ' A' 1622 ' ' LEU . 26.2 tp -109.92 8.05 24.11 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.434 0.635 . . . . 0.0 109.493 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 53.5 mtmt -58.54 143.7 45.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.665 ' H ' ' HB ' ' A' 1530 ' ' VAL . 32.2 tpt180 -127.25 97.9 5.09 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -25.38 60.27 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.522 0.514 . . . . 0.0 110.711 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 45.5 t -67.6 -26.31 66.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 88.14 153.82 26.66 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -89.8 114.78 26.56 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 6.5 p -103.56 92.34 4.42 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.03 0.919 . . . . 0.0 109.8 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.5 pt -120.55 153.44 23.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.742 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1519 ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' 1524 ' ' GLY . 15.5 p -103.95 118.27 36.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.79 174.69 1.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.515 0.509 . . . . 0.0 111.009 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.2 tp -61.85 -24.26 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.74 -5.82 58.48 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 73.73 74.44 0.13 Allowed 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.918 1.687 . . . . 0.0 112.454 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1524 ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1519 ' ' SER . . . -151.37 139.16 6.98 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 174.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 47.6 m -87.78 129.2 35.26 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.898 0.849 . . . . 0.0 111.673 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.4 tt -122.0 142.1 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -118.24 116.74 27.4 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.546 0.738 . . . . 0.0 109.076 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.61 125.92 43.92 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.86 129.74 10.0 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.449 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.665 ' HB ' ' H ' ' A' 1512 ' ' ARG . 47.5 t -79.52 115.22 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.514 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.673 ' HA ' ' CZ3' ' A' 1555 ' ' TRP . 69.9 m 46.25 66.91 0.85 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 125.141 1.526 . . . . 0.0 113.461 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -171.25 175.17 44.92 Favored Glycine 0 N--CA 1.404 -3.459 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.78 134.89 48.54 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.7 m -88.9 97.13 6.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.739 0.78 . . . . 0.0 110.689 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -22.54 54.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.941 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.22 -26.44 66.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.653 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 61.5 m -102.91 0.2 32.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.32 150.63 18.26 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.58 145.79 87.89 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.404 2.069 . . . . 0.0 112.48 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1540 ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' 1555 ' ' TRP . . . 82.41 14.73 75.67 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 114.81 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.33 131.62 63.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 118.082 0.941 . . . . 0.0 109.221 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.49 -28.31 7.18 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.901 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.796 0.332 . . . . 0.0 111.147 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 69.0 m -142.59 149.24 38.74 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.494 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 56.1 t80 -94.88 118.81 32.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.75 110.02 4.7 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.17 0.918 . . . . 0.0 112.488 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 144.82 -80.04 0.23 Allowed Glycine 0 C--N 1.296 -1.677 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.032 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 20.1 m -72.38 -19.77 61.56 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.321 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 79.29 41.78 13.06 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.621 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' 1545 ' ' PHE . 20.9 pt -93.46 131.01 41.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 56.4 mttm -85.44 129.2 34.87 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.552 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -98.86 7.73 45.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.055 0.455 . . . . 0.0 111.172 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.62 146.02 4.31 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.985 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 50.6 tttm -69.32 145.46 52.99 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.028 0.931 . . . . 0.0 109.588 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.673 ' CZ3' ' HA ' ' A' 1531 ' ' CYS . 7.0 t-105 -66.24 109.67 2.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -146.75 161.23 41.06 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1557 ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' 1493 ' ' ASN . 51.2 mt-30 -120.6 67.83 0.85 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.033 0.92 . . . . 0.0 108.849 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.4 tptt -96.86 95.38 7.82 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.776 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 4.2 mm? -104.7 104.85 14.73 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.111 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.809 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.3 m -100.07 139.46 35.71 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 89.3 t80 -113.98 117.8 32.33 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.479 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1562 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 67.6 t -103.43 153.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.28 100.79 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 123.901 0.881 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 68.47 19.06 8.89 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.959 1.704 . . . . 0.0 112.33 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1565 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 49.0 t -134.07 119.57 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.739 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.7 tp -87.37 140.18 29.79 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.809 ' HB2' ' HB2' ' A' 1560 ' ' SER . 14.7 mm100 -124.65 115.25 20.48 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.722 -0.611 . . . . 0.0 111.097 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 63.0 tp -109.9 120.31 42.08 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.494 HG22 HG23 ' A' 1587 ' ' VAL . 32.5 t -117.35 131.45 70.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.132 0.491 . . . . 0.0 110.461 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' 1586 ' ' SER . 63.5 m-85 -103.1 105.8 16.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.65 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.442 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.91 92.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.934 1.396 . . . . 0.0 112.179 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.33 -158.07 12.9 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.507 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.83 151.57 52.54 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.99 147.59 3.38 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.529 2.819 . . . . 0.0 114.766 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1576 ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 17.2 t -98.22 130.25 28.85 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.139 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1577 ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 21.9 Cg_exo -60.76 -27.48 84.88 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.142 2.562 . . . . 0.0 113.911 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.31 33.9 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 13.2 m120 -126.5 8.31 7.05 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.86 -62.54 0.34 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.785 1.234 . . . . 0.0 114.078 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.27 4.51 8.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' 1576 ' ' CYS . 92.5 mt -90.36 154.54 19.61 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' 1585 ' ' LYS . 94.1 mttt -123.86 154.09 40.15 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.431 ' HE2' ' HB ' ' A' 1550 ' ' ILE . 27.1 m-85 -62.73 116.82 5.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' 1583 ' ' LYS . 28.9 mtpp -115.05 133.82 55.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.723 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 37.5 m -120.01 122.36 40.96 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.212 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.494 HG23 HG22 ' A' 1569 ' ' VAL . 6.6 p -126.75 111.27 25.42 Favored 'Isoleucine or valine' 0 C--O 1.25 1.096 0 CA-C-O 121.975 0.893 . . . . 0.0 110.725 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.0 110.88 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.746 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 29.5 m -88.53 111.18 21.55 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.739 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.5 m-85 -86.97 106.64 17.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.0 m -98.53 153.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1620 ' ' THR . 48.7 t -86.96 133.85 33.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.16 0.981 . . . . 0.0 113.166 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.0 tptt -147.33 105.38 3.74 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.1 t -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.601 0.715 . . . . 0.0 110.645 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.29 -3.17 57.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.717 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.904 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.98 -42.81 15.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.5 -156.41 51.0 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.976 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.06 -4.1 14.69 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.441 2.761 . . . . 0.0 113.098 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 17.8 p -90.54 -49.69 6.36 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.904 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.5 m 69.34 145.77 0.05 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.379 1.072 . . . . 0.0 113.144 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 97.8 mt-30 -87.84 121.88 70.54 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.338 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.0 Cg_endo -88.43 118.67 1.07 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.466 2.777 . . . . 0.0 111.661 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' 1617 ' ' SER . 63.5 tp -130.8 124.69 31.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.224 0.535 . . . . 0.0 109.974 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.683 HD21 HG23 ' A' 1607 ' ' VAL . 62.6 tp -87.16 126.73 34.98 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 58.4 tp -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 60.4 p -178.35 142.67 0.26 Allowed 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.015 0.822 . . . . 0.0 109.943 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.683 HG23 HD21 ' A' 1604 ' ' LEU . 61.9 t -94.37 117.47 38.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.69 113.15 26.31 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.324 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.95 -2.0 45.96 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 45.9 m80 -82.33 -41.2 20.37 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.382 0.61 . . . . 0.0 110.677 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.582 ' HA ' HD13 ' A' 1582 ' ' LEU . 33.8 p -121.58 -9.81 8.89 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 75.5 m 65.68 35.07 7.18 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.149 0.976 . . . . 0.0 111.397 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -96.48 122.92 39.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.096 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.555 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 88.7 mt -91.27 112.81 24.88 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -98.41 115.6 28.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.086 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.555 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 86.9 m-85 -123.41 140.21 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' 1603 ' ' LEU . 40.0 m -120.67 103.69 9.33 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -95.51 122.01 37.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.856 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 46.9 m-70 -90.73 102.98 15.74 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.4 t -127.48 153.89 45.76 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.046 0.45 . . . . 0.0 110.447 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.2 m -79.59 -25.28 41.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' 1510 ' ' LEU . 33.4 mt -70.7 -4.75 25.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.708 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.45 -23.44 40.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.625 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 60.3 m -79.31 159.68 27.1 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -50.55 132.61 25.5 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -80.24 116.36 20.29 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -86.34 -31.04 21.76 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.69 -171.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.848 -179.727 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1490 ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' 1492 ' ' ASP . 38.9 t -95.05 141.64 14.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -75.54 -1.1 22.76 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.699 ' H ' HG12 ' A' 1490 ' ' VAL . 13.9 t70 51.7 79.48 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.633 1.573 . . . . 0.0 109.393 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -136.65 85.81 2.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.17 -174.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.445 ' HB2' ' OD1' ' A' 1508 ' ' ASN . 82.9 m 55.1 25.06 6.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' 1505 ' ' PHE . 25.0 pt20 -132.91 119.15 19.8 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 124.89 71.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.376 0.608 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 9.1 m -88.71 109.7 20.36 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.32 138.4 45.16 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.246 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.2 -2.75 12.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.686 2.257 . . . . 0.0 113.572 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -82.33 -63.89 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.813 0.34 . . . . 0.0 110.618 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1501 ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' 1625 ' ' GLU . 24.6 p -98.13 -20.17 17.48 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.4 3.35 81.72 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.87 133.62 43.17 Favored 'General case' 0 C--O 1.254 1.325 0 C-N-CA 123.074 0.55 . . . . 0.0 109.842 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 65.4 t -95.33 111.75 26.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' 1495 ' ' GLN . 82.8 m-85 -85.04 103.03 13.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.2 108.06 19.4 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1507 ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 32.5 tp -82.48 -8.75 59.61 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.477 ' HA ' ' HD3' ' A' 1511 ' ' LYS . 90.2 m-20 -59.79 -24.02 63.77 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.62 1.968 . . . . 0.0 112.789 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 6.9 p -86.36 -11.0 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.04 0.448 . . . . 0.0 111.531 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 49.1 tp -116.0 -22.33 9.05 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 122.207 -0.308 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1531 ' ' CYS . 22.2 pttp -46.79 131.38 11.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.035 0.921 . . . . 0.0 113.472 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -126.93 101.11 6.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.293 -172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.54 -37.75 87.62 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.91 0.756 . . . . 0.0 110.967 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 41.3 m -63.49 -18.42 63.78 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.395 0.617 . . . . 0.0 110.447 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 86.11 149.14 12.65 Favored Glycine 0 N--CA 1.415 -2.74 0 CA-C-N 115.278 -0.874 . . . . 0.0 114.635 173.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -80.83 114.35 19.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 20.0 m -99.45 98.84 9.7 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 27.4 pt -115.84 145.7 21.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.511 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 35.8 t -111.03 130.5 55.58 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.287 0.565 . . . . 0.0 109.912 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.44 153.86 42.94 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.97 -22.76 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.373 0.606 . . . . 0.0 111.62 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -79.51 3.75 17.78 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.43 0.692 . . . . 0.0 111.042 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 56.9 tptt 73.52 87.18 0.1 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.75 1.62 . . . . 0.0 110.442 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -169.11 117.2 0.7 Allowed Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 50.4 m -81.62 120.79 25.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 120.785 0.326 . . . . 0.0 110.815 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.802 ' HB ' ' HD1' ' A' 1545 ' ' PHE . 14.6 tt -114.41 128.24 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.5 ttm180 -116.95 115.5 25.59 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.2 mp -114.78 114.93 26.23 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.303 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -83.55 111.16 3.38 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' 1511 ' ' LYS . 7.2 p -85.97 116.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.981 -0.717 . . . . 0.0 109.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1511 ' ' LYS . 85.7 m 64.94 15.63 10.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.421 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.91 140.21 8.99 Favored Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -76.81 146.88 37.53 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.6 p -89.19 99.32 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 122.291 1.043 . . . . 0.0 110.959 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' 1535 ' ' LYS . 0.3 OUTLIER -65.48 -19.36 65.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.187 -174.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.57 -36.5 78.66 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.899 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 78.0 m -106.96 -24.29 12.06 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 129.63 152.61 7.61 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.482 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.25 146.86 95.79 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.981 2.454 . . . . 0.0 110.815 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 97.41 -14.61 63.23 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.866 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.98 136.15 51.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.446 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.39 -47.12 0.82 Allowed Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.99 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -108.28 125.9 52.21 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 43.9 t -141.98 139.12 32.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.802 ' HD1' ' HB ' ' A' 1526 ' ' ILE . 57.4 t80 -108.72 121.58 45.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.24 -30.96 71.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -66.2 112.91 5.29 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.4 m 72.93 1.31 3.98 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.029 0.932 . . . . 0.0 110.629 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 58.59 41.9 95.83 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' 1545 ' ' PHE . 27.5 pt -90.82 142.05 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.769 0.795 . . . . 0.0 112.238 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 84.7 mttt -82.08 137.74 34.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.756 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -120.41 15.39 12.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.189 0.519 . . . . 0.0 110.202 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.91 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 157.79 128.51 1.03 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.96 -1.114 . . . . 0.0 114.221 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.9 tttp -72.75 139.53 47.19 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 125.248 1.419 . . . . 0.0 107.319 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 55.5 t90 -72.78 134.43 44.94 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.88 159.57 35.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.39 88.69 2.83 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1558 ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 40.2 mmtm -131.21 90.81 2.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.35 111.05 23.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 17.6 m -116.16 127.82 55.13 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.4 101.1 13.31 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -138.38 150.15 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.7 t70 65.68 15.2 9.94 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.803 0.811 . . . . 0.0 108.979 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 70.08 12.71 7.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.058 1.743 . . . . 0.0 110.682 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 63.0 t -117.53 151.91 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.851 0.86 . . . . 0.0 109.865 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.1 mp -86.28 124.34 32.55 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.134 -0.354 . . . . 0.0 110.588 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.981 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.4 tp -128.55 118.01 22.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.485 HG22 ' HG3' ' A' 1571 ' ' GLU . 10.5 p -126.39 117.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 112.983 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.91 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 54.4 m-85 -92.13 102.34 14.87 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.893 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.579 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 44.6 mt-10 -107.67 166.58 10.57 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 20.6 t70 68.94 71.0 0.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.274 1.035 . . . . 0.0 111.734 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.0 -137.16 9.68 Favored Glycine 0 N--CA 1.421 -2.333 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.45 153.96 65.62 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.21 151.03 84.52 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.081 1.854 . . . . 0.0 110.587 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 72.7 m -97.3 137.87 21.18 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.8 -25.94 78.31 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.547 2.832 . . . . 0.0 113.449 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.11 -67.25 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.573 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.9 m120 -109.53 -3.68 16.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.1 mm? 67.98 -53.11 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.702 1.201 . . . . 0.0 113.336 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -61.8 -18.21 59.07 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.372 1.469 . . . . 0.0 111.82 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' 1611 ' ' THR . 81.0 mt -82.93 141.66 32.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -116.17 146.94 41.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.88 118.97 9.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 86.9 mttt -130.16 137.62 50.21 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 14.5 m -119.84 116.28 25.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -108.36 114.92 47.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.972 0.892 . . . . 0.0 110.408 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.61 122.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.443 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 19.6 m -109.16 114.77 28.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 91.7 m-85 -86.79 109.61 19.38 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -102.4 159.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 35.6 t -76.28 130.24 37.86 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.19 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.613 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 47.3 tptt -159.82 106.59 1.65 Allowed 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 19.8 m -72.04 -25.96 62.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1595 ' ' ASP . . . . . 0.613 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 34.4 t70 -81.54 19.81 0.98 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.564 1.146 . . . . 0.0 110.68 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.748 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -95.03 -39.39 10.19 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.691 -0.631 . . . . 0.0 110.508 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 71.57 -162.53 54.3 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.871 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.7 -14.69 33.31 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.228 2.619 . . . . 0.0 112.12 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.1 p -81.94 -50.9 8.62 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.748 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.3 m 65.54 108.87 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.025 0.828 . . . . 0.0 111.198 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 48.4 mt-30 -74.27 124.85 90.24 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.716 -172.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 11.7 Cg_endo -92.97 108.02 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 123.329 2.686 . . . . 0.0 111.251 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.21 116.23 28.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.776 HD21 HG23 ' A' 1607 ' ' VAL . 5.4 tt -77.8 108.3 10.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 63.5 tp -74.92 -54.58 6.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.987 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 23.1 t -169.4 151.19 4.42 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.776 HG23 HD21 ' A' 1604 ' ' LEU . 83.9 t -117.92 110.75 31.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.18 104.57 16.61 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.399 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.44 5.38 17.82 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.445 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 56.1 m80 -88.63 -44.23 10.76 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -112.05 -0.08 15.79 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.6 -176.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 60.3 m 63.01 30.64 16.32 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.185 0.994 . . . . 0.0 111.235 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -99.05 118.56 36.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.726 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.62 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 78.6 mt -97.26 119.29 35.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -102.75 115.44 30.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.62 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 69.4 m-85 -125.74 126.72 45.05 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.01 0.433 . . . . 0.0 110.263 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 20.2 m -106.07 112.66 25.8 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -97.17 119.03 34.92 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 64.6 m-70 -89.8 112.87 24.32 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 14.9 t -139.46 152.18 46.8 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.18 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 6.9 m -74.89 -23.7 58.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' 1505 ' ' PHE . 41.7 mt -72.6 -5.55 38.05 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.347 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.09 16.87 25.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.327 0.584 . . . . 0.0 110.404 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 59.0 m -113.15 151.26 31.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.062 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1625 ' ' GLU . . . . . 0.499 ' HG2' HG21 ' A' 1501 ' ' THR . 5.4 mp0 -83.89 132.94 34.75 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -81.8 118.08 22.6 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.13 -58.93 2.44 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.308 -1.23 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 34.4 m -84.54 131.04 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.35 112.89 24.1 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.941 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.19 53.31 2.22 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.157 0.98 . . . . 0.0 110.548 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -85.0 112.63 20.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 15.0 t 69.03 26.34 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.626 1.203 . . . . 0.0 109.503 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -156.13 151.17 26.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -114.02 132.33 63.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.827 HG23 HG22 ' A' 1504 ' ' VAL . 63.3 m -141.72 105.75 4.77 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.1 p30 -98.34 129.34 30.76 Favored Pre-proline 0 N--CA 1.435 -1.218 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.754 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.05 -11.78 31.1 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.425 2.083 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -55.72 10.7 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.586 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 38.9 p -118.98 -6.28 10.5 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 77.11 34.38 41.91 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1503 ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' 1497 ' ' THR . 41.0 t80 -83.57 109.61 17.55 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.827 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -128.01 107.6 16.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 O-C-N 123.748 0.655 . . . . 0.0 109.477 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' 1625 ' ' GLU . 8.3 m-85 -120.87 106.49 11.7 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -91.89 108.8 20.18 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.366 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1507 ' ' LEU . . . . . 0.497 HD11 HD23 ' A' 1510 ' ' LEU . 18.5 tp -89.27 -5.87 57.25 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.964 0.888 . . . . 0.0 109.321 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.427 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 53.1 m-80 -62.21 -26.8 68.56 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.8 t -74.29 -10.67 59.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.497 HD23 HD11 ' A' 1507 ' ' LEU . 35.8 tp -111.87 6.85 19.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.301 0.572 . . . . 0.0 110.451 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' 1530 ' ' VAL . 35.1 mtmm -57.29 153.8 11.58 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.64 ' HD2' ' H ' ' A' 1530 ' ' VAL . 0.0 OUTLIER -84.0 176.76 8.62 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.116 -174.301 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1513 ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' 1513 ' ' GLU . 0.0 OUTLIER -89.93 -51.75 5.32 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 35.1 t -128.16 -38.39 1.8 Allowed 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.594 ' HA2' ' HG3' ' A' 1512 ' ' ARG . . . 158.2 161.68 11.18 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.07 129.04 48.29 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 19.9 m -99.09 99.64 10.68 Favored 'General case' 0 N--CA 1.425 -1.711 0 O-C-N 123.788 0.68 . . . . 0.0 109.196 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.1 pt -119.58 155.84 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 8.1 t -107.59 141.17 39.48 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.22 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.36 170.05 16.86 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.842 1.257 . . . . 0.0 107.874 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.48 -23.91 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.899 0.857 . . . . 0.0 110.032 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -84.45 1.16 46.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.876 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 74.41 10.66 4.2 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 126.013 1.725 . . . . 0.0 114.459 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -71.83 123.57 9.88 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 41.5 m -81.79 124.14 29.4 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.76 132.99 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 CA-C-O 121.315 0.578 . . . . 0.0 109.566 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -107.24 116.35 31.78 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.39 140.77 52.64 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.273 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -106.62 151.17 16.92 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' 1511 ' ' LYS . 24.5 t -92.22 115.02 30.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 31.4 m 55.98 24.55 7.81 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.677 1.236 . . . . 0.0 111.88 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -139.06 169.82 24.31 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -99.15 131.25 45.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.615 HG23 ' HB2' ' A' 1537 ' ' CYS . 14.3 m -88.06 93.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.591 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -50.6 -38.27 44.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.653 -173.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.78 -19.67 65.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1537 ' ' CYS . . . . . 0.615 ' HB2' HG23 ' A' 1534 ' ' VAL . 64.6 m -109.73 9.43 24.88 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.476 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.74 155.11 10.98 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.093 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 131.43 13.34 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.612 2.208 . . . . 0.0 111.347 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1540 ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' 1554 ' ' LYS . . . 79.93 19.55 69.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.553 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' A' 1551 ' ' LYS . 45.1 mm -114.19 137.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -114.83 -18.04 6.62 Favored Glycine 0 C--N 1.32 -0.306 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.563 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.26 133.95 30.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 19.2 p -149.11 152.43 36.14 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.509 0.188 . . . . 0.0 111.509 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -94.46 118.53 31.78 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.17 110.48 13.19 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.454 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.6 -71.26 0.27 Allowed Glycine 0 C--N 1.282 -2.449 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 3.0 m -87.85 -20.4 26.09 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.91 44.53 11.96 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.75 150.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.48 ' HD3' ' CD1' ' A' 1541 ' ' ILE . 49.9 mttm -90.92 134.46 34.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.09 17.12 11.64 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.425 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 160.32 126.6 0.84 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.886 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' 1540 ' ' GLY . 32.6 ttmt -84.08 147.19 27.51 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.784 0.834 . . . . 0.0 109.997 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 64.3 t90 -64.86 129.25 39.04 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 123.775 0.672 . . . . 0.0 109.673 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.99 156.99 6.36 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -124.21 65.58 1.06 Allowed 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.913 0.863 . . . . 0.0 109.553 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -94.59 92.98 7.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.424 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.88 115.12 27.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 11.7 m -112.9 124.92 53.71 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.422 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.9 t80 -88.62 101.79 14.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 59.5 t -117.4 102.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.945 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.3 68.68 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.673 1.589 . . . . 0.0 112.739 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.57 9.77 6.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.051 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.5 t -125.78 135.44 63.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 O-C-N 121.948 -0.47 . . . . 0.0 110.018 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.11 118.27 25.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.86 118.21 36.31 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.08 119.63 37.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.463 HG22 HG23 ' A' 1587 ' ' VAL . 26.3 t -114.12 115.11 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.993 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.5 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 66.4 m-85 -96.82 92.33 6.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' 1585 ' ' LYS . 14.8 pt-20 -110.84 176.17 5.14 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.587 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.2 t70 66.8 80.15 0.22 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.921 1.288 . . . . 0.0 111.683 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -122.21 -131.44 3.9 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.81 159.17 63.93 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.62 157.93 16.43 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.226 1.95 . . . . 0.0 113.012 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 84.8 m -98.45 136.86 20.7 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.627 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.82 6.26 3.85 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.518 2.145 . . . . 0.0 113.64 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.52 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.732 0.301 . . . . 0.0 110.556 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 11.4 m120 -109.42 -1.13 18.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.913 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.95 -50.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 33.1 m80 -79.86 26.24 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.452 0.701 . . . . 0.0 112.419 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.88 125.54 44.13 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' 1585 ' ' LYS . 67.0 mttm -112.28 160.01 18.07 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -64.14 126.54 28.07 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1571 ' ' GLU . 1.3 mptp? -111.01 133.2 53.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.0 t -120.25 115.68 24.08 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.463 HG23 HG22 ' A' 1569 ' ' VAL . 7.8 p -112.7 124.73 69.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.607 0.718 . . . . 0.0 110.8 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.05 116.42 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 24.0 m -94.22 110.69 22.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.724 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 90.3 m-85 -88.25 111.07 21.25 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 22.3 m -110.14 155.2 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.778 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 25.4 t -75.08 123.24 24.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.338 0.589 . . . . 0.0 110.603 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 52.9 tptt -146.97 116.72 7.15 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 20.3 m -82.89 -20.41 35.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.294 0.568 . . . . 0.0 109.535 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1595 ' ' ASP . . . . . 0.597 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -79.29 14.19 1.62 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.592 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -94.22 -56.53 2.81 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.234 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.79 -166.39 41.14 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 -16.32 37.47 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.048 2.499 . . . . 0.0 112.561 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 11.5 p -91.74 -35.51 14.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.295 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.947 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 35.0 m 66.12 177.14 0.22 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.911 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 91.0 mt-30 -114.9 119.35 39.3 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.776 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -94.18 111.85 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 123.224 2.616 . . . . 0.0 109.597 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 59.3 tp -126.46 126.55 43.96 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.0 tp -74.93 120.31 20.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.85 -53.31 5.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.909 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 48.7 m -164.6 149.39 9.67 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 109.88 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 86.8 t -115.51 119.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.11 106.03 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.218 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.29 2.59 27.43 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.3 -24.21 16.3 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.759 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1611 ' ' THR . . . . . . . . . . . . . 24.5 p -115.39 -3.45 12.43 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.861 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 86.2 m 61.22 28.16 17.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.384 1.074 . . . . 0.0 111.532 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 25.3 m -105.56 124.61 49.84 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.378 0.609 . . . . 0.0 110.154 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.99 125.48 39.68 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.82 118.68 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 135.33 54.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 39.8 t -110.34 119.23 38.56 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -107.39 104.62 14.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.2 m-70 -83.74 105.83 14.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.6 t -132.26 152.36 51.39 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.532 0.682 . . . . 0.0 111.296 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 15.9 m -80.19 -22.6 41.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.339 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 37.2 tp -71.33 -6.52 40.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.347 0.594 . . . . 0.0 110.621 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.28 5.79 42.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.673 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 71.3 m -88.61 140.89 29.0 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.122 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1625 ' ' GLU . . . . . 0.707 ' HA ' ' HZ ' ' A' 1505 ' ' PHE . 2.3 mp0 -44.12 151.69 0.22 Allowed 'General case' 0 C--O 1.253 1.252 0 C-N-CA 126.066 1.746 . . . . 0.0 114.241 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.85 152.56 19.6 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -95.13 -26.26 16.09 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -178.18 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 CA--C 1.516 -0.341 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 21.8 t -74.14 -19.74 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 72.36 5.64 5.32 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.555 0.742 . . . . 0.0 111.426 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.65 61.58 1.62 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 t30 -126.1 124.41 40.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.582 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 43.9 t 71.17 3.95 4.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.794 1.283 . . . . 0.0 109.993 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.7 pt20 -150.56 143.55 24.74 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.4 p -136.05 128.51 45.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 121.216 0.531 . . . . 0.0 109.568 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.424 HG23 HG22 ' A' 1504 ' ' VAL . 23.4 m -92.65 108.21 19.8 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 3.4 p30 -81.52 138.8 47.7 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.799 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.25 4.49 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.612 2.208 . . . . 0.0 113.546 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -88.85 -59.25 2.28 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.924 0.392 . . . . 0.0 110.333 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1501 ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 6.8 p -104.41 -12.51 16.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.74 13.33 83.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.546 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 84.0 t80 -86.17 130.94 34.36 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.424 HG22 HG23 ' A' 1497 ' ' THR . 45.3 t -89.82 108.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.3 m-85 -79.11 105.93 10.79 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1506 ' ' ASP . . . . . 0.449 ' O ' HD11 ' A' 1622 ' ' LEU . 9.3 t70 -94.84 102.63 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 30.9 tp -86.58 2.7 47.29 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.626 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' 1511 ' ' LYS . 28.8 m-80 -71.84 -18.61 62.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.379 0.609 . . . . 0.0 109.84 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 59.0 m -82.18 -19.33 40.09 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.137 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' 1598 ' ' PRO . 0.2 OUTLIER -115.84 10.29 15.27 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.64 ' HA ' HG23 ' A' 1530 ' ' VAL . 19.3 pttp -76.17 134.03 40.03 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.574 0.702 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.599 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 1.9 tpm_? -127.81 94.03 3.84 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1513 ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' 1513 ' ' GLU . 0.2 OUTLIER -75.19 -14.93 60.58 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -174.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 13.8 p -78.84 -13.15 59.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 91.17 137.78 7.49 Favored Glycine 0 N--CA 1.424 -2.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.173 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' 1527 ' ' ARG . 83.0 m-85 -82.28 126.68 32.4 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 11.8 p -102.54 90.13 3.75 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 123.73 0.644 . . . . 0.0 109.452 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 19.3 pt -109.29 159.47 8.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.154 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.4 m -83.79 127.16 33.61 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.821 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.48 157.94 19.07 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1521 ' ' ILE . . . . . 0.717 ' HB ' HD21 ' A' 1604 ' ' LEU . 14.7 tt -70.84 -23.54 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.627 0.727 . . . . 0.0 109.432 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.446 HH22 HD21 ' A' 1614 ' ' LEU . 54.4 mtt180 -71.65 -0.92 11.97 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.234 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 71.22 83.56 0.14 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.055 1.342 . . . . 0.0 110.6 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 173.85 179.95 44.82 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 14.4 m -110.31 139.67 45.26 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.22 133.7 67.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' 1516 ' ' TYR . 24.5 ttm180 -111.31 112.87 24.95 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.71 120.63 37.15 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.49 125.3 8.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.0 m -96.19 117.73 41.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.52 ' HA ' ' CH2' ' A' 1555 ' ' TRP . 74.6 m 72.57 10.49 5.66 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.172 0.989 . . . . 0.0 112.776 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -145.8 142.65 10.82 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.77 140.53 30.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.7 m -76.67 97.23 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 122.829 1.3 . . . . 0.0 109.543 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.783 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -61.19 -21.2 63.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.867 -174.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.43 -19.01 36.73 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.787 0.327 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1537 ' ' CYS . . . . . 0.65 ' HB2' HG23 ' A' 1534 ' ' VAL . 76.2 m -105.76 4.95 30.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 110.03 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.47 145.96 13.18 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.188 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.46 129.18 23.14 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.9 2.4 . . . . 0.0 111.843 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 103.7 -5.79 47.87 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.552 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.8 mm -93.48 128.24 45.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.623 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -91.63 -40.64 5.28 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.85 134.92 33.96 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1544 ' ' CYS . . . . . 0.525 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.7 p -141.53 150.48 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 81.8 t80 -96.16 130.19 43.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.5 107.54 8.84 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 123.835 0.709 . . . . 0.0 109.765 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.79 -89.19 0.12 Allowed Glycine 0 C--N 1.283 -2.399 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.3 m -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.945 0.403 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 86.35 27.23 30.95 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 26.1 pt -82.96 141.53 14.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 22.9 pttm -94.51 138.58 32.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.96 12.0 37.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.73 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.887 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.49 147.52 4.68 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.443 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -82.69 150.79 26.56 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.699 0.399 . . . . 0.0 110.134 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.52 ' CH2' ' HA ' ' A' 1531 ' ' CYS . 30.0 t-105 -69.05 123.87 22.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.38 174.44 15.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.97 44.09 1.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1558 ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 32.2 mmtp -81.81 77.25 8.66 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.357 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.58 98.42 7.05 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 16.8 m -111.97 139.99 47.02 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 93.2 t80 -97.35 103.26 15.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 17.6 m -130.75 113.09 23.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.879 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.9 t70 59.5 44.08 15.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 110.439 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 62.7 17.22 9.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.348 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.9 t -110.49 126.14 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.944 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.3 tp -90.0 115.77 27.54 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -102.2 120.17 40.01 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.29 -0.256 . . . . 0.0 111.034 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1568 ' ' LEU . . . . . 0.41 ' HB2' ' HE1' ' A' 1590 ' ' PHE . 26.6 tp -106.31 109.08 20.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.438 HG22 HG23 ' A' 1587 ' ' VAL . 21.9 t -109.67 119.3 58.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.099 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.887 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 53.7 m-85 -94.61 115.9 28.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.44 161.2 16.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.053 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 12.0 t70 56.94 71.96 0.54 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.341 1.856 . . . . 0.0 113.499 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -90.84 -136.21 6.63 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -96.26 144.92 28.67 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.779 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 36.9 Cg_endo -67.89 141.84 55.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.225 1.95 . . . . 0.0 112.427 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 74.9 m -98.37 141.41 22.9 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.31 -12.52 35.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.658 2.905 . . . . 0.0 114.846 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -70.33 -61.95 1.58 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.1 m120 -119.97 -4.93 10.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.3 mm? 70.42 -48.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.202 1.001 . . . . 0.0 113.374 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 26.3 m80 -76.17 -4.54 42.25 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.959 0.409 . . . . 0.0 111.97 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.726 HD13 ' HA ' ' A' 1611 ' ' THR . 61.9 mt -101.06 120.13 39.75 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.779 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.6 mttt -118.41 163.23 17.05 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -52.63 110.64 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 36.2 tptt -116.93 130.96 57.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 9.3 t -127.0 118.97 25.55 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.581 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.438 HG23 HG22 ' A' 1569 ' ' VAL . 6.7 p -118.26 111.33 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.836 0.827 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.32 108.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 49.0 m -88.54 109.56 20.17 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.547 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.944 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.9 m-85 -85.92 104.57 15.69 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.3 m -101.52 163.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' 1620 ' ' THR . 46.2 t -97.23 144.65 26.83 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.399 -172.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.516 ' HG2' ' OE1' ' A' 1601 ' ' GLN . 17.6 tppt? -150.47 115.38 5.3 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 5.3 p -61.52 -41.51 97.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.19 25.64 1.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -97.1 -63.3 1.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.052 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 75.84 -156.01 47.16 Favored Glycine 0 C--O 1.25 1.104 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1598 ' ' PRO . . . . . 0.575 ' HA ' HD21 ' A' 1510 ' ' LEU . 41.4 Cg_endo -66.45 -20.95 54.11 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.888 2.392 . . . . 0.0 111.422 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 p -94.44 62.42 2.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 17.3 m -63.67 149.04 47.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.325 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 39.7 mt-30 -87.14 128.55 55.15 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.9 Cg_endo -91.36 134.35 1.63 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.977 2.451 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' 1617 ' ' SER . 64.7 tp -131.66 108.03 9.22 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.033 0.445 . . . . 0.0 110.388 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' 1521 ' ' ILE . 64.3 tp -68.15 116.4 8.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 39.1 tp -98.15 -63.36 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.016 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 34.8 m -150.33 137.49 19.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 81.0 t -131.61 119.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.03 126.75 52.91 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.514 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -80.91 -10.21 59.74 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.95 -52.17 6.92 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.343 0.592 . . . . 0.0 109.513 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' 1582 ' ' LEU . 46.0 p -92.41 -19.64 21.85 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 63.6 m 66.89 23.34 9.97 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.415 1.086 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -81.18 120.99 25.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.159 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.673 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 90.1 mt -102.39 115.94 31.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.299 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.32 114.77 29.22 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.673 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.0 m-85 -122.02 135.91 54.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.441 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 37.4 t -107.86 114.92 29.21 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -109.2 118.29 36.33 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 38.9 m-70 -98.58 101.33 12.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.2 t -129.27 152.95 48.28 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.395 0.617 . . . . 0.0 110.982 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.7 m -75.77 -25.68 56.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.317 0.58 . . . . 0.0 109.706 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' 1622 ' ' LEU . 6.8 tt -64.04 -16.8 62.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.673 0.789 . . . . 0.0 110.284 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.36 59.71 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 35.0 m -94.53 140.99 29.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.012 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1625 ' ' GLU . . . . . 0.506 ' HG2' ' OG1' ' A' 1501 ' ' THR . 3.5 mp0 -71.91 90.22 1.12 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -81.05 157.98 25.25 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.165 -1.834 . . . . 0.0 113.314 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -63.5 -33.95 76.7 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.079 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.432 -1.335 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.825 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 7.2 p -88.68 128.37 40.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 72.12 129.08 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.596 1.559 . . . . 0.0 110.606 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.407 ' OD1' HD13 ' A' 1559 ' ' LEU . 1.0 OUTLIER -81.92 151.25 27.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.588 0.709 . . . . 0.0 110.824 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -131.95 61.84 1.65 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.385 169.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 75.94 22.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.672 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.7 pt20 -153.27 118.66 5.22 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.644 -1.162 . . . . 0.0 107.999 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -121.83 130.36 74.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.262 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 3.8 m -103.84 106.05 16.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 6.7 p30 -91.67 134.09 29.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.62 -175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1499 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 6.6 Cg_exo -67.02 -25.36 44.33 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.893 2.395 . . . . 0.0 113.057 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -56.06 -61.81 2.13 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.014 0.435 . . . . 0.0 111.894 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 21.6 p -96.43 -15.18 21.91 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 69.33 41.23 79.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -128.85 136.42 50.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 120.827 0.346 . . . . 0.0 110.252 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.8 p -94.89 118.17 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.897 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.9 m-85 -87.18 106.72 18.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -86.39 99.02 11.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.2 tp -84.94 4.49 33.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 122.739 1.257 . . . . 0.0 108.791 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 62.9 m-20 -58.87 -28.6 66.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.478 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.1 t -79.33 -11.56 59.93 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.049 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' 1622 ' ' LEU . 20.0 tp -111.73 1.56 16.74 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.687 -0.633 . . . . 0.0 110.602 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.52 ' HE2' ' SG ' ' A' 1531 ' ' CYS . 100.0 mttt -50.21 160.48 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.563 ' HG3' ' CA ' ' A' 1515 ' ' GLY . 9.2 ttp180 -68.49 105.21 2.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.147 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -91.03 -44.68 9.16 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 167.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.3 t -121.96 -35.22 3.21 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.314 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' 1512 ' ' ARG . . . 103.19 162.68 25.55 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.31 121.03 44.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.0 m -117.57 99.18 6.8 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1518 ' ' ILE . . . . . 0.419 HG21 ' HG2' ' A' 1602 ' ' PRO . 20.1 pt -101.43 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.506 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1519 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1525 ' ' SER . 24.1 t -93.64 114.68 27.05 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.663 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1520 ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 13.7 t70 -89.3 113.96 25.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.83 -18.83 20.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.727 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.471 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.1 mtp180 -76.3 -47.32 24.08 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.73 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.83 -59.3 1.36 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.862 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -175.43 -165.44 31.54 Favored Glycine 0 C--O 1.215 -1.056 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.279 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1525 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1519 ' ' SER . 20.3 m -91.18 154.14 19.53 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 117.385 0.593 . . . . 0.0 111.167 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.0 tt -134.55 132.59 54.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -111.78 116.59 30.95 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.71 137.07 50.1 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.71 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -107.39 100.0 1.48 Allowed Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 7.1 p -76.64 116.69 20.2 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.52 ' SG ' ' HE2' ' A' 1511 ' ' LYS . 46.8 t 70.3 3.69 4.55 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.601 0.715 . . . . 0.0 111.418 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -132.16 149.1 19.34 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1533 ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' 1535 ' ' LYS . 38.5 mt-10 -88.16 131.84 34.56 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 11.3 m -87.95 81.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.311 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.632 ' HD2' ' HB2' ' A' 1533 ' ' GLU . 0.0 OUTLIER -67.6 -13.56 62.18 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.958 0.885 . . . . 0.0 110.7 -175.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.96 -32.96 70.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.45 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 51.8 t -108.01 3.67 24.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.398 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 124.22 150.52 7.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.699 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.66 149.31 38.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.402 2.068 . . . . 0.0 111.171 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.13 14.25 80.61 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.927 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.429 HD12 ' HD3' ' A' 1551 ' ' LYS . 44.7 mm -112.86 135.17 53.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -102.28 -35.03 4.01 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.184 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.58 141.23 39.22 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.993 -0.71 . . . . 0.0 110.676 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1544 ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' 1541 ' ' ILE . 57.2 m -141.75 146.79 36.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.7 ' HB3' HG13 ' A' 1550 ' ' ILE . 35.2 t80 -97.6 134.78 40.35 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.37 100.86 9.47 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.351 0.596 . . . . 0.0 109.841 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -162.98 -108.35 0.22 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.5 m -84.9 -5.94 59.34 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 101.03 46.49 1.73 Allowed Glycine 0 CA--C 1.491 -1.41 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' 1545 ' ' PHE . 14.0 pt -83.7 132.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.048 0.451 . . . . 0.0 109.991 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' 1541 ' ' ILE . 58.6 mttp -87.42 138.06 31.81 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.542 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -104.88 11.68 33.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.434 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.716 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.17 146.86 4.58 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.338 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1572 ' ' ASP . 1.9 mptm? -77.86 147.31 35.2 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 66.0 t90 -69.77 128.84 37.82 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -158.18 158.52 34.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -104.58 88.4 2.93 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.721 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.8 tptt -130.36 83.69 2.14 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.166 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.407 HD13 ' OD1' ' A' 1492 ' ' ASP . 11.0 mp -96.39 125.29 40.78 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.693 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 7.9 m -121.58 139.82 53.03 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.046 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.3 t80 -106.66 110.06 22.14 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 65.9 t -116.04 92.66 2.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 34.05 88.23 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.359 1.864 . . . . 0.0 115.018 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 67.12 9.34 6.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.506 1.123 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 48.0 t -132.29 136.17 56.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.5 tp -96.58 136.86 36.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' 1560 ' ' SER . 15.3 mm100 -120.33 127.05 51.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.844 -0.535 . . . . 0.0 110.771 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.7 tp -124.71 124.48 42.24 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.634 HG22 HG23 ' A' 1587 ' ' VAL . 19.6 t -120.47 122.82 69.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.26 0.552 . . . . 0.0 112.051 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.716 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 59.8 m-85 -101.51 113.43 26.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.3 161.14 17.59 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.762 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.499 ' O ' ' HD3' ' A' 1554 ' ' LYS . 35.7 t70 60.2 83.19 0.14 Allowed 'General case' 0 C--O 1.209 -1.033 0 O-C-N 124.657 1.223 . . . . 0.0 113.173 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.83 2.31 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.409 ' H ' ' HD2' ' A' 1584 ' ' TYR . 7.5 m-20 -124.23 150.25 63.15 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.21 136.7 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.623 2.216 . . . . 0.0 111.662 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 64.5 m -99.65 132.6 22.8 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.43 16.13 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.67 2.913 . . . . 0.0 113.949 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -79.41 -49.36 12.48 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.582 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 16.7 m120 -146.85 8.65 0.98 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 29.5 tp 68.93 -47.1 0.57 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.51 1.524 . . . . 0.0 113.98 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 36.3 m80 -75.34 -11.07 59.98 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.552 0.692 . . . . 0.0 110.045 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.698 HD22 HG22 ' A' 1611 ' ' THR . 57.8 mt -85.39 128.15 34.62 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.04 162.55 30.5 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.409 ' HD2' ' H ' ' A' 1574 ' ' ASP . 92.5 m-85 -65.74 112.2 3.59 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -126.14 134.8 51.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.1 t -126.92 125.46 41.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.634 HG23 HG22 ' A' 1569 ' ' VAL . 6.5 p -119.85 117.86 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.693 0.758 . . . . 0.0 109.307 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.77 116.37 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 8.4 t -96.17 104.96 16.95 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.925 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.3 m-85 -87.05 111.5 20.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 34.5 m -105.08 159.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 42.6 t -77.54 128.82 34.81 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 112.501 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 58.4 tptt -145.69 109.18 4.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.8 m -71.57 -28.14 63.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.143 0.496 . . . . 0.0 112.199 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.16 30.22 6.1 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.567 0.698 . . . . 0.0 111.15 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -84.74 -52.38 6.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.787 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 78.13 -159.49 47.22 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.71 -20.77 26.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.848 2.365 . . . . 0.0 111.708 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.2 t -96.81 58.55 1.65 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 123.031 1.396 . . . . 0.0 108.847 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 12.7 m -63.42 130.42 44.35 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.726 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.466 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 78.1 mt-30 -81.6 125.89 77.28 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -89.61 105.87 0.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.456 2.77 . . . . 0.0 110.873 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 62.9 tp -91.98 130.25 37.77 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.93 127.01 31.7 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1605 ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' 1617 ' ' SER . 99.3 mt -88.36 -58.32 2.6 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 44.6 m -164.62 147.26 8.66 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 108.989 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 64.6 t -107.91 111.71 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -98.59 91.66 5.25 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -70.04 -33.06 71.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.382 -1.735 . . . . 0.0 115.226 -165.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 51.4 t60 -70.68 -36.9 73.55 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.539 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.698 HG22 HD22 ' A' 1582 ' ' LEU . 0.0 OUTLIER -98.21 0.55 46.04 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.769 -176.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.9 m 55.27 31.1 15.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.565 0.746 . . . . 0.0 111.735 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 29.5 m -99.45 126.86 45.44 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.336 0.589 . . . . 0.0 110.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.581 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 87.0 mt -108.65 118.98 38.2 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.345 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.87 117.97 35.41 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.581 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 79.1 m-85 -128.14 135.95 50.47 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.616 0.366 . . . . 0.0 110.663 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.606 ' HB2' HD21 ' A' 1605 ' ' LEU . 22.7 t -106.68 110.94 23.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -98.25 111.89 24.07 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 17.0 m170 -81.4 98.36 8.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 12.1 t -129.4 153.09 48.24 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.611 0.72 . . . . 0.0 112.012 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 23.5 m -77.88 -21.45 51.26 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.71 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.8 -5.63 35.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.901 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.91 1.68 40.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.479 0.657 . . . . 0.0 109.48 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -103.18 162.31 13.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.837 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.11 133.7 45.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -81.54 114.51 20.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.9 -23.17 13.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.428 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.334 178.709 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 CA--C 1.511 -0.541 0 CA-C-O 121.146 0.498 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 35.1 m -126.1 161.44 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.493 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -98.96 89.22 4.21 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.85 117.97 6.79 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.34 -74.18 0.56 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1508 ' ' ASN . 6.5 t 61.69 23.03 13.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.687 1.195 . . . . 0.0 110.967 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' 1505 ' ' PHE . 21.5 pt20 -149.37 155.01 39.8 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -155.39 136.1 4.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 10.7 m -99.55 131.86 45.27 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -83.22 118.83 72.8 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.121 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.82 -16.46 44.45 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.991 2.46 . . . . 0.0 114.516 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -76.7 -62.89 1.48 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.542 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.5 p -97.16 -16.86 20.24 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 84.03 24.32 48.99 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.793 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -92.26 132.11 36.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.203 0.501 . . . . 0.0 109.88 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 25.6 t -101.13 106.8 20.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' 1495 ' ' GLN . 76.4 m-85 -81.38 104.15 11.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.76 93.08 7.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.646 0.736 . . . . 0.0 110.203 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 36.1 tp -84.69 -8.38 58.88 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' 1494 ' ' CYS . 59.6 t30 -65.99 -27.96 68.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.502 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 8.5 t -84.76 -11.86 54.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 -36.66 9.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' 1530 ' ' VAL . 2.2 pptp? -44.3 127.84 5.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -98.08 107.98 20.58 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.423 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -69.36 -34.63 74.87 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.74 0.65 . . . . 0.0 111.649 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 64.2 m -65.14 -17.4 64.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.247 0.546 . . . . 0.0 110.646 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 83.18 143.83 5.3 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.279 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -77.09 114.28 15.73 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1517 ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' 1526 ' ' ILE . 7.8 m -107.93 96.88 6.69 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1518 ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' 1525 ' ' SER . 27.6 pt -102.79 134.23 44.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.73 -175.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.2 m -89.15 92.61 9.26 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.73 123.2 40.35 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.579 0.704 . . . . 0.0 111.509 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.25 -16.07 20.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.595 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.515 ' HD2' HD23 ' A' 1604 ' ' LEU . 69.1 mtt180 -94.17 -26.38 16.71 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.227 -0.921 . . . . 0.0 112.283 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 52.4 tptt -129.36 -59.27 1.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.854 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 166.21 -166.74 38.96 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.526 -0.845 . . . . 0.0 110.999 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1525 ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' 1518 ' ' ILE . 20.2 m -94.4 112.27 24.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.323 0.582 . . . . 0.0 109.458 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' 1545 ' ' PHE . 10.8 tt -120.94 140.48 44.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.436 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -110.84 115.28 29.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.64 119.84 36.2 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -91.72 127.96 9.14 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' 1511 ' ' LYS . 21.7 t -81.04 116.39 25.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.418 ' SG ' HG12 ' A' 1530 ' ' VAL . 60.7 m 70.67 -24.46 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 172.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -105.07 140.83 15.17 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.69 142.61 44.43 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 120.7 0.286 . . . . 0.0 110.353 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 17.5 m -78.16 81.79 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.428 1.109 . . . . 0.0 109.075 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.628 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.38 -12.01 3.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.716 1.607 . . . . 0.0 112.941 -173.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 -29.17 35.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.664 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.0 t -93.66 -3.95 51.51 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 122.129 0.966 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 132.5 158.36 8.88 Favored Glycine 0 N--CA 1.422 -2.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.2 135.68 32.43 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 123.18 2.587 . . . . 0.0 111.351 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 76.48 9.74 85.91 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.871 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.604 HD12 ' HG2' ' A' 1551 ' ' LYS . 46.5 mm -93.04 133.32 34.61 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -103.58 -48.5 1.19 Allowed Glycine 0 C--N 1.323 -0.155 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.525 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.05 129.39 54.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 53.5 t -148.06 138.65 22.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.627 0.251 . . . . 0.0 110.467 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' 1526 ' ' ILE . 96.6 m-85 -78.57 127.45 32.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.48 103.43 6.48 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 123.728 0.643 . . . . 0.0 109.862 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.68 -76.26 0.22 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1548 ' ' THR . . . . . 0.524 ' HB ' HG13 ' A' 1550 ' ' ILE . 16.7 m -81.25 -23.59 37.92 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.072 0.463 . . . . 0.0 110.637 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.57 37.38 10.7 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.385 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.524 HG13 ' HB ' ' A' 1548 ' ' THR . 62.9 mt -84.77 129.33 37.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.604 ' HG2' HD12 ' A' 1541 ' ' ILE . 11.2 mptt -92.32 133.41 35.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1552 ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' 1584 ' ' TYR . . . -111.42 16.16 20.94 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.349 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.823 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.73 138.19 2.81 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.835 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.63 142.81 27.98 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 124.954 1.302 . . . . 0.0 109.188 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 68.5 t90 -64.16 140.2 58.84 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.887 0.875 . . . . 0.0 110.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -162.26 -179.96 7.43 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -130.95 31.64 4.44 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 118.195 0.452 . . . . 0.0 112.074 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1558 ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' 1560 ' ' SER . 48.8 tptt -84.15 81.79 8.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.834 0.826 . . . . 0.0 109.921 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' 1568 ' ' LEU . 0.5 OUTLIER -93.2 98.18 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.3 t -89.62 158.7 17.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.15 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -130.29 104.77 7.47 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 96.3 t -115.07 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 36.5 t70 49.95 74.55 0.2 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.843 1.257 . . . . 0.0 112.365 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 67.91 -9.73 0.45 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.829 1.252 . . . . 0.0 113.654 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 85.6 t -107.17 132.19 55.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.794 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 9.4 mp -81.86 141.3 33.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' 1560 ' ' SER . 26.8 mm-40 -131.56 114.86 15.37 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1568 ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' 1559 ' ' LEU . 64.0 tp -123.04 136.08 54.69 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 8.9 p -135.45 135.42 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-O 121.373 0.606 . . . . 0.0 110.413 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.823 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 70.8 m-85 -105.53 104.6 14.36 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -102.71 163.44 12.22 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 30.4 t70 64.95 79.29 0.26 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 124.282 1.033 . . . . 0.0 112.027 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.83 -106.35 2.95 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.86 160.05 35.05 Favored Pre-proline 0 C--N 1.281 -2.399 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.42 151.52 48.05 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.054 1.836 . . . . 0.0 110.969 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1576 ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 78.2 m -103.13 126.96 30.86 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1577 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.3 Cg_exo -58.18 -23.82 63.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.86 3.04 . . . . 0.0 113.681 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -63.6 -65.35 0.69 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.604 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 22.7 t-20 -111.72 -14.72 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.377 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.43 -45.08 0.61 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.116 0.966 . . . . 0.0 113.132 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 56.3 m80 -68.05 -19.32 64.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.721 0.772 . . . . 0.0 110.036 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.958 HD13 ' HA ' ' A' 1611 ' ' THR . 41.6 mt -95.08 140.96 29.29 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.642 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 62.0 mttm -132.42 161.41 33.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.529 ' HB3' ' HA ' ' A' 1552 ' ' ALA . 97.3 m-85 -65.34 116.53 6.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' 1613 ' ' THR . 21.5 mtpp -129.74 130.38 45.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' 1570 ' ' TYR . 12.3 p -120.82 120.43 35.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 120.724 0.297 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -116.1 119.54 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.97 108.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 11.8 p -86.01 114.85 23.22 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.617 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.83 ' HD1' ' HE3' ' A' 1618 ' ' TRP . 53.9 m-85 -93.98 109.17 20.92 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.3 m -108.91 168.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' 1624 ' ' CYS . 38.0 t -75.96 117.51 17.76 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.771 0.828 . . . . 0.0 111.084 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.758 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 56.7 tptt -146.13 88.06 1.78 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1594 ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' 1621 ' ' SER . 17.9 m -73.84 -13.35 60.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.621 0.724 . . . . 0.0 110.263 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1595 ' ' ASP . . . . . 0.758 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 29.9 t70 -80.96 -7.36 59.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -93.03 -64.39 1.1 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 72.63 -123.99 9.29 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.37 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.04 -16.57 49.7 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.741 2.961 . . . . 0.0 113.741 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.9 p -83.01 -66.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.463 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' 1620 ' ' THR . 51.3 m 61.05 97.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.322 1.014 . . . . 0.0 110.463 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 14.5 mm100 -101.61 131.61 22.74 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.072 -171.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.9 Cg_endo -86.03 112.76 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.431 2.754 . . . . 0.0 111.345 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.01 125.5 47.63 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.515 HD23 ' HD2' ' A' 1522 ' ' ARG . 47.6 tp -78.79 116.22 18.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.116 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.74 -51.37 8.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.074 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.5 t -164.08 135.68 4.65 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.488 HG23 HD21 ' A' 1604 ' ' LEU . 93.4 t -102.51 111.26 31.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.9 t70 -104.24 99.52 9.24 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.798 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.59 8.62 9.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -82.24 -51.58 7.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.958 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -103.23 -4.04 24.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.816 -173.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.7 m 62.53 31.19 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 110.376 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1613 ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' 1585 ' ' LYS . 23.6 m -103.72 125.56 50.28 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.921 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.602 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 85.7 mt -98.72 119.93 38.29 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.064 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.53 109.93 22.01 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.2 m-85 -121.29 134.72 55.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.1 t -108.73 107.28 17.66 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.83 ' HE3' ' HD1' ' A' 1590 ' ' PHE . 18.4 t90 -93.99 106.69 18.65 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.462 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 72.4 m-70 -83.32 103.6 12.84 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.733 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' 1600 ' ' SER . 9.8 t -139.21 153.83 47.93 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.359 0.599 . . . . 0.0 109.996 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1621 ' ' SER . . . . . 0.596 ' HB3' ' HA ' ' A' 1594 ' ' SER . 0.8 OUTLIER -76.86 -24.88 52.63 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.357 177.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.94 -8.64 54.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 122.203 1.002 . . . . 0.0 109.145 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -109.8 12.42 24.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.73 0.776 . . . . 0.0 110.173 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1624 ' ' CYS . . . . . 0.445 ' HB2' ' HA ' ' A' 1592 ' ' CYS . 33.8 t -110.7 164.9 12.29 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -56.3 139.52 47.96 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.2 115.66 19.88 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.077 0.941 . . . . 0.0 111.99 -164.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.41 7.17 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.149 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.58 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 CA--C 1.491 -1.289 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 42.1 t 60.88 74.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 70.01 82.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.918 -170.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.11 164.1 3.27 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1493 ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' 1495 ' ' GLN . 31.5 m-80 -94.04 12.43 26.34 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 123.004 0.522 . . . . 0.0 110.237 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' 1507 ' ' LEU . 72.4 m 71.16 22.95 4.25 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.111 0.964 . . . . 0.0 110.026 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' 1493 ' ' ASN . 10.4 pt20 -128.17 128.18 44.33 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 9.5 p -131.08 132.45 63.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.776 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 19.9 m -93.64 129.52 39.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 11.5 p30 -89.1 136.16 30.72 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.852 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1499 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 1.8 Cg_endo -82.14 -12.5 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.998 1.798 . . . . 0.0 110.8 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.49 76.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.679 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.7 p -126.23 -30.18 2.93 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 111.12 11.7 17.66 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.254 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 66.1 t80 -84.84 136.63 33.58 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.358 -0.495 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1497 ' ' THR . 64.7 t -99.91 119.3 47.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' 1495 ' ' GLN . 88.2 m-85 -87.61 104.45 16.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.76 101.02 12.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.791 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1507 ' ' LEU . . . . . 0.857 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 18.3 tp -83.31 -10.04 58.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.791 1.281 . . . . 0.0 107.975 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' 1511 ' ' LYS . 6.9 p30 -67.05 -14.87 63.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.213 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.7 m -89.42 -6.44 56.55 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.591 ' HB2' HD12 ' A' 1622 ' ' LEU . 34.2 tp -114.65 9.35 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' 1508 ' ' ASN . 48.7 mttp -43.34 148.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.492 ' HB2' ' HA2' ' A' 1515 ' ' GLY . 0.1 OUTLIER -68.22 147.85 51.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.66 -173.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.21 -66.14 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 42.9 t -116.89 -19.98 9.62 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 167.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' 1512 ' ' ARG . . . 137.16 143.42 4.58 Favored Glycine 0 N--CA 1.414 -2.829 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' 1527 ' ' ARG . 41.7 m-85 -69.02 113.72 6.65 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.2 m -113.01 90.94 3.48 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.76 152.88 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.475 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 41.4 m -92.62 137.13 32.63 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.88 175.48 7.27 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1521 ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' 1522 ' ' ARG . 15.2 tt -58.0 -25.49 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 CA-C-O 121.189 0.519 . . . . 0.0 111.95 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.437 ' HG3' HG23 ' A' 1521 ' ' ILE . 68.0 mtp180 -92.45 3.15 56.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.113 0.482 . . . . 0.0 111.135 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1523 ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.6 mmtt 77.83 25.49 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.687 1.595 . . . . 0.0 114.492 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -91.7 125.47 8.06 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 69.7 m -79.02 122.25 25.96 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 120.949 0.404 . . . . 0.0 110.282 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.57 136.03 52.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.593 ' HB3' ' SG ' ' A' 1544 ' ' CYS . 50.2 ttm-85 -114.92 123.42 49.09 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.02 134.68 53.39 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.253 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.79 119.08 5.14 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' 1511 ' ' LYS . 27.5 m -96.12 143.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-N 117.036 0.418 . . . . 0.0 109.969 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.65 ' HA ' HE22 ' A' 1557 ' ' GLN . 72.5 m 74.61 -37.75 0.36 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.873 1.269 . . . . 0.0 113.203 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -131.8 150.44 19.55 Favored Glycine 0 N--CA 1.416 -2.642 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.79 155.04 37.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 124.24 0.612 . . . . 0.0 111.531 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -96.92 89.64 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 122.265 1.031 . . . . 0.0 110.219 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -64.85 -20.86 66.63 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.491 -175.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.38 -45.64 80.46 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.021 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 54.0 m -92.78 -15.08 27.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.161 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 148.88 136.88 2.73 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.34 137.4 74.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.853 2.369 . . . . 0.0 112.572 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 85.44 -5.92 81.74 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.705 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.0 mm -91.68 141.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.04 -29.59 3.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.179 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -135.86 120.05 17.77 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1544 ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' 1527 ' ' ARG . 8.1 p -127.95 144.61 51.1 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 111.17 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 78.7 t80 -105.35 125.53 51.08 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.26 57.26 3.53 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.054 0.931 . . . . 0.0 111.246 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1547 ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' 1549 ' ' GLY . . . -164.28 114.13 0.58 Allowed Glycine 0 C--N 1.289 -2.043 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1548 ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' 1550 ' ' ILE . 28.2 m 72.46 -22.23 0.22 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.122 0.969 . . . . 0.0 110.938 -174.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1549 ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' 1547 ' ' GLY . . . 85.49 35.29 12.1 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 72.8 mt -64.33 138.22 23.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 123.934 0.432 . . . . 0.0 109.926 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' 1551 ' ' LYS . 10.1 mptt -101.55 120.56 40.5 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -102.44 14.82 30.94 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.165 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 147.6 144.13 3.95 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.348 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 54.0 pttt -96.0 155.14 16.88 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.687 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 42.1 t90 -63.82 134.95 56.17 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.824 0.703 . . . . 0.0 110.164 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -169.86 164.06 9.71 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1557 ' ' GLN . . . . . 0.65 HE22 ' HA ' ' A' 1531 ' ' CYS . 19.2 mm-40 -122.32 83.25 2.08 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 120.933 0.397 . . . . 0.0 110.475 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1558 ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' 1560 ' ' SER . 1.7 tmtp? -107.06 98.94 8.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 111.6 23.41 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.494 ' HB2' ' HE2' ' A' 1558 ' ' LYS . 9.7 t -120.14 119.59 33.73 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.53 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 58.3 t80 -86.31 113.53 22.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.66 84.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 15.4 t70 45.52 81.77 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.016 1.726 . . . . 0.0 113.334 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 68.26 -0.23 2.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.341 1.056 . . . . 0.0 113.434 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.3 t -116.89 128.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.725 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 13.4 tp -96.52 122.66 39.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -103.95 119.82 39.74 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.079 -0.388 . . . . 0.0 110.666 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 66.9 tp -116.16 130.18 56.67 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 82.4 t -118.83 129.9 74.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.687 ' HE1' ' HA ' ' A' 1555 ' ' TRP . 38.7 m-85 -121.54 97.26 5.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.04 -178.68 3.56 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.444 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 23.4 t70 61.71 63.7 1.12 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.829 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.82 -121.62 4.67 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.367 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.8 145.21 34.39 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 16.0 Cg_exo -72.23 142.98 38.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.605 2.203 . . . . 0.0 109.676 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 69.1 m -98.13 134.05 22.46 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.56 8.34 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.136 2.557 . . . . 0.0 113.625 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -80.36 -51.71 8.54 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.1 m120 -134.2 0.93 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1580 ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' 1580 ' ' LEU . 4.0 mm? 68.99 -54.47 0.56 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 44.0 m80 -75.1 -16.33 60.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.882 0.373 . . . . 0.0 110.959 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.832 HD13 ' HA ' ' A' 1611 ' ' THR . 62.0 mt -82.52 123.62 29.35 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 94.5 mttt -122.78 162.62 21.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -64.1 115.08 4.61 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' 1613 ' ' THR . 8.7 mtpm? -128.54 131.87 48.25 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.543 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 20.4 t -120.12 131.27 54.98 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -121.88 120.82 62.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.53 105.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 23.6 m -90.35 110.55 21.63 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.725 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.6 m-85 -86.21 112.47 21.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.7 m -101.13 161.56 3.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' 1624 ' ' CYS . 45.0 t -81.24 137.08 35.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.713 0.768 . . . . 0.0 112.117 -173.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 25.1 tptp -154.65 98.76 2.1 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 46.8 t -61.41 -28.8 69.52 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.12 0.486 . . . . 0.0 110.358 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.93 81.82 1.55 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.573 1.177 . . . . 0.0 109.054 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -125.96 -29.64 3.06 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.593 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.01 168.46 40.59 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.43 -10.96 30.56 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 123.21 2.607 . . . . 0.0 111.86 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.1 p -90.7 -40.76 11.67 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.847 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.404 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 38.2 m 68.27 169.54 0.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.735 1.214 . . . . 0.0 110.955 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 13.2 mm-40 -114.5 120.85 37.13 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.347 -174.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.2 Cg_endo -91.19 101.95 0.24 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 123.117 2.545 . . . . 0.0 111.288 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' 1617 ' ' SER . 63.3 tp -89.75 119.66 30.34 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.17 109.86 16.11 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.18 -63.5 1.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.171 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.9 m -144.51 143.33 30.79 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.903 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 60.7 t -118.93 110.88 31.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.29 108.71 20.3 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.139 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -80.4 -0.1 35.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -100.8 -48.24 4.54 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.423 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.832 ' HA ' HD13 ' A' 1582 ' ' LEU . 58.0 p -95.42 -7.0 39.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.43 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.4 m 64.63 25.88 13.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.765 0.826 . . . . 0.0 111.476 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1613 ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' 1585 ' ' LYS . 57.8 m -93.59 127.03 39.07 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 121.352 0.596 . . . . 0.0 109.918 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 69.8 mt -102.51 127.77 49.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.786 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -110.63 114.75 28.38 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.37 135.35 54.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.299 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 15.2 m -108.71 103.52 12.62 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 1.7 t-105 -94.03 107.84 19.72 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.472 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 76.4 m-70 -78.79 99.92 6.91 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 13.2 t -134.08 153.05 52.06 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 110.264 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.7 m -73.17 -29.07 62.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.448 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' 1510 ' ' LEU . 62.5 mt -74.42 -4.58 37.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1623 ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' 1590 ' ' PHE . . . -82.81 -25.7 32.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.336 0.589 . . . . 0.0 111.722 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1624 ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' 1592 ' ' CYS . 14.4 p -117.52 177.98 4.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.4 84.75 0.81 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.23 1.014 . . . . 0.0 110.157 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -81.77 137.06 35.39 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.209 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -124.8 -22.59 4.5 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.337 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--O 1.243 0.744 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.311 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 46.8 t -108.17 -24.11 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 71.34 16.35 6.11 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.793 1.237 . . . . 0.0 111.181 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.68 77.6 1.37 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -147.65 92.87 2.13 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.119 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 6.6 t 62.11 30.92 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.274 1.035 . . . . 0.0 110.965 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' 1505 ' ' PHE . 24.8 pt20 -152.61 145.7 24.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.061 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.3 p -145.5 134.99 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.693 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 22.7 m -92.03 125.66 36.8 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' 1503 ' ' TYR . 9.5 p30 -86.39 147.25 43.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.091 -0.643 . . . . 0.0 109.859 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.45 2.71 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.574 2.183 . . . . 0.0 113.894 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -92.88 -57.77 2.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.203 0.525 . . . . 0.0 111.297 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 35.0 p -105.99 -17.7 14.26 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.945 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 80.66 19.23 68.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.842 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1503 ' ' TYR . . . . . 0.524 ' HB3' ' ND2' ' A' 1498 ' ' ASN . 53.3 t80 -79.45 133.62 36.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 48.6 t -99.83 110.11 26.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' 1495 ' ' GLN . 96.2 m-85 -80.86 106.77 13.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -97.97 102.77 14.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.299 0.571 . . . . 0.0 112.048 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.04 -4.88 56.0 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.341 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.689 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 52.3 m-80 -62.6 -29.9 70.94 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 25.3 t -71.93 -14.97 62.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.793 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.12 3.05 15.89 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 122.397 -0.189 . . . . 0.0 111.129 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 55.6 mtmt -58.8 118.79 6.12 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.851 0.834 . . . . 0.0 112.985 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -106.6 97.33 7.14 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.001 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -34.59 64.7 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 125.44 1.496 . . . . 0.0 113.53 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.5 m -81.26 -19.82 42.27 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 85.32 155.99 25.64 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.904 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' 1527 ' ' ARG . 71.5 m-85 -92.43 133.09 36.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 9.4 p -112.07 91.5 3.68 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 16.9 pt -96.39 152.07 3.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.301 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 19.6 t -97.82 118.89 35.4 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.704 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1520 ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 1.9 t70 -74.46 151.65 39.55 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.569 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.7 tt -79.55 -16.25 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.645 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.549 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 10.4 mtp-105 -87.62 1.96 52.24 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1523 ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.9 mmtt 72.45 77.75 0.15 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.002 1.721 . . . . 0.0 113.603 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -165.09 163.26 36.36 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 107.431 -2.267 . . . . 0.0 107.431 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.3 m -109.71 140.54 43.45 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 118.184 0.992 . . . . 0.0 109.488 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.8 tt -124.65 130.39 73.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' 1516 ' ' TYR . 17.7 ttm180 -112.68 119.14 37.06 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.383 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.39 127.01 47.85 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.947 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.37 129.47 9.89 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' 1511 ' ' LYS . 18.4 m -85.86 115.49 27.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.112 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.473 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 21.7 m 62.92 12.61 5.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.469 1.107 . . . . 0.0 111.714 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -135.56 147.56 19.24 Favored Glycine 0 N--CA 1.415 -2.76 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1533 ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' 1533 ' ' GLU . 0.1 OUTLIER -77.9 141.18 39.22 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 123.802 0.354 . . . . 0.0 110.219 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.3 m -85.23 87.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 122.01 0.909 . . . . 0.0 109.28 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.638 ' HD2' ' H ' ' A' 1535 ' ' LYS . 2.1 mptp? -59.39 -28.96 67.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.683 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.19 -36.75 71.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.579 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.5 m -96.86 -29.14 13.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.053 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 152.32 159.25 8.88 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.932 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.5 143.88 31.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.288 1.992 . . . . 0.0 111.323 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.46 6.21 89.38 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.537 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.0 131.62 59.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -95.57 -32.88 6.7 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.302 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.21 138.96 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.6 p -145.37 158.3 43.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' 1526 ' ' ILE . 38.8 t80 -113.91 106.17 14.13 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.31 106.76 7.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 122.011 0.91 . . . . 0.0 109.976 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.8 -67.39 0.3 Allowed Glycine 0 C--N 1.276 -2.754 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 -21.77 29.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 81.91 21.31 61.57 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 43.1 pt -91.7 151.1 3.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.215 0.531 . . . . 0.0 111.124 -176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.735 ' HD2' ' HB2' ' A' 1574 ' ' ASP . 74.7 mttt -87.43 156.43 19.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -124.41 7.51 8.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.415 0.626 . . . . 0.0 110.593 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 146.75 144.46 4.04 Favored Glycine 0 C--O 1.256 1.473 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.948 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' 1572 ' ' ASP . 14.1 ptmt -85.28 160.73 19.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.688 0.744 . . . . 0.0 110.377 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 70.3 t90 -62.86 132.63 52.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.368 0.667 . . . . 0.0 110.795 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' 1570 ' ' TYR . 9.1 p30 -167.35 173.08 9.15 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -128.92 41.06 3.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 118.127 0.422 . . . . 0.0 110.04 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -72.11 103.31 3.25 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.077 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 98.8 mt -116.91 96.86 5.66 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 20.0 m -87.51 115.22 24.79 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 72.4 t80 -94.97 102.37 14.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -118.99 92.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-O 121.165 0.507 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.9 t70 54.04 69.97 0.66 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.371 1.068 . . . . 0.0 112.012 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 67.98 2.83 3.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.543 -1.208 . . . . 0.0 114.028 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.37 126.76 66.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.9 mp -94.05 118.03 30.95 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.402 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.837 ' HB2' ' HB2' ' A' 1560 ' ' SER . 17.4 mm-40 -102.64 114.01 27.87 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.57 107.7 18.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.606 HG22 HG23 ' A' 1587 ' ' VAL . 17.5 t -111.85 117.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.867 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 50.6 m-85 -93.64 101.73 13.89 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.9 177.72 4.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.865 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.774 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 34.2 t0 47.16 63.23 2.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 112.289 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1573 ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' 1584 ' ' TYR . . . -73.73 -77.08 0.64 Allowed Glycine 0 N--CA 1.42 -2.396 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.816 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.735 ' HB2' ' HD2' ' A' 1551 ' ' LYS . 13.7 t70 -165.55 156.08 11.89 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.63 145.85 46.43 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.34 2.026 . . . . 0.0 112.38 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1576 ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 52.0 t -97.43 139.07 21.2 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1577 ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 22.3 Cg_exo -62.75 -28.07 76.0 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.203 2.602 . . . . 0.0 114.376 -177.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.48 -44.9 49.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.881 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.84 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 40.5 t-20 -144.8 110.98 5.52 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.54 -15.07 9.7 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 46.1 m80 -94.0 -1.93 53.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 122.085 -0.384 . . . . 0.0 111.843 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.84 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 42.5 mt -90.66 154.8 19.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 66.4 mttm -127.35 151.35 48.89 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.282 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' 1573 ' ' GLY . 83.5 m-85 -61.43 120.09 9.81 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' 1583 ' ' LYS . 92.8 mttt -137.92 140.59 40.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' 1614 ' ' LEU . 15.1 p -130.92 123.68 29.44 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 120.799 0.333 . . . . 0.0 110.417 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.606 HG23 HG22 ' A' 1569 ' ' VAL . 7.5 p -108.97 113.85 45.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.688 0.756 . . . . 0.0 110.178 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.89 109.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 25.9 m -92.37 111.96 23.73 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.0 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.5 m-85 -86.22 108.22 18.27 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 30.7 m -111.73 167.0 5.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.577 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 46.2 t -76.56 150.89 36.47 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.287 0.565 . . . . 0.0 112.258 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.774 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 22.6 tptp -170.86 115.06 0.44 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 174.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 8.3 t -75.44 -28.93 59.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.296 0.498 . . . . 0.0 111.921 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.03 12.34 24.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.287 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -66.73 -51.84 51.33 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -172.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.63 179.04 40.81 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.71 -28.99 19.97 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.773 2.315 . . . . 0.0 113.033 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 -26.4 20.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 109.855 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' 1619 ' ' HIS . 21.3 m 63.38 -175.94 0.15 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.586 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.813 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 6.9 pt20 -116.24 121.44 33.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.821 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 9.6 Cg_endo -92.34 117.45 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.47 2.78 . . . . 0.0 112.111 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.2 tp -97.15 124.86 41.31 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.585 HD11 HG23 ' A' 1607 ' ' VAL . 60.4 tp -80.35 112.78 18.01 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.73 -50.49 8.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.144 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.9 t -175.22 140.28 0.5 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.445 0.466 . . . . 0.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.585 HG23 HD11 ' A' 1604 ' ' LEU . 83.9 t -107.9 110.17 30.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.57 102.41 12.29 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.24 -1.44 44.92 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.958 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -91.92 -39.74 11.54 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.617 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.629 ' HA ' HD13 ' A' 1582 ' ' LEU . 25.3 p -99.96 -2.15 35.34 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 90.8 m 58.57 33.93 23.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.901 0.858 . . . . 0.0 111.033 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 24.5 m -112.75 128.75 56.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.555 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.6 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 67.2 mt -105.13 134.64 47.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.033 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.68 115.94 26.07 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.6 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.5 m-85 -130.14 137.27 50.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.76 0.314 . . . . 0.0 110.892 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 21.0 t -108.45 108.27 19.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' 1600 ' ' SER . 11.7 t-105 -97.59 106.9 19.29 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.813 ' HB2' ' HG3' ' A' 1601 ' ' GLN . 66.0 m-70 -86.77 109.58 19.35 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 7.7 t -130.59 149.9 52.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.298 0.57 . . . . 0.0 110.916 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.1 p -78.87 -26.41 43.96 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' 1622 ' ' LEU . 3.1 tm? -72.81 -6.93 48.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.113 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.15 2.41 40.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 0.0 109.819 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 63.4 m -87.59 133.05 33.86 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.08 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -61.79 150.28 37.54 Favored 'General case' 0 C--O 1.252 1.211 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -83.41 127.18 33.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.88 -56.77 11.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.11 0.481 . . . . 0.0 110.742 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.415 -2.177 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.636 177.664 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 43.1 t -110.09 94.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.46 133.47 35.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.89 62.93 6.72 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.044 0.926 . . . . 0.0 109.434 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1493 ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' 1495 ' ' GLN . 39.6 t-20 -112.45 102.58 10.69 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 38.5 t 76.48 -21.23 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.385 1.474 . . . . 0.0 110.834 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.3 pt20 -118.04 154.28 32.29 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -142.36 136.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 40.2 m -88.5 126.69 35.37 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.815 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.449 HD22 ' HE2' ' A' 1505 ' ' PHE . 27.9 t-20 -91.57 106.65 17.55 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.29 -19.62 55.97 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.263 2.642 . . . . 0.0 114.61 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -72.65 -53.75 10.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.061 0.458 . . . . 0.0 110.852 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 17.5 p -96.53 -12.34 24.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 79.31 3.93 88.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.67 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1503 ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' 1628 ' ' VAL . 68.8 t80 -85.02 135.24 34.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.401 0.619 . . . . 0.0 110.485 -176.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 38.9 t -97.68 115.85 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.449 ' HE2' HD22 ' A' 1498 ' ' ASN . 97.3 m-85 -89.35 107.63 19.17 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -107.14 120.16 41.35 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.57 0.7 . . . . 0.0 110.7 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1507 ' ' LEU . . . . . 0.513 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 38.3 tp -79.42 -6.38 56.73 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -53.81 -31.07 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.47 1.508 . . . . 0.0 112.641 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 33.3 t -77.74 -20.9 52.68 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.028 0.442 . . . . 0.0 110.663 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 23.0 tp -116.63 -5.59 11.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.97 0.414 . . . . 0.0 111.568 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.6 154.07 42.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.493 0.663 . . . . 0.0 111.901 -175.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -121.63 122.01 38.67 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.187 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -68.79 -26.35 65.16 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.539 0.736 . . . . 0.0 110.476 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 14.0 t -89.2 -7.23 56.0 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 75.73 -164.43 53.94 Favored Glycine 0 N--CA 1.427 -1.921 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.473 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.76 145.81 43.24 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1517 ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' 1526 ' ' ILE . 32.6 m -142.61 100.63 3.72 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 28.2 pt -121.51 132.4 70.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.87 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1519 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.0 t -80.0 112.65 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.72 136.95 32.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.089 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.65 -32.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.606 1.163 . . . . 0.0 112.839 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -74.73 -34.13 62.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 28.8 tptp -141.21 -58.69 0.49 Allowed 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.054 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 175.21 -163.41 33.45 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.379 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1525 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1519 ' ' SER . 45.4 t -81.01 144.01 32.1 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.409 0.623 . . . . 0.0 111.289 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' THR . 14.2 tt -127.44 134.26 66.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' 1534 ' ' VAL . 41.3 ttm180 -124.23 103.78 8.44 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.432 0.634 . . . . 0.0 109.593 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.83 144.84 51.74 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.016 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -111.66 139.53 15.64 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.519 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 16.2 m -98.01 117.8 43.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 16.4 m 69.73 19.08 7.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.975 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -153.42 168.71 32.13 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.26 149.56 26.76 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' 1527 ' ' ARG . 20.7 m -94.87 90.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.318 1.056 . . . . 0.0 108.306 173.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.622 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -63.94 -13.72 48.06 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.402 -172.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.56 -12.96 60.33 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 123.149 0.58 . . . . 0.0 110.569 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1537 ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' 1551 ' ' LYS . 24.9 t -117.12 11.81 14.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.43 163.5 14.58 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.238 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 136.29 12.65 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.472 2.114 . . . . 0.0 111.48 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.83 21.6 79.09 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.588 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 118.19 50.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -94.04 -24.82 18.72 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.678 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.13 132.34 31.83 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 14.1 t -139.94 147.81 41.06 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.521 ' HB3' HG13 ' A' 1550 ' ' ILE . 63.8 t80 -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.13 81.57 8.4 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.306 1.051 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -158.27 85.02 0.13 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 7.6 m 69.63 16.76 7.97 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.214 1.007 . . . . 0.0 109.351 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 62.69 67.31 2.14 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.182 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' 1545 ' ' PHE . 23.7 pt -108.6 138.46 35.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 117.061 0.431 . . . . 0.0 110.015 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.434 ' HG2' ' SG ' ' A' 1537 ' ' CYS . 54.6 mttm -88.69 138.86 31.04 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -114.94 18.28 16.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.065 0.46 . . . . 0.0 111.231 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 148.2 136.71 2.77 Favored Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.948 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 61.0 tttm -85.07 143.54 28.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.439 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 37.3 t90 -69.29 134.27 48.92 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.632 0.73 . . . . 0.0 111.099 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 p30 -158.88 164.42 35.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -124.27 78.45 1.65 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 118.808 0.731 . . . . 0.0 112.4 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1558 ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 59.5 mmtt -108.23 92.19 3.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.551 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.14 96.36 7.44 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.8 m -96.93 138.14 34.94 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.542 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1561 ' ' TYR . . . . . 0.593 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 7.4 t80 -110.8 101.02 9.67 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 52.9 t -103.64 88.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.175 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.18 72.72 0.28 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.606 1.163 . . . . 0.0 111.49 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1564 ' ' GLN . . . . . 0.593 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 26.6 mp0 57.67 24.56 10.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.269 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 51.6 t -126.81 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 11.0 tp -82.31 135.96 35.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' 1560 ' ' SER . 15.2 mm100 -124.45 135.54 53.33 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.804 0.442 . . . . 0.0 110.115 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.95 120.79 18.56 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.59 HG22 HG23 ' A' 1587 ' ' VAL . 39.2 t -119.14 129.48 75.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.322 0.582 . . . . 0.0 111.25 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.84 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.9 m-85 -107.34 111.86 24.41 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.462 174.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.551 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 48.1 mt-10 -117.56 177.26 4.82 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.198 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 17.5 t70 64.51 43.88 4.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.2 1.0 . . . . 0.0 111.446 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -89.32 -139.59 7.31 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.2 155.33 84.28 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 117.062 0.431 . . . . 0.0 110.351 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.69 148.97 72.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.339 2.026 . . . . 0.0 110.459 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 52.4 t -98.21 126.22 40.72 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -63.99 -7.18 12.73 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.091 2.527 . . . . 0.0 114.335 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -76.71 -61.16 2.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.036 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.429 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 3.2 m-20 -117.67 -5.37 11.14 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 69.5 -45.28 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -70.56 -21.99 62.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.8 0.809 . . . . 0.0 109.173 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.906 HD13 ' HA ' ' A' 1611 ' ' THR . 93.5 mt -82.91 142.42 31.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 60.8 mttm -127.88 162.59 26.34 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -68.38 114.23 6.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.551 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.5 mtpt -128.03 138.99 52.79 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.569 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 27.0 t -120.91 120.0 34.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.59 HG23 HG22 ' A' 1569 ' ' VAL . 7.7 p -112.31 110.27 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 121.98 0.895 . . . . 0.0 109.941 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 107.74 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 15.4 p -90.73 112.91 24.87 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.069 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 85.4 m-85 -89.06 106.35 18.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -105.64 156.66 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' 1620 ' ' THR . 26.2 t -95.1 139.16 31.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.409 -1.317 . . . . 0.0 113.612 -171.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 27.9 tptp -137.67 98.25 3.63 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.6 m -57.59 -29.26 64.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -100.76 6.21 43.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.285 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -64.67 -58.11 7.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 51.91 -114.53 3.24 Favored Glycine 0 N--CA 1.446 -0.694 0 O-C-N 123.767 0.667 . . . . 0.0 112.625 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.63 -19.96 53.65 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.269 2.646 . . . . 0.0 112.957 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.6 t -117.24 74.46 0.92 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.705 1.241 . . . . 0.0 110.399 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.43 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 50.7 m -86.42 116.88 24.86 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.09 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 98.6 mt-30 -93.52 123.92 58.76 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -173.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 1.4 Cg_endo -84.79 113.15 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.244 2.63 . . . . 0.0 110.449 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.473 HD12 HD23 ' A' 1605 ' ' LEU . 2.2 tm? -96.45 117.55 31.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 34.7 tp -82.96 111.59 18.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1605 ' ' LEU . . . . . 0.473 HD23 HD12 ' A' 1603 ' ' LEU . 90.6 mt -70.78 -55.68 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.483 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 11.9 t -170.88 153.04 3.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 99.4 t -105.19 111.66 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.56 108.35 19.38 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.626 -1.229 . . . . 0.0 110.163 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -81.46 1.84 31.47 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.1 t60 -89.85 -51.36 5.53 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.906 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -98.03 -7.37 29.98 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.361 -170.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 77.8 m 55.19 34.09 21.93 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.276 1.036 . . . . 0.0 112.361 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1613 ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' 1585 ' ' LYS . 22.3 m -104.55 127.05 52.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.023 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 83.1 mt -92.62 120.9 33.51 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.125 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -103.12 104.19 14.32 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.476 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 67.2 m-85 -118.66 128.99 55.04 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 67.2 m -109.25 105.63 15.14 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.494 ' HE3' ' CD2' ' A' 1590 ' ' PHE . 11.5 t90 -92.49 109.54 20.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.599 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 59.9 m-70 -80.53 96.81 6.9 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.616 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' 1592 ' ' CYS . 7.9 t -127.88 153.43 46.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.886 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 11.6 m -72.67 -25.86 61.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.145 0.497 . . . . 0.0 111.333 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' 1622 ' ' LEU . 7.2 tt -68.26 -13.26 62.12 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -89.28 -3.35 58.55 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 46.5 m -78.4 169.46 18.21 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.937 -0.477 . . . . 0.0 109.965 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.77 82.46 3.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -83.48 121.81 27.69 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.678 -170.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1627 ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' 1627 ' ' GLU . 1.1 mp0 -51.33 -64.57 0.77 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 124.567 1.167 . . . . 0.0 109.059 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1628 ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' 1503 ' ' TYR . 84.7 t . . . . . 0 C--N 1.317 -0.843 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 C--O 1.224 -0.289 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 63.5 t -68.12 -59.17 4.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 117.969 0.349 . . . . 0.0 110.365 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -126.7 83.64 2.19 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.38 -171.47 3.37 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.076 -168.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.9 169.36 10.98 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 6.3 t 68.84 9.66 7.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.919 0.888 . . . . 0.0 111.102 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' 1505 ' ' PHE . 15.8 pt20 -140.46 138.22 34.51 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.5 p -139.33 132.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.7 m -93.64 114.38 26.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 4.7 p30 -79.99 133.08 58.56 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1499 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 12.2 Cg_exo -67.87 -32.15 29.83 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.535 2.157 . . . . 0.0 112.903 -176.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -55.75 -64.38 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 32.1 p -96.78 -20.51 18.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.94 0.4 . . . . 0.0 111.958 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.34 1.54 74.99 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.183 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -77.18 128.78 34.99 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.672 0.749 . . . . 0.0 111.931 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1497 ' ' THR . 22.1 t -85.9 108.2 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' 1495 ' ' GLN . 87.9 m-85 -84.67 100.58 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.41 120.51 39.72 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1507 ' ' LEU . . . . . 0.595 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 25.7 tp -83.96 3.83 32.41 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 121.993 0.902 . . . . 0.0 109.146 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.607 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 1.8 m-20 -57.68 -29.34 64.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.535 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1509 ' ' SER . . . . . 0.435 ' HB2' HD11 ' A' 1622 ' ' LEU . 10.0 m -71.41 -20.25 62.15 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.642 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.447 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.2 OUTLIER -101.63 -11.02 19.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.607 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 46.3 mtmt -70.54 152.65 43.74 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.764 0.792 . . . . 0.0 112.317 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' 1515 ' ' GLY . 38.7 ttt180 -127.23 119.81 27.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 104.173 -2.529 . . . . 0.0 104.173 172.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.11 -45.74 71.95 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.828 0.705 . . . . 0.0 112.004 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.6 m -81.68 -2.49 50.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.154 0.502 . . . . 0.0 111.136 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 77.98 177.77 48.0 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.411 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.98 114.25 27.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 28.9 m -103.63 102.27 12.14 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.7 pt -122.41 138.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1519 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1525 ' ' SER . 34.3 t -94.39 109.72 21.55 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.59 129.32 37.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.62 -20.09 22.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.85 0.719 . . . . 0.0 112.716 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -99.9 -32.25 11.09 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.595 -0.69 . . . . 0.0 110.583 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1523 ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' 1607 ' ' VAL . 26.7 mmtm -102.62 -62.94 1.21 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 151.87 -168.54 31.2 Favored Glycine 0 C--N 1.296 -1.655 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1525 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1519 ' ' SER . 44.7 m -85.39 126.6 33.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 -177.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.93 140.31 48.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.401 ' HG2' HG11 ' A' 1534 ' ' VAL . 35.8 ttm180 -118.72 117.2 28.27 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.48 120.67 38.83 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.358 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -97.09 102.44 2.74 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 57.5 t -62.24 115.67 2.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.559 ' HB2' ' CD ' ' A' 1511 ' ' LYS . 21.8 m 60.0 24.83 14.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.553 1.141 . . . . 0.0 111.824 176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.12 173.08 25.02 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -108.84 139.08 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.38 0.609 . . . . 0.0 110.846 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' 1537 ' ' CYS . 15.1 m -94.61 93.49 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.038 0.923 . . . . 0.0 109.149 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' 1535 ' ' LYS . 9.1 mptt -54.73 -30.06 55.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.521 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.56 -18.11 63.62 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.681 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1537 ' ' CYS . . . . . 0.472 ' HB2' HG23 ' A' 1534 ' ' VAL . 80.9 m -113.44 14.0 19.02 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.978 0.418 . . . . 0.0 110.323 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1538 ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 110.68 128.91 5.48 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1539 ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 52.7 Cg_exo -59.54 127.98 25.61 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.932 2.421 . . . . 0.0 111.547 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 91.96 0.16 71.94 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.496 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' 1554 ' ' LYS . 47.7 mm -93.79 134.82 30.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -105.07 -37.68 2.65 Favored Glycine 0 CA--C 1.503 -0.684 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.484 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.6 42.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1544 ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' 1534 ' ' VAL . 31.0 p -137.76 153.83 49.67 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.602 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.46 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 51.6 t80 -94.88 138.33 32.78 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.95 89.64 8.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.666 0.746 . . . . 0.0 110.311 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -178.96 85.43 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 71.3 m 76.85 -37.17 0.27 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.155 0.982 . . . . 0.0 112.394 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 132.32 46.23 0.12 Allowed Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.744 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 73.4 mt -78.52 134.73 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' 1574 ' ' ASP . 9.4 mptt -96.32 140.86 30.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.53 12.19 10.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.528 0.68 . . . . 0.0 109.552 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 142.04 134.82 3.02 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.476 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' 1541 ' ' ILE . 25.2 pttm -82.76 153.73 25.11 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.66 135.62 50.11 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 173.62 16.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -100.02 11.58 38.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.402 0.439 . . . . 0.0 111.077 -172.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -84.94 100.28 11.52 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -168.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' 1494 ' ' CYS . 68.2 mt -115.63 119.92 37.69 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.308 172.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 51.0 m -107.85 122.52 46.95 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 78.9 t80 -94.93 101.32 13.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.988 0.899 . . . . 0.0 108.826 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 85.1 t -93.71 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -34.57 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.862 1.665 . . . . 0.0 113.137 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 20.2 mp0 56.95 18.25 3.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.868 2.067 . . . . 0.0 114.571 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 135.12 62.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.137 0.494 . . . . 0.0 111.088 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.51 113.95 26.04 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -102.94 114.1 28.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.35 124.11 49.86 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 13.1 p -120.48 133.93 65.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 111.355 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.865 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 64.6 m-85 -107.6 106.3 16.59 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.06 167.56 10.16 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.252 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.98 78.38 0.29 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.304 1.041 . . . . 0.0 111.796 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1573 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -106.26 -149.6 17.28 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' 1551 ' ' LYS . 24.3 t70 -94.92 143.88 26.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.511 ' HG3' ' HE2' ' A' 1583 ' ' LYS . 13.7 Cg_exo -69.01 146.75 65.88 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.845 2.364 . . . . 0.0 113.218 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 67.7 m -107.59 141.76 23.73 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.66 13.58 0.45 Allowed 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.574 2.849 . . . . 0.0 113.599 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.95 -38.5 22.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.686 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 28.1 t-20 -150.95 -6.7 0.27 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.041 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.14 -43.12 0.55 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.99 0.916 . . . . 0.0 113.424 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 59.9 m80 -77.37 -6.53 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.716 0.77 . . . . 0.0 110.78 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.758 HD13 ' HA ' ' A' 1611 ' ' THR . 63.3 mt -98.94 130.72 45.33 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.511 ' HE2' ' HG3' ' A' 1575 ' ' PRO . 96.1 mttt -128.73 161.95 28.54 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.456 0.473 . . . . 0.0 109.794 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' 1573 ' ' GLY . 98.9 m-85 -65.01 113.84 4.16 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.985 0.803 . . . . 0.0 109.1 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -129.33 137.62 51.1 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 17.3 t -121.49 130.81 53.79 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.3 p -125.43 116.83 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-O 121.96 0.886 . . . . 0.0 109.141 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.3 113.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.7 p -89.81 109.52 20.51 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.698 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.709 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.6 m-85 -86.81 103.06 14.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -99.39 166.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.552 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 18.6 t -84.6 130.31 34.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.469 0.652 . . . . 0.0 112.094 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 17.4 tptp -152.32 100.07 2.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.1 t -70.84 -14.4 62.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 0.0 111.591 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.19 1.89 55.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.375 0.607 . . . . 0.0 109.68 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -75.12 -65.9 0.83 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 108.18 -166.27 12.97 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.944 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.0 -20.23 44.82 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 124.275 3.317 . . . . 0.0 115.028 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 5.7 t -111.98 -22.09 11.23 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.891 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.759 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 48.0 m 65.41 -174.25 0.18 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.713 174.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.618 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 45.9 mt-30 -110.47 120.59 43.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.2 Cg_endo -90.69 125.7 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.906 2.404 . . . . 0.0 110.256 174.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 55.0 tp -129.0 126.05 38.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.676 -0.64 . . . . 0.0 111.027 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.13 118.68 20.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.24 -56.17 4.08 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.291 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 13.7 p -168.69 150.43 4.85 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' 1523 ' ' LYS . 98.2 t -115.0 114.26 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.71 109.05 20.05 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.01 -3.77 52.87 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.056 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -87.35 -51.79 5.75 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.758 ' HA ' HD13 ' A' 1582 ' ' LEU . 27.2 p -96.55 -8.25 32.41 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.614 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 72.9 m 65.7 25.92 11.45 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.929 0.892 . . . . 0.0 112.024 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 30.5 m -90.67 123.79 34.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.121 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.554 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 73.0 mt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.488 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -107.33 116.44 31.94 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 76.7 m-85 -126.96 140.04 52.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.981 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 78.3 p -111.21 116.3 30.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' 1590 ' ' PHE . 4.7 t-105 -99.74 111.79 24.09 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.618 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 71.0 m-70 -86.85 99.08 11.57 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 9.4 t -124.99 152.37 44.31 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.911 0.862 . . . . 0.0 112.131 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.3 m -76.46 -22.75 54.18 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.453 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.9 mt -73.38 -5.21 38.3 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.175 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.77 12.77 30.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.525 0.679 . . . . 0.0 110.391 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 61.3 m -100.23 137.84 38.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.911 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.55 123.12 31.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -81.99 121.95 27.17 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.88 -45.81 73.44 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.803 0.811 . . . . 0.0 108.826 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 N--CA 1.423 -1.81 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.552 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 24.0 m -62.8 98.29 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.592 0.71 . . . . 0.0 112.892 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 57.65 31.93 21.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.693 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 11.4 t70 -138.75 86.38 2.14 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.099 -1.409 . . . . 0.0 107.573 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -139.7 136.17 33.94 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 63.52 26.84 14.92 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.615 0.721 . . . . 0.0 111.392 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' 1505 ' ' PHE . 2.7 pt20 -156.52 134.93 11.45 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.9 p -142.32 131.57 22.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.786 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.512 HG23 HG22 ' A' 1504 ' ' VAL . 10.6 m -98.63 129.09 45.13 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 38.5 p30 -85.91 127.63 61.47 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -70.2 -15.21 35.39 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.72 1.613 . . . . 0.0 110.855 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -65.63 -63.32 1.12 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.832 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 72.4 p -110.13 -14.06 14.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.579 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.12 14.78 58.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.303 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 71.0 t80 -92.16 137.42 32.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.512 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -102.91 128.49 55.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' 1495 ' ' GLN . 79.3 m-85 -104.14 98.6 8.39 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.22 102.07 14.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 120.805 0.336 . . . . 0.0 110.339 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 25.1 tp -79.03 -15.96 57.52 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -66.8 -16.81 64.53 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.516 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 17.9 m -87.61 -13.2 43.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.307 0.575 . . . . 0.0 109.61 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' 1598 ' ' PRO . 36.6 tp -116.44 16.53 15.64 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.975 0.893 . . . . 0.0 109.034 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.71 173.1 1.85 Allowed 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.865 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -53.57 104.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.639 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -100.26 -45.05 5.74 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 50.9 m -119.12 -23.65 6.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.543 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 87.4 129.44 2.88 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -74.83 114.88 13.8 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 5.8 m -119.21 100.18 7.17 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1518 ' ' ILE . . . . . 0.486 HG21 ' HG3' ' A' 1602 ' ' PRO . 21.1 pt -103.3 140.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.774 -173.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 36.7 t -99.64 115.59 29.78 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.19 160.29 27.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 14.2 tt -62.93 -23.16 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.036 0.535 . . . . 0.0 112.311 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -81.73 3.58 25.1 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.2 tptm 76.34 30.7 0.66 Allowed 'General case' 0 C--N 1.351 0.661 0 C-N-CA 125.895 1.678 . . . . 0.0 108.085 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -82.43 108.72 2.98 Favored Glycine 0 N--CA 1.418 -2.517 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.063 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.1 m -86.63 102.87 14.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.8 tt -113.87 134.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.472 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -115.41 126.98 55.04 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.516 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 125.26 41.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -104.45 90.39 0.72 Allowed Glycine 0 N--CA 1.418 -2.518 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 21.3 m -62.61 116.04 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.556 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 98.9 m 61.03 20.44 10.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.971 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -146.27 91.13 0.15 Allowed Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.55 132.66 49.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 124.548 0.793 . . . . 0.0 110.384 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 18.1 m -93.91 104.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.246 0.546 . . . . 0.0 111.362 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -16.41 60.87 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.176 0.512 . . . . 0.0 111.896 -175.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.34 -27.96 68.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.879 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.1 t -113.55 24.1 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 91.55 137.33 7.46 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.949 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.41 156.41 60.46 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.267 1.978 . . . . 0.0 111.457 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.7 8.55 87.65 Favored Glycine 0 C--N 1.304 -1.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.483 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' 1544 ' ' CYS . 45.3 mm -110.44 134.77 51.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -89.37 -42.55 5.49 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.217 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.29 147.35 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 122.661 -0.317 . . . . 0.0 110.598 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1544 ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' 1541 ' ' ILE . 59.2 m -152.43 156.22 39.06 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.278 0.631 . . . . 0.0 111.046 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' 1550 ' ' ILE . 64.9 t80 -94.22 119.05 32.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.09 102.09 3.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.985 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 151.49 -64.86 0.37 Allowed Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.367 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 21.9 p -91.25 -24.4 19.88 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.742 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.61 19.7 59.57 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.789 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' 1545 ' ' PHE . 44.6 pt -71.37 126.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 58.3 mttm -83.45 134.77 34.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.19 10.09 41.78 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.068 0.461 . . . . 0.0 111.402 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 139.0 146.04 4.87 Favored Glycine 0 C--O 1.254 1.357 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.817 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.54 146.5 36.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.635 0.255 . . . . 0.0 110.773 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.556 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 28.1 t90 -75.57 133.33 40.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.124 0.487 . . . . 0.0 110.332 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 10.2 p30 -146.76 -178.81 6.38 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.55 27.41 7.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.306 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1558 ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 44.0 mmtm -85.24 82.4 8.39 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.035 0.921 . . . . 0.0 111.849 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.44 103.93 16.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.338 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 6.9 t -90.05 109.68 20.71 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -83.6 101.8 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.8 t -114.75 95.13 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.067 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 23.5 t70 52.49 67.62 0.95 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.699 1.199 . . . . 0.0 112.137 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 63.92 9.88 4.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.851 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 37.5 t -119.75 136.7 56.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.38 131.6 39.87 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.299 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' 1560 ' ' SER . 86.9 mm-40 -116.28 114.63 24.63 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.57 119.47 38.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' 1571 ' ' GLU . 14.1 p -121.12 122.59 67.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.133 0.968 . . . . 0.0 112.526 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.679 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 57.6 m-85 -100.1 108.4 20.54 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.659 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' 1569 ' ' VAL . 46.0 mt-10 -117.68 168.54 10.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.296 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 35.8 t70 61.28 70.18 0.62 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.075 1.35 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.94 -133.17 5.62 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.875 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' 1584 ' ' TYR . 31.0 t70 -74.93 136.81 73.2 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.55 138.29 17.18 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.46 2.106 . . . . 0.0 112.589 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 56.2 m -98.78 126.3 39.26 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.87 8.15 2.12 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.944 2.429 . . . . 0.0 114.645 -173.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -77.2 -35.67 55.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 109.965 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.606 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 18.9 t-20 -136.05 -20.92 1.45 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.684 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 18.8 tp 75.83 -33.13 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.075 1.35 . . . . 0.0 112.504 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1581 ' ' HIS . . . . . 0.508 ' HB3' ' OD1' ' A' 1579 ' ' ASN . 40.8 t-80 -81.47 -14.88 56.51 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' 1611 ' ' THR . 83.3 mt -82.47 133.45 35.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.367 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 49.2 mttm -130.04 163.8 25.71 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' 1574 ' ' ASP . 97.4 m-85 -72.05 117.61 13.88 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.85 171.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 134.18 55.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.497 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 16.0 m -119.41 116.56 26.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -109.3 111.0 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.893 0.854 . . . . 0.0 110.051 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.3 mp -102.15 107.41 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.244 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 113.44 25.72 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.3 m-85 -86.22 112.32 21.25 Favored 'General case' 0 C--O 1.256 1.395 0 CA-C-O 120.708 0.289 . . . . 0.0 110.244 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.5 m -106.93 166.74 3.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 124.26 1.024 . . . . 0.0 109.124 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 43.0 t -77.05 143.24 39.44 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.412 0.625 . . . . 0.0 112.648 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 25.5 tptp -167.07 101.71 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.8 m -68.66 -28.52 66.96 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.649 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.2 71.04 3.86 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -142.63 -64.02 0.42 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.936 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 68.78 -144.76 42.41 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.402 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1598 ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' 1510 ' ' LEU . 40.7 Cg_endo -66.23 -11.96 33.54 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.013 3.142 . . . . 0.0 113.396 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.4 t -123.24 77.08 1.44 Allowed 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.608 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 51.0 m -70.74 147.8 48.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.795 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.612 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 9.3 pt20 -108.55 120.85 45.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-O 121.56 0.695 . . . . 0.0 112.492 -170.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.486 ' HG3' HG21 ' A' 1518 ' ' ILE . 88.2 Cg_endo -80.78 139.42 12.36 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.4 tm? -106.66 111.02 23.38 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.775 HD21 HG23 ' A' 1607 ' ' VAL . 4.8 tt -81.53 112.5 18.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.14 -66.38 0.8 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 55.0 m -158.09 136.25 10.84 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.742 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.775 HG23 HD21 ' A' 1604 ' ' LEU . 90.9 t -95.36 111.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.99 118.65 29.71 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.599 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -80.72 -6.84 58.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.37 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -94.22 -51.81 4.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.563 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.89 ' HA ' HD13 ' A' 1582 ' ' LEU . 41.7 p -97.16 -14.77 21.27 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.012 0.195 . . . . 0.0 111.447 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1612 ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' 1584 ' ' TYR . 69.5 m 67.33 26.54 8.47 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.364 1.04 . . . . 0.0 110.742 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 19.3 m -86.87 116.81 25.19 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.714 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 74.6 mt -94.07 116.21 28.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -100.58 111.75 24.04 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.714 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 91.5 m-85 -128.44 136.73 51.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.334 0.587 . . . . 0.0 111.577 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.9 m -112.22 106.41 14.98 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.466 ' HB2' HG23 ' A' 1588 ' ' ILE . 1.4 t-105 -89.99 114.95 26.89 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 96.3 m-70 -78.0 101.26 6.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 11.7 t -129.35 153.31 47.99 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.576 0.703 . . . . 0.0 111.074 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.2 m -73.28 -28.82 62.32 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.3 -6.49 43.51 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 121.45 0.643 . . . . 0.0 111.558 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -92.84 -4.45 52.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.435 0.636 . . . . 0.0 110.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 7.4 m -99.12 129.23 45.37 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.38 124.06 24.36 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.753 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -81.12 116.62 21.13 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -88.66 -51.96 5.4 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.232 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.238 0.484 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 11.1 p -92.95 142.75 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.89 99.69 12.02 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.293 0.568 . . . . 0.0 111.881 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' 1557 ' ' GLN . 3.4 p30 -118.66 141.53 48.51 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -178.7 -179.75 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 37.6 m -87.71 11.53 15.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.596 0.713 . . . . 0.0 109.484 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.5 pt20 -152.01 136.33 16.73 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.6 p -132.61 126.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.35 0.595 . . . . 0.0 110.209 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 14.3 m -90.32 116.68 28.47 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.49 HD22 ' HE1' ' A' 1505 ' ' PHE . 28.1 p30 -73.8 143.94 82.15 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.777 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1499 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 7.7 Cg_exo -73.52 -31.73 8.58 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.876 1.717 . . . . 0.0 112.01 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -62.08 -65.42 0.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 8.7 p -97.69 -11.65 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 74.28 40.17 41.77 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 83.9 t80 -111.72 130.5 55.76 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.033 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' 1497 ' ' THR . 47.6 t -90.28 118.95 36.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.49 ' HE1' HD22 ' A' 1498 ' ' ASN . 90.8 m-85 -91.29 108.21 19.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.55 106.43 17.53 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.335 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1507 ' ' LEU . . . . . 0.564 HD11 HD23 ' A' 1510 ' ' LEU . 28.1 tp -83.97 -3.12 57.75 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -51.17 -38.42 52.08 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 125.855 1.662 . . . . 0.0 111.571 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 4.9 m -68.13 -19.21 64.8 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.564 HD23 HD11 ' A' 1507 ' ' LEU . 50.6 tp -117.24 5.69 12.69 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.928 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' 1531 ' ' CYS . 22.8 pttm -88.09 129.53 35.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.319 -175.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -128.44 118.29 22.85 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.99 -37.28 78.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 2.7 m -56.17 -25.1 45.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.744 1.218 . . . . 0.0 110.273 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 87.07 177.12 49.05 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.316 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.65 124.9 43.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1517 ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' 1527 ' ' ARG . 2.6 m -103.04 98.41 8.36 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 15.4 pt -106.39 151.11 8.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.268 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1519 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1525 ' ' SER . 12.8 p -109.44 130.98 55.47 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.94 154.91 40.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.3 tp -62.94 -26.16 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.287 0.635 . . . . 0.0 111.824 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' 1522 ' ' ARG . 50.1 mtp180 -85.86 3.42 41.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1523 ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 44.5 mmtm 86.92 20.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.613 1.565 . . . . 0.0 112.519 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -83.58 80.23 1.84 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1525 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1519 ' ' SER . 15.0 m -69.65 127.7 33.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.425 HD11 ' HB1' ' A' 1543 ' ' ALA . 7.6 tt -129.49 134.07 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.45 0.643 . . . . 0.0 110.153 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' 1517 ' ' THR . 58.2 ttt180 -105.82 119.77 40.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1528 ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' 1528 ' ' LEU . 0.7 OUTLIER -122.61 125.14 45.06 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -178.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -97.79 143.93 16.99 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 23.8 t -100.01 116.49 43.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.584 ' HA ' ' OE1' ' A' 1557 ' ' GLN . 62.0 m 63.95 20.99 12.46 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.078 0.862 . . . . 0.0 110.801 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -142.84 111.91 0.69 Allowed Glycine 0 N--CA 1.407 -3.271 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.76 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.18 133.4 47.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.9 m -90.85 95.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 122.258 1.028 . . . . 0.0 108.313 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.05 -28.17 64.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.913 -173.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.21 -16.56 61.95 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1537 ' ' CYS . . . . . 0.671 ' HB2' HG23 ' A' 1534 ' ' VAL . 96.7 m -102.76 -5.33 23.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.243 0.544 . . . . 0.0 109.538 173.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 131.44 145.03 5.52 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 132.49 29.67 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.166 1.91 . . . . 0.0 111.119 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.14 23.08 76.87 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.042 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.44 127.28 66.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' 1570 ' ' TYR . . . -100.8 -35.21 4.38 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.69 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1543 ' ' ALA . . . . . 0.425 ' HB1' HD11 ' A' 1526 ' ' ILE . . . -129.22 121.88 28.55 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.2 p -132.42 142.74 49.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.013 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' 1552 ' ' ALA . 73.8 m-85 -90.05 141.49 28.62 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.66 -26.27 64.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -89.88 126.79 8.45 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 6.7 m 75.48 -21.34 0.31 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 124.762 1.225 . . . . 0.0 112.009 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.22 30.36 54.88 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.63 150.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.165 0.507 . . . . 0.0 110.252 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.689 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 18.3 pttm -97.06 145.58 25.83 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1552 ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.02 8.9 32.58 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.218 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.831 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.35 141.13 3.18 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.553 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.55 150.52 36.54 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.484 ' HA ' ' HE2' ' A' 1570 ' ' TYR . 35.2 t90 -63.78 124.49 21.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.694 0.759 . . . . 0.0 110.506 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1556 ' ' ASN . . . . . 0.425 HD21 ' HA ' ' A' 1570 ' ' TYR . 8.3 p30 -149.14 153.06 37.16 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1557 ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' 1531 ' ' CYS . 13.4 mm100 -108.72 22.63 15.67 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 123.753 0.658 . . . . 0.0 109.653 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 27.9 tptp -77.17 82.44 3.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.144 0.973 . . . . 0.0 111.57 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' 1566 ' ' LEU . 50.5 tp -91.33 116.2 28.64 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.262 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.4 m -103.31 147.14 27.44 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1561 ' ' TYR . . . . . 0.406 ' HD1' HD23 ' A' 1566 ' ' LEU . 60.7 t80 -117.51 135.0 54.23 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1562 ' ' VAL . . . . . 0.734 HG23 ' HB ' ' A' 1565 ' ' VAL . 18.0 m -134.05 160.51 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.33 106.1 0.09 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.073 0.949 . . . . 0.0 112.887 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 71.9 17.59 5.25 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.15 1.78 . . . . 0.0 112.413 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1565 ' ' VAL . . . . . 0.734 ' HB ' HG23 ' A' 1562 ' ' VAL . 59.5 t -139.8 124.68 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.697 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 93.3 mt -96.04 129.39 43.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' 1560 ' ' SER . 18.1 mm-40 -113.6 114.27 26.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1568 ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' 1568 ' ' LEU . 19.6 mt -104.81 119.47 39.08 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 36.1 t -116.72 108.58 25.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.294 0.569 . . . . 0.0 110.517 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.831 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 45.8 m-85 -93.22 113.35 25.54 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.812 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.54 -177.17 3.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.448 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.668 ' HA ' ' HD2' ' A' 1583 ' ' LYS . 5.1 m-20 68.33 27.98 6.38 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.713 0.633 . . . . 0.0 112.242 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1573 ' ' GLY . . . . . 0.689 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -74.07 -167.63 16.37 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 1.5 m-20 -72.19 162.63 72.65 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 122.338 -0.507 . . . . 0.0 112.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -65.23 144.35 80.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.572 2.181 . . . . 0.0 112.479 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1576 ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 43.9 t -98.23 140.18 21.7 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 124.677 1.191 . . . . 0.0 109.991 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.61 -22.12 73.63 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.068 2.512 . . . . 0.0 114.069 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.21 -26.56 60.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.83 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 36.9 t-20 -171.11 120.21 0.51 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1580 ' ' LEU . . . . . 0.578 HD22 ' H ' ' A' 1580 ' ' LEU . 2.4 mm? -56.16 -27.22 53.47 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.593 1.157 . . . . 0.0 114.112 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.6 m80 -91.09 3.23 55.29 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.83 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 57.6 mt -89.94 121.55 32.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' A' 1572 ' ' ASP . 50.7 mtmt -103.27 156.88 17.4 Favored 'General case' 0 C--N 1.272 -2.795 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -61.88 119.83 9.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.73 0.644 . . . . 0.0 110.881 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' 1583 ' ' LYS . 0.6 OUTLIER -104.38 131.11 52.09 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' 1570 ' ' TYR . 23.1 t -123.15 116.07 22.83 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -116.82 112.87 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-O 122.097 0.951 . . . . 0.0 110.321 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.41 101.51 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 47.5 m -90.96 110.25 21.49 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.21 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.5 m-85 -86.05 104.84 16.02 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.3 m -98.13 159.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.638 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 41.6 t -76.02 122.28 23.98 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.624 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' 1595 ' ' ASP . 20.4 tptm -149.7 90.12 1.68 Allowed 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.6 t -68.37 -15.26 63.49 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.466 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1595 ' ' ASP . . . . . 0.426 ' HB2' ' HE2' ' A' 1593 ' ' LYS . 29.3 m-20 -85.63 4.3 36.93 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 122.175 -0.328 . . . . 0.0 111.505 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.28 -61.12 1.93 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-O 120.734 0.302 . . . . 0.0 111.165 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 87.87 -141.75 17.28 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.838 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.52 -16.9 38.81 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.337 2.691 . . . . 0.0 112.97 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.8 t -125.97 89.78 3.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 122.45 1.119 . . . . 0.0 109.553 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.751 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.2 m -76.25 148.17 37.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.2 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 56.3 mt-30 -96.19 122.06 58.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.4 Cg_endo -87.14 113.67 1.0 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.402 2.734 . . . . 0.0 110.708 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.59 119.33 36.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.871 0.367 . . . . 0.0 110.291 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.448 HD13 ' CZ ' ' A' 1616 ' ' PHE . 39.0 tp -76.5 126.07 30.33 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.39 -65.47 1.01 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 73.7 m -159.51 156.29 27.94 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.513 HG13 HD23 ' A' 1614 ' ' LEU . 96.0 t -110.37 112.39 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 171.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.68 109.03 13.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.86 -6.42 58.59 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.208 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -95.16 -29.0 14.77 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.043 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' 1582 ' ' LEU . 35.9 p -114.86 -15.22 11.87 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.961 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 97.8 m 66.14 58.8 0.7 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.556 1.169 . . . . 0.0 111.097 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 23.5 m -120.94 130.37 53.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.281 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.513 HD23 HG13 ' A' 1607 ' ' VAL . 73.6 mt -96.81 117.4 31.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.33 103.33 13.33 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -114.82 131.53 56.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.829 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 74.7 p -109.53 108.46 18.93 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -92.68 108.01 19.65 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' 1600 ' ' SER . 64.4 m-70 -83.66 97.72 9.25 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -126.45 152.14 46.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.759 0.79 . . . . 0.0 111.808 -173.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.6 m -78.25 -25.99 47.06 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.405 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' 1510 ' ' LEU . 43.2 mt -70.61 -6.07 34.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.957 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -95.18 -9.55 33.07 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.538 0.685 . . . . 0.0 110.432 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -82.85 135.77 34.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.85 89.08 0.57 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -91.6 121.03 32.9 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.492 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.09 -44.21 18.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 -179.731 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1489 ' ' MET . . . . . 0.706 ' N ' ' HG1' ' A' 1497 ' ' THR . 89.7 mmm . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 -41.93 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.208 1.004 . . . . 0.0 108.44 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -123.51 106.67 10.8 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.052 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' 1495 ' ' GLN . 63.4 m-20 -87.73 72.14 9.52 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.849 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 26.2 m120 -89.34 94.09 9.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 45.1 t 61.86 33.41 17.63 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 123.042 1.401 . . . . 0.0 110.16 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' 1505 ' ' PHE . 8.6 pt20 -156.46 146.55 21.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 11.7 p -148.14 135.55 13.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.706 ' HG1' ' N ' ' A' 1489 ' ' MET . 14.0 m -94.94 116.98 29.38 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.462 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.4 p30 -78.66 138.03 58.54 Favored Pre-proline 0 C--N 1.31 -1.134 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.604 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.08 -1.9 11.98 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 113.647 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -83.52 -68.57 0.7 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.68 0.276 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 12.1 p -89.22 -24.99 21.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.65 13.95 64.19 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.55 139.97 30.34 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 44.5 t -92.55 116.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.484 ' HZ ' ' HG2' ' A' 1625 ' ' GLU . 82.3 m-85 -81.24 95.33 6.91 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.04 95.35 10.28 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.001 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 31.8 tp -86.01 -11.1 53.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.51 0.672 . . . . 0.0 110.996 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' 1511 ' ' LYS . 9.1 p30 -71.68 -13.22 61.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.947 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 74.3 m -84.23 -10.85 57.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.128 173.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.76 4.06 19.63 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.004 -0.435 . . . . 0.0 111.033 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 58.0 pttt -90.79 157.74 17.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.079 0.466 . . . . 0.0 111.262 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -128.88 137.03 51.22 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -30.08 70.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 22.3 t -78.27 -11.54 59.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.805 0.812 . . . . 0.0 109.101 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 76.57 -174.67 53.75 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.512 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.87 121.36 44.44 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.5 m -105.88 103.87 13.46 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1518 ' ' ILE . . . . . 0.442 HG21 ' HG3' ' A' 1602 ' ' PRO . 25.9 pt -108.66 139.91 29.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.201 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 10.0 p -87.11 139.29 30.72 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 121.616 0.722 . . . . 0.0 111.571 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -95.23 151.84 18.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.16 -25.87 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 124.567 1.147 . . . . 0.0 112.952 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.58 2.67 18.48 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.08 -0.387 . . . . 0.0 111.841 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.9 tptm 70.04 68.97 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.731 1.253 . . . . 0.0 109.481 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -150.47 174.61 29.79 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 16.5 t -146.39 146.79 30.75 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 118.559 1.18 . . . . 0.0 108.421 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.34 134.47 60.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.1 ttm105 -110.15 113.85 26.87 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.17 129.36 56.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.18 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.75 91.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' 1511 ' ' LYS . 92.8 t -64.1 116.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.643 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 60.8 m 58.45 18.46 5.65 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.79 0.681 . . . . 0.0 112.695 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1532 ' ' GLY . . . . . 0.41 ' N ' ' HE1' ' A' 1555 ' ' TRP . . . -154.07 101.85 0.21 Allowed Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 178.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.0 132.64 54.5 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 121.26 0.552 . . . . 0.0 111.723 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.5 m -78.87 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.958 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -18.01 17.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.095 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.33 -31.82 73.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.27 -0.38 26.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.501 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 123.97 158.11 10.01 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.378 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.9 130.77 11.63 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.395 2.063 . . . . 0.0 111.935 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.86 5.24 81.4 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.572 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.447 ' CD1' ' HD2' ' A' 1551 ' ' LYS . 41.1 mm -98.77 117.49 43.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.15 -19.73 18.11 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.49 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -137.27 120.28 16.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.4 p -131.03 136.77 48.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.395 0.617 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 76.8 t80 -96.26 116.12 28.51 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.6 104.81 4.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.623 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -176.12 -105.67 0.19 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 5.2 m -73.88 -25.23 59.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 109.46 57.53 0.53 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 61.3 mt -94.14 125.12 46.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.447 ' HD2' ' CD1' ' A' 1541 ' ' ILE . 43.2 mtmt -83.91 126.26 32.82 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -105.48 9.0 33.69 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.246 0.546 . . . . 0.0 110.767 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.784 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 147.86 146.58 4.37 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.329 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.5 144.93 27.66 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.733 0.777 . . . . 0.0 111.541 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.504 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 65.6 t90 -65.54 151.21 46.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.158 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -164.99 167.31 18.58 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -119.26 20.52 12.56 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -91.01 96.71 10.76 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.463 0.649 . . . . 0.0 110.336 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.479 HD23 HD13 ' A' 1568 ' ' LEU . 69.2 mt -94.19 109.38 21.18 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 20.1 m -92.94 120.84 33.67 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 75.6 t80 -93.23 102.39 14.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1562 ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' 1565 ' ' VAL . 49.2 t -115.65 88.88 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.681 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.0 t70 48.03 81.41 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.927 1.291 . . . . 0.0 113.799 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 70.35 -9.19 0.79 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1565 ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' 1562 ' ' VAL . 7.4 p -116.98 132.13 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.539 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.874 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 14.7 tp -88.15 119.08 28.2 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -107.06 129.11 54.86 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.435 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1568 ' ' LEU . . . . . 0.479 HD13 HD23 ' A' 1559 ' ' LEU . 54.9 tp -126.8 109.88 12.49 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 172.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 38.7 t -110.9 128.5 67.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.784 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 75.2 m-85 -104.43 119.33 38.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.13 177.28 4.78 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.781 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 8.7 t70 52.65 70.33 0.59 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.227 1.411 . . . . 0.0 111.85 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.94 -135.82 8.87 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.321 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 19.5 t70 -83.5 145.54 48.23 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 6.4 Cg_exo -74.18 142.72 31.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.607 2.205 . . . . 0.0 111.526 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1576 ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' 1578 ' ' ALA . 78.2 m -98.39 132.17 24.76 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.746 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.44 20.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.578 2.852 . . . . 0.0 112.714 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1578 ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -86.81 -55.47 3.83 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.55 7.67 2.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.282 0.563 . . . . 0.0 109.766 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 2.2 tm? 68.93 -50.88 0.59 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.508 1.523 . . . . 0.0 112.358 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.7 t60 -68.49 -13.46 62.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.358 0.663 . . . . 0.0 110.408 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.67 134.98 35.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 85.6 mttt -125.84 152.45 45.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 95.5 m-85 -67.08 117.48 9.18 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.864 0.728 . . . . 0.0 109.393 174.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.14 135.45 48.88 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 13.1 p -121.03 121.25 37.54 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.683 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 4.2 p -106.15 113.63 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.552 0.691 . . . . 0.0 109.735 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.42 110.12 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1589 ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' 1565 ' ' VAL . 42.3 m -93.34 118.62 31.5 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.874 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 90.9 m-85 -86.58 110.2 19.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.2 m -107.42 152.38 9.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' 1620 ' ' THR . 40.3 t -81.98 142.53 32.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.273 0.558 . . . . 0.0 112.404 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.518 ' CB ' ' HB3' ' A' 1619 ' ' HIS . 42.4 tptt -163.29 97.35 0.9 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.457 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 9.5 p -56.65 -32.28 65.21 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.871 0.868 . . . . 0.0 112.09 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1595 ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.674 0.79 . . . . 0.0 112.037 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -80.27 -41.6 24.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.767 0.318 . . . . 0.0 111.519 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.2 -163.68 39.66 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.7 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.63 -15.64 21.63 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.272 2.648 . . . . 0.0 113.168 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.3 p -86.13 -42.02 14.24 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.814 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.4 m 72.21 161.75 0.25 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.18 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -115.52 121.65 34.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.442 ' HG3' HG21 ' A' 1518 ' ' ILE . 55.3 Cg_endo -84.2 121.46 2.72 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.73 118.38 33.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.482 HD21 HG23 ' A' 1607 ' ' VAL . 49.7 tp -78.42 116.84 19.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 46.8 tp -79.94 -56.12 4.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.608 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 50.9 m -164.21 136.24 4.75 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 122.614 0.365 . . . . 0.0 110.171 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.482 HG23 HD21 ' A' 1604 ' ' LEU . 82.3 t -103.35 110.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.22 100.17 10.35 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.487 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -80.58 7.07 10.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.081 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -89.8 -51.34 5.55 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.942 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1611 ' ' THR . . . . . . . . . . . . . 49.9 p -99.74 -9.53 22.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.581 0.229 . . . . 0.0 111.218 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1612 ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 66.6 m 69.54 23.27 6.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.656 1.182 . . . . 0.0 111.075 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 13.4 m -91.22 114.23 26.7 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' 1616 ' ' PHE . 79.6 mt -93.83 121.91 35.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.92 113.56 27.18 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' 1614 ' ' LEU . 76.0 m-85 -121.9 139.19 53.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.1 m -119.92 108.81 14.79 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.403 ' HE1' ' HB2' ' A' 1600 ' ' SER . 24.3 t-105 -93.14 110.24 21.74 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.518 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 39.4 m-70 -83.04 107.77 15.87 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.8 t -132.79 152.98 51.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.622 0.576 . . . . 0.0 110.068 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.7 m -70.62 -27.62 64.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.41 0.624 . . . . 0.0 110.065 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.82 -5.87 37.43 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.347 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1623 ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' 1592 ' ' CYS . . . -84.73 -9.01 58.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.605 0.717 . . . . 0.0 110.501 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.7 m -94.58 144.26 25.74 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1625 ' ' GLU . . . . . 0.484 ' HG2' ' HZ ' ' A' 1505 ' ' PHE . 47.3 mt-10 -69.83 105.54 2.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.51 0.671 . . . . 0.0 109.698 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -81.17 136.93 35.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.58 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -62.48 1.85 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.792 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.878 0.371 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 50.4 t -94.06 -48.53 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -74.45 155.73 37.71 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.77 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' 1496 ' ' VAL . 9.2 m-20 -54.66 104.52 0.12 Allowed 'General case' 0 C--O 1.239 0.515 0 O-C-N 124.654 1.221 . . . . 0.0 110.123 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.42 126.78 51.31 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 95.3 m 70.91 -1.4 2.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.602 0.715 . . . . 0.0 112.325 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' 1492 ' ' ASP . 29.4 pt20 -149.2 161.53 41.81 Favored 'General case' 0 N--CA 1.405 -2.692 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1496 ' ' VAL . . . . . 0.508 ' HA ' ' HB3' ' A' 1492 ' ' ASP . 14.5 p -146.74 121.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-O 121.88 0.847 . . . . 0.0 110.514 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.62 HG23 HG22 ' A' 1504 ' ' VAL . 17.7 m -91.67 104.18 16.68 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.05 135.9 47.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.087 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 -12.37 20.18 Favored 'Trans proline' 0 C--N 1.332 -0.324 0 C-N-CA 122.591 2.194 . . . . 0.0 112.212 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -66.51 -67.34 0.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.544 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1501 ' ' THR . . . . . 0.443 ' H ' ' HG1' ' A' 1501 ' ' THR . 25.4 p -99.54 -23.0 15.23 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.45 73.28 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.376 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -74.63 137.4 42.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.177 0.513 . . . . 0.0 110.023 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.62 HG22 HG23 ' A' 1497 ' ' THR . 41.7 t -100.02 121.56 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -115.08 108.56 16.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1506 ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' 1495 ' ' GLN . 2.5 p-10 -104.33 127.44 51.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.722 0.772 . . . . 0.0 109.479 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.4 tp -90.78 4.65 51.06 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' 1511 ' ' LYS . 79.7 m-20 -67.42 -27.21 66.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.415 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 35.9 p -79.61 -18.29 51.93 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.801 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' 1598 ' ' PRO . 25.6 mt -109.63 4.26 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.08 -0.388 . . . . 0.0 111.657 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' 1508 ' ' ASN . 21.1 pttp -85.17 153.02 22.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' 1515 ' ' GLY . 55.1 ttt180 -120.88 129.49 53.53 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.32 -42.76 92.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 111.111 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.0 m -82.25 1.45 36.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.54 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.567 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 76.37 166.21 22.37 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.405 0.447 . . . . 0.0 113.981 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' 1527 ' ' ARG . 89.0 m-85 -98.68 123.78 43.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.1 m -103.93 97.75 7.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.87 125.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.134 0.492 . . . . 0.0 111.664 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1519 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1525 ' ' SER . 38.7 m -94.3 116.65 29.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1520 ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' 1604 ' ' LEU . 2.0 m-20 -119.43 99.72 6.85 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 47.8 mt 63.26 -104.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.932 170.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.97 -12.52 12.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.59 -35.6 79.29 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.728 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 122.26 -161.94 16.24 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1525 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1519 ' ' SER . 9.0 m -96.21 123.1 39.71 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 7.7 tt -112.13 127.45 69.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.489 ' HG2' HG11 ' A' 1534 ' ' VAL . 40.1 ttm180 -104.83 118.57 36.89 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1528 ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' 1528 ' ' LEU . 1.2 mp -118.3 122.46 42.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.513 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' 1532 ' ' GLY . . . -100.88 97.2 1.66 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.31 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' 1511 ' ' LYS . 60.3 t -66.27 115.2 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1531 ' ' CYS . . . . . 0.466 ' HB2' ' HD2' ' A' 1511 ' ' LYS . 68.0 m 59.65 15.15 4.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.858 0.863 . . . . 0.0 113.207 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1532 ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' 1529 ' ' GLY . . . -141.16 112.73 0.79 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1533 ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' 1535 ' ' LYS . 33.6 mt-10 -63.41 140.96 58.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.489 HG11 ' HG2' ' A' 1527 ' ' ARG . 16.0 m -85.41 89.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.265 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -62.33 -19.04 62.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.219 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.66 -23.08 64.51 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.708 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 32.0 t -121.74 4.7 10.02 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.599 0.714 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 102.41 152.08 24.1 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.979 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.09 153.19 75.51 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.492 2.128 . . . . 0.0 111.264 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.45 -10.07 70.83 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.331 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.433 HD12 ' HD3' ' A' 1551 ' ' LYS . 42.4 mm -98.37 129.8 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.5 -50.64 1.28 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.108 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.03 132.49 55.49 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 49.1 t -136.52 149.98 48.42 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.414 0.15 . . . . 0.0 110.889 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.467 ' HZ ' HD11 ' A' 1614 ' ' LEU . 67.1 m-85 -93.63 160.75 14.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.817 0.818 . . . . 0.0 112.867 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.77 -22.18 66.78 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.701 2.0 . . . . 0.0 113.073 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -119.65 130.18 8.35 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.035 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1548 ' ' THR . . . . . 0.482 ' HB ' HG23 ' A' 1550 ' ' ILE . 23.9 m 73.77 -13.65 0.73 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 112.562 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.28 36.02 35.98 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.482 HG23 ' HB ' ' A' 1548 ' ' THR . 36.2 pt -81.51 143.03 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.623 ' HG2' ' OD1' ' A' 1574 ' ' ASP . 17.2 pttm -92.99 145.05 24.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.593 0.711 . . . . 0.0 111.434 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1552 ' ' ALA . . . . . 0.435 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.15 15.67 26.0 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.627 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.785 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 141.2 141.48 3.98 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.934 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 48.0 mtpt -78.78 159.9 27.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 72.7 t90 -67.22 141.26 57.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.774 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.39 172.37 18.46 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.2 24.25 5.95 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.448 1.099 . . . . 0.0 109.757 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.37 103.36 15.41 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.258 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.33 130.56 54.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.0 t -121.38 109.67 15.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.12 103.54 15.59 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 95.8 t -127.7 105.01 13.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.318 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.4 t70 58.19 60.93 2.47 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 111.223 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.99 24.51 9.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.207 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1565 ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' 1590 ' ' PHE . 96.2 t -126.6 122.44 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.88 123.75 34.64 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' A' 1560 ' ' SER . 17.4 mm-40 -102.0 114.5 28.66 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.418 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.0 tp -116.64 102.71 9.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.53 HG22 HG23 ' A' 1587 ' ' VAL . 35.0 t -107.12 120.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.095 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.785 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 79.5 m-85 -86.21 108.94 18.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.7 154.44 21.64 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.219 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 13.0 t70 56.21 86.11 0.07 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.753 1.621 . . . . 0.0 113.852 173.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1573 ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -107.32 -152.23 18.0 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.623 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 0.7 OUTLIER -83.23 146.57 51.46 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 116.962 0.381 . . . . 0.0 110.276 176.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 7.2 Cg_exo -73.52 143.92 35.22 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.234 2.623 . . . . 0.0 112.665 -175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.4 142.78 25.44 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.825 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.56 11.66 0.78 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.172 2.582 . . . . 0.0 114.091 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.45 -56.15 4.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.869 0.366 . . . . 0.0 110.543 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.778 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.4 m120 -133.91 7.91 3.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.806 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.0 mm? 70.48 -55.53 0.62 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.403 1.081 . . . . 0.0 113.096 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -74.88 -12.99 60.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.489 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 65.1 mt -82.45 131.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 95.3 mttt -131.39 162.09 30.93 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.733 0.645 . . . . 0.0 110.142 -174.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.431 ' O ' ' HA3' ' A' 1573 ' ' GLY . 97.0 m-85 -66.87 112.64 4.39 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 123.937 0.773 . . . . 0.0 109.531 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -129.32 147.04 51.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.0 p -129.85 121.67 27.17 Favored 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.364 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.53 HG23 HG22 ' A' 1569 ' ' VAL . 3.0 p -111.36 111.22 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.853 0.835 . . . . 0.0 109.364 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.95 106.06 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 43.8 m -87.48 110.0 20.0 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.763 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.796 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.7 m-85 -86.04 101.66 13.13 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.4 m -100.02 160.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.224 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 28.3 t -76.46 120.53 21.81 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.6 tptt -143.16 97.08 3.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -107.7 19.2 20.46 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.073 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -70.52 -38.82 74.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.157 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 91.51 -174.07 37.75 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.146 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1598 ' ' PRO . . . . . 0.417 ' O ' HD22 ' A' 1510 ' ' LEU . 70.8 Cg_endo -71.78 -15.23 30.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.36 2.707 . . . . 0.0 112.028 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.7 p -79.91 -48.83 12.81 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.634 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 40.0 m 68.47 161.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.815 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.506 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 19.5 mt-30 -107.0 119.77 50.17 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.448 -0.783 . . . . 0.0 110.571 -174.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 3.8 Cg_endo -89.96 116.25 0.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.429 2.752 . . . . 0.0 112.006 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 56.6 tp -115.47 120.01 38.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' 1520 ' ' ASP . 60.8 tp -70.9 113.24 7.76 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.9 tp -87.93 -63.49 1.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.571 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 67.2 m -147.34 138.38 23.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.922 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 62.5 t -122.78 112.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -97.87 124.66 42.37 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.552 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.21 -8.27 59.36 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -102.78 -51.5 3.28 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.214 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.735 ' HA ' HD13 ' A' 1582 ' ' LEU . 36.4 p -86.83 -14.69 41.4 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 73.4 m 61.85 23.19 13.59 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.082 0.953 . . . . 0.0 111.637 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -86.14 115.65 23.84 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.467 HD11 ' HZ ' ' A' 1545 ' ' PHE . 87.1 mt -91.52 126.71 36.69 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.958 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.05 116.37 31.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.23 137.58 53.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.6 m -110.25 103.68 12.39 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' A' 1600 ' ' SER . 11.3 t-105 -99.47 105.81 17.78 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 85.2 m-70 -81.02 100.65 9.08 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.4 t -122.71 153.66 39.14 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.647 0.736 . . . . 0.0 111.474 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.7 m -76.11 -26.37 56.33 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.365 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' 1622 ' ' LEU . 26.6 mt -71.43 -5.23 31.22 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -90.59 -23.95 20.69 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.553 0.692 . . . . 0.0 110.242 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 66.8 m -72.91 142.26 47.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.483 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.73 94.23 1.74 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.8 129.68 34.66 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.42 -170.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.05 -44.71 19.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.891 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.31 -1.129 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.717 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 23.8 ptm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1490 ' ' VAL . . . . . 0.499 HG13 ' HG3' ' A' 1491 ' ' GLN . 12.3 p 176.16 -33.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -176.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1491 ' ' GLN . . . . . 0.499 ' HG3' HG13 ' A' 1490 ' ' VAL . 98.1 mt-30 -94.91 22.09 6.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.356 1.074 . . . . 0.0 108.985 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1492 ' ' ASP . . . . . 0.609 ' HA ' ' O ' ' A' 1495 ' ' GLN . 4.4 m-20 -86.97 72.54 10.08 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.788 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.0 p30 -88.58 -72.85 0.52 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.36 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.432 ' HA ' ' HG ' ' A' 1559 ' ' LEU . 85.3 m -121.99 15.29 10.78 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.49 1.138 . . . . 0.0 108.818 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' 1505 ' ' PHE . 17.1 pt20 -139.05 116.88 11.54 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.2 p -137.57 141.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' 1504 ' ' VAL . 6.7 t -121.12 167.76 12.3 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 24.5 p30 -131.96 150.99 77.68 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.92 16.12 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.311 2.007 . . . . 0.0 112.413 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -93.69 -56.79 2.77 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.39 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.7 p -103.08 -27.97 12.25 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.61 0.719 . . . . 0.0 110.198 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.68 27.38 57.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.857 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 61.4 t80 -98.4 132.68 43.66 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' 1497 ' ' THR . 43.1 t -96.54 110.1 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' 1495 ' ' GLN . 65.7 m-85 -76.56 102.84 6.25 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.88 107.38 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.836 0.35 . . . . 0.0 110.777 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 -4.48 59.17 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.199 1.0 . . . . 0.0 109.153 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.539 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 48.6 m-80 -71.07 -21.28 62.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.896 -177.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 58.8 p -80.98 -7.65 59.59 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.667 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.66 11.35 15.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 33.1 mtmm -59.55 176.24 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.153 0.501 . . . . 0.0 111.677 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.811 ' HD3' HG12 ' A' 1534 ' ' VAL . 18.3 ttp180 -66.97 93.46 0.28 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.201 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.93 -38.99 10.43 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 168.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 28.3 t -118.37 -40.23 2.95 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.194 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.62 175.56 32.48 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' 1527 ' ' ARG . 12.4 m-85 -113.79 141.95 46.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1517 ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' 1526 ' ' ILE . 88.2 m -142.72 103.41 4.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.379 0.609 . . . . 0.0 110.845 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 22.7 pt -119.82 148.73 22.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 45.4 m -114.48 123.65 49.95 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.138 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.79 155.45 39.29 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.841 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.64 -24.7 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 124.087 0.955 . . . . 0.0 112.079 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1522 ' ' ARG . . . . . 0.86 HH22 HG11 ' A' 1607 ' ' VAL . 80.0 mtm180 -81.01 3.1 24.22 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.311 0.644 . . . . 0.0 111.262 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.78 62.15 0.33 Allowed 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.554 1.142 . . . . 0.0 111.038 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -121.42 91.48 0.47 Allowed Glycine 0 N--CA 1.409 -3.134 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.5 m -78.85 104.18 9.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1526 ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.2 tt -98.18 125.98 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.515 0.674 . . . . 0.0 109.317 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' 1516 ' ' TYR . 44.1 ttt180 -108.35 125.27 51.52 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.34 140.39 50.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.121 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -122.66 126.41 6.35 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 106.568 -2.613 . . . . 0.0 106.568 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.1 m -89.51 118.74 35.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.126 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 55.8 m 69.86 10.9 7.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.823 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -136.43 130.47 5.27 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1533 ' ' GLU . . . . . 0.572 ' HG3' ' HE3' ' A' 1535 ' ' LYS . 12.7 pt-20 -74.91 129.3 37.43 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.265 0.555 . . . . 0.0 111.62 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.811 HG12 ' HD3' ' A' 1512 ' ' ARG . 17.7 m -92.58 99.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 122.005 0.907 . . . . 0.0 109.842 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.572 ' HE3' ' HG3' ' A' 1533 ' ' GLU . 9.8 mptt -67.15 -12.12 59.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.071 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.18 -43.64 74.53 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 125.683 1.593 . . . . 0.0 109.151 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 58.1 m -104.23 -7.19 20.26 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.95 163.5 9.54 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.533 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.86 139.16 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.112 1.875 . . . . 0.0 111.365 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 71.88 30.43 65.84 Favored Glycine 0 C--N 1.305 -1.193 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.388 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.21 129.04 75.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -104.6 -35.84 3.19 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.116 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -122.78 124.67 43.86 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 27.4 p -140.07 154.64 47.12 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.755 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' 1550 ' ' ILE . 91.1 m-85 -93.96 116.48 28.93 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.13 100.65 3.7 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.484 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -174.8 -94.92 0.1 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 94.0 m -95.78 -37.42 10.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 117.153 0.477 . . . . 0.0 110.706 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 143.44 31.21 0.1 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.581 -1.295 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.588 ' HB ' ' HB2' ' A' 1545 ' ' PHE . 64.9 mt -71.39 125.17 29.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.631 ' H ' ' HB2' ' A' 1574 ' ' ASP . 36.3 mttp -99.29 132.45 44.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.03 4.89 29.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.924 0.392 . . . . 0.0 111.285 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.962 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 156.94 140.19 2.89 Favored Glycine 0 C--O 1.254 1.403 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.027 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 60.4 mttp -79.21 155.51 28.57 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 67.5 t90 -64.57 124.91 23.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -163.17 140.53 7.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1557 ' ' GLN . . . . . 0.403 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 90.1 mt-30 -106.63 79.53 1.36 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -127.68 98.25 5.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.272 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' 1494 ' ' CYS . 34.6 mt -101.43 107.57 18.92 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.343 0.592 . . . . 0.0 109.89 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.07 113.72 26.06 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -90.71 101.35 14.1 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1562 ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' 1565 ' ' VAL . 78.3 t -135.47 141.4 42.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 60.54 24.02 13.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.791 0.836 . . . . 0.0 110.397 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 65.92 16.62 10.54 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 124.166 0.986 . . . . 0.0 110.855 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1565 ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' 1562 ' ' VAL . 7.3 p -121.49 155.29 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.826 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.6 mp -91.28 129.81 37.23 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -119.99 115.66 24.21 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.13 102.02 8.95 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1587 ' ' VAL . 7.6 p -106.95 112.51 40.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.563 0.697 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.962 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 30.6 m-85 -81.75 102.38 10.72 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' 1569 ' ' VAL . 49.5 mt-10 -102.3 161.64 13.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.111 0.482 . . . . 0.0 111.896 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 8.5 t70 63.15 66.02 0.75 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.102 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -91.16 -93.0 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.391 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.631 ' HB2' ' H ' ' A' 1551 ' ' LYS . 3.3 t70 -123.25 149.82 58.58 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.02 137.58 82.58 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.776 2.317 . . . . 0.0 112.855 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 24.8 t -101.79 128.93 27.65 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.251 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.67 16.92 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.559 2.84 . . . . 0.0 114.283 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.54 -41.12 16.8 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.39 10.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.167 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 1.7 tm? 69.84 -53.7 0.61 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.274 1.43 . . . . 0.0 111.761 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -65.92 -24.01 66.74 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.032 0.533 . . . . 0.0 110.752 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' 1611 ' ' THR . 85.4 mt -81.11 141.08 34.64 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' 1585 ' ' LYS . 62.1 mttp -132.08 158.0 42.72 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -59.66 121.36 11.44 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 124.122 0.889 . . . . 0.0 109.474 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' 1583 ' ' LYS . 43.9 mtmt -130.76 134.42 46.86 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.651 ' HB3' HD12 ' A' 1614 ' ' LEU . 13.6 p -123.53 116.77 23.72 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.426 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1569 ' ' VAL . 7.5 p -102.83 109.31 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.066 0.936 . . . . 0.0 110.649 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1588 ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.4 mp -97.62 108.85 22.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 14.7 t -95.9 119.51 34.52 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.826 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 88.8 m-85 -89.83 106.35 18.41 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 169.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' 1620 ' ' THR . 38.7 t -104.77 141.23 36.86 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 117.484 -1.686 . . . . 0.0 115.325 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 53.8 tptt -151.45 100.57 2.74 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.952 170.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1594 ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' 1621 ' ' SER . 41.0 p -66.09 -9.63 32.9 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1595 ' ' ASP . . . . . 0.522 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 8.0 m-20 -92.97 6.21 48.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.893 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -76.55 -74.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 109.45 -120.13 5.69 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.614 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.05 17.77 1.69 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.477 2.785 . . . . 0.0 110.708 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 t -153.76 -176.05 5.65 Favored 'General case' 1 N--CA 1.377 -4.121 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.726 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 41.4 m -155.48 155.7 33.95 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.566 0.746 . . . . 0.0 109.004 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.78 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 44.5 mt-30 -87.79 121.44 70.84 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.454 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.0 OUTLIER -88.95 128.78 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.391 2.727 . . . . 0.0 111.51 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' 1617 ' ' SER . 2.2 tm? -130.54 114.91 16.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.97 106.91 4.45 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 61.0 tp -75.02 -53.98 7.98 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.242 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.2 t -169.81 151.58 4.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.86 HG11 HH22 ' A' 1522 ' ' ARG . 65.0 t -125.91 131.78 71.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 19.2 t70 -110.74 117.17 32.72 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.8 -8.58 59.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -72.09 -40.46 68.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.761 0.315 . . . . 0.0 110.479 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.592 ' HA ' HD13 ' A' 1582 ' ' LEU . 23.4 p -121.66 -5.45 9.19 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 62.1 m 67.56 32.6 5.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.048 0.928 . . . . 0.0 111.152 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 44.1 m -92.04 126.61 37.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.959 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' 1586 ' ' SER . 59.0 mt -101.39 132.12 47.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.68 119.15 37.09 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.38 137.05 54.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.86 0.362 . . . . 0.0 111.621 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 27.3 m -104.11 105.42 15.57 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 12.6 t-105 -101.44 118.85 37.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.78 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 14.8 m-70 -94.79 97.57 10.14 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' 1592 ' ' CYS . 11.7 t -123.26 151.05 42.73 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.348 0.594 . . . . 0.0 111.608 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1621 ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' 1594 ' ' SER . 1.0 OUTLIER -74.23 -23.81 59.22 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.778 0.799 . . . . 0.0 110.49 178.153 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.74 -4.91 34.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.519 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -93.29 -5.86 48.78 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.793 0.33 . . . . 0.0 111.445 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 20.5 m -91.64 137.61 32.22 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 111.98 10.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -80.69 117.93 21.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.67 -22.23 43.76 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.932 -174.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.306 -1.303 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.179 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1489 ' ' MET . . . . . 0.559 ' HG3' HG23 ' A' 1490 ' ' VAL . 13.7 tpt . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1490 ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' 1489 ' ' MET . 25.5 t 62.64 56.46 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 122.713 1.244 . . . . 0.0 108.631 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -131.74 117.57 18.78 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.01 75.46 10.14 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.963 1.363 . . . . 0.0 110.696 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -71.28 -54.77 9.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.942 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 6.1 t 59.03 33.3 22.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.003 1.321 . . . . 0.0 110.255 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -150.27 154.45 37.92 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.7 p -141.62 138.24 32.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.452 HG23 HG22 ' A' 1504 ' ' VAL . 23.7 m -104.08 113.59 27.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1498 ' ' ASN . . . . . 0.574 HD21 ' HB2' ' A' 1503 ' ' TYR . 6.0 p30 -81.89 130.86 59.01 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.34 -3.37 13.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.568 2.179 . . . . 0.0 112.649 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -75.44 -53.95 7.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.727 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1501 ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' 1503 ' ' TYR . 17.2 p -109.21 -14.11 14.54 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.5 26.54 59.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.599 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1503 ' ' TYR . . . . . 0.574 ' HB2' HD21 ' A' 1498 ' ' ASN . 13.8 m-85 -99.22 120.4 39.46 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.22 -0.49 . . . . 0.0 109.977 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.452 HG22 HG23 ' A' 1497 ' ' THR . 25.4 t -89.39 113.35 25.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -100.23 111.18 23.44 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 3.0 p30 -104.01 130.87 51.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.059 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.79 0.18 56.12 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.082 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1508 ' ' ASN . . . . . 0.623 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 23.6 m120 -63.0 -38.5 91.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.49 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.9 t -71.08 -3.97 22.64 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.315 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.635 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.9 OUTLIER -114.16 -41.78 3.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.266 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' 1508 ' ' ASN . 22.0 pttp -65.57 144.21 57.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' 1515 ' ' GLY . 40.5 ttm180 -88.58 161.92 16.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -50.11 -54.98 16.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.346 1.058 . . . . 0.0 111.342 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 3.0 p -87.6 -2.62 58.74 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 123.675 0.79 . . . . 0.0 111.872 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' 1529 ' ' GLY . . . 86.74 -139.74 16.65 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -176.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 95.7 m-85 -124.63 121.65 35.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 117.467 0.633 . . . . 0.0 111.124 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 32.9 m -110.5 94.83 5.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.25 155.3 11.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.355 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 22.4 m -79.9 131.21 35.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.447 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.31 147.8 27.74 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.852 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.77 -25.97 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.901 0.88 . . . . 0.0 112.727 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -83.87 3.26 34.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.987 0.422 . . . . 0.0 110.165 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.28 84.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.772 1.629 . . . . 0.0 111.358 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1524 ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' 1545 ' ' PHE . . . -175.22 156.36 22.19 Favored Glycine 0 N--CA 1.404 -3.465 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 4.2 m -114.13 101.68 9.44 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.6 tt -83.41 119.71 33.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.196 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 43.3 ttm180 -109.78 112.74 24.97 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.974 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.36 118.78 30.33 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.583 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' 1515 ' ' GLY . . . -90.03 106.79 3.37 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 89.2 t -59.73 116.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 36.1 m 63.21 12.6 6.24 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.071 0.857 . . . . 0.0 111.609 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -129.27 172.4 19.79 Favored Glycine 0 N--CA 1.42 -2.395 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.063 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.97 141.74 40.64 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.413 HG11 ' HG2' ' A' 1527 ' ' ARG . 26.6 m -103.9 90.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.252 1.025 . . . . 0.0 109.605 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -65.1 -16.61 63.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.82 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -64.83 -22.21 66.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.92 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 21.6 t -111.87 -13.67 13.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.429 0.633 . . . . 0.0 110.043 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.67 155.27 6.46 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.217 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.08 141.12 35.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.467 2.111 . . . . 0.0 111.071 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.85 8.87 87.23 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.331 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1541 ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' 1551 ' ' LYS . 46.5 mm -106.56 135.05 46.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.23 -37.29 2.51 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.007 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -124.03 123.99 41.57 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 122.707 -0.29 . . . . 0.0 110.325 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 45.0 t -136.69 153.43 50.89 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.296 0.569 . . . . 0.0 110.821 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' 1524 ' ' GLY . 58.9 t80 -90.15 100.29 13.15 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.494 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1546 ' ' GLU . . . . . 0.725 ' HG3' HG23 ' A' 1548 ' ' THR . 11.8 pt-20 47.71 21.24 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.784 2.034 . . . . 0.0 115.221 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 63.55 27.47 70.97 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.516 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1548 ' ' THR . . . . . 0.725 HG23 ' HG3' ' A' 1546 ' ' GLU . 32.9 p -83.24 -15.95 48.33 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 118.689 1.244 . . . . 0.0 109.985 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 122.6 -14.91 8.6 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.718 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 50.7 mt -79.48 118.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' 1541 ' ' ILE . 8.6 mtmp? -97.79 137.48 36.6 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.499 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -111.48 11.63 21.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.369 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.859 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 155.53 130.55 1.33 Allowed Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.432 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.4 tttp -81.71 155.26 25.62 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1555 ' ' TRP . . . . . 0.53 ' HH2' ' HA ' ' A' 1490 ' ' VAL . 61.6 t90 -73.21 128.53 35.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.315 0.578 . . . . 0.0 110.08 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.47 139.5 14.31 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -86.89 78.16 9.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.287 0.565 . . . . 0.0 110.46 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 54.0 tptt -114.82 96.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.805 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 86.2 mt -109.84 103.34 12.12 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.568 -1.196 . . . . 0.0 107.997 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.877 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 29.2 t -101.77 141.47 34.58 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 20.3 t80 -121.59 101.16 7.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1562 ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' 1565 ' ' VAL . 98.5 t -134.88 127.29 48.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.281 -176.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.37 33.83 22.57 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.441 1.115 . . . . 0.0 110.0 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 70.94 -0.03 3.2 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.351 1.06 . . . . 0.0 113.236 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1565 ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' 1562 ' ' VAL . 9.5 p -98.98 134.18 38.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.752 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.2 tp -84.97 132.26 34.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.877 ' HB2' ' HB3' ' A' 1560 ' ' SER . 94.0 mt-30 -122.07 114.99 21.68 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.739 -0.601 . . . . 0.0 112.121 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 48.4 tp -102.86 112.65 25.55 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.471 HG12 ' HG2' ' A' 1571 ' ' GLU . 44.4 t -105.83 112.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.592 -172.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.859 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 77.4 m-85 -95.19 115.2 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.471 ' HG2' HG12 ' A' 1569 ' ' VAL . 8.9 mm-40 -111.56 165.54 11.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 33.5 t70 60.72 80.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.474 1.109 . . . . 0.0 111.871 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.46 -127.56 6.14 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 1.0 OUTLIER -113.5 147.25 37.11 Favored Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 122.604 -0.35 . . . . 0.0 111.033 175.379 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 23.5 Cg_exo -66.52 134.31 35.19 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.404 2.736 . . . . 0.0 112.832 -176.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 85.6 m -98.8 149.06 35.38 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.276 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.42 3.99 4.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.849 2.366 . . . . 0.0 115.869 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.29 -67.18 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.915 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.523 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 6.8 m-20 -110.26 2.19 19.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.246 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? 71.69 -57.62 0.61 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.337 1.055 . . . . 0.0 113.707 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -76.23 -10.44 59.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 111.168 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.669 HD13 ' HA ' ' A' 1611 ' ' THR . 70.8 mt -83.17 124.58 30.66 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 88.0 mttt -119.31 162.75 18.22 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.835 0.709 . . . . 0.0 110.043 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -58.97 109.34 0.81 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 124.01 0.819 . . . . 0.0 109.705 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -112.2 131.77 55.29 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.5 t -121.77 118.72 29.74 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.701 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -115.33 107.49 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.969 0.89 . . . . 0.0 109.844 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.96 107.32 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1589 ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' 1617 ' ' SER . 25.0 m -91.52 116.3 28.75 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 92.4 m-85 -86.12 105.53 16.6 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1591 ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' 1617 ' ' SER . 65.3 t -93.95 152.05 3.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.009 -175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.5 t -75.26 134.52 41.09 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.107 0.955 . . . . 0.0 112.822 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 54.3 tptt -149.68 101.34 3.06 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 171.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 71.1 m -63.21 -37.76 88.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.494 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -97.77 71.69 2.24 Favored 'General case' 0 N--CA 1.423 -1.813 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.937 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -133.3 -57.76 0.9 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.756 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.69 -147.67 38.91 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.94 -21.9 36.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.217 1.944 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.7 p -91.06 67.21 5.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 122.312 1.053 . . . . 0.0 109.356 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.535 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 15.1 m -76.85 161.77 28.16 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.685 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 16.9 mm-40 -105.43 121.11 47.29 Favored Pre-proline 0 C--N 1.301 -1.5 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.096 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.7 Cg_exo -77.31 152.76 30.87 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.678 2.252 . . . . 0.0 110.104 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1603 ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' 1617 ' ' SER . 66.3 tp -154.88 120.3 5.03 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.102 -0.374 . . . . 0.0 110.979 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.61 113.47 16.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 42.8 tp -88.93 -43.51 11.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 40.1 t -167.62 150.65 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 84.9 t -130.6 111.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1608 ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' 1612 ' ' CYS . 31.7 t70 -93.65 122.74 36.42 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.521 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -80.14 -11.78 59.72 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.38 -52.5 5.16 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.166 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.669 ' HA ' HD13 ' A' 1582 ' ' LEU . 47.2 p -98.03 -17.03 19.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.974 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1612 ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' 1608 ' ' ASP . 75.6 m 69.95 25.18 4.94 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 124.108 0.88 . . . . 0.0 111.586 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 21.6 m -80.38 118.1 21.71 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.98 126.88 41.52 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.16 118.03 35.67 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.37 139.23 53.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1617 ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' 1589 ' ' SER . 21.7 m -121.65 103.72 9.1 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.666 0.746 . . . . 0.0 109.382 175.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -92.89 107.53 19.29 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -175.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.6 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 96.9 m-70 -78.0 97.42 5.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.8 t -131.09 154.02 48.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.528 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.5 m -76.15 -25.09 54.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1622 ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.89 -5.03 31.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.471 0.653 . . . . 0.0 111.835 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.7 -3.05 30.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.066 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.1 m -96.04 144.71 26.07 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.64 112.27 3.57 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 168.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1626 ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' 1628 ' ' VAL . 5.4 tp60 -80.58 142.29 34.23 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -164.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -71.71 -32.83 68.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.035 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1628 ' ' VAL . . . . . 0.567 ' H ' ' HG3' ' A' 1626 ' ' GLN . 2.6 p . . . . . 0 C--N 1.308 -1.207 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.54 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 68.0 t -89.34 119.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.26 124.28 27.9 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.33 127.66 39.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -132.19 166.53 21.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1494 ' ' CYS . . . . . 0.406 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 79.4 m -77.44 1.24 19.75 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.009 0.923 . . . . 0.0 111.816 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1495 ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.6 pt20 -117.15 118.25 31.82 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -118.96 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.831 0.824 . . . . 0.0 110.784 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1497 ' ' THR . . . . . 0.477 HG23 HG22 ' A' 1504 ' ' VAL . 24.8 m -96.49 125.9 41.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.243 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.93 133.52 30.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.73 4.53 6.84 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.21 1.94 . . . . 0.0 112.468 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -78.67 -68.38 0.65 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 19.7 p -101.26 -19.75 15.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.043 0.449 . . . . 0.0 111.826 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 100.29 2.24 55.72 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.539 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1503 ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' 1625 ' ' GLU . 56.3 m-85 -72.45 141.25 48.61 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.068 0.461 . . . . 0.0 111.605 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1504 ' ' VAL . . . . . 0.477 HG22 HG23 ' A' 1497 ' ' THR . 48.2 t -108.84 118.94 57.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1505 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1495 ' ' GLN . 58.7 m-85 -95.39 101.56 13.29 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.25 112.32 24.51 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.066 0.46 . . . . 0.0 110.084 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 27.7 tp -84.86 -2.02 57.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.485 0.66 . . . . 0.0 111.143 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -79.6 -21.96 44.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.6 0.714 . . . . 0.0 109.781 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 28.4 t -78.24 -10.13 59.52 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1510 ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' 1598 ' ' PRO . 0.5 OUTLIER -106.34 -45.66 4.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1511 ' ' LYS . . . . . 0.577 ' HB2' ' HB ' ' A' 1530 ' ' VAL . 21.3 pttp -49.5 146.53 3.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 114.326 -173.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1512 ' ' ARG . . . . . 0.511 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 0.0 OUTLIER -103.72 127.31 51.2 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.177 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -64.04 -43.19 96.31 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.668 0.605 . . . . 0.0 112.391 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 47.6 m -86.25 6.27 30.44 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.037 0.446 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1515 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 80.33 161.14 23.9 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 113.152 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 81.0 m-85 -100.22 118.17 35.98 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 94.0 m -93.97 100.64 12.75 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.88 142.02 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 42.5 t -102.74 136.43 42.58 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1520 ' ' ASP . . . . . 0.54 ' HB2' HD22 ' A' 1604 ' ' LEU . 0.1 OUTLIER -84.49 175.14 9.5 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.82 -21.02 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 121.212 0.529 . . . . 0.0 111.293 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -91.9 3.05 56.05 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.15 0.58 . . . . 0.0 111.489 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1523 ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 17.2 mmtm 80.96 19.09 0.47 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -80.38 105.02 2.32 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 19.2 m -84.2 98.08 9.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.0 tt -103.78 133.86 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.125 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 29.4 ttt180 -108.9 112.74 25.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.99 122.99 47.94 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1529 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -98.15 127.0 9.09 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 174.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1530 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1511 ' ' LYS . 58.9 t -87.85 116.94 30.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 83.7 m 69.68 0.63 3.06 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -134.34 140.76 12.04 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.0 137.75 41.74 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.008 0.432 . . . . 0.0 110.508 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1534 ' ' VAL . . . . . 0.406 HG21 ' SG ' ' A' 1544 ' ' CYS . 9.5 m -79.26 87.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.034 0.921 . . . . 0.0 109.973 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1535 ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.14 -18.56 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.379 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.91 -20.65 62.47 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 110.969 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.1 m -117.52 -20.49 9.01 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.304 -0.248 . . . . 0.0 111.561 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1538 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 146.94 154.11 6.1 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.31 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1539 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 24.2 Cg_exo -69.6 142.24 48.1 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 123.288 2.659 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.51 10.26 79.14 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.331 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.04 134.17 49.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1542 ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -101.25 -41.3 2.61 Favored Glycine 0 C--O 1.221 -0.661 0 C-N-CA 119.97 -1.11 . . . . 0.0 112.096 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -126.26 134.97 51.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1544 ' ' CYS . . . . . 0.406 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.4 p -145.11 151.99 39.36 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 121.221 -0.192 . . . . 0.0 110.682 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1545 ' ' PHE . . . . . 0.435 ' HB2' HG13 ' A' 1550 ' ' ILE . 85.4 m-85 -92.26 120.1 32.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.77 109.73 10.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.612 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 165.09 -73.21 0.17 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 16.8 p -97.3 -18.09 19.38 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.526 0.679 . . . . 0.0 110.194 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 89.63 19.06 50.06 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1550 ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' 1545 ' ' PHE . 23.5 pt -66.43 135.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.712 0.768 . . . . 0.0 111.192 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1551 ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' 1574 ' ' ASP . 29.2 mttp -79.42 137.54 37.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.735 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1552 ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' 1584 ' ' TYR . . . -120.3 19.52 12.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.925 0.869 . . . . 0.0 108.763 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1553 ' ' GLY . . . . . 0.882 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 151.81 124.38 1.11 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.894 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1554 ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' 1554 ' ' LYS . 33.2 ttmt -83.83 144.59 29.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 90.0 t90 -59.92 131.74 51.81 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 123.73 0.644 . . . . 0.0 110.353 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -164.29 145.35 8.33 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -112.2 85.8 2.22 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -126.75 104.84 8.29 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.736 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1559 ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 3.5 mm? -100.57 118.06 35.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.188 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1560 ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 32.1 t -110.84 147.86 33.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 28.6 t80 -130.0 128.66 42.48 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.661 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1562 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 73.2 t -113.33 156.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1563 ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' 1564 ' ' GLN . 19.5 t70 -48.11 113.21 0.69 Allowed 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 118.056 0.389 . . . . 0.0 110.653 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1564 ' ' GLN . . . . . 0.608 ' HB2' ' SG ' ' A' 1624 ' ' CYS . 7.4 pt20 56.2 21.28 5.12 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.857 2.063 . . . . 0.0 113.466 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1565 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 58.9 t -137.11 118.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1566 ' ' LEU . . . . . 0.778 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.0 tp -89.26 131.84 35.17 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1567 ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' 1560 ' ' SER . 13.3 mm100 -115.64 114.87 25.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -123.78 111.39 16.07 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1569 ' ' VAL . . . . . 0.712 HG22 HG23 ' A' 1587 ' ' VAL . 32.3 t -112.15 123.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.621 0.724 . . . . 0.0 111.285 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1570 ' ' TYR . . . . . 0.882 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 33.9 m-85 -98.96 100.82 12.04 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.245 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1571 ' ' GLU . . . . . 0.557 ' HG2' ' HD3' ' A' 1585 ' ' LYS . 34.6 mt-10 -99.91 179.34 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.048 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.61 68.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.759 1.624 . . . . 0.0 112.766 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.97 -131.5 7.32 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.291 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1574 ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' 1551 ' ' LYS . 0.2 OUTLIER -89.83 140.38 27.82 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.488 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1575 ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 25.2 Cg_exo -66.27 142.26 65.91 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.663 2.242 . . . . 0.0 112.051 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1576 ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 81.5 m -98.15 138.42 20.91 Favored Pre-proline 0 C--N 1.285 -2.224 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1577 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.2 Cg_exo -58.47 -22.74 60.63 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.619 2.879 . . . . 0.0 114.529 -172.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.29 46.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1579 ' ' ASN . . . . . 0.624 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.7 m120 -124.17 -8.24 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1580 ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' 1575 ' ' PRO . 3.7 mm? 68.17 -51.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.635 1.174 . . . . 0.0 113.376 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.1 m80 -73.42 -13.5 61.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.635 0.255 . . . . 0.0 111.578 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1582 ' ' LEU . . . . . 0.624 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 33.1 mt -90.28 132.56 35.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1583 ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.1 mttt -132.96 162.16 32.39 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1584 ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 82.8 m-85 -62.86 117.46 6.39 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1585 ' ' LYS . . . . . 0.557 ' HD3' ' HG2' ' A' 1571 ' ' GLU . 96.1 mttt -130.34 143.28 50.67 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1586 ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 19.7 m -119.77 116.96 26.97 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1587 ' ' VAL . . . . . 0.712 HG23 HG22 ' A' 1569 ' ' VAL . 3.6 p -106.87 110.02 30.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.49 111.06 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.9 t -95.93 109.26 21.65 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1590 ' ' PHE . . . . . 0.778 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 88.0 m-85 -87.29 115.02 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.9 m -107.58 152.79 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1592 ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' 1620 ' ' THR . 6.3 m -76.39 124.64 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.206 0.527 . . . . 0.0 111.53 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1593 ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 21.8 tptp -139.32 112.37 8.03 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.0 t -70.64 -22.3 62.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.505 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 110.95 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1596 ' ' ALA . . . . . 0.749 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -90.35 -77.28 0.41 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 74.13 -143.68 32.33 Favored Glycine 0 C--O 1.248 1.011 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1598 ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' 1510 ' ' LEU . 40.2 Cg_endo -67.28 -21.72 47.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.344 2.03 . . . . 0.0 110.802 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 4.1 p -94.37 70.68 3.73 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.343 1.068 . . . . 0.0 109.352 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1600 ' ' SER . . . . . 0.749 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 30.5 m -75.73 167.83 21.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.931 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1601 ' ' GLN . . . . . 0.854 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 23.1 mt-30 -107.5 121.39 44.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.419 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1602 ' ' PRO . . . . . 0.446 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.3 Cg_endo -88.97 128.77 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.063 2.509 . . . . 0.0 110.658 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 44.8 tp -141.75 136.82 31.13 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.905 -0.497 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1604 ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' 1520 ' ' ASP . 67.7 tp -79.63 124.84 28.91 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.49 -39.7 9.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.3 t -177.0 161.41 1.92 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1607 ' ' VAL . . . . . 0.518 HG23 HD23 ' A' 1614 ' ' LEU . 7.5 p -141.78 138.92 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.0 119.87 36.09 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.04 -5.81 58.06 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 57.2 m80 -83.62 -51.2 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.599 0.714 . . . . 0.0 109.08 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1611 ' ' THR . . . . . 0.607 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -100.64 -9.3 22.05 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.917 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 1612 ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 74.6 m 63.99 37.53 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.294 1.038 . . . . 0.0 110.534 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1613 ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' 1611 ' ' THR . 6.1 m -87.53 113.97 23.71 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.414 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1614 ' ' LEU . . . . . 0.594 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 60.0 mt -93.38 115.72 28.27 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -100.74 112.47 24.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1616 ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 54.7 m-85 -120.79 131.28 54.38 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.764 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 12.8 p -102.82 104.41 14.68 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.886 0.85 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1618 ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 17.2 t-105 -92.63 114.93 27.62 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1619 ' ' HIS . . . . . 0.854 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.7 m-70 -88.45 102.06 14.53 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1620 ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.5 t -135.92 153.66 51.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.056 0.455 . . . . 0.0 110.739 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.5 m -74.15 -26.09 60.11 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.13 -5.65 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.045 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -77.1 -34.39 56.84 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.606 0.717 . . . . 0.0 109.527 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1624 ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' 1564 ' ' GLN . 1.8 m -98.58 171.81 7.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.54 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1625 ' ' GLU . . . . . 0.43 ' HB3' ' CD2' ' A' 1503 ' ' TYR . 40.9 mt-10 -66.76 107.46 2.17 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1626 ' ' GLN . . . . . 0.434 ' H ' ' CD ' ' A' 1626 ' ' GLN . 4.9 pm0 -80.28 154.67 27.7 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.541 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.04 -50.43 66.22 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 124.379 1.05 . . . . 0.0 109.651 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 C--N 1.307 -1.245 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.362 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.8 p30 . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 62.3 m 57.89 28.85 16.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.331 1.02 . . . . 0.0 112.228 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' 1505 ' ' PHE . 9.5 pt20 -142.2 141.5 32.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.12 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 8.9 p -140.81 138.45 34.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 26.0 m -97.67 127.16 43.42 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.3 p30 -89.25 143.13 30.51 Favored Pre-proline 0 C--N 1.312 -1.022 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.454 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.05 -13.67 19.2 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.885 2.39 . . . . 0.0 113.752 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -74.34 -58.87 3.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 22.0 p -109.27 -10.9 14.93 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 75.06 33.38 54.81 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.728 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -103.07 143.29 32.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 46.1 t -102.4 127.35 56.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' 1495 ' ' GLN . 93.7 m-85 -93.99 103.61 15.68 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.98 103.15 15.02 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 34.4 tp -85.94 10.06 15.13 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-O 121.847 0.832 . . . . 0.0 110.045 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.69 -19.45 52.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.09 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 20.8 p -71.16 -14.43 62.27 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.328 0.585 . . . . 0.0 111.469 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.66 -69.6 0.76 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.832 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 58.9 mmtt 61.55 146.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' 1512 ' ' ARG . 4.2 tmm_? -71.84 96.9 1.72 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.69 -42.73 11.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 16.8 p -121.62 -31.54 3.98 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.924 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.26 133.17 7.87 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -77.77 125.21 29.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' 1526 ' ' ILE . 13.3 t -129.77 100.93 5.67 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 122.86 1.314 . . . . 0.0 110.697 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . 0.503 HG21 ' HG2' ' A' 1602 ' ' PRO . 16.4 pt -93.82 155.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.053 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 32.7 t -98.15 130.73 44.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 16.7 t70 -99.73 126.53 45.8 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.25 -24.91 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.577 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' 1522 ' ' ARG . 28.7 mtp-105 -85.61 -43.01 13.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . 0.481 ' HB2' ' HZ ' ' A' 1545 ' ' PHE . 31.9 mmmt -113.97 -73.93 0.64 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -169.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 179.49 -152.88 11.44 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 3.9 m -84.03 154.49 23.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.2 0.524 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.0 tt -130.6 118.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -103.26 115.52 30.72 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.14 132.27 54.32 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.173 0.511 . . . . 0.0 110.733 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -99.28 87.41 0.76 Allowed Glycine 0 N--CA 1.422 -2.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.895 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 34.7 m -72.56 128.41 35.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.882 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 47.6 t 66.27 15.6 10.15 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 121.513 0.673 . . . . 0.0 111.389 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . 178.44 113.96 0.39 Allowed Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.71 160.32 11.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 21.3 m -96.99 122.07 48.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.62 0.724 . . . . 0.0 110.281 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.76 -24.67 58.73 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -53.14 -38.54 62.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.852 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 67.1 m -110.01 13.47 23.33 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.105 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 107.92 120.86 4.54 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.51 134.02 59.57 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.144 2.562 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 106.68 -29.36 11.0 Favored Glycine 0 C--N 1.286 -2.214 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.053 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.16 125.88 39.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.612 ' HA3' ' HE2' ' A' 1570 ' ' TYR . . . -99.69 -46.24 1.98 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.78 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -103.11 118.45 36.82 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 48.8 t -124.8 136.88 54.22 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 35.5 t80 -114.45 138.62 50.36 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.85 86.86 2.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.224 1.011 . . . . 0.0 110.868 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' 1550 ' ' ILE . . . -165.67 69.34 0.19 Allowed Glycine 0 C--N 1.289 -2.068 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.328 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.0 m 74.95 -34.77 0.27 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 111.595 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 146.09 50.32 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 79.3 mt -78.86 122.21 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -96.92 115.16 26.94 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.28 12.73 36.95 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.974 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.9 133.83 2.12 Favored Glycine 0 N--CA 1.416 -2.64 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.641 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -81.83 141.55 33.34 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.433 ' HB2' ' HA3' ' A' 1542 ' ' GLY . 54.5 t90 -78.32 124.74 28.44 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.21 148.43 33.52 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . 0.255 24.0 mt-30 -77.91 73.54 4.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -99.34 77.43 2.12 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 95.5 mt -104.93 97.78 7.6 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 7.8 t -117.46 139.1 51.35 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.782 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 86.1 t80 -106.42 109.19 21.04 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.384 0.611 . . . . 0.0 110.045 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 81.4 t -96.23 158.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.63 101.9 0.03 OUTLIER 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.171 0.989 . . . . 0.0 111.514 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 67.73 16.58 9.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.611 1.564 . . . . 0.0 113.549 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 20.2 t -139.94 119.79 13.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 121.987 -0.445 . . . . 0.0 110.317 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.8 tp -81.91 129.01 34.63 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -112.95 125.35 54.3 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.268 -0.27 . . . . 0.0 111.337 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . 0.588 ' HB3' ' HE1' ' A' 1590 ' ' PHE . 66.2 tp -129.68 114.39 15.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 10.4 p -117.99 129.45 74.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.861 0.838 . . . . 0.0 111.334 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.827 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 81.6 m-85 -95.04 115.17 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.64 177.29 4.69 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 5.3 m-20 56.67 64.04 1.78 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.72 -145.12 18.11 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -90.57 146.63 34.68 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.69 141.83 38.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.003 2.468 . . . . 0.0 110.976 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 75.7 m -99.68 142.21 24.2 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 16.9 Cg_exo -61.91 -22.26 73.95 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 123.652 2.901 . . . . 0.0 113.911 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -58.21 -65.14 0.7 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.204 0.602 . . . . 0.0 112.399 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.463 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 5.4 m-20 -120.25 -2.53 10.11 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.877 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.9 mm? 69.45 -53.02 0.6 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.208 1.003 . . . . 0.0 113.419 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -62.71 -28.32 69.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.164 0.586 . . . . 0.0 109.836 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' 1611 ' ' THR . 64.5 mt -82.32 128.72 34.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.859 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 58.7 mttp -118.09 162.49 18.12 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 98.3 m-85 -63.62 116.73 5.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -126.98 140.97 51.92 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 25.0 m -120.3 116.81 26.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -115.16 114.68 47.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.609 0.718 . . . . 0.0 109.797 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.36 115.48 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 7.7 t -96.67 106.58 18.88 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 94.3 m-85 -86.56 111.58 20.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.761 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.7 m -108.66 144.96 16.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' 1620 ' ' THR . 3.1 p -76.66 143.44 40.11 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' 1593 ' ' LYS . 49.4 tptt -157.66 114.01 2.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 24.4 m -71.82 -21.7 61.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.02 7.82 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 110.508 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.668 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -81.94 -67.59 0.77 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 61.47 -129.68 45.42 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.84 -16.78 54.3 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.593 2.196 . . . . 0.0 112.464 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.1 t -120.74 83.53 2.08 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 122.847 1.308 . . . . 0.0 110.59 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.668 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 18.1 m -77.86 143.02 38.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.402 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.476 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 13.9 pt20 -104.8 126.11 32.06 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-O 120.984 0.421 . . . . 0.0 111.878 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' 1518 ' ' ILE . 5.1 Cg_exo -82.83 160.01 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.327 2.685 . . . . 0.0 111.688 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.6 tp -148.78 130.13 14.71 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.61 HD11 HG23 ' A' 1607 ' ' VAL . 43.9 tp -86.36 115.97 24.22 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.2 -52.4 5.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.818 0.342 . . . . 0.0 110.372 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.8 t -167.25 138.85 3.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.61 HG23 HD11 ' A' 1604 ' ' LEU . 69.5 t -110.58 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.9 t70 -94.03 117.89 30.74 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.334 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.56 -6.21 57.9 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -95.93 -51.48 4.44 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.163 0.983 . . . . 0.0 108.935 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.844 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -95.04 -6.99 40.9 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.208 -1.815 . . . . 0.0 110.443 -171.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 80.1 m 57.25 26.4 12.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.8 m -93.37 119.58 32.66 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.597 ' HB3' ' HE2' ' A' 1616 ' ' PHE . 85.5 mt -93.82 114.11 26.29 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.957 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.77 108.95 21.76 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -121.06 138.52 54.14 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.82 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 39.1 t -102.97 138.15 40.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.423 ' HE1' ' HB2' ' A' 1600 ' ' SER . 8.0 t-105 -126.42 114.43 18.17 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.05 100.95 13.32 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.1 t -135.28 153.01 52.03 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.269 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 10.2 m -77.98 -26.48 48.68 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 48.3 mt -72.1 -5.16 33.34 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.146 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.2 59.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 111.793 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 91.0 m -123.28 162.55 22.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' 1505 ' ' PHE . 2.8 mp0 . . . . . 0 N--CA 1.417 -2.103 0 CA-C-O 121.229 0.538 . . . . 0.0 109.921 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' 1557 ' ' GLN . 10.1 p30 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 84.2 m 63.59 21.53 12.77 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.471 1.129 . . . . 0.0 110.393 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.3 pt20 -152.35 141.2 21.06 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.4 p -136.52 134.96 49.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 8.8 m -106.93 121.89 45.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.43 125.25 50.49 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.16 -6.46 18.35 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.408 2.072 . . . . 0.0 113.143 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.26 -65.49 0.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.259 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 62.0 p -92.99 -24.88 18.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.859 0.837 . . . . 0.0 110.028 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 88.58 9.31 69.22 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 60.5 t80 -80.81 127.86 33.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.309 0.576 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.7 p -98.96 116.0 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.4 m-85 -79.28 98.92 6.85 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -95.09 104.51 16.38 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.332 0.586 . . . . 0.0 110.739 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.84 -9.37 59.83 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.541 0.686 . . . . 0.0 109.913 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.432 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 45.8 m-80 -70.25 -12.3 61.5 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 57.9 m -84.74 -16.14 42.66 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 32.2 tp -114.1 -20.5 10.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.755 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.574 ' CB ' ' HB ' ' A' 1530 ' ' VAL . 56.4 pttt -54.69 140.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.716 0.635 . . . . 0.0 112.076 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -127.44 102.64 6.97 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . 0.443 ' HG3' ' HA3' ' A' 1532 ' ' GLY . 31.9 tt0 -76.21 -20.47 57.43 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 24.6 m -61.32 -25.11 66.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.084 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 96.06 136.39 8.78 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.75 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' 1527 ' ' ARG . 74.3 m-85 -83.5 118.21 23.62 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 172.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 26.6 m -110.6 104.01 12.66 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.68 150.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.21 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.9 m -79.17 115.29 18.74 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.529 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.86 144.64 56.9 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.855 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.3 tt -74.03 -18.46 17.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.642 1.177 . . . . 0.0 110.94 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' 1522 ' ' ARG . 3.7 mmp_? -90.25 2.82 55.03 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.848 -0.533 . . . . 0.0 109.583 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.5 tptp 79.14 90.19 0.06 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.939 1.696 . . . . 0.0 110.098 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . 0.41 ' HA3' ' HZ ' ' A' 1545 ' ' PHE . . . -176.77 -161.02 24.85 Favored Glycine 0 N--CA 1.412 -2.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.2 t -144.6 139.74 28.3 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 15.0 tt -132.62 139.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' 1516 ' ' TYR . 33.4 ttt180 -127.91 120.33 27.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.3 136.08 54.52 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.921 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.7 158.97 14.08 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' 1511 ' ' LYS . 59.9 t -106.48 115.81 48.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 118.237 1.018 . . . . 0.0 108.31 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 77.9 m 57.58 26.83 13.28 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.951 0.782 . . . . 0.0 112.445 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' 1513 ' ' GLU . . . -130.04 142.15 13.37 Favored Glycine 0 N--CA 1.414 -2.769 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.38 126.62 35.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.8 m -94.9 98.95 8.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' 1535 ' ' LYS . 10.0 mptt -67.19 -20.88 65.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.639 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.81 -10.17 59.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.892 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . 0.585 ' HB2' HG23 ' A' 1534 ' ' VAL . 73.3 m -116.06 7.63 14.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 115.94 137.27 6.1 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.656 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.33 128.07 19.57 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.351 2.034 . . . . 0.0 110.126 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.62 11.73 61.82 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.426 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.8 mm -112.74 128.5 69.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.66 -22.06 7.92 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.929 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -134.1 127.21 31.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 29.0 p -144.36 154.92 43.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.482 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.41 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 44.4 t80 -84.92 134.91 34.25 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -86.2 97.66 10.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 160.41 -91.74 0.11 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.7 p -71.2 -21.15 62.18 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 90.85 18.6 46.89 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.792 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 22.8 pt -74.14 131.4 35.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.248 0.547 . . . . 0.0 110.004 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 19.8 pttm -84.17 142.52 30.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.38 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -113.21 11.56 18.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.943 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.28 135.94 2.18 Favored Glycine 0 N--CA 1.433 -1.509 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.755 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' 1572 ' ' ASP . 29.3 mtpp -75.37 150.89 38.28 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.157 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.77 125.98 26.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.322 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.11 158.39 43.87 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' 1493 ' ' ASN . 3.4 pt20 -124.16 33.53 5.26 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.927 0.87 . . . . 0.0 109.622 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.88 95.73 7.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.482 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.31 110.9 23.37 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 15.9 p -89.48 119.19 29.71 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.264 0.554 . . . . 0.0 111.359 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . 0.675 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 16.0 t80 -92.93 101.17 13.52 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 94.3 t -106.89 104.89 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.739 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.32 63.32 1.91 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.214 1.406 . . . . 0.0 111.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . 0.675 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 64.5 mt-30 66.12 11.62 7.95 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 113.908 -1.496 . . . . 0.0 114.197 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 93.4 t -116.87 139.2 44.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.6 113.64 22.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -109.02 114.68 28.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.898 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.79 110.81 17.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.53 121.61 66.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.859 0.837 . . . . 0.0 111.703 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.943 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.3 m-85 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.167 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.438 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 36.9 mt-10 -101.02 174.31 6.07 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' 1554 ' ' LYS . 9.8 t70 53.97 73.26 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.738 1.615 . . . . 0.0 111.5 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -96.25 -140.09 10.89 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.37 138.94 31.9 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 14.9 Cg_exo -68.38 135.39 33.79 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.854 2.369 . . . . 0.0 112.975 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 62.7 m -98.76 131.02 26.49 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.823 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.1 2.54 2.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.414 2.742 . . . . 0.0 115.542 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -72.88 -50.45 23.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.965 0.412 . . . . 0.0 110.172 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.89 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 17.3 m120 -132.43 -0.1 3.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.45 -47.12 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.39 -5.81 48.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.146 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 61.5 mt -89.05 126.54 35.48 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 98.1 mttt -133.24 159.04 41.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 91.9 m-85 -61.51 113.24 2.57 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.986 0.804 . . . . 0.0 108.86 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.438 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.6 mtpt -124.51 136.16 53.77 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.8 m -120.0 116.12 25.11 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 6.1 p -110.34 109.76 29.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.927 0.87 . . . . 0.0 109.67 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.85 111.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.036 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 67.1 m -92.3 112.01 23.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 94.9 m-85 -86.53 103.1 14.73 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' 1619 ' ' HIS . 29.7 m -105.84 161.49 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.194 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.7 t -76.88 136.89 38.88 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 23.3 tptm -149.99 105.23 3.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 77.0 p -62.36 -37.78 87.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.256 0.55 . . . . 0.0 110.281 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.64 76.3 3.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.531 0.682 . . . . 0.0 110.213 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -128.09 -64.38 0.96 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.837 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 66.91 -133.6 31.74 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 -20.1 35.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.405 2.07 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.9 p -102.49 73.22 1.3 Allowed 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.66 0.743 . . . . 0.0 111.034 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.51 ' HB3' ' HB ' ' A' 1620 ' ' THR . 42.1 m -86.03 105.56 16.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.473 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 24.4 mt-30 -77.01 126.14 85.91 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -171.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.1 Cg_endo -83.99 111.37 1.65 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 123.398 2.732 . . . . 0.0 110.702 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' 1617 ' ' SER . 62.0 tp -88.68 123.53 33.22 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.04 91.72 5.52 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.25 -59.13 3.44 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.865 -175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1615 ' ' PHE . 46.4 m -158.91 132.4 7.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 65.2 t -106.75 111.04 33.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.15 102.47 14.51 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.97 -20.2 60.43 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.438 -170.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.57 -45.52 12.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.962 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.806 ' HA ' HD13 ' A' 1582 ' ' LEU . 68.4 p -85.72 -16.35 39.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.504 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 79.6 m 71.1 26.64 3.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 110.413 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 9.7 m -93.11 116.7 29.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.825 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 80.2 mt -99.09 116.91 32.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . 0.407 ' HD2' ' HB2' ' A' 1606 ' ' SER . 80.5 m-85 -100.82 117.33 34.69 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -120.68 133.42 55.35 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.866 0.466 . . . . 0.0 110.216 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.655 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 19.5 m -107.21 103.77 13.23 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -95.46 107.05 19.18 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 26.2 m80 -83.37 104.18 13.32 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' 1600 ' ' SER . 10.2 t -131.99 150.42 52.16 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.449 0.642 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.7 p -77.13 -22.15 53.07 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.28 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 44.6 tp -71.42 -7.09 45.05 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.434 0.635 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.72 -4.19 26.89 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.226 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.9 m -87.07 176.61 7.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 . . . . . 0 N--CA 1.437 -1.091 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 72.3 m 64.55 40.32 6.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.853 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.4 pt20 -136.63 152.03 49.98 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 13.8 p -157.87 139.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.6 m -97.59 132.94 42.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' 1503 ' ' TYR . 8.2 p30 -99.23 126.77 36.75 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.06 -10.69 29.67 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.786 2.324 . . . . 0.0 113.828 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -61.58 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 27.2 p -96.46 -26.55 15.26 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.135 0.493 . . . . 0.0 111.653 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 89.81 11.57 63.47 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . 0.464 ' HB3' HD21 ' A' 1498 ' ' ASN . 87.7 t80 -83.92 136.91 33.91 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 114.954 -0.623 . . . . 0.0 109.914 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' 1497 ' ' THR . 49.0 t -99.54 114.18 36.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' 1495 ' ' GLN . 98.5 m-85 -77.12 98.66 5.12 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.11 108.05 19.63 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . 0.556 HD11 HD23 ' A' 1510 ' ' LEU . 15.7 tp -86.22 4.24 39.55 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.673 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.566 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 51.2 m-80 -70.92 -18.66 62.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 47.4 t -80.18 -10.83 59.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.556 HD23 HD11 ' A' 1507 ' ' LEU . 69.0 tp -116.6 -25.61 7.33 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.95 -0.469 . . . . 0.0 111.469 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' 1530 ' ' VAL . 19.2 pttp -56.49 142.33 39.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.647 0.737 . . . . 0.0 112.571 -174.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -128.76 106.07 8.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . 0.423 ' HA ' ' HA3' ' A' 1532 ' ' GLY . 32.4 tt0 -65.01 -34.11 77.66 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.634 0.773 . . . . 0.0 110.799 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 20.4 m -72.95 -11.69 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.429 0.633 . . . . 0.0 110.341 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 78.33 161.66 18.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 114.587 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' 1527 ' ' ARG . 94.5 m-85 -97.98 128.74 44.73 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 25.2 m -100.53 98.2 8.82 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . 0.424 HG13 HG23 ' A' 1526 ' ' ILE . 18.1 pt -109.04 111.14 34.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.822 0.82 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.7 t -95.67 112.38 24.11 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.686 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 15.2 t70 -100.62 120.68 40.41 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.4 -10.16 11.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.521 0.677 . . . . 0.0 112.384 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 16.3 mtp180 -92.99 -39.01 11.35 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 121.956 -0.465 . . . . 0.0 110.713 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -109.23 -34.9 6.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 136.99 177.74 15.27 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1519 ' ' SER . 32.5 t -79.85 127.99 32.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.424 HG23 HG13 ' A' 1518 ' ' ILE . 10.7 tt -123.08 122.3 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' 1516 ' ' TYR . 16.9 ttm180 -108.35 116.05 31.25 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.13 120.29 37.31 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.297 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -93.52 118.96 5.82 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' 1511 ' ' LYS . 46.0 t -75.45 116.17 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.691 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 68.1 m 59.1 20.43 8.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.216 0.948 . . . . 0.0 112.047 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' 1513 ' ' GLU . . . -135.86 132.8 6.3 Favored Glycine 0 N--CA 1.401 -3.685 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' 1535 ' ' LYS . 21.6 mt-10 -76.39 130.02 37.44 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 15.4 m -80.1 93.1 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.52 0.676 . . . . 0.0 110.901 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' 1533 ' ' GLU . 0.0 OUTLIER -59.3 -26.45 64.99 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.49 -178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.17 -37.3 66.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.176 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 43.3 t -107.19 -25.37 11.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.948 0.404 . . . . 0.0 110.133 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 143.17 144.92 4.34 Favored Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.3 152.2 81.09 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.547 2.165 . . . . 0.0 110.795 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.5 -27.35 6.43 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.807 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.0 mm -89.59 136.09 24.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.04 -37.12 2.58 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.294 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -125.84 128.07 47.06 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 44.2 t -139.59 139.86 36.9 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.686 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.42 ' HZ ' HD11 ' A' 1614 ' ' LEU . 98.2 m-85 -87.02 124.29 33.04 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' 1525 ' ' SER . 47.4 mt-10 -82.05 107.99 15.19 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.738 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 172.39 -71.65 0.1 Allowed Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.3 m -106.9 -24.82 11.91 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.572 0.701 . . . . 0.0 109.397 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 103.7 34.33 3.85 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.02 131.03 35.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.444 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 25.8 pttm -93.22 138.65 31.41 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.95 8.06 43.26 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.611 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 140.74 149.48 5.28 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.876 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.31 155.72 17.36 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.385 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.691 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 39.0 t90 -71.49 143.61 49.95 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.2 152.74 38.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -106.07 9.88 32.29 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.59 107.12 19.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.063 0.458 . . . . 0.0 110.651 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.403 HD23 HD13 ' A' 1568 ' ' LEU . 74.6 mt -88.59 125.8 34.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.886 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.8 m -90.24 121.84 32.62 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.2 t80 -98.89 116.12 30.4 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 122.23 -0.294 . . . . 0.0 110.416 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.4 t -121.24 80.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 38.7 t70 40.45 83.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.154 1.781 . . . . 0.0 114.518 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 64.05 19.24 11.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.498 1.119 . . . . 0.0 112.849 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 58.6 t -133.9 119.89 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.42 133.87 37.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.943 0.401 . . . . 0.0 110.302 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.886 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -110.83 114.7 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.573 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . 0.403 HD13 HD23 ' A' 1559 ' ' LEU . 34.1 tp -116.45 107.35 14.66 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 17.1 t -105.99 108.55 25.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.095 -174.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.611 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 61.3 m-85 -82.08 107.16 14.56 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.5 178.33 4.59 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.585 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 24.4 t70 56.73 67.06 1.04 Allowed 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.87 1.356 . . . . 0.0 111.241 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . 0.444 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -93.25 -155.25 31.81 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 173.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -82.57 158.17 66.22 Favored Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 117.605 0.703 . . . . 0.0 109.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.63 140.08 35.28 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.272 1.981 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 83.5 m -101.33 133.92 20.61 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.196 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.09 7.8 1.0 Allowed 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.31 2.673 . . . . 0.0 113.633 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.33 -52.96 6.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.13 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.541 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 2.4 m-20 -131.83 -2.36 3.71 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.802 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 31.9 tp 71.47 -47.82 0.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.908 1.283 . . . . 0.0 113.032 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -73.33 -12.81 60.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.451 0.643 . . . . 0.0 110.277 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.904 HD13 ' HA ' ' A' 1611 ' ' THR . 89.4 mt -85.58 127.62 34.51 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.042 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.616 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 44.5 mttm -112.54 152.92 28.27 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.494 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -60.07 123.62 17.7 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.725 0.64 . . . . 0.0 109.87 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.69 131.4 43.06 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.6 t -120.86 116.66 25.6 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 3.3 p -108.12 101.32 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.966 0.889 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.72 114.11 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.3 m -95.93 109.63 21.97 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.731 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.4 m-85 -86.18 108.1 18.18 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 m -103.87 166.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 13.0 t -75.96 120.39 21.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 123.988 0.915 . . . . 0.0 112.91 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.745 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 48.1 tptt -152.55 99.47 2.47 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.3 m -65.82 -30.81 71.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . 0.745 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 10.3 t70 -85.57 67.76 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -143.54 -56.44 0.39 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.718 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 79.09 -160.92 46.84 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.63 -20.14 35.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 110.869 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -92.31 53.97 2.23 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.923 0.868 . . . . 0.0 109.102 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.1 m -62.3 140.66 58.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.015 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -106.32 124.61 35.24 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 52.8 Cg_endo -87.92 133.88 3.07 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.167 2.578 . . . . 0.0 112.515 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.1 tp -118.92 134.93 54.85 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.425 HD11 HG23 ' A' 1607 ' ' VAL . 45.1 tp -72.76 118.86 16.21 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.34 -43.37 12.93 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' 1615 ' ' PHE . 21.6 t -179.9 146.98 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.425 HG23 HD11 ' A' 1604 ' ' LEU . 95.9 t -123.09 121.14 62.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' 1610 ' ' HIS . 32.5 t70 -115.2 103.09 10.5 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.742 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.4 8.28 7.93 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.049 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . 0.428 ' HB2' ' OD2' ' A' 1608 ' ' ASP . 51.7 m80 -88.81 -51.48 5.62 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.904 ' HA ' HD13 ' A' 1582 ' ' LEU . 1.6 m -98.84 -6.17 29.63 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.526 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 76.6 m 62.1 30.74 17.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.257 1.023 . . . . 0.0 111.198 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 14.5 m -97.3 116.7 30.0 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.41 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.599 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 84.7 mt -96.93 120.2 36.83 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.31 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' 1606 ' ' SER . 72.7 m-85 -105.21 112.22 25.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.599 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.1 m-85 -122.41 135.39 54.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 42.1 p -113.05 110.89 21.22 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' 1602 ' ' PRO . 1.5 t-105 -97.24 115.91 28.49 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 48.6 m80 -83.59 99.43 10.17 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -128.74 151.12 49.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.881 0.848 . . . . 0.0 111.485 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.9 m -76.88 -27.69 55.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.434 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.44 -5.95 40.22 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.277 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.59 -1.44 35.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.594 0.711 . . . . 0.0 110.345 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 12.3 t -113.77 170.32 8.34 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.442 -0.841 0 O-C-N 123.869 0.731 . . . . 0.0 110.022 178.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' 1557 ' ' GLN . 3.6 p-10 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.421 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 64.9 m 73.27 0.09 3.55 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.053 0.93 . . . . 0.0 112.113 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.411 ' HB3' ' OD1' ' A' 1506 ' ' ASP . 21.1 pt20 -128.91 147.39 50.83 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.9 p -132.48 118.25 34.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 122.112 0.958 . . . . 0.0 110.868 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.787 HG23 HG22 ' A' 1504 ' ' VAL . 6.0 m -96.37 101.51 13.16 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.19 122.17 49.38 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.36 -8.02 19.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.215 2.61 . . . . 0.0 112.53 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.95 -56.61 17.4 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.758 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . 0.415 ' HB ' ' CD2' ' A' 1503 ' ' TYR . 57.7 p -101.01 -28.39 12.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 85.46 10.77 76.44 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.45 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . 0.415 ' CD2' ' HB ' ' A' 1501 ' ' THR . 56.6 m-85 -99.54 131.6 45.43 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.787 HG22 HG23 ' A' 1497 ' ' THR . 28.3 t -90.48 99.23 9.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -83.32 105.71 14.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' 1495 ' ' GLN . 24.3 t70 -105.26 112.03 25.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.228 0.537 . . . . 0.0 111.862 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.9 tp -85.27 -4.49 59.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.035 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.65 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 62.6 m-80 -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 69.6 m -77.3 -10.03 59.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.111 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.452 ' HB2' HD12 ' A' 1622 ' ' LEU . 26.2 tp -109.92 8.05 24.11 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.434 0.635 . . . . 0.0 109.493 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 53.5 mtmt -58.54 143.7 45.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.665 ' H ' ' HB ' ' A' 1530 ' ' VAL . 32.2 tpt180 -127.25 97.9 5.09 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -25.38 60.27 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.522 0.514 . . . . 0.0 110.711 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 45.5 t -67.6 -26.31 66.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 88.14 153.82 26.66 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -89.8 114.78 26.56 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 6.5 p -103.56 92.34 4.42 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.03 0.919 . . . . 0.0 109.8 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.5 pt -120.55 153.44 23.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.742 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' 1524 ' ' GLY . 15.5 p -103.95 118.27 36.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.79 174.69 1.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.515 0.509 . . . . 0.0 111.009 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.2 tp -61.85 -24.26 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.74 -5.82 58.48 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 73.73 74.44 0.13 Allowed 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.918 1.687 . . . . 0.0 112.454 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1519 ' ' SER . . . -151.37 139.16 6.98 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 174.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 47.6 m -87.78 129.2 35.26 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.898 0.849 . . . . 0.0 111.673 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.4 tt -122.0 142.1 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -118.24 116.74 27.4 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.546 0.738 . . . . 0.0 109.076 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.61 125.92 43.92 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.86 129.74 10.0 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.449 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.665 ' HB ' ' H ' ' A' 1512 ' ' ARG . 47.5 t -79.52 115.22 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.514 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.673 ' HA ' ' CZ3' ' A' 1555 ' ' TRP . 69.9 m 46.25 66.91 0.85 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 125.141 1.526 . . . . 0.0 113.461 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -171.25 175.17 44.92 Favored Glycine 0 N--CA 1.404 -3.459 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.78 134.89 48.54 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.7 m -88.9 97.13 6.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.739 0.78 . . . . 0.0 110.689 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -22.54 54.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.941 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.22 -26.44 66.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.653 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 61.5 m -102.91 0.2 32.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.32 150.63 18.26 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.58 145.79 87.89 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.404 2.069 . . . . 0.0 112.48 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' 1555 ' ' TRP . . . 82.41 14.73 75.67 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 114.81 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.33 131.62 63.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 118.082 0.941 . . . . 0.0 109.221 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.49 -28.31 7.18 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.901 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.796 0.332 . . . . 0.0 111.147 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 69.0 m -142.59 149.24 38.74 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.494 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 56.1 t80 -94.88 118.81 32.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.75 110.02 4.7 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.17 0.918 . . . . 0.0 112.488 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 144.82 -80.04 0.23 Allowed Glycine 0 C--N 1.296 -1.677 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.032 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 20.1 m -72.38 -19.77 61.56 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.321 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 79.29 41.78 13.06 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.621 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' 1545 ' ' PHE . 20.9 pt -93.46 131.01 41.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 56.4 mttm -85.44 129.2 34.87 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.552 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -98.86 7.73 45.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.055 0.455 . . . . 0.0 111.172 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.62 146.02 4.31 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.985 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 50.6 tttm -69.32 145.46 52.99 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.028 0.931 . . . . 0.0 109.588 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.673 ' CZ3' ' HA ' ' A' 1531 ' ' CYS . 7.0 t-105 -66.24 109.67 2.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' 1570 ' ' TYR . 0.1 OUTLIER -146.75 161.23 41.06 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -178.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' 1493 ' ' ASN . 51.2 mt-30 -120.6 67.83 0.85 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.033 0.92 . . . . 0.0 108.849 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.4 tptt -96.86 95.38 7.82 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.776 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 4.2 mm? -104.7 104.85 14.73 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.111 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.809 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.3 m -100.07 139.46 35.71 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 89.3 t80 -113.98 117.8 32.33 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.479 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 67.6 t -103.43 153.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.28 100.79 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 123.901 0.881 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 68.47 19.06 8.89 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.959 1.704 . . . . 0.0 112.33 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 49.0 t -134.07 119.57 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.739 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.7 tp -87.37 140.18 29.79 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.809 ' HB2' ' HB2' ' A' 1560 ' ' SER . 23.9 mm-40 -124.65 115.25 20.48 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.722 -0.611 . . . . 0.0 111.097 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 63.0 tp -109.9 120.31 42.08 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.494 HG22 HG23 ' A' 1587 ' ' VAL . 32.5 t -117.35 131.45 70.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.132 0.491 . . . . 0.0 110.461 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' 1586 ' ' SER . 63.5 m-85 -103.1 105.8 16.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.65 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.442 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.91 92.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.934 1.396 . . . . 0.0 112.179 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.33 -158.07 12.9 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.507 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.83 151.57 52.54 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.99 147.59 3.38 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.529 2.819 . . . . 0.0 114.766 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 17.2 t -98.22 130.25 28.85 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.139 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 21.9 Cg_exo -60.76 -27.48 84.88 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.142 2.562 . . . . 0.0 113.911 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.31 33.9 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.518 HD22 HD11 ' A' 1582 ' ' LEU . 92.8 m-20 -126.5 8.31 7.05 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.86 -62.54 0.34 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.785 1.234 . . . . 0.0 114.078 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.27 4.51 8.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' 1576 ' ' CYS . 92.5 mt -90.36 154.54 19.61 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' 1585 ' ' LYS . 94.1 mttt -123.86 154.09 40.15 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.431 ' HE2' ' HB ' ' A' 1550 ' ' ILE . 27.1 m-85 -62.73 116.82 5.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' 1583 ' ' LYS . 28.9 mtpp -115.05 133.82 55.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.723 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 37.5 m -120.01 122.36 40.96 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.212 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.494 HG23 HG22 ' A' 1569 ' ' VAL . 6.6 p -126.75 111.27 25.42 Favored 'Isoleucine or valine' 0 C--O 1.25 1.096 0 CA-C-O 121.975 0.893 . . . . 0.0 110.725 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.0 110.88 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.746 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . 0.498 ' HA ' ' NE2' ' A' 1567 ' ' GLN . 29.5 m -88.53 111.18 21.55 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.739 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.5 m-85 -86.97 106.64 17.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.0 m -98.53 153.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1620 ' ' THR . 48.7 t -86.96 133.85 33.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.16 0.981 . . . . 0.0 113.166 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.0 tptt -147.33 105.38 3.74 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.1 t -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.601 0.715 . . . . 0.0 110.645 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.29 -3.17 57.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.717 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.904 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.98 -42.81 15.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.5 -156.41 51.0 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.976 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.06 -4.1 14.69 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.441 2.761 . . . . 0.0 113.098 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 17.8 p -90.54 -49.69 6.36 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.904 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.5 m 69.34 145.77 0.05 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.379 1.072 . . . . 0.0 113.144 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 97.8 mt-30 -87.84 121.88 70.54 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.338 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.0 Cg_endo -88.43 118.67 1.07 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.466 2.777 . . . . 0.0 111.661 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' 1617 ' ' SER . 63.5 tp -130.8 124.69 31.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.224 0.535 . . . . 0.0 109.974 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.683 HD21 HG23 ' A' 1607 ' ' VAL . 62.6 tp -87.16 126.73 34.98 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 58.4 tp -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 60.4 p -178.35 142.67 0.26 Allowed 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.015 0.822 . . . . 0.0 109.943 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.683 HG23 HD21 ' A' 1604 ' ' LEU . 61.9 t -94.37 117.47 38.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.69 113.15 26.31 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.324 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.95 -2.0 45.96 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 45.9 m80 -82.33 -41.2 20.37 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.382 0.61 . . . . 0.0 110.677 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.582 ' HA ' HD13 ' A' 1582 ' ' LEU . 33.8 p -121.58 -9.81 8.89 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 75.5 m 65.68 35.07 7.18 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.149 0.976 . . . . 0.0 111.397 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -96.48 122.92 39.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.096 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.555 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 88.7 mt -91.27 112.81 24.88 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -98.41 115.6 28.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.086 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.555 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 86.9 m-85 -123.41 140.21 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' 1603 ' ' LEU . 40.0 m -120.67 103.69 9.33 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -95.51 122.01 37.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.856 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 46.9 m-70 -90.73 102.98 15.74 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.4 t -127.48 153.89 45.76 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.046 0.45 . . . . 0.0 110.447 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.2 m -79.59 -25.28 41.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' 1510 ' ' LEU . 33.4 mt -70.7 -4.75 25.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.708 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.45 -23.44 40.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.625 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 60.3 m -79.31 159.68 27.1 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 CA--C 1.507 -0.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.088 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.6 p-10 . . . . . 0 N--CA 1.434 -1.229 0 CA-C-O 121.086 0.469 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.445 ' HB2' ' OD1' ' A' 1508 ' ' ASN . 82.9 m 55.1 25.06 6.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' 1505 ' ' PHE . 25.0 pt20 -132.91 119.15 19.8 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 124.89 71.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.376 0.608 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 9.1 m -88.71 109.7 20.36 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.32 138.4 45.16 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.246 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.2 -2.75 12.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.686 2.257 . . . . 0.0 113.572 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -82.33 -63.89 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.813 0.34 . . . . 0.0 110.618 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' 1625 ' ' GLU . 24.6 p -98.13 -20.17 17.48 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.4 3.35 81.72 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.87 133.62 43.17 Favored 'General case' 0 C--O 1.254 1.325 0 C-N-CA 123.074 0.55 . . . . 0.0 109.842 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 65.4 t -95.33 111.75 26.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' 1495 ' ' GLN . 82.8 m-85 -85.04 103.03 13.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.2 108.06 19.4 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 32.5 tp -82.48 -8.75 59.61 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.477 ' HA ' ' HD3' ' A' 1511 ' ' LYS . 90.2 m-20 -59.79 -24.02 63.77 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.62 1.968 . . . . 0.0 112.789 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 6.9 p -86.36 -11.0 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.04 0.448 . . . . 0.0 111.531 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 49.1 tp -116.0 -22.33 9.05 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 122.207 -0.308 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1531 ' ' CYS . 22.2 pttp -46.79 131.38 11.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.035 0.921 . . . . 0.0 113.472 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -126.93 101.11 6.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.293 -172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.54 -37.75 87.62 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.91 0.756 . . . . 0.0 110.967 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 41.3 m -63.49 -18.42 63.78 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.395 0.617 . . . . 0.0 110.447 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 86.11 149.14 12.65 Favored Glycine 0 N--CA 1.415 -2.74 0 CA-C-N 115.278 -0.874 . . . . 0.0 114.635 173.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -80.83 114.35 19.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 20.0 m -99.45 98.84 9.7 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 27.4 pt -115.84 145.7 21.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.511 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 35.8 t -111.03 130.5 55.58 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.287 0.565 . . . . 0.0 109.912 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.44 153.86 42.94 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.97 -22.76 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.373 0.606 . . . . 0.0 111.62 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -79.51 3.75 17.78 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.43 0.692 . . . . 0.0 111.042 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 56.9 tptt 73.52 87.18 0.1 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.75 1.62 . . . . 0.0 110.442 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -169.11 117.2 0.7 Allowed Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 50.4 m -81.62 120.79 25.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 120.785 0.326 . . . . 0.0 110.815 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.802 ' HB ' ' HD1' ' A' 1545 ' ' PHE . 14.6 tt -114.41 128.24 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.5 ttm180 -116.95 115.5 25.59 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.2 mp -114.78 114.93 26.23 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.303 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -83.55 111.16 3.38 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' 1511 ' ' LYS . 7.2 p -85.97 116.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.981 -0.717 . . . . 0.0 109.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1511 ' ' LYS . 85.7 m 64.94 15.63 10.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.421 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.91 140.21 8.99 Favored Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -76.81 146.88 37.53 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.6 p -89.19 99.32 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 122.291 1.043 . . . . 0.0 110.959 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' 1535 ' ' LYS . 0.3 OUTLIER -65.48 -19.36 65.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.187 -174.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.57 -36.5 78.66 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.899 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 78.0 m -106.96 -24.29 12.06 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 129.63 152.61 7.61 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.482 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.25 146.86 95.79 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.981 2.454 . . . . 0.0 110.815 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 97.41 -14.61 63.23 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.866 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.98 136.15 51.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.446 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.39 -47.12 0.82 Allowed Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.99 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -108.28 125.9 52.21 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 43.9 t -141.98 139.12 32.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.802 ' HD1' ' HB ' ' A' 1526 ' ' ILE . 57.4 t80 -108.72 121.58 45.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.24 -30.96 71.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -66.2 112.91 5.29 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.4 m 72.93 1.31 3.98 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.029 0.932 . . . . 0.0 110.629 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 58.59 41.9 95.83 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' 1545 ' ' PHE . 27.5 pt -90.82 142.05 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.769 0.795 . . . . 0.0 112.238 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 84.7 mttt -82.08 137.74 34.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.756 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -120.41 15.39 12.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.189 0.519 . . . . 0.0 110.202 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.91 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 157.79 128.51 1.03 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.96 -1.114 . . . . 0.0 114.221 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.9 tttp -72.75 139.53 47.19 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 125.248 1.419 . . . . 0.0 107.319 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 55.5 t90 -72.78 134.43 44.94 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.88 159.57 35.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.39 88.69 2.83 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 40.2 mmtm -131.21 90.81 2.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.35 111.05 23.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 17.6 m -116.16 127.82 55.13 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.4 101.1 13.31 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -138.38 150.15 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.7 t70 65.68 15.2 9.94 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.803 0.811 . . . . 0.0 108.979 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 70.08 12.71 7.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.058 1.743 . . . . 0.0 110.682 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 63.0 t -117.53 151.91 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.851 0.86 . . . . 0.0 109.865 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.1 mp -86.28 124.34 32.55 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.134 -0.354 . . . . 0.0 110.588 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.981 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.4 tp -128.55 118.01 22.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.485 HG22 ' HG3' ' A' 1571 ' ' GLU . 10.5 p -126.39 117.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 112.983 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.91 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 54.4 m-85 -92.13 102.34 14.87 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.893 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.579 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 44.6 mt-10 -107.67 166.58 10.57 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 20.6 t70 68.94 71.0 0.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.274 1.035 . . . . 0.0 111.734 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.0 -137.16 9.68 Favored Glycine 0 N--CA 1.421 -2.333 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.45 153.96 65.62 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.21 151.03 84.52 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.081 1.854 . . . . 0.0 110.587 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 72.7 m -97.3 137.87 21.18 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.8 -25.94 78.31 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.547 2.832 . . . . 0.0 113.449 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.11 -67.25 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.573 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.9 m120 -109.53 -3.68 16.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.1 mm? 67.98 -53.11 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.702 1.201 . . . . 0.0 113.336 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -61.8 -18.21 59.07 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.372 1.469 . . . . 0.0 111.82 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' 1611 ' ' THR . 81.0 mt -82.93 141.66 32.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -116.17 146.94 41.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.88 118.97 9.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 86.9 mttt -130.16 137.62 50.21 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 14.5 m -119.84 116.28 25.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -108.36 114.92 47.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.972 0.892 . . . . 0.0 110.408 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.61 122.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.443 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 19.6 m -109.16 114.77 28.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 91.7 m-85 -86.79 109.61 19.38 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -102.4 159.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 35.6 t -76.28 130.24 37.86 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.19 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.613 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 47.3 tptt -159.82 106.59 1.65 Allowed 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 19.8 m -72.04 -25.96 62.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . 0.613 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 34.4 t70 -81.54 19.81 0.98 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.564 1.146 . . . . 0.0 110.68 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.748 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -95.03 -39.39 10.19 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.691 -0.631 . . . . 0.0 110.508 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 71.57 -162.53 54.3 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.871 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.7 -14.69 33.31 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.228 2.619 . . . . 0.0 112.12 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.1 p -81.94 -50.9 8.62 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.748 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.3 m 65.54 108.87 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.025 0.828 . . . . 0.0 111.198 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 48.4 mt-30 -74.27 124.85 90.24 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.716 -172.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 11.7 Cg_endo -92.97 108.02 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 123.329 2.686 . . . . 0.0 111.251 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.21 116.23 28.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.776 HD21 HG23 ' A' 1607 ' ' VAL . 5.4 tt -77.8 108.3 10.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 63.5 tp -74.92 -54.58 6.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.987 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 23.1 t -169.4 151.19 4.42 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.776 HG23 HD21 ' A' 1604 ' ' LEU . 83.9 t -117.92 110.75 31.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.18 104.57 16.61 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.399 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.44 5.38 17.82 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.445 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 56.1 m80 -88.63 -44.23 10.76 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -112.05 -0.08 15.79 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.6 -176.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 60.3 m 63.01 30.64 16.32 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.185 0.994 . . . . 0.0 111.235 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -99.05 118.56 36.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.726 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.62 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 78.6 mt -97.26 119.29 35.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -102.75 115.44 30.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.62 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 69.4 m-85 -125.74 126.72 45.05 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.01 0.433 . . . . 0.0 110.263 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 20.2 m -106.07 112.66 25.8 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -97.17 119.03 34.92 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 64.6 m-70 -89.8 112.87 24.32 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 14.9 t -139.46 152.18 46.8 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.18 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 6.9 m -74.89 -23.7 58.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' 1505 ' ' PHE . 41.7 mt -72.6 -5.55 38.05 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.347 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.09 16.87 25.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.327 0.584 . . . . 0.0 110.404 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 59.0 m -113.15 151.26 31.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.062 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . 0.499 ' HG2' HG21 ' A' 1501 ' ' THR . 5.4 mp0 . . . . . 0 C--N 1.316 -0.862 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.245 0.867 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 15.0 t 69.03 26.34 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.626 1.203 . . . . 0.0 109.503 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -156.13 151.17 26.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -114.02 132.33 63.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.827 HG23 HG22 ' A' 1504 ' ' VAL . 63.3 m -141.72 105.75 4.77 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.1 p30 -98.34 129.34 30.76 Favored Pre-proline 0 N--CA 1.435 -1.218 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.754 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.05 -11.78 31.1 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.425 2.083 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -55.72 10.7 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.586 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 38.9 p -118.98 -6.28 10.5 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 77.11 34.38 41.91 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' 1497 ' ' THR . 41.0 t80 -83.57 109.61 17.55 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.827 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -128.01 107.6 16.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 O-C-N 123.748 0.655 . . . . 0.0 109.477 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' 1625 ' ' GLU . 8.3 m-85 -120.87 106.49 11.7 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -91.89 108.8 20.18 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.366 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . 0.497 HD11 HD23 ' A' 1510 ' ' LEU . 18.5 tp -89.27 -5.87 57.25 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.964 0.888 . . . . 0.0 109.321 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.427 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 53.1 m-80 -62.21 -26.8 68.56 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.8 t -74.29 -10.67 59.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.497 HD23 HD11 ' A' 1507 ' ' LEU . 35.8 tp -111.87 6.85 19.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.301 0.572 . . . . 0.0 110.451 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' 1530 ' ' VAL . 35.1 mtmm -57.29 153.8 11.58 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.64 ' HD2' ' H ' ' A' 1530 ' ' VAL . 0.0 OUTLIER -84.0 176.76 8.62 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.116 -174.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' 1513 ' ' GLU . 0.0 OUTLIER -89.93 -51.75 5.32 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 35.1 t -128.16 -38.39 1.8 Allowed 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.594 ' HA2' ' HG3' ' A' 1512 ' ' ARG . . . 158.2 161.68 11.18 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.07 129.04 48.29 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 19.9 m -99.09 99.64 10.68 Favored 'General case' 0 N--CA 1.425 -1.711 0 O-C-N 123.788 0.68 . . . . 0.0 109.196 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.1 pt -119.58 155.84 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 8.1 t -107.59 141.17 39.48 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.22 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.36 170.05 16.86 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.842 1.257 . . . . 0.0 107.874 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.48 -23.91 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.899 0.857 . . . . 0.0 110.032 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -84.45 1.16 46.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.876 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 74.41 10.66 4.2 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 126.013 1.725 . . . . 0.0 114.459 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -71.83 123.57 9.88 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 41.5 m -81.79 124.14 29.4 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.76 132.99 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 CA-C-O 121.315 0.578 . . . . 0.0 109.566 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -107.24 116.35 31.78 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.39 140.77 52.64 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.273 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -106.62 151.17 16.92 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' 1511 ' ' LYS . 24.5 t -92.22 115.02 30.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 31.4 m 55.98 24.55 7.81 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.677 1.236 . . . . 0.0 111.88 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -139.06 169.82 24.31 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -99.15 131.25 45.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.615 HG23 ' HB2' ' A' 1537 ' ' CYS . 14.3 m -88.06 93.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.591 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -50.6 -38.27 44.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.653 -173.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.78 -19.67 65.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . 0.615 ' HB2' HG23 ' A' 1534 ' ' VAL . 64.6 m -109.73 9.43 24.88 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.476 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.74 155.11 10.98 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.093 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 131.43 13.34 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.612 2.208 . . . . 0.0 111.347 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' 1554 ' ' LYS . . . 79.93 19.55 69.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.553 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' A' 1551 ' ' LYS . 45.1 mm -114.19 137.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -114.83 -18.04 6.62 Favored Glycine 0 C--N 1.32 -0.306 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.563 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.26 133.95 30.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 19.2 p -149.11 152.43 36.14 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.509 0.188 . . . . 0.0 111.509 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -94.46 118.53 31.78 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.17 110.48 13.19 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.454 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.6 -71.26 0.27 Allowed Glycine 0 C--N 1.282 -2.449 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 3.0 m -87.85 -20.4 26.09 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.91 44.53 11.96 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.75 150.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.48 ' HD3' ' CD1' ' A' 1541 ' ' ILE . 49.9 mttm -90.92 134.46 34.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.09 17.12 11.64 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.425 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 160.32 126.6 0.84 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.886 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' 1540 ' ' GLY . 32.6 ttmt -84.08 147.19 27.51 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.784 0.834 . . . . 0.0 109.997 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 64.3 t90 -64.86 129.25 39.04 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 123.775 0.672 . . . . 0.0 109.673 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.99 156.99 6.36 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -124.21 65.58 1.06 Allowed 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.913 0.863 . . . . 0.0 109.553 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -94.59 92.98 7.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.424 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.88 115.12 27.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 11.7 m -112.9 124.92 53.71 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.422 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.9 t80 -88.62 101.79 14.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 59.5 t -117.4 102.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.945 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.3 68.68 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.673 1.589 . . . . 0.0 112.739 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.57 9.77 6.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.051 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.5 t -125.78 135.44 63.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 O-C-N 121.948 -0.47 . . . . 0.0 110.018 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.11 118.27 25.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.86 118.21 36.31 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.08 119.63 37.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.463 HG22 HG23 ' A' 1587 ' ' VAL . 26.3 t -114.12 115.11 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.993 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.5 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 66.4 m-85 -96.82 92.33 6.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' 1585 ' ' LYS . 14.8 pt-20 -110.84 176.17 5.14 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.587 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.2 t70 66.8 80.15 0.22 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.921 1.288 . . . . 0.0 111.683 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -122.21 -131.44 3.9 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.81 159.17 63.93 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.62 157.93 16.43 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.226 1.95 . . . . 0.0 113.012 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 84.8 m -98.45 136.86 20.7 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.627 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.82 6.26 3.85 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.518 2.145 . . . . 0.0 113.64 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.52 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.732 0.301 . . . . 0.0 110.556 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.41 HD22 HD11 ' A' 1582 ' ' LEU . 88.2 m-20 -109.42 -1.13 18.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.913 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.95 -50.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 33.1 m80 -79.86 26.24 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.452 0.701 . . . . 0.0 112.419 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.41 HD11 HD22 ' A' 1579 ' ' ASN . 94.3 mt -124.88 125.54 44.13 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' 1585 ' ' LYS . 67.0 mttm -112.28 160.01 18.07 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -64.14 126.54 28.07 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1571 ' ' GLU . 1.3 mptp? -111.01 133.2 53.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.0 t -120.25 115.68 24.08 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.463 HG23 HG22 ' A' 1569 ' ' VAL . 7.8 p -112.7 124.73 69.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.607 0.718 . . . . 0.0 110.8 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.05 116.42 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 24.0 m -94.22 110.69 22.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.724 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 90.3 m-85 -88.25 111.07 21.25 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 22.3 m -110.14 155.2 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.778 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 25.4 t -75.08 123.24 24.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.338 0.589 . . . . 0.0 110.603 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 52.9 tptt -146.97 116.72 7.15 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 20.3 m -82.89 -20.41 35.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.294 0.568 . . . . 0.0 109.535 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . 0.597 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -79.29 14.19 1.62 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.592 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -94.22 -56.53 2.81 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.234 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.79 -166.39 41.14 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 -16.32 37.47 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.048 2.499 . . . . 0.0 112.561 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 11.5 p -91.74 -35.51 14.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.295 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.947 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 35.0 m 66.12 177.14 0.22 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.911 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 91.0 mt-30 -114.9 119.35 39.3 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.776 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -94.18 111.85 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 123.224 2.616 . . . . 0.0 109.597 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 59.3 tp -126.46 126.55 43.96 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.0 tp -74.93 120.31 20.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.85 -53.31 5.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.909 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 48.7 m -164.6 149.39 9.67 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 109.88 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 86.8 t -115.51 119.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.11 106.03 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.218 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.29 2.59 27.43 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.3 -24.21 16.3 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.759 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . . . . . . . . . 24.5 p -115.39 -3.45 12.43 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.861 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 86.2 m 61.22 28.16 17.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.384 1.074 . . . . 0.0 111.532 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 25.3 m -105.56 124.61 49.84 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.378 0.609 . . . . 0.0 110.154 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.99 125.48 39.68 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.82 118.68 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 135.33 54.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 39.8 t -110.34 119.23 38.56 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -107.39 104.62 14.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.2 m-70 -83.74 105.83 14.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.6 t -132.26 152.36 51.39 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.532 0.682 . . . . 0.0 111.296 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 15.9 m -80.19 -22.6 41.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.339 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 37.2 tp -71.33 -6.52 40.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.347 0.594 . . . . 0.0 110.621 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.28 5.79 42.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.673 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 71.3 m -88.61 140.89 29.0 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.122 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . 0.707 ' HA ' ' HZ ' ' A' 1505 ' ' PHE . 2.3 mp0 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.066 1.746 . . . . 0.0 114.241 -174.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 22.5 t-20 . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 43.9 t 71.17 3.95 4.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.794 1.283 . . . . 0.0 109.993 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.7 pt20 -150.56 143.55 24.74 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.4 p -136.05 128.51 45.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 121.216 0.531 . . . . 0.0 109.568 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.424 HG23 HG22 ' A' 1504 ' ' VAL . 23.4 m -92.65 108.21 19.8 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 3.4 p30 -81.52 138.8 47.7 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.799 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.25 4.49 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.612 2.208 . . . . 0.0 113.546 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -88.85 -59.25 2.28 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.924 0.392 . . . . 0.0 110.333 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 6.8 p -104.41 -12.51 16.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.74 13.33 83.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.546 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 84.0 t80 -86.17 130.94 34.36 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.424 HG22 HG23 ' A' 1497 ' ' THR . 45.3 t -89.82 108.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.3 m-85 -79.11 105.93 10.79 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . 0.449 ' O ' HD11 ' A' 1622 ' ' LEU . 9.3 t70 -94.84 102.63 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 30.9 tp -86.58 2.7 47.29 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.626 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' 1511 ' ' LYS . 28.8 m-80 -71.84 -18.61 62.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.379 0.609 . . . . 0.0 109.84 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 59.0 m -82.18 -19.33 40.09 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.137 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' 1598 ' ' PRO . 0.2 OUTLIER -115.84 10.29 15.27 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.64 ' HA ' HG23 ' A' 1530 ' ' VAL . 19.3 pttp -76.17 134.03 40.03 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.574 0.702 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.599 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 1.9 tpm_? -127.81 94.03 3.84 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' 1513 ' ' GLU . 0.2 OUTLIER -75.19 -14.93 60.58 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -174.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 13.8 p -78.84 -13.15 59.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 91.17 137.78 7.49 Favored Glycine 0 N--CA 1.424 -2.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.173 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' 1527 ' ' ARG . 83.0 m-85 -82.28 126.68 32.4 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 11.8 p -102.54 90.13 3.75 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 123.73 0.644 . . . . 0.0 109.452 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 19.3 pt -109.29 159.47 8.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.154 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.4 m -83.79 127.16 33.61 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.821 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.48 157.94 19.07 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . 0.717 ' HB ' HD21 ' A' 1604 ' ' LEU . 14.7 tt -70.84 -23.54 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.627 0.727 . . . . 0.0 109.432 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.446 HH22 HD21 ' A' 1614 ' ' LEU . 54.4 mtt180 -71.65 -0.92 11.97 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.234 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 71.22 83.56 0.14 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.055 1.342 . . . . 0.0 110.6 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 173.85 179.95 44.82 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 14.4 m -110.31 139.67 45.26 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.22 133.7 67.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' 1516 ' ' TYR . 24.5 ttm180 -111.31 112.87 24.95 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.71 120.63 37.15 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.49 125.3 8.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.0 m -96.19 117.73 41.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.52 ' HA ' ' CH2' ' A' 1555 ' ' TRP . 74.6 m 72.57 10.49 5.66 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.172 0.989 . . . . 0.0 112.776 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -145.8 142.65 10.82 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.77 140.53 30.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.7 m -76.67 97.23 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 122.829 1.3 . . . . 0.0 109.543 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.783 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -61.19 -21.2 63.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.867 -174.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.43 -19.01 36.73 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.787 0.327 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . 0.65 ' HB2' HG23 ' A' 1534 ' ' VAL . 76.2 m -105.76 4.95 30.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 110.03 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.47 145.96 13.18 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.188 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.46 129.18 23.14 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.9 2.4 . . . . 0.0 111.843 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 103.7 -5.79 47.87 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.552 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.8 mm -93.48 128.24 45.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.623 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -91.63 -40.64 5.28 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.85 134.92 33.96 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . 0.525 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.7 p -141.53 150.48 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 81.8 t80 -96.16 130.19 43.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.5 107.54 8.84 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 123.835 0.709 . . . . 0.0 109.765 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.79 -89.19 0.12 Allowed Glycine 0 C--N 1.283 -2.399 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.3 m -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.945 0.403 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 86.35 27.23 30.95 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 26.1 pt -82.96 141.53 14.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 22.9 pttm -94.51 138.58 32.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.96 12.0 37.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.73 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.887 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.49 147.52 4.68 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.443 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -82.69 150.79 26.56 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.699 0.399 . . . . 0.0 110.134 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.52 ' CH2' ' HA ' ' A' 1531 ' ' CYS . 30.0 t-105 -69.05 123.87 22.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.38 174.44 15.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.97 44.09 1.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 32.2 mmtp -81.81 77.25 8.66 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.357 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.58 98.42 7.05 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 16.8 m -111.97 139.99 47.02 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 93.2 t80 -97.35 103.26 15.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 17.6 m -130.75 113.09 23.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.879 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.9 t70 59.5 44.08 15.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 110.439 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 62.7 17.22 9.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.348 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.9 t -110.49 126.14 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.944 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.3 tp -90.0 115.77 27.54 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -102.2 120.17 40.01 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.29 -0.256 . . . . 0.0 111.034 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . 0.41 ' HB2' ' HE1' ' A' 1590 ' ' PHE . 26.6 tp -106.31 109.08 20.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.438 HG22 HG23 ' A' 1587 ' ' VAL . 21.9 t -109.67 119.3 58.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.099 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.887 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 53.7 m-85 -94.61 115.9 28.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.44 161.2 16.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.053 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 12.0 t70 56.94 71.96 0.54 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.341 1.856 . . . . 0.0 113.499 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -90.84 -136.21 6.63 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -96.26 144.92 28.67 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.779 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 36.9 Cg_endo -67.89 141.84 55.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.225 1.95 . . . . 0.0 112.427 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 74.9 m -98.37 141.41 22.9 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.31 -12.52 35.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.658 2.905 . . . . 0.0 114.846 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -70.33 -61.95 1.58 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.1 m120 -119.97 -4.93 10.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.3 mm? 70.42 -48.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.202 1.001 . . . . 0.0 113.374 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 26.3 m80 -76.17 -4.54 42.25 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.959 0.409 . . . . 0.0 111.97 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.726 HD13 ' HA ' ' A' 1611 ' ' THR . 61.9 mt -101.06 120.13 39.75 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.779 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.6 mttt -118.41 163.23 17.05 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -52.63 110.64 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 36.2 tptt -116.93 130.96 57.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 9.3 t -127.0 118.97 25.55 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.581 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.438 HG23 HG22 ' A' 1569 ' ' VAL . 6.7 p -118.26 111.33 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.836 0.827 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.32 108.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 49.0 m -88.54 109.56 20.17 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.547 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.944 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.9 m-85 -85.92 104.57 15.69 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.3 m -101.52 163.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' 1620 ' ' THR . 46.2 t -97.23 144.65 26.83 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.399 -172.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.516 ' HG2' ' OE1' ' A' 1601 ' ' GLN . 17.6 tppt? -150.47 115.38 5.3 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 5.3 p -61.52 -41.51 97.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.19 25.64 1.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -97.1 -63.3 1.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.052 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 75.84 -156.01 47.16 Favored Glycine 0 C--O 1.25 1.104 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . 0.575 ' HA ' HD21 ' A' 1510 ' ' LEU . 41.4 Cg_endo -66.45 -20.95 54.11 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.888 2.392 . . . . 0.0 111.422 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 p -94.44 62.42 2.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 17.3 m -63.67 149.04 47.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.325 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 39.7 mt-30 -87.14 128.55 55.15 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.9 Cg_endo -91.36 134.35 1.63 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.977 2.451 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' 1617 ' ' SER . 64.7 tp -131.66 108.03 9.22 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.033 0.445 . . . . 0.0 110.388 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' 1521 ' ' ILE . 64.3 tp -68.15 116.4 8.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 39.1 tp -98.15 -63.36 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.016 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 34.8 m -150.33 137.49 19.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 81.0 t -131.61 119.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.03 126.75 52.91 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.514 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -80.91 -10.21 59.74 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.95 -52.17 6.92 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.343 0.592 . . . . 0.0 109.513 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' 1582 ' ' LEU . 46.0 p -92.41 -19.64 21.85 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 63.6 m 66.89 23.34 9.97 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.415 1.086 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -81.18 120.99 25.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.159 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.673 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 90.1 mt -102.39 115.94 31.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.299 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.32 114.77 29.22 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.673 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.0 m-85 -122.02 135.91 54.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.441 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 37.4 t -107.86 114.92 29.21 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -109.2 118.29 36.33 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 38.9 m-70 -98.58 101.33 12.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.2 t -129.27 152.95 48.28 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.395 0.617 . . . . 0.0 110.982 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.7 m -75.77 -25.68 56.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.317 0.58 . . . . 0.0 109.706 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' 1622 ' ' LEU . 6.8 tt -64.04 -16.8 62.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.673 0.789 . . . . 0.0 110.284 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.36 59.71 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 35.0 m -94.53 140.99 29.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.012 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . 0.506 ' HG2' ' OG1' ' A' 1501 ' ' THR . 3.5 mp0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 166.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.429 -1.519 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 75.94 22.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.672 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.7 pt20 -153.27 118.66 5.22 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.644 -1.162 . . . . 0.0 107.999 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -121.83 130.36 74.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.262 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 3.8 m -103.84 106.05 16.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 6.7 p30 -91.67 134.09 29.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.62 -175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 6.6 Cg_exo -67.02 -25.36 44.33 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.893 2.395 . . . . 0.0 113.057 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -56.06 -61.81 2.13 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.014 0.435 . . . . 0.0 111.894 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 21.6 p -96.43 -15.18 21.91 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 69.33 41.23 79.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -128.85 136.42 50.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 120.827 0.346 . . . . 0.0 110.252 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.8 p -94.89 118.17 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.897 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.9 m-85 -87.18 106.72 18.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -86.39 99.02 11.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.2 tp -84.94 4.49 33.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 122.739 1.257 . . . . 0.0 108.791 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 62.9 m-20 -58.87 -28.6 66.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.478 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.1 t -79.33 -11.56 59.93 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.049 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' 1622 ' ' LEU . 20.0 tp -111.73 1.56 16.74 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.687 -0.633 . . . . 0.0 110.602 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.52 ' HE2' ' SG ' ' A' 1531 ' ' CYS . 100.0 mttt -50.21 160.48 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.563 ' HG3' ' CA ' ' A' 1515 ' ' GLY . 9.2 ttp180 -68.49 105.21 2.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.147 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -91.03 -44.68 9.16 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 167.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.3 t -121.96 -35.22 3.21 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.314 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' 1512 ' ' ARG . . . 103.19 162.68 25.55 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.31 121.03 44.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.0 m -117.57 99.18 6.8 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . 0.419 HG21 ' HG2' ' A' 1602 ' ' PRO . 20.1 pt -101.43 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.506 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1525 ' ' SER . 24.1 t -93.64 114.68 27.05 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.663 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 13.7 t70 -89.3 113.96 25.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.83 -18.83 20.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.727 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.471 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.1 mtp180 -76.3 -47.32 24.08 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.73 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.83 -59.3 1.36 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.862 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -175.43 -165.44 31.54 Favored Glycine 0 C--O 1.215 -1.056 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.279 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1519 ' ' SER . 20.3 m -91.18 154.14 19.53 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 117.385 0.593 . . . . 0.0 111.167 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.0 tt -134.55 132.59 54.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -111.78 116.59 30.95 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.71 137.07 50.1 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.71 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -107.39 100.0 1.48 Allowed Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 7.1 p -76.64 116.69 20.2 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.52 ' SG ' ' HE2' ' A' 1511 ' ' LYS . 46.8 t 70.3 3.69 4.55 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.601 0.715 . . . . 0.0 111.418 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -132.16 149.1 19.34 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' 1535 ' ' LYS . 38.5 mt-10 -88.16 131.84 34.56 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 11.3 m -87.95 81.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.311 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.632 ' HD2' ' HB2' ' A' 1533 ' ' GLU . 0.0 OUTLIER -67.6 -13.56 62.18 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.958 0.885 . . . . 0.0 110.7 -175.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.96 -32.96 70.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.45 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 51.8 t -108.01 3.67 24.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.398 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 124.22 150.52 7.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.699 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.66 149.31 38.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.402 2.068 . . . . 0.0 111.171 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.13 14.25 80.61 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.927 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.429 HD12 ' HD3' ' A' 1551 ' ' LYS . 44.7 mm -112.86 135.17 53.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -102.28 -35.03 4.01 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.184 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.58 141.23 39.22 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.993 -0.71 . . . . 0.0 110.676 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' 1541 ' ' ILE . 57.2 m -141.75 146.79 36.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.7 ' HB3' HG13 ' A' 1550 ' ' ILE . 35.2 t80 -97.6 134.78 40.35 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.37 100.86 9.47 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.351 0.596 . . . . 0.0 109.841 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -162.98 -108.35 0.22 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.5 m -84.9 -5.94 59.34 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 101.03 46.49 1.73 Allowed Glycine 0 CA--C 1.491 -1.41 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' 1545 ' ' PHE . 14.0 pt -83.7 132.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.048 0.451 . . . . 0.0 109.991 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' 1541 ' ' ILE . 58.6 mttp -87.42 138.06 31.81 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.542 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -104.88 11.68 33.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.434 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.716 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.17 146.86 4.58 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.338 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1572 ' ' ASP . 1.9 mptm? -77.86 147.31 35.2 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 66.0 t90 -69.77 128.84 37.82 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -158.18 158.52 34.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -104.58 88.4 2.93 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.721 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.8 tptt -130.36 83.69 2.14 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.166 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.39 125.29 40.78 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.693 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 7.9 m -121.58 139.82 53.03 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.046 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.3 t80 -106.66 110.06 22.14 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 65.9 t -116.04 92.66 2.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 34.05 88.23 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.359 1.864 . . . . 0.0 115.018 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 67.12 9.34 6.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.506 1.123 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 48.0 t -132.29 136.17 56.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.5 tp -96.58 136.86 36.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -120.33 127.05 51.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.844 -0.535 . . . . 0.0 110.771 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.7 tp -124.71 124.48 42.24 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.634 HG22 HG23 ' A' 1587 ' ' VAL . 19.6 t -120.47 122.82 69.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.26 0.552 . . . . 0.0 112.051 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.716 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 59.8 m-85 -101.51 113.43 26.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.3 161.14 17.59 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.762 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.499 ' O ' ' HD3' ' A' 1554 ' ' LYS . 35.7 t70 60.2 83.19 0.14 Allowed 'General case' 0 C--O 1.209 -1.033 0 O-C-N 124.657 1.223 . . . . 0.0 113.173 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.83 2.31 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.409 ' H ' ' HD2' ' A' 1584 ' ' TYR . 7.5 m-20 -124.23 150.25 63.15 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.21 136.7 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.623 2.216 . . . . 0.0 111.662 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 64.5 m -99.65 132.6 22.8 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.43 16.13 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.67 2.913 . . . . 0.0 113.949 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -79.41 -49.36 12.48 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.582 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 16.7 m120 -146.85 8.65 0.98 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 29.5 tp 68.93 -47.1 0.57 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.51 1.524 . . . . 0.0 113.98 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 36.3 m80 -75.34 -11.07 59.98 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.552 0.692 . . . . 0.0 110.045 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.698 HD22 HG22 ' A' 1611 ' ' THR . 57.8 mt -85.39 128.15 34.62 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.04 162.55 30.5 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.409 ' HD2' ' H ' ' A' 1574 ' ' ASP . 92.5 m-85 -65.74 112.2 3.59 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -126.14 134.8 51.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.1 t -126.92 125.46 41.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.634 HG23 HG22 ' A' 1569 ' ' VAL . 6.5 p -119.85 117.86 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.693 0.758 . . . . 0.0 109.307 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.77 116.37 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 8.4 t -96.17 104.96 16.95 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.925 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.3 m-85 -87.05 111.5 20.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 34.5 m -105.08 159.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 42.6 t -77.54 128.82 34.81 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 112.501 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 58.4 tptt -145.69 109.18 4.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.8 m -71.57 -28.14 63.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.143 0.496 . . . . 0.0 112.199 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.16 30.22 6.1 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.567 0.698 . . . . 0.0 111.15 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -84.74 -52.38 6.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.787 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 78.13 -159.49 47.22 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.71 -20.77 26.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.848 2.365 . . . . 0.0 111.708 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.2 t -96.81 58.55 1.65 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 123.031 1.396 . . . . 0.0 108.847 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . . . . . . . . . 12.7 m -63.42 130.42 44.35 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.726 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.466 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.7 mt-30 -81.6 125.89 77.28 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -89.61 105.87 0.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.456 2.77 . . . . 0.0 110.873 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 62.9 tp -91.98 130.25 37.77 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.93 127.01 31.7 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' 1617 ' ' SER . 99.3 mt -88.36 -58.32 2.6 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 44.6 m -164.62 147.26 8.66 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 108.989 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 64.6 t -107.91 111.71 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -98.59 91.66 5.25 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -70.04 -33.06 71.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.382 -1.735 . . . . 0.0 115.226 -165.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 51.4 t60 -70.68 -36.9 73.55 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.539 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.698 HG22 HD22 ' A' 1582 ' ' LEU . 0.0 OUTLIER -98.21 0.55 46.04 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.769 -176.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.9 m 55.27 31.1 15.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.565 0.746 . . . . 0.0 111.735 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 29.5 m -99.45 126.86 45.44 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.336 0.589 . . . . 0.0 110.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.581 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 87.0 mt -108.65 118.98 38.2 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.345 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.87 117.97 35.41 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.581 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 79.1 m-85 -128.14 135.95 50.47 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.616 0.366 . . . . 0.0 110.663 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.606 ' HB2' HD21 ' A' 1605 ' ' LEU . 22.7 t -106.68 110.94 23.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -98.25 111.89 24.07 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 17.0 m170 -81.4 98.36 8.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 12.1 t -129.4 153.09 48.24 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.611 0.72 . . . . 0.0 112.012 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 23.5 m -77.88 -21.45 51.26 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.71 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.8 -5.63 35.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.901 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.91 1.68 40.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.479 0.657 . . . . 0.0 109.48 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -103.18 162.31 13.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.837 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 173.471 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1508 ' ' ASN . 6.5 t 61.69 23.03 13.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.687 1.195 . . . . 0.0 110.967 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' 1505 ' ' PHE . 21.5 pt20 -149.37 155.01 39.8 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -155.39 136.1 4.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 10.7 m -99.55 131.86 45.27 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -83.22 118.83 72.8 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.121 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.82 -16.46 44.45 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.991 2.46 . . . . 0.0 114.516 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -76.7 -62.89 1.48 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.542 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.5 p -97.16 -16.86 20.24 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 84.03 24.32 48.99 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.793 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -92.26 132.11 36.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.203 0.501 . . . . 0.0 109.88 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 25.6 t -101.13 106.8 20.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' 1495 ' ' GLN . 76.4 m-85 -81.38 104.15 11.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.76 93.08 7.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.646 0.736 . . . . 0.0 110.203 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 36.1 tp -84.69 -8.38 58.88 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' 1494 ' ' CYS . 59.6 t30 -65.99 -27.96 68.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.502 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 8.5 t -84.76 -11.86 54.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 -36.66 9.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' 1530 ' ' VAL . 2.2 pptp? -44.3 127.84 5.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -98.08 107.98 20.58 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.423 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -69.36 -34.63 74.87 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.74 0.65 . . . . 0.0 111.649 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 64.2 m -65.14 -17.4 64.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.247 0.546 . . . . 0.0 110.646 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 83.18 143.83 5.3 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.279 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -77.09 114.28 15.73 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' 1526 ' ' ILE . 7.8 m -107.93 96.88 6.69 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' 1525 ' ' SER . 27.6 pt -102.79 134.23 44.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.73 -175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.2 m -89.15 92.61 9.26 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.73 123.2 40.35 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.579 0.704 . . . . 0.0 111.509 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.25 -16.07 20.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.595 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.515 ' HD2' HD23 ' A' 1604 ' ' LEU . 69.1 mtt180 -94.17 -26.38 16.71 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.227 -0.921 . . . . 0.0 112.283 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 52.4 tptt -129.36 -59.27 1.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.854 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 166.21 -166.74 38.96 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.526 -0.845 . . . . 0.0 110.999 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' 1518 ' ' ILE . 20.2 m -94.4 112.27 24.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.323 0.582 . . . . 0.0 109.458 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' 1545 ' ' PHE . 10.8 tt -120.94 140.48 44.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.436 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -110.84 115.28 29.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.64 119.84 36.2 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -91.72 127.96 9.14 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' 1511 ' ' LYS . 21.7 t -81.04 116.39 25.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.418 ' SG ' HG12 ' A' 1530 ' ' VAL . 60.7 m 70.67 -24.46 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 172.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -105.07 140.83 15.17 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.69 142.61 44.43 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 120.7 0.286 . . . . 0.0 110.353 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 17.5 m -78.16 81.79 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.428 1.109 . . . . 0.0 109.075 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.628 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.38 -12.01 3.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.716 1.607 . . . . 0.0 112.941 -173.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 -29.17 35.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.664 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.0 t -93.66 -3.95 51.51 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 122.129 0.966 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 132.5 158.36 8.88 Favored Glycine 0 N--CA 1.422 -2.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.2 135.68 32.43 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 123.18 2.587 . . . . 0.0 111.351 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 76.48 9.74 85.91 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.871 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.604 HD12 ' HG2' ' A' 1551 ' ' LYS . 46.5 mm -93.04 133.32 34.61 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -103.58 -48.5 1.19 Allowed Glycine 0 C--N 1.323 -0.155 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.525 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.05 129.39 54.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 53.5 t -148.06 138.65 22.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.627 0.251 . . . . 0.0 110.467 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' 1526 ' ' ILE . 96.6 m-85 -78.57 127.45 32.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.48 103.43 6.48 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 123.728 0.643 . . . . 0.0 109.862 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.68 -76.26 0.22 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . 0.524 ' HB ' HG13 ' A' 1550 ' ' ILE . 16.7 m -81.25 -23.59 37.92 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.072 0.463 . . . . 0.0 110.637 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.57 37.38 10.7 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.385 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.524 HG13 ' HB ' ' A' 1548 ' ' THR . 62.9 mt -84.77 129.33 37.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.604 ' HG2' HD12 ' A' 1541 ' ' ILE . 11.2 mptt -92.32 133.41 35.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' 1584 ' ' TYR . . . -111.42 16.16 20.94 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.349 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.823 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.73 138.19 2.81 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.835 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.63 142.81 27.98 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 124.954 1.302 . . . . 0.0 109.188 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 68.5 t90 -64.16 140.2 58.84 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.887 0.875 . . . . 0.0 110.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -162.26 -179.96 7.43 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -130.95 31.64 4.44 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 118.195 0.452 . . . . 0.0 112.074 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' 1560 ' ' SER . 48.8 tptt -84.15 81.79 8.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.834 0.826 . . . . 0.0 109.921 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' 1568 ' ' LEU . 0.5 OUTLIER -93.2 98.18 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.3 t -89.62 158.7 17.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.15 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -130.29 104.77 7.47 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 96.3 t -115.07 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 36.5 t70 49.95 74.55 0.2 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.843 1.257 . . . . 0.0 112.365 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 67.91 -9.73 0.45 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.829 1.252 . . . . 0.0 113.654 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 85.6 t -107.17 132.19 55.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.794 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 9.4 mp -81.86 141.3 33.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' 1560 ' ' SER . 26.8 mm-40 -131.56 114.86 15.37 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' 1559 ' ' LEU . 64.0 tp -123.04 136.08 54.69 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 8.9 p -135.45 135.42 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-O 121.373 0.606 . . . . 0.0 110.413 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.823 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 70.8 m-85 -105.53 104.6 14.36 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -102.71 163.44 12.22 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 30.4 t70 64.95 79.29 0.26 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 124.282 1.033 . . . . 0.0 112.027 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.83 -106.35 2.95 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.86 160.05 35.05 Favored Pre-proline 0 C--N 1.281 -2.399 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.42 151.52 48.05 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.054 1.836 . . . . 0.0 110.969 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 78.2 m -103.13 126.96 30.86 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.3 Cg_exo -58.18 -23.82 63.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.86 3.04 . . . . 0.0 113.681 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -63.6 -65.35 0.69 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.604 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 22.7 t-20 -111.72 -14.72 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.377 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.43 -45.08 0.61 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.116 0.966 . . . . 0.0 113.132 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 56.3 m80 -68.05 -19.32 64.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.721 0.772 . . . . 0.0 110.036 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.958 HD13 ' HA ' ' A' 1611 ' ' THR . 41.6 mt -95.08 140.96 29.29 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.642 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 62.0 mttm -132.42 161.41 33.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.529 ' HB3' ' HA ' ' A' 1552 ' ' ALA . 97.3 m-85 -65.34 116.53 6.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' 1613 ' ' THR . 21.5 mtpp -129.74 130.38 45.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' 1570 ' ' TYR . 12.3 p -120.82 120.43 35.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 120.724 0.297 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -116.1 119.54 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.97 108.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 11.8 p -86.01 114.85 23.22 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.617 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.83 ' HD1' ' HE3' ' A' 1618 ' ' TRP . 53.9 m-85 -93.98 109.17 20.92 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.3 m -108.91 168.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' 1624 ' ' CYS . 38.0 t -75.96 117.51 17.76 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.771 0.828 . . . . 0.0 111.084 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.758 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 56.7 tptt -146.13 88.06 1.78 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' 1621 ' ' SER . 17.9 m -73.84 -13.35 60.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.621 0.724 . . . . 0.0 110.263 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . 0.758 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 29.9 t70 -80.96 -7.36 59.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -93.03 -64.39 1.1 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 72.63 -123.99 9.29 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.37 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.04 -16.57 49.7 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.741 2.961 . . . . 0.0 113.741 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.9 p -83.01 -66.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.463 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' 1620 ' ' THR . 51.3 m 61.05 97.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.322 1.014 . . . . 0.0 110.463 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 14.5 mm100 -101.61 131.61 22.74 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.072 -171.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.9 Cg_endo -86.03 112.76 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.431 2.754 . . . . 0.0 111.345 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.01 125.5 47.63 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.515 HD23 ' HD2' ' A' 1522 ' ' ARG . 47.6 tp -78.79 116.22 18.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.116 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.74 -51.37 8.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.074 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.5 t -164.08 135.68 4.65 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.488 HG23 HD21 ' A' 1604 ' ' LEU . 93.4 t -102.51 111.26 31.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.9 t70 -104.24 99.52 9.24 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.798 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.59 8.62 9.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -82.24 -51.58 7.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.958 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -103.23 -4.04 24.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.816 -173.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.7 m 62.53 31.19 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 110.376 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' 1585 ' ' LYS . 23.6 m -103.72 125.56 50.28 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.921 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.602 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 85.7 mt -98.72 119.93 38.29 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.064 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.53 109.93 22.01 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.2 m-85 -121.29 134.72 55.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.1 t -108.73 107.28 17.66 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.83 ' HE3' ' HD1' ' A' 1590 ' ' PHE . 18.4 t90 -93.99 106.69 18.65 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.462 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 72.4 m-70 -83.32 103.6 12.84 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.733 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' 1600 ' ' SER . 9.8 t -139.21 153.83 47.93 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.359 0.599 . . . . 0.0 109.996 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . 0.596 ' HB3' ' HA ' ' A' 1594 ' ' SER . 0.8 OUTLIER -76.86 -24.88 52.63 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.357 177.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.94 -8.64 54.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 122.203 1.002 . . . . 0.0 109.145 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -109.8 12.42 24.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.73 0.776 . . . . 0.0 110.173 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . 0.445 ' HB2' ' HA ' ' A' 1592 ' ' CYS . 33.8 t -110.7 164.9 12.29 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.734 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' 1495 ' ' GLN . 31.5 m-80 . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' 1507 ' ' LEU . 72.4 m 71.16 22.95 4.25 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.111 0.964 . . . . 0.0 110.026 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' 1493 ' ' ASN . 10.4 pt20 -128.17 128.18 44.33 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 9.5 p -131.08 132.45 63.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.776 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 19.9 m -93.64 129.52 39.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 11.5 p30 -89.1 136.16 30.72 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.852 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 1.8 Cg_endo -82.14 -12.5 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.998 1.798 . . . . 0.0 110.8 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.49 76.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.679 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.7 p -126.23 -30.18 2.93 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 111.12 11.7 17.66 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.254 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 66.1 t80 -84.84 136.63 33.58 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.358 -0.495 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1497 ' ' THR . 64.7 t -99.91 119.3 47.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' 1495 ' ' GLN . 88.2 m-85 -87.61 104.45 16.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.76 101.02 12.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.791 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . 0.857 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 18.3 tp -83.31 -10.04 58.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.791 1.281 . . . . 0.0 107.975 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' 1511 ' ' LYS . 6.9 p30 -67.05 -14.87 63.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.213 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.7 m -89.42 -6.44 56.55 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.591 ' HB2' HD12 ' A' 1622 ' ' LEU . 34.2 tp -114.65 9.35 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' 1508 ' ' ASN . 48.7 mttp -43.34 148.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.492 ' HB2' ' HA2' ' A' 1515 ' ' GLY . 0.1 OUTLIER -68.22 147.85 51.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.66 -173.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.21 -66.14 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 42.9 t -116.89 -19.98 9.62 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 167.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' 1512 ' ' ARG . . . 137.16 143.42 4.58 Favored Glycine 0 N--CA 1.414 -2.829 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' 1527 ' ' ARG . 41.7 m-85 -69.02 113.72 6.65 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.2 m -113.01 90.94 3.48 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.76 152.88 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.475 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 41.4 m -92.62 137.13 32.63 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.88 175.48 7.27 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' 1522 ' ' ARG . 15.2 tt -58.0 -25.49 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 CA-C-O 121.189 0.519 . . . . 0.0 111.95 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.437 ' HG3' HG23 ' A' 1521 ' ' ILE . 68.0 mtp180 -92.45 3.15 56.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.113 0.482 . . . . 0.0 111.135 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.6 mmtt 77.83 25.49 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.687 1.595 . . . . 0.0 114.492 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -91.7 125.47 8.06 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 69.7 m -79.02 122.25 25.96 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 120.949 0.404 . . . . 0.0 110.282 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.57 136.03 52.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.593 ' HB3' ' SG ' ' A' 1544 ' ' CYS . 50.2 ttm-85 -114.92 123.42 49.09 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.02 134.68 53.39 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.253 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.79 119.08 5.14 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' 1511 ' ' LYS . 27.5 m -96.12 143.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-N 117.036 0.418 . . . . 0.0 109.969 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.65 ' HA ' HE22 ' A' 1557 ' ' GLN . 72.5 m 74.61 -37.75 0.36 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.873 1.269 . . . . 0.0 113.203 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -131.8 150.44 19.55 Favored Glycine 0 N--CA 1.416 -2.642 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.79 155.04 37.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 124.24 0.612 . . . . 0.0 111.531 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -96.92 89.64 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 122.265 1.031 . . . . 0.0 110.219 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -64.85 -20.86 66.63 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.491 -175.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.38 -45.64 80.46 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.021 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 54.0 m -92.78 -15.08 27.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.161 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 148.88 136.88 2.73 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.34 137.4 74.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.853 2.369 . . . . 0.0 112.572 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 85.44 -5.92 81.74 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.705 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.0 mm -91.68 141.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.04 -29.59 3.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.179 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -135.86 120.05 17.77 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' 1527 ' ' ARG . 8.1 p -127.95 144.61 51.1 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 111.17 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 78.7 t80 -105.35 125.53 51.08 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.26 57.26 3.53 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.054 0.931 . . . . 0.0 111.246 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' 1549 ' ' GLY . . . -164.28 114.13 0.58 Allowed Glycine 0 C--N 1.289 -2.043 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' 1550 ' ' ILE . 28.2 m 72.46 -22.23 0.22 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.122 0.969 . . . . 0.0 110.938 -174.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' 1547 ' ' GLY . . . 85.49 35.29 12.1 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 72.8 mt -64.33 138.22 23.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 123.934 0.432 . . . . 0.0 109.926 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' 1551 ' ' LYS . 10.1 mptt -101.55 120.56 40.5 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -102.44 14.82 30.94 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.165 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 147.6 144.13 3.95 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.348 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 54.0 pttt -96.0 155.14 16.88 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.687 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 42.1 t90 -63.82 134.95 56.17 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.824 0.703 . . . . 0.0 110.164 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -169.86 164.06 9.71 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . 0.65 HE22 ' HA ' ' A' 1531 ' ' CYS . 19.2 mm-40 -122.32 83.25 2.08 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 120.933 0.397 . . . . 0.0 110.475 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' 1560 ' ' SER . 1.7 tmtp? -107.06 98.94 8.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 111.6 23.41 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.494 ' HB2' ' HE2' ' A' 1558 ' ' LYS . 9.7 t -120.14 119.59 33.73 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.53 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 58.3 t80 -86.31 113.53 22.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.66 84.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 15.4 t70 45.52 81.77 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.016 1.726 . . . . 0.0 113.334 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 68.26 -0.23 2.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.341 1.056 . . . . 0.0 113.434 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.3 t -116.89 128.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.725 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 13.4 tp -96.52 122.66 39.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -103.95 119.82 39.74 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.079 -0.388 . . . . 0.0 110.666 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 66.9 tp -116.16 130.18 56.67 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 82.4 t -118.83 129.9 74.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.687 ' HE1' ' HA ' ' A' 1555 ' ' TRP . 38.7 m-85 -121.54 97.26 5.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.04 -178.68 3.56 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.444 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 23.4 t70 61.71 63.7 1.12 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.829 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.82 -121.62 4.67 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.367 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.8 145.21 34.39 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 16.0 Cg_exo -72.23 142.98 38.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.605 2.203 . . . . 0.0 109.676 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 69.1 m -98.13 134.05 22.46 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.56 8.34 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.136 2.557 . . . . 0.0 113.625 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -80.36 -51.71 8.54 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.1 m120 -134.2 0.93 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' 1580 ' ' LEU . 4.0 mm? 68.99 -54.47 0.56 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 44.0 m80 -75.1 -16.33 60.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.882 0.373 . . . . 0.0 110.959 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.832 HD13 ' HA ' ' A' 1611 ' ' THR . 62.0 mt -82.52 123.62 29.35 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 94.5 mttt -122.78 162.62 21.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -64.1 115.08 4.61 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' 1613 ' ' THR . 8.7 mtpm? -128.54 131.87 48.25 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.543 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 20.4 t -120.12 131.27 54.98 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -121.88 120.82 62.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.53 105.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 23.6 m -90.35 110.55 21.63 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.725 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.6 m-85 -86.21 112.47 21.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.7 m -101.13 161.56 3.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' 1624 ' ' CYS . 45.0 t -81.24 137.08 35.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.713 0.768 . . . . 0.0 112.117 -173.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 25.1 tptp -154.65 98.76 2.1 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 46.8 t -61.41 -28.8 69.52 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.12 0.486 . . . . 0.0 110.358 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.93 81.82 1.55 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.573 1.177 . . . . 0.0 109.054 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -125.96 -29.64 3.06 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.593 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.01 168.46 40.59 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.43 -10.96 30.56 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 123.21 2.607 . . . . 0.0 111.86 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.1 p -90.7 -40.76 11.67 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.847 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.404 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 38.2 m 68.27 169.54 0.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.735 1.214 . . . . 0.0 110.955 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 13.2 mm-40 -114.5 120.85 37.13 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.347 -174.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.2 Cg_endo -91.19 101.95 0.24 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 123.117 2.545 . . . . 0.0 111.288 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' 1617 ' ' SER . 63.3 tp -89.75 119.66 30.34 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.17 109.86 16.11 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.18 -63.5 1.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.171 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.9 m -144.51 143.33 30.79 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.903 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 60.7 t -118.93 110.88 31.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.29 108.71 20.3 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.139 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -80.4 -0.1 35.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -100.8 -48.24 4.54 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.423 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.832 ' HA ' HD13 ' A' 1582 ' ' LEU . 58.0 p -95.42 -7.0 39.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.43 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.4 m 64.63 25.88 13.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.765 0.826 . . . . 0.0 111.476 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' 1585 ' ' LYS . 57.8 m -93.59 127.03 39.07 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 121.352 0.596 . . . . 0.0 109.918 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 69.8 mt -102.51 127.77 49.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.786 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -110.63 114.75 28.38 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.37 135.35 54.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.299 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 15.2 m -108.71 103.52 12.62 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 1.7 t-105 -94.03 107.84 19.72 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.472 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 76.4 m-70 -78.79 99.92 6.91 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 13.2 t -134.08 153.05 52.06 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 110.264 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.7 m -73.17 -29.07 62.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.448 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' 1510 ' ' LEU . 62.5 mt -74.42 -4.58 37.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' 1590 ' ' PHE . . . -82.81 -25.7 32.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.336 0.589 . . . . 0.0 111.722 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' 1592 ' ' CYS . 14.4 p -117.52 177.98 4.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.432 -1.347 0 CA-C-O 122.23 1.014 . . . . 0.0 110.157 177.706 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 64.4 m-80 . . . . . 0 CA--C 1.481 -1.676 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 6.6 t 62.11 30.92 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.274 1.035 . . . . 0.0 110.965 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' 1505 ' ' PHE . 24.8 pt20 -152.61 145.7 24.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.061 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.3 p -145.5 134.99 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.693 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 22.7 m -92.03 125.66 36.8 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' 1503 ' ' TYR . 9.5 p30 -86.39 147.25 43.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.091 -0.643 . . . . 0.0 109.859 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.45 2.71 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.574 2.183 . . . . 0.0 113.894 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -92.88 -57.77 2.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.203 0.525 . . . . 0.0 111.297 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 35.0 p -105.99 -17.7 14.26 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.945 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 80.66 19.23 68.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.842 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . 0.524 ' HB3' ' ND2' ' A' 1498 ' ' ASN . 53.3 t80 -79.45 133.62 36.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 48.6 t -99.83 110.11 26.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' 1495 ' ' GLN . 96.2 m-85 -80.86 106.77 13.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -97.97 102.77 14.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.299 0.571 . . . . 0.0 112.048 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.04 -4.88 56.0 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.341 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.689 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 52.3 m-80 -62.6 -29.9 70.94 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 25.3 t -71.93 -14.97 62.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.793 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.12 3.05 15.89 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 122.397 -0.189 . . . . 0.0 111.129 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 55.6 mtmt -58.8 118.79 6.12 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.851 0.834 . . . . 0.0 112.985 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -106.6 97.33 7.14 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.001 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -34.59 64.7 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 125.44 1.496 . . . . 0.0 113.53 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.5 m -81.26 -19.82 42.27 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 85.32 155.99 25.64 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.904 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' 1527 ' ' ARG . 71.5 m-85 -92.43 133.09 36.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 9.4 p -112.07 91.5 3.68 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 16.9 pt -96.39 152.07 3.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.301 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 19.6 t -97.82 118.89 35.4 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.704 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 1.9 t70 -74.46 151.65 39.55 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.569 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.7 tt -79.55 -16.25 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.645 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.549 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 10.4 mtp-105 -87.62 1.96 52.24 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.9 mmtt 72.45 77.75 0.15 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.002 1.721 . . . . 0.0 113.603 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -165.09 163.26 36.36 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 107.431 -2.267 . . . . 0.0 107.431 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.3 m -109.71 140.54 43.45 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 118.184 0.992 . . . . 0.0 109.488 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.8 tt -124.65 130.39 73.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' 1516 ' ' TYR . 17.7 ttm180 -112.68 119.14 37.06 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.383 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.39 127.01 47.85 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.947 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.37 129.47 9.89 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' 1511 ' ' LYS . 18.4 m -85.86 115.49 27.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.112 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.473 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 21.7 m 62.92 12.61 5.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.469 1.107 . . . . 0.0 111.714 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -135.56 147.56 19.24 Favored Glycine 0 N--CA 1.415 -2.76 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' 1533 ' ' GLU . 0.1 OUTLIER -77.9 141.18 39.22 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 123.802 0.354 . . . . 0.0 110.219 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.3 m -85.23 87.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 122.01 0.909 . . . . 0.0 109.28 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.638 ' HD2' ' H ' ' A' 1535 ' ' LYS . 2.1 mptp? -59.39 -28.96 67.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.683 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.19 -36.75 71.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.579 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.5 m -96.86 -29.14 13.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.053 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 152.32 159.25 8.88 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.932 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.5 143.88 31.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.288 1.992 . . . . 0.0 111.323 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.46 6.21 89.38 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.537 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.0 131.62 59.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -95.57 -32.88 6.7 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.302 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.21 138.96 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.6 p -145.37 158.3 43.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' 1526 ' ' ILE . 38.8 t80 -113.91 106.17 14.13 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.31 106.76 7.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 122.011 0.91 . . . . 0.0 109.976 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.8 -67.39 0.3 Allowed Glycine 0 C--N 1.276 -2.754 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 -21.77 29.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 81.91 21.31 61.57 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 43.1 pt -91.7 151.1 3.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.215 0.531 . . . . 0.0 111.124 -176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.735 ' HD2' ' HB2' ' A' 1574 ' ' ASP . 74.7 mttt -87.43 156.43 19.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -124.41 7.51 8.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.415 0.626 . . . . 0.0 110.593 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 146.75 144.46 4.04 Favored Glycine 0 C--O 1.256 1.473 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.948 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' 1572 ' ' ASP . 14.1 ptmt -85.28 160.73 19.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.688 0.744 . . . . 0.0 110.377 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 70.3 t90 -62.86 132.63 52.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.368 0.667 . . . . 0.0 110.795 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' 1570 ' ' TYR . 9.1 p30 -167.35 173.08 9.15 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -128.92 41.06 3.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 118.127 0.422 . . . . 0.0 110.04 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -72.11 103.31 3.25 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.077 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 98.8 mt -116.91 96.86 5.66 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 20.0 m -87.51 115.22 24.79 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 72.4 t80 -94.97 102.37 14.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -118.99 92.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-O 121.165 0.507 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.9 t70 54.04 69.97 0.66 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.371 1.068 . . . . 0.0 112.012 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 67.98 2.83 3.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.543 -1.208 . . . . 0.0 114.028 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.37 126.76 66.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.9 mp -94.05 118.03 30.95 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.402 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.837 ' HB2' ' HB2' ' A' 1560 ' ' SER . 17.4 mm-40 -102.64 114.01 27.87 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.57 107.7 18.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.606 HG22 HG23 ' A' 1587 ' ' VAL . 17.5 t -111.85 117.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.867 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 50.6 m-85 -93.64 101.73 13.89 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.9 177.72 4.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.865 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.774 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 34.2 t0 47.16 63.23 2.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 112.289 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' 1584 ' ' TYR . . . -73.73 -77.08 0.64 Allowed Glycine 0 N--CA 1.42 -2.396 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.816 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.735 ' HB2' ' HD2' ' A' 1551 ' ' LYS . 13.7 t70 -165.55 156.08 11.89 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.63 145.85 46.43 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.34 2.026 . . . . 0.0 112.38 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 52.0 t -97.43 139.07 21.2 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 22.3 Cg_exo -62.75 -28.07 76.0 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.203 2.602 . . . . 0.0 114.376 -177.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.48 -44.9 49.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.881 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.84 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 40.5 t-20 -144.8 110.98 5.52 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.54 -15.07 9.7 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 46.1 m80 -94.0 -1.93 53.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 122.085 -0.384 . . . . 0.0 111.843 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.84 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 42.5 mt -90.66 154.8 19.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 66.4 mttm -127.35 151.35 48.89 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.282 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' 1573 ' ' GLY . 83.5 m-85 -61.43 120.09 9.81 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' 1583 ' ' LYS . 92.8 mttt -137.92 140.59 40.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' 1614 ' ' LEU . 15.1 p -130.92 123.68 29.44 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 120.799 0.333 . . . . 0.0 110.417 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.606 HG23 HG22 ' A' 1569 ' ' VAL . 7.5 p -108.97 113.85 45.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.688 0.756 . . . . 0.0 110.178 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.89 109.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 25.9 m -92.37 111.96 23.73 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.0 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.5 m-85 -86.22 108.22 18.27 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 30.7 m -111.73 167.0 5.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.577 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 46.2 t -76.56 150.89 36.47 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.287 0.565 . . . . 0.0 112.258 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.774 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 22.6 tptp -170.86 115.06 0.44 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 174.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 8.3 t -75.44 -28.93 59.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.296 0.498 . . . . 0.0 111.921 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.03 12.34 24.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.287 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -66.73 -51.84 51.33 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -172.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.63 179.04 40.81 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.71 -28.99 19.97 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.773 2.315 . . . . 0.0 113.033 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 -26.4 20.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 109.855 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' 1619 ' ' HIS . 21.3 m 63.38 -175.94 0.15 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.586 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.813 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 6.9 pt20 -116.24 121.44 33.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.821 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 9.6 Cg_endo -92.34 117.45 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.47 2.78 . . . . 0.0 112.111 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.2 tp -97.15 124.86 41.31 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.585 HD11 HG23 ' A' 1607 ' ' VAL . 60.4 tp -80.35 112.78 18.01 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.73 -50.49 8.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.144 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.9 t -175.22 140.28 0.5 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.445 0.466 . . . . 0.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.585 HG23 HD11 ' A' 1604 ' ' LEU . 83.9 t -107.9 110.17 30.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.57 102.41 12.29 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.24 -1.44 44.92 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.958 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -91.92 -39.74 11.54 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.617 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.629 ' HA ' HD13 ' A' 1582 ' ' LEU . 25.3 p -99.96 -2.15 35.34 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 90.8 m 58.57 33.93 23.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.901 0.858 . . . . 0.0 111.033 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 24.5 m -112.75 128.75 56.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.555 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.6 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 67.2 mt -105.13 134.64 47.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.033 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.68 115.94 26.07 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.6 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.5 m-85 -130.14 137.27 50.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.76 0.314 . . . . 0.0 110.892 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 21.0 t -108.45 108.27 19.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' 1600 ' ' SER . 11.7 t-105 -97.59 106.9 19.29 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.813 ' HB2' ' HG3' ' A' 1601 ' ' GLN . 66.0 m-70 -86.77 109.58 19.35 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 7.7 t -130.59 149.9 52.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.298 0.57 . . . . 0.0 110.916 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.1 p -78.87 -26.41 43.96 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' 1622 ' ' LEU . 3.1 tm? -72.81 -6.93 48.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.113 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.15 2.41 40.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 0.0 109.819 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 63.4 m -87.59 133.05 33.86 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.08 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 . . . . . 0 C--O 1.252 1.211 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.338 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' 1495 ' ' GLN . 39.6 t-20 . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 38.5 t 76.48 -21.23 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.385 1.474 . . . . 0.0 110.834 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.3 pt20 -118.04 154.28 32.29 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -142.36 136.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 40.2 m -88.5 126.69 35.37 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.815 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.449 HD22 ' HE2' ' A' 1505 ' ' PHE . 27.9 t-20 -91.57 106.65 17.55 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.29 -19.62 55.97 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.263 2.642 . . . . 0.0 114.61 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -72.65 -53.75 10.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.061 0.458 . . . . 0.0 110.852 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 17.5 p -96.53 -12.34 24.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 79.31 3.93 88.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.67 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 68.8 t80 -85.02 135.24 34.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.401 0.619 . . . . 0.0 110.485 -176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 38.9 t -97.68 115.85 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.449 ' HE2' HD22 ' A' 1498 ' ' ASN . 97.3 m-85 -89.35 107.63 19.17 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -107.14 120.16 41.35 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.57 0.7 . . . . 0.0 110.7 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . 0.513 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 38.3 tp -79.42 -6.38 56.73 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -53.81 -31.07 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.47 1.508 . . . . 0.0 112.641 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 33.3 t -77.74 -20.9 52.68 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.028 0.442 . . . . 0.0 110.663 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 23.0 tp -116.63 -5.59 11.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.97 0.414 . . . . 0.0 111.568 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.6 154.07 42.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.493 0.663 . . . . 0.0 111.901 -175.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -121.63 122.01 38.67 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.187 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -68.79 -26.35 65.16 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.539 0.736 . . . . 0.0 110.476 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 14.0 t -89.2 -7.23 56.0 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 75.73 -164.43 53.94 Favored Glycine 0 N--CA 1.427 -1.921 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.473 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.76 145.81 43.24 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' 1526 ' ' ILE . 32.6 m -142.61 100.63 3.72 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 28.2 pt -121.51 132.4 70.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.87 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.0 t -80.0 112.65 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.72 136.95 32.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.089 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.65 -32.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.606 1.163 . . . . 0.0 112.839 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -74.73 -34.13 62.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 28.8 tptp -141.21 -58.69 0.49 Allowed 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.054 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 175.21 -163.41 33.45 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.379 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1519 ' ' SER . 45.4 t -81.01 144.01 32.1 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.409 0.623 . . . . 0.0 111.289 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' THR . 14.2 tt -127.44 134.26 66.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' 1534 ' ' VAL . 41.3 ttm180 -124.23 103.78 8.44 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.432 0.634 . . . . 0.0 109.593 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.83 144.84 51.74 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.016 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -111.66 139.53 15.64 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.519 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 16.2 m -98.01 117.8 43.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 16.4 m 69.73 19.08 7.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.975 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -153.42 168.71 32.13 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.26 149.56 26.76 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' 1527 ' ' ARG . 20.7 m -94.87 90.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.318 1.056 . . . . 0.0 108.306 173.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.622 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -63.94 -13.72 48.06 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.402 -172.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.56 -12.96 60.33 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 123.149 0.58 . . . . 0.0 110.569 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' 1551 ' ' LYS . 24.9 t -117.12 11.81 14.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.43 163.5 14.58 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.238 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 136.29 12.65 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.472 2.114 . . . . 0.0 111.48 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.83 21.6 79.09 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.588 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 118.19 50.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -94.04 -24.82 18.72 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.678 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.13 132.34 31.83 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 14.1 t -139.94 147.81 41.06 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.521 ' HB3' HG13 ' A' 1550 ' ' ILE . 63.8 t80 -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.13 81.57 8.4 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.306 1.051 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -158.27 85.02 0.13 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 7.6 m 69.63 16.76 7.97 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.214 1.007 . . . . 0.0 109.351 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 62.69 67.31 2.14 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.182 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' 1545 ' ' PHE . 23.7 pt -108.6 138.46 35.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 117.061 0.431 . . . . 0.0 110.015 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.434 ' HG2' ' SG ' ' A' 1537 ' ' CYS . 54.6 mttm -88.69 138.86 31.04 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -114.94 18.28 16.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.065 0.46 . . . . 0.0 111.231 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 148.2 136.71 2.77 Favored Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.948 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 61.0 tttm -85.07 143.54 28.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.439 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 37.3 t90 -69.29 134.27 48.92 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.632 0.73 . . . . 0.0 111.099 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 p30 -158.88 164.42 35.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -124.27 78.45 1.65 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 118.808 0.731 . . . . 0.0 112.4 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 59.5 mmtt -108.23 92.19 3.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.551 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.14 96.36 7.44 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.8 m -96.93 138.14 34.94 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.542 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . 0.593 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 7.4 t80 -110.8 101.02 9.67 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 52.9 t -103.64 88.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.175 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.18 72.72 0.28 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.606 1.163 . . . . 0.0 111.49 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . 0.593 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 26.6 mp0 57.67 24.56 10.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.269 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 51.6 t -126.81 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 11.0 tp -82.31 135.96 35.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' 1560 ' ' SER . 26.6 mm-40 -124.45 135.54 53.33 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.804 0.442 . . . . 0.0 110.115 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.95 120.79 18.56 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.59 HG22 HG23 ' A' 1587 ' ' VAL . 39.2 t -119.14 129.48 75.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.322 0.582 . . . . 0.0 111.25 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.84 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.9 m-85 -107.34 111.86 24.41 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.462 174.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.551 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 48.1 mt-10 -117.56 177.26 4.82 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.198 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 17.5 t70 64.51 43.88 4.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.2 1.0 . . . . 0.0 111.446 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -89.32 -139.59 7.31 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.2 155.33 84.28 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 117.062 0.431 . . . . 0.0 110.351 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.69 148.97 72.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.339 2.026 . . . . 0.0 110.459 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 52.4 t -98.21 126.22 40.72 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -63.99 -7.18 12.73 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.091 2.527 . . . . 0.0 114.335 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -76.71 -61.16 2.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.036 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.429 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 3.2 m-20 -117.67 -5.37 11.14 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 69.5 -45.28 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -70.56 -21.99 62.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.8 0.809 . . . . 0.0 109.173 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.906 HD13 ' HA ' ' A' 1611 ' ' THR . 93.5 mt -82.91 142.42 31.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 60.8 mttm -127.88 162.59 26.34 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -68.38 114.23 6.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.551 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.5 mtpt -128.03 138.99 52.79 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.569 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 27.0 t -120.91 120.0 34.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.59 HG23 HG22 ' A' 1569 ' ' VAL . 7.7 p -112.31 110.27 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 121.98 0.895 . . . . 0.0 109.941 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 107.74 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 15.4 p -90.73 112.91 24.87 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.069 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 85.4 m-85 -89.06 106.35 18.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -105.64 156.66 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' 1620 ' ' THR . 26.2 t -95.1 139.16 31.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.409 -1.317 . . . . 0.0 113.612 -171.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 27.9 tptp -137.67 98.25 3.63 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.6 m -57.59 -29.26 64.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -100.76 6.21 43.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.285 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -64.67 -58.11 7.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 51.91 -114.53 3.24 Favored Glycine 0 N--CA 1.446 -0.694 0 O-C-N 123.767 0.667 . . . . 0.0 112.625 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.63 -19.96 53.65 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.269 2.646 . . . . 0.0 112.957 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.6 t -117.24 74.46 0.92 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.705 1.241 . . . . 0.0 110.399 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.43 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 50.7 m -86.42 116.88 24.86 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.09 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.2 mt-30 -93.52 123.92 58.76 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -173.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 1.4 Cg_endo -84.79 113.15 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.244 2.63 . . . . 0.0 110.449 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.473 HD12 HD23 ' A' 1605 ' ' LEU . 2.2 tm? -96.45 117.55 31.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 34.7 tp -82.96 111.59 18.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . 0.473 HD23 HD12 ' A' 1603 ' ' LEU . 90.6 mt -70.78 -55.68 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.483 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 11.9 t -170.88 153.04 3.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 99.4 t -105.19 111.66 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.56 108.35 19.38 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.626 -1.229 . . . . 0.0 110.163 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -81.46 1.84 31.47 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.1 t60 -89.85 -51.36 5.53 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.906 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -98.03 -7.37 29.98 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.361 -170.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 77.8 m 55.19 34.09 21.93 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.276 1.036 . . . . 0.0 112.361 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' 1585 ' ' LYS . 22.3 m -104.55 127.05 52.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.023 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 83.1 mt -92.62 120.9 33.51 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.125 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -103.12 104.19 14.32 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.476 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 67.2 m-85 -118.66 128.99 55.04 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 67.2 m -109.25 105.63 15.14 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.494 ' HE3' ' CD2' ' A' 1590 ' ' PHE . 11.5 t90 -92.49 109.54 20.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.599 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 59.9 m-70 -80.53 96.81 6.9 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.616 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' 1592 ' ' CYS . 7.9 t -127.88 153.43 46.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.886 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 11.6 m -72.67 -25.86 61.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.145 0.497 . . . . 0.0 111.333 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' 1622 ' ' LEU . 7.2 tt -68.26 -13.26 62.12 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -89.28 -3.35 58.55 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 46.5 m -78.4 169.46 18.21 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.937 -0.477 . . . . 0.0 109.965 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 168.545 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 7.7 p30 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 6.3 t 68.84 9.66 7.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.919 0.888 . . . . 0.0 111.102 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.1 pt20 -140.46 138.22 34.51 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.5 p -139.33 132.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.7 m -93.64 114.38 26.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 4.7 p30 -79.99 133.08 58.56 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 12.2 Cg_exo -67.87 -32.15 29.83 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.535 2.157 . . . . 0.0 112.903 -176.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -55.75 -64.38 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 32.1 p -96.78 -20.51 18.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.94 0.4 . . . . 0.0 111.958 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.34 1.54 74.99 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.183 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -77.18 128.78 34.99 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.672 0.749 . . . . 0.0 111.931 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1497 ' ' THR . 22.1 t -85.9 108.2 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' 1495 ' ' GLN . 87.9 m-85 -84.67 100.58 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.41 120.51 39.72 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . 0.595 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 25.7 tp -83.96 3.83 32.41 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 121.993 0.902 . . . . 0.0 109.146 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.607 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 1.8 m-20 -57.68 -29.34 64.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.535 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . 0.435 ' HB2' HD11 ' A' 1622 ' ' LEU . 10.0 m -71.41 -20.25 62.15 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.642 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.447 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.2 OUTLIER -101.63 -11.02 19.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.607 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 46.3 mtmt -70.54 152.65 43.74 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.764 0.792 . . . . 0.0 112.317 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' 1515 ' ' GLY . 38.7 ttt180 -127.23 119.81 27.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 104.173 -2.529 . . . . 0.0 104.173 172.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.11 -45.74 71.95 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.828 0.705 . . . . 0.0 112.004 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.6 m -81.68 -2.49 50.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.154 0.502 . . . . 0.0 111.136 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 77.98 177.77 48.0 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.411 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.98 114.25 27.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 28.9 m -103.63 102.27 12.14 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.7 pt -122.41 138.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1525 ' ' SER . 34.3 t -94.39 109.72 21.55 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.59 129.32 37.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.62 -20.09 22.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.85 0.719 . . . . 0.0 112.716 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -99.9 -32.25 11.09 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.595 -0.69 . . . . 0.0 110.583 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' 1607 ' ' VAL . 26.7 mmtm -102.62 -62.94 1.21 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 151.87 -168.54 31.2 Favored Glycine 0 C--N 1.296 -1.655 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1519 ' ' SER . 44.7 m -85.39 126.6 33.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 -177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.93 140.31 48.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.401 ' HG2' HG11 ' A' 1534 ' ' VAL . 35.8 ttm180 -118.72 117.2 28.27 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.48 120.67 38.83 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.358 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -97.09 102.44 2.74 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 57.5 t -62.24 115.67 2.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.559 ' HB2' ' CD ' ' A' 1511 ' ' LYS . 21.8 m 60.0 24.83 14.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.553 1.141 . . . . 0.0 111.824 176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.12 173.08 25.02 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -108.84 139.08 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.38 0.609 . . . . 0.0 110.846 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' 1537 ' ' CYS . 15.1 m -94.61 93.49 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.038 0.923 . . . . 0.0 109.149 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' 1535 ' ' LYS . 9.1 mptt -54.73 -30.06 55.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.521 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.56 -18.11 63.62 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.681 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . 0.472 ' HB2' HG23 ' A' 1534 ' ' VAL . 80.9 m -113.44 14.0 19.02 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.978 0.418 . . . . 0.0 110.323 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 110.68 128.91 5.48 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 52.7 Cg_exo -59.54 127.98 25.61 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.932 2.421 . . . . 0.0 111.547 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 91.96 0.16 71.94 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.496 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' 1554 ' ' LYS . 47.7 mm -93.79 134.82 30.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -105.07 -37.68 2.65 Favored Glycine 0 CA--C 1.503 -0.684 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.484 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.6 42.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' 1534 ' ' VAL . 31.0 p -137.76 153.83 49.67 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.602 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.46 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 51.6 t80 -94.88 138.33 32.78 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.95 89.64 8.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.666 0.746 . . . . 0.0 110.311 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -178.96 85.43 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 71.3 m 76.85 -37.17 0.27 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.155 0.982 . . . . 0.0 112.394 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 132.32 46.23 0.12 Allowed Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.744 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 73.4 mt -78.52 134.73 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' 1574 ' ' ASP . 9.4 mptt -96.32 140.86 30.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.53 12.19 10.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.528 0.68 . . . . 0.0 109.552 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 142.04 134.82 3.02 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.476 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' 1541 ' ' ILE . 25.2 pttm -82.76 153.73 25.11 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.66 135.62 50.11 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 173.62 16.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . 0.544 ' H ' ' NE2' ' A' 1557 ' ' GLN . 0.0 OUTLIER -100.02 11.58 38.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.402 0.439 . . . . 0.0 111.077 -172.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -84.94 100.28 11.52 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -168.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' 1494 ' ' CYS . 68.2 mt -115.63 119.92 37.69 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.308 172.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 51.0 m -107.85 122.52 46.95 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 78.9 t80 -94.93 101.32 13.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.988 0.899 . . . . 0.0 108.826 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 85.1 t -93.71 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -34.57 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.862 1.665 . . . . 0.0 113.137 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 20.2 mp0 56.95 18.25 3.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.868 2.067 . . . . 0.0 114.571 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 135.12 62.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.137 0.494 . . . . 0.0 111.088 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.51 113.95 26.04 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -102.94 114.1 28.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.35 124.11 49.86 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 13.1 p -120.48 133.93 65.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 111.355 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.865 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 64.6 m-85 -107.6 106.3 16.59 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.06 167.56 10.16 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.252 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.98 78.38 0.29 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.304 1.041 . . . . 0.0 111.796 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -106.26 -149.6 17.28 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' 1551 ' ' LYS . 24.3 t70 -94.92 143.88 26.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.511 ' HG3' ' HE2' ' A' 1583 ' ' LYS . 13.7 Cg_exo -69.01 146.75 65.88 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.845 2.364 . . . . 0.0 113.218 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 67.7 m -107.59 141.76 23.73 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.66 13.58 0.45 Allowed 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.574 2.849 . . . . 0.0 113.599 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.95 -38.5 22.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.686 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 28.1 t-20 -150.95 -6.7 0.27 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.041 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.14 -43.12 0.55 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.99 0.916 . . . . 0.0 113.424 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 59.9 m80 -77.37 -6.53 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.716 0.77 . . . . 0.0 110.78 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.758 HD13 ' HA ' ' A' 1611 ' ' THR . 63.3 mt -98.94 130.72 45.33 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.511 ' HE2' ' HG3' ' A' 1575 ' ' PRO . 96.1 mttt -128.73 161.95 28.54 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.456 0.473 . . . . 0.0 109.794 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' 1573 ' ' GLY . 98.9 m-85 -65.01 113.84 4.16 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.985 0.803 . . . . 0.0 109.1 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -129.33 137.62 51.1 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 17.3 t -121.49 130.81 53.79 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.3 p -125.43 116.83 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-O 121.96 0.886 . . . . 0.0 109.141 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.3 113.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.7 p -89.81 109.52 20.51 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.698 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.709 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.6 m-85 -86.81 103.06 14.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -99.39 166.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.552 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 18.6 t -84.6 130.31 34.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.469 0.652 . . . . 0.0 112.094 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 17.4 tptp -152.32 100.07 2.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.1 t -70.84 -14.4 62.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 0.0 111.591 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.19 1.89 55.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.375 0.607 . . . . 0.0 109.68 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -75.12 -65.9 0.83 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 108.18 -166.27 12.97 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.944 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.0 -20.23 44.82 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 124.275 3.317 . . . . 0.0 115.028 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 5.7 t -111.98 -22.09 11.23 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.891 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.759 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 48.0 m 65.41 -174.25 0.18 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.713 174.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.618 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 45.9 mt-30 -110.47 120.59 43.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.2 Cg_endo -90.69 125.7 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.906 2.404 . . . . 0.0 110.256 174.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 55.0 tp -129.0 126.05 38.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.676 -0.64 . . . . 0.0 111.027 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.13 118.68 20.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.24 -56.17 4.08 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.291 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 13.7 p -168.69 150.43 4.85 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' 1523 ' ' LYS . 98.2 t -115.0 114.26 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.71 109.05 20.05 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.01 -3.77 52.87 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.056 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -87.35 -51.79 5.75 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.758 ' HA ' HD13 ' A' 1582 ' ' LEU . 27.2 p -96.55 -8.25 32.41 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.614 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 72.9 m 65.7 25.92 11.45 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.929 0.892 . . . . 0.0 112.024 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 30.5 m -90.67 123.79 34.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.121 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.554 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 73.0 mt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.488 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -107.33 116.44 31.94 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 76.7 m-85 -126.96 140.04 52.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.981 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 78.3 p -111.21 116.3 30.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' 1590 ' ' PHE . 4.7 t-105 -99.74 111.79 24.09 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.618 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 71.0 m-70 -86.85 99.08 11.57 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 9.4 t -124.99 152.37 44.31 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.911 0.862 . . . . 0.0 112.131 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.3 m -76.46 -22.75 54.18 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.453 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.9 mt -73.38 -5.21 38.3 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.175 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.77 12.77 30.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.525 0.679 . . . . 0.0 110.391 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 61.3 m -100.23 137.84 38.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.911 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.4 p-10 . . . . . 0 N--CA 1.425 -1.707 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 63.52 26.84 14.92 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.615 0.721 . . . . 0.0 111.392 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.2 pt20 -156.52 134.93 11.45 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.9 p -142.32 131.57 22.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.786 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.512 HG23 HG22 ' A' 1504 ' ' VAL . 10.6 m -98.63 129.09 45.13 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 38.5 p30 -85.91 127.63 61.47 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -70.2 -15.21 35.39 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.72 1.613 . . . . 0.0 110.855 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -65.63 -63.32 1.12 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.832 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 72.4 p -110.13 -14.06 14.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.579 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.12 14.78 58.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.303 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 71.0 t80 -92.16 137.42 32.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.512 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -102.91 128.49 55.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' 1495 ' ' GLN . 79.3 m-85 -104.14 98.6 8.39 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.22 102.07 14.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 120.805 0.336 . . . . 0.0 110.339 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 25.1 tp -79.03 -15.96 57.52 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -66.8 -16.81 64.53 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.516 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 17.9 m -87.61 -13.2 43.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.307 0.575 . . . . 0.0 109.61 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' 1598 ' ' PRO . 36.6 tp -116.44 16.53 15.64 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.975 0.893 . . . . 0.0 109.034 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.71 173.1 1.85 Allowed 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.865 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -53.57 104.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.639 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -100.26 -45.05 5.74 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 50.9 m -119.12 -23.65 6.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.543 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 87.4 129.44 2.88 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -74.83 114.88 13.8 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 5.8 m -119.21 100.18 7.17 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . 0.486 HG21 ' HG3' ' A' 1602 ' ' PRO . 21.1 pt -103.3 140.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.774 -173.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 36.7 t -99.64 115.59 29.78 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.19 160.29 27.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 14.2 tt -62.93 -23.16 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.036 0.535 . . . . 0.0 112.311 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -81.73 3.58 25.1 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.2 tptm 76.34 30.7 0.66 Allowed 'General case' 0 C--N 1.351 0.661 0 C-N-CA 125.895 1.678 . . . . 0.0 108.085 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -82.43 108.72 2.98 Favored Glycine 0 N--CA 1.418 -2.517 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.063 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.1 m -86.63 102.87 14.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.8 tt -113.87 134.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.472 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -115.41 126.98 55.04 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.516 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 125.26 41.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -104.45 90.39 0.72 Allowed Glycine 0 N--CA 1.418 -2.518 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 21.3 m -62.61 116.04 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.556 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 98.9 m 61.03 20.44 10.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.971 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -146.27 91.13 0.15 Allowed Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.55 132.66 49.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 124.548 0.793 . . . . 0.0 110.384 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 18.1 m -93.91 104.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.246 0.546 . . . . 0.0 111.362 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -16.41 60.87 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.176 0.512 . . . . 0.0 111.896 -175.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.34 -27.96 68.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.879 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.1 t -113.55 24.1 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 91.55 137.33 7.46 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.949 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.41 156.41 60.46 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.267 1.978 . . . . 0.0 111.457 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.7 8.55 87.65 Favored Glycine 0 C--N 1.304 -1.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.483 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' 1544 ' ' CYS . 45.3 mm -110.44 134.77 51.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -89.37 -42.55 5.49 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.217 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.29 147.35 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 122.661 -0.317 . . . . 0.0 110.598 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' 1541 ' ' ILE . 59.2 m -152.43 156.22 39.06 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.278 0.631 . . . . 0.0 111.046 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' 1550 ' ' ILE . 64.9 t80 -94.22 119.05 32.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.09 102.09 3.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.985 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 151.49 -64.86 0.37 Allowed Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.367 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 21.9 p -91.25 -24.4 19.88 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.742 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.61 19.7 59.57 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.789 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' 1545 ' ' PHE . 44.6 pt -71.37 126.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 58.3 mttm -83.45 134.77 34.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.19 10.09 41.78 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.068 0.461 . . . . 0.0 111.402 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 139.0 146.04 4.87 Favored Glycine 0 C--O 1.254 1.357 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.817 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.54 146.5 36.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.635 0.255 . . . . 0.0 110.773 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.556 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 28.1 t90 -75.57 133.33 40.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.124 0.487 . . . . 0.0 110.332 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 10.2 p30 -146.76 -178.81 6.38 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.55 27.41 7.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.306 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 44.0 mmtm -85.24 82.4 8.39 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.035 0.921 . . . . 0.0 111.849 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.44 103.93 16.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.338 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 6.9 t -90.05 109.68 20.71 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -83.6 101.8 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.8 t -114.75 95.13 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.067 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 23.5 t70 52.49 67.62 0.95 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.699 1.199 . . . . 0.0 112.137 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 63.92 9.88 4.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.851 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 37.5 t -119.75 136.7 56.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.38 131.6 39.87 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.299 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' 1560 ' ' SER . 86.9 mm-40 -116.28 114.63 24.63 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.57 119.47 38.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' 1571 ' ' GLU . 14.1 p -121.12 122.59 67.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.133 0.968 . . . . 0.0 112.526 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.679 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 57.6 m-85 -100.1 108.4 20.54 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.659 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' 1569 ' ' VAL . 46.0 mt-10 -117.68 168.54 10.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.296 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 35.8 t70 61.28 70.18 0.62 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.075 1.35 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.94 -133.17 5.62 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.875 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' 1584 ' ' TYR . 31.0 t70 -74.93 136.81 73.2 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.55 138.29 17.18 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.46 2.106 . . . . 0.0 112.589 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 56.2 m -98.78 126.3 39.26 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.87 8.15 2.12 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.944 2.429 . . . . 0.0 114.645 -173.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -77.2 -35.67 55.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 109.965 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.606 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 18.9 t-20 -136.05 -20.92 1.45 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.684 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 18.8 tp 75.83 -33.13 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.075 1.35 . . . . 0.0 112.504 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . 0.508 ' HB3' ' OD1' ' A' 1579 ' ' ASN . 40.8 t-80 -81.47 -14.88 56.51 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' 1611 ' ' THR . 83.3 mt -82.47 133.45 35.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.367 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 49.2 mttm -130.04 163.8 25.71 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' 1574 ' ' ASP . 97.4 m-85 -72.05 117.61 13.88 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.85 171.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 134.18 55.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.497 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 16.0 m -119.41 116.56 26.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -109.3 111.0 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.893 0.854 . . . . 0.0 110.051 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.3 mp -102.15 107.41 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.244 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 113.44 25.72 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.3 m-85 -86.22 112.32 21.25 Favored 'General case' 0 C--O 1.256 1.395 0 CA-C-O 120.708 0.289 . . . . 0.0 110.244 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.5 m -106.93 166.74 3.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 124.26 1.024 . . . . 0.0 109.124 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 43.0 t -77.05 143.24 39.44 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.412 0.625 . . . . 0.0 112.648 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 25.5 tptp -167.07 101.71 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.8 m -68.66 -28.52 66.96 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.649 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.2 71.04 3.86 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -142.63 -64.02 0.42 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.936 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 68.78 -144.76 42.41 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.402 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' 1510 ' ' LEU . 40.7 Cg_endo -66.23 -11.96 33.54 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.013 3.142 . . . . 0.0 113.396 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.4 t -123.24 77.08 1.44 Allowed 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.608 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 51.0 m -70.74 147.8 48.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.795 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.612 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 9.3 pt20 -108.55 120.85 45.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-O 121.56 0.695 . . . . 0.0 112.492 -170.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.486 ' HG3' HG21 ' A' 1518 ' ' ILE . 88.2 Cg_endo -80.78 139.42 12.36 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.4 tm? -106.66 111.02 23.38 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.775 HD21 HG23 ' A' 1607 ' ' VAL . 4.8 tt -81.53 112.5 18.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.14 -66.38 0.8 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 55.0 m -158.09 136.25 10.84 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.742 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.775 HG23 HD21 ' A' 1604 ' ' LEU . 90.9 t -95.36 111.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.99 118.65 29.71 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.599 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -80.72 -6.84 58.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.37 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -94.22 -51.81 4.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.563 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.89 ' HA ' HD13 ' A' 1582 ' ' LEU . 41.7 p -97.16 -14.77 21.27 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.012 0.195 . . . . 0.0 111.447 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' 1584 ' ' TYR . 69.5 m 67.33 26.54 8.47 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.364 1.04 . . . . 0.0 110.742 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 19.3 m -86.87 116.81 25.19 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.714 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 74.6 mt -94.07 116.21 28.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -100.58 111.75 24.04 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.714 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 91.5 m-85 -128.44 136.73 51.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.334 0.587 . . . . 0.0 111.577 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.9 m -112.22 106.41 14.98 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.466 ' HB2' HG23 ' A' 1588 ' ' ILE . 1.4 t-105 -89.99 114.95 26.89 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 42.6 m80 -78.0 101.26 6.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 11.7 t -129.35 153.31 47.99 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.576 0.703 . . . . 0.0 111.074 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.2 m -73.28 -28.82 62.32 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.3 -6.49 43.51 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 121.45 0.643 . . . . 0.0 111.558 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -92.84 -4.45 52.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.435 0.636 . . . . 0.0 110.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 7.4 m -99.12 129.23 45.37 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 . . . . . 0 N--CA 1.424 -1.725 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.753 178.719 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--O 1.223 -0.293 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 37.6 m -87.71 11.53 15.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.596 0.713 . . . . 0.0 109.484 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.5 pt20 -152.01 136.33 16.73 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.6 p -132.61 126.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.35 0.595 . . . . 0.0 110.209 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 14.3 m -90.32 116.68 28.47 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.49 HD22 ' HE1' ' A' 1505 ' ' PHE . 28.1 p30 -73.8 143.94 82.15 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.777 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 7.7 Cg_exo -73.52 -31.73 8.58 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.876 1.717 . . . . 0.0 112.01 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -62.08 -65.42 0.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 8.7 p -97.69 -11.65 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 74.28 40.17 41.77 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 83.9 t80 -111.72 130.5 55.76 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.033 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' 1497 ' ' THR . 47.6 t -90.28 118.95 36.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.49 ' HE1' HD22 ' A' 1498 ' ' ASN . 90.8 m-85 -91.29 108.21 19.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.55 106.43 17.53 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.335 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . 0.564 HD11 HD23 ' A' 1510 ' ' LEU . 28.1 tp -83.97 -3.12 57.75 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -51.17 -38.42 52.08 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 125.855 1.662 . . . . 0.0 111.571 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 4.9 m -68.13 -19.21 64.8 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.564 HD23 HD11 ' A' 1507 ' ' LEU . 50.6 tp -117.24 5.69 12.69 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.928 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' 1531 ' ' CYS . 22.8 pttm -88.09 129.53 35.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.319 -175.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -128.44 118.29 22.85 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.99 -37.28 78.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 2.7 m -56.17 -25.1 45.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.744 1.218 . . . . 0.0 110.273 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 87.07 177.12 49.05 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.316 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.65 124.9 43.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' 1527 ' ' ARG . 2.6 m -103.04 98.41 8.36 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 15.4 pt -106.39 151.11 8.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.268 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1525 ' ' SER . 12.8 p -109.44 130.98 55.47 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.94 154.91 40.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.3 tp -62.94 -26.16 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.287 0.635 . . . . 0.0 111.824 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' 1522 ' ' ARG . 50.1 mtp180 -85.86 3.42 41.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1523 ' ' LYS . 44.5 mmtm 86.92 20.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.613 1.565 . . . . 0.0 112.519 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -83.58 80.23 1.84 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1519 ' ' SER . 15.0 m -69.65 127.7 33.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.425 HD11 ' HB1' ' A' 1543 ' ' ALA . 7.6 tt -129.49 134.07 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.45 0.643 . . . . 0.0 110.153 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' 1517 ' ' THR . 58.2 ttt180 -105.82 119.77 40.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' 1528 ' ' LEU . 0.7 OUTLIER -122.61 125.14 45.06 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -178.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -97.79 143.93 16.99 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 23.8 t -100.01 116.49 43.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.584 ' HA ' ' OE1' ' A' 1557 ' ' GLN . 62.0 m 63.95 20.99 12.46 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.078 0.862 . . . . 0.0 110.801 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -142.84 111.91 0.69 Allowed Glycine 0 N--CA 1.407 -3.271 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.76 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.18 133.4 47.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.9 m -90.85 95.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 122.258 1.028 . . . . 0.0 108.313 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.05 -28.17 64.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.913 -173.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.21 -16.56 61.95 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . 0.671 ' HB2' HG23 ' A' 1534 ' ' VAL . 96.7 m -102.76 -5.33 23.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.243 0.544 . . . . 0.0 109.538 173.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 131.44 145.03 5.52 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 132.49 29.67 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.166 1.91 . . . . 0.0 111.119 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.14 23.08 76.87 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.042 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.44 127.28 66.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' 1570 ' ' TYR . . . -100.8 -35.21 4.38 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.69 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . 0.425 ' HB1' HD11 ' A' 1526 ' ' ILE . . . -129.22 121.88 28.55 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.2 p -132.42 142.74 49.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.013 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' 1552 ' ' ALA . 73.8 m-85 -90.05 141.49 28.62 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.66 -26.27 64.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -89.88 126.79 8.45 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 6.7 m 75.48 -21.34 0.31 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 124.762 1.225 . . . . 0.0 112.009 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.22 30.36 54.88 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.63 150.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.165 0.507 . . . . 0.0 110.252 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.689 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 18.3 pttm -97.06 145.58 25.83 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.02 8.9 32.58 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.218 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.831 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.35 141.13 3.18 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.553 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.55 150.52 36.54 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.484 ' HA ' ' HE2' ' A' 1570 ' ' TYR . 35.2 t90 -63.78 124.49 21.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.694 0.759 . . . . 0.0 110.506 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . 0.425 HD21 ' HA ' ' A' 1570 ' ' TYR . 8.3 p30 -149.14 153.06 37.16 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' 1531 ' ' CYS . 13.4 mm100 -108.72 22.63 15.67 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 123.753 0.658 . . . . 0.0 109.653 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 27.9 tptp -77.17 82.44 3.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.144 0.973 . . . . 0.0 111.57 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' 1566 ' ' LEU . 50.5 tp -91.33 116.2 28.64 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.262 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.4 m -103.31 147.14 27.44 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . 0.406 ' HD1' HD23 ' A' 1566 ' ' LEU . 60.7 t80 -117.51 135.0 54.23 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . 0.734 HG23 ' HB ' ' A' 1565 ' ' VAL . 18.0 m -134.05 160.51 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.33 106.1 0.09 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.073 0.949 . . . . 0.0 112.887 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 71.9 17.59 5.25 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.15 1.78 . . . . 0.0 112.413 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . 0.734 ' HB ' HG23 ' A' 1562 ' ' VAL . 59.5 t -139.8 124.68 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.697 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 93.3 mt -96.04 129.39 43.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' 1560 ' ' SER . 18.1 mm-40 -113.6 114.27 26.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' 1568 ' ' LEU . 19.6 mt -104.81 119.47 39.08 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 36.1 t -116.72 108.58 25.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.294 0.569 . . . . 0.0 110.517 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.831 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 45.8 m-85 -93.22 113.35 25.54 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.812 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.54 -177.17 3.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.448 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.668 ' HA ' ' HD2' ' A' 1583 ' ' LYS . 5.1 m-20 68.33 27.98 6.38 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.713 0.633 . . . . 0.0 112.242 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . 0.689 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -74.07 -167.63 16.37 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 1.5 m-20 -72.19 162.63 72.65 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 122.338 -0.507 . . . . 0.0 112.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -65.23 144.35 80.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.572 2.181 . . . . 0.0 112.479 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 43.9 t -98.23 140.18 21.7 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 124.677 1.191 . . . . 0.0 109.991 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.61 -22.12 73.63 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.068 2.512 . . . . 0.0 114.069 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.21 -26.56 60.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.83 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 36.9 t-20 -171.11 120.21 0.51 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' 1580 ' ' LEU . 2.4 mm? -56.16 -27.22 53.47 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.593 1.157 . . . . 0.0 114.112 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.6 m80 -91.09 3.23 55.29 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.83 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 57.6 mt -89.94 121.55 32.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' A' 1572 ' ' ASP . 50.7 mtmt -103.27 156.88 17.4 Favored 'General case' 0 C--N 1.272 -2.795 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -61.88 119.83 9.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.73 0.644 . . . . 0.0 110.881 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' 1583 ' ' LYS . 0.6 OUTLIER -104.38 131.11 52.09 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' 1570 ' ' TYR . 23.1 t -123.15 116.07 22.83 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -116.82 112.87 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-O 122.097 0.951 . . . . 0.0 110.321 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.41 101.51 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 47.5 m -90.96 110.25 21.49 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.21 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.5 m-85 -86.05 104.84 16.02 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.3 m -98.13 159.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.638 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 41.6 t -76.02 122.28 23.98 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.624 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' 1595 ' ' ASP . 20.4 tptm -149.7 90.12 1.68 Allowed 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.6 t -68.37 -15.26 63.49 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.466 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . 0.426 ' HB2' ' HE2' ' A' 1593 ' ' LYS . 29.3 m-20 -85.63 4.3 36.93 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 122.175 -0.328 . . . . 0.0 111.505 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.28 -61.12 1.93 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-O 120.734 0.302 . . . . 0.0 111.165 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 87.87 -141.75 17.28 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.838 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.52 -16.9 38.81 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.337 2.691 . . . . 0.0 112.97 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.8 t -125.97 89.78 3.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 122.45 1.119 . . . . 0.0 109.553 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.751 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.2 m -76.25 148.17 37.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.2 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 56.3 mt-30 -96.19 122.06 58.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.4 Cg_endo -87.14 113.67 1.0 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.402 2.734 . . . . 0.0 110.708 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.59 119.33 36.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.871 0.367 . . . . 0.0 110.291 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.448 HD13 ' CZ ' ' A' 1616 ' ' PHE . 39.0 tp -76.5 126.07 30.33 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.39 -65.47 1.01 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 73.7 m -159.51 156.29 27.94 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.513 HG13 HD23 ' A' 1614 ' ' LEU . 96.0 t -110.37 112.39 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 171.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.68 109.03 13.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.86 -6.42 58.59 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.208 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -95.16 -29.0 14.77 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.043 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' 1582 ' ' LEU . 35.9 p -114.86 -15.22 11.87 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.961 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 97.8 m 66.14 58.8 0.7 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.556 1.169 . . . . 0.0 111.097 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 23.5 m -120.94 130.37 53.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.281 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.513 HD23 HG13 ' A' 1607 ' ' VAL . 73.6 mt -96.81 117.4 31.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.33 103.33 13.33 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -114.82 131.53 56.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.829 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 74.7 p -109.53 108.46 18.93 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -92.68 108.01 19.65 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' 1600 ' ' SER . 64.4 m-70 -83.66 97.72 9.25 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -126.45 152.14 46.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.759 0.79 . . . . 0.0 111.808 -173.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.6 m -78.25 -25.99 47.06 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.405 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' 1510 ' ' LEU . 43.2 mt -70.61 -6.07 34.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.957 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -95.18 -9.55 33.07 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.538 0.685 . . . . 0.0 110.432 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -82.85 135.77 34.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.151 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 48.0 m-80 . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 45.1 t 61.86 33.41 17.63 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 123.042 1.401 . . . . 0.0 110.16 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' 1505 ' ' PHE . 8.6 pt20 -156.46 146.55 21.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 11.7 p -148.14 135.55 13.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . . . . . . . . . 14.0 m -94.94 116.98 29.38 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.462 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.4 p30 -78.66 138.03 58.54 Favored Pre-proline 0 C--N 1.31 -1.134 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.604 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.08 -1.9 11.98 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 113.647 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -83.52 -68.57 0.7 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.68 0.276 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 12.1 p -89.22 -24.99 21.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.65 13.95 64.19 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.55 139.97 30.34 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 44.5 t -92.55 116.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.484 ' HZ ' ' HG2' ' A' 1625 ' ' GLU . 82.3 m-85 -81.24 95.33 6.91 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.04 95.35 10.28 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.001 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 31.8 tp -86.01 -11.1 53.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.51 0.672 . . . . 0.0 110.996 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' 1511 ' ' LYS . 9.1 p30 -71.68 -13.22 61.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.947 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 74.3 m -84.23 -10.85 57.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.128 173.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.76 4.06 19.63 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.004 -0.435 . . . . 0.0 111.033 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 58.0 pttt -90.79 157.74 17.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.079 0.466 . . . . 0.0 111.262 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -128.88 137.03 51.22 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -30.08 70.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 22.3 t -78.27 -11.54 59.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.805 0.812 . . . . 0.0 109.101 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 76.57 -174.67 53.75 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.512 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.87 121.36 44.44 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.5 m -105.88 103.87 13.46 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . 0.442 HG21 ' HG3' ' A' 1602 ' ' PRO . 25.9 pt -108.66 139.91 29.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.201 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 10.0 p -87.11 139.29 30.72 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 121.616 0.722 . . . . 0.0 111.571 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -95.23 151.84 18.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.16 -25.87 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 124.567 1.147 . . . . 0.0 112.952 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.58 2.67 18.48 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.08 -0.387 . . . . 0.0 111.841 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.9 tptm 70.04 68.97 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.731 1.253 . . . . 0.0 109.481 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -150.47 174.61 29.79 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 16.5 t -146.39 146.79 30.75 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 118.559 1.18 . . . . 0.0 108.421 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.34 134.47 60.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.1 ttm105 -110.15 113.85 26.87 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.17 129.36 56.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.18 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.75 91.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' 1511 ' ' LYS . 92.8 t -64.1 116.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.643 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 60.8 m 58.45 18.46 5.65 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.79 0.681 . . . . 0.0 112.695 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . 0.41 ' N ' ' HE1' ' A' 1555 ' ' TRP . . . -154.07 101.85 0.21 Allowed Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 178.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.0 132.64 54.5 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 121.26 0.552 . . . . 0.0 111.723 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.5 m -78.87 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.958 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -18.01 17.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.095 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.33 -31.82 73.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.27 -0.38 26.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.501 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 123.97 158.11 10.01 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.378 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.9 130.77 11.63 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.395 2.063 . . . . 0.0 111.935 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.86 5.24 81.4 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.572 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.447 ' CD1' ' HD2' ' A' 1551 ' ' LYS . 41.1 mm -98.77 117.49 43.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.15 -19.73 18.11 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.49 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -137.27 120.28 16.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.4 p -131.03 136.77 48.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.395 0.617 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 76.8 t80 -96.26 116.12 28.51 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.6 104.81 4.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.623 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -176.12 -105.67 0.19 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 5.2 m -73.88 -25.23 59.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 109.46 57.53 0.53 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 61.3 mt -94.14 125.12 46.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.447 ' HD2' ' CD1' ' A' 1541 ' ' ILE . 43.2 mtmt -83.91 126.26 32.82 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -105.48 9.0 33.69 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.246 0.546 . . . . 0.0 110.767 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.784 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 147.86 146.58 4.37 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.329 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.5 144.93 27.66 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.733 0.777 . . . . 0.0 111.541 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . 0.504 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 65.6 t90 -65.54 151.21 46.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.158 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -164.99 167.31 18.58 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -119.26 20.52 12.56 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -91.01 96.71 10.76 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.463 0.649 . . . . 0.0 110.336 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.479 HD23 HD13 ' A' 1568 ' ' LEU . 69.2 mt -94.19 109.38 21.18 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 20.1 m -92.94 120.84 33.67 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 75.6 t80 -93.23 102.39 14.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' 1565 ' ' VAL . 49.2 t -115.65 88.88 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.681 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.0 t70 48.03 81.41 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.927 1.291 . . . . 0.0 113.799 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 70.35 -9.19 0.79 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' 1562 ' ' VAL . 7.4 p -116.98 132.13 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.539 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.874 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 14.7 tp -88.15 119.08 28.2 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -107.06 129.11 54.86 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.435 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . 0.479 HD13 HD23 ' A' 1559 ' ' LEU . 54.9 tp -126.8 109.88 12.49 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 172.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 38.7 t -110.9 128.5 67.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.784 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 75.2 m-85 -104.43 119.33 38.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.13 177.28 4.78 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.781 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 8.7 t70 52.65 70.33 0.59 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.227 1.411 . . . . 0.0 111.85 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.94 -135.82 8.87 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.321 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 19.5 t70 -83.5 145.54 48.23 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 6.4 Cg_exo -74.18 142.72 31.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.607 2.205 . . . . 0.0 111.526 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' 1578 ' ' ALA . 78.2 m -98.39 132.17 24.76 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.746 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.44 20.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.578 2.852 . . . . 0.0 112.714 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -86.81 -55.47 3.83 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.55 7.67 2.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.282 0.563 . . . . 0.0 109.766 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 2.2 tm? 68.93 -50.88 0.59 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.508 1.523 . . . . 0.0 112.358 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.7 t60 -68.49 -13.46 62.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.358 0.663 . . . . 0.0 110.408 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.67 134.98 35.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 85.6 mttt -125.84 152.45 45.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 95.5 m-85 -67.08 117.48 9.18 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.864 0.728 . . . . 0.0 109.393 174.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.14 135.45 48.88 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 13.1 p -121.03 121.25 37.54 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.683 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 4.2 p -106.15 113.63 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.552 0.691 . . . . 0.0 109.735 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.42 110.12 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' 1565 ' ' VAL . 42.3 m -93.34 118.62 31.5 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.874 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 90.9 m-85 -86.58 110.2 19.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.2 m -107.42 152.38 9.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' 1620 ' ' THR . 40.3 t -81.98 142.53 32.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.273 0.558 . . . . 0.0 112.404 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.518 ' CB ' ' HB3' ' A' 1619 ' ' HIS . 42.4 tptt -163.29 97.35 0.9 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.457 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 9.5 p -56.65 -32.28 65.21 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.871 0.868 . . . . 0.0 112.09 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.674 0.79 . . . . 0.0 112.037 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -80.27 -41.6 24.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.767 0.318 . . . . 0.0 111.519 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.2 -163.68 39.66 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.7 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.63 -15.64 21.63 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.272 2.648 . . . . 0.0 113.168 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.3 p -86.13 -42.02 14.24 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.814 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.4 m 72.21 161.75 0.25 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.18 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -115.52 121.65 34.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.442 ' HG3' HG21 ' A' 1518 ' ' ILE . 55.3 Cg_endo -84.2 121.46 2.72 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.73 118.38 33.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.482 HD21 HG23 ' A' 1607 ' ' VAL . 49.7 tp -78.42 116.84 19.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 46.8 tp -79.94 -56.12 4.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.608 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 50.9 m -164.21 136.24 4.75 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 122.614 0.365 . . . . 0.0 110.171 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.482 HG23 HD21 ' A' 1604 ' ' LEU . 82.3 t -103.35 110.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.22 100.17 10.35 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.487 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -80.58 7.07 10.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.081 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -89.8 -51.34 5.55 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.942 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . . . . . . . . . 49.9 p -99.74 -9.53 22.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.581 0.229 . . . . 0.0 111.218 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 66.6 m 69.54 23.27 6.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.656 1.182 . . . . 0.0 111.075 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 13.4 m -91.22 114.23 26.7 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' 1616 ' ' PHE . 79.6 mt -93.83 121.91 35.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.92 113.56 27.18 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' 1614 ' ' LEU . 76.0 m-85 -121.9 139.19 53.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.1 m -119.92 108.81 14.79 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.403 ' HE1' ' HB2' ' A' 1600 ' ' SER . 24.3 t-105 -93.14 110.24 21.74 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.518 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 39.4 m-70 -83.04 107.77 15.87 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.8 t -132.79 152.98 51.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.622 0.576 . . . . 0.0 110.068 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.7 m -70.62 -27.62 64.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.41 0.624 . . . . 0.0 110.065 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.82 -5.87 37.43 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.347 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' 1592 ' ' CYS . . . -84.73 -9.01 58.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.605 0.717 . . . . 0.0 110.501 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.7 m -94.58 144.26 25.74 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . 0.484 ' HG2' ' HZ ' ' A' 1505 ' ' PHE . 47.3 mt-10 . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 121.51 0.671 . . . . 0.0 109.698 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 CA--C 1.499 -1.008 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 95.3 m 70.91 -1.4 2.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.602 0.715 . . . . 0.0 112.325 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' 1506 ' ' ASP . 29.4 pt20 -149.2 161.53 41.81 Favored 'General case' 0 N--CA 1.405 -2.692 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.5 p -146.74 121.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-O 121.88 0.847 . . . . 0.0 110.514 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.62 HG23 HG22 ' A' 1504 ' ' VAL . 17.7 m -91.67 104.18 16.68 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.05 135.9 47.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.087 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 -12.37 20.18 Favored 'Trans proline' 0 C--N 1.332 -0.324 0 C-N-CA 122.591 2.194 . . . . 0.0 112.212 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -66.51 -67.34 0.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.544 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . 0.443 ' H ' ' HG1' ' A' 1501 ' ' THR . 25.4 p -99.54 -23.0 15.23 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.45 73.28 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.376 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -74.63 137.4 42.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.177 0.513 . . . . 0.0 110.023 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.62 HG22 HG23 ' A' 1497 ' ' THR . 41.7 t -100.02 121.56 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -115.08 108.56 16.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' 1495 ' ' GLN . 2.5 p-10 -104.33 127.44 51.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.722 0.772 . . . . 0.0 109.479 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.4 tp -90.78 4.65 51.06 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' 1511 ' ' LYS . 79.7 m-20 -67.42 -27.21 66.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.415 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 35.9 p -79.61 -18.29 51.93 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.801 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' 1598 ' ' PRO . 25.6 mt -109.63 4.26 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.08 -0.388 . . . . 0.0 111.657 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' 1508 ' ' ASN . 21.1 pttp -85.17 153.02 22.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' 1515 ' ' GLY . 55.1 ttt180 -120.88 129.49 53.53 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.32 -42.76 92.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 111.111 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.0 m -82.25 1.45 36.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.54 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.567 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 76.37 166.21 22.37 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.405 0.447 . . . . 0.0 113.981 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' 1527 ' ' ARG . 89.0 m-85 -98.68 123.78 43.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.1 m -103.93 97.75 7.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.87 125.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.134 0.492 . . . . 0.0 111.664 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1525 ' ' SER . 38.7 m -94.3 116.65 29.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' 1604 ' ' LEU . 2.0 m-20 -119.43 99.72 6.85 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 47.8 mt 63.26 -104.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.932 170.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.97 -12.52 12.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.59 -35.6 79.29 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.728 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 122.26 -161.94 16.24 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1519 ' ' SER . 9.0 m -96.21 123.1 39.71 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 7.7 tt -112.13 127.45 69.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.489 ' HG2' HG11 ' A' 1534 ' ' VAL . 40.1 ttm180 -104.83 118.57 36.89 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' 1528 ' ' LEU . 1.2 mp -118.3 122.46 42.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.513 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' 1532 ' ' GLY . . . -100.88 97.2 1.66 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.31 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' 1511 ' ' LYS . 60.3 t -66.27 115.2 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . 0.466 ' HB2' ' HD2' ' A' 1511 ' ' LYS . 68.0 m 59.65 15.15 4.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.858 0.863 . . . . 0.0 113.207 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' 1529 ' ' GLY . . . -141.16 112.73 0.79 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' 1535 ' ' LYS . 33.6 mt-10 -63.41 140.96 58.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.489 HG11 ' HG2' ' A' 1527 ' ' ARG . 16.0 m -85.41 89.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.265 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -62.33 -19.04 62.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.219 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.66 -23.08 64.51 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.708 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 32.0 t -121.74 4.7 10.02 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.599 0.714 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 102.41 152.08 24.1 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.979 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.09 153.19 75.51 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.492 2.128 . . . . 0.0 111.264 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.45 -10.07 70.83 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.331 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.433 HD12 ' HD3' ' A' 1551 ' ' LYS . 42.4 mm -98.37 129.8 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.5 -50.64 1.28 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.108 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.03 132.49 55.49 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 49.1 t -136.52 149.98 48.42 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.414 0.15 . . . . 0.0 110.889 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.467 ' HZ ' HD11 ' A' 1614 ' ' LEU . 67.1 m-85 -93.63 160.75 14.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.817 0.818 . . . . 0.0 112.867 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.77 -22.18 66.78 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.701 2.0 . . . . 0.0 113.073 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -119.65 130.18 8.35 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.035 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . 0.482 ' HB ' HG23 ' A' 1550 ' ' ILE . 23.9 m 73.77 -13.65 0.73 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 112.562 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.28 36.02 35.98 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.482 HG23 ' HB ' ' A' 1548 ' ' THR . 36.2 pt -81.51 143.03 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.623 ' HG2' ' OD1' ' A' 1574 ' ' ASP . 17.2 pttm -92.99 145.05 24.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.593 0.711 . . . . 0.0 111.434 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . 0.435 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.15 15.67 26.0 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.627 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.785 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 141.2 141.48 3.98 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.934 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 48.0 mtpt -78.78 159.9 27.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 72.7 t90 -67.22 141.26 57.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.774 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.39 172.37 18.46 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.2 24.25 5.95 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.448 1.099 . . . . 0.0 109.757 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.37 103.36 15.41 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.258 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.33 130.56 54.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.0 t -121.38 109.67 15.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.12 103.54 15.59 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 95.8 t -127.7 105.01 13.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.318 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.4 t70 58.19 60.93 2.47 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 111.223 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.99 24.51 9.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.207 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' 1590 ' ' PHE . 96.2 t -126.6 122.44 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.88 123.75 34.64 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' A' 1560 ' ' SER . 17.4 mm-40 -102.0 114.5 28.66 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.418 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.0 tp -116.64 102.71 9.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.53 HG22 HG23 ' A' 1587 ' ' VAL . 35.0 t -107.12 120.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.095 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.785 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 79.5 m-85 -86.21 108.94 18.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.7 154.44 21.64 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.219 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 13.0 t70 56.21 86.11 0.07 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.753 1.621 . . . . 0.0 113.852 173.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -107.32 -152.23 18.0 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.623 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 0.7 OUTLIER -83.23 146.57 51.46 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 116.962 0.381 . . . . 0.0 110.276 176.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 7.2 Cg_exo -73.52 143.92 35.22 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.234 2.623 . . . . 0.0 112.665 -175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.4 142.78 25.44 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.825 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.56 11.66 0.78 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.172 2.582 . . . . 0.0 114.091 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.45 -56.15 4.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.869 0.366 . . . . 0.0 110.543 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.778 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.4 m120 -133.91 7.91 3.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.806 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.0 mm? 70.48 -55.53 0.62 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.403 1.081 . . . . 0.0 113.096 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -74.88 -12.99 60.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.489 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 65.1 mt -82.45 131.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 95.3 mttt -131.39 162.09 30.93 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.733 0.645 . . . . 0.0 110.142 -174.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.431 ' O ' ' HA3' ' A' 1573 ' ' GLY . 97.0 m-85 -66.87 112.64 4.39 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 123.937 0.773 . . . . 0.0 109.531 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -129.32 147.04 51.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.0 p -129.85 121.67 27.17 Favored 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.364 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.53 HG23 HG22 ' A' 1569 ' ' VAL . 3.0 p -111.36 111.22 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.853 0.835 . . . . 0.0 109.364 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.95 106.06 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 43.8 m -87.48 110.0 20.0 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.763 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.796 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.7 m-85 -86.04 101.66 13.13 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.4 m -100.02 160.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.224 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 28.3 t -76.46 120.53 21.81 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.6 tptt -143.16 97.08 3.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -107.7 19.2 20.46 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.073 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -70.52 -38.82 74.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.157 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 91.51 -174.07 37.75 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.146 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . 0.417 ' O ' HD22 ' A' 1510 ' ' LEU . 70.8 Cg_endo -71.78 -15.23 30.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.36 2.707 . . . . 0.0 112.028 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.7 p -79.91 -48.83 12.81 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.634 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 40.0 m 68.47 161.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.815 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.506 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 19.5 mt-30 -107.0 119.77 50.17 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.448 -0.783 . . . . 0.0 110.571 -174.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 3.8 Cg_endo -89.96 116.25 0.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.429 2.752 . . . . 0.0 112.006 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 56.6 tp -115.47 120.01 38.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' 1520 ' ' ASP . 60.8 tp -70.9 113.24 7.76 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.9 tp -87.93 -63.49 1.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.571 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 67.2 m -147.34 138.38 23.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.922 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 62.5 t -122.78 112.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -97.87 124.66 42.37 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.552 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.21 -8.27 59.36 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -102.78 -51.5 3.28 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.214 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.735 ' HA ' HD13 ' A' 1582 ' ' LEU . 36.4 p -86.83 -14.69 41.4 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 73.4 m 61.85 23.19 13.59 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.082 0.953 . . . . 0.0 111.637 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -86.14 115.65 23.84 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.467 HD11 ' HZ ' ' A' 1545 ' ' PHE . 87.1 mt -91.52 126.71 36.69 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.958 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.05 116.37 31.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.23 137.58 53.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.6 m -110.25 103.68 12.39 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' A' 1600 ' ' SER . 11.3 t-105 -99.47 105.81 17.78 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 85.2 m-70 -81.02 100.65 9.08 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.4 t -122.71 153.66 39.14 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.647 0.736 . . . . 0.0 111.474 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.7 m -76.11 -26.37 56.33 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.365 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' 1622 ' ' LEU . 26.6 mt -71.43 -5.23 31.22 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -90.59 -23.95 20.69 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.553 0.692 . . . . 0.0 110.242 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 66.8 m -72.91 142.26 47.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.483 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 N--CA 1.428 -1.559 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.938 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.0 p30 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.407 0.146 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.432 ' HA ' ' HG ' ' A' 1559 ' ' LEU . 85.3 m -121.99 15.29 10.78 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.49 1.138 . . . . 0.0 108.818 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.6 pt20 -139.05 116.88 11.54 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.2 p -137.57 141.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' 1504 ' ' VAL . 6.7 t -121.12 167.76 12.3 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 24.5 p30 -131.96 150.99 77.68 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.92 16.12 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.311 2.007 . . . . 0.0 112.413 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -93.69 -56.79 2.77 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.39 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.7 p -103.08 -27.97 12.25 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.61 0.719 . . . . 0.0 110.198 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.68 27.38 57.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.857 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 61.4 t80 -98.4 132.68 43.66 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' 1497 ' ' THR . 43.1 t -96.54 110.1 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' 1495 ' ' GLN . 65.7 m-85 -76.56 102.84 6.25 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.88 107.38 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.836 0.35 . . . . 0.0 110.777 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 -4.48 59.17 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.199 1.0 . . . . 0.0 109.153 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.539 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 48.6 m-80 -71.07 -21.28 62.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.896 -177.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 58.8 p -80.98 -7.65 59.59 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.667 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.66 11.35 15.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 33.1 mtmm -59.55 176.24 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.153 0.501 . . . . 0.0 111.677 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.811 ' HD3' HG12 ' A' 1534 ' ' VAL . 18.3 ttp180 -66.97 93.46 0.28 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.201 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.93 -38.99 10.43 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 168.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 28.3 t -118.37 -40.23 2.95 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.194 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.62 175.56 32.48 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' 1527 ' ' ARG . 12.4 m-85 -113.79 141.95 46.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' 1526 ' ' ILE . 88.2 m -142.72 103.41 4.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.379 0.609 . . . . 0.0 110.845 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 22.7 pt -119.82 148.73 22.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 45.4 m -114.48 123.65 49.95 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.138 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.79 155.45 39.29 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.841 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.64 -24.7 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 124.087 0.955 . . . . 0.0 112.079 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . 0.86 HH22 HG11 ' A' 1607 ' ' VAL . 80.0 mtm180 -81.01 3.1 24.22 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.311 0.644 . . . . 0.0 111.262 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.78 62.15 0.33 Allowed 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.554 1.142 . . . . 0.0 111.038 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -121.42 91.48 0.47 Allowed Glycine 0 N--CA 1.409 -3.134 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.5 m -78.85 104.18 9.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.2 tt -98.18 125.98 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.515 0.674 . . . . 0.0 109.317 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' 1516 ' ' TYR . 44.1 ttt180 -108.35 125.27 51.52 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.34 140.39 50.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.121 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -122.66 126.41 6.35 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 106.568 -2.613 . . . . 0.0 106.568 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.1 m -89.51 118.74 35.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.126 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 55.8 m 69.86 10.9 7.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.823 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -136.43 130.47 5.27 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . 0.572 ' HG3' ' HE3' ' A' 1535 ' ' LYS . 12.7 pt-20 -74.91 129.3 37.43 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.265 0.555 . . . . 0.0 111.62 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.811 HG12 ' HD3' ' A' 1512 ' ' ARG . 17.7 m -92.58 99.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 122.005 0.907 . . . . 0.0 109.842 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.572 ' HE3' ' HG3' ' A' 1533 ' ' GLU . 9.8 mptt -67.15 -12.12 59.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.071 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.18 -43.64 74.53 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 125.683 1.593 . . . . 0.0 109.151 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 58.1 m -104.23 -7.19 20.26 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.95 163.5 9.54 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.533 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.86 139.16 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.112 1.875 . . . . 0.0 111.365 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 71.88 30.43 65.84 Favored Glycine 0 C--N 1.305 -1.193 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.388 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.21 129.04 75.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -104.6 -35.84 3.19 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.116 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -122.78 124.67 43.86 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 27.4 p -140.07 154.64 47.12 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.755 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' 1550 ' ' ILE . 91.1 m-85 -93.96 116.48 28.93 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.13 100.65 3.7 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.484 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -174.8 -94.92 0.1 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 94.0 m -95.78 -37.42 10.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 117.153 0.477 . . . . 0.0 110.706 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 143.44 31.21 0.1 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.581 -1.295 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.588 ' HB ' ' HB2' ' A' 1545 ' ' PHE . 64.9 mt -71.39 125.17 29.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.631 ' H ' ' HB2' ' A' 1574 ' ' ASP . 36.3 mttp -99.29 132.45 44.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.03 4.89 29.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.924 0.392 . . . . 0.0 111.285 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.962 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 156.94 140.19 2.89 Favored Glycine 0 C--O 1.254 1.403 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.027 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 60.4 mttp -79.21 155.51 28.57 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 67.5 t90 -64.57 124.91 23.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.17 140.53 7.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . 0.403 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 90.1 mt-30 -106.63 79.53 1.36 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -127.68 98.25 5.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.272 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' 1494 ' ' CYS . 34.6 mt -101.43 107.57 18.92 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.343 0.592 . . . . 0.0 109.89 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.07 113.72 26.06 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -90.71 101.35 14.1 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' 1565 ' ' VAL . 78.3 t -135.47 141.4 42.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 60.54 24.02 13.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.791 0.836 . . . . 0.0 110.397 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 65.92 16.62 10.54 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 124.166 0.986 . . . . 0.0 110.855 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' 1562 ' ' VAL . 7.3 p -121.49 155.29 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.826 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.6 mp -91.28 129.81 37.23 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -119.99 115.66 24.21 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.13 102.02 8.95 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1587 ' ' VAL . 7.6 p -106.95 112.51 40.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.563 0.697 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.962 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 30.6 m-85 -81.75 102.38 10.72 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' 1569 ' ' VAL . 49.5 mt-10 -102.3 161.64 13.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.111 0.482 . . . . 0.0 111.896 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 8.5 t70 63.15 66.02 0.75 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.102 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -91.16 -93.0 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.391 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.631 ' HB2' ' H ' ' A' 1551 ' ' LYS . 3.3 t70 -123.25 149.82 58.58 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.02 137.58 82.58 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.776 2.317 . . . . 0.0 112.855 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 24.8 t -101.79 128.93 27.65 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.251 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.67 16.92 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.559 2.84 . . . . 0.0 114.283 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.54 -41.12 16.8 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.39 10.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.167 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 1.7 tm? 69.84 -53.7 0.61 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.274 1.43 . . . . 0.0 111.761 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -65.92 -24.01 66.74 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.032 0.533 . . . . 0.0 110.752 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' 1611 ' ' THR . 85.4 mt -81.11 141.08 34.64 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' 1585 ' ' LYS . 62.1 mttp -132.08 158.0 42.72 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -59.66 121.36 11.44 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 124.122 0.889 . . . . 0.0 109.474 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' 1583 ' ' LYS . 43.9 mtmt -130.76 134.42 46.86 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.651 ' HB3' HD12 ' A' 1614 ' ' LEU . 13.6 p -123.53 116.77 23.72 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.426 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1569 ' ' VAL . 7.5 p -102.83 109.31 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.066 0.936 . . . . 0.0 110.649 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.4 mp -97.62 108.85 22.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 14.7 t -95.9 119.51 34.52 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.826 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 88.8 m-85 -89.83 106.35 18.41 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 169.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' 1620 ' ' THR . 38.7 t -104.77 141.23 36.86 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 117.484 -1.686 . . . . 0.0 115.325 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 53.8 tptt -151.45 100.57 2.74 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.952 170.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' 1621 ' ' SER . 41.0 p -66.09 -9.63 32.9 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . 0.522 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 8.0 m-20 -92.97 6.21 48.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.893 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -76.55 -74.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 109.45 -120.13 5.69 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.614 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.05 17.77 1.69 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.477 2.785 . . . . 0.0 110.708 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 t -153.76 -176.05 5.65 Favored 'General case' 1 N--CA 1.377 -4.121 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.726 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 41.4 m -155.48 155.7 33.95 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.566 0.746 . . . . 0.0 109.004 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.78 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 44.5 mt-30 -87.79 121.44 70.84 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.454 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.0 OUTLIER -88.95 128.78 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.391 2.727 . . . . 0.0 111.51 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' 1617 ' ' SER . 2.2 tm? -130.54 114.91 16.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.97 106.91 4.45 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 61.0 tp -75.02 -53.98 7.98 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.242 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.2 t -169.81 151.58 4.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.86 HG11 HH22 ' A' 1522 ' ' ARG . 65.0 t -125.91 131.78 71.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 19.2 t70 -110.74 117.17 32.72 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.8 -8.58 59.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -72.09 -40.46 68.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.761 0.315 . . . . 0.0 110.479 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.592 ' HA ' HD13 ' A' 1582 ' ' LEU . 23.4 p -121.66 -5.45 9.19 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 62.1 m 67.56 32.6 5.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.048 0.928 . . . . 0.0 111.152 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 44.1 m -92.04 126.61 37.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.959 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' 1586 ' ' SER . 59.0 mt -101.39 132.12 47.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.68 119.15 37.09 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.38 137.05 54.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.86 0.362 . . . . 0.0 111.621 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 27.3 m -104.11 105.42 15.57 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 12.6 t-105 -101.44 118.85 37.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.78 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 14.8 m-70 -94.79 97.57 10.14 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' 1592 ' ' CYS . 11.7 t -123.26 151.05 42.73 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.348 0.594 . . . . 0.0 111.608 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' 1594 ' ' SER . 1.0 OUTLIER -74.23 -23.81 59.22 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.778 0.799 . . . . 0.0 110.49 178.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.74 -4.91 34.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.519 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -93.29 -5.86 48.78 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.793 0.33 . . . . 0.0 111.445 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 20.5 m -91.64 137.61 32.22 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 169.824 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 23.1 p-10 . . . . . 0 C--O 1.244 0.796 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 6.1 t 59.03 33.3 22.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.003 1.321 . . . . 0.0 110.255 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -150.27 154.45 37.92 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.7 p -141.62 138.24 32.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.452 HG23 HG22 ' A' 1504 ' ' VAL . 23.7 m -104.08 113.59 27.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . 0.574 HD21 ' HB2' ' A' 1503 ' ' TYR . 6.0 p30 -81.89 130.86 59.01 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.34 -3.37 13.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.568 2.179 . . . . 0.0 112.649 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -75.44 -53.95 7.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.727 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' 1503 ' ' TYR . 17.2 p -109.21 -14.11 14.54 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.5 26.54 59.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.599 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . 0.574 ' HB2' HD21 ' A' 1498 ' ' ASN . 13.8 m-85 -99.22 120.4 39.46 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.22 -0.49 . . . . 0.0 109.977 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.452 HG22 HG23 ' A' 1497 ' ' THR . 25.4 t -89.39 113.35 25.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -100.23 111.18 23.44 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . 0.76 ' HB2' HD22 ' A' 1508 ' ' ASN . 3.0 p30 -104.01 130.87 51.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.059 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.79 0.18 56.12 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.082 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . 0.76 HD22 ' HB2' ' A' 1506 ' ' ASP . 41.4 m-80 -63.0 -38.5 91.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.49 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.9 t -71.08 -3.97 22.64 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.315 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.635 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.9 OUTLIER -114.16 -41.78 3.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' 1508 ' ' ASN . 22.0 pttp -65.57 144.21 57.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' 1515 ' ' GLY . 40.5 ttm180 -88.58 161.92 16.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -50.11 -54.98 16.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.346 1.058 . . . . 0.0 111.342 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 3.0 p -87.6 -2.62 58.74 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 123.675 0.79 . . . . 0.0 111.872 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' 1529 ' ' GLY . . . 86.74 -139.74 16.65 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -176.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 95.7 m-85 -124.63 121.65 35.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 117.467 0.633 . . . . 0.0 111.124 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 32.9 m -110.5 94.83 5.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.25 155.3 11.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.355 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 22.4 m -79.9 131.21 35.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.447 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.31 147.8 27.74 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.852 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.77 -25.97 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.901 0.88 . . . . 0.0 112.727 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -83.87 3.26 34.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.987 0.422 . . . . 0.0 110.165 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.28 84.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.772 1.629 . . . . 0.0 111.358 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' 1545 ' ' PHE . . . -175.22 156.36 22.19 Favored Glycine 0 N--CA 1.404 -3.465 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 4.2 m -114.13 101.68 9.44 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.6 tt -83.41 119.71 33.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.196 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 43.3 ttm180 -109.78 112.74 24.97 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.974 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.36 118.78 30.33 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.583 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' 1515 ' ' GLY . . . -90.03 106.79 3.37 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 89.2 t -59.73 116.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 36.1 m 63.21 12.6 6.24 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.071 0.857 . . . . 0.0 111.609 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -129.27 172.4 19.79 Favored Glycine 0 N--CA 1.42 -2.395 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.063 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.97 141.74 40.64 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.413 HG11 ' HG2' ' A' 1527 ' ' ARG . 26.6 m -103.9 90.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.252 1.025 . . . . 0.0 109.605 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -65.1 -16.61 63.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.82 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -64.83 -22.21 66.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.92 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 21.6 t -111.87 -13.67 13.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.429 0.633 . . . . 0.0 110.043 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.67 155.27 6.46 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.217 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.08 141.12 35.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.467 2.111 . . . . 0.0 111.071 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.85 8.87 87.23 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.331 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' 1551 ' ' LYS . 46.5 mm -106.56 135.05 46.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.23 -37.29 2.51 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.007 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -124.03 123.99 41.57 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 122.707 -0.29 . . . . 0.0 110.325 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 45.0 t -136.69 153.43 50.89 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.296 0.569 . . . . 0.0 110.821 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' 1524 ' ' GLY . 58.9 t80 -90.15 100.29 13.15 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.494 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . 0.725 ' HG3' HG23 ' A' 1548 ' ' THR . 11.8 pt-20 47.71 21.24 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.784 2.034 . . . . 0.0 115.221 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 63.55 27.47 70.97 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.516 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . 0.725 HG23 ' HG3' ' A' 1546 ' ' GLU . 32.9 p -83.24 -15.95 48.33 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 118.689 1.244 . . . . 0.0 109.985 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 122.6 -14.91 8.6 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.718 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 50.7 mt -79.48 118.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' 1541 ' ' ILE . 8.6 mtmp? -97.79 137.48 36.6 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.499 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -111.48 11.63 21.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.369 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.859 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 155.53 130.55 1.33 Allowed Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.432 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.4 tttp -81.71 155.26 25.62 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 61.6 t90 -73.21 128.53 35.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.315 0.578 . . . . 0.0 110.08 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.47 139.5 14.31 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -86.89 78.16 9.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.287 0.565 . . . . 0.0 110.46 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 54.0 tptt -114.82 96.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.805 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 86.2 mt -109.84 103.34 12.12 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.568 -1.196 . . . . 0.0 107.997 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.877 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 29.2 t -101.77 141.47 34.58 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 20.3 t80 -121.59 101.16 7.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' 1565 ' ' VAL . 98.5 t -134.88 127.29 48.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.281 -176.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.37 33.83 22.57 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.441 1.115 . . . . 0.0 110.0 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 70.94 -0.03 3.2 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.351 1.06 . . . . 0.0 113.236 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' 1562 ' ' VAL . 9.5 p -98.98 134.18 38.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.752 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.2 tp -84.97 132.26 34.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.877 ' HB2' ' HB3' ' A' 1560 ' ' SER . 94.0 mt-30 -122.07 114.99 21.68 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.739 -0.601 . . . . 0.0 112.121 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 48.4 tp -102.86 112.65 25.55 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.471 HG12 ' HG2' ' A' 1571 ' ' GLU . 44.4 t -105.83 112.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.592 -172.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.859 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 77.4 m-85 -95.19 115.2 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.471 ' HG2' HG12 ' A' 1569 ' ' VAL . 8.9 mm-40 -111.56 165.54 11.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 33.5 t70 60.72 80.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.474 1.109 . . . . 0.0 111.871 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.46 -127.56 6.14 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 1.0 OUTLIER -113.5 147.25 37.11 Favored Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 122.604 -0.35 . . . . 0.0 111.033 175.379 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 23.5 Cg_exo -66.52 134.31 35.19 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.404 2.736 . . . . 0.0 112.832 -176.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 85.6 m -98.8 149.06 35.38 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.276 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.42 3.99 4.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.849 2.366 . . . . 0.0 115.869 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.29 -67.18 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.915 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.523 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 6.8 m-20 -110.26 2.19 19.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.246 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? 71.69 -57.62 0.61 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.337 1.055 . . . . 0.0 113.707 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -76.23 -10.44 59.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 111.168 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.669 HD13 ' HA ' ' A' 1611 ' ' THR . 70.8 mt -83.17 124.58 30.66 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 88.0 mttt -119.31 162.75 18.22 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.835 0.709 . . . . 0.0 110.043 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -58.97 109.34 0.81 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 124.01 0.819 . . . . 0.0 109.705 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -112.2 131.77 55.29 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.5 t -121.77 118.72 29.74 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.701 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -115.33 107.49 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.969 0.89 . . . . 0.0 109.844 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.96 107.32 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' 1617 ' ' SER . 25.0 m -91.52 116.3 28.75 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 92.4 m-85 -86.12 105.53 16.6 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' 1617 ' ' SER . 65.3 t -93.95 152.05 3.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.009 -175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.5 t -75.26 134.52 41.09 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.107 0.955 . . . . 0.0 112.822 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 54.3 tptt -149.68 101.34 3.06 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 171.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 71.1 m -63.21 -37.76 88.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.494 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -97.77 71.69 2.24 Favored 'General case' 0 N--CA 1.423 -1.813 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.937 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -133.3 -57.76 0.9 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.756 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.69 -147.67 38.91 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.94 -21.9 36.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.217 1.944 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.7 p -91.06 67.21 5.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 122.312 1.053 . . . . 0.0 109.356 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.535 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 15.1 m -76.85 161.77 28.16 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.685 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 16.9 mm-40 -105.43 121.11 47.29 Favored Pre-proline 0 C--N 1.301 -1.5 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.096 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.7 Cg_exo -77.31 152.76 30.87 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.678 2.252 . . . . 0.0 110.104 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' 1617 ' ' SER . 66.3 tp -154.88 120.3 5.03 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.102 -0.374 . . . . 0.0 110.979 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.61 113.47 16.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 42.8 tp -88.93 -43.51 11.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 40.1 t -167.62 150.65 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 84.9 t -130.6 111.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' 1612 ' ' CYS . 31.7 t70 -93.65 122.74 36.42 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.521 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -80.14 -11.78 59.72 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.38 -52.5 5.16 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.166 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.669 ' HA ' HD13 ' A' 1582 ' ' LEU . 47.2 p -98.03 -17.03 19.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.974 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' 1608 ' ' ASP . 75.6 m 69.95 25.18 4.94 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 124.108 0.88 . . . . 0.0 111.586 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . . . . . . . . . 21.6 m -80.38 118.1 21.71 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.98 126.88 41.52 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.16 118.03 35.67 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.37 139.23 53.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' 1589 ' ' SER . 21.7 m -121.65 103.72 9.1 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.666 0.746 . . . . 0.0 109.382 175.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -92.89 107.53 19.29 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -175.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.6 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 43.5 m80 -78.0 97.42 5.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.8 t -131.09 154.02 48.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.528 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.5 m -76.15 -25.09 54.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.89 -5.03 31.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.471 0.653 . . . . 0.0 111.835 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.7 -3.05 30.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.066 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.1 m -96.04 144.71 26.07 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 168.142 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 38.6 t-20 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1494 ' ' CYS . . . . . 0.406 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 79.4 m -77.44 1.24 19.75 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.009 0.923 . . . . 0.0 111.816 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1495 ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.6 pt20 -117.15 118.25 31.82 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -118.96 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.831 0.824 . . . . 0.0 110.784 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1497 ' ' THR . . . . . 0.477 HG23 HG22 ' A' 1504 ' ' VAL . 24.8 m -96.49 125.9 41.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.243 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.93 133.52 30.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.73 4.53 6.84 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.21 1.94 . . . . 0.0 112.468 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -78.67 -68.38 0.65 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1501 ' ' THR . . . . . . . . . . . . . 19.7 p -101.26 -19.75 15.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.043 0.449 . . . . 0.0 111.826 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 100.29 2.24 55.72 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.539 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1503 ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' 1625 ' ' GLU . 56.3 m-85 -72.45 141.25 48.61 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.068 0.461 . . . . 0.0 111.605 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1504 ' ' VAL . . . . . 0.477 HG22 HG23 ' A' 1497 ' ' THR . 48.2 t -108.84 118.94 57.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1505 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1495 ' ' GLN . 58.7 m-85 -95.39 101.56 13.29 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.25 112.32 24.51 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.066 0.46 . . . . 0.0 110.084 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 27.7 tp -84.86 -2.02 57.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.485 0.66 . . . . 0.0 111.143 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -79.6 -21.96 44.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.6 0.714 . . . . 0.0 109.781 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1509 ' ' SER . . . . . . . . . . . . . 28.4 t -78.24 -10.13 59.52 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1510 ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' 1598 ' ' PRO . 0.5 OUTLIER -106.34 -45.66 4.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1511 ' ' LYS . . . . . 0.577 ' HB2' ' HB ' ' A' 1530 ' ' VAL . 21.3 pttp -49.5 146.53 3.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 114.326 -173.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1512 ' ' ARG . . . . . 0.511 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 0.0 OUTLIER -103.72 127.31 51.2 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -64.04 -43.19 96.31 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.668 0.605 . . . . 0.0 112.391 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1514 ' ' SER . . . . . . . . . . . . . 47.6 m -86.25 6.27 30.44 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.037 0.446 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1515 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 80.33 161.14 23.9 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 113.152 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 81.0 m-85 -100.22 118.17 35.98 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1517 ' ' THR . . . . . . . . . . . . . 94.0 m -93.97 100.64 12.75 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.88 142.02 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1519 ' ' SER . . . . . . . . . . . . . 42.5 t -102.74 136.43 42.58 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1520 ' ' ASP . . . . . 0.54 ' HB2' HD22 ' A' 1604 ' ' LEU . 0.1 OUTLIER -84.49 175.14 9.5 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.82 -21.02 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 121.212 0.529 . . . . 0.0 111.293 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -91.9 3.05 56.05 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.15 0.58 . . . . 0.0 111.489 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1523 ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 17.2 mmtm 80.96 19.09 0.47 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -80.38 105.02 2.32 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1525 ' ' SER . . . . . . . . . . . . . 19.2 m -84.2 98.08 9.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.0 tt -103.78 133.86 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.125 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 29.4 ttt180 -108.9 112.74 25.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.99 122.99 47.94 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1529 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -98.15 127.0 9.09 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 174.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1530 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1511 ' ' LYS . 58.9 t -87.85 116.94 30.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 83.7 m 69.68 0.63 3.06 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -134.34 140.76 12.04 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.0 137.75 41.74 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.008 0.432 . . . . 0.0 110.508 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1534 ' ' VAL . . . . . 0.406 HG21 ' SG ' ' A' 1544 ' ' CYS . 9.5 m -79.26 87.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.034 0.921 . . . . 0.0 109.973 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1535 ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.14 -18.56 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.379 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.91 -20.65 62.47 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 110.969 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.1 m -117.52 -20.49 9.01 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.304 -0.248 . . . . 0.0 111.561 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1538 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 146.94 154.11 6.1 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.31 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1539 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 24.2 Cg_exo -69.6 142.24 48.1 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 123.288 2.659 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.51 10.26 79.14 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.331 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.04 134.17 49.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1542 ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -101.25 -41.3 2.61 Favored Glycine 0 C--O 1.221 -0.661 0 C-N-CA 119.97 -1.11 . . . . 0.0 112.096 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -126.26 134.97 51.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1544 ' ' CYS . . . . . 0.406 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.4 p -145.11 151.99 39.36 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 121.221 -0.192 . . . . 0.0 110.682 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1545 ' ' PHE . . . . . 0.435 ' HB2' HG13 ' A' 1550 ' ' ILE . 85.4 m-85 -92.26 120.1 32.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.77 109.73 10.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.612 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 165.09 -73.21 0.17 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1548 ' ' THR . . . . . . . . . . . . . 16.8 p -97.3 -18.09 19.38 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.526 0.679 . . . . 0.0 110.194 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 89.63 19.06 50.06 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1550 ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' 1545 ' ' PHE . 23.5 pt -66.43 135.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.712 0.768 . . . . 0.0 111.192 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1551 ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' 1574 ' ' ASP . 29.2 mttp -79.42 137.54 37.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.735 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1552 ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' 1584 ' ' TYR . . . -120.3 19.52 12.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.925 0.869 . . . . 0.0 108.763 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1553 ' ' GLY . . . . . 0.882 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 151.81 124.38 1.11 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.894 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1554 ' ' LYS . . . . . 0.47 ' HB2' ' HE3' ' A' 1554 ' ' LYS . 33.2 ttmt -83.83 144.59 29.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 90.0 t90 -59.92 131.74 51.81 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 123.73 0.644 . . . . 0.0 110.353 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -164.29 145.35 8.33 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -112.2 85.8 2.22 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -126.75 104.84 8.29 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.736 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1559 ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 3.5 mm? -100.57 118.06 35.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.188 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1560 ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 32.1 t -110.84 147.86 33.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 28.6 t80 -130.0 128.66 42.48 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.661 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1562 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 73.2 t -113.33 156.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1563 ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' 1564 ' ' GLN . 19.5 t70 -48.11 113.21 0.69 Allowed 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 118.056 0.389 . . . . 0.0 110.653 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1564 ' ' GLN . . . . . 0.608 ' HB2' ' SG ' ' A' 1624 ' ' CYS . 7.4 pt20 56.2 21.28 5.12 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.857 2.063 . . . . 0.0 113.466 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1565 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 58.9 t -137.11 118.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1566 ' ' LEU . . . . . 0.778 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.0 tp -89.26 131.84 35.17 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1567 ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' 1560 ' ' SER . 79.9 mm-40 -115.64 114.87 25.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -123.78 111.39 16.07 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1569 ' ' VAL . . . . . 0.712 HG22 HG23 ' A' 1587 ' ' VAL . 32.3 t -112.15 123.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.621 0.724 . . . . 0.0 111.285 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1570 ' ' TYR . . . . . 0.882 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 33.9 m-85 -98.96 100.82 12.04 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.245 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1571 ' ' GLU . . . . . 0.557 ' HG2' ' HD3' ' A' 1585 ' ' LYS . 34.6 mt-10 -99.91 179.34 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.048 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.61 68.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.759 1.624 . . . . 0.0 112.766 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.97 -131.5 7.32 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.291 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1574 ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' 1551 ' ' LYS . 0.2 OUTLIER -89.83 140.38 27.82 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1575 ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 25.2 Cg_exo -66.27 142.26 65.91 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.663 2.242 . . . . 0.0 112.051 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1576 ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 81.5 m -98.15 138.42 20.91 Favored Pre-proline 0 C--N 1.285 -2.224 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1577 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.2 Cg_exo -58.47 -22.74 60.63 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.619 2.879 . . . . 0.0 114.529 -172.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.29 46.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1579 ' ' ASN . . . . . 0.624 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.7 m120 -124.17 -8.24 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1580 ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' 1575 ' ' PRO . 3.7 mm? 68.17 -51.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.635 1.174 . . . . 0.0 113.376 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.1 m80 -73.42 -13.5 61.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.635 0.255 . . . . 0.0 111.578 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1582 ' ' LEU . . . . . 0.624 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 33.1 mt -90.28 132.56 35.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1583 ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.1 mttt -132.96 162.16 32.39 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1584 ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 82.8 m-85 -62.86 117.46 6.39 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1585 ' ' LYS . . . . . 0.557 ' HD3' ' HG2' ' A' 1571 ' ' GLU . 96.1 mttt -130.34 143.28 50.67 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1586 ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 19.7 m -119.77 116.96 26.97 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1587 ' ' VAL . . . . . 0.712 HG23 HG22 ' A' 1569 ' ' VAL . 3.6 p -106.87 110.02 30.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.49 111.06 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.9 t -95.93 109.26 21.65 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1590 ' ' PHE . . . . . 0.778 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 88.0 m-85 -87.29 115.02 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.9 m -107.58 152.79 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1592 ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' 1620 ' ' THR . 6.3 m -76.39 124.64 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.206 0.527 . . . . 0.0 111.53 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1593 ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 21.8 tptp -139.32 112.37 8.03 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.0 t -70.64 -22.3 62.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.505 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 110.95 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1596 ' ' ALA . . . . . 0.749 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -90.35 -77.28 0.41 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 74.13 -143.68 32.33 Favored Glycine 0 C--O 1.248 1.011 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1598 ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' 1510 ' ' LEU . 40.2 Cg_endo -67.28 -21.72 47.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.344 2.03 . . . . 0.0 110.802 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1599 ' ' THR . . . . . . . . . . . . . 4.1 p -94.37 70.68 3.73 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.343 1.068 . . . . 0.0 109.352 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1600 ' ' SER . . . . . 0.749 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 30.5 m -75.73 167.83 21.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.931 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1601 ' ' GLN . . . . . 0.854 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 23.1 mt-30 -107.5 121.39 44.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.419 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1602 ' ' PRO . . . . . 0.446 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.3 Cg_endo -88.97 128.77 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.063 2.509 . . . . 0.0 110.658 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 44.8 tp -141.75 136.82 31.13 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.905 -0.497 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1604 ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' 1520 ' ' ASP . 67.7 tp -79.63 124.84 28.91 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.49 -39.7 9.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.3 t -177.0 161.41 1.92 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1607 ' ' VAL . . . . . 0.518 HG23 HD23 ' A' 1614 ' ' LEU . 7.5 p -141.78 138.92 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.0 119.87 36.09 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.04 -5.81 58.06 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 57.2 m80 -83.62 -51.2 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.599 0.714 . . . . 0.0 109.08 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1611 ' ' THR . . . . . 0.607 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -100.64 -9.3 22.05 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.917 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 1612 ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 74.6 m 63.99 37.53 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.294 1.038 . . . . 0.0 110.534 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1613 ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' 1611 ' ' THR . 6.1 m -87.53 113.97 23.71 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.414 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1614 ' ' LEU . . . . . 0.594 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 60.0 mt -93.38 115.72 28.27 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -100.74 112.47 24.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1616 ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 54.7 m-85 -120.79 131.28 54.38 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.764 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1617 ' ' SER . . . . . . . . . . . . . 12.8 p -102.82 104.41 14.68 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.886 0.85 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1618 ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 17.2 t-105 -92.63 114.93 27.62 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1619 ' ' HIS . . . . . 0.854 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.7 m-70 -88.45 102.06 14.53 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1620 ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.5 t -135.92 153.66 51.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.056 0.455 . . . . 0.0 110.739 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.5 m -74.15 -26.09 60.11 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.13 -5.65 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.045 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -77.1 -34.39 56.84 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.606 0.717 . . . . 0.0 109.527 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1624 ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' 1564 ' ' GLN . 1.8 m -98.58 171.81 7.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.54 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1625 ' ' GLU . . . . . 0.43 ' HB3' ' CD2' ' A' 1503 ' ' TYR . 40.9 mt-10 . . . . . 0 N--CA 1.426 -1.674 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 64.9 mtm . . . . . 0 CA--C 1.495 -1.135 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 35.8 m -92.29 124.62 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -67.17 120.59 14.01 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.419 ' HA ' ' HH2' ' A' 1555 ' ' TRP . 5.0 p-10 -126.69 79.74 1.89 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.528 1.156 . . . . 0.0 108.648 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.8 p30 -93.6 -34.73 13.2 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.132 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 62.3 m 57.89 28.85 16.68 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 124.331 1.02 . . . . 0.0 112.228 173.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' 1505 ' ' PHE . 9.5 pt20 -142.2 141.5 32.56 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.12 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 8.9 p -140.81 138.45 34.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 26.0 m -97.67 127.16 43.42 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.428 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.3 p30 -89.25 143.13 30.51 Favored Pre-proline 0 C--N 1.312 -1.022 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.454 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.05 -13.67 19.2 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 122.885 2.39 . . . . 0.0 113.752 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -74.34 -58.87 3.01 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 22.0 p -109.27 -10.9 14.93 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 75.06 33.38 54.81 Favored Glycine 0 C--O 1.226 -0.391 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.728 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -103.07 143.29 32.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 46.1 t -102.4 127.35 56.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' 1495 ' ' GLN . 93.7 m-85 -93.99 103.61 15.68 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.98 103.15 15.02 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 34.4 tp -85.94 10.06 15.13 Favored 'General case' 0 C--O 1.255 1.381 0 CA-C-O 121.847 0.832 . . . . 0.0 110.045 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.69 -19.45 52.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.09 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 20.8 p -71.16 -14.43 62.27 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 121.328 0.585 . . . . 0.0 111.469 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.66 -69.6 0.76 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.832 175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 58.9 mmtt 61.55 146.44 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' 1512 ' ' ARG . 4.2 tmm_? -71.84 96.9 1.72 Allowed 'General case' 0 N--CA 1.421 -1.895 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 164.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.69 -42.73 11.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 16.8 p -121.62 -31.54 3.98 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.924 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.26 133.17 7.87 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -77.77 125.21 29.0 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' 1526 ' ' ILE . 13.3 t -129.77 100.93 5.67 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 122.86 1.314 . . . . 0.0 110.697 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . 0.503 HG21 ' HG2' ' A' 1602 ' ' PRO . 16.4 pt -93.82 155.82 3.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.053 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 32.7 t -98.15 130.73 44.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 -175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 16.7 t70 -99.73 126.53 45.8 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.25 -24.91 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.577 -172.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' 1522 ' ' ARG . 28.7 mtp-105 -85.61 -43.01 13.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -177.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . 0.481 ' HB2' ' HZ ' ' A' 1545 ' ' PHE . 31.9 mmmt -113.97 -73.93 0.64 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -169.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 179.49 -152.88 11.44 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 3.9 m -84.03 154.49 23.22 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.2 0.524 . . . . 0.0 111.259 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.0 tt -130.6 118.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 170.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -103.26 115.52 30.72 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.6 mp -110.14 132.27 54.32 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-O 121.173 0.511 . . . . 0.0 110.733 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -99.28 87.41 0.76 Allowed Glycine 0 N--CA 1.422 -2.285 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.895 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 34.7 m -72.56 128.41 35.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 C-N-CA 120.636 -0.426 . . . . 0.0 109.882 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 47.6 t 66.27 15.6 10.15 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 121.513 0.673 . . . . 0.0 111.389 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . 178.44 113.96 0.39 Allowed Glycine 0 N--CA 1.423 -2.178 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.71 160.32 11.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 21.3 m -96.99 122.07 48.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.62 0.724 . . . . 0.0 110.281 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -74.76 -24.67 58.73 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 26.4 t70 -53.14 -38.54 62.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.852 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 67.1 m -110.01 13.47 23.33 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.105 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 107.92 120.86 4.54 Favored Glycine 0 N--CA 1.437 -1.25 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -54.51 134.02 59.57 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 123.144 2.562 . . . . 0.0 111.443 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 106.68 -29.36 11.0 Favored Glycine 0 C--N 1.286 -2.214 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.053 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 48.4 mm -81.16 125.88 39.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.612 ' HA3' ' HE2' ' A' 1570 ' ' TYR . . . -99.69 -46.24 1.98 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.78 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -103.11 118.45 36.82 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 48.8 t -124.8 136.88 54.22 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 35.5 t80 -114.45 138.62 50.36 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -75.85 86.86 2.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.224 1.011 . . . . 0.0 110.868 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . 0.424 ' O ' HG13 ' A' 1550 ' ' ILE . . . -165.67 69.34 0.19 Allowed Glycine 0 C--N 1.289 -2.068 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.328 174.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.0 m 74.95 -34.77 0.27 Allowed 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.317 1.047 . . . . 0.0 111.595 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 146.09 50.32 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.622 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 79.3 mt -78.86 122.21 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -96.92 115.16 26.94 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.28 12.73 36.95 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.974 -172.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.827 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.9 133.83 2.12 Favored Glycine 0 N--CA 1.416 -2.64 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.641 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 86.4 tttt -81.83 141.55 33.34 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.433 ' HB2' ' HA3' ' A' 1542 ' ' GLY . 54.5 t90 -78.32 124.74 28.44 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.21 148.43 33.52 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . 0.255 24.0 mt-30 -77.91 73.54 4.48 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -99.34 77.43 2.12 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 95.5 mt -104.93 97.78 7.6 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 7.8 t -117.46 139.1 51.35 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.782 -174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 86.1 t80 -106.42 109.19 21.04 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.384 0.611 . . . . 0.0 110.045 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 81.4 t -96.23 158.36 3.1 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 173.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 12.7 t70 -49.63 101.9 0.03 OUTLIER 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.171 0.989 . . . . 0.0 111.514 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 67.73 16.58 9.77 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.611 1.564 . . . . 0.0 113.549 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 20.2 t -139.94 119.79 13.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 121.987 -0.445 . . . . 0.0 110.317 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.8 tp -81.91 129.01 34.63 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -112.95 125.35 54.3 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 122.268 -0.27 . . . . 0.0 111.337 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . 0.588 ' HB3' ' HE1' ' A' 1590 ' ' PHE . 66.2 tp -129.68 114.39 15.95 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 173.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 10.4 p -117.99 129.45 74.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.861 0.838 . . . . 0.0 111.334 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.827 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 81.6 m-85 -95.04 115.17 27.08 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -113.64 177.29 4.69 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 5.3 m-20 56.67 64.04 1.78 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.72 -145.12 18.11 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -90.57 146.63 34.68 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.69 141.83 38.52 Favored 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.003 2.468 . . . . 0.0 110.976 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 75.7 m -99.68 142.21 24.2 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 16.9 Cg_exo -61.91 -22.26 73.95 Favored 'Trans proline' 0 N--CA 1.482 0.794 0 C-N-CA 123.652 2.901 . . . . 0.0 113.911 -178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -58.21 -65.14 0.7 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.204 0.602 . . . . 0.0 112.399 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.463 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 5.4 m-20 -120.25 -2.53 10.11 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.877 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.9 mm? 69.45 -53.02 0.6 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.208 1.003 . . . . 0.0 113.419 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -62.71 -28.32 69.87 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.164 0.586 . . . . 0.0 109.836 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' 1611 ' ' THR . 64.5 mt -82.32 128.72 34.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.109 -0.95 . . . . 0.0 108.859 -178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 58.7 mttp -118.09 162.49 18.12 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 98.3 m-85 -63.62 116.73 5.94 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 173.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -126.98 140.97 51.92 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 25.0 m -120.3 116.81 26.29 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -115.16 114.68 47.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.609 0.718 . . . . 0.0 109.797 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.36 115.48 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 7.7 t -96.67 106.58 18.88 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 94.3 m-85 -86.56 111.58 20.74 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.761 -177.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.7 m -108.66 144.96 16.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.629 ' HA ' ' O ' ' A' 1620 ' ' THR . 3.1 p -76.66 143.44 40.11 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -172.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' 1593 ' ' LYS . 49.4 tptt -157.66 114.01 2.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 24.4 m -71.82 -21.7 61.66 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -170.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -86.02 7.82 23.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.511 0.672 . . . . 0.0 110.508 -177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.668 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -81.94 -67.59 0.77 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 61.47 -129.68 45.42 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.84 -16.78 54.3 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.593 2.196 . . . . 0.0 112.464 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.1 t -120.74 83.53 2.08 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 122.847 1.308 . . . . 0.0 110.59 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.668 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 18.1 m -77.86 143.02 38.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.402 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.476 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 13.9 pt20 -104.8 126.11 32.06 Favored Pre-proline 0 C--N 1.312 -1.022 0 CA-C-O 120.984 0.421 . . . . 0.0 111.878 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' 1518 ' ' ILE . 5.1 Cg_exo -82.83 160.01 16.15 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.327 2.685 . . . . 0.0 111.688 177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.6 tp -148.78 130.13 14.71 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.61 HD11 HG23 ' A' 1607 ' ' VAL . 43.9 tp -86.36 115.97 24.22 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.2 -52.4 5.95 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.818 0.342 . . . . 0.0 110.372 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.8 t -167.25 138.85 3.2 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.61 HG23 HD11 ' A' 1604 ' ' LEU . 69.5 t -110.58 115.54 50.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.9 t70 -94.03 117.89 30.74 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.334 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -80.56 -6.21 57.9 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -95.93 -51.48 4.44 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.163 0.983 . . . . 0.0 108.935 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.844 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -95.04 -6.99 40.9 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 113.208 -1.815 . . . . 0.0 110.443 -171.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 80.1 m 57.25 26.4 12.24 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.251 1.02 . . . . 0.0 112.052 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.8 m -93.37 119.58 32.66 Favored 'General case' 0 N--CA 1.405 -2.703 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.597 ' HB3' ' HE2' ' A' 1616 ' ' PHE . 85.5 mt -93.82 114.11 26.29 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.957 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -98.77 108.95 21.76 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -121.06 138.52 54.14 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.82 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 39.1 t -102.97 138.15 40.23 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.423 ' HE1' ' HB2' ' A' 1600 ' ' SER . 8.0 t-105 -126.42 114.43 18.17 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 55.2 m80 -88.05 100.95 13.32 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.1 t -135.28 153.01 52.03 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.269 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 10.2 m -77.98 -26.48 48.68 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 48.3 mt -72.1 -5.16 33.34 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.146 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.2 59.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.168 0.509 . . . . 0.0 111.793 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 91.0 m -123.28 162.55 22.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' 1505 ' ' PHE . 2.8 mp0 -70.02 102.82 2.11 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.229 0.538 . . . . 0.0 109.921 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -81.86 145.12 30.55 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -82.07 -11.17 58.93 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.43 0.633 . . . . 0.0 110.784 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 C--N 1.31 -1.112 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 177.64 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 92.3 t -89.56 97.38 6.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 120.991 0.424 . . . . 0.0 110.586 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 52.6 tt0 55.22 81.13 0.12 Allowed 'General case' 0 C--O 1.241 0.606 0 C-N-CA 125.043 1.337 . . . . 0.0 110.934 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -118.72 92.67 3.87 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 122.579 1.181 . . . . 0.0 111.821 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . 0.634 ' HB2' ' HB2' ' A' 1557 ' ' GLN . 10.1 p30 -125.57 127.99 47.24 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.915 174.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 84.2 m 63.59 21.53 12.77 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.471 1.129 . . . . 0.0 110.393 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.3 pt20 -152.35 141.2 21.06 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.4 p -136.52 134.96 49.36 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 8.8 m -106.93 121.89 45.33 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.3 p30 -95.43 125.25 50.49 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 107.41 -1.329 . . . . 0.0 107.41 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.16 -6.46 18.35 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.408 2.072 . . . . 0.0 113.143 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.26 -65.49 0.69 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.259 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 62.0 p -92.99 -24.88 18.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.859 0.837 . . . . 0.0 110.028 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 88.58 9.31 69.22 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 60.5 t80 -80.81 127.86 33.01 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.309 0.576 . . . . 0.0 109.456 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.7 p -98.96 116.0 40.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.4 m-85 -79.28 98.92 6.85 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -95.09 104.51 16.38 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.332 0.586 . . . . 0.0 110.739 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 37.9 tp -80.84 -9.37 59.83 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.541 0.686 . . . . 0.0 109.913 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.432 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 45.8 m-80 -70.25 -12.3 61.5 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.678 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 57.9 m -84.74 -16.14 42.66 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 32.2 tp -114.1 -20.5 10.94 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.755 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.574 ' CB ' ' HB ' ' A' 1530 ' ' VAL . 56.4 pttt -54.69 140.83 34.34 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.716 0.635 . . . . 0.0 112.076 -176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -127.44 102.64 6.97 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . 0.443 ' HG3' ' HA3' ' A' 1532 ' ' GLY . 31.9 tt0 -76.21 -20.47 57.43 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 24.6 m -61.32 -25.11 66.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.084 172.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 96.06 136.39 8.78 Favored Glycine 0 N--CA 1.416 -2.686 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.75 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' 1527 ' ' ARG . 74.3 m-85 -83.5 118.21 23.62 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 172.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 26.6 m -110.6 104.01 12.66 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.8 pt -115.68 150.17 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.21 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.9 m -79.17 115.29 18.74 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.529 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.86 144.64 56.9 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.855 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.3 tt -74.03 -18.46 17.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 C-N-CA 124.642 1.177 . . . . 0.0 110.94 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' 1522 ' ' ARG . 3.7 mmp_? -90.25 2.82 55.03 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.848 -0.533 . . . . 0.0 109.583 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.5 tptp 79.14 90.19 0.06 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.939 1.696 . . . . 0.0 110.098 -175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . 0.41 ' HA3' ' HZ ' ' A' 1545 ' ' PHE . . . -176.77 -161.02 24.85 Favored Glycine 0 N--CA 1.412 -2.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.2 t -144.6 139.74 28.3 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 15.0 tt -132.62 139.02 50.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' 1516 ' ' TYR . 33.4 ttt180 -127.91 120.33 27.45 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.7 mp -123.3 136.08 54.52 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.921 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.7 158.97 14.08 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' 1511 ' ' LYS . 59.9 t -106.48 115.81 48.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 118.237 1.018 . . . . 0.0 108.31 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 77.9 m 57.58 26.83 13.28 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.951 0.782 . . . . 0.0 112.445 177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . 0.443 ' HA3' ' HG3' ' A' 1513 ' ' GLU . . . -130.04 142.15 13.37 Favored Glycine 0 N--CA 1.414 -2.769 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.38 126.62 35.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.8 m -94.9 98.95 8.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' 1535 ' ' LYS . 10.0 mptt -67.19 -20.88 65.78 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.639 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.81 -10.17 59.21 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.892 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . 0.585 ' HB2' HG23 ' A' 1534 ' ' VAL . 73.3 m -116.06 7.63 14.32 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.211 0.529 . . . . 0.0 110.06 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 115.94 137.27 6.1 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.656 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.33 128.07 19.57 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.351 2.034 . . . . 0.0 110.126 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 90.62 11.73 61.82 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.426 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.8 mm -112.74 128.5 69.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.66 -22.06 7.92 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.929 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -134.1 127.21 31.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 29.0 p -144.36 154.92 43.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.187 0.518 . . . . 0.0 110.482 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.41 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 44.4 t80 -84.92 134.91 34.25 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -86.2 97.66 10.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 160.41 -91.74 0.11 Allowed Glycine 0 N--CA 1.422 -2.283 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.7 p -71.2 -21.15 62.18 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 90.85 18.6 46.89 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.792 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 22.8 pt -74.14 131.4 35.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.248 0.547 . . . . 0.0 110.004 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 19.8 pttm -84.17 142.52 30.27 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.38 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -113.21 11.56 18.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.514 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.943 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.28 135.94 2.18 Favored Glycine 0 N--CA 1.433 -1.509 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.755 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' 1572 ' ' ASP . 29.3 mtpp -75.37 150.89 38.28 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.097 0.475 . . . . 0.0 111.157 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 73.9 t90 -63.77 125.98 26.1 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.322 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.4 p30 -146.11 158.39 43.87 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' 1493 ' ' ASN . 3.4 pt20 -124.16 33.53 5.26 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.927 0.87 . . . . 0.0 109.622 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -99.88 95.73 7.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.482 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 51.8 tp -99.31 110.9 23.37 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 15.9 p -89.48 119.19 29.71 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-O 121.264 0.554 . . . . 0.0 111.359 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . 0.675 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 16.0 t80 -92.93 101.17 13.52 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 94.3 t -106.89 104.89 17.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.739 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.32 63.32 1.91 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.214 1.406 . . . . 0.0 111.904 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . 0.675 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 64.5 mt-30 66.12 11.62 7.95 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 113.908 -1.496 . . . . 0.0 114.197 176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 93.4 t -116.87 139.2 44.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.847 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.6 113.64 22.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.975 0.417 . . . . 0.0 109.948 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -109.02 114.68 28.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.898 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -118.79 110.81 17.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 7.6 p -114.53 121.61 66.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.859 0.837 . . . . 0.0 111.703 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.943 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.3 m-85 -93.48 104.17 16.32 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.167 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.438 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 36.9 mt-10 -101.02 174.31 6.07 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' 1554 ' ' LYS . 9.8 t70 53.97 73.26 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.738 1.615 . . . . 0.0 111.5 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -96.25 -140.09 10.89 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.37 138.94 31.9 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 14.9 Cg_exo -68.38 135.39 33.79 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.854 2.369 . . . . 0.0 112.975 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 62.7 m -98.76 131.02 26.49 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.823 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -68.1 2.54 2.6 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.414 2.742 . . . . 0.0 115.542 -173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -72.88 -50.45 23.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.965 0.412 . . . . 0.0 110.172 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.89 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 17.3 m120 -132.43 -0.1 3.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.45 -47.12 0.54 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -76.39 -5.81 48.9 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.146 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.89 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 61.5 mt -89.05 126.54 35.48 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.623 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 98.1 mttt -133.24 159.04 41.38 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.425 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 91.9 m-85 -61.51 113.24 2.57 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.986 0.804 . . . . 0.0 108.86 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.438 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.6 mtpt -124.51 136.16 53.77 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.8 m -120.0 116.12 25.11 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 6.1 p -110.34 109.76 29.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.927 0.87 . . . . 0.0 109.67 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.85 111.54 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.036 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 67.1 m -92.3 112.01 23.79 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.847 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 94.9 m-85 -86.53 103.1 14.73 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' 1619 ' ' HIS . 29.7 m -105.84 161.49 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 CA-C-N 114.717 -1.128 . . . . 0.0 109.194 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.7 t -76.88 136.89 38.88 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -171.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 23.3 tptm -149.99 105.23 3.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 171.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 77.0 p -62.36 -37.78 87.01 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.256 0.55 . . . . 0.0 110.281 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -94.64 76.3 3.74 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.531 0.682 . . . . 0.0 110.213 176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -128.09 -64.38 0.96 Allowed 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.837 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 66.91 -133.6 31.74 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.67 -20.1 35.68 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.405 2.07 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.9 p -102.49 73.22 1.3 Allowed 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.66 0.743 . . . . 0.0 111.034 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.51 ' HB3' ' HB ' ' A' 1620 ' ' THR . 42.1 m -86.03 105.56 16.56 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.473 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 24.4 mt-30 -77.01 126.14 85.91 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -171.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.1 Cg_endo -83.99 111.37 1.65 Allowed 'Trans proline' 0 N--CA 1.441 -1.585 0 C-N-CA 123.398 2.732 . . . . 0.0 110.702 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.655 ' HB3' ' HB2' ' A' 1617 ' ' SER . 62.0 tp -88.68 123.53 33.22 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 53.7 tp -80.04 91.72 5.52 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 55.6 tp -68.25 -59.13 3.44 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.865 -175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' 1615 ' ' PHE . 46.4 m -158.91 132.4 7.37 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 65.2 t -106.75 111.04 33.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 14.0 t70 -94.15 102.47 14.51 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -73.97 -20.2 60.43 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.779 -1.1 . . . . 0.0 113.438 -170.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.6 t60 -84.57 -45.52 12.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.962 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.806 ' HA ' HD13 ' A' 1582 ' ' LEU . 68.4 p -85.72 -16.35 39.27 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.504 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 79.6 m 71.1 26.64 3.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 110.413 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 9.7 m -93.11 116.7 29.29 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.19 -0.914 . . . . 0.0 108.825 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 80.2 mt -99.09 116.91 32.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . 0.407 ' HD2' ' HB2' ' A' 1606 ' ' SER . 80.5 m-85 -100.82 117.33 34.69 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -120.68 133.42 55.35 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.866 0.466 . . . . 0.0 110.216 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.655 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 19.5 m -107.21 103.77 13.23 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -95.46 107.05 19.18 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 26.2 m80 -83.37 104.18 13.32 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' 1600 ' ' SER . 10.2 t -131.99 150.42 52.16 Favored 'General case' 0 N--CA 1.41 -2.43 0 CA-C-O 121.449 0.642 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.7 p -77.13 -22.15 53.07 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.28 177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 44.6 tp -71.42 -7.09 45.05 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.434 0.635 . . . . 0.0 110.111 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.72 -4.19 26.89 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.226 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.9 m -87.07 176.61 7.53 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.99 122.26 31.38 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -111.09 117.17 32.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -83.44 -23.32 32.34 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--O 1.251 1.138 0 CA-C-N 113.335 -1.757 . . . . 0.0 108.901 -178.806 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . 0.696 ' HG3' HG23 ' A' 1490 ' ' VAL . 22.5 ptp . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 121.029 0.443 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . 0.696 HG23 ' HG3' ' A' 1489 ' ' MET . 57.2 t -116.31 88.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -87.37 91.53 8.76 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 173.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.548 ' HA ' ' HG2' ' A' 1495 ' ' GLN . 10.4 p-10 -73.46 82.16 1.45 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 113.724 -1.58 . . . . 0.0 114.042 -170.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -92.88 80.58 4.64 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 72.3 m 64.55 40.32 6.16 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.853 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.548 ' HG2' ' HA ' ' A' 1492 ' ' ASP . 10.4 pt20 -136.63 152.03 49.98 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 13.8 p -157.87 139.22 5.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.6 m -97.59 132.94 42.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.464 HD21 ' HB3' ' A' 1503 ' ' TYR . 8.2 p30 -99.23 126.77 36.75 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.06 -10.69 29.67 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.786 2.324 . . . . 0.0 113.828 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -61.58 1.76 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.908 0.385 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 27.2 p -96.46 -26.55 15.26 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.135 0.493 . . . . 0.0 111.653 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 89.81 11.57 63.47 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . 0.464 ' HB3' HD21 ' A' 1498 ' ' ASN . 87.7 t80 -83.92 136.91 33.91 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-N 114.954 -0.623 . . . . 0.0 109.914 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' 1497 ' ' THR . 49.0 t -99.54 114.18 36.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' 1495 ' ' GLN . 98.5 m-85 -77.12 98.66 5.12 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.11 108.05 19.63 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . 0.556 HD11 HD23 ' A' 1510 ' ' LEU . 15.7 tp -86.22 4.24 39.55 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.244 0.545 . . . . 0.0 110.673 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.566 ' HA ' ' HG2' ' A' 1511 ' ' LYS . 51.2 m-80 -70.92 -18.66 62.64 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 47.4 t -80.18 -10.83 59.78 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.345 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.556 HD23 HD11 ' A' 1507 ' ' LEU . 69.0 tp -116.6 -25.61 7.33 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.95 -0.469 . . . . 0.0 111.469 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.678 ' HB2' ' O ' ' A' 1530 ' ' VAL . 19.2 pttp -56.49 142.33 39.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 121.647 0.737 . . . . 0.0 112.571 -174.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -128.76 106.07 8.68 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . 0.423 ' HA ' ' HA3' ' A' 1532 ' ' GLY . 32.4 tt0 -65.01 -34.11 77.66 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.634 0.773 . . . . 0.0 110.799 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 20.4 m -72.95 -11.69 60.67 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.429 0.633 . . . . 0.0 110.341 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 78.33 161.66 18.68 Favored Glycine 0 N--CA 1.434 -1.445 0 CA-C-N 115.43 -0.805 . . . . 0.0 114.587 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' 1527 ' ' ARG . 94.5 m-85 -97.98 128.74 44.73 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 25.2 m -100.53 98.2 8.82 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . 0.424 HG13 HG23 ' A' 1526 ' ' ILE . 18.1 pt -109.04 111.14 34.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.822 0.82 . . . . 0.0 109.687 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.7 t -95.67 112.38 24.11 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.686 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 15.2 t70 -100.62 120.68 40.41 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 173.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.4 -10.16 11.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.521 0.677 . . . . 0.0 112.384 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 16.3 mtp180 -92.99 -39.01 11.35 Favored 'General case' 0 N--CA 1.432 -1.327 0 O-C-N 121.956 -0.465 . . . . 0.0 110.713 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -109.23 -34.9 6.43 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 136.99 177.74 15.27 Favored Glycine 0 N--CA 1.433 -1.527 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.491 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' 1519 ' ' SER . 32.5 t -79.85 127.99 32.9 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.424 HG23 HG13 ' A' 1518 ' ' ILE . 10.7 tt -123.08 122.3 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.226 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' 1516 ' ' TYR . 16.9 ttm180 -108.35 116.05 31.25 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -118.13 120.29 37.31 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.297 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.674 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -93.52 118.96 5.82 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' 1511 ' ' LYS . 46.0 t -75.45 116.17 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.348 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.691 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 68.1 m 59.1 20.43 8.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.216 0.948 . . . . 0.0 112.047 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' 1513 ' ' GLU . . . -135.86 132.8 6.3 Favored Glycine 0 N--CA 1.401 -3.685 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' 1535 ' ' LYS . 21.6 mt-10 -76.39 130.02 37.44 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 15.4 m -80.1 93.1 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.52 0.676 . . . . 0.0 110.901 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' 1533 ' ' GLU . 0.0 OUTLIER -59.3 -26.45 64.99 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.49 -178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.17 -37.3 66.84 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.176 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 43.3 t -107.19 -25.37 11.56 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.948 0.404 . . . . 0.0 110.133 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 143.17 144.92 4.34 Favored Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.3 152.2 81.09 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.547 2.165 . . . . 0.0 110.795 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.5 -27.35 6.43 Favored Glycine 0 C--N 1.305 -1.152 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.807 -176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.0 mm -89.59 136.09 24.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.04 -37.12 2.58 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.789 -1.196 . . . . 0.0 112.294 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -125.84 128.07 47.06 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 44.2 t -139.59 139.86 36.9 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.686 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.42 ' HZ ' HD11 ' A' 1614 ' ' LEU . 98.2 m-85 -87.02 124.29 33.04 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' 1525 ' ' SER . 47.4 mt-10 -82.05 107.99 15.19 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.738 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 172.39 -71.65 0.1 Allowed Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.3 m -106.9 -24.82 11.91 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.572 0.701 . . . . 0.0 109.397 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 103.7 34.33 3.85 Favored Glycine 0 N--CA 1.432 -1.59 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.02 131.03 35.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.444 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 25.8 pttm -93.22 138.65 31.41 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.134 0.492 . . . . 0.0 110.291 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.95 8.06 43.26 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.281 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.611 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 140.74 149.48 5.28 Favored Glycine 0 N--CA 1.432 -1.575 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.876 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -99.31 155.72 17.36 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.385 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.691 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 39.0 t90 -71.49 143.61 49.95 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.8 p30 -147.2 152.74 38.87 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -106.07 9.88 32.29 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.59 107.12 19.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.063 0.458 . . . . 0.0 110.651 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.403 HD23 HD13 ' A' 1568 ' ' LEU . 74.6 mt -88.59 125.8 34.97 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.886 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.8 m -90.24 121.84 32.62 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.2 t80 -98.89 116.12 30.4 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 122.23 -0.294 . . . . 0.0 110.416 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.4 t -121.24 80.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 38.7 t70 40.45 83.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.154 1.781 . . . . 0.0 114.518 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 64.05 19.24 11.67 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.498 1.119 . . . . 0.0 112.849 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 58.6 t -133.9 119.89 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 172.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.684 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.42 133.87 37.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 120.943 0.401 . . . . 0.0 110.302 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.886 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -110.83 114.7 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.573 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . 0.403 HD13 HD23 ' A' 1559 ' ' LEU . 34.1 tp -116.45 107.35 14.66 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 171.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 17.1 t -105.99 108.55 25.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.095 -174.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.611 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 61.3 m-85 -82.08 107.16 14.56 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.5 178.33 4.59 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.585 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.616 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 24.4 t70 56.73 67.06 1.04 Allowed 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 124.87 1.356 . . . . 0.0 111.241 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . 0.444 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -93.25 -155.25 31.81 Favored Glycine 0 N--CA 1.416 -2.647 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 173.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -82.57 158.17 66.22 Favored Pre-proline 0 C--N 1.287 -2.146 0 CA-C-N 117.605 0.703 . . . . 0.0 109.704 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.63 140.08 35.28 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.272 1.981 . . . . 0.0 111.082 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 83.5 m -101.33 133.92 20.61 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.196 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.09 7.8 1.0 Allowed 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.31 2.673 . . . . 0.0 113.633 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.33 -52.96 6.74 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.13 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.541 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 2.4 m-20 -131.83 -2.36 3.71 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.802 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 31.9 tp 71.47 -47.82 0.66 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.908 1.283 . . . . 0.0 113.032 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -73.33 -12.81 60.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.451 0.643 . . . . 0.0 110.277 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.904 HD13 ' HA ' ' A' 1611 ' ' THR . 89.4 mt -85.58 127.62 34.51 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.042 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.616 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 44.5 mttm -112.54 152.92 28.27 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.494 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -60.07 123.62 17.7 Favored 'General case' 0 C--N 1.312 -1.053 0 O-C-N 123.725 0.64 . . . . 0.0 109.87 174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 62.8 mttt -131.69 131.4 43.06 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 15.6 t -120.86 116.66 25.6 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 3.3 p -108.12 101.32 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.966 0.889 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.72 114.11 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.702 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.3 m -95.93 109.63 21.97 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.731 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.684 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.4 m-85 -86.18 108.1 18.18 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 26.9 m -103.87 166.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.395 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 13.0 t -75.96 120.39 21.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 123.988 0.915 . . . . 0.0 112.91 -175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.745 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 48.1 tptt -152.55 99.47 2.47 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.3 m -65.82 -30.81 71.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.087 0.47 . . . . 0.0 110.596 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . 0.745 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 10.3 t70 -85.57 67.76 10.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -143.54 -56.44 0.39 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.718 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 79.09 -160.92 46.84 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.63 -20.14 35.83 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.728 2.285 . . . . 0.0 110.869 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -92.31 53.97 2.23 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.923 0.868 . . . . 0.0 109.102 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 14.1 m -62.3 140.66 58.5 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.094 -1.412 . . . . 0.0 111.015 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -106.32 124.61 35.24 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 52.8 Cg_endo -87.92 133.88 3.07 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 123.167 2.578 . . . . 0.0 112.515 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.1 tp -118.92 134.93 54.85 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.425 HD11 HG23 ' A' 1607 ' ' VAL . 45.1 tp -72.76 118.86 16.21 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 2.6 tm? -86.34 -43.37 12.93 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' 1615 ' ' PHE . 21.6 t -179.9 146.98 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.425 HG23 HD11 ' A' 1604 ' ' LEU . 95.9 t -123.09 121.14 62.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' 1610 ' ' HIS . 32.5 t70 -115.2 103.09 10.5 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.742 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -80.4 8.28 7.93 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.049 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . 0.428 ' HB2' ' OD2' ' A' 1608 ' ' ASP . 51.7 m80 -88.81 -51.48 5.62 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.904 ' HA ' HD13 ' A' 1582 ' ' LEU . 1.6 m -98.84 -6.17 29.63 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.526 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 76.6 m 62.1 30.74 17.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.257 1.023 . . . . 0.0 111.198 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 14.5 m -97.3 116.7 30.0 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.41 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.599 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 84.7 mt -96.93 120.2 36.83 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.31 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' 1606 ' ' SER . 72.7 m-85 -105.21 112.22 25.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.599 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.1 m-85 -122.41 135.39 54.68 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 42.1 p -113.05 110.89 21.22 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' 1602 ' ' PRO . 1.5 t-105 -97.24 115.91 28.49 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 48.6 m80 -83.59 99.43 10.17 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -128.74 151.12 49.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.881 0.848 . . . . 0.0 111.485 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.9 m -76.88 -27.69 55.09 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.434 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.44 -5.95 40.22 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.277 -177.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.59 -1.44 35.45 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.594 0.711 . . . . 0.0 110.345 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 12.3 t -113.77 170.32 8.34 Favored 'General case' 0 N--CA 1.412 -2.355 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -63.59 99.08 0.2 Allowed 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 123.869 0.731 . . . . 0.0 110.022 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -122.78 141.63 51.61 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 -26.08 15.01 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.583 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--N 1.309 -1.169 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 -175.747 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . 0.715 ' HG2' HG13 ' A' 1490 ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . 0.715 HG13 ' HG2' ' A' 1489 ' ' MET . 26.8 m -127.18 149.26 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.584 -0.447 . . . . 0.0 110.91 -175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -153.58 88.69 1.29 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.887 ' HB2' ' HG3' ' A' 1495 ' ' GLN . 38.2 p-10 -150.8 107.58 3.53 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.826 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' 1557 ' ' GLN . 3.6 p-10 -117.32 123.43 46.5 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.421 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 64.9 m 73.27 0.09 3.55 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.053 0.93 . . . . 0.0 112.113 -173.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.887 ' HG3' ' HB2' ' A' 1492 ' ' ASP . 21.1 pt20 -128.91 147.39 50.83 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 172.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.9 p -132.48 118.25 34.54 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 122.112 0.958 . . . . 0.0 110.868 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.787 HG23 HG22 ' A' 1504 ' ' VAL . 6.0 m -96.37 101.51 13.16 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.19 122.17 49.38 Favored Pre-proline 0 C--N 1.288 -2.083 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.36 -8.02 19.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.215 2.61 . . . . 0.0 112.53 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.95 -56.61 17.4 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.758 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . 0.415 ' HB ' ' CD2' ' A' 1503 ' ' TYR . 57.7 p -101.01 -28.39 12.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 85.46 10.77 76.44 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.45 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . 0.415 ' CD2' ' HB ' ' A' 1501 ' ' THR . 56.6 m-85 -99.54 131.6 45.43 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.787 HG22 HG23 ' A' 1497 ' ' THR . 28.3 t -90.48 99.23 9.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -83.32 105.71 14.5 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' 1495 ' ' GLN . 24.3 t70 -105.26 112.03 25.0 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.228 0.537 . . . . 0.0 111.862 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.9 tp -85.27 -4.49 59.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.035 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.65 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 62.6 m-80 -65.2 -29.65 70.48 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.768 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 69.6 m -77.3 -10.03 59.18 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.515 -0.474 . . . . 0.0 112.111 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.452 ' HB2' HD12 ' A' 1622 ' ' LEU . 26.2 tp -109.92 8.05 24.11 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.434 0.635 . . . . 0.0 109.493 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 53.5 mtmt -58.54 143.7 45.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.665 ' H ' ' HB ' ' A' 1530 ' ' VAL . 32.2 tpt180 -127.25 97.9 5.09 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -25.38 60.27 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.522 0.514 . . . . 0.0 110.711 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 45.5 t -67.6 -26.31 66.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 88.14 153.82 26.66 Favored Glycine 0 N--CA 1.423 -2.198 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.48 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -89.8 114.78 26.56 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 6.5 p -103.56 92.34 4.42 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 122.03 0.919 . . . . 0.0 109.8 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.5 pt -120.55 153.44 23.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.742 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' 1524 ' ' GLY . 15.5 p -103.95 118.27 36.27 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 1.5 p30 -64.79 174.69 1.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 O-C-N 123.515 0.509 . . . . 0.0 111.009 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.2 tp -61.85 -24.26 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -81.74 -5.82 58.48 Favored 'General case' 0 C--O 1.248 1.022 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 73.73 74.44 0.13 Allowed 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.918 1.687 . . . . 0.0 112.454 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' 1519 ' ' SER . . . -151.37 139.16 6.98 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 174.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 47.6 m -87.78 129.2 35.26 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.898 0.849 . . . . 0.0 111.673 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.4 tt -122.0 142.1 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -118.24 116.74 27.4 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 123.546 0.738 . . . . 0.0 109.076 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.61 125.92 43.92 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.499 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.86 129.74 10.0 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.449 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.665 ' HB ' ' H ' ' A' 1512 ' ' ARG . 47.5 t -79.52 115.22 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.514 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.673 ' HA ' ' CZ3' ' A' 1555 ' ' TRP . 69.9 m 46.25 66.91 0.85 Allowed 'General case' 0 C--N 1.306 -1.297 0 O-C-N 125.141 1.526 . . . . 0.0 113.461 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -171.25 175.17 44.92 Favored Glycine 0 N--CA 1.404 -3.459 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -128.78 134.89 48.54 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.7 m -88.9 97.13 6.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-O 121.739 0.78 . . . . 0.0 110.689 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -22.54 54.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.941 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.22 -26.44 66.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.653 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 61.5 m -102.91 0.2 32.07 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.32 150.63 18.26 Favored Glycine 0 N--CA 1.425 -2.062 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -173.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.58 145.79 87.89 Favored 'Trans proline' 0 C--O 1.256 1.39 0 C-N-CA 122.404 2.069 . . . . 0.0 112.48 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' 1555 ' ' TRP . . . 82.41 14.73 75.67 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-N 115.008 -0.996 . . . . 0.0 114.81 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 46.9 mm -112.33 131.62 63.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 118.082 0.941 . . . . 0.0 109.221 176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.49 -28.31 7.18 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.901 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.03 137.5 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.796 0.332 . . . . 0.0 111.147 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 69.0 m -142.59 149.24 38.74 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.475 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.494 ' HZ ' ' HA3' ' A' 1524 ' ' GLY . 56.1 t80 -94.88 118.81 32.4 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 172.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.75 110.02 4.7 Favored 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.17 0.918 . . . . 0.0 112.488 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 144.82 -80.04 0.23 Allowed Glycine 0 C--N 1.296 -1.677 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.032 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 20.1 m -72.38 -19.77 61.56 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.321 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 79.29 41.78 13.06 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.621 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.439 ' CG1' ' HB3' ' A' 1545 ' ' PHE . 20.9 pt -93.46 131.01 41.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 56.4 mttm -85.44 129.2 34.87 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.552 -173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -98.86 7.73 45.73 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.055 0.455 . . . . 0.0 111.172 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.614 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.62 146.02 4.31 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.985 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 50.6 tttm -69.32 145.46 52.99 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.028 0.931 . . . . 0.0 109.588 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.673 ' CZ3' ' HA ' ' A' 1531 ' ' CYS . 7.0 t-105 -66.24 109.67 2.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' 1570 ' ' TYR . 0.1 OUTLIER -146.75 161.23 41.06 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -178.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' 1493 ' ' ASN . 51.2 mt-30 -120.6 67.83 0.85 Allowed 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.033 0.92 . . . . 0.0 108.849 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.4 tptt -96.86 95.38 7.82 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.387 -1.279 . . . . 0.0 109.776 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 4.2 mm? -104.7 104.85 14.73 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.111 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.809 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 15.3 m -100.07 139.46 35.71 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 89.3 t80 -113.98 117.8 32.33 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.479 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 67.6 t -103.43 153.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 172.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -51.28 100.79 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 123.901 0.881 . . . . 0.0 111.663 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 68.47 19.06 8.89 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 125.959 1.704 . . . . 0.0 112.33 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . 0.712 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 49.0 t -134.07 119.57 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.739 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.7 tp -87.37 140.18 29.79 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.809 ' HB2' ' HB2' ' A' 1560 ' ' SER . 23.9 mm-40 -124.65 115.25 20.48 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.722 -0.611 . . . . 0.0 111.097 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 63.0 tp -109.9 120.31 42.08 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.494 HG22 HG23 ' A' 1587 ' ' VAL . 32.5 t -117.35 131.45 70.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.132 0.491 . . . . 0.0 110.461 -176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' 1586 ' ' SER . 63.5 m-85 -103.1 105.8 16.19 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -97.65 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.442 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.3 t70 61.91 92.54 0.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.934 1.396 . . . . 0.0 112.179 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.33 -158.07 12.9 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.507 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.83 151.57 52.54 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -45.99 147.59 3.38 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.529 2.819 . . . . 0.0 114.766 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . 0.676 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 17.2 t -98.22 130.25 28.85 Favored Pre-proline 0 C--N 1.292 -1.898 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.139 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 21.9 Cg_exo -60.76 -27.48 84.88 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.142 2.562 . . . . 0.0 113.911 -175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.47 -52.31 33.9 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.518 HD22 HD11 ' A' 1582 ' ' LEU . 92.8 m-20 -126.5 8.31 7.05 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.2 mm? 67.86 -62.54 0.34 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.785 1.234 . . . . 0.0 114.078 177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.27 4.51 8.64 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.676 ' HB2' ' HB3' ' A' 1576 ' ' CYS . 92.5 mt -90.36 154.54 19.61 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 173.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' 1585 ' ' LYS . 94.1 mttt -123.86 154.09 40.15 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.431 ' HE2' ' HB ' ' A' 1550 ' ' ILE . 27.1 m-85 -62.73 116.82 5.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' 1583 ' ' LYS . 28.9 mtpp -115.05 133.82 55.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.723 ' HB2' ' HB2' ' A' 1570 ' ' TYR . 37.5 m -120.01 122.36 40.96 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.212 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.494 HG23 HG22 ' A' 1569 ' ' VAL . 6.6 p -126.75 111.27 25.42 Favored 'Isoleucine or valine' 0 C--O 1.25 1.096 0 CA-C-O 121.975 0.893 . . . . 0.0 110.725 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.0 110.88 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.746 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . 0.498 ' HA ' ' NE2' ' A' 1567 ' ' GLN . 29.5 m -88.53 111.18 21.55 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.341 177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.739 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.5 m-85 -86.97 106.64 17.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.0 m -98.53 153.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.498 ' HA ' ' O ' ' A' 1620 ' ' THR . 48.7 t -86.96 133.85 33.55 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 122.16 0.981 . . . . 0.0 113.166 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.0 tptt -147.33 105.38 3.74 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.1 t -75.3 -14.74 60.52 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.601 0.715 . . . . 0.0 110.645 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.29 -3.17 57.2 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.717 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.904 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.98 -42.81 15.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.5 -156.41 51.0 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.976 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -76.06 -4.1 14.69 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.441 2.761 . . . . 0.0 113.098 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 17.8 p -90.54 -49.69 6.36 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.904 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.5 m 69.34 145.77 0.05 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 124.379 1.072 . . . . 0.0 113.144 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.856 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 97.8 mt-30 -87.84 121.88 70.54 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.338 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.0 Cg_endo -88.43 118.67 1.07 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 123.466 2.777 . . . . 0.0 111.661 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' 1617 ' ' SER . 63.5 tp -130.8 124.69 31.9 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.224 0.535 . . . . 0.0 109.974 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.683 HD21 HG23 ' A' 1607 ' ' VAL . 62.6 tp -87.16 126.73 34.98 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 58.4 tp -80.97 -48.34 12.41 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 60.4 p -178.35 142.67 0.26 Allowed 'General case' 0 C--O 1.249 1.036 0 O-C-N 124.015 0.822 . . . . 0.0 109.943 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.683 HG23 HD21 ' A' 1604 ' ' LEU . 61.9 t -94.37 117.47 38.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.69 113.15 26.31 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.324 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -80.95 -2.0 45.96 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-O 120.524 0.202 . . . . 0.0 111.446 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 45.9 m80 -82.33 -41.2 20.37 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.382 0.61 . . . . 0.0 110.677 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.582 ' HA ' HD13 ' A' 1582 ' ' LEU . 33.8 p -121.58 -9.81 8.89 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 75.5 m 65.68 35.07 7.18 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.149 0.976 . . . . 0.0 111.397 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -96.48 122.92 39.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.096 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.555 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 88.7 mt -91.27 112.81 24.88 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -98.41 115.6 28.83 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.086 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.555 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 86.9 m-85 -123.41 140.21 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' 1603 ' ' LEU . 40.0 m -120.67 103.69 9.33 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 8.7 t-105 -95.51 122.01 37.8 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.856 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 46.9 m-70 -90.73 102.98 15.74 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.4 t -127.48 153.89 45.76 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.046 0.45 . . . . 0.0 110.447 -175.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.2 m -79.59 -25.28 41.59 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' 1510 ' ' LEU . 33.4 mt -70.7 -4.75 25.23 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.708 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.45 -23.44 40.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.228 0.537 . . . . 0.0 110.625 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 60.3 m -79.31 159.68 27.1 Favored 'General case' 0 C--O 1.248 0.989 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -50.55 132.61 25.5 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -80.24 116.36 20.29 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -86.34 -31.04 21.76 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.69 -171.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.848 -179.727 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 59.5 ttp . . . . . 0 CA--C 1.5 -0.976 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' 1492 ' ' ASP . 38.9 t -95.05 141.64 14.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 59.1 tp60 -75.54 -1.1 22.76 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.159 0.504 . . . . 0.0 109.917 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.699 ' H ' HG12 ' A' 1490 ' ' VAL . 13.9 t70 51.7 79.48 0.1 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.633 1.573 . . . . 0.0 109.393 -175.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -136.65 85.81 2.17 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.17 -174.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.445 ' HB2' ' OD1' ' A' 1508 ' ' ASN . 82.9 m 55.1 25.06 6.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' 1505 ' ' PHE . 25.0 pt20 -132.91 119.15 19.8 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -122.91 124.89 71.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-O 121.376 0.608 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 9.1 m -88.71 109.7 20.36 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 5.4 p30 -82.32 138.4 45.16 Favored Pre-proline 0 C--N 1.305 -1.359 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.246 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.2 -2.75 12.97 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.686 2.257 . . . . 0.0 113.572 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -82.33 -63.89 1.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.813 0.34 . . . . 0.0 110.618 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' 1625 ' ' GLU . 24.6 p -98.13 -20.17 17.48 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.4 3.35 81.72 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 67.2 t80 -73.87 133.62 43.17 Favored 'General case' 0 C--O 1.254 1.325 0 C-N-CA 123.074 0.55 . . . . 0.0 109.842 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 65.4 t -95.33 111.75 26.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' 1495 ' ' GLN . 82.8 m-85 -85.04 103.03 13.7 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.2 108.06 19.4 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 32.5 tp -82.48 -8.75 59.61 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.477 ' HA ' ' HD3' ' A' 1511 ' ' LYS . 90.2 m-20 -59.79 -24.02 63.77 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.62 1.968 . . . . 0.0 112.789 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 6.9 p -86.36 -11.0 53.26 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.04 0.448 . . . . 0.0 111.531 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 49.1 tp -116.0 -22.33 9.05 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 122.207 -0.308 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1531 ' ' CYS . 22.2 pttp -46.79 131.38 11.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 122.035 0.921 . . . . 0.0 113.472 -175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -126.93 101.11 6.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.293 -172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -65.54 -37.75 87.62 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.91 0.756 . . . . 0.0 110.967 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 41.3 m -63.49 -18.42 63.78 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.395 0.617 . . . . 0.0 110.447 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 86.11 149.14 12.65 Favored Glycine 0 N--CA 1.415 -2.74 0 CA-C-N 115.278 -0.874 . . . . 0.0 114.635 173.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -80.83 114.35 19.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 20.0 m -99.45 98.84 9.7 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 27.4 pt -115.84 145.7 21.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.511 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 35.8 t -111.03 130.5 55.58 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.287 0.565 . . . . 0.0 109.912 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.44 153.86 42.94 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.62 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.3 tp -62.97 -22.76 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.373 0.606 . . . . 0.0 111.62 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -79.51 3.75 17.78 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 123.43 0.692 . . . . 0.0 111.042 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 56.9 tptt 73.52 87.18 0.1 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.75 1.62 . . . . 0.0 110.442 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -169.11 117.2 0.7 Allowed Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 50.4 m -81.62 120.79 25.52 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 120.785 0.326 . . . . 0.0 110.815 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.802 ' HB ' ' HD1' ' A' 1545 ' ' PHE . 14.6 tt -114.41 128.24 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.784 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.5 ttm180 -116.95 115.5 25.59 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.2 mp -114.78 114.93 26.23 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.303 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.473 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -83.55 111.16 3.38 Favored Glycine 0 N--CA 1.423 -2.216 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.518 HG13 ' HA ' ' A' 1511 ' ' LYS . 7.2 p -85.97 116.56 29.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.981 -0.717 . . . . 0.0 109.158 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.576 ' HB2' ' HB2' ' A' 1511 ' ' LYS . 85.7 m 64.94 15.63 10.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.421 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.91 140.21 8.99 Favored Glycine 0 N--CA 1.416 -2.646 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -76.81 146.88 37.53 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 14.6 p -89.19 99.32 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-O 122.291 1.043 . . . . 0.0 110.959 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' 1535 ' ' LYS . 0.3 OUTLIER -65.48 -19.36 65.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.187 -174.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 30.9 t70 -60.57 -36.5 78.66 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.899 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 78.0 m -106.96 -24.29 12.06 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.764 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 129.63 152.61 7.61 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.482 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -62.25 146.86 95.79 Favored 'Trans proline' 0 C--O 1.241 0.636 0 C-N-CA 122.981 2.454 . . . . 0.0 110.815 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 97.41 -14.61 63.23 Favored Glycine 0 C--N 1.301 -1.399 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.866 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 47.2 mm -113.98 136.15 51.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.446 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.39 -47.12 0.82 Allowed Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.99 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -108.28 125.9 52.21 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 43.9 t -141.98 139.12 32.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.802 ' HD1' ' HB ' ' A' 1526 ' ' ILE . 57.4 t80 -108.72 121.58 45.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.24 -30.96 71.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -66.2 112.91 5.29 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 32.4 m 72.93 1.31 3.98 Favored 'General case' 0 CA--C 1.572 1.802 0 C-N-CA 124.029 0.932 . . . . 0.0 110.629 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 58.59 41.9 95.83 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.489 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.467 HG13 ' HB3' ' A' 1545 ' ' PHE . 27.5 pt -90.82 142.05 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.769 0.795 . . . . 0.0 112.238 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 84.7 mttt -82.08 137.74 34.97 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.756 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -120.41 15.39 12.11 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.189 0.519 . . . . 0.0 110.202 -178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.91 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 157.79 128.51 1.03 Allowed Glycine 0 N--CA 1.432 -1.632 0 C-N-CA 119.96 -1.114 . . . . 0.0 114.221 178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.9 tttp -72.75 139.53 47.19 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 125.248 1.419 . . . . 0.0 107.319 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 55.5 t90 -72.78 134.43 44.94 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.88 159.57 35.16 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.39 88.69 2.83 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 40.2 mmtm -131.21 90.81 2.93 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 59.5 mt -106.35 111.05 23.47 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 17.6 m -116.16 127.82 55.13 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.977 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 85.5 t80 -93.4 101.1 13.31 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -138.38 150.15 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.7 t70 65.68 15.2 9.94 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.803 0.811 . . . . 0.0 108.979 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 70.08 12.71 7.79 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.058 1.743 . . . . 0.0 110.682 -174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 63.0 t -117.53 151.91 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.851 0.86 . . . . 0.0 109.865 -176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.808 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.1 mp -86.28 124.34 32.55 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.134 -0.354 . . . . 0.0 110.588 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.981 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.4 tp -128.55 118.01 22.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.485 HG22 ' HG3' ' A' 1571 ' ' GLU . 10.5 p -126.39 117.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.408 1.099 . . . . 0.0 112.983 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.91 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 54.4 m-85 -92.13 102.34 14.87 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.893 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.579 ' HA ' ' HG2' ' A' 1585 ' ' LYS . 44.6 mt-10 -107.67 166.58 10.57 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 20.6 t70 68.94 71.0 0.27 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 122.274 1.035 . . . . 0.0 111.734 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.0 -137.16 9.68 Favored Glycine 0 N--CA 1.421 -2.333 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.45 153.96 65.62 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.21 151.03 84.52 Favored 'Trans proline' 0 C--O 1.247 0.93 0 C-N-CA 122.081 1.854 . . . . 0.0 110.587 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 72.7 m -97.3 137.87 21.18 Favored Pre-proline 0 C--N 1.29 -2.002 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.8 -25.94 78.31 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.547 2.832 . . . . 0.0 113.449 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.11 -67.25 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.573 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.9 m120 -109.53 -3.68 16.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.1 mm? 67.98 -53.11 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.702 1.201 . . . . 0.0 113.336 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -61.8 -18.21 59.07 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.372 1.469 . . . . 0.0 111.82 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' 1611 ' ' THR . 81.0 mt -82.93 141.66 32.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -116.17 146.94 41.89 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.88 118.97 9.15 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.579 ' HG2' ' HA ' ' A' 1571 ' ' GLU . 86.9 mttt -130.16 137.62 50.21 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 14.5 m -119.84 116.28 25.55 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -108.36 114.92 47.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.972 0.892 . . . . 0.0 110.408 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -104.61 122.55 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.443 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 19.6 m -109.16 114.77 28.77 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.808 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 91.7 m-85 -86.79 109.61 19.38 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -102.4 159.59 4.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 35.6 t -76.28 130.24 37.86 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.19 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.613 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 47.3 tptt -159.82 106.59 1.65 Allowed 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 19.8 m -72.04 -25.96 62.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.587 0.708 . . . . 0.0 110.107 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . 0.613 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 34.4 t70 -81.54 19.81 0.98 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.564 1.146 . . . . 0.0 110.68 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.748 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -95.03 -39.39 10.19 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.691 -0.631 . . . . 0.0 110.508 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 71.57 -162.53 54.3 Favored Glycine 0 N--CA 1.439 -1.146 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.871 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.7 -14.69 33.31 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 123.228 2.619 . . . . 0.0 112.12 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.1 p -81.94 -50.9 8.62 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.852 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.748 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 49.3 m 65.54 108.87 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 O-C-N 124.025 0.828 . . . . 0.0 111.198 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.499 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 48.4 mt-30 -74.27 124.85 90.24 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.716 -172.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 11.7 Cg_endo -92.97 108.02 0.19 Allowed 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 123.329 2.686 . . . . 0.0 111.251 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.21 116.23 28.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.776 HD21 HG23 ' A' 1607 ' ' VAL . 5.4 tt -77.8 108.3 10.93 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 63.5 tp -74.92 -54.58 6.98 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.987 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 23.1 t -169.4 151.19 4.42 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.776 HG23 HD21 ' A' 1604 ' ' LEU . 83.9 t -117.92 110.75 31.7 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.18 104.57 16.61 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.399 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.44 5.38 17.82 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.445 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 56.1 m80 -88.63 -44.23 10.76 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -112.05 -0.08 15.79 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.6 -176.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 60.3 m 63.01 30.64 16.32 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.185 0.994 . . . . 0.0 111.235 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -99.05 118.56 36.09 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.726 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.62 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 78.6 mt -97.26 119.29 35.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -102.75 115.44 30.6 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.62 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 69.4 m-85 -125.74 126.72 45.05 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.01 0.433 . . . . 0.0 110.263 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 20.2 m -106.07 112.66 25.8 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -97.17 119.03 34.92 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 64.6 m-70 -89.8 112.87 24.32 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 14.9 t -139.46 152.18 46.8 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.18 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 6.9 m -74.89 -23.7 58.43 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' 1505 ' ' PHE . 41.7 mt -72.6 -5.55 38.05 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.347 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.09 16.87 25.08 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.327 0.584 . . . . 0.0 110.404 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 59.0 m -113.15 151.26 31.1 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.062 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . 0.499 ' HG2' HG21 ' A' 1501 ' ' THR . 5.4 mp0 -83.89 132.94 34.75 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -81.8 118.08 22.6 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -86.13 -58.93 2.44 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.308 -1.23 0 C-N-CA 124.2 1.0 . . . . 0.0 108.487 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 26.4 ptm . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 34.4 m -84.54 131.04 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.35 112.89 24.1 Favored 'General case' 0 C--N 1.286 -2.182 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.941 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.19 53.31 2.22 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 122.157 0.98 . . . . 0.0 110.548 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -85.0 112.63 20.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 15.0 t 69.03 26.34 5.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.626 1.203 . . . . 0.0 109.503 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -156.13 151.17 26.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -114.02 132.33 63.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.827 HG23 HG22 ' A' 1504 ' ' VAL . 63.3 m -141.72 105.75 4.77 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.743 0.306 . . . . 0.0 110.622 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.1 p30 -98.34 129.34 30.76 Favored Pre-proline 0 N--CA 1.435 -1.218 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.754 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -70.05 -11.78 31.1 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.425 2.083 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -68.57 -55.72 10.7 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.586 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 38.9 p -118.98 -6.28 10.5 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 77.11 34.38 41.91 Favored Glycine 0 CA--C 1.502 -0.748 0 N-CA-C 110.434 -1.067 . . . . 0.0 110.434 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' 1497 ' ' THR . 41.0 t80 -83.57 109.61 17.55 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.827 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -128.01 107.6 16.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 O-C-N 123.748 0.655 . . . . 0.0 109.477 -174.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' 1625 ' ' GLU . 8.3 m-85 -120.87 106.49 11.7 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 24.3 t70 -91.89 108.8 20.18 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.366 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . 0.497 HD11 HD23 ' A' 1510 ' ' LEU . 18.5 tp -89.27 -5.87 57.25 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.964 0.888 . . . . 0.0 109.321 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.427 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 53.1 m-80 -62.21 -26.8 68.56 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.248 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.8 t -74.29 -10.67 59.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.161 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.497 HD23 HD11 ' A' 1507 ' ' LEU . 35.8 tp -111.87 6.85 19.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.301 0.572 . . . . 0.0 110.451 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.723 ' HA ' ' HB ' ' A' 1530 ' ' VAL . 35.1 mtmm -57.29 153.8 11.58 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.64 ' HD2' ' H ' ' A' 1530 ' ' VAL . 0.0 OUTLIER -84.0 176.76 8.62 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.116 -174.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' 1513 ' ' GLU . 0.0 OUTLIER -89.93 -51.75 5.32 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 173.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 35.1 t -128.16 -38.39 1.8 Allowed 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.594 ' HA2' ' HG3' ' A' 1512 ' ' ARG . . . 158.2 161.68 11.18 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -102.07 129.04 48.29 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 19.9 m -99.09 99.64 10.68 Favored 'General case' 0 N--CA 1.425 -1.711 0 O-C-N 123.788 0.68 . . . . 0.0 109.196 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.1 pt -119.58 155.84 22.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 8.1 t -107.59 141.17 39.48 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.22 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -75.36 170.05 16.86 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 124.842 1.257 . . . . 0.0 107.874 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.48 -23.91 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.899 0.857 . . . . 0.0 110.032 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -84.45 1.16 46.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.876 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 74.41 10.66 4.2 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 126.013 1.725 . . . . 0.0 114.459 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -71.83 123.57 9.88 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 41.5 m -81.79 124.14 29.4 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.76 132.99 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 CA-C-O 121.315 0.578 . . . . 0.0 109.566 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -107.24 116.35 31.78 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.39 140.77 52.64 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.273 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -106.62 151.17 16.92 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 174.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.723 ' HB ' ' HA ' ' A' 1511 ' ' LYS . 24.5 t -92.22 115.02 30.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 31.4 m 55.98 24.55 7.81 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.677 1.236 . . . . 0.0 111.88 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -139.06 169.82 24.31 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -99.15 131.25 45.32 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.615 HG23 ' HB2' ' A' 1537 ' ' CYS . 14.3 m -88.06 93.01 4.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.591 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -50.6 -38.27 44.68 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.653 -173.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.78 -19.67 65.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.352 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . 0.615 ' HB2' HG23 ' A' 1534 ' ' VAL . 64.6 m -109.73 9.43 24.88 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.829 0.347 . . . . 0.0 111.476 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.74 155.11 10.98 Favored Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.093 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.84 131.43 13.34 Favored 'Trans proline' 0 C--O 1.249 1.072 0 C-N-CA 122.612 2.208 . . . . 0.0 111.347 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' 1554 ' ' LYS . . . 79.93 19.55 69.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.553 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.48 ' CD1' ' HD3' ' A' 1551 ' ' LYS . 45.1 mm -114.19 137.04 48.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -114.83 -18.04 6.62 Favored Glycine 0 C--N 1.32 -0.306 0 C-N-CA 119.823 -1.179 . . . . 0.0 113.563 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.26 133.95 30.35 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 19.2 p -149.11 152.43 36.14 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.509 0.188 . . . . 0.0 111.509 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -94.46 118.53 31.78 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.051 0.453 . . . . 0.0 110.814 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.17 110.48 13.19 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.454 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.6 -71.26 0.27 Allowed Glycine 0 C--N 1.282 -2.449 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 3.0 m -87.85 -20.4 26.09 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.91 44.53 11.96 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 37.1 pt -103.75 150.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.48 ' HD3' ' CD1' ' A' 1541 ' ' ILE . 49.9 mttm -90.92 134.46 34.45 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.09 17.12 11.64 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.097 0.475 . . . . 0.0 110.425 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.5 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 160.32 126.6 0.84 Allowed Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.886 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' 1540 ' ' GLY . 32.6 ttmt -84.08 147.19 27.51 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.784 0.834 . . . . 0.0 109.997 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 64.3 t90 -64.86 129.25 39.04 Favored 'General case' 0 N--CA 1.431 -1.375 0 O-C-N 123.775 0.672 . . . . 0.0 109.673 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.99 156.99 6.36 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 104.651 -2.352 . . . . 0.0 104.651 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -124.21 65.58 1.06 Allowed 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.913 0.863 . . . . 0.0 109.553 -175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -94.59 92.98 7.32 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.424 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.88 115.12 27.47 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 11.7 m -112.9 124.92 53.71 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.422 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.9 t80 -88.62 101.79 14.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 59.5 t -117.4 102.97 14.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.945 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.6 t70 46.3 68.68 0.57 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.673 1.589 . . . . 0.0 112.739 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.57 9.77 6.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.051 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.5 t -125.78 135.44 63.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 O-C-N 121.948 -0.47 . . . . 0.0 110.018 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.724 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.2 mp -86.11 118.27 25.47 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -102.86 118.21 36.31 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.08 119.63 37.81 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.463 HG22 HG23 ' A' 1587 ' ' VAL . 26.3 t -114.12 115.11 48.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.12 0.486 . . . . 0.0 111.993 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.5 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 66.4 m-85 -96.82 92.33 6.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 170.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' 1585 ' ' LYS . 14.8 pt-20 -110.84 176.17 5.14 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.587 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 19.2 t70 66.8 80.15 0.22 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.921 1.288 . . . . 0.0 111.683 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -122.21 -131.44 3.9 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.81 159.17 63.93 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.62 157.93 16.43 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.226 1.95 . . . . 0.0 113.012 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 84.8 m -98.45 136.86 20.7 Favored Pre-proline 0 C--N 1.288 -2.08 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.627 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.82 6.26 3.85 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.518 2.145 . . . . 0.0 113.64 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.39 -67.52 0.78 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.732 0.301 . . . . 0.0 110.556 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.41 HD22 HD11 ' A' 1582 ' ' LEU . 88.2 m-20 -109.42 -1.13 18.6 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.913 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.95 -50.96 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 33.1 m80 -79.86 26.24 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.452 0.701 . . . . 0.0 112.419 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.41 HD11 HD22 ' A' 1579 ' ' ASN . 94.3 mt -124.88 125.54 44.13 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' 1585 ' ' LYS . 67.0 mttm -112.28 160.01 18.07 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -64.14 126.54 28.07 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' 1571 ' ' GLU . 1.3 mptp? -111.01 133.2 53.59 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.0 t -120.25 115.68 24.08 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.463 HG23 HG22 ' A' 1569 ' ' VAL . 7.8 p -112.7 124.73 69.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.607 0.718 . . . . 0.0 110.8 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.05 116.42 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 24.0 m -94.22 110.69 22.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.724 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 90.3 m-85 -88.25 111.07 21.25 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 22.3 m -110.14 155.2 11.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.778 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 25.4 t -75.08 123.24 24.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.338 0.589 . . . . 0.0 110.603 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.597 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 52.9 tptt -146.97 116.72 7.15 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 176.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 20.3 m -82.89 -20.41 35.5 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.294 0.568 . . . . 0.0 109.535 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . 0.597 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -79.29 14.19 1.62 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.592 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.947 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -94.22 -56.53 2.81 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.234 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.79 -166.39 41.14 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 -16.32 37.47 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.048 2.499 . . . . 0.0 112.561 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 11.5 p -91.74 -35.51 14.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.295 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.947 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 35.0 m 66.12 177.14 0.22 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.911 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.692 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 91.0 mt-30 -114.9 119.35 39.3 Favored Pre-proline 0 C--N 1.313 -1.021 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.776 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -94.18 111.85 0.18 Allowed 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 123.224 2.616 . . . . 0.0 109.597 173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 59.3 tp -126.46 126.55 43.96 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.423 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.0 tp -74.93 120.31 20.29 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.85 -53.31 5.41 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.909 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 48.7 m -164.6 149.39 9.67 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 109.88 -175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 86.8 t -115.51 119.35 61.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.11 106.03 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.218 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -81.29 2.59 27.43 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.3 -24.21 16.3 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.759 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . . . . . . . . . 24.5 p -115.39 -3.45 12.43 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.861 173.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 86.2 m 61.22 28.16 17.78 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.384 1.074 . . . . 0.0 111.532 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 25.3 m -105.56 124.61 49.84 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.378 0.609 . . . . 0.0 110.154 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.99 125.48 39.68 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -105.82 118.68 37.23 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 135.33 54.59 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 39.8 t -110.34 119.23 38.56 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -107.39 104.62 14.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.2 m-70 -83.74 105.83 14.96 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.6 t -132.26 152.36 51.39 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.532 0.682 . . . . 0.0 111.296 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 15.9 m -80.19 -22.6 41.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.339 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 37.2 tp -71.33 -6.52 40.59 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 121.347 0.594 . . . . 0.0 110.621 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.28 5.79 42.58 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.673 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 71.3 m -88.61 140.89 29.0 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.122 177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . 0.707 ' HA ' ' HZ ' ' A' 1505 ' ' PHE . 2.3 mp0 -44.12 151.69 0.22 Allowed 'General case' 0 C--O 1.253 1.252 0 C-N-CA 126.066 1.746 . . . . 0.0 114.241 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -98.85 152.56 19.6 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -95.13 -26.26 16.09 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 -178.18 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 CA--C 1.516 -0.341 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 21.8 t -74.14 -19.74 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 72.36 5.64 5.32 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.555 0.742 . . . . 0.0 111.426 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.65 61.58 1.62 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -126.1 124.41 40.51 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.582 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 43.9 t 71.17 3.95 4.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.794 1.283 . . . . 0.0 109.993 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.7 pt20 -150.56 143.55 24.74 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 176.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.4 p -136.05 128.51 45.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-O 121.216 0.531 . . . . 0.0 109.568 177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.424 HG23 HG22 ' A' 1504 ' ' VAL . 23.4 m -92.65 108.21 19.8 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 3.4 p30 -81.52 138.8 47.7 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.799 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -83.25 4.49 7.03 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.612 2.208 . . . . 0.0 113.546 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -88.85 -59.25 2.28 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.924 0.392 . . . . 0.0 110.333 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . 0.506 ' OG1' ' HG2' ' A' 1625 ' ' GLU . 6.8 p -104.41 -12.51 16.51 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.862 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.74 13.33 83.26 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.546 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 84.0 t80 -86.17 130.94 34.36 Favored 'General case' 0 C--O 1.254 1.319 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.424 HG22 HG23 ' A' 1497 ' ' THR . 45.3 t -89.82 108.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.3 m-85 -79.11 105.93 10.79 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . 0.449 ' O ' HD11 ' A' 1622 ' ' LEU . 9.3 t70 -94.84 102.63 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 30.9 tp -86.58 2.7 47.29 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.939 0.4 . . . . 0.0 110.626 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' 1511 ' ' LYS . 28.8 m-80 -71.84 -18.61 62.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.379 0.609 . . . . 0.0 109.84 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 59.0 m -82.18 -19.33 40.09 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.137 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' 1598 ' ' PRO . 0.2 OUTLIER -115.84 10.29 15.27 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.64 ' HA ' HG23 ' A' 1530 ' ' VAL . 19.3 pttp -76.17 134.03 40.03 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.574 0.702 . . . . 0.0 111.434 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.599 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 1.9 tpm_? -127.81 94.03 3.84 Favored 'General case' 0 N--CA 1.408 -2.558 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 173.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' 1513 ' ' GLU . 0.2 OUTLIER -75.19 -14.93 60.58 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.232 1.013 . . . . 0.0 111.248 -174.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 13.8 p -78.84 -13.15 59.97 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.179 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 91.17 137.78 7.49 Favored Glycine 0 N--CA 1.424 -2.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.173 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' 1527 ' ' ARG . 83.0 m-85 -82.28 126.68 32.4 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 11.8 p -102.54 90.13 3.75 Favored 'General case' 0 C--N 1.284 -2.261 0 O-C-N 123.73 0.644 . . . . 0.0 109.452 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 19.3 pt -109.29 159.47 8.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.154 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.4 m -83.79 127.16 33.61 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.821 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 10.0 t0 -87.48 157.94 19.07 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . 0.717 ' HB ' HD21 ' A' 1604 ' ' LEU . 14.7 tt -70.84 -23.54 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.627 0.727 . . . . 0.0 109.432 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.446 HH22 HD21 ' A' 1614 ' ' LEU . 54.4 mtt180 -71.65 -0.92 11.97 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.234 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 71.22 83.56 0.14 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.055 1.342 . . . . 0.0 110.6 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 173.85 179.95 44.82 Favored Glycine 0 N--CA 1.414 -2.807 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 14.4 m -110.31 139.67 45.26 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.22 133.7 67.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' 1516 ' ' TYR . 24.5 ttm180 -111.31 112.87 24.95 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -174.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.7 mp -119.71 120.63 37.15 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.479 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -96.49 125.3 8.39 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.0 m -96.19 117.73 41.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.52 ' HA ' ' CH2' ' A' 1555 ' ' TRP . 74.6 m 72.57 10.49 5.66 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.172 0.989 . . . . 0.0 112.776 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -145.8 142.65 10.82 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -85.77 140.53 30.39 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.7 m -76.67 97.23 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 122.829 1.3 . . . . 0.0 109.543 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.783 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -61.19 -21.2 63.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.048 -1.433 . . . . 0.0 112.867 -174.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.43 -19.01 36.73 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.787 0.327 . . . . 0.0 110.979 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . 0.65 ' HB2' HG23 ' A' 1534 ' ' VAL . 76.2 m -105.76 4.95 30.48 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.538 0.685 . . . . 0.0 110.03 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 106.47 145.96 13.18 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.188 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.46 129.18 23.14 Favored 'Trans proline' 0 C--O 1.248 0.983 0 C-N-CA 122.9 2.4 . . . . 0.0 111.843 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 103.7 -5.79 47.87 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.552 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 41.8 mm -93.48 128.24 45.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.623 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -91.63 -40.64 5.28 Favored Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.85 134.92 33.96 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . 0.525 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.7 p -141.53 150.48 42.19 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . . . . . . . . . 81.8 t80 -96.16 130.19 43.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -76.5 107.54 8.84 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 123.835 0.709 . . . . 0.0 109.765 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.79 -89.19 0.12 Allowed Glycine 0 C--N 1.283 -2.399 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 4.3 m -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.945 0.403 . . . . 0.0 110.56 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 86.35 27.23 30.95 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 26.1 pt -82.96 141.53 14.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 120.761 0.315 . . . . 0.0 110.376 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 22.9 pttm -94.51 138.58 32.25 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.296 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -101.96 12.0 37.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.73 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.887 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.49 147.52 4.68 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.443 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 62.7 mttm -82.69 150.79 26.56 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.699 0.399 . . . . 0.0 110.134 177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.52 ' CH2' ' HA ' ' A' 1531 ' ' CYS . 30.0 t-105 -69.05 123.87 22.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.38 174.44 15.42 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -174.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.97 44.09 1.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' 1558 ' ' LYS . 32.2 mmtp -81.81 77.25 8.66 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 119.856 -0.737 . . . . 0.0 110.357 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 96.3 mt -113.58 98.42 7.05 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 175.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 16.8 m -111.97 139.99 47.02 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 93.2 t80 -97.35 103.26 15.18 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 17.6 m -130.75 113.09 23.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.879 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 20.9 t70 59.5 44.08 15.3 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 122.207 1.003 . . . . 0.0 110.439 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 62.7 17.22 9.59 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.348 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.9 t -110.49 126.14 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.944 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.3 tp -90.0 115.77 27.54 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -102.2 120.17 40.01 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 122.29 -0.256 . . . . 0.0 111.034 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . 0.41 ' HB2' ' HE1' ' A' 1590 ' ' PHE . 26.6 tp -106.31 109.08 20.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 170.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.438 HG22 HG23 ' A' 1587 ' ' VAL . 21.9 t -109.67 119.3 58.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.099 -175.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.887 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 53.7 m-85 -94.61 115.9 28.12 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.44 161.2 16.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.053 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 12.0 t70 56.94 71.96 0.54 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 126.341 1.856 . . . . 0.0 113.499 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -90.84 -136.21 6.63 Favored Glycine 0 N--CA 1.424 -2.103 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -96.26 144.92 28.67 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.779 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 36.9 Cg_endo -67.89 141.84 55.16 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.225 1.95 . . . . 0.0 112.427 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 74.9 m -98.37 141.41 22.9 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.31 -12.52 35.27 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.658 2.905 . . . . 0.0 114.846 -173.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -70.33 -61.95 1.58 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.559 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.1 m120 -119.97 -4.93 10.09 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.3 mm? 70.42 -48.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.202 1.001 . . . . 0.0 113.374 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 26.3 m80 -76.17 -4.54 42.25 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.959 0.409 . . . . 0.0 111.97 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.726 HD13 ' HA ' ' A' 1611 ' ' THR . 61.9 mt -101.06 120.13 39.75 Favored 'General case' 0 C--N 1.29 -2.022 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.779 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.6 mttt -118.41 163.23 17.05 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -52.63 110.64 0.53 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 36.2 tptt -116.93 130.96 57.04 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -172.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 9.3 t -127.0 118.97 25.55 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.581 -177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.438 HG23 HG22 ' A' 1569 ' ' VAL . 6.7 p -118.26 111.33 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-O 121.836 0.827 . . . . 0.0 109.903 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.32 108.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 49.0 m -88.54 109.56 20.17 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.547 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.944 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 96.9 m-85 -85.92 104.57 15.69 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.3 m -101.52 163.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' 1620 ' ' THR . 46.2 t -97.23 144.65 26.83 Favored 'General case' 0 C--N 1.278 -2.53 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.399 -172.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.516 ' HG2' ' OE1' ' A' 1601 ' ' GLN . 17.6 tppt? -150.47 115.38 5.3 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 5.3 p -61.52 -41.51 97.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -86.19 25.64 1.14 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -97.1 -63.3 1.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.052 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 75.84 -156.01 47.16 Favored Glycine 0 C--O 1.25 1.104 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -176.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . 0.575 ' HA ' HD21 ' A' 1510 ' ' LEU . 41.4 Cg_endo -66.45 -20.95 54.11 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.888 2.392 . . . . 0.0 111.422 177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 p -94.44 62.42 2.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 17.3 m -63.67 149.04 47.49 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.325 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.625 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 39.7 mt-30 -87.14 128.55 55.15 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -173.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.9 Cg_endo -91.36 134.35 1.63 Allowed 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 122.977 2.451 . . . . 0.0 111.193 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' 1617 ' ' SER . 64.7 tp -131.66 108.03 9.22 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.033 0.445 . . . . 0.0 110.388 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.717 HD21 ' HB ' ' A' 1521 ' ' ILE . 64.3 tp -68.15 116.4 8.72 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 39.1 tp -98.15 -63.36 1.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.016 -174.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 34.8 m -150.33 137.49 19.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.63 -174.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 81.0 t -131.61 119.33 42.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.03 126.75 52.91 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.514 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -80.91 -10.21 59.74 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.95 -52.17 6.92 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.343 0.592 . . . . 0.0 109.513 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.726 ' HA ' HD13 ' A' 1582 ' ' LEU . 46.0 p -92.41 -19.64 21.85 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 63.6 m 66.89 23.34 9.97 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.415 1.086 . . . . 0.0 110.601 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 11.0 m -81.18 120.99 25.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.159 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.673 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 90.1 mt -102.39 115.94 31.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.299 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.32 114.77 29.22 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.673 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.0 m-85 -122.02 135.91 54.87 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.441 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.715 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 37.4 t -107.86 114.92 29.21 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -109.2 118.29 36.33 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.625 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 38.9 m-70 -98.58 101.33 12.73 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.2 t -129.27 152.95 48.28 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.395 0.617 . . . . 0.0 110.982 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.7 m -75.77 -25.68 56.69 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.317 0.58 . . . . 0.0 109.706 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' 1622 ' ' LEU . 6.8 tt -64.04 -16.8 62.48 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.673 0.789 . . . . 0.0 110.284 -176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -80.16 -9.36 59.71 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 35.0 m -94.53 140.99 29.11 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.012 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . 0.506 ' HG2' ' OG1' ' A' 1501 ' ' THR . 3.5 mp0 -71.91 90.22 1.12 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.05 157.98 25.25 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 113.165 -1.834 . . . . 0.0 113.314 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -63.5 -33.95 76.7 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.079 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 N--CA 1.432 -1.335 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.825 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 7.2 p -88.68 128.37 40.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 72.12 129.08 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.596 1.559 . . . . 0.0 110.606 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.407 ' OD1' HD13 ' A' 1559 ' ' LEU . 1.0 OUTLIER -81.92 151.25 27.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.588 0.709 . . . . 0.0 110.824 -175.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -131.95 61.84 1.65 Allowed 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 114.156 -1.384 . . . . 0.0 108.385 169.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 75.94 22.21 1.48 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.672 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.7 pt20 -153.27 118.66 5.22 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.644 -1.162 . . . . 0.0 107.999 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.1 p -121.83 130.36 74.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.262 -176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 3.8 m -103.84 106.05 16.44 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 6.7 p30 -91.67 134.09 29.82 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.62 -175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 6.6 Cg_exo -67.02 -25.36 44.33 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.893 2.395 . . . . 0.0 113.057 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -56.06 -61.81 2.13 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.014 0.435 . . . . 0.0 111.894 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 21.6 p -96.43 -15.18 21.91 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 69.33 41.23 79.25 Favored Glycine 0 CA--C 1.497 -1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 73.8 t80 -128.85 136.42 50.45 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 120.827 0.346 . . . . 0.0 110.252 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' 1497 ' ' THR . 2.8 p -94.89 118.17 40.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.897 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' 1495 ' ' GLN . 97.9 m-85 -87.18 106.72 18.09 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -86.39 99.02 11.33 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.2 tp -84.94 4.49 33.3 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 122.739 1.257 . . . . 0.0 108.791 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.496 ' HA ' ' HE3' ' A' 1511 ' ' LYS . 62.9 m-20 -58.87 -28.6 66.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.478 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.1 t -79.33 -11.56 59.93 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.049 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.603 ' HB2' HD12 ' A' 1622 ' ' LEU . 20.0 tp -111.73 1.56 16.74 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.687 -0.633 . . . . 0.0 110.602 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.52 ' HE2' ' SG ' ' A' 1531 ' ' CYS . 100.0 mttt -50.21 160.48 0.36 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.563 ' HG3' ' CA ' ' A' 1515 ' ' GLY . 9.2 ttp180 -68.49 105.21 2.13 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.147 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -91.03 -44.68 9.16 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 167.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.3 t -121.96 -35.22 3.21 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.314 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.563 ' CA ' ' HG3' ' A' 1512 ' ' ARG . . . 103.19 162.68 25.55 Favored Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.31 121.03 44.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.0 m -117.57 99.18 6.8 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . 0.419 HG21 ' HG2' ' A' 1602 ' ' PRO . 20.1 pt -101.43 137.98 27.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.506 -177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1525 ' ' SER . 24.1 t -93.64 114.68 27.05 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.663 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 13.7 t70 -89.3 113.96 25.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.83 -18.83 20.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.727 -175.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.471 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 28.1 mtp180 -76.3 -47.32 24.08 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.73 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.83 -59.3 1.36 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.479 -0.888 . . . . 0.0 112.862 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -175.43 -165.44 31.54 Favored Glycine 0 C--O 1.215 -1.056 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.279 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' 1519 ' ' SER . 20.3 m -91.18 154.14 19.53 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 117.385 0.593 . . . . 0.0 111.167 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.472 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.0 tt -134.55 132.59 54.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -111.78 116.59 30.95 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.71 137.07 50.1 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.71 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -107.39 100.0 1.48 Allowed Glycine 0 N--CA 1.411 -2.98 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 7.1 p -76.64 116.69 20.2 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.52 ' SG ' ' HE2' ' A' 1511 ' ' LYS . 46.8 t 70.3 3.69 4.55 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 121.601 0.715 . . . . 0.0 111.418 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -132.16 149.1 19.34 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' 1535 ' ' LYS . 38.5 mt-10 -88.16 131.84 34.56 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 11.3 m -87.95 81.8 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.311 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.632 ' HD2' ' HB2' ' A' 1533 ' ' GLU . 0.0 OUTLIER -67.6 -13.56 62.18 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.958 0.885 . . . . 0.0 110.7 -175.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -58.96 -32.96 70.11 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.45 173.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 51.8 t -108.01 3.67 24.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.398 -178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 124.22 150.52 7.93 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.699 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.66 149.31 38.23 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.402 2.068 . . . . 0.0 111.171 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.13 14.25 80.61 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.927 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.429 HD12 ' HD3' ' A' 1551 ' ' LYS . 44.7 mm -112.86 135.17 53.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -102.28 -35.03 4.01 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 119.669 -1.253 . . . . 0.0 113.184 -176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.58 141.23 39.22 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.993 -0.71 . . . . 0.0 110.676 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' 1541 ' ' ILE . 57.2 m -141.75 146.79 36.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.085 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.7 ' HB3' HG13 ' A' 1550 ' ' ILE . 35.2 t80 -97.6 134.78 40.35 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -81.37 100.86 9.47 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.351 0.596 . . . . 0.0 109.841 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -162.98 -108.35 0.22 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 26.5 m -84.9 -5.94 59.34 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 122.158 0.98 . . . . 0.0 109.057 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 101.03 46.49 1.73 Allowed Glycine 0 CA--C 1.491 -1.41 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.7 HG13 ' HB3' ' A' 1545 ' ' PHE . 14.0 pt -83.7 132.42 31.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.048 0.451 . . . . 0.0 109.991 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.429 ' HD3' HD12 ' A' 1541 ' ' ILE . 58.6 mttp -87.42 138.06 31.81 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.542 -175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -104.88 11.68 33.38 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.434 -176.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.716 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 144.17 146.86 4.58 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.338 176.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' 1572 ' ' ASP . 1.9 mptm? -77.86 147.31 35.2 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 66.0 t90 -69.77 128.84 37.82 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -158.18 158.52 34.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -104.58 88.4 2.93 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.721 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 55.8 tptt -130.36 83.69 2.14 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.166 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.407 HD13 ' OD1' ' A' 1492 ' ' ASP . 11.0 mp -96.39 125.29 40.78 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.28 172.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.693 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 7.9 m -121.58 139.82 53.03 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.046 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 87.3 t80 -106.66 110.06 22.14 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 65.9 t -116.04 92.66 2.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 34.05 88.23 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.359 1.864 . . . . 0.0 115.018 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 67.12 9.34 6.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.506 1.123 . . . . 0.0 112.491 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 48.0 t -132.29 136.17 56.81 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.5 tp -96.58 136.86 36.52 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' 1560 ' ' SER . 28.9 mm-40 -120.33 127.05 51.98 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.844 -0.535 . . . . 0.0 110.771 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.7 tp -124.71 124.48 42.24 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.634 HG22 HG23 ' A' 1587 ' ' VAL . 19.6 t -120.47 122.82 69.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-O 121.26 0.552 . . . . 0.0 112.051 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.716 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 59.8 m-85 -101.51 113.43 26.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 172.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.3 161.14 17.59 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.762 -177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.499 ' O ' ' HD3' ' A' 1554 ' ' LYS . 35.7 t70 60.2 83.19 0.14 Allowed 'General case' 0 C--O 1.209 -1.033 0 O-C-N 124.657 1.223 . . . . 0.0 113.173 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.93 -96.83 2.31 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.409 ' H ' ' HD2' ' A' 1584 ' ' TYR . 7.5 m-20 -124.23 150.25 63.15 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.21 136.7 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.623 2.216 . . . . 0.0 111.662 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 64.5 m -99.65 132.6 22.8 Favored Pre-proline 0 C--N 1.292 -1.902 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.43 16.13 0.2 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.67 2.913 . . . . 0.0 113.949 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -79.41 -49.36 12.48 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.582 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 16.7 m120 -146.85 8.65 0.98 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 29.5 tp 68.93 -47.1 0.57 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.51 1.524 . . . . 0.0 113.98 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 36.3 m80 -75.34 -11.07 59.98 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.552 0.692 . . . . 0.0 110.045 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.698 HD22 HG22 ' A' 1611 ' ' THR . 57.8 mt -85.39 128.15 34.62 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 92.9 mttt -132.04 162.55 30.5 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.409 ' HD2' ' H ' ' A' 1574 ' ' ASP . 92.5 m-85 -65.74 112.2 3.59 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -126.14 134.8 51.21 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 23.1 t -126.92 125.46 41.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.634 HG23 HG22 ' A' 1569 ' ' VAL . 6.5 p -119.85 117.86 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 CA-C-O 121.693 0.758 . . . . 0.0 109.307 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.77 116.37 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.897 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 8.4 t -96.17 104.96 16.95 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.925 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.3 m-85 -87.05 111.5 20.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 34.5 m -105.08 159.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 42.6 t -77.54 128.82 34.81 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.638 0.732 . . . . 0.0 112.501 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 58.4 tptt -145.69 109.18 4.69 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 172.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.8 m -71.57 -28.14 63.64 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.143 0.496 . . . . 0.0 112.199 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.16 30.22 6.1 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.567 0.698 . . . . 0.0 111.15 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -84.74 -52.38 6.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.787 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 78.13 -159.49 47.22 Favored Glycine 0 N--CA 1.434 -1.449 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.71 -20.77 26.1 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.848 2.365 . . . . 0.0 111.708 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 8.2 t -96.81 58.55 1.65 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 123.031 1.396 . . . . 0.0 108.847 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . . . . . . . . . 12.7 m -63.42 130.42 44.35 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.459 -1.7 . . . . 0.0 109.726 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.466 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.7 mt-30 -81.6 125.89 77.28 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.6 Cg_endo -89.61 105.87 0.38 Allowed 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 123.456 2.77 . . . . 0.0 110.873 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 62.9 tp -91.98 130.25 37.77 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 65.1 tp -77.93 127.01 31.7 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' 1617 ' ' SER . 99.3 mt -88.36 -58.32 2.6 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 44.6 m -164.62 147.26 8.66 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.55 -0.75 . . . . 0.0 108.989 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 64.6 t -107.91 111.71 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -98.59 91.66 5.25 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -70.04 -33.06 71.48 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.382 -1.735 . . . . 0.0 115.226 -165.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 51.4 t60 -70.68 -36.9 73.55 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.539 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.698 HG22 HD22 ' A' 1582 ' ' LEU . 0.0 OUTLIER -98.21 0.55 46.04 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.769 -176.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.9 m 55.27 31.1 15.92 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.565 0.746 . . . . 0.0 111.735 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 29.5 m -99.45 126.86 45.44 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.336 0.589 . . . . 0.0 110.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.581 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 87.0 mt -108.65 118.98 38.2 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.345 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -105.87 117.97 35.41 Favored 'General case' 0 C--O 1.254 1.339 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.581 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 79.1 m-85 -128.14 135.95 50.47 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 122.616 0.366 . . . . 0.0 110.663 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.606 ' HB2' HD21 ' A' 1605 ' ' LEU . 22.7 t -106.68 110.94 23.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -98.25 111.89 24.07 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . . . . . . . . . 17.0 m170 -81.4 98.36 8.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 12.1 t -129.4 153.09 48.24 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.611 0.72 . . . . 0.0 112.012 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 23.5 m -77.88 -21.45 51.26 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.71 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.8 -5.63 35.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.901 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.91 1.68 40.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.479 0.657 . . . . 0.0 109.48 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -103.18 162.31 13.08 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.837 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -72.11 133.7 45.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -81.54 114.51 20.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.9 -23.17 13.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.428 -1.54 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.334 178.709 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 CA--C 1.511 -0.541 0 CA-C-O 121.146 0.498 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 35.1 m -126.1 161.44 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.493 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -98.96 89.22 4.21 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.85 117.97 6.79 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.8 m120 -129.34 -74.18 0.56 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' 1508 ' ' ASN . 6.5 t 61.69 23.03 13.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.687 1.195 . . . . 0.0 110.967 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' 1505 ' ' PHE . 21.5 pt20 -149.37 155.01 39.8 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -155.39 136.1 4.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 10.7 m -99.55 131.86 45.27 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 30.3 p30 -83.22 118.83 72.8 Favored Pre-proline 0 C--N 1.313 -1.006 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.121 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.82 -16.46 44.45 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.991 2.46 . . . . 0.0 114.516 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -76.7 -62.89 1.48 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.542 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.5 p -97.16 -16.86 20.24 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 84.03 24.32 48.99 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.793 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -92.26 132.11 36.94 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 117.203 0.501 . . . . 0.0 109.88 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 25.6 t -101.13 106.8 20.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' 1495 ' ' GLN . 76.4 m-85 -81.38 104.15 11.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.76 93.08 7.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.646 0.736 . . . . 0.0 110.203 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 36.1 tp -84.69 -8.38 58.88 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.509 ' HB2' ' HB3' ' A' 1494 ' ' CYS . 59.6 t30 -65.99 -27.96 68.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.502 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 8.5 t -84.76 -11.86 54.91 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.559 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.19 -36.66 9.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' 1530 ' ' VAL . 2.2 pptp? -44.3 127.84 5.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -172.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -98.08 107.98 20.58 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.491 -1.231 . . . . 0.0 108.423 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -69.36 -34.63 74.87 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.74 0.65 . . . . 0.0 111.649 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 64.2 m -65.14 -17.4 64.44 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.247 0.546 . . . . 0.0 110.646 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 83.18 143.83 5.3 Favored Glycine 0 N--CA 1.424 -2.143 0 CA-C-N 115.672 -0.695 . . . . 0.0 113.279 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -77.09 114.28 15.73 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' 1526 ' ' ILE . 7.8 m -107.93 96.88 6.69 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' 1525 ' ' SER . 27.6 pt -102.79 134.23 44.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.73 -175.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 16.2 m -89.15 92.61 9.26 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.73 123.2 40.35 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.579 0.704 . . . . 0.0 111.509 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.25 -16.07 20.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 114.271 -1.331 . . . . 0.0 112.595 -175.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.515 ' HD2' HD23 ' A' 1604 ' ' LEU . 69.1 mtt180 -94.17 -26.38 16.71 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.227 -0.921 . . . . 0.0 112.283 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 52.4 tptt -129.36 -59.27 1.1 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.854 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 166.21 -166.74 38.96 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.526 -0.845 . . . . 0.0 110.999 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' 1518 ' ' ILE . 20.2 m -94.4 112.27 24.05 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.323 0.582 . . . . 0.0 109.458 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' 1545 ' ' PHE . 10.8 tt -120.94 140.48 44.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.436 -175.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -110.84 115.28 29.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.64 119.84 36.2 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.415 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -91.72 127.96 9.14 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' 1511 ' ' LYS . 21.7 t -81.04 116.39 25.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.418 ' SG ' HG12 ' A' 1530 ' ' VAL . 60.7 m 70.67 -24.46 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 172.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -105.07 140.83 15.17 Favored Glycine 0 N--CA 1.421 -2.324 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -74.69 142.61 44.43 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 120.7 0.286 . . . . 0.0 110.353 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 17.5 m -78.16 81.79 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-O 122.428 1.109 . . . . 0.0 109.075 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.628 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.38 -12.01 3.39 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.716 1.607 . . . . 0.0 112.941 -173.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -81.01 -29.17 35.22 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.664 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.0 t -93.66 -3.95 51.51 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-O 122.129 0.966 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 132.5 158.36 8.88 Favored Glycine 0 N--CA 1.422 -2.296 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -69.2 135.68 32.43 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 C-N-CA 123.18 2.587 . . . . 0.0 111.351 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 76.48 9.74 85.91 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.815 -0.63 . . . . 0.0 113.871 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.604 HD12 ' HG2' ' A' 1551 ' ' LYS . 46.5 mm -93.04 133.32 34.61 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -103.58 -48.5 1.19 Allowed Glycine 0 C--N 1.323 -0.155 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.525 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.05 129.39 54.21 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 53.5 t -148.06 138.65 22.98 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.627 0.251 . . . . 0.0 110.467 -177.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' 1526 ' ' ILE . 96.6 m-85 -78.57 127.45 32.15 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.48 103.43 6.48 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 123.728 0.643 . . . . 0.0 109.862 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 154.68 -76.26 0.22 Allowed Glycine 0 N--CA 1.433 -1.511 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . 0.524 ' HB ' HG13 ' A' 1550 ' ' ILE . 16.7 m -81.25 -23.59 37.92 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.072 0.463 . . . . 0.0 110.637 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.57 37.38 10.7 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.385 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.524 HG13 ' HB ' ' A' 1548 ' ' THR . 62.9 mt -84.77 129.33 37.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.604 ' HG2' HD12 ' A' 1541 ' ' ILE . 11.2 mptt -92.32 133.41 35.87 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . 0.529 ' HA ' ' HB3' ' A' 1584 ' ' TYR . . . -111.42 16.16 20.94 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.349 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.823 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 150.73 138.19 2.81 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.835 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 87.0 tttt -86.63 142.81 27.98 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 124.954 1.302 . . . . 0.0 109.188 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 68.5 t90 -64.16 140.2 58.84 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 123.887 0.875 . . . . 0.0 110.321 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -162.26 -179.96 7.43 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -130.95 31.64 4.44 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 118.195 0.452 . . . . 0.0 112.074 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' 1560 ' ' SER . 48.8 tptt -84.15 81.79 8.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.834 0.826 . . . . 0.0 109.921 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.442 HD22 ' HB2' ' A' 1568 ' ' LEU . 0.5 OUTLIER -93.2 98.18 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.3 t -89.62 158.7 17.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.15 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.1 t80 -130.29 104.77 7.47 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 96.3 t -115.07 97.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 36.5 t70 49.95 74.55 0.2 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.843 1.257 . . . . 0.0 112.365 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 67.91 -9.73 0.45 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.829 1.252 . . . . 0.0 113.654 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 85.6 t -107.17 132.19 55.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.794 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 9.4 mp -81.86 141.3 33.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' 1560 ' ' SER . 26.8 mm-40 -131.56 114.86 15.37 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.2 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . 0.442 ' HB2' HD22 ' A' 1559 ' ' LEU . 64.0 tp -123.04 136.08 54.69 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 173.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 8.9 p -135.45 135.42 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-O 121.373 0.606 . . . . 0.0 110.413 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.823 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 70.8 m-85 -105.53 104.6 14.36 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -102.71 163.44 12.22 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.109 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 30.4 t70 64.95 79.29 0.26 Allowed 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 124.282 1.033 . . . . 0.0 112.027 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -101.83 -106.35 2.95 Favored Glycine 0 N--CA 1.42 -2.416 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -114.86 160.05 35.05 Favored Pre-proline 0 C--N 1.281 -2.399 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 172.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.42 151.52 48.05 Favored 'Trans proline' 0 C--O 1.247 0.972 0 C-N-CA 122.054 1.836 . . . . 0.0 110.969 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 78.2 m -103.13 126.96 30.86 Favored Pre-proline 0 C--N 1.298 -1.651 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.369 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.3 Cg_exo -58.18 -23.82 63.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.86 3.04 . . . . 0.0 113.681 -177.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -63.6 -65.35 0.69 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.604 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 22.7 t-20 -111.72 -14.72 13.56 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.734 -0.787 . . . . 0.0 112.377 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.43 -45.08 0.61 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.116 0.966 . . . . 0.0 113.132 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 56.3 m80 -68.05 -19.32 64.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.721 0.772 . . . . 0.0 110.036 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.958 HD13 ' HA ' ' A' 1611 ' ' THR . 41.6 mt -95.08 140.96 29.29 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.642 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 62.0 mttm -132.42 161.41 33.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.529 ' HB3' ' HA ' ' A' 1552 ' ' ALA . 97.3 m-85 -65.34 116.53 6.75 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' 1613 ' ' THR . 21.5 mtpp -129.74 130.38 45.36 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' 1570 ' ' TYR . 12.3 p -120.82 120.43 35.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-O 120.724 0.297 . . . . 0.0 110.335 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -116.1 119.54 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 121.792 0.806 . . . . 0.0 109.949 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.97 108.5 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 11.8 p -86.01 114.85 23.22 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.617 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.83 ' HD1' ' HE3' ' A' 1618 ' ' TRP . 53.9 m-85 -93.98 109.17 20.92 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.3 m -108.91 168.36 3.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' 1624 ' ' CYS . 38.0 t -75.96 117.51 17.76 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.771 0.828 . . . . 0.0 111.084 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.758 ' HE3' ' HB3' ' A' 1595 ' ' ASP . 56.7 tptt -146.13 88.06 1.78 Allowed 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . 0.596 ' HA ' ' HB3' ' A' 1621 ' ' SER . 17.9 m -73.84 -13.35 60.91 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.621 0.724 . . . . 0.0 110.263 -178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . 0.758 ' HB3' ' HE3' ' A' 1593 ' ' LYS . 29.9 t70 -80.96 -7.36 59.5 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.611 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . . . . . . . . . . . -93.03 -64.39 1.1 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 72.63 -123.99 9.29 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.37 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.04 -16.57 49.7 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 123.741 2.961 . . . . 0.0 113.741 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.9 p -83.01 -66.95 0.83 Allowed 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.463 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' 1620 ' ' THR . 51.3 m 61.05 97.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 O-C-N 124.322 1.014 . . . . 0.0 110.463 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 14.5 mm100 -101.61 131.61 22.74 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.072 -171.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 2.9 Cg_endo -86.03 112.76 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.431 2.754 . . . . 0.0 111.345 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.01 125.5 47.63 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.515 HD23 ' HD2' ' A' 1522 ' ' ARG . 47.6 tp -78.79 116.22 18.98 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.116 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 95.1 mt -81.74 -51.37 8.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.074 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.5 t -164.08 135.68 4.65 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.488 HG23 HD21 ' A' 1604 ' ' LEU . 93.4 t -102.51 111.26 31.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.9 t70 -104.24 99.52 9.24 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.798 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.59 8.62 9.29 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -82.24 -51.58 7.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.958 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.7 OUTLIER -103.23 -4.04 24.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.816 -173.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 79.7 m 62.53 31.19 17.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 110.376 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' 1585 ' ' LYS . 23.6 m -103.72 125.56 50.28 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.921 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.602 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 85.7 mt -98.72 119.93 38.29 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.064 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -104.53 109.93 22.01 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.602 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 63.2 m-85 -121.29 134.72 55.17 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.1 t -108.73 107.28 17.66 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.83 ' HE3' ' HD1' ' A' 1590 ' ' PHE . 18.4 t90 -93.99 106.69 18.65 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.462 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 72.4 m-70 -83.32 103.6 12.84 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.733 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' 1600 ' ' SER . 9.8 t -139.21 153.83 47.93 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.359 0.599 . . . . 0.0 109.996 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . 0.596 ' HB3' ' HA ' ' A' 1594 ' ' SER . 0.8 OUTLIER -76.86 -24.88 52.63 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.357 177.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 2.6 tt -70.94 -8.64 54.51 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 122.203 1.002 . . . . 0.0 109.145 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -109.8 12.42 24.01 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 121.73 0.776 . . . . 0.0 110.173 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . 0.445 ' HB2' ' HA ' ' A' 1592 ' ' CYS . 33.8 t -110.7 164.9 12.29 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -56.3 139.52 47.96 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.2 115.66 19.88 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.077 0.941 . . . . 0.0 111.99 -164.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -110.41 7.17 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.149 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 35.1 t . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 CA--C 1.491 -1.289 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 42.1 t 60.88 74.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -173.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 70.01 82.86 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 113.785 -1.552 . . . . 0.0 108.918 -170.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -59.11 164.1 3.27 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.575 1.15 . . . . 0.0 111.169 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' 1495 ' ' GLN . 31.5 m-80 -94.04 12.43 26.34 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 123.004 0.522 . . . . 0.0 110.237 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' 1507 ' ' LEU . 72.4 m 71.16 22.95 4.25 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 124.111 0.964 . . . . 0.0 110.026 -178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' 1493 ' ' ASN . 10.4 pt20 -128.17 128.18 44.33 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.322 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 9.5 p -131.08 132.45 63.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.776 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 19.9 m -93.64 129.52 39.9 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.422 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 11.5 p30 -89.1 136.16 30.72 Favored Pre-proline 0 N--CA 1.435 -1.208 0 C-N-CA 119.649 -0.82 . . . . 0.0 108.852 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 1.8 Cg_endo -82.14 -12.5 10.56 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.998 1.798 . . . . 0.0 110.8 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.49 76.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.679 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 22.7 p -126.23 -30.18 2.93 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 111.12 11.7 17.66 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.254 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 66.1 t80 -84.84 136.63 33.58 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.358 -0.495 . . . . 0.0 109.916 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' 1497 ' ' THR . 64.7 t -99.91 119.3 47.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.59 ' O ' ' HA ' ' A' 1495 ' ' GLN . 88.2 m-85 -87.61 104.45 16.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.76 101.02 12.67 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.791 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . 0.857 ' HB3' ' HB3' ' A' 1494 ' ' CYS . 18.3 tp -83.31 -10.04 58.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.791 1.281 . . . . 0.0 107.975 175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' 1511 ' ' LYS . 6.9 p30 -67.05 -14.87 63.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.213 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 23.7 m -89.42 -6.44 56.55 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.591 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.591 ' HB2' HD12 ' A' 1622 ' ' LEU . 34.2 tp -114.65 9.35 16.48 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.442 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' 1508 ' ' ASN . 48.7 mttp -43.34 148.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.492 ' HB2' ' HA2' ' A' 1515 ' ' GLY . 0.1 OUTLIER -68.22 147.85 51.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.66 -173.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -74.21 -66.14 0.76 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 42.9 t -116.89 -19.98 9.62 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 167.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' 1512 ' ' ARG . . . 137.16 143.42 4.58 Favored Glycine 0 N--CA 1.414 -2.829 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 -173.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' 1527 ' ' ARG . 41.7 m-85 -69.02 113.72 6.65 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.2 m -113.01 90.94 3.48 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 33.7 pt -117.76 152.88 19.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.475 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 41.4 m -92.62 137.13 32.63 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.88 175.48 7.27 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . 0.437 HG23 ' HG3' ' A' 1522 ' ' ARG . 15.2 tt -58.0 -25.49 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 CA-C-O 121.189 0.519 . . . . 0.0 111.95 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.437 ' HG3' HG23 ' A' 1521 ' ' ILE . 68.0 mtp180 -92.45 3.15 56.05 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.113 0.482 . . . . 0.0 111.135 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.6 mmtt 77.83 25.49 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.687 1.595 . . . . 0.0 114.492 175.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -91.7 125.47 8.06 Favored Glycine 0 N--CA 1.419 -2.474 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 173.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 69.7 m -79.02 122.25 25.96 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 120.949 0.404 . . . . 0.0 110.282 -178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 13.7 tt -114.57 136.03 52.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.593 ' HB3' ' SG ' ' A' 1544 ' ' CYS . 50.2 ttm-85 -114.92 123.42 49.09 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.4 mp -124.02 134.68 53.39 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.253 -178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -110.79 119.08 5.14 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' 1511 ' ' LYS . 27.5 m -96.12 143.27 12.46 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 CA-C-N 117.036 0.418 . . . . 0.0 109.969 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.65 ' HA ' HE22 ' A' 1557 ' ' GLN . 72.5 m 74.61 -37.75 0.36 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.873 1.269 . . . . 0.0 113.203 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -131.8 150.44 19.55 Favored Glycine 0 N--CA 1.416 -2.642 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.79 155.04 37.41 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 124.24 0.612 . . . . 0.0 111.531 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 7.7 p -96.92 89.64 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 122.265 1.031 . . . . 0.0 110.219 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -64.85 -20.86 66.63 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.491 -175.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 7.7 t70 -56.38 -45.64 80.46 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.021 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 54.0 m -92.78 -15.08 27.0 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.161 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 148.88 136.88 2.73 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.34 137.4 74.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.853 2.369 . . . . 0.0 112.572 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 85.44 -5.92 81.74 Favored Glycine 0 C--N 1.31 -0.901 0 CA-C-N 115.501 -0.772 . . . . 0.0 113.705 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.0 mm -91.68 141.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.472 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -110.04 -29.59 3.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.058 -1.067 . . . . 0.0 112.179 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -135.86 120.05 17.77 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' 1527 ' ' ARG . 8.1 p -127.95 144.61 51.1 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.195 0.521 . . . . 0.0 111.17 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 78.7 t80 -105.35 125.53 51.08 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -82.26 57.26 3.53 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.054 0.931 . . . . 0.0 111.246 -176.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' 1549 ' ' GLY . . . -164.28 114.13 0.58 Allowed Glycine 0 C--N 1.289 -2.043 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . 0.46 ' HB ' HG13 ' A' 1550 ' ' ILE . 28.2 m 72.46 -22.23 0.22 Allowed 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 124.122 0.969 . . . . 0.0 110.938 -174.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' 1547 ' ' GLY . . . 85.49 35.29 12.1 Favored Glycine 0 N--CA 1.422 -2.264 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -176.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 72.8 mt -64.33 138.22 23.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 O-C-N 123.934 0.432 . . . . 0.0 109.926 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' 1551 ' ' LYS . 10.1 mptt -101.55 120.56 40.5 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -102.44 14.82 30.94 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.165 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . . . . . . . . . . . 147.6 144.13 3.95 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.348 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 54.0 pttt -96.0 155.14 16.88 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.687 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 42.1 t90 -63.82 134.95 56.17 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.824 0.703 . . . . 0.0 110.164 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 5.6 p30 -169.86 164.06 9.71 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . 0.65 HE22 ' HA ' ' A' 1531 ' ' CYS . 19.2 mm-40 -122.32 83.25 2.08 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 120.933 0.397 . . . . 0.0 110.475 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . 0.494 ' HE2' ' HB2' ' A' 1560 ' ' SER . 1.7 tmtp? -107.06 98.94 8.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 111.6 23.41 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.494 ' HB2' ' HE2' ' A' 1558 ' ' LYS . 9.7 t -120.14 119.59 33.73 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 120.096 -0.641 . . . . 0.0 109.53 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 58.3 t80 -86.31 113.53 22.37 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.66 84.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 15.4 t70 45.52 81.77 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.016 1.726 . . . . 0.0 113.334 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 68.26 -0.23 2.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.341 1.056 . . . . 0.0 113.434 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 53.3 t -116.89 128.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.725 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 13.4 tp -96.52 122.66 39.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -103.95 119.82 39.74 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 122.079 -0.388 . . . . 0.0 110.666 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 66.9 tp -116.16 130.18 56.67 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 82.4 t -118.83 129.9 74.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.687 ' HE1' ' HA ' ' A' 1555 ' ' TRP . 38.7 m-85 -121.54 97.26 5.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -118.04 -178.68 3.56 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.444 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 23.4 t70 61.71 63.7 1.12 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 125.245 1.418 . . . . 0.0 111.829 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -99.82 -121.62 4.67 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.367 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.8 145.21 34.39 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.542 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 16.0 Cg_exo -72.23 142.98 38.69 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.605 2.203 . . . . 0.0 109.676 174.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 69.1 m -98.13 134.05 22.46 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -69.56 8.34 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.136 2.557 . . . . 0.0 113.625 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -80.36 -51.71 8.54 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.578 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.1 m120 -134.2 0.93 3.17 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' 1580 ' ' LEU . 4.0 mm? 68.99 -54.47 0.56 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 44.0 m80 -75.1 -16.33 60.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.882 0.373 . . . . 0.0 110.959 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.832 HD13 ' HA ' ' A' 1611 ' ' THR . 62.0 mt -82.52 123.62 29.35 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 174.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 94.5 mttt -122.78 162.62 21.72 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -64.1 115.08 4.61 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' 1613 ' ' THR . 8.7 mtpm? -128.54 131.87 48.25 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.543 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 20.4 t -120.12 131.27 54.98 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.2 p -121.88 120.82 62.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.53 105.77 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 23.6 m -90.35 110.55 21.63 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.725 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 95.6 m-85 -86.21 112.47 21.39 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.7 m -101.13 161.56 3.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' 1624 ' ' CYS . 45.0 t -81.24 137.08 35.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.713 0.768 . . . . 0.0 112.117 -173.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' A' 1596 ' ' ALA . 25.1 tptp -154.65 98.76 2.1 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 46.8 t -61.41 -28.8 69.52 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.12 0.486 . . . . 0.0 110.358 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.93 81.82 1.55 Allowed 'General case' 0 N--CA 1.432 -1.369 0 CA-C-O 122.573 1.177 . . . . 0.0 109.054 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -125.96 -29.64 3.06 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.593 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.01 168.46 40.59 Favored Glycine 0 N--CA 1.421 -2.302 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.43 -10.96 30.56 Favored 'Trans proline' 0 N--CA 1.482 0.807 0 C-N-CA 123.21 2.607 . . . . 0.0 111.86 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.1 p -90.7 -40.76 11.67 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.847 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.404 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 38.2 m 68.27 169.54 0.28 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.735 1.214 . . . . 0.0 110.955 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 13.2 mm-40 -114.5 120.85 37.13 Favored Pre-proline 0 C--N 1.311 -1.09 0 C-N-CA 119.258 -0.977 . . . . 0.0 112.347 -174.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 10.2 Cg_endo -91.19 101.95 0.24 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 123.117 2.545 . . . . 0.0 111.288 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' 1617 ' ' SER . 63.3 tp -89.75 119.66 30.34 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 54.4 tp -81.17 109.86 16.11 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.18 -63.5 1.35 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.171 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.9 m -144.51 143.33 30.79 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.903 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 60.7 t -118.93 110.88 31.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.29 108.71 20.3 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.139 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -80.4 -0.1 35.59 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -100.8 -48.24 4.54 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.423 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.832 ' HA ' HD13 ' A' 1582 ' ' LEU . 58.0 p -95.42 -7.0 39.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.43 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 82.4 m 64.63 25.88 13.15 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.765 0.826 . . . . 0.0 111.476 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' 1585 ' ' LYS . 57.8 m -93.59 127.03 39.07 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-O 121.352 0.596 . . . . 0.0 109.918 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 69.8 mt -102.51 127.77 49.43 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.786 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -110.63 114.75 28.38 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -118.37 135.35 54.38 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.299 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.518 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 15.2 m -108.71 103.52 12.62 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 1.7 t-105 -94.03 107.84 19.72 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.472 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 76.4 m-70 -78.79 99.92 6.91 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 13.2 t -134.08 153.05 52.06 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 110.264 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.7 m -73.17 -29.07 62.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.448 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' 1510 ' ' LEU . 62.5 mt -74.42 -4.58 37.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -175.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' 1590 ' ' PHE . . . -82.81 -25.7 32.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.336 0.589 . . . . 0.0 111.722 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' 1592 ' ' CYS . 14.4 p -117.52 177.98 4.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.967 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.4 84.75 0.81 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 122.23 1.014 . . . . 0.0 110.157 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -81.77 137.06 35.39 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 113.924 -1.489 . . . . 0.0 110.209 -175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -124.8 -22.59 4.5 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.337 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--O 1.243 0.744 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.311 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 46.8 t -108.17 -24.11 4.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 71.34 16.35 6.11 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.793 1.237 . . . . 0.0 111.181 -177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.68 77.6 1.37 Allowed 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -147.65 92.87 2.13 Favored 'General case' 0 CA--C 1.481 -1.676 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.119 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 6.6 t 62.11 30.92 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.274 1.035 . . . . 0.0 110.965 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' 1505 ' ' PHE . 24.8 pt20 -152.61 145.7 24.59 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.061 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.3 p -145.5 134.99 17.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.693 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 22.7 m -92.03 125.66 36.8 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' 1503 ' ' TYR . 9.5 p30 -86.39 147.25 43.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 C-N-CA 120.091 -0.643 . . . . 0.0 109.859 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.45 2.71 8.33 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.574 2.183 . . . . 0.0 113.894 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -92.88 -57.77 2.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.203 0.525 . . . . 0.0 111.297 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 35.0 p -105.99 -17.7 14.26 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.945 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 80.66 19.23 68.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.394 -0.908 . . . . 0.0 110.842 -176.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . 0.524 ' HB3' ' ND2' ' A' 1498 ' ' ASN . 53.3 t80 -79.45 133.62 36.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 48.6 t -99.83 110.11 26.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' 1495 ' ' GLN . 96.2 m-85 -80.86 106.77 13.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -97.97 102.77 14.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.299 0.571 . . . . 0.0 112.048 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 19.5 mt -91.04 -4.88 56.0 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.341 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.689 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 52.3 m-80 -62.6 -29.9 70.94 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 25.3 t -71.93 -14.97 62.07 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.793 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 81.9 mt -113.12 3.05 15.89 Favored 'General case' 0 C--N 1.317 -0.829 0 O-C-N 122.397 -0.189 . . . . 0.0 111.129 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.689 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 55.6 mtmt -58.8 118.79 6.12 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.851 0.834 . . . . 0.0 112.985 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 -106.6 97.33 7.14 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.001 -177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -34.59 64.7 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 125.44 1.496 . . . . 0.0 113.53 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 40.5 m -81.26 -19.82 42.27 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 85.32 155.99 25.64 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.904 -176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.516 ' O ' ' HA ' ' A' 1527 ' ' ARG . 71.5 m-85 -92.43 133.09 36.22 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 9.4 p -112.07 91.5 3.68 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.258 0.551 . . . . 0.0 111.096 -177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 16.9 pt -96.39 152.07 3.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.301 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 19.6 t -97.82 118.89 35.4 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.704 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' 1522 ' ' ARG . 1.9 t70 -74.46 151.65 39.55 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.569 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 15.7 tt -79.55 -16.25 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.645 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.549 ' HB2' ' OD2' ' A' 1520 ' ' ASP . 10.4 mtp-105 -87.62 1.96 52.24 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 73.9 mmtt 72.45 77.75 0.15 Allowed 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.002 1.721 . . . . 0.0 113.603 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -165.09 163.26 36.36 Favored Glycine 0 N--CA 1.42 -2.409 0 N-CA-C 107.431 -2.267 . . . . 0.0 107.431 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.3 m -109.71 140.54 43.45 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 118.184 0.992 . . . . 0.0 109.488 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' 1545 ' ' PHE . 12.8 tt -124.65 130.39 73.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' 1516 ' ' TYR . 17.7 ttm180 -112.68 119.14 37.06 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.383 -176.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.39 127.01 47.85 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.947 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.37 129.47 9.89 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 108.403 -1.879 . . . . 0.0 108.403 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' 1511 ' ' LYS . 18.4 m -85.86 115.49 27.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.112 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.473 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 21.7 m 62.92 12.61 5.95 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.469 1.107 . . . . 0.0 111.714 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -135.56 147.56 19.24 Favored Glycine 0 N--CA 1.415 -2.76 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' 1533 ' ' GLU . 0.1 OUTLIER -77.9 141.18 39.22 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 123.802 0.354 . . . . 0.0 110.219 -178.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 10.3 m -85.23 87.97 2.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-O 122.01 0.909 . . . . 0.0 109.28 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.638 ' HD2' ' H ' ' A' 1535 ' ' LYS . 2.1 mptp? -59.39 -28.96 67.36 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.683 -172.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.19 -36.75 71.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.579 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.5 m -96.86 -29.14 13.89 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.053 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 152.32 159.25 8.88 Favored Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.932 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.5 143.88 31.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.288 1.992 . . . . 0.0 111.323 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 81.46 6.21 89.38 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.537 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.0 131.62 59.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -95.57 -32.88 6.7 Favored Glycine 0 C--N 1.319 -0.392 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.302 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.21 138.96 35.52 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 26.6 p -145.37 158.3 43.86 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' 1526 ' ' ILE . 38.8 t80 -113.91 106.17 14.13 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.31 106.76 7.0 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 122.011 0.91 . . . . 0.0 109.976 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 155.8 -67.39 0.3 Allowed Glycine 0 C--N 1.276 -2.754 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.75 -21.77 29.91 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 81.91 21.31 61.57 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 43.1 pt -91.7 151.1 3.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.215 0.531 . . . . 0.0 111.124 -176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.735 ' HD2' ' HB2' ' A' 1574 ' ' ASP . 74.7 mttt -87.43 156.43 19.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -124.41 7.51 8.36 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.415 0.626 . . . . 0.0 110.593 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.817 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 146.75 144.46 4.04 Favored Glycine 0 C--O 1.256 1.473 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.948 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.486 ' HD2' ' HB3' ' A' 1572 ' ' ASP . 14.1 ptmt -85.28 160.73 19.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.688 0.744 . . . . 0.0 110.377 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 70.3 t90 -62.86 132.63 52.78 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.368 0.667 . . . . 0.0 110.795 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' 1570 ' ' TYR . 9.1 p30 -167.35 173.08 9.15 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -128.92 41.06 3.54 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 118.127 0.422 . . . . 0.0 110.04 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -72.11 103.31 3.25 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.077 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 98.8 mt -116.91 96.86 5.66 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.837 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 20.0 m -87.51 115.22 24.79 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 72.4 t80 -94.97 102.37 14.19 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 14.7 m -118.99 92.37 2.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 CA-C-O 121.165 0.507 . . . . 0.0 111.122 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 37.9 t70 54.04 69.97 0.66 Allowed 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 124.371 1.068 . . . . 0.0 112.012 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 67.98 2.83 3.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.543 -1.208 . . . . 0.0 114.028 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 61.1 t -109.37 126.76 66.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.9 mp -94.05 118.03 30.95 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.402 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.837 ' HB2' ' HB2' ' A' 1560 ' ' SER . 17.4 mm-40 -102.64 114.01 27.87 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.57 107.7 18.64 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.606 HG22 HG23 ' A' 1587 ' ' VAL . 17.5 t -111.85 117.46 55.22 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.867 -175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.817 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 50.6 m-85 -93.64 101.73 13.89 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.9 177.72 4.82 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.865 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.774 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 34.2 t0 47.16 63.23 2.04 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 112.289 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . 0.414 ' HA3' ' HB2' ' A' 1584 ' ' TYR . . . -73.73 -77.08 0.64 Allowed Glycine 0 N--CA 1.42 -2.396 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.816 175.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.735 ' HB2' ' HD2' ' A' 1551 ' ' LYS . 13.7 t70 -165.55 156.08 11.89 Favored Pre-proline 0 C--N 1.29 -1.981 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -53.63 145.85 46.43 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.34 2.026 . . . . 0.0 112.38 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . 0.575 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 52.0 t -97.43 139.07 21.2 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 22.3 Cg_exo -62.75 -28.07 76.0 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.203 2.602 . . . . 0.0 114.376 -177.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.48 -44.9 49.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.881 -177.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.84 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 40.5 t-20 -144.8 110.98 5.52 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.54 -15.07 9.7 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 46.1 m80 -94.0 -1.93 53.81 Favored 'General case' 0 N--CA 1.436 -1.143 0 O-C-N 122.085 -0.384 . . . . 0.0 111.843 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.84 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 42.5 mt -90.66 154.8 19.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 66.4 mttm -127.35 151.35 48.89 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.282 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.414 ' HB2' ' HA3' ' A' 1573 ' ' GLY . 83.5 m-85 -61.43 120.09 9.81 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' 1583 ' ' LYS . 92.8 mttt -137.92 140.59 40.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -177.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.427 ' HB3' HD12 ' A' 1614 ' ' LEU . 15.1 p -130.92 123.68 29.44 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 120.799 0.333 . . . . 0.0 110.417 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.606 HG23 HG22 ' A' 1569 ' ' VAL . 7.5 p -108.97 113.85 45.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.688 0.756 . . . . 0.0 110.178 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.89 109.99 28.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 25.9 m -92.37 111.96 23.73 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.0 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.907 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.5 m-85 -86.22 108.22 18.27 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 30.7 m -111.73 167.0 5.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.577 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 46.2 t -76.56 150.89 36.47 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.287 0.565 . . . . 0.0 112.258 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.774 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 22.6 tptp -170.86 115.06 0.44 Allowed 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 174.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 8.3 t -75.44 -28.93 59.53 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.296 0.498 . . . . 0.0 111.921 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.03 12.34 24.4 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.195 -0.316 . . . . 0.0 111.287 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' 1593 ' ' LYS . . . -66.73 -51.84 51.33 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 -172.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 92.63 179.04 40.81 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.71 -28.99 19.97 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.773 2.315 . . . . 0.0 113.033 -176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 -26.4 20.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.294 0.568 . . . . 0.0 109.855 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.563 ' HB3' ' O ' ' A' 1619 ' ' HIS . 21.3 m 63.38 -175.94 0.15 Allowed 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.586 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.813 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 6.9 pt20 -116.24 121.44 33.59 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.821 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 9.6 Cg_endo -92.34 117.45 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.47 2.78 . . . . 0.0 112.111 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' 1617 ' ' SER . 54.2 tp -97.15 124.86 41.31 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.585 HD11 HG23 ' A' 1607 ' ' VAL . 60.4 tp -80.35 112.78 18.01 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.73 -50.49 8.1 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.144 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 32.9 t -175.22 140.28 0.5 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.445 0.466 . . . . 0.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.585 HG23 HD11 ' A' 1604 ' ' LEU . 83.9 t -107.9 110.17 30.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 170.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.57 102.41 12.29 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.24 -1.44 44.92 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.958 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -91.92 -39.74 11.54 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.617 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.629 ' HA ' HD13 ' A' 1582 ' ' LEU . 25.3 p -99.96 -2.15 35.34 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.769 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 90.8 m 58.57 33.93 23.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.901 0.858 . . . . 0.0 111.033 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 24.5 m -112.75 128.75 56.51 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.555 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.6 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 67.2 mt -105.13 134.64 47.9 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.033 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.68 115.94 26.07 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.6 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 62.5 m-85 -130.14 137.27 50.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.76 0.314 . . . . 0.0 110.892 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' 1603 ' ' LEU . 21.0 t -108.45 108.27 19.15 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' 1600 ' ' SER . 11.7 t-105 -97.59 106.9 19.29 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.813 ' HB2' ' HG3' ' A' 1601 ' ' GLN . 66.0 m-70 -86.77 109.58 19.35 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 7.7 t -130.59 149.9 52.04 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.298 0.57 . . . . 0.0 110.916 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 1.1 p -78.87 -26.41 43.96 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.446 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' 1622 ' ' LEU . 3.1 tm? -72.81 -6.93 48.21 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.113 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -101.15 2.41 40.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.314 0.578 . . . . 0.0 109.819 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 63.4 m -87.59 133.05 33.86 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.08 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -61.79 150.28 37.54 Favored 'General case' 0 C--O 1.252 1.211 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -83.41 127.18 33.48 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.88 -56.77 11.33 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.11 0.481 . . . . 0.0 110.742 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.415 -2.177 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.636 177.664 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 CA--C 1.507 -0.696 0 CA-C-O 120.971 0.415 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 43.1 t -110.09 94.97 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.46 133.47 35.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.89 62.93 6.72 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.044 0.926 . . . . 0.0 109.434 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' 1495 ' ' GLN . 39.6 t-20 -112.45 102.58 10.69 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 38.5 t 76.48 -21.23 0.33 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.385 1.474 . . . . 0.0 110.834 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.3 pt20 -118.04 154.28 32.29 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.2 p -142.36 136.88 28.93 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . . . . . . . . . 40.2 m -88.5 126.69 35.37 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.815 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.449 HD22 ' HE2' ' A' 1505 ' ' PHE . 27.9 t-20 -91.57 106.65 17.55 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.29 -19.62 55.97 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.263 2.642 . . . . 0.0 114.61 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -72.65 -53.75 10.93 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 121.061 0.458 . . . . 0.0 110.852 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 17.5 p -96.53 -12.34 24.21 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 79.31 3.93 88.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.67 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' 1628 ' ' VAL . 68.8 t80 -85.02 135.24 34.1 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.401 0.619 . . . . 0.0 110.485 -176.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 38.9 t -97.68 115.85 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.449 ' HE2' HD22 ' A' 1498 ' ' ASN . 97.3 m-85 -89.35 107.63 19.17 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -107.14 120.16 41.35 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.57 0.7 . . . . 0.0 110.7 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . 0.513 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 38.3 tp -79.42 -6.38 56.73 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -53.81 -31.07 47.83 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.47 1.508 . . . . 0.0 112.641 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 33.3 t -77.74 -20.9 52.68 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 121.028 0.442 . . . . 0.0 110.663 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 23.0 tp -116.63 -5.59 11.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.97 0.414 . . . . 0.0 111.568 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.3 pttp -69.6 154.07 42.53 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.493 0.663 . . . . 0.0 111.901 -175.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -121.63 122.01 38.67 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.187 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -68.79 -26.35 65.16 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.539 0.736 . . . . 0.0 110.476 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 14.0 t -89.2 -7.23 56.0 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 75.73 -164.43 53.94 Favored Glycine 0 N--CA 1.427 -1.921 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.473 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.76 145.81 43.24 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' 1526 ' ' ILE . 32.6 m -142.61 100.63 3.72 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 28.2 pt -121.51 132.4 70.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.87 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1525 ' ' SER . 43.0 t -80.0 112.65 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 173.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.72 136.95 32.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.089 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.0 tp -56.65 -32.36 37.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 C-N-CA 124.606 1.163 . . . . 0.0 112.839 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -74.73 -34.13 62.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 28.8 tptp -141.21 -58.69 0.49 Allowed 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.054 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 175.21 -163.41 33.45 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.379 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' 1519 ' ' SER . 45.4 t -81.01 144.01 32.1 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.409 0.623 . . . . 0.0 111.289 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' 1517 ' ' THR . 14.2 tt -127.44 134.26 66.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.409 ' HG2' HG11 ' A' 1534 ' ' VAL . 41.3 ttm180 -124.23 103.78 8.44 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 121.432 0.634 . . . . 0.0 109.593 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.83 144.84 51.74 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.016 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -111.66 139.53 15.64 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.519 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 16.2 m -98.01 117.8 43.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 16.4 m 69.73 19.08 7.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.975 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -153.42 168.71 32.13 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -106.26 149.56 26.76 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.409 HG11 ' HG2' ' A' 1527 ' ' ARG . 20.7 m -94.87 90.51 2.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.318 1.056 . . . . 0.0 108.306 173.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.622 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -63.94 -13.72 48.06 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.402 -172.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.56 -12.96 60.33 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 123.149 0.58 . . . . 0.0 110.569 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . 0.434 ' SG ' ' HG2' ' A' 1551 ' ' LYS . 24.9 t -117.12 11.81 14.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 114.43 163.5 14.58 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.238 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 136.29 12.65 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 122.472 2.114 . . . . 0.0 111.48 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.83 21.6 79.09 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.588 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.8 mm -103.7 118.19 50.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -94.04 -24.82 18.72 Favored Glycine 0 C--N 1.306 -1.115 0 C-N-CA 119.545 -1.312 . . . . 0.0 112.678 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -138.13 132.34 31.83 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 14.1 t -139.94 147.81 41.06 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.521 ' HB3' HG13 ' A' 1550 ' ' ILE . 63.8 t80 -120.01 136.66 54.47 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -86.13 81.57 8.4 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 122.306 1.051 . . . . 0.0 109.45 178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -158.27 85.02 0.13 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.087 -2.005 . . . . 0.0 108.087 177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 7.6 m 69.63 16.76 7.97 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.214 1.007 . . . . 0.0 109.351 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 62.69 67.31 2.14 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.182 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' 1545 ' ' PHE . 23.7 pt -108.6 138.46 35.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 117.061 0.431 . . . . 0.0 110.015 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.434 ' HG2' ' SG ' ' A' 1537 ' ' CYS . 54.6 mttm -88.69 138.86 31.04 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -114.94 18.28 16.49 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.065 0.46 . . . . 0.0 111.231 -172.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 148.2 136.71 2.77 Favored Glycine 0 N--CA 1.431 -1.669 0 C-N-CA 119.569 -1.3 . . . . 0.0 113.948 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 61.0 tttm -85.07 143.54 28.81 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.439 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 37.3 t90 -69.29 134.27 48.92 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.632 0.73 . . . . 0.0 111.099 -175.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.6 p30 -158.88 164.42 35.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 103.291 -2.855 . . . . 0.0 103.291 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -124.27 78.45 1.65 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 118.808 0.731 . . . . 0.0 112.4 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 59.5 mmtt -108.23 92.19 3.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.551 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.14 96.36 7.44 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.8 m -96.93 138.14 34.94 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.542 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . 0.593 ' CZ ' ' HA ' ' A' 1564 ' ' GLN . 7.4 t80 -110.8 101.02 9.67 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 52.9 t -103.64 88.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.175 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.18 72.72 0.28 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.606 1.163 . . . . 0.0 111.49 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . 0.593 ' HA ' ' CZ ' ' A' 1561 ' ' TYR . 26.6 mp0 57.67 24.56 10.7 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.895 -1.502 . . . . 0.0 114.269 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 51.6 t -126.81 120.13 55.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.848 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 11.0 tp -82.31 135.96 35.11 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' 1560 ' ' SER . 26.6 mm-40 -124.45 135.54 53.33 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.804 0.442 . . . . 0.0 110.115 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.95 120.79 18.56 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.59 HG22 HG23 ' A' 1587 ' ' VAL . 39.2 t -119.14 129.48 75.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.322 0.582 . . . . 0.0 111.25 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.84 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 55.9 m-85 -107.34 111.86 24.41 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.462 174.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.551 ' HG2' ' HE3' ' A' 1585 ' ' LYS . 48.1 mt-10 -117.56 177.26 4.82 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.198 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 17.5 t70 64.51 43.88 4.28 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.2 1.0 . . . . 0.0 111.446 175.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -89.32 -139.59 7.31 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.2 155.33 84.28 Favored Pre-proline 0 C--N 1.309 -1.154 0 CA-C-N 117.062 0.431 . . . . 0.0 110.351 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.69 148.97 72.99 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.339 2.026 . . . . 0.0 110.459 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 52.4 t -98.21 126.22 40.72 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -63.99 -7.18 12.73 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.091 2.527 . . . . 0.0 114.335 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -76.71 -61.16 2.06 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.036 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.429 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 3.2 m-20 -117.67 -5.37 11.14 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 69.5 -45.28 0.56 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -70.56 -21.99 62.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.8 0.809 . . . . 0.0 109.173 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.906 HD13 ' HA ' ' A' 1611 ' ' THR . 93.5 mt -82.91 142.42 31.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 60.8 mttm -127.88 162.59 26.34 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -68.38 114.23 6.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.551 ' HE3' ' HG2' ' A' 1571 ' ' GLU . 55.5 mtpt -128.03 138.99 52.79 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.569 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 27.0 t -120.91 120.0 34.24 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.59 HG23 HG22 ' A' 1569 ' ' VAL . 7.7 p -112.31 110.27 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-O 121.98 0.895 . . . . 0.0 109.941 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 107.74 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.86 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 15.4 p -90.73 112.91 24.87 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.069 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.848 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 85.4 m-85 -89.06 106.35 18.38 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -105.64 156.66 6.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' 1620 ' ' THR . 26.2 t -95.1 139.16 31.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.409 -1.317 . . . . 0.0 113.612 -171.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.599 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 27.9 tptp -137.67 98.25 3.63 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 30.6 m -57.59 -29.26 64.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 3.2 p30 -100.76 6.21 43.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 119.367 -0.933 . . . . 0.0 112.285 -178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -64.67 -58.11 7.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.915 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 51.91 -114.53 3.24 Favored Glycine 0 N--CA 1.446 -0.694 0 O-C-N 123.767 0.667 . . . . 0.0 112.625 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.63 -19.96 53.65 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.269 2.646 . . . . 0.0 112.957 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.6 t -117.24 74.46 0.92 Allowed 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 122.705 1.241 . . . . 0.0 110.399 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.43 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 50.7 m -86.42 116.88 24.86 Favored 'General case' 0 N--CA 1.432 -1.369 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.09 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 27.2 mt-30 -93.52 123.92 58.76 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -173.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' 1618 ' ' TRP . 1.4 Cg_endo -84.79 113.15 1.57 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 123.244 2.63 . . . . 0.0 110.449 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.473 HD12 HD23 ' A' 1605 ' ' LEU . 2.2 tm? -96.45 117.55 31.12 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 34.7 tp -82.96 111.59 18.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . 0.473 HD23 HD12 ' A' 1603 ' ' LEU . 90.6 mt -70.78 -55.68 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.483 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 11.9 t -170.88 153.04 3.77 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 99.4 t -105.19 111.66 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 17.2 t70 -88.56 108.35 19.38 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.626 -1.229 . . . . 0.0 110.163 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -81.46 1.84 31.47 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 5.1 t60 -89.85 -51.36 5.53 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.906 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -98.03 -7.37 29.98 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 113.298 -1.774 . . . . 0.0 110.361 -170.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 77.8 m 55.19 34.09 21.93 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 122.276 1.036 . . . . 0.0 112.361 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' 1585 ' ' LYS . 22.3 m -104.55 127.05 52.17 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.023 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.476 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 83.1 mt -92.62 120.9 33.51 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.125 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -103.12 104.19 14.32 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.476 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 67.2 m-85 -118.66 128.99 55.04 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 67.2 m -109.25 105.63 15.14 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.494 ' HE3' ' CD2' ' A' 1590 ' ' PHE . 11.5 t90 -92.49 109.54 20.94 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.599 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 59.9 m-70 -80.53 96.81 6.9 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.616 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' 1592 ' ' CYS . 7.9 t -127.88 153.43 46.66 Favored 'General case' 0 N--CA 1.423 -1.822 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.886 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 11.6 m -72.67 -25.86 61.42 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.145 0.497 . . . . 0.0 111.333 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' 1622 ' ' LEU . 7.2 tt -68.26 -13.26 62.12 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -89.28 -3.35 58.55 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 46.5 m -78.4 169.46 18.21 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 121.937 -0.477 . . . . 0.0 109.965 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.77 82.46 3.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.748 -2.315 . . . . 0.0 104.748 168.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -83.48 121.81 27.69 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.678 -170.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' 1627 ' ' GLU . 1.1 mp0 -51.33 -64.57 0.77 Allowed 'General case' 0 C--N 1.322 -0.621 0 O-C-N 124.567 1.167 . . . . 0.0 109.059 176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' 1503 ' ' TYR . 84.7 t . . . . . 0 C--N 1.317 -0.843 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 C--O 1.224 -0.289 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 63.5 t -68.12 -59.17 4.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 117.969 0.349 . . . . 0.0 110.365 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -126.7 83.64 2.19 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 173.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 5.6 t70 -88.38 -171.47 3.37 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 113.561 -1.654 . . . . 0.0 110.076 -168.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.9 169.36 10.98 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' 1507 ' ' LEU . 6.3 t 68.84 9.66 7.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.919 0.888 . . . . 0.0 111.102 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.1 pt20 -140.46 138.22 34.51 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 12.5 p -139.33 132.91 38.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 22.7 m -93.64 114.38 26.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' 1499 ' ' PRO . 4.7 p30 -79.99 133.08 58.56 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 12.2 Cg_exo -67.87 -32.15 29.83 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 122.535 2.157 . . . . 0.0 112.903 -176.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -55.75 -64.38 0.87 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 32.1 p -96.78 -20.51 18.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.94 0.4 . . . . 0.0 111.958 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.34 1.54 74.99 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.183 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -77.18 128.78 34.99 Favored 'General case' 0 C--O 1.252 1.189 0 CA-C-O 121.672 0.749 . . . . 0.0 111.931 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' 1497 ' ' THR . 22.1 t -85.9 108.2 17.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' 1495 ' ' GLN . 87.9 m-85 -84.67 100.58 11.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -99.41 120.51 39.72 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . 0.595 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 25.7 tp -83.96 3.83 32.41 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-O 121.993 0.902 . . . . 0.0 109.146 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.607 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 1.8 m-20 -57.68 -29.34 64.56 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.535 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . 0.435 ' HB2' HD11 ' A' 1622 ' ' LEU . 10.0 m -71.41 -20.25 62.15 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.642 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.447 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.2 OUTLIER -101.63 -11.02 19.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -175.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.607 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 46.3 mtmt -70.54 152.65 43.74 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.764 0.792 . . . . 0.0 112.317 -176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' 1515 ' ' GLY . 38.7 ttt180 -127.23 119.81 27.25 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 104.173 -2.529 . . . . 0.0 104.173 172.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.11 -45.74 71.95 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 123.828 0.705 . . . . 0.0 112.004 -176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.6 m -81.68 -2.49 50.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.154 0.502 . . . . 0.0 111.136 -178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 77.98 177.77 48.0 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.411 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -110.98 114.25 27.43 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 28.9 m -103.63 102.27 12.14 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.7 pt -122.41 138.26 53.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.878 0.371 . . . . 0.0 110.57 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1525 ' ' SER . 34.3 t -94.39 109.72 21.55 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -75.59 129.32 37.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.62 -20.09 22.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.85 0.719 . . . . 0.0 112.716 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -99.9 -32.25 11.09 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.595 -0.69 . . . . 0.0 110.583 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . 0.642 ' HE2' HG11 ' A' 1607 ' ' VAL . 26.7 mmtm -102.62 -62.94 1.21 Allowed 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 151.87 -168.54 31.2 Favored Glycine 0 C--N 1.296 -1.655 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' 1519 ' ' SER . 44.7 m -85.39 126.6 33.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.984 -177.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.93 140.31 48.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.401 ' HG2' HG11 ' A' 1534 ' ' VAL . 35.8 ttm180 -118.72 117.2 28.27 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.0 mp -117.48 120.67 38.83 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.358 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -97.09 102.44 2.74 Favored Glycine 0 N--CA 1.423 -2.211 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 57.5 t -62.24 115.67 2.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.559 ' HB2' ' CD ' ' A' 1511 ' ' LYS . 21.8 m 60.0 24.83 14.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.553 1.141 . . . . 0.0 111.824 176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -144.12 173.08 25.02 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -108.84 139.08 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.38 0.609 . . . . 0.0 110.846 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' 1537 ' ' CYS . 15.1 m -94.61 93.49 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 CA-C-O 122.038 0.923 . . . . 0.0 109.149 176.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.552 ' HD2' ' H ' ' A' 1535 ' ' LYS . 9.1 mptt -54.73 -30.06 55.16 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.521 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.56 -18.11 63.62 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.681 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . 0.472 ' HB2' HG23 ' A' 1534 ' ' VAL . 80.9 m -113.44 14.0 19.02 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.978 0.418 . . . . 0.0 110.323 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 110.68 128.91 5.48 Favored Glycine 0 N--CA 1.425 -2.035 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 52.7 Cg_exo -59.54 127.98 25.61 Favored 'Trans proline' 0 C--O 1.245 0.83 0 C-N-CA 122.932 2.421 . . . . 0.0 111.547 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 91.96 0.16 71.94 Favored Glycine 0 C--N 1.292 -1.872 0 CA-C-N 115.556 -0.747 . . . . 0.0 113.496 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' 1554 ' ' LYS . 47.7 mm -93.79 134.82 30.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.71 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -105.07 -37.68 2.65 Favored Glycine 0 CA--C 1.503 -0.684 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.484 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -121.35 123.6 42.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . 0.43 ' SG ' HG21 ' A' 1534 ' ' VAL . 31.0 p -137.76 153.83 49.67 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.602 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.46 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 51.6 t80 -94.88 138.33 32.78 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.95 89.64 8.07 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-O 121.666 0.746 . . . . 0.0 110.311 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -178.96 85.43 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 71.3 m 76.85 -37.17 0.27 Allowed 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.155 0.982 . . . . 0.0 112.394 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 132.32 46.23 0.12 Allowed Glycine 0 N--CA 1.438 -1.232 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.744 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 73.4 mt -78.52 134.73 27.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' 1574 ' ' ASP . 9.4 mptt -96.32 140.86 30.37 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -121.53 12.19 10.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.528 0.68 . . . . 0.0 109.552 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.865 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 142.04 134.82 3.02 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.476 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' 1541 ' ' ILE . 25.2 pttm -82.76 153.73 25.11 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 21.9 t90 -69.66 135.62 50.11 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 173.62 16.67 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . 0.544 ' H ' ' NE2' ' A' 1557 ' ' GLN . 0.0 OUTLIER -100.02 11.58 38.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 123.402 0.439 . . . . 0.0 111.077 -172.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -84.94 100.28 11.52 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -168.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' 1494 ' ' CYS . 68.2 mt -115.63 119.92 37.69 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 113.894 -1.503 . . . . 0.0 107.308 172.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 51.0 m -107.85 122.52 46.95 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 78.9 t80 -94.93 101.32 13.09 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.988 0.899 . . . . 0.0 108.826 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 85.1 t -93.71 167.75 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 177.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -34.57 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.862 1.665 . . . . 0.0 113.137 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 20.2 mp0 56.95 18.25 3.81 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.868 2.067 . . . . 0.0 114.571 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 135.12 62.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.137 0.494 . . . . 0.0 111.088 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.709 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.51 113.95 26.04 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -102.94 114.1 28.1 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 47.5 tp -108.35 124.11 49.86 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 13.1 p -120.48 133.93 65.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 111.355 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.865 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 64.6 m-85 -107.6 106.3 16.59 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.06 167.56 10.16 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.252 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 6.2 m-20 63.98 78.38 0.29 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.304 1.041 . . . . 0.0 111.796 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -106.26 -149.6 17.28 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' 1551 ' ' LYS . 24.3 t70 -94.92 143.88 26.88 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.511 ' HG3' ' HE2' ' A' 1583 ' ' LYS . 13.7 Cg_exo -69.01 146.75 65.88 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.845 2.364 . . . . 0.0 113.218 -177.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 67.7 m -107.59 141.76 23.73 Favored Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.217 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.66 13.58 0.45 Allowed 'Trans proline' 0 N--CA 1.483 0.856 0 C-N-CA 123.574 2.849 . . . . 0.0 113.599 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -82.95 -38.5 22.67 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.686 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 28.1 t-20 -150.95 -6.7 0.27 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.041 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.5 mm? 71.14 -43.12 0.55 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.99 0.916 . . . . 0.0 113.424 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 59.9 m80 -77.37 -6.53 53.66 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.716 0.77 . . . . 0.0 110.78 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.758 HD13 ' HA ' ' A' 1611 ' ' THR . 63.3 mt -98.94 130.72 45.33 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.511 ' HE2' ' HG3' ' A' 1575 ' ' PRO . 96.1 mttt -128.73 161.95 28.54 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 123.456 0.473 . . . . 0.0 109.794 -177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.435 ' O ' ' HA3' ' A' 1573 ' ' GLY . 98.9 m-85 -65.01 113.84 4.16 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.985 0.803 . . . . 0.0 109.1 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -129.33 137.62 51.1 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 17.3 t -121.49 130.81 53.79 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.3 p -125.43 116.83 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 CA-C-O 121.96 0.886 . . . . 0.0 109.141 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.3 113.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 20.7 p -89.81 109.52 20.51 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.698 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.709 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.6 m-85 -86.81 103.06 14.88 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 31.2 m -99.39 166.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.552 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 18.6 t -84.6 130.31 34.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.469 0.652 . . . . 0.0 112.094 -174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.511 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 17.4 tptp -152.32 100.07 2.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.1 t -70.84 -14.4 62.39 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.014 0.435 . . . . 0.0 111.591 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.19 1.89 55.96 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.375 0.607 . . . . 0.0 109.68 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.759 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -75.12 -65.9 0.83 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 108.18 -166.27 12.97 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.944 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.0 -20.23 44.82 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 124.275 3.317 . . . . 0.0 115.028 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 5.7 t -111.98 -22.09 11.23 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.891 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.759 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 48.0 m 65.41 -174.25 0.18 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.713 174.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.618 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 45.9 mt-30 -110.47 120.59 43.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.2 Cg_endo -90.69 125.7 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.906 2.404 . . . . 0.0 110.256 174.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 55.0 tp -129.0 126.05 38.69 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.676 -0.64 . . . . 0.0 111.027 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.13 118.68 20.6 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 97.1 mt -82.24 -56.17 4.08 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.291 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 13.7 p -168.69 150.43 4.85 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.642 HG11 ' HE2' ' A' 1523 ' ' LYS . 98.2 t -115.0 114.26 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.71 109.05 20.05 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.01 -3.77 52.87 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.056 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -87.35 -51.79 5.75 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.758 ' HA ' HD13 ' A' 1582 ' ' LEU . 27.2 p -96.55 -8.25 32.41 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.614 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 72.9 m 65.7 25.92 11.45 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.929 0.892 . . . . 0.0 112.024 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 30.5 m -90.67 123.79 34.56 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.121 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.554 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 73.0 mt -95.6 123.17 39.02 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.488 -177.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -107.33 116.44 31.94 Favored 'General case' 0 C--O 1.247 0.965 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.554 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 76.7 m-85 -126.96 140.04 52.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.981 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 78.3 p -111.21 116.3 30.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' 1590 ' ' PHE . 4.7 t-105 -99.74 111.79 24.09 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.618 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 71.0 m-70 -86.85 99.08 11.57 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 9.4 t -124.99 152.37 44.31 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.911 0.862 . . . . 0.0 112.131 -172.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 18.3 m -76.46 -22.75 54.18 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.453 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.9 mt -73.38 -5.21 38.3 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.175 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -105.77 12.77 30.52 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.525 0.679 . . . . 0.0 110.391 -177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 61.3 m -100.23 137.84 38.11 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.911 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -86.55 123.12 31.39 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -81.99 121.95 27.17 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.88 -45.81 73.44 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.803 0.811 . . . . 0.0 108.826 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 90.1 t . . . . . 0 N--CA 1.423 -1.81 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 177.552 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 24.0 m -62.8 98.29 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.196 0 CA-C-O 121.592 0.71 . . . . 0.0 112.892 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 57.65 31.93 21.11 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.693 -174.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 11.4 t70 -138.75 86.38 2.14 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.099 -1.409 . . . . 0.0 107.573 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -139.7 136.17 33.94 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 57.9 m 63.52 26.84 14.92 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 121.615 0.721 . . . . 0.0 111.392 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' 1505 ' ' PHE . 13.2 pt20 -156.52 134.93 11.45 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 14.9 p -142.32 131.57 22.49 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.786 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.512 HG23 HG22 ' A' 1504 ' ' VAL . 10.6 m -98.63 129.09 45.13 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 38.5 p30 -85.91 127.63 61.47 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.271 -0.972 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -70.2 -15.21 35.39 Favored 'Trans proline' 0 C--O 1.243 0.77 0 C-N-CA 121.72 1.613 . . . . 0.0 110.855 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -65.63 -63.32 1.12 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.832 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 72.4 p -110.13 -14.06 14.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.579 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 90.12 14.78 58.57 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.303 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 71.0 t80 -92.16 137.42 32.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.512 HG22 HG23 ' A' 1497 ' ' THR . 43.3 t -102.91 128.49 55.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' 1495 ' ' GLN . 79.3 m-85 -104.14 98.6 8.39 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -88.22 102.07 14.46 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 120.805 0.336 . . . . 0.0 110.339 177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 25.1 tp -79.03 -15.96 57.52 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 10.4 p30 -66.8 -16.81 64.53 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.516 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 17.9 m -87.61 -13.2 43.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.307 0.575 . . . . 0.0 109.61 176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' 1598 ' ' PRO . 36.6 tp -116.44 16.53 15.64 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.975 0.893 . . . . 0.0 109.034 -177.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.71 173.1 1.85 Allowed 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.865 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -53.57 104.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.639 176.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -100.26 -45.05 5.74 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 50.9 m -119.12 -23.65 6.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.543 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 87.4 129.44 2.88 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -74.83 114.88 13.8 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 5.8 m -119.21 100.18 7.17 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . 0.486 HG21 ' HG3' ' A' 1602 ' ' PRO . 21.1 pt -103.3 140.57 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.774 -173.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 36.7 t -99.64 115.59 29.78 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.281 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.19 160.29 27.0 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 14.2 tt -62.93 -23.16 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.036 0.535 . . . . 0.0 112.311 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -81.73 3.58 25.1 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.2 tptm 76.34 30.7 0.66 Allowed 'General case' 0 C--N 1.351 0.661 0 C-N-CA 125.895 1.678 . . . . 0.0 108.085 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -82.43 108.72 2.98 Favored Glycine 0 N--CA 1.418 -2.517 0 CA-C-N 113.76 -1.564 . . . . 0.0 111.063 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 15.1 m -86.63 102.87 14.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.8 tt -113.87 134.63 56.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.472 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -115.41 126.98 55.04 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.516 -174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 125.26 41.69 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -104.45 90.39 0.72 Allowed Glycine 0 N--CA 1.418 -2.518 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 21.3 m -62.61 116.04 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.556 ' HA ' ' NE1' ' A' 1555 ' ' TRP . 98.9 m 61.03 20.44 10.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.971 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -146.27 91.13 0.15 Allowed Glycine 0 N--CA 1.414 -2.799 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -55.55 132.66 49.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 124.548 0.793 . . . . 0.0 110.384 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 18.1 m -93.91 104.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.246 0.546 . . . . 0.0 111.362 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -16.41 60.87 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.176 0.512 . . . . 0.0 111.896 -175.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.34 -27.96 68.3 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.879 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 42.1 t -113.55 24.1 12.51 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 91.55 137.33 7.46 Favored Glycine 0 N--CA 1.432 -1.595 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.949 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.41 156.41 60.46 Favored 'Trans proline' 0 C--O 1.245 0.852 0 C-N-CA 122.267 1.978 . . . . 0.0 111.457 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 78.7 8.55 87.65 Favored Glycine 0 C--N 1.304 -1.224 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.483 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.504 HG21 ' SG ' ' A' 1544 ' ' CYS . 45.3 mm -110.44 134.77 51.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -89.37 -42.55 5.49 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.217 -175.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -140.29 147.35 39.79 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 122.661 -0.317 . . . . 0.0 110.598 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . 0.504 ' SG ' HG21 ' A' 1541 ' ' ILE . 59.2 m -152.43 156.22 39.06 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.278 0.631 . . . . 0.0 111.046 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' 1550 ' ' ILE . 64.9 t80 -94.22 119.05 32.46 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -73.09 102.09 3.46 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.985 -177.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 151.49 -64.86 0.37 Allowed Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.367 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 21.9 p -91.25 -24.4 19.88 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.742 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 84.61 19.7 59.57 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.789 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' 1545 ' ' PHE . 44.6 pt -71.37 126.48 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . . . . . . . . . 58.3 mttm -83.45 134.77 34.85 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -100.19 10.09 41.78 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.068 0.461 . . . . 0.0 111.402 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.679 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 139.0 146.04 4.87 Favored Glycine 0 C--O 1.254 1.357 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.817 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.54 146.5 36.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.635 0.255 . . . . 0.0 110.773 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.556 ' NE1' ' HA ' ' A' 1531 ' ' CYS . 28.1 t90 -75.57 133.33 40.98 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.124 0.487 . . . . 0.0 110.332 -177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 10.2 p30 -146.76 -178.81 6.38 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.55 27.41 7.85 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.306 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' 1558 ' ' LYS . 44.0 mmtm -85.24 82.4 8.39 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.035 0.921 . . . . 0.0 111.849 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.44 103.93 16.31 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.338 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 6.9 t -90.05 109.68 20.71 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 73.5 t80 -83.6 101.8 11.73 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 54.8 t -114.75 95.13 3.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.067 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 23.5 t70 52.49 67.62 0.95 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.699 1.199 . . . . 0.0 112.137 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 63.92 9.88 4.87 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.867 -1.515 . . . . 0.0 113.851 177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . . . . . . . . . 37.5 t -119.75 136.7 56.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.9 mp -94.38 131.6 39.87 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.299 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' 1560 ' ' SER . 86.9 mm-40 -116.28 114.63 24.63 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.926 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -112.57 119.47 38.27 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.583 HG22 ' HG3' ' A' 1571 ' ' GLU . 14.1 p -121.12 122.59 67.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 122.133 0.968 . . . . 0.0 112.526 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.679 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 57.6 m-85 -100.1 108.4 20.54 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.659 176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.583 ' HG3' HG22 ' A' 1569 ' ' VAL . 46.0 mt-10 -117.68 168.54 10.35 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.296 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 35.8 t70 61.28 70.18 0.62 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.075 1.35 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -113.94 -133.17 5.62 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.875 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' 1584 ' ' TYR . 31.0 t70 -74.93 136.81 73.2 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.55 138.29 17.18 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 122.46 2.106 . . . . 0.0 112.589 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 56.2 m -98.78 126.3 39.26 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -73.87 8.15 2.12 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.944 2.429 . . . . 0.0 114.645 -173.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -77.2 -35.67 55.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.531 0.681 . . . . 0.0 109.965 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.606 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 18.9 t-20 -136.05 -20.92 1.45 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.684 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 18.8 tp 75.83 -33.13 0.22 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.075 1.35 . . . . 0.0 112.504 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . 0.508 ' HB3' ' OD1' ' A' 1579 ' ' ASN . 40.8 t-80 -81.47 -14.88 56.51 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' 1611 ' ' THR . 83.3 mt -82.47 133.45 35.2 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.367 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.689 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 49.2 mttm -130.04 163.8 25.71 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.474 ' CD2' ' HB3' ' A' 1574 ' ' ASP . 97.4 m-85 -72.05 117.61 13.88 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.85 171.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 134.18 55.21 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.497 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 16.0 m -119.41 116.56 26.41 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.4 p -109.3 111.0 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.893 0.854 . . . . 0.0 110.051 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.3 mp -102.15 107.41 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.244 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.7 t -92.82 113.44 25.72 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.69 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 96.3 m-85 -86.22 112.32 21.25 Favored 'General case' 0 C--O 1.256 1.395 0 CA-C-O 120.708 0.289 . . . . 0.0 110.244 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 35.5 m -106.93 166.74 3.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 C-N-CA 124.26 1.024 . . . . 0.0 109.124 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 43.0 t -77.05 143.24 39.44 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.412 0.625 . . . . 0.0 112.648 -172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 25.5 tptp -167.07 101.71 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 66.8 m -68.66 -28.52 66.96 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.337 0.589 . . . . 0.0 110.649 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.2 71.04 3.86 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.608 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -142.63 -64.02 0.42 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.936 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 68.78 -144.76 42.41 Favored Glycine 0 C--O 1.245 0.823 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.402 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' 1510 ' ' LEU . 40.7 Cg_endo -66.23 -11.96 33.54 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 124.013 3.142 . . . . 0.0 113.396 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 7.4 t -123.24 77.08 1.44 Allowed 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.608 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 51.0 m -70.74 147.8 48.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.565 -1.198 . . . . 0.0 109.795 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.612 ' HG3' ' HB2' ' A' 1619 ' ' HIS . 9.3 pt20 -108.55 120.85 45.13 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-O 121.56 0.695 . . . . 0.0 112.492 -170.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.486 ' HG3' HG21 ' A' 1518 ' ' ILE . 88.2 Cg_endo -80.78 139.42 12.36 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 C-N-CA 122.892 2.395 . . . . 0.0 112.46 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 2.4 tm? -106.66 111.02 23.38 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 104.499 -2.408 . . . . 0.0 104.499 172.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.775 HD21 HG23 ' A' 1607 ' ' VAL . 4.8 tt -81.53 112.5 18.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.14 -66.38 0.8 Allowed 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 55.0 m -158.09 136.25 10.84 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.742 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.775 HG23 HD21 ' A' 1604 ' ' LEU . 90.9 t -95.36 111.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 170.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.99 118.65 29.71 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.599 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -80.72 -6.84 58.99 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.37 -175.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -94.22 -51.81 4.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.563 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.89 ' HA ' HD13 ' A' 1582 ' ' LEU . 41.7 p -97.16 -14.77 21.27 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 123.012 0.195 . . . . 0.0 111.447 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . 0.428 ' HB3' ' CD1' ' A' 1584 ' ' TYR . 69.5 m 67.33 26.54 8.47 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 124.364 1.04 . . . . 0.0 110.742 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 19.3 m -86.87 116.81 25.19 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.714 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 74.6 mt -94.07 116.21 28.61 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.513 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -100.58 111.75 24.04 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.508 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.714 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 91.5 m-85 -128.44 136.73 51.25 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.334 0.587 . . . . 0.0 111.577 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 48.9 m -112.22 106.41 14.98 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 172.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.466 ' HB2' HG23 ' A' 1588 ' ' ILE . 1.4 t-105 -89.99 114.95 26.89 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.622 ' HB3' ' HB2' ' A' 1593 ' ' LYS . 42.6 m80 -78.0 101.26 6.82 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 11.7 t -129.35 153.31 47.99 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.576 0.703 . . . . 0.0 111.074 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.2 m -73.28 -28.82 62.32 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 53.7 tp -72.3 -6.49 43.51 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 121.45 0.643 . . . . 0.0 111.558 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -92.84 -4.45 52.91 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.435 0.636 . . . . 0.0 110.094 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 7.4 m -99.12 129.23 45.37 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.38 124.06 24.36 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.753 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -81.12 116.62 21.13 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -88.66 -51.96 5.4 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.232 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 C--O 1.238 0.484 0 N-CA-C 110.55 -0.167 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 11.1 p -92.95 142.75 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.89 99.69 12.02 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.293 0.568 . . . . 0.0 111.881 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' 1557 ' ' GLN . 3.4 p30 -118.66 141.53 48.51 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 172.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -178.7 -179.75 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 37.6 m -87.71 11.53 15.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.596 0.713 . . . . 0.0 109.484 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' 1505 ' ' PHE . 29.5 pt20 -152.01 136.33 16.73 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.6 p -132.61 126.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.35 0.595 . . . . 0.0 110.209 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' 1504 ' ' VAL . 14.3 m -90.32 116.68 28.47 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.49 HD22 ' HE1' ' A' 1505 ' ' PHE . 28.1 p30 -73.8 143.94 82.15 Favored Pre-proline 0 C--N 1.306 -1.299 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.777 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' 1498 ' ' ASN . 7.7 Cg_exo -73.52 -31.73 8.58 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.876 1.717 . . . . 0.0 112.01 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -62.08 -65.42 0.69 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 8.7 p -97.69 -11.65 23.25 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 112.889 0.699 . . . . 0.0 112.889 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 74.28 40.17 41.77 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 83.9 t80 -111.72 130.5 55.76 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.033 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' 1497 ' ' THR . 47.6 t -90.28 118.95 36.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.49 ' HE1' HD22 ' A' 1498 ' ' ASN . 90.8 m-85 -91.29 108.21 19.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 175.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.55 106.43 17.53 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.335 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . 0.564 HD11 HD23 ' A' 1510 ' ' LEU . 28.1 tp -83.97 -3.12 57.75 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -51.17 -38.42 52.08 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 125.855 1.662 . . . . 0.0 111.571 174.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 4.9 m -68.13 -19.21 64.8 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.993 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.564 HD23 HD11 ' A' 1507 ' ' LEU . 50.6 tp -117.24 5.69 12.69 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.928 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.507 ' HD2' ' HB2' ' A' 1531 ' ' CYS . 22.8 pttm -88.09 129.53 35.27 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.319 -175.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -128.44 118.29 22.85 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -68.99 -37.28 78.63 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 2.7 m -56.17 -25.1 45.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.744 1.218 . . . . 0.0 110.273 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 87.07 177.12 49.05 Favored Glycine 0 N--CA 1.417 -2.576 0 CA-C-N 115.35 -0.841 . . . . 0.0 114.316 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.65 124.9 43.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' 1527 ' ' ARG . 2.6 m -103.04 98.41 8.36 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 15.4 pt -106.39 151.11 8.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.268 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1525 ' ' SER . 12.8 p -109.44 130.98 55.47 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -175.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.94 154.91 40.9 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 172.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.3 tp -62.94 -26.16 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 C-N-CA 123.287 0.635 . . . . 0.0 111.824 -174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' 1522 ' ' ARG . 50.1 mtp180 -85.86 3.42 41.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.379 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' 1523 ' ' LYS . 44.5 mmtm 86.92 20.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.613 1.565 . . . . 0.0 112.519 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -83.58 80.23 1.84 Allowed Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . 0.606 ' HA ' ' HA ' ' A' 1519 ' ' SER . 15.0 m -69.65 127.7 33.86 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.425 HD11 ' HB1' ' A' 1543 ' ' ALA . 7.6 tt -129.49 134.07 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.692 0 CA-C-O 121.45 0.643 . . . . 0.0 110.153 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' 1517 ' ' THR . 58.2 ttt180 -105.82 119.77 40.02 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' 1528 ' ' LEU . 0.7 OUTLIER -122.61 125.14 45.06 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -178.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.722 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -97.79 143.93 16.99 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 177.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 23.8 t -100.01 116.49 43.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.584 ' HA ' ' OE1' ' A' 1557 ' ' GLN . 62.0 m 63.95 20.99 12.46 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.078 0.862 . . . . 0.0 110.801 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -142.84 111.91 0.69 Allowed Glycine 0 N--CA 1.407 -3.271 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.76 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.18 133.4 47.05 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.671 HG23 ' HB2' ' A' 1537 ' ' CYS . 27.9 m -90.85 95.21 5.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-O 122.258 1.028 . . . . 0.0 108.313 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.74 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.05 -28.17 64.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.913 -173.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.21 -16.56 61.95 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . 0.671 ' HB2' HG23 ' A' 1534 ' ' VAL . 96.7 m -102.76 -5.33 23.81 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.243 0.544 . . . . 0.0 109.538 173.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 131.44 145.03 5.52 Favored Glycine 0 N--CA 1.425 -2.058 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.31 132.49 29.67 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.166 1.91 . . . . 0.0 111.119 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 74.14 23.08 76.87 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.042 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.44 127.28 66.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.455 ' HA3' ' CE2' ' A' 1570 ' ' TYR . . . -100.8 -35.21 4.38 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.69 -176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . 0.425 ' HB1' HD11 ' A' 1526 ' ' ILE . . . -129.22 121.88 28.55 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.2 p -132.42 142.74 49.39 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.013 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' 1552 ' ' ALA . 73.8 m-85 -90.05 141.49 28.62 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -69.66 -26.27 64.31 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -89.88 126.79 8.45 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 6.7 m 75.48 -21.34 0.31 Allowed 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 124.762 1.225 . . . . 0.0 112.009 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.22 30.36 54.88 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 34.4 pt -88.63 150.37 3.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.165 0.507 . . . . 0.0 110.252 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.689 ' HG3' ' HA2' ' A' 1573 ' ' GLY . 18.3 pttm -97.06 145.58 25.83 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.02 8.9 32.58 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.218 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.831 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 154.35 141.13 3.18 Favored Glycine 0 N--CA 1.413 -2.846 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.553 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 68.2 mttm -76.55 150.52 36.54 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.484 ' HA ' ' HE2' ' A' 1570 ' ' TYR . 35.2 t90 -63.78 124.49 21.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.694 0.759 . . . . 0.0 110.506 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . 0.425 HD21 ' HA ' ' A' 1570 ' ' TYR . 8.3 p30 -149.14 153.06 37.16 Favored 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' 1531 ' ' CYS . 13.4 mm100 -108.72 22.63 15.67 Favored 'General case' 0 C--N 1.279 -2.463 0 O-C-N 123.753 0.658 . . . . 0.0 109.653 -175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 27.9 tptp -77.17 82.44 3.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.144 0.973 . . . . 0.0 111.57 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' 1566 ' ' LEU . 50.5 tp -91.33 116.2 28.64 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.262 176.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' 1567 ' ' GLN . 12.4 m -103.31 147.14 27.44 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . 0.406 ' HD1' HD23 ' A' 1566 ' ' LEU . 60.7 t80 -117.51 135.0 54.23 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . 0.734 HG23 ' HB ' ' A' 1565 ' ' VAL . 18.0 m -134.05 160.51 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.33 106.1 0.09 Allowed 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.073 0.949 . . . . 0.0 112.887 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 52.2 mm-40 71.9 17.59 5.25 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.15 1.78 . . . . 0.0 112.413 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . 0.734 ' HB ' HG23 ' A' 1562 ' ' VAL . 59.5 t -139.8 124.68 20.22 Favored 'Isoleucine or valine' 0 C--O 1.245 0.838 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.697 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 93.3 mt -96.04 129.39 43.33 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' 1560 ' ' SER . 18.1 mm-40 -113.6 114.27 26.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' 1568 ' ' LEU . 19.6 mt -104.81 119.47 39.08 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . . . . . . . . . 36.1 t -116.72 108.58 25.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-O 121.294 0.569 . . . . 0.0 110.517 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.831 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 45.8 m-85 -93.22 113.35 25.54 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.812 176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -117.54 -177.17 3.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.448 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.668 ' HA ' ' HD2' ' A' 1583 ' ' LYS . 5.1 m-20 68.33 27.98 6.38 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.713 0.633 . . . . 0.0 112.242 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . 0.689 ' HA2' ' HG3' ' A' 1551 ' ' LYS . . . -74.07 -167.63 16.37 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.6 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 1.5 m-20 -72.19 162.63 72.65 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 122.338 -0.507 . . . . 0.0 112.093 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -65.23 144.35 80.68 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.572 2.181 . . . . 0.0 112.479 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' 1582 ' ' LEU . 43.9 t -98.23 140.18 21.7 Favored Pre-proline 0 C--N 1.299 -1.609 0 C-N-CA 124.677 1.191 . . . . 0.0 109.991 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -62.61 -22.12 73.63 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.068 2.512 . . . . 0.0 114.069 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -74.21 -26.56 60.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.83 ' HB3' ' HG ' ' A' 1582 ' ' LEU . 36.9 t-20 -171.11 120.21 0.51 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' 1580 ' ' LEU . 2.4 mm? -56.16 -27.22 53.47 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.593 1.157 . . . . 0.0 114.112 -175.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 35.6 m80 -91.09 3.23 55.29 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.83 ' HG ' ' HB3' ' A' 1579 ' ' ASN . 57.6 mt -89.94 121.55 32.15 Favored 'General case' 0 N--CA 1.425 -1.71 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.668 ' HD2' ' HA ' ' A' 1572 ' ' ASP . 50.7 mtmt -103.27 156.88 17.4 Favored 'General case' 0 C--N 1.272 -2.795 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -61.88 119.83 9.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 123.73 0.644 . . . . 0.0 110.881 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' 1583 ' ' LYS . 0.6 OUTLIER -104.38 131.11 52.09 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 174.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.623 ' HB3' ' HB2' ' A' 1570 ' ' TYR . 23.1 t -123.15 116.07 22.83 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -116.82 112.87 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 CA-C-O 122.097 0.951 . . . . 0.0 110.321 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.41 101.51 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 47.5 m -90.96 110.25 21.49 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.21 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.697 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 92.5 m-85 -86.05 104.84 16.02 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.3 m -98.13 159.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.638 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 41.6 t -76.02 122.28 23.98 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.624 -175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' 1595 ' ' ASP . 20.4 tptm -149.7 90.12 1.68 Allowed 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 173.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 31.6 t -68.37 -15.26 63.49 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.466 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . 0.426 ' HB2' ' HE2' ' A' 1593 ' ' LYS . 29.3 m-20 -85.63 4.3 36.93 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 122.175 -0.328 . . . . 0.0 111.505 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -83.28 -61.12 1.93 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-O 120.734 0.302 . . . . 0.0 111.165 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 87.87 -141.75 17.28 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.838 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.52 -16.9 38.81 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.337 2.691 . . . . 0.0 112.97 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 6.8 t -125.97 89.78 3.08 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-O 122.45 1.119 . . . . 0.0 109.553 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.751 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.2 m -76.25 148.17 37.81 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.2 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 56.3 mt-30 -96.19 122.06 58.93 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -175.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 6.4 Cg_endo -87.14 113.67 1.0 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 123.402 2.734 . . . . 0.0 110.708 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 53.5 tp -114.59 119.33 36.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.871 0.367 . . . . 0.0 110.291 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.448 HD13 ' CZ ' ' A' 1616 ' ' PHE . 39.0 tp -76.5 126.07 30.33 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.39 -65.47 1.01 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 73.7 m -159.51 156.29 27.94 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.513 HG13 HD23 ' A' 1614 ' ' LEU . 96.0 t -110.37 112.39 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 171.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.68 109.03 13.69 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.86 -6.42 58.59 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.208 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -95.16 -29.0 14.77 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.411 -0.516 . . . . 0.0 111.043 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.734 ' HA ' HD13 ' A' 1582 ' ' LEU . 35.9 p -114.86 -15.22 11.87 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.961 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 97.8 m 66.14 58.8 0.7 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 122.556 1.169 . . . . 0.0 111.097 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 23.5 m -120.94 130.37 53.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.281 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.513 HD23 HG13 ' A' 1607 ' ' VAL . 73.6 mt -96.81 117.4 31.0 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -103.33 103.33 13.33 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 77.2 m-85 -114.82 131.53 56.79 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.829 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 74.7 p -109.53 108.46 18.93 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -92.68 108.01 19.65 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' 1600 ' ' SER . 64.4 m-70 -83.66 97.72 9.25 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.2 t -126.45 152.14 46.8 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.759 0.79 . . . . 0.0 111.808 -173.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 13.6 m -78.25 -25.99 47.06 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.405 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' 1510 ' ' LEU . 43.2 mt -70.61 -6.07 34.06 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.957 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -95.18 -9.55 33.07 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 121.538 0.685 . . . . 0.0 110.432 -176.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.0 m -82.85 135.77 34.84 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.85 89.08 0.57 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -91.6 121.03 32.9 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.492 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.09 -44.21 18.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 -179.731 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . 0.706 ' N ' ' HG1' ' A' 1497 ' ' THR . 89.7 mmm . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 95.8 t -62.69 -41.93 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 122.208 1.004 . . . . 0.0 108.44 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -123.51 106.67 10.8 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.052 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' 1495 ' ' GLN . 63.4 m-20 -87.73 72.14 9.52 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.849 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -89.34 94.09 9.77 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 45.1 t 61.86 33.41 17.63 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 123.042 1.401 . . . . 0.0 110.16 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' 1505 ' ' PHE . 8.6 pt20 -156.46 146.55 21.23 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 11.7 p -148.14 135.55 13.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.706 ' HG1' ' N ' ' A' 1489 ' ' MET . 14.0 m -94.94 116.98 29.38 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.462 ' HB3' ' HE2' ' A' 1505 ' ' PHE . 7.4 p30 -78.66 138.03 58.54 Favored Pre-proline 0 C--N 1.31 -1.134 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.604 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.08 -1.9 11.98 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.425 2.083 . . . . 0.0 113.647 -176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -83.52 -68.57 0.7 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.68 0.276 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 12.1 p -89.22 -24.99 21.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 87.65 13.95 64.19 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 74.3 t80 -86.55 139.97 30.34 Favored 'General case' 0 C--O 1.252 1.234 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . . . . . . . . . 44.5 t -92.55 116.73 34.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.484 ' HZ ' ' HG2' ' A' 1625 ' ' GLU . 82.3 m-85 -81.24 95.33 6.91 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 17.7 t70 -89.04 95.35 10.28 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.001 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 31.8 tp -86.01 -11.1 53.83 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.51 0.672 . . . . 0.0 110.996 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' 1511 ' ' LYS . 9.1 p30 -71.68 -13.22 61.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.947 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 74.3 m -84.23 -10.85 57.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.128 173.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 66.2 mt -110.76 4.06 19.63 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 122.004 -0.435 . . . . 0.0 111.033 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.643 ' HD3' ' HB2' ' A' 1531 ' ' CYS . 58.0 pttt -90.79 157.74 17.22 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.079 0.466 . . . . 0.0 111.262 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -128.88 137.03 51.22 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -30.08 70.36 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 22.3 t -78.27 -11.54 59.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.805 0.812 . . . . 0.0 109.101 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 76.57 -174.67 53.75 Favored Glycine 0 N--CA 1.425 -2.097 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.512 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.87 121.36 44.44 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 15.5 m -105.88 103.87 13.46 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . 0.442 HG21 ' HG3' ' A' 1602 ' ' PRO . 25.9 pt -108.66 139.91 29.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.201 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 10.0 p -87.11 139.29 30.72 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 121.616 0.722 . . . . 0.0 111.571 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 23.6 t70 -95.23 151.84 18.89 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.8 tp -58.16 -25.87 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 124.567 1.147 . . . . 0.0 112.952 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.58 2.67 18.48 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.08 -0.387 . . . . 0.0 111.841 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 21.9 tptm 70.04 68.97 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.731 1.253 . . . . 0.0 109.481 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -150.47 174.61 29.79 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 16.5 t -146.39 146.79 30.75 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 118.559 1.18 . . . . 0.0 108.421 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.34 134.47 60.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . . . . . . . . . 46.1 ttm105 -110.15 113.85 26.87 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.17 129.36 56.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.18 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -103.75 91.27 0.81 Allowed Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' 1511 ' ' LYS . 92.8 t -64.1 116.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.643 ' HB2' ' HD3' ' A' 1511 ' ' LYS . 60.8 m 58.45 18.46 5.65 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.79 0.681 . . . . 0.0 112.695 176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . 0.41 ' N ' ' HE1' ' A' 1555 ' ' TRP . . . -154.07 101.85 0.21 Allowed Glycine 0 N--CA 1.423 -2.175 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 178.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.0 132.64 54.5 Favored 'General case' 0 C--O 1.256 1.419 0 CA-C-O 121.26 0.552 . . . . 0.0 111.723 -178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . . . . . . . . . 2.5 m -78.87 93.58 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.958 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -18.01 17.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.095 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.8 t70 -65.33 -31.82 73.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.193 0.521 . . . . 0.0 110.421 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.27 -0.38 26.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.501 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 123.97 158.11 10.01 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.378 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -76.9 130.77 11.63 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.395 2.063 . . . . 0.0 111.935 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 86.86 5.24 81.4 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.572 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.447 ' CD1' ' HD2' ' A' 1551 ' ' LYS . 41.1 mm -98.77 117.49 43.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.15 -19.73 18.11 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.997 -1.097 . . . . 0.0 112.49 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -137.27 120.28 16.55 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 24.4 p -131.03 136.77 48.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.395 0.617 . . . . 0.0 111.236 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' 1550 ' ' ILE . 76.8 t80 -96.26 116.12 28.51 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.6 104.81 4.67 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.623 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -176.12 -105.67 0.19 Allowed Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 5.2 m -73.88 -25.23 59.92 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 109.46 57.53 0.53 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' 1545 ' ' PHE . 61.3 mt -94.14 125.12 46.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.447 ' HD2' ' CD1' ' A' 1541 ' ' ILE . 43.2 mtmt -83.91 126.26 32.82 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -105.48 9.0 33.69 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.246 0.546 . . . . 0.0 110.767 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.784 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 147.86 146.58 4.37 Favored Glycine 0 N--CA 1.425 -2.064 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.329 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 91.9 mttt -85.5 144.93 27.66 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 121.733 0.777 . . . . 0.0 111.541 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.504 ' HA ' ' HE1' ' A' 1570 ' ' TYR . 65.6 t90 -65.54 151.21 46.97 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.158 -173.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -164.99 167.31 18.58 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -119.26 20.52 12.56 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -91.01 96.71 10.76 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-O 121.463 0.649 . . . . 0.0 110.336 -174.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.479 HD23 HD13 ' A' 1568 ' ' LEU . 69.2 mt -94.19 109.38 21.18 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 20.1 m -92.94 120.84 33.67 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 75.6 t80 -93.23 102.39 14.67 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' 1565 ' ' VAL . 49.2 t -115.65 88.88 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.681 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.0 t70 48.03 81.41 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.927 1.291 . . . . 0.0 113.799 175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 70.35 -9.19 0.79 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' 1562 ' ' VAL . 7.4 p -116.98 132.13 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.539 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.874 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 14.7 tp -88.15 119.08 28.2 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -107.06 129.11 54.86 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.435 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . 0.479 HD13 HD23 ' A' 1559 ' ' LEU . 54.9 tp -126.8 109.88 12.49 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.418 -1.326 . . . . 0.0 107.418 172.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.566 HG22 HG23 ' A' 1587 ' ' VAL . 38.7 t -110.9 128.5 67.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.221 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.784 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 75.2 m-85 -104.43 119.33 38.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -117.13 177.28 4.78 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.781 -177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.554 ' HA ' ' HD3' ' A' 1583 ' ' LYS . 8.7 t70 52.65 70.33 0.59 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.227 1.411 . . . . 0.0 111.85 -178.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.94 -135.82 8.87 Favored Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.321 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 19.5 t70 -83.5 145.54 48.23 Favored Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 6.4 Cg_exo -74.18 142.72 31.02 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.607 2.205 . . . . 0.0 111.526 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' 1578 ' ' ALA . 78.2 m -98.39 132.17 24.76 Favored Pre-proline 0 C--N 1.284 -2.26 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.746 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -71.44 20.19 0.25 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.578 2.852 . . . . 0.0 112.714 178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' 1576 ' ' CYS . . . -86.81 -55.47 3.83 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 66.9 t30 -139.55 7.67 2.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.282 0.563 . . . . 0.0 109.766 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 2.2 tm? 68.93 -50.88 0.59 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.508 1.523 . . . . 0.0 112.358 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.7 t60 -68.49 -13.46 62.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.358 0.663 . . . . 0.0 110.408 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.67 134.98 35.15 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.554 ' HD3' ' HA ' ' A' 1572 ' ' ASP . 85.6 mttt -125.84 152.45 45.48 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.429 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 95.5 m-85 -67.08 117.48 9.18 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.864 0.728 . . . . 0.0 109.393 174.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.14 135.45 48.88 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 13.1 p -121.03 121.25 37.54 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.004 0.431 . . . . 0.0 111.683 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.566 HG23 HG22 ' A' 1569 ' ' VAL . 4.2 p -106.15 113.63 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.552 0.691 . . . . 0.0 109.735 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.3 mp -101.42 110.12 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' 1565 ' ' VAL . 42.3 m -93.34 118.62 31.5 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.874 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 90.9 m-85 -86.58 110.2 19.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 27.2 m -107.42 152.38 9.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' 1620 ' ' THR . 40.3 t -81.98 142.53 32.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.273 0.558 . . . . 0.0 112.404 -173.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.518 ' CB ' ' HB3' ' A' 1619 ' ' HIS . 42.4 tptt -163.29 97.35 0.9 Allowed 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.457 175.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 9.5 p -56.65 -32.28 65.21 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.871 0.868 . . . . 0.0 112.09 -179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 7.9 m-20 -68.93 -14.5 63.07 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.674 0.79 . . . . 0.0 112.037 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.814 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -80.27 -41.6 24.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.767 0.318 . . . . 0.0 111.519 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 84.2 -163.68 39.66 Favored Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.7 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.63 -15.64 21.63 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.272 2.648 . . . . 0.0 113.168 -176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 3.3 p -86.13 -42.02 14.24 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.814 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 23.4 m 72.21 161.75 0.25 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.18 174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -115.52 121.65 34.2 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.442 ' HG3' HG21 ' A' 1518 ' ' ILE . 55.3 Cg_endo -84.2 121.46 2.72 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.73 118.38 33.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.482 HD21 HG23 ' A' 1607 ' ' VAL . 49.7 tp -78.42 116.84 19.11 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 46.8 tp -79.94 -56.12 4.48 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.608 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 50.9 m -164.21 136.24 4.75 Favored 'General case' 0 C--O 1.247 0.927 0 C-N-CA 122.614 0.365 . . . . 0.0 110.171 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.482 HG23 HD21 ' A' 1604 ' ' LEU . 82.3 t -103.35 110.86 31.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.22 100.17 10.35 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.487 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -80.58 7.07 10.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.081 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -89.8 -51.34 5.55 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.942 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . . . . . . . . . 49.9 p -99.74 -9.53 22.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.581 0.229 . . . . 0.0 111.218 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 66.6 m 69.54 23.27 6.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.656 1.182 . . . . 0.0 111.075 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 13.4 m -91.22 114.23 26.7 Favored 'General case' 0 N--CA 1.415 -2.175 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' 1616 ' ' PHE . 79.6 mt -93.83 121.91 35.77 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -103.92 113.56 27.18 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' 1614 ' ' LEU . 76.0 m-85 -121.9 139.19 53.95 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.154 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.1 m -119.92 108.81 14.79 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.403 ' HE1' ' HB2' ' A' 1600 ' ' SER . 24.3 t-105 -93.14 110.24 21.74 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -176.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.518 ' HB3' ' CB ' ' A' 1593 ' ' LYS . 39.4 m-70 -83.04 107.77 15.87 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' 1592 ' ' CYS . 8.8 t -132.79 152.98 51.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.622 0.576 . . . . 0.0 110.068 -178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 14.7 m -70.62 -27.62 64.21 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.41 0.624 . . . . 0.0 110.065 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 36.9 tp -71.82 -5.87 37.43 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.347 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . 0.411 ' HB3' ' HA ' ' A' 1592 ' ' CYS . . . -84.73 -9.01 58.62 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.605 0.717 . . . . 0.0 110.501 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 55.7 m -94.58 144.26 25.74 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . 0.484 ' HG2' ' HZ ' ' A' 1505 ' ' PHE . 47.3 mt-10 -69.83 105.54 2.82 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.51 0.671 . . . . 0.0 109.698 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -81.17 136.93 35.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.58 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -62.48 1.85 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 99.0 t . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.792 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.878 0.371 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 50.4 t -94.06 -48.53 13.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -74.45 155.73 37.71 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.77 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' 1496 ' ' VAL . 9.2 m-20 -54.66 104.52 0.12 Allowed 'General case' 0 C--O 1.239 0.515 0 O-C-N 124.654 1.221 . . . . 0.0 110.123 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.42 126.78 51.31 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . . . . . . . . . 95.3 m 70.91 -1.4 2.67 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.602 0.715 . . . . 0.0 112.325 -177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' 1492 ' ' ASP . 29.4 pt20 -149.2 161.53 41.81 Favored 'General case' 0 N--CA 1.405 -2.692 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . 0.508 ' HA ' ' HB3' ' A' 1492 ' ' ASP . 14.5 p -146.74 121.96 2.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 CA-C-O 121.88 0.847 . . . . 0.0 110.514 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.62 HG23 HG22 ' A' 1504 ' ' VAL . 17.7 m -91.67 104.18 16.68 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 174.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.05 135.9 47.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.087 -176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.7 -12.37 20.18 Favored 'Trans proline' 0 C--N 1.332 -0.324 0 C-N-CA 122.591 2.194 . . . . 0.0 112.212 -177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -66.51 -67.34 0.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.544 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . 0.443 ' H ' ' HG1' ' A' 1501 ' ' THR . 25.4 p -99.54 -23.0 15.23 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 92.67 -2.45 73.28 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.376 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -74.63 137.4 42.23 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.177 0.513 . . . . 0.0 110.023 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.62 HG22 HG23 ' A' 1497 ' ' THR . 41.7 t -100.02 121.56 50.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -115.08 108.56 16.82 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' 1495 ' ' GLN . 2.5 p-10 -104.33 127.44 51.98 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 121.722 0.772 . . . . 0.0 109.479 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 21.4 tp -90.78 4.65 51.06 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' 1511 ' ' LYS . 79.7 m-20 -67.42 -27.21 66.87 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.415 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 35.9 p -79.61 -18.29 51.93 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.801 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.417 HD22 ' O ' ' A' 1598 ' ' PRO . 25.6 mt -109.63 4.26 21.88 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.08 -0.388 . . . . 0.0 111.657 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' 1508 ' ' ASN . 21.1 pttp -85.17 153.02 22.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' 1515 ' ' GLY . 55.1 ttt180 -120.88 129.49 53.53 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.32 -42.76 92.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.356 0.598 . . . . 0.0 111.111 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 10.0 m -82.25 1.45 36.62 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.54 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.567 ' O ' ' HD3' ' A' 1512 ' ' ARG . . . 76.37 166.21 22.37 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-O 121.405 0.447 . . . . 0.0 113.981 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' 1527 ' ' ARG . 89.0 m-85 -98.68 123.78 43.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 14.1 m -103.93 97.75 7.7 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 30.2 pt -109.87 125.46 67.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.134 0.492 . . . . 0.0 111.664 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1525 ' ' SER . 38.7 m -94.3 116.65 29.07 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' 1604 ' ' LEU . 2.0 m-20 -119.43 99.72 6.85 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 47.8 mt 63.26 -104.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-N 113.645 -1.616 . . . . 0.0 111.932 170.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -114.97 -12.52 12.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -67.59 -35.6 79.29 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.728 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . 122.26 -161.94 16.24 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' 1519 ' ' SER . 9.0 m -96.21 123.1 39.71 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 7.7 tt -112.13 127.45 69.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.489 ' HG2' HG11 ' A' 1534 ' ' VAL . 40.1 ttm180 -104.83 118.57 36.89 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.695 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' 1528 ' ' LEU . 1.2 mp -118.3 122.46 42.96 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.513 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' 1532 ' ' GLY . . . -100.88 97.2 1.66 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.31 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' 1511 ' ' LYS . 60.3 t -66.27 115.2 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . 0.466 ' HB2' ' HD2' ' A' 1511 ' ' LYS . 68.0 m 59.65 15.15 4.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.858 0.863 . . . . 0.0 113.207 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' 1529 ' ' GLY . . . -141.16 112.73 0.79 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 177.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' 1535 ' ' LYS . 33.6 mt-10 -63.41 140.96 58.93 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.489 HG11 ' HG2' ' A' 1527 ' ' ARG . 16.0 m -85.41 89.09 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.265 177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' 1535 ' ' LYS . 0.2 OUTLIER -62.33 -19.04 62.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.219 -179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.66 -23.08 64.51 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 110.708 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 32.0 t -121.74 4.7 10.02 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.599 0.714 . . . . 0.0 109.4 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 102.41 152.08 24.1 Favored Glycine 0 N--CA 1.442 -0.924 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.979 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.09 153.19 75.51 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 122.492 2.128 . . . . 0.0 111.264 178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 87.45 -10.07 70.83 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.331 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.433 HD12 ' HD3' ' A' 1551 ' ' LYS . 42.4 mm -98.37 129.8 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -100.5 -50.64 1.28 Allowed Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.108 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -120.03 132.49 55.49 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 49.1 t -136.52 149.98 48.42 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.414 0.15 . . . . 0.0 110.889 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.467 ' HZ ' HD11 ' A' 1614 ' ' LEU . 67.1 m-85 -93.63 160.75 14.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.817 0.818 . . . . 0.0 112.867 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.77 -22.18 66.78 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.701 2.0 . . . . 0.0 113.073 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -119.65 130.18 8.35 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.035 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . 0.482 ' HB ' HG23 ' A' 1550 ' ' ILE . 23.9 m 73.77 -13.65 0.73 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 112.562 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 77.28 36.02 35.98 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.482 HG23 ' HB ' ' A' 1548 ' ' THR . 36.2 pt -81.51 143.03 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.623 ' HG2' ' OD1' ' A' 1574 ' ' ASP . 17.2 pttm -92.99 145.05 24.65 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-O 121.593 0.711 . . . . 0.0 111.434 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . 0.435 ' HB2' ' CE2' ' A' 1545 ' ' PHE . . . -106.15 15.67 26.0 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.627 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.785 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 141.2 141.48 3.98 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.934 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 48.0 mtpt -78.78 159.9 27.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 121.195 0.521 . . . . 0.0 110.827 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 72.7 t90 -67.22 141.26 57.35 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.774 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 9.4 p30 -158.39 172.37 18.46 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.2 24.25 5.95 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.448 1.099 . . . . 0.0 109.757 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 19.9 tptm -87.37 103.36 15.41 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.258 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . . . . . . . . . 4.5 mm? -107.33 130.56 54.76 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.73 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 23.0 t -121.38 109.67 15.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 66.8 t80 -94.12 103.54 15.59 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . . . . . . . . . 95.8 t -127.7 105.01 13.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.318 -178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 32.4 t70 58.19 60.93 2.47 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 111.223 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 56.99 24.51 9.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.207 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' 1590 ' ' PHE . 96.2 t -126.6 122.44 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 10.0 mp -90.88 123.75 34.64 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' A' 1560 ' ' SER . 17.4 mm-40 -102.0 114.5 28.66 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.418 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 57.0 tp -116.64 102.71 9.69 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.53 HG22 HG23 ' A' 1587 ' ' VAL . 35.0 t -107.12 120.59 58.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.095 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.785 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 79.5 m-85 -86.21 108.94 18.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -85.7 154.44 21.64 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.219 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 13.0 t70 56.21 86.11 0.07 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.753 1.621 . . . . 0.0 113.852 173.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' 1584 ' ' TYR . . . -107.32 -152.23 18.0 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.623 ' OD1' ' HG2' ' A' 1551 ' ' LYS . 0.7 OUTLIER -83.23 146.57 51.46 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 116.962 0.381 . . . . 0.0 110.276 176.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.422 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 7.2 Cg_exo -73.52 143.92 35.22 Favored 'Trans proline' 0 C--O 1.243 0.74 0 C-N-CA 123.234 2.623 . . . . 0.0 112.665 -175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 59.1 m -105.4 142.78 25.44 Favored Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.825 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.56 11.66 0.78 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.172 2.582 . . . . 0.0 114.091 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -81.45 -56.15 4.23 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.869 0.366 . . . . 0.0 110.543 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.778 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 14.4 m120 -133.91 7.91 3.77 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.806 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.0 mm? 70.48 -55.53 0.62 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.403 1.081 . . . . 0.0 113.096 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -74.88 -12.99 60.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.453 0.644 . . . . 0.0 110.489 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 65.1 mt -82.45 131.06 35.22 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 95.3 mttt -131.39 162.09 30.93 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 123.733 0.645 . . . . 0.0 110.142 -174.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.431 ' O ' ' HA3' ' A' 1573 ' ' GLY . 97.0 m-85 -66.87 112.64 4.39 Favored 'General case' 0 C--N 1.311 -1.093 0 O-C-N 123.937 0.773 . . . . 0.0 109.531 175.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -129.32 147.04 51.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.0 p -129.85 121.67 27.17 Favored 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.364 -176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.53 HG23 HG22 ' A' 1569 ' ' VAL . 3.0 p -111.36 111.22 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.853 0.835 . . . . 0.0 109.364 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.95 106.06 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 43.8 m -87.48 110.0 20.0 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 115.297 -0.865 . . . . 0.0 108.763 177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.796 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 97.7 m-85 -86.04 101.66 13.13 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 28.4 m -100.02 160.8 3.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.224 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 28.3 t -76.46 120.53 21.81 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 55.6 tptt -143.16 97.08 3.03 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 169.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -27.15 68.76 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -107.7 19.2 20.46 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.073 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.634 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -70.52 -38.82 74.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.157 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 91.51 -174.07 37.75 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.146 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . 0.417 ' O ' HD22 ' A' 1510 ' ' LEU . 70.8 Cg_endo -71.78 -15.23 30.02 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.36 2.707 . . . . 0.0 112.028 -178.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 1.7 p -79.91 -48.83 12.81 Favored 'General case' 0 N--CA 1.413 -2.321 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.634 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 40.0 m 68.47 161.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.815 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.506 ' HA ' ' HD3' ' A' 1602 ' ' PRO . 19.5 mt-30 -107.0 119.77 50.17 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.448 -0.783 . . . . 0.0 110.571 -174.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 3.8 Cg_endo -89.96 116.25 0.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.429 2.752 . . . . 0.0 112.006 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 56.6 tp -115.47 120.01 38.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.152 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' 1520 ' ' ASP . 60.8 tp -70.9 113.24 7.76 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 57.9 tp -87.93 -63.49 1.29 Allowed 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.571 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 67.2 m -147.34 138.38 23.7 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.922 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 62.5 t -122.78 112.03 32.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -97.87 124.66 42.37 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.552 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -80.21 -8.27 59.36 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.888 1.069 . . . . 0.0 113.888 -176.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -102.78 -51.5 3.28 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.663 -0.815 . . . . 0.0 112.214 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.735 ' HA ' HD13 ' A' 1582 ' ' LEU . 36.4 p -86.83 -14.69 41.4 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 73.4 m 61.85 23.19 13.59 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 124.082 0.953 . . . . 0.0 111.637 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 17.9 m -86.14 115.65 23.84 Favored 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.467 HD11 ' HZ ' ' A' 1545 ' ' PHE . 87.1 mt -91.52 126.71 36.69 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.958 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -110.05 116.37 31.45 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -119.23 137.58 53.55 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.294 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 19.6 m -110.25 103.68 12.39 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' A' 1600 ' ' SER . 11.3 t-105 -99.47 105.81 17.78 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 85.2 m-70 -81.02 100.65 9.08 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 10.4 t -122.71 153.66 39.14 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-O 121.647 0.736 . . . . 0.0 111.474 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.7 m -76.11 -26.37 56.33 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.365 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' 1622 ' ' LEU . 26.6 mt -71.43 -5.23 31.22 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -90.59 -23.95 20.69 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.553 0.692 . . . . 0.0 110.242 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 66.8 m -72.91 142.26 47.87 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.483 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.73 94.23 1.74 Allowed 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -80.8 129.68 34.66 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.42 -170.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.05 -44.71 19.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.891 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.31 -1.129 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -178.717 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 23.8 ptm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . 0.499 HG13 ' HG3' ' A' 1491 ' ' GLN . 12.3 p 176.16 -33.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 121.066 0.46 . . . . 0.0 111.34 -176.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . 0.499 ' HG3' HG13 ' A' 1490 ' ' VAL . 98.1 mt-30 -94.91 22.09 6.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 122.356 1.074 . . . . 0.0 108.985 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . 0.609 ' HA ' ' O ' ' A' 1495 ' ' GLN . 4.4 m-20 -86.97 72.54 10.08 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.788 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 16.0 p30 -88.58 -72.85 0.52 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.36 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.432 ' HA ' ' HG ' ' A' 1559 ' ' LEU . 85.3 m -121.99 15.29 10.78 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.49 1.138 . . . . 0.0 108.818 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' 1505 ' ' PHE . 10.6 pt20 -139.05 116.88 11.54 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.2 p -137.57 141.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' 1504 ' ' VAL . 6.7 t -121.12 167.76 12.3 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 24.5 p30 -131.96 150.99 77.68 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -82.92 16.12 1.92 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.311 2.007 . . . . 0.0 112.413 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -93.69 -56.79 2.77 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.39 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 16.7 p -103.08 -27.97 12.25 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.61 0.719 . . . . 0.0 110.198 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.68 27.38 57.07 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.857 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . . . . . . . . . 61.4 t80 -98.4 132.68 43.66 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' 1497 ' ' THR . 43.1 t -96.54 110.1 24.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' 1495 ' ' GLN . 65.7 m-85 -76.56 102.84 6.25 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 177.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -102.88 107.38 18.2 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.836 0.35 . . . . 0.0 110.777 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 50.4 tp -85.61 -4.48 59.17 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 122.199 1.0 . . . . 0.0 109.153 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.539 ' HA ' ' HG3' ' A' 1511 ' ' LYS . 48.6 m-80 -71.07 -21.28 62.26 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.896 -177.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 58.8 p -80.98 -7.65 59.59 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.667 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.66 11.35 15.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.539 ' HG3' ' HA ' ' A' 1508 ' ' ASN . 33.1 mtmm -59.55 176.24 0.28 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.153 0.501 . . . . 0.0 111.677 177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.811 ' HD3' HG12 ' A' 1534 ' ' VAL . 18.3 ttp180 -66.97 93.46 0.28 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.201 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.93 -38.99 10.43 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 168.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 28.3 t -118.37 -40.23 2.95 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.194 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . . . . . . . . . . . 98.62 175.56 32.48 Favored Glycine 0 N--CA 1.434 -1.5 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' 1527 ' ' ARG . 12.4 m-85 -113.79 141.95 46.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' 1526 ' ' ILE . 88.2 m -142.72 103.41 4.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.379 0.609 . . . . 0.0 110.845 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 22.7 pt -119.82 148.73 22.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 45.4 m -114.48 123.65 49.95 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.138 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 7.5 t70 -67.79 155.45 39.29 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.841 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.64 -24.7 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.395 0 C-N-CA 124.087 0.955 . . . . 0.0 112.079 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . 0.86 HH22 HG11 ' A' 1607 ' ' VAL . 80.0 mtm180 -81.01 3.1 24.22 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.311 0.644 . . . . 0.0 111.262 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 68.78 62.15 0.33 Allowed 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 124.554 1.142 . . . . 0.0 111.038 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -121.42 91.48 0.47 Allowed Glycine 0 N--CA 1.409 -3.134 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 40.5 m -78.85 104.18 9.31 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' 1517 ' ' THR . 11.2 tt -98.18 125.98 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-O 121.515 0.674 . . . . 0.0 109.317 -177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' 1516 ' ' TYR . 44.1 ttt180 -108.35 125.27 51.52 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.34 140.39 50.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.121 -175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . . . . . . . . . . . -122.66 126.41 6.35 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 106.568 -2.613 . . . . 0.0 106.568 170.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' 1511 ' ' LYS . 17.1 m -89.51 118.74 35.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.126 -176.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 55.8 m 69.86 10.9 7.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.823 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -136.43 130.47 5.27 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . 0.572 ' HG3' ' HE3' ' A' 1535 ' ' LYS . 12.7 pt-20 -74.91 129.3 37.43 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.265 0.555 . . . . 0.0 111.62 -178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.811 HG12 ' HD3' ' A' 1512 ' ' ARG . 17.7 m -92.58 99.68 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-O 122.005 0.907 . . . . 0.0 109.842 177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.572 ' HE3' ' HG3' ' A' 1533 ' ' GLU . 9.8 mptt -67.15 -12.12 59.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.071 -174.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.18 -43.64 74.53 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 125.683 1.593 . . . . 0.0 109.151 175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 58.1 m -104.23 -7.19 20.26 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.534 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.95 163.5 9.54 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.533 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.86 139.16 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.112 1.875 . . . . 0.0 111.365 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 71.88 30.43 65.84 Favored Glycine 0 C--N 1.305 -1.193 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.388 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 49.8 mm -122.21 129.04 75.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -104.6 -35.84 3.19 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 119.603 -1.284 . . . . 0.0 112.116 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -122.78 124.67 43.86 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 27.4 p -140.07 154.64 47.12 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.755 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' 1550 ' ' ILE . 91.1 m-85 -93.96 116.48 28.93 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.13 100.65 3.7 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.484 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . -174.8 -94.92 0.1 OUTLIER Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 94.0 m -95.78 -37.42 10.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 117.153 0.477 . . . . 0.0 110.706 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 143.44 31.21 0.1 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 119.581 -1.295 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.588 ' HB ' ' HB2' ' A' 1545 ' ' PHE . 64.9 mt -71.39 125.17 29.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.631 ' H ' ' HB2' ' A' 1574 ' ' ASP . 36.3 mttp -99.29 132.45 44.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -174.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -106.03 4.89 29.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.924 0.392 . . . . 0.0 111.285 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.962 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 156.94 140.19 2.89 Favored Glycine 0 C--O 1.254 1.403 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.027 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' 1572 ' ' ASP . 60.4 mttp -79.21 155.51 28.57 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.032 0.444 . . . . 0.0 111.446 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 67.5 t90 -64.57 124.91 23.08 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.95 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -163.17 140.53 7.64 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . 0.403 ' HB3' ' SG ' ' A' 1494 ' ' CYS . 90.1 mt-30 -106.63 79.53 1.36 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -127.68 98.25 5.13 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.272 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.432 ' HG ' ' HA ' ' A' 1494 ' ' CYS . 34.6 mt -101.43 107.57 18.92 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.343 0.592 . . . . 0.0 109.89 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.07 113.72 26.06 Favored 'General case' 0 N--CA 1.413 -2.302 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -90.71 101.35 14.1 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' 1565 ' ' VAL . 78.3 t -135.47 141.4 42.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 33.9 t70 60.54 24.02 13.7 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.791 0.836 . . . . 0.0 110.397 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 65.92 16.62 10.54 Favored 'General case' 0 C--O 1.252 1.217 0 C-N-CA 124.166 0.986 . . . . 0.0 110.855 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' 1562 ' ' VAL . 7.3 p -121.49 155.29 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.826 ' HB2' ' HB2' ' A' 1590 ' ' PHE . 8.6 mp -91.28 129.81 37.23 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -119.99 115.66 24.21 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 60.4 tp -117.13 102.02 8.95 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1587 ' ' VAL . 7.6 p -106.95 112.51 40.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.563 0.697 . . . . 0.0 111.486 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.962 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 30.6 m-85 -81.75 102.38 10.72 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' 1569 ' ' VAL . 49.5 mt-10 -102.3 161.64 13.54 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.111 0.482 . . . . 0.0 111.896 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' 1554 ' ' LYS . 8.5 t70 63.15 66.02 0.75 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.102 173.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -91.16 -93.0 1.31 Allowed Glycine 0 N--CA 1.426 -2.026 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.391 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.631 ' HB2' ' H ' ' A' 1551 ' ' LYS . 3.3 t70 -123.25 149.82 58.58 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -57.02 137.58 82.58 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.776 2.317 . . . . 0.0 112.855 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 24.8 t -101.79 128.93 27.65 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.251 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.67 16.92 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.559 2.84 . . . . 0.0 114.283 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.54 -41.12 16.8 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . . . . . . . . . 65.7 t30 -154.39 10.59 0.37 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.167 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 1.7 tm? 69.84 -53.7 0.61 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.274 1.43 . . . . 0.0 111.761 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -65.92 -24.01 66.74 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.032 0.533 . . . . 0.0 110.752 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' 1611 ' ' THR . 85.4 mt -81.11 141.08 34.64 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' 1585 ' ' LYS . 62.1 mttp -132.08 158.0 42.72 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -59.66 121.36 11.44 Favored 'General case' 0 C--O 1.243 0.711 0 O-C-N 124.122 0.889 . . . . 0.0 109.474 177.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' 1583 ' ' LYS . 43.9 mtmt -130.76 134.42 46.86 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.651 ' HB3' HD12 ' A' 1614 ' ' LEU . 13.6 p -123.53 116.77 23.72 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-O 120.9 0.381 . . . . 0.0 111.426 -177.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' 1569 ' ' VAL . 7.5 p -102.83 109.31 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.066 0.936 . . . . 0.0 110.649 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' 1618 ' ' TRP . 3.4 mp -97.62 108.85 22.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 14.7 t -95.9 119.51 34.52 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.826 ' HB2' ' HB2' ' A' 1566 ' ' LEU . 88.8 m-85 -89.83 106.35 18.41 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.122 -176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 33.8 m -98.57 169.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' 1620 ' ' THR . 38.7 t -104.77 141.23 36.86 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 117.484 -1.686 . . . . 0.0 115.325 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' A' 1595 ' ' ASP . 53.8 tptt -151.45 100.57 2.74 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.952 170.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' 1621 ' ' SER . 41.0 p -66.09 -9.63 32.9 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -176.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . 0.522 ' HB2' ' HE3' ' A' 1593 ' ' LYS . 8.0 m-20 -92.97 6.21 48.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.893 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -76.55 -74.99 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 109.45 -120.13 5.69 Favored Glycine 0 CA--C 1.507 -0.443 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.614 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -87.05 17.77 1.69 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.477 2.785 . . . . 0.0 110.708 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.6 t -153.76 -176.05 5.65 Favored 'General case' 1 N--CA 1.377 -4.121 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.726 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 41.4 m -155.48 155.7 33.95 Favored 'General case' 0 C--N 1.255 -3.505 0 C-N-CA 123.566 0.746 . . . . 0.0 109.004 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.78 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 44.5 mt-30 -87.79 121.44 70.84 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.454 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.0 OUTLIER -88.95 128.78 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.391 2.727 . . . . 0.0 111.51 178.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' 1617 ' ' SER . 2.2 tm? -130.54 114.91 16.07 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 176.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.97 106.91 4.45 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 61.0 tp -75.02 -53.98 7.98 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.242 -176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 33.2 t -169.81 151.58 4.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.86 HG11 HH22 ' A' 1522 ' ' ARG . 65.0 t -125.91 131.78 71.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 19.2 t70 -110.74 117.17 32.72 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -80.8 -8.58 59.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -72.09 -40.46 68.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.761 0.315 . . . . 0.0 110.479 -178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.592 ' HA ' HD13 ' A' 1582 ' ' LEU . 23.4 p -121.66 -5.45 9.19 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . . . . . . . . . 62.1 m 67.56 32.6 5.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.048 0.928 . . . . 0.0 111.152 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 44.1 m -92.04 126.61 37.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.959 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' 1586 ' ' SER . 59.0 mt -101.39 132.12 47.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.68 119.15 37.09 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.38 137.05 54.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.86 0.362 . . . . 0.0 111.621 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.527 ' HB2' ' HB3' ' A' 1603 ' ' LEU . 27.3 m -104.11 105.42 15.57 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 12.6 t-105 -101.44 118.85 37.8 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.78 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 14.8 m-70 -94.79 97.57 10.14 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -178.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' 1592 ' ' CYS . 11.7 t -123.26 151.05 42.73 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.348 0.594 . . . . 0.0 111.608 -175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' 1594 ' ' SER . 1.0 OUTLIER -74.23 -23.81 59.22 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.778 0.799 . . . . 0.0 110.49 178.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 49.7 mt -72.74 -4.91 34.28 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.519 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -93.29 -5.86 48.78 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.793 0.33 . . . . 0.0 111.445 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 20.5 m -91.64 137.61 32.22 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -74.59 111.98 10.32 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 169.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -80.69 117.93 21.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -174.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.67 -22.23 43.76 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.932 -174.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.306 -1.303 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.179 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . 0.559 ' HG3' HG23 ' A' 1490 ' ' VAL . 13.7 tpt . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' 1489 ' ' MET . 25.5 t 62.64 56.46 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 122.713 1.244 . . . . 0.0 108.631 -177.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -131.74 117.57 18.78 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.53 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.01 75.46 10.14 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.963 1.363 . . . . 0.0 110.696 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -71.28 -54.77 9.72 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.942 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.464 ' HA ' HD11 ' A' 1559 ' ' LEU . 6.1 t 59.03 33.3 22.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 125.003 1.321 . . . . 0.0 110.255 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -150.27 154.45 37.92 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 10.7 p -141.62 138.24 32.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.452 HG23 HG22 ' A' 1504 ' ' VAL . 23.7 m -104.08 113.59 27.25 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . 0.574 HD21 ' HB2' ' A' 1503 ' ' TYR . 6.0 p30 -81.89 130.86 59.01 Favored Pre-proline 0 C--N 1.312 -1.06 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.34 -3.37 13.59 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.568 2.179 . . . . 0.0 112.649 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -75.44 -53.95 7.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.727 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . 0.416 ' HB ' ' CD1' ' A' 1503 ' ' TYR . 17.2 p -109.21 -14.11 14.54 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 78.5 26.54 59.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.599 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . 0.574 ' HB2' HD21 ' A' 1498 ' ' ASN . 13.8 m-85 -99.22 120.4 39.46 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.22 -0.49 . . . . 0.0 109.977 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.452 HG22 HG23 ' A' 1497 ' ' THR . 25.4 t -89.39 113.35 25.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 175.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -100.23 111.18 23.44 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . 0.76 ' HB2' HD22 ' A' 1508 ' ' ASN . 3.0 p30 -104.01 130.87 51.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.059 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 15.9 tp -87.79 0.18 56.12 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.082 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . 0.76 HD22 ' HB2' ' A' 1506 ' ' ASP . 41.4 m-80 -63.0 -38.5 91.43 Favored 'General case' 0 CA--C 1.505 -0.766 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.49 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 32.9 t -71.08 -3.97 22.64 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.315 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.635 ' HB2' HD12 ' A' 1622 ' ' LEU . 0.9 OUTLIER -114.16 -41.78 3.46 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' A' 1508 ' ' ASN . 22.0 pttp -65.57 144.21 57.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' 1515 ' ' GLY . 40.5 ttm180 -88.58 161.92 16.66 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -50.11 -54.98 16.86 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.346 1.058 . . . . 0.0 111.342 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 3.0 p -87.6 -2.62 58.74 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 123.675 0.79 . . . . 0.0 111.872 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.525 ' HA3' ' HA2' ' A' 1529 ' ' GLY . . . 86.74 -139.74 16.65 Favored Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -176.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 95.7 m-85 -124.63 121.65 35.31 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 117.467 0.633 . . . . 0.0 111.124 177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 32.9 m -110.5 94.83 5.2 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 31.7 pt -110.25 155.3 11.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.355 -174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 22.4 m -79.9 131.21 35.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.447 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . . . . . . . . . 22.1 t70 -105.31 147.8 27.74 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.852 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.77 -25.97 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 123.901 0.88 . . . . 0.0 112.727 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -83.87 3.26 34.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.987 0.422 . . . . 0.0 110.165 -176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 74.28 84.91 0.1 Allowed 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.772 1.629 . . . . 0.0 111.358 -177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' 1545 ' ' PHE . . . -175.22 156.36 22.19 Favored Glycine 0 N--CA 1.404 -3.465 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 4.2 m -114.13 101.68 9.44 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.6 tt -83.41 119.71 33.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.196 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 43.3 ttm180 -109.78 112.74 24.97 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.974 177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.36 118.78 30.33 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.583 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.525 ' HA2' ' HA3' ' A' 1515 ' ' GLY . . . -90.03 106.79 3.37 Favored Glycine 0 N--CA 1.421 -2.318 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . . . . . . . . . 89.2 t -59.73 116.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 36.1 m 63.21 12.6 6.24 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 124.071 0.857 . . . . 0.0 111.609 178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -129.27 172.4 19.79 Favored Glycine 0 N--CA 1.42 -2.395 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.063 -174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -108.97 141.74 40.64 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.413 HG11 ' HG2' ' A' 1527 ' ' ARG . 26.6 m -103.9 90.95 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-O 122.252 1.025 . . . . 0.0 109.605 174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -65.1 -16.61 63.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.41 -0.813 . . . . 0.0 111.82 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 3.6 p30 -64.83 -22.21 66.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.92 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 21.6 t -111.87 -13.67 13.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.429 0.633 . . . . 0.0 110.043 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . . . . . . . . . . . 140.67 155.27 6.46 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.217 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.08 141.12 35.71 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.467 2.111 . . . . 0.0 111.071 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 77.85 8.87 87.23 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.331 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . 0.403 HD12 ' HD2' ' A' 1551 ' ' LYS . 46.5 mm -106.56 135.05 46.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . . . . . . . . . . . -106.23 -37.29 2.51 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.007 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -124.03 123.99 41.57 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 122.707 -0.29 . . . . 0.0 110.325 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . . . . . . . . . 45.0 t -136.69 153.43 50.89 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.296 0.569 . . . . 0.0 110.821 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' 1524 ' ' GLY . 58.9 t80 -90.15 100.29 13.15 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.494 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . 0.725 ' HG3' HG23 ' A' 1548 ' ' THR . 11.8 pt-20 47.71 21.24 0.25 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 126.784 2.034 . . . . 0.0 115.221 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 63.55 27.47 70.97 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.516 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . 0.725 HG23 ' HG3' ' A' 1546 ' ' GLU . 32.9 p -83.24 -15.95 48.33 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 118.689 1.244 . . . . 0.0 109.985 177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 122.6 -14.91 8.6 Favored Glycine 0 N--CA 1.425 -2.1 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.718 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . . . . . . . . . 50.7 mt -79.48 118.89 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' 1541 ' ' ILE . 8.6 mtmp? -97.79 137.48 36.6 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.499 -173.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . . . . . . . . . . . -111.48 11.63 21.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.369 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.859 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 155.53 130.55 1.33 Allowed Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.432 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . . . . . . . . . 53.4 tttp -81.71 155.26 25.62 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . 0.53 ' HH2' ' HA ' ' A' 1490 ' ' VAL . 61.6 t90 -73.21 128.53 35.75 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.315 0.578 . . . . 0.0 110.08 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.47 139.5 14.31 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -86.89 78.16 9.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.287 0.565 . . . . 0.0 110.46 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 54.0 tptt -114.82 96.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.805 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' 1494 ' ' CYS . 86.2 mt -109.84 103.34 12.12 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.568 -1.196 . . . . 0.0 107.997 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.877 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 29.2 t -101.77 141.47 34.58 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 20.3 t80 -121.59 101.16 7.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' 1565 ' ' VAL . 98.5 t -134.88 127.29 48.53 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.52 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.281 -176.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.37 33.83 22.57 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.441 1.115 . . . . 0.0 110.0 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 70.94 -0.03 3.2 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.351 1.06 . . . . 0.0 113.236 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' 1562 ' ' VAL . 9.5 p -98.98 134.18 38.85 Favored 'Isoleucine or valine' 0 C--O 1.252 1.218 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.752 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 9.2 tp -84.97 132.26 34.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.877 ' HB2' ' HB3' ' A' 1560 ' ' SER . 94.0 mt-30 -122.07 114.99 21.68 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.739 -0.601 . . . . 0.0 112.121 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 48.4 tp -102.86 112.65 25.55 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.471 HG12 ' HG2' ' A' 1571 ' ' GLU . 44.4 t -105.83 112.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.592 -172.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.859 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 77.4 m-85 -95.19 115.2 27.11 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.471 ' HG2' HG12 ' A' 1569 ' ' VAL . 8.9 mm-40 -111.56 165.54 11.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 33.5 t70 60.72 80.75 0.2 Allowed 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.474 1.109 . . . . 0.0 111.871 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -102.46 -127.56 6.14 Favored Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' 1575 ' ' PRO . 1.0 OUTLIER -113.5 147.25 37.11 Favored Pre-proline 0 C--N 1.295 -1.794 0 O-C-N 122.604 -0.35 . . . . 0.0 111.033 175.379 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' 1574 ' ' ASP . 23.5 Cg_exo -66.52 134.31 35.19 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.404 2.736 . . . . 0.0 112.832 -176.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . . . . . . . . . 85.6 m -98.8 149.06 35.38 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.276 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -73.42 3.99 4.29 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.849 2.366 . . . . 0.0 115.869 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -84.29 -67.18 0.81 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.915 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.523 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 6.8 m-20 -110.26 2.19 19.07 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.761 -0.2 . . . . 0.0 111.246 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . . . . . . . . . 3.8 mm? 71.69 -57.62 0.61 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.337 1.055 . . . . 0.0 113.707 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -76.23 -10.44 59.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 111.168 -176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.669 HD13 ' HA ' ' A' 1611 ' ' THR . 70.8 mt -83.17 124.58 30.66 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . . . . . . . . . 88.0 mttt -119.31 162.75 18.22 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.835 0.709 . . . . 0.0 110.043 -174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -58.97 109.34 0.81 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 124.01 0.819 . . . . 0.0 109.705 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -112.2 131.77 55.29 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . . . . . . . . . 10.5 t -121.77 118.72 29.74 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.701 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . . . . . . . . . 7.1 p -115.33 107.49 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.969 0.89 . . . . 0.0 109.844 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.96 107.32 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' 1617 ' ' SER . 25.0 m -91.52 116.3 28.75 Favored 'General case' 0 N--CA 1.402 -2.865 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.752 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 92.4 m-85 -86.12 105.53 16.6 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' 1617 ' ' SER . 65.3 t -93.95 152.05 3.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.009 -175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . . . . . . . . . 50.5 t -75.26 134.52 41.09 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 122.107 0.955 . . . . 0.0 112.822 -173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.543 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 54.3 tptt -149.68 101.34 3.06 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 171.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 71.1 m -63.21 -37.76 88.52 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.965 0.412 . . . . 0.0 111.494 -177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -97.77 71.69 2.24 Favored 'General case' 0 N--CA 1.423 -1.813 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.937 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -133.3 -57.76 0.9 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.756 175.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 73.69 -147.67 38.91 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.94 -21.9 36.72 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.217 1.944 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 13.7 p -91.06 67.21 5.92 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-O 122.312 1.053 . . . . 0.0 109.356 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.535 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 15.1 m -76.85 161.77 28.16 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 113.404 -1.725 . . . . 0.0 109.685 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 16.9 mm-40 -105.43 121.11 47.29 Favored Pre-proline 0 C--N 1.301 -1.5 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.096 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' 1601 ' ' GLN . 5.7 Cg_exo -77.31 152.76 30.87 Favored 'Trans proline' 0 C--O 1.244 0.803 0 C-N-CA 122.678 2.252 . . . . 0.0 110.104 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' 1617 ' ' SER . 66.3 tp -154.88 120.3 5.03 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.102 -0.374 . . . . 0.0 110.979 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . . . . . . . . . 57.4 tp -78.61 113.47 16.69 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 171.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 42.8 tp -88.93 -43.51 11.12 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 40.1 t -167.62 150.65 6.03 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -176.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . . . . . . . . . 84.9 t -130.6 111.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' 1612 ' ' CYS . 31.7 t70 -93.65 122.74 36.42 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.521 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -80.14 -11.78 59.72 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.38 -52.5 5.16 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.166 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.669 ' HA ' HD13 ' A' 1582 ' ' LEU . 47.2 p -98.03 -17.03 19.37 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.974 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' 1608 ' ' ASP . 75.6 m 69.95 25.18 4.94 Favored 'General case' 0 CA--C 1.512 -0.509 0 O-C-N 124.108 0.88 . . . . 0.0 111.586 -177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . . . . . . . . . 21.6 m -80.38 118.1 21.71 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.98 126.88 41.52 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.16 118.03 35.67 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -121.37 139.23 53.72 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' 1589 ' ' SER . 21.7 m -121.65 103.72 9.1 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.666 0.746 . . . . 0.0 109.382 175.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -92.89 107.53 19.29 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -175.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.6 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 43.5 m80 -78.0 97.42 5.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . . . . . . . . . 8.8 t -131.09 154.02 48.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.528 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 9.5 m -76.15 -25.09 54.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.696 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . 0.635 HD12 ' HB2' ' A' 1510 ' ' LEU . 39.4 mt -71.89 -5.03 31.59 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.471 0.653 . . . . 0.0 111.835 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -100.7 -3.05 30.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.066 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . . . . . . . . . 57.1 m -96.04 144.71 26.07 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -65.64 112.27 3.57 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 168.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' 1628 ' ' VAL . 5.4 tp60 -80.58 142.29 34.23 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -164.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -71.71 -32.83 68.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.133 -1.394 . . . . 0.0 111.035 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . 0.567 ' H ' ' HG3' ' A' 1626 ' ' GLN . 2.6 p . . . . . 0 C--N 1.308 -1.207 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.54 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1489 ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1490 ' ' VAL . . . . . . . . . . . . . 68.0 t -89.34 119.37 36.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1491 ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.26 124.28 27.9 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1492 ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.33 127.66 39.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1493 ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -132.19 166.53 21.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1494 ' ' CYS . . . . . 0.406 ' HA ' ' CD2' ' A' 1559 ' ' LEU . 79.4 m -77.44 1.24 19.75 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.009 0.923 . . . . 0.0 111.816 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1495 ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' 1505 ' ' PHE . 11.6 pt20 -117.15 118.25 31.82 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 172.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1496 ' ' VAL . . . . . . . . . . . . . 7.7 p -118.96 124.19 72.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 CA-C-O 121.831 0.824 . . . . 0.0 110.784 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1497 ' ' THR . . . . . 0.477 HG23 HG22 ' A' 1504 ' ' VAL . 24.8 m -96.49 125.9 41.3 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.243 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1498 ' ' ASN . . . . . . . . . . . . . 9.8 p30 -91.93 133.52 30.42 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1499 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.73 4.53 6.84 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.21 1.94 . . . . 0.0 112.468 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1500 ' ' ALA . . . . . . . . . . . . . . . -78.67 -68.38 0.65 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.368 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1501 ' ' THR . . . . . . . . . . . . . 19.7 p -101.26 -19.75 15.54 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.043 0.449 . . . . 0.0 111.826 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1502 ' ' GLY . . . . . . . . . . . . . . . 100.29 2.24 55.72 Favored Glycine 0 C--O 1.243 0.707 0 C-N-CA 120.621 -0.8 . . . . 0.0 113.539 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1503 ' ' TYR . . . . . 0.43 ' CD2' ' HB3' ' A' 1625 ' ' GLU . 56.3 m-85 -72.45 141.25 48.61 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.068 0.461 . . . . 0.0 111.605 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1504 ' ' VAL . . . . . 0.477 HG22 HG23 ' A' 1497 ' ' THR . 48.2 t -108.84 118.94 57.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1505 ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' 1495 ' ' GLN . 58.7 m-85 -95.39 101.56 13.29 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1506 ' ' ASP . . . . . . . . . . . . . 20.0 t70 -99.25 112.32 24.51 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.066 0.46 . . . . 0.0 110.084 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1507 ' ' LEU . . . . . . . . . . . . . 27.7 tp -84.86 -2.02 57.25 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.485 0.66 . . . . 0.0 111.143 -178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1508 ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -79.6 -21.96 44.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.6 0.714 . . . . 0.0 109.781 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1509 ' ' SER . . . . . . . . . . . . . 28.4 t -78.24 -10.13 59.52 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.679 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1510 ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' 1598 ' ' PRO . 0.5 OUTLIER -106.34 -45.66 4.23 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1511 ' ' LYS . . . . . 0.577 ' HB2' ' HB ' ' A' 1530 ' ' VAL . 21.3 pttp -49.5 146.53 3.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.825 1.25 . . . . 0.0 114.326 -173.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1512 ' ' ARG . . . . . 0.511 ' HA ' ' NE ' ' A' 1512 ' ' ARG . 0.0 OUTLIER -103.72 127.31 51.2 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1513 ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -64.04 -43.19 96.31 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.668 0.605 . . . . 0.0 112.391 -173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1514 ' ' SER . . . . . . . . . . . . . 47.6 m -86.25 6.27 30.44 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.037 0.446 . . . . 0.0 111.127 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1515 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1529 ' ' GLY . . . 80.33 161.14 23.9 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 116.163 -0.471 . . . . 0.0 113.152 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1516 ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' 1527 ' ' ARG . 81.0 m-85 -100.22 118.17 35.98 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1517 ' ' THR . . . . . . . . . . . . . 94.0 m -93.97 100.64 12.75 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1518 ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.88 142.02 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.887 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1519 ' ' SER . . . . . . . . . . . . . 42.5 t -102.74 136.43 42.58 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1520 ' ' ASP . . . . . 0.54 ' HB2' HD22 ' A' 1604 ' ' LEU . 0.1 OUTLIER -84.49 175.14 9.5 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1521 ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.82 -21.02 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-O 121.212 0.529 . . . . 0.0 111.293 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1522 ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 -91.9 3.05 56.05 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.15 0.58 . . . . 0.0 111.489 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1523 ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' 1523 ' ' LYS . 17.2 mmtm 80.96 19.09 0.47 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 175.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1524 ' ' GLY . . . . . . . . . . . . . . . -80.38 105.02 2.32 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 174.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1525 ' ' SER . . . . . . . . . . . . . 19.2 m -84.2 98.08 9.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.387 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1526 ' ' ILE . . . . . . . . . . . . . 11.0 tt -103.78 133.86 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.96 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.125 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1527 ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' 1516 ' ' TYR . 29.4 ttt180 -108.9 112.74 25.13 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1528 ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.99 122.99 47.94 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.616 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1529 ' ' GLY . . . . . 0.427 ' HA2' ' HA2' ' A' 1515 ' ' GLY . . . -98.15 127.0 9.09 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 174.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1530 ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' 1511 ' ' LYS . 58.9 t -87.85 116.94 30.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1531 ' ' CYS . . . . . . . . . . . . . 83.7 m 69.68 0.63 3.06 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1532 ' ' GLY . . . . . . . . . . . . . . . -134.34 140.76 12.04 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1533 ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.0 137.75 41.74 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.008 0.432 . . . . 0.0 110.508 -176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1534 ' ' VAL . . . . . 0.406 HG21 ' SG ' ' A' 1544 ' ' CYS . 9.5 m -79.26 87.33 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.034 0.921 . . . . 0.0 109.973 174.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1535 ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' 1535 ' ' LYS . 0.0 OUTLIER -58.14 -18.56 26.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.379 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1536 ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.91 -20.65 62.47 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 124.569 1.148 . . . . 0.0 110.969 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1537 ' ' CYS . . . . . . . . . . . . . 77.1 m -117.52 -20.49 9.01 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.304 -0.248 . . . . 0.0 111.561 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1538 ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' 1539 ' ' PRO . . . 146.94 154.11 6.1 Favored Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.121 -1.038 . . . . 0.0 112.31 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1539 ' ' PRO . . . . . 0.433 ' HD3' ' HA2' ' A' 1538 ' ' GLY . 24.2 Cg_exo -69.6 142.24 48.1 Favored 'Trans proline' 0 C--O 1.246 0.916 0 C-N-CA 123.288 2.659 . . . . 0.0 111.644 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1540 ' ' GLY . . . . . . . . . . . . . . . 73.51 10.26 79.14 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.331 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1541 ' ' ILE . . . . . . . . . . . . . 44.0 mm -107.04 134.17 49.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1542 ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' 1570 ' ' TYR . . . -101.25 -41.3 2.61 Favored Glycine 0 C--O 1.221 -0.661 0 C-N-CA 119.97 -1.11 . . . . 0.0 112.096 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1543 ' ' ALA . . . . . . . . . . . . . . . -126.26 134.97 51.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1544 ' ' CYS . . . . . 0.406 ' SG ' HG21 ' A' 1534 ' ' VAL . 26.4 p -145.11 151.99 39.36 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 121.221 -0.192 . . . . 0.0 110.682 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1545 ' ' PHE . . . . . 0.435 ' HB2' HG13 ' A' 1550 ' ' ILE . 85.4 m-85 -92.26 120.1 32.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1546 ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.77 109.73 10.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.612 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1547 ' ' GLY . . . . . . . . . . . . . . . 165.09 -73.21 0.17 Allowed Glycine 0 C--N 1.29 -1.978 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1548 ' ' THR . . . . . . . . . . . . . 16.8 p -97.3 -18.09 19.38 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.526 0.679 . . . . 0.0 110.194 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1549 ' ' GLY . . . . . . . . . . . . . . . 89.63 19.06 50.06 Favored Glycine 0 N--CA 1.436 -1.357 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1550 ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' 1545 ' ' PHE . 23.5 pt -66.43 135.66 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.712 0.768 . . . . 0.0 111.192 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1551 ' ' LYS . . . . . 0.416 ' HG3' ' OD1' ' A' 1574 ' ' ASP . 29.2 mttp -79.42 137.54 37.3 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.735 -174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1552 ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' 1584 ' ' TYR . . . -120.3 19.52 12.11 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.925 0.869 . . . . 0.0 108.763 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1553 ' ' GLY . . . . . 0.882 ' HA3' ' HB3' ' A' 1570 ' ' TYR . . . 151.81 124.38 1.11 Allowed Glycine 0 N--CA 1.424 -2.157 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.894 -179.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1554 ' ' LYS . . . . . 0.47 ' HB2' ' HE3' ' A' 1554 ' ' LYS . 33.2 ttmt -83.83 144.59 29.17 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1555 ' ' TRP . . . . . . . . . . . . . 90.0 t90 -59.92 131.74 51.81 Favored 'General case' 0 C--O 1.243 0.714 0 O-C-N 123.73 0.644 . . . . 0.0 110.353 -177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1556 ' ' ASN . . . . . . . . . . . . . 7.1 p30 -164.29 145.35 8.33 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1557 ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -112.2 85.8 2.22 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1558 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -126.75 104.84 8.29 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.736 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1559 ' ' LEU . . . . . 0.406 ' CD2' ' HA ' ' A' 1494 ' ' CYS . 3.5 mm? -100.57 118.06 35.98 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.188 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1560 ' ' SER . . . . . 0.511 ' HB3' ' HB2' ' A' 1567 ' ' GLN . 32.1 t -110.84 147.86 33.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1561 ' ' TYR . . . . . . . . . . . . . 28.6 t80 -130.0 128.66 42.48 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.661 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1562 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1565 ' ' VAL . 73.2 t -113.33 156.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1563 ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' 1564 ' ' GLN . 19.5 t70 -48.11 113.21 0.69 Allowed 'General case' 0 CA--C 1.495 -1.145 0 CA-C-N 118.056 0.389 . . . . 0.0 110.653 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1564 ' ' GLN . . . . . 0.608 ' HB2' ' SG ' ' A' 1624 ' ' CYS . 7.4 pt20 56.2 21.28 5.12 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.857 2.063 . . . . 0.0 113.466 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1565 ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' 1562 ' ' VAL . 58.9 t -137.11 118.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1566 ' ' LEU . . . . . 0.778 ' HB3' ' HB2' ' A' 1590 ' ' PHE . 12.0 tp -89.26 131.84 35.17 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1567 ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' 1560 ' ' SER . 79.9 mm-40 -115.64 114.87 25.47 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1568 ' ' LEU . . . . . . . . . . . . . 62.6 tp -123.78 111.39 16.07 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1569 ' ' VAL . . . . . 0.712 HG22 HG23 ' A' 1587 ' ' VAL . 32.3 t -112.15 123.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.621 0.724 . . . . 0.0 111.285 -177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1570 ' ' TYR . . . . . 0.882 ' HB3' ' HA3' ' A' 1553 ' ' GLY . 33.9 m-85 -98.96 100.82 12.04 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.245 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1571 ' ' GLU . . . . . 0.557 ' HG2' ' HD3' ' A' 1585 ' ' LYS . 34.6 mt-10 -99.91 179.34 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.048 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1572 ' ' ASP . . . . . . . . . . . . . 22.2 t70 52.61 68.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.759 1.624 . . . . 0.0 112.766 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1573 ' ' GLY . . . . . . . . . . . . . . . -98.97 -131.5 7.32 Favored Glycine 0 N--CA 1.432 -1.607 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.291 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1574 ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' 1551 ' ' LYS . 0.2 OUTLIER -89.83 140.38 27.82 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1575 ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' 1583 ' ' LYS . 25.2 Cg_exo -66.27 142.26 65.91 Favored 'Trans proline' 0 C--O 1.245 0.833 0 C-N-CA 122.663 2.242 . . . . 0.0 112.051 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1576 ' ' CYS . . . . . 0.468 ' HA ' ' HD3' ' A' 1577 ' ' PRO . 81.5 m -98.15 138.42 20.91 Favored Pre-proline 0 C--N 1.285 -2.224 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1577 ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' 1576 ' ' CYS . 23.2 Cg_exo -58.47 -22.74 60.63 Favored 'Trans proline' 0 N--CA 1.479 0.661 0 C-N-CA 123.619 2.879 . . . . 0.0 114.529 -172.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1578 ' ' ALA . . . . . . . . . . . . . . . -68.35 -51.29 46.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1579 ' ' ASN . . . . . 0.624 ' HB2' ' HG ' ' A' 1582 ' ' LEU . 15.7 m120 -124.17 -8.24 7.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1580 ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' 1575 ' ' PRO . 3.7 mm? 68.17 -51.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.635 1.174 . . . . 0.0 113.376 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1581 ' ' HIS . . . . . . . . . . . . . 13.1 m80 -73.42 -13.5 61.09 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.635 0.255 . . . . 0.0 111.578 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1582 ' ' LEU . . . . . 0.624 ' HG ' ' HB2' ' A' 1579 ' ' ASN . 33.1 mt -90.28 132.56 35.47 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1583 ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' 1575 ' ' PRO . 96.1 mttt -132.96 162.16 32.39 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 -173.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1584 ' ' TYR . . . . . 0.461 ' HA ' ' HB3' ' A' 1612 ' ' CYS . 82.8 m-85 -62.86 117.46 6.39 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 176.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1585 ' ' LYS . . . . . 0.557 ' HD3' ' HG2' ' A' 1571 ' ' GLU . 96.1 mttt -130.34 143.28 50.67 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1586 ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' 1614 ' ' LEU . 19.7 m -119.77 116.96 26.97 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1587 ' ' VAL . . . . . 0.712 HG23 HG22 ' A' 1569 ' ' VAL . 3.6 p -106.87 110.02 30.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1588 ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.49 111.06 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1589 ' ' SER . . . . . . . . . . . . . 22.9 t -95.93 109.26 21.65 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1590 ' ' PHE . . . . . 0.778 ' HB2' ' HB3' ' A' 1566 ' ' LEU . 88.0 m-85 -87.29 115.02 24.42 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1591 ' ' VAL . . . . . . . . . . . . . 23.9 m -107.58 152.79 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1592 ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' 1620 ' ' THR . 6.3 m -76.39 124.64 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.206 0.527 . . . . 0.0 111.53 -172.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1593 ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' 1619 ' ' HIS . 21.8 tptp -139.32 112.37 8.03 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1594 ' ' SER . . . . . . . . . . . . . 15.0 t -70.64 -22.3 62.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.181 0.515 . . . . 0.0 110.505 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1595 ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.65 -8.36 54.92 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 110.95 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1596 ' ' ALA . . . . . 0.749 ' HB1' ' HA ' ' A' 1600 ' ' SER . . . -90.35 -77.28 0.41 Allowed 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1597 ' ' GLY . . . . . . . . . . . . . . . 74.13 -143.68 32.33 Favored Glycine 0 C--O 1.248 1.011 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -170.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1598 ' ' PRO . . . . . 0.578 ' HA ' HD22 ' A' 1510 ' ' LEU . 40.2 Cg_endo -67.28 -21.72 47.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.344 2.03 . . . . 0.0 110.802 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1599 ' ' THR . . . . . . . . . . . . . 4.1 p -94.37 70.68 3.73 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 122.343 1.068 . . . . 0.0 109.352 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1600 ' ' SER . . . . . 0.749 ' HA ' ' HB1' ' A' 1596 ' ' ALA . 30.5 m -75.73 167.83 21.15 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.931 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1601 ' ' GLN . . . . . 0.854 ' HB2' ' HB2' ' A' 1619 ' ' HIS . 23.1 mt-30 -107.5 121.39 44.49 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.419 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1602 ' ' PRO . . . . . 0.446 ' HB3' ' CZ3' ' A' 1618 ' ' TRP . 1.3 Cg_endo -88.97 128.77 1.96 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.063 2.509 . . . . 0.0 110.658 174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1603 ' ' LEU . . . . . . . . . . . . . 44.8 tp -141.75 136.82 31.13 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.905 -0.497 . . . . 0.0 110.266 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1604 ' ' LEU . . . . . 0.54 HD22 ' HB2' ' A' 1520 ' ' ASP . 67.7 tp -79.63 124.84 28.91 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1605 ' ' LEU . . . . . . . . . . . . . 40.7 tp -95.49 -39.7 9.83 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1606 ' ' SER . . . . . . . . . . . . . 27.3 t -177.0 161.41 1.92 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1607 ' ' VAL . . . . . 0.518 HG23 HD23 ' A' 1614 ' ' LEU . 7.5 p -141.78 138.92 31.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1608 ' ' ASP . . . . . . . . . . . . . 18.3 t70 -118.0 119.87 36.09 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1609 ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -81.04 -5.81 58.06 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1610 ' ' HIS . . . . . . . . . . . . . 57.2 m80 -83.62 -51.2 7.49 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.599 0.714 . . . . 0.0 109.08 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1611 ' ' THR . . . . . 0.607 ' HA ' HD13 ' A' 1582 ' ' LEU . 0.2 OUTLIER -100.64 -9.3 22.05 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.917 -176.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1612 ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' 1584 ' ' TYR . 74.6 m 63.99 37.53 9.26 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.294 1.038 . . . . 0.0 110.534 -177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1613 ' ' THR . . . . . 0.51 ' OG1' ' HB ' ' A' 1611 ' ' THR . 6.1 m -87.53 113.97 23.71 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.414 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1614 ' ' LEU . . . . . 0.594 ' HB3' ' HE1' ' A' 1616 ' ' PHE . 60.0 mt -93.38 115.72 28.27 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1615 ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -100.74 112.47 24.88 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1616 ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' 1614 ' ' LEU . 54.7 m-85 -120.79 131.28 54.38 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.764 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1617 ' ' SER . . . . . . . . . . . . . 12.8 p -102.82 104.41 14.68 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-O 121.886 0.85 . . . . 0.0 109.096 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1618 ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' 1602 ' ' PRO . 17.2 t-105 -92.63 114.93 27.62 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -176.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1619 ' ' HIS . . . . . 0.854 ' HB2' ' HB2' ' A' 1601 ' ' GLN . 69.7 m-70 -88.45 102.06 14.53 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1620 ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' 1592 ' ' CYS . 9.5 t -135.92 153.66 51.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.056 0.455 . . . . 0.0 110.739 -177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1621 ' ' SER . . . . . . . . . . . . . 16.5 m -74.15 -26.09 60.11 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1622 ' ' LEU . . . . . . . . . . . . . 47.7 mt -70.13 -5.65 28.53 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.045 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1623 ' ' ALA . . . . . . . . . . . . . . . -77.1 -34.39 56.84 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.606 0.717 . . . . 0.0 109.527 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1624 ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' 1564 ' ' GLN . 1.8 m -98.58 171.81 7.9 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.54 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1625 ' ' GLU . . . . . 0.43 ' HB3' ' CD2' ' A' 1503 ' ' TYR . 40.9 mt-10 -66.76 107.46 2.17 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1626 ' ' GLN . . . . . 0.453 ' NE2' ' H ' ' A' 1626 ' ' GLN . 0.0 OUTLIER -80.28 154.67 27.7 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.541 -172.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 1627 ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.04 -50.43 66.22 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 124.379 1.05 . . . . 0.0 109.651 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1628 ' ' VAL . . . . . . . . . . . . . 62.9 t . . . . . 0 C--N 1.307 -1.245 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.362 . . . . . . . . 0 0 . 1 stop_ save_